Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,establishment of endothelial barrier (GO:0061028),-0.732038344450932,-2.3709515232231837,0.0,0.0,0.0,21/29,20.44%,TJP1;RAPGEF2;PECAM1;AFDN;RAPGEF6;EZR;F11R;RDX;RAP1A;RAPGEF1;TJP2;PPP1R16B;ICAM1;ROBO4;RAPGEF3;RAP2C;RAB1A;SOX18;RAP2B;MSN;RAB1B
prerank,cytoplasmic translation (GO:0002181),-0.5732341962234828,-2.342326452358888,0.0,0.0,0.0,59/91,28.30%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;DRG2;RPL36A;FTSJ1;RPL22L1;RPL34;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;RPL31;RPS23;RPL23A;RPL19;RPL36;GSPT2;RPL17;RPL23;UBA52;RPS11;GSPT1;RPL15;RPL38;RPL13A;RPS25;RPS12;RPL24;RPL18A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5708015843613318,-2.3115958923201756,0.0,0.0,0.0,48/91,18.25%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;SSR2;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;ARL6IP1;RPL31;RPS23;RPL23A;RPL19;RPL36
prerank,protein targeting to ER (GO:0045047),-0.5601106746322645,-2.3002242473398953,0.0,0.0,0.0,51/99,18.44%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;SPCS2;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;RPL31;RPS23;RPL23A;SGTB;CHMP4B;CHMP4A;RPL19;RPL36;EDEM1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5677555143106422,-2.2789314829118066,0.0,0.0,0.0,50/87,22.69%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;RPL31;RPS23;RPL23A;RPL19;RPL36;RPL17;RPL23;UBA52;ZFAND2B;RPS11
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.657322170951403,-2.2412739301586715,0.0,0.00020663908129143774,0.001,18/34,15.33%,FLT1;FOXC1;GAS1;NRP1;KDR;NOTCH1;VEGFD;ANXA1;VEGFC;SEMA6A;GAB1;MAPK14;ITGB1BP1;NR4A1;HSPB1;FLT4;RAMP2;ERN1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5189121747454105,-2.191242266075273,0.0,0.0012398344877486264,0.007,61/110,24.80%,RPS14;RPS9;SMG6;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;PPP2R1A;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;HELZ2;RPL36A;PYM1;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;SMG5;RPS8;RPL31;RPS23;PABPC1;EIF3E;RPL23A;RPL19;RPL36;GSPT2;RPL17;RPL23;RBM8A;NCBP2;UBA52;RPS11;GSPT1;MAGOH;RPL15;RPL38
prerank,collagen fibril organization (GO:0030199),0.6552058430238191,2.1865631935095178,0.0,0.012169862090780994,0.011,25/88,6.84%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;LOXL4;COL23A1;LUM;PLOD1;COL10A1;ADAMTS14;COL22A1;COL7A1;COLGALT1;DPT;LOXL3;LOXL2;COLGALT2;COL12A1;COL26A1;NF1;COL1A2;COL16A1
prerank,regulation of cell junction assembly (GO:1901888),-0.6840735320272773,-2.130197347651024,0.0,0.004959337950994506,0.028,12/27,6.08%,TJP1;RAPGEF2;ROCK2;PRKCH;MEF2C;PDLIM5;OCLN;F11R;CLDN5;RAP1A;RUNX1;RAPGEF1
prerank,dopamine metabolic process (GO:0042417),-0.7192915066440948,-2.0788979372606855,0.0,0.010745232227154762,0.066,6/18,8.47%,SNCAIP;MOXD1;TGFB2;MAOB;GCH1;MAOA
prerank,muscle cell development (GO:0055001),-0.6359386639543523,-2.071890556872254,0.0,0.011406477287287362,0.079,11/30,17.04%,NEBL;MYOF;IGF1;CXADR;ANK2;MYH11;DMD;HEY2;RAMP2;DYSF;SDC1
prerank,vascular process in circulatory system (GO:0003018),-0.7868486373317544,-2.060377918275545,0.002403846153846154,0.011468469011674795,0.096,10/13,18.40%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,regulation of tube diameter (GO:0035296),-0.7868486373317544,-2.060377918275545,0.002403846153846154,0.011468469011674795,0.096,10/13,18.40%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,extracellular structure organization (GO:0043062),0.552131553200411,2.0480847967533786,0.0,0.10344382777163844,0.156,47/204,7.01%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP28;MMP24;MMP25;TNR;VCAN;ST7;RECK;APLP1;SPP1;NF1;ADAM19;COLQ;COL1A2;COL16A1;TEX14;ADAMTS12
prerank,external encapsulating structure organization (GO:0045229),0.551343878565241,2.0414493610230364,0.0,0.07736555186282201,0.172,46/205,7.01%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP28;MMP24;MMP25;TNR;VCAN;ST7;RECK;APLP1;SPP1;NF1;ADAM19;COLQ;COL1A2;COL16A1;ADAMTS12
prerank,extracellular matrix organization (GO:0030198),0.5381718917934349,2.0390171171997467,0.0,0.059762715624370945,0.173,59/276,7.01%,LAMA1;COL15A1;SCUBE1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;FLRT2;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;LOXL4;GPM6B;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;PLOD1;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP28;MMP24;MMP25;TNR;COLGALT1;DPT;VCAN;ST7;LOXL3;LOXL2;COLGALT2;RECK;KLKB1;APLP1;SPP1;COL12A1;COL26A1;NF1;ADAM19;COLQ;COL1A2;COL16A1;ADAMTS12
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.7174957213290202,-2.0275970833975134,0.0,0.017834542246845626,0.151,10/17,11.42%,DOCK5;IGF1;DOCK4;ADAMTS1;IGFBP5;NRP1;VTN;S100A11;CCN4;MDK
prerank,embryonic appendage morphogenesis (GO:0035113),-0.807724402853947,-2.008142159601027,0.0,0.022051341960671995,0.198,6/12,7.73%,CYP26B1;MBNL1;TGFB2;SKI;MEGF8;LRP6
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7845952157207978,-1.9905761870602268,0.0,0.02595386861020458,0.247,10/11,20.44%,TJP1;RAPGEF2;AFDN;RAPGEF6;F11R;TJP2;RAP2C;RAB1A;RAP2B;RAB1B
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.7627301781890926,-1.9735540890684269,0.0,0.032313186336948574,0.309,9/14,13.36%,FOXC1;NRP1;KDR;VEGFD;VEGFC;GAB1;PIK3CD;MYO1C;FLT4
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.727324753235028,1.9654446765446378,0.0,0.17176891065273742,0.491,5/25,6.54%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,epithelial cell morphogenesis (GO:0003382),0.7961228649968747,1.963719454491344,0.0,0.1460383450893719,0.497,4/17,6.13%,COL15A1;COL18A1;COL22A1;SIPA1L3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6627920285545212,-1.9545825510914623,0.0,0.04054988089342566,0.385,9/20,15.79%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,positive regulation of wound healing (GO:0090303),-0.5700060107842904,-1.9499974057938454,0.0,0.04057013962688561,0.401,11/36,5.01%,OCLN;PLPP3;MYLK;ITGB1;THBS1;FOXC2;ST3GAL4;ACTG1;VTN;KANK1;ANXA1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5605797744360781,-1.943103351439649,0.0,0.04248064481707135,0.431,17/35,18.22%,PLXNA2;SEMA3D;SEMA3C;PLXNA4;SEMA7A;NRP2;NRP1;RAC1;SEMA6A;SEMA4B;PLXNB1;SEMA5B;FLNA;MET;SEMA6C;SEMA3G;SEMA6B
prerank,cell junction organization (GO:0034330),-0.4925143918168544,-1.9413744251445724,0.0,0.04147246361519155,0.438,17/71,9.04%,SDK1;TJP1;APBB2;LIMS2;OCLN;CXADR;SLC8A3;ACTB;APP;TGFB2;ACTG1;DVL1;CDC42;TJP2;MAPT;SMAD3;PPFIBP1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.5759932188617471,-1.9389552226163689,0.0,0.040855498358192834,0.446,21/36,22.05%,CAV1;NPR3;EGFR;NOS3;ZDHHC21;NOSTRIN;SCARB1;CALM1;APOE;GCH1;PIK3CB;TERT;DDAH1;NOS1AP;DHFR;AKT1;WASL;NOSIP;NUS1;LYPLA1;DDAH2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7725410585704514,-1.9320881811240909,0.0,0.043168782618883995,0.473,6/12,2.44%,DOCK5;MEF2C;DOCK4;ADAMTS1;IGFBP5;TPM1
prerank,icosanoid secretion (GO:0032309),-0.7564901263811101,-1.9233433375287812,0.0,0.04576606435211234,0.501,4/12,6.29%,ABCC4;ANXA1;ACE;BDKRB2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.5978025601815673,-1.9136277818836982,0.0,0.05036827606478795,0.557,13/27,19.40%,HMBOX1;BMPR2;SMG6;DACH1;PDGFA;ACVRL1;NIBAN2;SMG5;ATM;CDKN1A;PARP4;HGF;RGCC
prerank,carbohydrate biosynthetic process (GO:0016051),-0.6389697630528134,-1.8982385440896012,0.0,0.06005758258654346,0.633,9/21,15.79%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.5376902785167474,-1.893656514107962,0.0,0.0607042039578462,0.65,17/44,11.40%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6670727006711562,1.8864437653579436,0.0029717682020802376,0.4078145623073957,0.862,5/32,6.54%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,negative regulation of hemostasis (GO:1900047),-0.7202925465324256,-1.8736541584667912,0.002352941176470588,0.07549214436513857,0.75,7/12,15.37%,THBD;VTN;CD34;APOE;SERPINE1;SERPINE2;EDN1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.41665662991104907,-1.8654171193236293,0.0,0.08103203973499952,0.779,56/168,13.28%,DDX5;CSDE1;RPS14;RPS9;SMG6;RPS16;TUT7;RPLP1;RPL13;SAMD4A;CNOT10;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;PPP2R1A;RPL41;RPS18;RPS20;PARN;RPS19;PAN3;RPS24;NBAS;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;ERI1;CNOT8;RPL10A;RPS5;RPL11;HELZ2;RPL36A;RC3H1;PYM1;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;SMG5;POLR2G;ATM;RPS8
prerank,regulation of cellular component biogenesis (GO:0044087),-0.5208022906461194,-1.8513247030927829,0.0,0.09350062154159468,0.826,15/39,12.98%,SNCAIP;TJP1;RAPGEF2;ROCK2;EZR;TIE1;RDX;RAP1A;HSPA8;NOTCH1;RAPGEF1;APOE;PARP10;NCLN;VPS11
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.6616213495530363,-1.8506721484257351,0.0026041666666666665,0.09121049048204062,0.83,5/17,3.73%,ROCK2;VCL;F11R;CLDN5;ZDHHC21
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7307241193677055,-1.8505728151048162,0.002288329519450801,0.0883082112564183,0.83,5/12,9.74%,CAV1;CAMK2D;SRI;CALM1;GJD3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.5080844141322297,-1.844608381135902,0.0034129692832764505,0.09120532450500832,0.851,19/51,14.89%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A;RAPGEF3;CX3CL1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.4937873542742073,1.8439510467077214,0.0,0.615338651965114,0.962,72/224,18.14%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;SLC18A3;CHRNB4;NRXN2;CEL;GRIN2B;NRXN1;NOVA1;GABRA1;ASIC2;GRIK2;KCNQ3;GRIA4;GRIA1;GABRD;SLC12A6;SCN2B;PCDHB16;PDYN;HTR2B;DLG2;GRIK4;CAMKK2;KCNIP2;GRIN2A;GRIK1;PCDHB4;PTCHD1;PCDHB11;PRKACB;HTR5A;LPAR3;GABRG3;HTR1A;GPR176;PRKACA;NPY;CACNB4;HTR2C;MBP;CAMK4;GLRA3;PLP1;GABRG2;KCND2;GRM5;GLRA1;DLG4;SYT5;CBLN1;HTR4;GLRA2;GABRB1;ATXN3;PRKAR1A;SYN2;APBA2;GLRB;GABBR2;GRM7;HTR6;CDK5;UNC13C;AMPH;GRM1;GRIA2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.7992975605900201,1.843704688517293,0.0071301247771836,0.54909258719119,0.963,5/12,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,lipid catabolic process (GO:0016042),0.7348357785680513,1.8417023021480368,0.006993006993006993,0.5076571043582928,0.968,5/18,5.09%,HSD11B1;CEL;ACADL;LIPH;LIPC
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.6473601193777669,1.8388674739140058,0.0030816640986132513,0.4758099977181322,0.973,9/32,14.70%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;TRPC3;P2RX4;AKAP6;F2R
prerank,genitalia development (GO:0048806),0.7966591023688913,1.8321641412889422,0.0017513134851138354,0.47064044049883397,0.982,4/12,4.31%,CHD7;WNT5A;DNAJC19;TBX3
prerank,negative regulation of vascular permeability (GO:0043116),-0.7266699774312357,-1.8268753199833183,0.004878048780487805,0.10933085937419705,0.905,7/12,14.58%,PTPRJ;SLIT2;CLDN5;PDE3A;CEACAM1;DDAH1;RAMP2
prerank,regulation of tissue remodeling (GO:0034103),-0.6402232518424685,-1.8257870861044134,0.005115089514066497,0.10753740895207939,0.906,7/18,13.36%,LEPR;IL18;CST3;RUNX1;MDK;CEACAM1;FLT4
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7429886835575299,1.8254915834616194,0.005136986301369863,0.470411976970573,0.987,7/16,12.41%,APOD;PPARA;ABCD2;ADCY7;APPL2;PYCARD;PDCD4
prerank,organophosphate ester transport (GO:0015748),-0.6008242293149019,-1.8208798359375207,0.002638522427440633,0.11006187866957091,0.921,11/24,17.78%,PITPNC1;OSBPL8;EPG5;PLTP;SCARB1;PITPNA;ABCA3;TNFAIP8L3;PRELID2;PRELID1;PCTP
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6523185331209859,-1.8178145119674172,0.005333333333333333,0.11089630695973826,0.926,7/19,4.27%,TJP1;ROCK2;PRKCH;OCLN;F11R;CLDN5;RUNX1
prerank,organic anion transport (GO:0015711),-0.4541950576045123,-1.8176075627029848,0.0,0.10803314563517759,0.926,29/76,26.05%,ABCG2;ABCC4;SLC4A10;LRRC8C;SLC16A2;SLC26A7;SLCO2A1;SLCO1C1;SLC22A6;SLC39A8;SLC4A3;ABCC6;LRRC8D;CA4;SLC4A8;CYB5R1;SLC35A2;SLC26A6;SLC52A3;SLCO5A1;SLC35C2;SLC35B2;CFTR;SLC4A7;SLC17A9;CYB5R4;SLCO4A1;SLC25A4;SLC52A2
prerank,atrial septum morphogenesis (GO:0060413),-0.7621610239160612,-1.8153195340978356,0.002207505518763797,0.10845289045464299,0.933,6/10,12.73%,NOTCH2;BMPR2;TGFB2;SOX4;ACVR1;HEY2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.7091511357166488,1.8103921852901768,0.0064516129032258064,0.5150459491991242,0.991,5/19,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,myotube cell development (GO:0014904),-0.7536764606058818,-1.8098046869199358,0.00425531914893617,0.11234807896676013,0.949,4/10,5.87%,IGF1;SKI;CAV2;SIX1
prerank,muscle contraction (GO:0006936),-0.4235681733720197,-1.8052266585439805,0.0,0.11493265701429767,0.958,29/126,13.05%,SORBS1;MYOF;TMOD3;ROCK2;SNTB1;SORBS3;ACTN2;VIM;CALD1;VCL;MYLK;EDNRA;TPM1;SNTA1;MYL6;CRYAB;BDKRB2;CALM1;ITGA1;MYL9;MYH11;DMD;GJC1;LMOD1;KCNJ12;ACTA2;DTNA;NOS1;TMOD1
prerank,myelin maintenance (GO:0043217),0.8207373910741856,1.7940318093144365,0.001763668430335097,0.573432311372752,0.997,7/10,15.09%,EPB41L3;PTEN;ABCD2;PRX;DEGS1;MYRF;CLU
prerank,cellular response to sterol (GO:0036315),0.756177668102304,1.7923089051535974,0.005235602094240838,0.5469918371874242,0.997,3/13,2.27%,RORA;GRAMD1B;GPLD1
prerank,translation (GO:0006412),-0.3863698826073489,-1.7907594758920424,0.0,0.1302733408102703,0.969,102/208,29.75%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;EEF1G;RPL35A;RPS15A;RPL10A;RPS5;RPL11;ABCF1;DRG2;RPL36A;FTSJ1;EEF1A1;RPL22L1;RPL34;KARS1;RPLP2;RPS29;RPL32;RPL4;RPLP0;EEF2K;IARS2;RPL30;RPL26;RPS4X;RPS21;GARS1;RPL29;RPS8;EEFSEC;EEF1D;MRPS7;RPL31;APEH;RPS23;NOA1;RPL23A;GTPBP1;SRBD1;MRPS17;AGO2;RPL19;RPL36;MRPL16;EEF1E1;GSPT2;MRPS18A;MRPL2;RARS1;MRPS18B;RPL17;RPL23;GATC;UBA52;MRPL24;RPS11;MRPL57;MRPL55;QARS1;PTCD3;LARS2;GSPT1;RPL15;MRPS34;RPL38;HARS2;TRMT112;MRPL36;MRPL35;RPL13A;RPS25;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A;FASTKD2;MRPS2;MRPL18;GTPBP2;EIF4EBP2
prerank,chemical synaptic transmission (GO:0007268),0.4687486089461098,1.783218954808809,0.0,0.5678416744458946,0.998,82/284,16.25%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;PTEN;SLC18A3;CHRNB4;NRXN2;GRID2;CEL;PTPRN2;GRIN2B;NRXN1;NOVA1;GRID1;GABRA1;ASIC2;GRIK2;GRIK5;KCNQ3;GRIA4;GRIA1;GABRD;SLC12A6;SCN2B;PCDHB16;PDYN;VAMP2;HTR2B;CHAT;DLG2;GRIK4;CAMKK2;FCHSD2;KCNIP2;NAPB;GRIN2A;GRIK1;PCDHB4;PTCHD1;PCDHB11;PRKACB;SNPH;HTR5A;LPAR3;GABRG3;HTR1A;GPR176;PRKACA;NPY;CACNB4;HTR2C;MBP;CAMK4;GLRA3;ERC2;PLP1;GABRG2;KCND2;GRM5;SHISA6;GLRA1;RIMS1;DLG4;SYT5;DNAJC5;CBLN1;HTR4;GLRA2;UNC13A;GABRB1;ATXN3;PRKAR1A;SYN2;APBA2;GLRB;GABBR2;PDZD11;GRM7
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.4365836575739113,-1.7781020167124304,0.0,0.14526727414788074,0.983,33/92,13.99%,ANXA3;DOCK5;ROCK2;FOXP1;TEK;DOCK1;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;KDR;TGFB2;RAC1;SCARB1;PPM1F;AAMP;FGF1;ITGB1BP1;ATOH8;HYAL1;PIK3CB;ENPP2;PIK3CD;ETS1;MAPRE2;CTSH;ITGB3;PLCG2;FLT4;PTK2B;RRAS
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7429112614410045,-1.775555675512501,0.002320185614849188,0.14586796915163489,0.984,5/10,6.68%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.724283787423446,-1.7751013891943377,0.004291845493562232,0.14328541750458557,0.984,6/11,18.69%,NOS3;CALM1;GCH1;DHFR;AKT1;PRKG2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5736742625947555,-1.7739520296601112,0.002506265664160401,0.14186461727594837,0.987,11/24,26.02%,PECAM1;ITGB1;EZR;F11R;ICAM1;NT5E;VCAM1;MSN;GFUS;CERCAM;ITGB2
prerank,regulation of stress fiber assembly (GO:0051492),-0.4430289638285934,-1.7734130159436248,0.0,0.13945442694807375,0.987,27/74,11.67%,PHLDB2;TJP1;ROCK2;ARHGEF18;PPM1E;SORBS3;WASF2;CCN2;TPM1;F11R;NRP1;LIMCH1;S100A10;ACTG1;RAC1;CGNL1;CDC42;PPM1F;ARHGEF15;TMEFF2;RHOC;RHPN2;ITGB1BP1;SFRP1;FHOD1;CCDC88A;ARHGAP28
prerank,platelet degranulation (GO:0002576),-0.41766268511235227,-1.7698136585092608,0.0,0.14229079206204448,0.988,37/118,18.27%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;LHFPL2;ANXA5;APP;PCDH7;SPARC;ECM1;SRGN;TGFB2;VEGFD;VEGFC;CD109;PDGFA;CALM1;ENDOD1;SERPINE1;TAGLN2;CD63;LGALS3BP;ITGB3;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;ALDOA;LAMP2;EGF
prerank,neuron cell-cell adhesion (GO:0007158),0.7308707924771243,1.7633362512561122,0.010256410256410256,0.6594423287683113,0.999,7/14,8.56%,ASTN2;NRXN2;CEL;NRXN1;CNTN4;ASTN1;NRXN3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7577631674087392,1.7601656301620687,0.008726003490401396,0.6468327452611341,0.999,2/12,2.01%,APOD;CBLB
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5565374388031127,1.7588356743435087,0.001422475106685633,0.6222276631843596,0.999,11/55,6.00%,CEMIP;DCN;LUM;HSPG2;BGN;GPC4;VCAN;GPC5;HMMR;CEMIP2;SLC9A1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5983650460703663,1.7474073984322813,0.01188707280832095,0.6631333016813317,1.0,17/37,18.03%,DYNLL1;TRAF3IP1;WDR35;DYNC2LI1;IFT81;KIFAP3;TTC21B;IFT74;SSX2IP;TNPO1;IFT88;DYNLL2;TRIP11;KIF3C;IFT43;CLUAP1;PCM1
prerank,arachidonate transport (GO:1903963),-0.7139618513228629,-1.743767250883721,0.0045871559633027525,0.1805603858076367,0.995,3/10,6.29%,ANXA1;ACE;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),-0.7139618513228629,-1.743767250883721,0.0045871559633027525,0.1805603858076367,0.995,3/10,6.29%,ANXA1;ACE;BDKRB2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6371738145480377,1.7402094998827575,0.004846526655896607,0.6794181125031791,1.0,8/26,10.44%,PPARA;SLC30A10;ABCD2;TLR6;ADGRB1;TLR4;CYBA;SLC25A33
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5024301290248872,-1.738392056142052,0.0058823529411764705,0.18723980433979756,0.995,12/38,10.45%,BCL2L1;NOS3;THBS1;TNFSF10;FAS;GSK3B;CASP8;MADD;GPX1;SFRP1;SERPINE1;ICAM1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.37947097107471944,-1.7362089855144,0.0,0.1875067334118658,0.995,49/182,12.73%,IGF1;PICALM;SLC24A3;ROCK2;FOXP1;ITGB8;MEF2C;OCLN;ROBO1;NOTCH2;APP;KLF4;NFKB1;KDM4A;CLDN5;KDR;RIN3;WWP2;NOTCH1;RUNX1;TGFB2;WNT4;SMO;CD34;PRKAA2;ADAM10;DICER1;APOE;XDH;CELF1;ACVRL1;MAPT;ATOH8;CITED2;SFRP1;GATA2;TNRC6A;PARP10;OPTN;VHL;PARP9;SLC7A5;TARDBP;MAP2K2;TLE5;TERT;TNRC6C;PTRH2;HEY2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.7437066236393511,1.7355011293329488,0.010327022375215147,0.6805674120145756,1.0,7/13,15.76%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81;BRSK2
prerank,inner ear morphogenesis (GO:0042472),0.6578344221164483,1.7343685691884165,0.01288244766505636,0.6593095227335904,1.0,4/22,7.24%,TBX18;CHD7;ZIC1;MYO6
prerank,regulation of glucose metabolic process (GO:0010906),0.596370313259808,1.732327756342566,0.011922503725782414,0.6461501349513805,1.0,7/34,7.56%,RORA;OGT;GPLD1;PDK1;IRS1;IRS2;DGKQ
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5302291170729287,-1.7321137093527312,0.01694915254237288,0.1913636845898168,0.995,19/30,35.70%,CAV1;INPP5F;PPP2R1A;MVP;SFRP1;PTPN2;PRKCZ;PRKCD;DMTN;SOCS3;HYAL2;PTPN6;NTF3;SOCS1;SAMSN1;SH3BP5L;PPP2CA;NF2;SH3BP5
prerank,positive regulation of angiogenesis (GO:0045766),-0.412035117974815,-1.7278272492877356,0.0,0.19631492492804667,0.996,40/108,15.24%,FLT1;ANXA3;TJP1;TEK;ITGB8;BMPER;ITGB1;NOS3;THBS1;KLF4;FOXC2;TIE1;ECM1;KDR;RUNX1;CYP1B1;VEGFD;VEGFC;CD34;GAB1;HIPK1;HK2;FGF1;HYAL1;GATA2;SERPINE1;PIK3CD;ETS1;CTSH;MDK;HSPB1;PKM;HIPK2;SMAD1;GATA6;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.5364423280209877,-1.7266608230663558,0.006153846153846154,0.1947458541682194,0.996,6/31,5.70%,RANBP3L;CRIM1;SMAD6;NOTCH1;SKI;CDK6
prerank,positive regulation of leukocyte migration (GO:0002687),0.6310336899699844,1.7265789028606222,0.017241379310344827,0.6544309905630417,1.0,3/27,1.27%,PTN;XCL1;EDN3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.585743057630544,-1.726161898934511,0.002564102564102564,0.1887426608581614,0.996,5/21,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.585743057630544,-1.726161898934511,0.002564102564102564,0.1887426608581614,0.996,5/21,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6715032049665589,1.7254210735033,0.00825082508250825,0.6367284724057557,1.0,9/21,12.86%,EPHA7;GRIN2B;NGFR;SOX2;DELE1;BIRC2;PYCARD;FYN;PSMB9
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.530691172820789,-1.724493768746586,0.008595988538681949,0.18886812030037406,0.996,15/30,26.33%,BCL2L1;NOS3;TNFSF10;FAS;GSK3B;CASP8;GPX1;SERPINE1;ICAM1;TRADD;TNFAIP3;CFLAR;RFFL;BRCA1;PARK7
prerank,peptide biosynthetic process (GO:0043043),-0.3900192000702481,-1.7237354918586076,0.0,0.18687298434307745,0.996,76/153,28.65%,RPS14;RPS9;GGTA1;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;ABCF1;RPL36A;EEF1A1;DMD;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;FURIN;MRPS7;RPL31;PCSK5;RPS23;RPL23A;SRBD1;MRPS17;AGO2;RPL19;RPL36;GSPT2;MRPS18A;MRPS18B;RPL17;RPL23;MRPL24;RPS11;MRPL55;GSPT1;RPL15;RPL38;HARS2;MRPL36;MRPL35;RPL13A;RPS25;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A;GGT1
prerank,oogenesis (GO:0048477),0.6971705413206655,1.722137132843161,0.013029315960912053,0.632398190788798,1.0,2/15,2.60%,PTN;NANOS3
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.7885319083109398,1.7220858708793059,0.010771992818671455,0.6108611318916892,1.0,2/10,0.48%,APOD;LRP1
prerank,blood circulation (GO:0008015),-0.47261508773040617,-1.7211447132294124,0.009900990099009901,0.18801354511672813,0.997,19/49,14.82%,MYOF;ROCK2;NOS3;TBC1D8;GUCY1A1;GCLC;COL4A3;ACE;CYB5R3;BDKRB2;ELN;ACVRL1;ITGB1BP1;NPR1;GPX1;ADCY6;SCPEP1;AGTR1;F5
prerank,hyaluronan catabolic process (GO:0030214),0.6807105875101955,1.718661241209306,0.013311148086522463,0.610231656266304,1.0,4/18,6.00%,CEMIP;HMMR;CEMIP2;SLC9A1
prerank,steroid catabolic process (GO:0006706),0.7864992700208816,1.7182958414443446,0.0051813471502590676,0.5925096451110654,1.0,2/10,5.26%,HSD11B1;SPP1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.627646492118032,-1.7182203801856002,0.009950248756218905,0.18971534053366898,0.997,7/16,16.72%,ROCK2;GSN;RUFY3;KANK1;PTK2B;CDH5;BCAS3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5073884192949719,-1.7175019987231277,0.0,0.18808898933812768,0.997,15/38,15.37%,ROCK2;CAV1;KLF4;SIRPA;INSR;RAC1;CD34;KLF2;SMAD3;CX3CR1;ASS1;DDAH1;NOS1AP;PTGS2;EDN1
prerank,lymphocyte chemotaxis (GO:0048247),0.6075726991313627,1.7105121983743128,0.006033182503770739,0.6159091142506192,1.0,7/34,10.56%,CYP7B1;XCL1;CXCL10;MSMP;CCL15;GPR183;CCL25
prerank,camera-type eye development (GO:0043010),0.6428221067116244,1.7103673035253006,0.011111111111111112,0.5979827690970115,1.0,2/25,1.20%,LAMA1;TENM3
prerank,regulation of steroid metabolic process (GO:0019218),0.6529123600659404,1.7099128718503358,0.009966777408637873,0.5827216318762193,1.0,4/23,7.56%,RORA;NR1H4;ACADL;DGKQ
prerank,hyaluronan metabolic process (GO:0030212),0.6398992443053354,1.7093858436350244,0.012841091492776886,0.5683077231862259,1.0,4/23,6.00%,CEMIP;HMMR;CEMIP2;SLC9A1
prerank,cardiac conduction system development (GO:0003161),0.6351007609387576,1.7070955616022547,0.00974025974025974,0.5643532079082011,1.0,5/24,6.11%,TBX18;MSC;SMAD5;GJA1;CACNA1G
prerank,response to ketone (GO:1901654),-0.548210622981752,-1.7070209848523943,0.007159904534606206,0.20525259971374035,1.0,9/24,19.16%,CAV1;SLIT2;THBS1;TGFB2;WBP2;ABHD2;ABCB4;CATSPER2;TGFBR3
prerank,diol metabolic process (GO:0034311),-0.5870111462882838,-1.7057263270938778,0.009685230024213076,0.20512372802863385,1.0,8/19,21.50%,PLPP3;NOS3;DEGS2;CALM1;GCH1;AKT1;PRKG2;SPHK2
prerank,embryonic digit morphogenesis (GO:0042733),0.6937895738519991,1.704705956501907,0.013888888888888888,0.5609648593466752,1.0,8/18,11.47%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3;MSX1
prerank,triglyceride catabolic process (GO:0019433),0.6709801640970824,1.6951034823328301,0.014950166112956811,0.5936010364542781,1.0,5/19,12.16%,LIPH;LIPC;FABP5;FABP4;FABP3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7477137099522458,1.6905467670175836,0.01926444833625219,0.6013160063829481,1.0,5/11,14.94%,PPARA;SLC30A10;ABCD2;FYN;ABCB7
prerank,ribosomal small subunit assembly (GO:0000028),-0.5949757266333009,-1.6892339824845226,0.013986013986013986,0.23742830440386195,1.0,7/16,14.65%,RPS14;PRKDC;RPS19;RPS27;RPS15;RPS5;MRPS7
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5874684552609531,-1.687214994317892,0.005128205128205128,0.2379337753873287,1.0,6/20,10.64%,PICALM;BCL2L1;RHOQ;DAB2;PKDCC;TMEM59
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6404611646256875,-1.686759248732196,0.019464720194647202,0.23528677210684157,1.0,7/13,23.18%,ACTN2;CAV1;CAB39;NOS1;PTK2B;STK39;CASQ2
prerank,cAMP biosynthetic process (GO:0006171),0.7644837015025547,1.6865711529723562,0.008787346221441126,0.6066241614322512,1.0,6/10,8.88%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,histone H3-K9 demethylation (GO:0033169),-0.6767911897867886,-1.6860061252004828,0.009070294784580499,0.2332924386126408,1.0,7/11,25.65%,KDM4A;KDM4C;PHF8;HR;KDM4B;KDM3B;KDM1A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7270669359264735,1.6846727057586817,0.009933774834437087,0.6013904846777053,1.0,6/13,12.93%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81
prerank,phospholipid transport (GO:0015914),-0.4601323556317912,-1.6766643231214626,0.003424657534246575,0.24896970485599254,1.0,18/52,18.60%,PITPNC1;ATP10A;OSBPL8;ATP8A1;PLTP;ATP11B;SCARB1;PITPNA;APOE;ABCA3;ATP8B1;TNFAIP8L3;MFSD2A;ABCB4;PRELID2;PRELID1;PCTP;ATP8A2
prerank,central nervous system development (GO:0007417),0.4450890750058214,1.6756669054931619,0.0,0.6336193164067506,1.0,70/250,17.24%,APOD;CHST8;ROBO2;CHD7;ADGRL3;EPHA7;COL4A1;ZFHX3;MEIS1;HSPG2;MARCKS;PTEN;SH3GL3;CNTNAP2;ADGRA2;GRIN2B;ZIC4;ASIC2;MEIS2;VCAN;AFF2;POU3F3;LOXL3;TBX3;SOX6;ZIC1;ZBTB16;ADORA2A;NF1;CNTN4;GRIN2A;GRIK1;IER3IP1;SZT2;HAPLN2;RPS6KA6;NPAS2;C1QA;DSCAML1;RELN;DHX30;MBP;ABCB6;CNTN6;AMIGO3;AHI1;SOX10;ALDH5A1;SMARCA1;PLXNB2;SOX9;ANKLE2;ATN1;EML1;ADAM22;MYRF;ARNT2;BPTF;HAPLN3;BAG6;CHD8;PBX2;HAPLN1;TBC1D23;NRCAM;NDUFS4;SMG9;NHEJ1;ZIC5;CDK5
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6680373315505498,1.6704795834400494,0.025041736227045076,0.6454070051665681,1.0,7/17,13.23%,KCNS2;ANK3;VAMP2;KCNG1;KCNAB1;KCNE4;AKAP6
prerank,basement membrane organization (GO:0071711),0.7113637766894378,1.6702932779111066,0.017064846416382253,0.6317659901607054,1.0,4/14,0.96%,FLRT2;LAMB1;COL4A1;NID1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5878915450765227,1.6690479526933146,0.015174506828528073,0.6237537252560608,1.0,6/34,7.16%,RORA;ENPP1;WNT5A;LRP3;RUNX1T1;ZFP36L2
prerank,positive regulation of vasculature development (GO:1904018),-0.4014107244111019,-1.668277793670752,0.0,0.26480349052103636,1.0,34/94,16.00%,FLT1;ANXA3;TEK;ITGB8;ITGB1;NOS3;THBS1;TIE1;ECM1;KDR;RUNX1;CYP1B1;VEGFD;VEGFC;CD34;GAB1;HIPK1;HK2;FGF1;HYAL1;GATA2;SERPINE1;PIK3CD;ETS1;CTSH;HSPB1;HIPK2;GATA6;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6;SIRT1
prerank,positive regulation of cell migration (GO:0030335),-0.3582213086074539,-1.6664635276247248,0.0,0.26484635850436017,1.0,67/253,11.42%,FLT1;PDGFD;FN1;DOCK5;IGF1;TJP1;RAPGEF2;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PECAM1;PODXL;EGFR;MYLK;DOCK1;IGF1R;ITGB1;FER;THBS1;SEMA7A;ITGA6;NRP1;BMPR2;RDX;KDR;INSR;SOD2;NOTCH1;RUFY3;TGFB2;ACTG1;VTN;S100A11;APC;SMO;DAB2;NEDD9;ADAM10;SEMA6A;GAB1;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;RHOC;FGF1;SMURF2;PDGFC;HYAL1;ENPP2;PIK3CD;CCN4;FAM107A;SPAG9;EPHB2;ELP5;SEMA5B;CTSH;MYO1C;CD151;MDK
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5564220379066986,1.6641925571356757,0.022727272727272728,0.6354784509142597,1.0,8/40,4.84%,PDGFRA;NTRK3;NTRK2;TXK;C5AR1;FGFR1;ARHGAP6;HTR2B
prerank,catecholamine biosynthetic process (GO:0042423),-0.6725675625267982,-1.6638365439490397,0.016241299303944315,0.2669311264750071,1.0,3/11,8.26%,MOXD1;TGFB2;GCH1
prerank,apical junction assembly (GO:0043297),-0.452403205489339,-1.66207094022345,0.007142857142857143,0.2678042493537033,1.0,20/53,19.75%,VCL;OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RHOC;RAB13;ARL2;RAMP2;CDH5;CTNNA1;PAK2;PKN2;DLG1;CLDN11;PDCD6IP
prerank,response to sterol (GO:0036314),0.7178878256595225,1.66132334329545,0.02154398563734291,0.6375491126615678,1.0,1/11,0.04%,RORA
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.6092766304077143,-1.6595954378205657,0.012224938875305624,0.2699442376476256,1.0,12/17,31.75%,ATP5F1B;ATP5F1C;ATP5MG;VPS9D1;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,integrated stress response signaling (GO:0140467),0.6899582213621795,1.6584573248487193,0.023688663282571912,0.6395697166637224,1.0,10/14,23.89%,OMA1;HERPUD1;EIF2AK1;EIF2S1;HSPA5;IMPACT;EIF2AK3;CCL2;DDIT3;ATF4
prerank,actin filament bundle organization (GO:0061572),-0.5048301994413774,-1.6582699072824263,0.005633802816901409,0.26926189260281314,1.0,16/33,23.71%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;LIMA1;SHROOM1;BAIAP2;RFLNA;RFLNB;DMTN;ADD2;CORO1B
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.6257026440076258,-1.6565548661610052,0.026829268292682926,0.2696722666485779,1.0,9/15,23.08%,LEMD3;MAGI2;SKI;ACVR1;ACVR2B;CSNK2B;SMAD7;ACVR2A;FSTL3
prerank,polyol metabolic process (GO:0019751),-0.46500425446893795,-1.6558824688742853,0.011834319526627219,0.26765742684857513,1.0,17/46,15.70%,PLCE1;PLCB1;ITPKB;INPP4B;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;PLCH1;ITPK1;INPP5B
prerank,cochlea morphogenesis (GO:0090103),0.7615463036702591,1.6549373968965726,0.018148820326678767,0.6444172601277253,1.0,1/10,0.03%,TBX18
prerank,regulation of small molecule metabolic process (GO:0062012),0.603707131570224,1.6544915276225707,0.016233766233766232,0.6336673335496937,1.0,6/28,7.56%,RORA;PPARA;NR1H4;PDK1;ACADL;DGKQ
prerank,negative regulation of coagulation (GO:0050819),-0.6193237828292988,-1.6517697719070288,0.009456264775413711,0.2735847763809989,1.0,9/14,24.60%,THBD;VTN;CD34;APOE;SERPINE1;SERPINE2;EDN1;TFPI;PROCR
prerank,actomyosin structure organization (GO:0031032),-0.42777297809776277,-1.6514068666097854,0.0,0.27084025431729286,1.0,32/75,24.89%,SORBS1;TJP1;TMOD3;FAM171A1;ROCK2;EPB41L5;ACTN2;PGM5;ITGB1;TPM1;F11R;PHACTR1;CDC42BPB;FRMD5;ZYX;LMOD1;CSRP2;TMOD1;MYH10;CDC42BPG;EPB41L1;CUL3;FHDC1;TNNT3;TNFAIP1;MYO18A;SIX4;MYH9;EPB41;EPB41L4A;SRC;MYOM2
prerank,response to laminar fluid shear stress (GO:0034616),-0.701290391596378,-1.6495047909059777,0.021834061135371178,0.2721672112219833,1.0,6/10,15.15%,SMAD6;KLF4;SREBF2;KLF2;ASS1;MAP2K5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.708752439165901,1.6469778942867657,0.021164021164021163,0.6600530944894873,1.0,2/13,3.16%,ENPP1;TPST1
prerank,cranial nerve development (GO:0021545),0.7361279802330118,1.6453136785092348,0.015517241379310345,0.6561026749161709,1.0,3/11,7.28%,CHD7;SALL1;TMEM126A
prerank,tight junction assembly (GO:0120192),-0.45047272677544475,-1.6438703270961788,0.013559322033898305,0.2819073666518439,1.0,19/49,19.75%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;ACTG1;APC;LSR;RAB13;ARL2;CLDN12;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5642252027588148,-1.6434777423792781,0.012594458438287154,0.2795291038921656,1.0,5/20,10.64%,PICALM;BCL2L1;RHOQ;DAB2;TMEM59
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.6080752588912357,1.6414346164252784,0.01929260450160772,0.6642087669681372,1.0,3/24,4.82%,CEMIP;ANK3;MTCL1
prerank,negative regulation of viral life cycle (GO:1903901),-0.614169064442991,-1.6409839851081436,0.018604651162790697,0.2816541077778221,1.0,9/15,20.88%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;PPIA;SNX3;IFITM2
prerank,inositol phosphate metabolic process (GO:0043647),-0.46187203125446147,-1.6357489049530793,0.011869436201780416,0.290673967434946,1.0,17/46,15.70%,PLCE1;PLCB1;ITPKB;INPP4B;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;PLCH1;ITPK1;INPP5B
prerank,actin crosslink formation (GO:0051764),-0.6574518849583785,-1.6355025293530403,0.026066350710900472,0.2877006408951932,1.0,6/12,19.59%,BAIAP2L1;DPYSL3;FLNA;BAIAP2;GAS2L3;GAS2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6917601588999527,-1.632944801872929,0.02127659574468085,0.2907484805210985,1.0,6/10,17.06%,ATP5F1C;ATP5MG;VPS9D1;ATP5MC2;ATP5F1D;ATP5MC1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6823042339551102,1.631497021610015,0.017064846416382253,0.7060934667829718,1.0,5/15,6.25%,PPARA;GPLD1;PPARD;IRS1;IRS2
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4083105907422497,-1.6293317436011554,0.0044444444444444444,0.29642135933255237,1.0,37/84,18.27%,ANXA3;ROCK2;FOXP1;TEK;PLPP3;NOS3;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;ATP5F1B;KDR;RAC1;MAPK14;SCARB1;AAMP;FGF1;ITGB1BP1;ATOH8;PIK3CB;GATA2;PIK3CD;ETS1;HSPB1;ITGB3;FLT4;PTK2B;RRAS;TMSB4X;EDN1;MET;SIRT1;BCAS3;AKT1;EGF
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.5835849568665058,1.6290201166323228,0.0319634703196347,0.7079856783851098,1.0,7/30,4.67%,VAMP5;GGA2;RAB34;SEC16A;SPTBN1;ANK3;VAMP2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5688496320594487,1.6282611160262497,0.023564064801178203,0.6992237728051401,1.0,7/32,3.78%,APOD;DLC1;CASK;PTEN;CDKN2A;MAP4K4;ARHGAP6
prerank,cilium movement (GO:0003341),0.5288051310229813,1.6262481929494759,0.01585014409221902,0.6978607635014263,1.0,13/47,15.25%,CFAP251;CCDC63;ODAD4;ADCY10;DNAAF4;RSPH9;DNAI4;DNAH9;SPA17;CABYR;GAS8;ZBBX;CCDC39
prerank,muscle cell differentiation (GO:0042692),0.5825570781212825,1.6251864196092891,0.015698587127158554,0.6917937122983608,1.0,4/32,2.79%,TBX18;RORA;TMEM204;GLMN
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5467779992229423,1.6226301333711772,0.018404907975460124,0.6929896651814577,1.0,9/37,12.41%,APOD;PPARA;ABCD2;TLR6;ADCY7;APPL2;TLR4;PYCARD;PDCD4
prerank,ethanol metabolic process (GO:0006067),0.7046502821692315,1.6211220600869012,0.02772963604852686,0.690118108133645,1.0,2/12,1.50%,ADH1A;ALDH1A1
prerank,regulation of protein targeting to membrane (GO:0090313),0.5796196219732616,1.621020123249463,0.022257551669316374,0.6793747134846523,1.0,3/28,4.82%,CEMIP;ANK3;MTCL1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6033409755757064,-1.620054621695937,0.01937046004842615,0.3160722885491584,1.0,12/16,35.07%,ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3;STOML2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5645435953927879,1.6187423541633783,0.0202808112324493,0.6808533098967924,1.0,13/33,11.54%,GRID2;CEL;GRID1;GRIK2;GRIK5;ABR;GRIK4;FABP5;GRIK1;RELN;LRRC4C;NRG3;PSMC5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.406564121114065,-1.6181034931291542,0.0,0.3173835398353785,1.0,15/75,9.79%,PLCE1;PLCB1;ROCK2;RGS3;RGS6;RGS5;NMT2;MGRN1;RGS12;MGLL;YWHAB;CALM1;FRMPD1;RGS4;GIT1
prerank,actin filament bundle assembly (GO:0051017),-0.49496480853533026,-1.616835149440501,0.016853932584269662,0.316979707126205,1.0,11/33,14.18%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;LIMA1;SHROOM1;BAIAP2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.5415158773323707,-1.6152888670118666,0.017241379310344827,0.3174665085574122,1.0,12/22,30.42%,PDGFD;ACE;PDGFA;CALM1;PDGFC;NBN;RAP2C;NEK10;TAOK2;GREM1;RAD50;RASSF2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5629757274559256,-1.6147737454322812,0.017587939698492462,0.3152177000939805,1.0,11/18,33.53%,ITGB1;JAM2;SLC39A8;CX3CR1;GCNT1;VCAM1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,triglyceride homeostasis (GO:0070328),0.6054452014026787,1.61341311869399,0.02511773940345369,0.6976697697235367,1.0,3/26,5.09%,RORA;NR1H4;LIPC
prerank,cellular response to fluid shear stress (GO:0071498),-0.645363262442983,-1.6127091740672652,0.022935779816513763,0.31730329363088483,1.0,7/12,15.15%,MEF2C;KLF4;SREBF2;KLF2;HDAC3;ASS1;MAP2K5
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6003201280093727,-1.612100991806333,0.03282828282828283,0.3156245322306315,1.0,4/15,5.61%,PRKCH;IL18;NFKB1;MAPK9
prerank,sprouting angiogenesis (GO:0002040),-0.4311797497054039,-1.6096804182044164,0.017123287671232876,0.3184923763368732,1.0,23/51,17.86%,TEK;RSPO3;BMPER;SLIT2;ROBO1;THBS1;NRP1;EFNB2;KDR;OTULIN;VEGFD;EPHB4;VEGFC;CCBE1;ACVRL1;ITGB1BP1;NR4A1;FLT4;PTK2B;RAMP2;ESM1;NAXE;AKT1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.5353962811698385,-1.6070941169372521,0.01652892561983471,0.32238306859333227,1.0,10/24,26.31%,PICALM;BCL2L1;RHOQ;DAB2;ITGB1BP1;TMEM59;PID1;DMTN;MRAP2;NUMB
prerank,positive regulation of signaling (GO:0023056),0.5585838374688603,1.605368650648533,0.027900146842878122,0.7305177038957198,1.0,9/37,11.37%,ECE1;HCRT;EDN3;GRIK2;SCRIB;RIMS2;RAB29;RIMS1;DLG4
prerank,actin filament depolymerization (GO:0030042),-0.6619620110035384,-1.6044200924060992,0.009592326139088728,0.32623144958885736,1.0,6/11,21.46%,MICAL2;GSN;CFL1;DSTN;MICAL3;TWF2
prerank,Rap protein signal transduction (GO:0032486),-0.672791299367149,-1.6035704270682223,0.01643192488262911,0.32511783536468103,1.0,7/10,23.30%,RAPGEF2;RAP1A;RAPGEF1;RAPGEF3;RAP2C;RAP2B;RAP1B
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5799826945530242,-1.6033217863972948,0.03307888040712468,0.32250878328253046,1.0,6/16,6.48%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;MAPK14
prerank,negative regulation of lipid metabolic process (GO:0045833),0.618781964383501,1.6025942471072023,0.022508038585209004,0.7347119599377211,1.0,3/22,8.09%,APOD;CIDEA;BSCL2
prerank,brain development (GO:0007420),0.44721193932236564,1.602331884498621,0.0024630541871921183,0.7251077787292822,1.0,36/136,16.34%,APOD;ROBO2;ADGRL3;EPHA7;COL4A1;ZFHX3;MEIS1;CTNNA2;HSPG2;PTEN;CNTNAP2;GRIN2B;MEIS2;AFF2;SOX6;ZIC1;NF1;CNTN4;GRIN2A;IER3IP1;DSCAML1;RELN;ABCB6;AMIGO3;SMARCA1;PLXNB2;EML1;ARNT2;BPTF;BAG6;CHD8;PBX2;CENPF;TBC1D23;NDUFS4;SMG9
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.56527872486323,-1.602263907250966,0.035443037974683546,0.32194368865205997,1.0,8/18,16.72%,ROCK2;TEK;RUFY3;KANK1;PTK2B;CDH5;LLGL2;BCAS3
prerank,protein autoprocessing (GO:0016540),0.6401189432830404,1.6010298636474165,0.03814262023217247,0.7216027609435579,1.0,6/17,13.88%,CASP4;OMA1;FXN;HTRA2;SPRTN;MYRF
prerank,acylglycerol homeostasis (GO:0055090),0.6320770615794832,1.6005565233325458,0.03770491803278689,0.7136243501636115,1.0,2/20,5.09%,RORA;LIPC
prerank,regulation of receptor recycling (GO:0001919),0.660583526906168,1.5976566954024283,0.01938610662358643,0.7193194780510583,1.0,4/16,8.89%,ECE1;TBC1D16;SCRIB;RAB29
prerank,lamellipodium assembly (GO:0030032),-0.5076162956927293,-1.596396562335664,0.020050125313283207,0.3332303152721983,1.0,9/26,11.40%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SRGAP2;SPATA13;CCDC88A
prerank,regulation of GTPase activity (GO:0043087),-0.360646055293012,-1.5938139195914474,0.0,0.33711222477775027,1.0,57/177,15.41%,PKP4;PLXNA2;EPHA4;PICALM;RAPGEF2;LRCH1;FGD5;PLXNA4;CHN2;SIPA1L1;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;RASGRF1;RDX;S100A10;RAP1A;NDEL1;RASIP1;SH3BP4;CAV2;WNK1;SRGAP2;RAPGEF1;EFNA5;GSK3B;RSU1;RALBP1;ITGB1BP1;PLXNB1;NGEF;SGSM2;CPEB2;SFRP1;MAPRE2;ARL2;ARHGAP12;GMIP;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;PRKG1;TBC1D10B;ARHGAP15;RAPGEF3;CX3CL1;EZH2;PLXNA1;RAP1GDS1;RGS10
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6171226020624196,1.5922339985240588,0.0420032310177706,0.7395550683207871,1.0,4/20,2.93%,SULF1;SPRY4;SPRY1;FGFBP3
prerank,presynapse organization (GO:0099172),0.7115289569211355,1.5920552092918057,0.03411131059245961,0.7300448055825844,1.0,3/10,4.15%,WNT5A;C5AR1;LRRTM3
prerank,negative regulation of cell motility (GO:2000146),-0.37733456892848743,-1.591561817120523,0.0,0.33966602868281975,1.0,33/108,11.77%,CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;TPM1;CDH1;CLDN5;DACH1;MAGI2;LIMCH1;MCTP1;CYP1B1;KANK1;SRGAP3;SRGAP2;TMEFF2;ACVRL1;FRMD5;CITED2;IFITM1;SFRP1;SERPINE1;RNF41;DAG1;ARPIN;DLG5
prerank,cAMP metabolic process (GO:0046058),0.6766547376184736,1.5908789640679777,0.02555366269165247,0.7265335228540951,1.0,6/13,8.88%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,positive regulation of neuron projection development (GO:0010976),0.47228914978919767,1.5906272681522384,0.006361323155216285,0.7177837055852216,1.0,22/85,14.06%,ROR1;PTN;NTRK3;ROR2;TENM3;WNT5A;NTRK2;CAPRIN1;PRKCI;PRKD1;RELN;STMN2;P3H1;BMP7;EPHA3;DHX36;PLXNB2;RETREG3;ARHGAP35;LRRC7;CUX2;LYN
prerank,regulation of keratinocyte migration (GO:0051547),0.6815266526411995,1.5901828852899524,0.03709949409780776,0.7106565124575074,1.0,4/12,9.11%,PTEN;MAP4K4;IQSEC1;MTOR
prerank,macrophage activation involved in immune response (GO:0002281),-0.6370069990468,-1.5878962390945774,0.017937219730941704,0.34679253972852353,1.0,8/13,26.77%,LBP;NMI;IFI35;CX3CR1;PLCG2;DYSF;TYROBP;SBNO2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.661815775825346,1.5874406003687176,0.041811846689895474,0.7159703723179184,1.0,5/13,8.63%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA
prerank,anion transport (GO:0006820),-0.48332756651705566,-1.5866991594008144,0.011661807580174927,0.3467006401221687,1.0,7/33,7.78%,ABCG2;SLC13A4;SLC13A3;LRRC8C;SLC26A7;SLC22A6;LRRC8D
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5029211349339833,-1.5860075129042137,0.015625,0.3451581134417152,1.0,14/26,24.35%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;TIFA;ALPK1;TNFAIP3;UBA52;IKBKG;NOD2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.6285449439798475,1.5851266503193542,0.032679738562091505,0.7186051932119336,1.0,4/18,5.64%,PTN;IL34;TENM4;NF1
prerank,positive regulation of cell motility (GO:2000147),-0.34959737032679167,-1.5845613488859895,0.0,0.3458553393230107,1.0,56/205,11.42%,FLT1;PDGFD;IGF1;TJP1;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAVIN1;CAV1;PECAM1;PODXL;EGFR;SPOCK2;MYLK;IGF1R;ITGB1;FER;NTN1;THBS1;SEMA7A;ITGA6;RDX;KDR;INSR;SOD2;NOTCH1;RUFY3;ACTG1;APC;SMO;DAB2;NEDD9;ADAM10;SEMA6A;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;RHOC;FGF1;PDGFC;PIK3CD;FAM107A;SPAG9;EPHB2;ELP5;SEMA5B;CTSH;MYO1C;CD151;MDK
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6955817417300508,1.5845590122056268,0.022847100175746926,0.712794918877385,1.0,4/12,3.66%,DCN;BGN;DSE;VCAN
prerank,DNA damage checkpoint signaling (GO:0000077),-0.5152931191650068,-1.5841031556184195,0.016260162601626018,0.3436890723468412,1.0,15/28,27.52%,ATR;ATM;CDC5L;NBN;CLOCK;DONSON;HUS1;E2F1;PRPF19;ATRIP;HINFP;CHEK2;BRIP1;CHEK1;RHNO1
prerank,regulation of organelle organization (GO:0033043),-0.39443509610487637,-1.5825409979294602,0.0,0.3446969474920394,1.0,23/80,19.08%,CLIC4;TJP1;EZR;DIAPH1;MTM1;ARMH3;F11R;STX18;RDX;VPS35;SQSTM1;MAVS;MAPT;PLXNB1;CLEC16A;SURF4;VPS11;ARL6IP1;LMAN1;PAK2;CAMSAP2;MSN;MARK2
prerank,regulation of cell migration (GO:0030334),-0.32373412888066483,-1.58178903643264,0.0,0.3434682769913534,1.0,119/382,15.37%,FLT1;PDGFD;PLXNA2;CLIC4;EPHA4;IGF1;TJP1;LMO4;SYNE2;ROCK2;DPYSL3;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PLXNA4;VCL;PTPRJ;SLIT2;PECAM1;ROBO1;PODXL;EGFR;AFDN;MYLK;IGF1R;ITGB1;FER;PTPRK;THBS1;IGFBP5;SEMA7A;ARID2;TPM1;CDH1;ITGA6;CLDN5;RDX;DACH1;MAGI2;LIMCH1;MCTP1;KDR;INSR;SOD2;NOTCH1;RUFY3;CYP1B1;ACTG1;PHACTR1;AMOT;KANK1;MINK1;ANXA1;APC;RAC1;SMO;DAB2;NEDD9;ACE;ADAM10;SRGAP3;SRGAP2;SEMA6A;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;PRR5L;TMEFF2;RHOC;FGF1;ACVRL1;PDGFC;PLXNB1;FRMD5;CITED2;IFITM1;ENPP2;SFRP1;SERPINE1;PIK3CD;FAM107A;CAMK2B;SPAG9;SPATA13;EPHB2;ELP5;ROBO4;SEMA5B;RNF41;CTSH;MYO1C;LMNA;CD151;MDK;DAG1;ARPIN;DLG5;RET;CEACAM1;TRIP6;AMOTL2;ATM;FLNA;MACF1;PTK2B;SERPINE2;CPNE3;TMSB4X;CDH5;CX3CL1;RAP2C;PLXNA1;ARSB;EDN1
prerank,neurotransmitter uptake (GO:0001504),0.6881972399016352,1.5806261433045636,0.02586206896551724,0.7246528779568246,1.0,2/12,1.47%,SLC1A3;ATP1A2
prerank,negative regulation of developmental process (GO:0051093),-0.402827192520591,-1.5792677744929704,0.0037313432835820895,0.34701840189822464,1.0,25/69,20.89%,NFIB;ROCK2;FOXC1;NOS3;CST3;KLF7;NOTCH1;KANK1;TFRC;CDK6;TBX1;ARHGEF15;MAPT;RC3H1;SFRP1;TBX2;ARPIN;HEY2;ADCK1;RAPGEF3;FGFR3;WNT11;VASH1;HOPX;MIF
prerank,phagosome-lysosome fusion (GO:0090385),0.7373327809617749,1.5786851762349872,0.02909090909090909,0.7258783566045574,1.0,4/10,10.41%,RAB34;RAB20;SYT7;ARL8B
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.6938596542959338,1.578550292412096,0.02882882882882883,0.717522029734493,1.0,5/11,6.91%,LIG3;TIPIN;FBXO5;MSH3;GMNN
prerank,sensory perception of sound (GO:0007605),0.47311013005689195,1.5781903246377778,0.016,0.7105525300093558,1.0,6/88,1.84%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6439073381934928,-1.5776358039115355,0.03588516746411483,0.34796904321471134,1.0,6/11,9.80%,MLLT3;RSPO3;WNT5B;CSNK1D;DAB2;SFRP1
prerank,negative regulation of chemokine production (GO:0032682),0.6642049771143147,1.5764895279250817,0.049403747870528106,0.7105376101887515,1.0,1/14,0.04%,APOD
prerank,neural tube development (GO:0021915),-0.5802733639054344,-1.5757833044043215,0.0332541567695962,0.34995435411783327,1.0,5/15,18.84%,ALDH1A2;DVL1;SOX4;SOX11;ARL13B
prerank,regulation of histone deacetylation (GO:0031063),-0.611507295928478,-1.5741903173263085,0.026726057906458798,0.3511913476447613,1.0,6/13,22.66%,CAMK2D;SAP30BP;AKAP8;ZBTB7B;SPHK2;APLNR
prerank,renal system development (GO:0072001),0.5051966343171035,1.5739048847660386,0.027065527065527065,0.7156549194382502,1.0,7/52,3.13%,TBX18;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3
prerank,regulation of stem cell population maintenance (GO:2000036),0.6249594479889123,1.5727720645190948,0.0415944540727903,0.7130545727067802,1.0,8/18,17.60%,PTN;LOXL2;REST;NCOA3;KAT2A;CNOT1;MYC;CNOT3
prerank,smooth muscle cell differentiation (GO:0051145),0.6837395071748166,1.5726009495763005,0.051001821493624776,0.7056065586685086,1.0,2/12,0.68%,TBX18;TMEM204
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.662107206299853,1.571131375912408,0.05699481865284974,0.7047401367885651,1.0,6/14,15.02%,ENPP1;ENPP3;ITPA;AK4;AK8;AK3
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5223499453341341,1.5710443442162683,0.022189349112426034,0.697169234305619,1.0,9/46,2.28%,LAMC3;LAMC1;PIK3R1;LAMB1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,retina homeostasis (GO:0001895),-0.510917987109374,-1.5704585660205574,0.01680672268907563,0.35751823785754905,1.0,7/23,12.23%,ACTB;POTEF;ACTG1;WHRN;B2M;HSPB1;PRDX1
prerank,regulation of phospholipase activity (GO:0010517),0.7317557290283467,1.5704471766419532,0.030418250950570342,0.6921905408176108,1.0,3/10,3.87%,LRP1;FGFR1;PDPK1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4291971179428491,-1.5640710099533175,0.0033112582781456954,0.3721659697137616,1.0,17/51,15.60%,CRIM1;SMAD6;BMPER;LEMD3;NBL1;FSTL1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SMURF2;HIPK2;SMAD1;GREM2;CHRDL1;RBPMS2
prerank,macrophage differentiation (GO:0030225),-0.6017183935897611,-1.564029489290938,0.02843601895734597,0.36906452467206957,1.0,6/13,24.09%,IL31RA;CDC42;CASP8;SIRT1;CSF1R;PARP1
prerank,muscle filament sliding (GO:0030049),-0.45479921041323973,-1.563571777575317,0.008571428571428572,0.36418562016826383,1.0,20/38,40.33%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,actin-myosin filament sliding (GO:0033275),-0.45479921041323973,-1.563571777575317,0.008571428571428572,0.36418562016826383,1.0,20/38,40.33%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,phosphate ion homeostasis (GO:0055062),0.7312055467440807,1.5631965166220954,0.04440497335701599,0.7208738695603386,1.0,1/10,0.11%,ENPP1
prerank,sulfate transport (GO:0008272),-0.5891989561822162,-1.5620604658610258,0.034739454094292806,0.3655115420100615,1.0,4/14,4.04%,SLC13A4;SLC26A7;SLC26A2;SLC26A11
prerank,small GTPase mediated signal transduction (GO:0007264),-0.37054160026943495,-1.5596716034699347,0.0,0.3688507601052164,1.0,30/103,15.59%,PLCE1;IGF1;RAPGEF2;RAPGEF5;ARHGEF18;TIAM2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;RAC1;PLD2;RASGRP3;MAPK14;NUCB1;RALBP1;ARHGAP18;RRAGC;RGL2;CCDC88A;RALB;CCDC88C;BCR;RAB38;RRAS;GRB2;CDKN1A;GRAP
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4889434673484104,-1.5596488779525959,0.021447721179624665,0.36586388611200377,1.0,14/28,24.35%,IRAK2;OTULIN;UBB;AAMP;CASP8;LACC1;TAB2;CYLD;UBE2N;UBC;TNFAIP3;UBA52;IKBKG;NOD2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.6136281325375119,-1.5593852546265972,0.049886621315192746,0.36347475646571614,1.0,8/13,25.59%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,response to estrogen (GO:0043627),-0.47763519428972323,-1.558928081900559,0.019498607242339833,0.361618392260016,1.0,11/31,16.99%,CAV1;NCOA4;TRIM24;TRIM25;WBP2;CITED2;SFRP1;ARID5A;SFR1;BCAS3;ESR1
prerank,T cell differentiation in thymus (GO:0033077),0.6672229643541631,1.5580022908501219,0.05087719298245614,0.7391259496008059,1.0,4/14,9.85%,MR1;RABL3;ZFP36L2;GLI3
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.6186848533513589,-1.557612982089515,0.021791767554479417,0.3623316303793123,1.0,6/13,20.42%,GOPC;YWHAB;NFKBIA;FLNA;SUFU;GET4
prerank,sodium-independent organic anion transport (GO:0043252),-0.6476680036716854,-1.5571866852524696,0.04212860310421286,0.36063313712041845,1.0,3/10,1.96%,SLC16A2;SLCO2A1;SLCO1C1
prerank,regulation of T cell migration (GO:2000404),0.6204558856266279,1.5568877759794677,0.04215851602023609,0.7368307004492872,1.0,3/18,1.10%,APOD;CXCL10;TMEM102
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6249773868395082,1.5565329559097487,0.03559870550161812,0.7304657363169159,1.0,3/18,1.27%,PTN;XCL1;EDN3
prerank,ganglioside biosynthetic process (GO:0001574),-0.5770705269481068,-1.5546276391834875,0.04449648711943794,0.3643932599230725,1.0,7/15,15.79%,ST8SIA4;B4GALT5;ST3GAL1;ST6GALNAC3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,glucose metabolic process (GO:0006006),0.49238843360092766,1.554333674777444,0.02170767004341534,0.7337436053197449,1.0,10/58,7.97%,APOD;MDH1;PFKFB1;GDPGP1;PPARD;IRS2;CRTC2;OMA1;ALDOB;PER2
prerank,regulation of nervous system development (GO:0051960),0.5379976133043761,1.5542364985955095,0.02823179791976226,0.726409450678524,1.0,8/37,9.91%,PTN;GBX1;NPHP3;TENM4;DOCK7;PER2;LGI4;WNT3
prerank,receptor clustering (GO:0043113),0.5710754149245894,1.5527298185715146,0.03064516129032258,0.7267786738980917,1.0,6/27,5.11%,PTN;NRXN2;NRXN1;SCRIB;DLG3;DLG2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6181897044702955,1.55182056180046,0.04631217838765009,0.7238442006509982,1.0,3/17,4.49%,PTN;IL34;TENM4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5296901640001517,1.551421011508047,0.030927835051546393,0.7185237133392035,1.0,7/38,11.89%,RORA;CCDC22;NR1H4;CARD19;TLE1;PYCARD;TRIM59
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6334261900847721,1.551367121625644,0.050590219224283306,0.7114402032457582,1.0,2/16,3.88%,RORA;PDK1
prerank,modified amino acid transport (GO:0072337),0.646288152575009,1.5497305064610694,0.041811846689895474,0.7123671799603621,1.0,3/15,1.44%,SLC6A13;SLC6A8;SLC16A12
prerank,protein oxidation (GO:0018158),0.6870331419529565,1.5495678375311301,0.03671328671328671,0.7061649405762034,1.0,3/11,4.22%,LOXL4;LOXL3;LOXL2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.589033347937838,-1.5491384404468473,0.0425531914893617,0.3728027325349151,1.0,4/15,4.52%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,stress fiber assembly (GO:0043149),-0.589033347937838,-1.5491384404468473,0.0425531914893617,0.3728027325349151,1.0,4/15,4.52%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,leukocyte tethering or rolling (GO:0050901),-0.5492102992578505,-1.5488029966188608,0.051470588235294115,0.3708642897578004,1.0,10/17,33.53%,ITGB1;JAM2;CX3CR1;GCNT1;VCAM1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,glycogen metabolic process (GO:0005977),-0.5068297832611253,-1.5482325374525305,0.020527859237536656,0.3695374376676618,1.0,11/27,13.49%,PRKAG2;PYGB;PGM2L1;GBE1;CALM1;GSK3B;GYG1;UGP2;GAA;PGM2;PPP1R3C
prerank,epidermis development (GO:0008544),0.5009560388156927,1.5477075613784612,0.010263929618768328,0.7079434273530343,1.0,11/56,9.47%,EMP1;EDA2R;PLOD1;HDAC1;COL7A1;SVEP1;FABP5;ATP2A2;FLOT2;GLI1;EVPL
prerank,nitric oxide metabolic process (GO:0046209),-0.6031340760660963,-1.5474057691818854,0.051643192488262914,0.3687135265168778,1.0,8/14,25.59%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,fatty acid metabolic process (GO:0006631),0.44801472076040744,1.5470619511000854,0.008827238335435058,0.7041645834123741,1.0,25/115,15.43%,LPIN3;GGT5;PPARA;ACOX2;ACSF2;ABCD2;CEL;PEX2;PPARD;CRAT;LIPH;LIPC;ACADSB;ECHDC3;PER2;HSD17B8;FA2H;ACOT7;ACSL6;ACLY;SGPL1;NDUFAB1;NUDT19;ACOT2;LPIN2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.6424310388465841,1.546838643824833,0.04882154882154882,0.6986024093540764,1.0,5/14,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4584314893457675,-1.5456170448361377,0.008771929824561403,0.3710768265718559,1.0,8/34,5.90%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;RAC1;NEDD9;CDC42
prerank,peptide catabolic process (GO:0043171),0.5779618901359278,1.5455708597881814,0.04126984126984127,0.6981956869279656,1.0,4/23,4.90%,ECE1;GGT5;GGT7;CPQ
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.48650308132006714,1.5453643524578973,0.02877697841726619,0.6926390081381638,1.0,19/57,24.26%,ADCY5;AKAP5;GPR37L1;ADCY8;ADCY3;ADCY2;HTR5A;HTR1A;ADCY7;LPAR1;HTR4;GPR37;GRM7;ADRA2A;CHRM2;GNAI3;ADCY1;P2RY12;GRM8
prerank,negative regulation of cell junction assembly (GO:1901889),0.5645068784947925,1.544223970947337,0.03987240829346093,0.6916483616822566,1.0,5/25,3.78%,APOD;ROBO2;DLC1;PTEN;ARHGAP6
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6211710331101366,-1.5438332032990736,0.0319634703196347,0.37297577334453036,1.0,8/12,20.88%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;SNX3;IFITM2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6274355730947211,-1.5430353010308606,0.031862745098039214,0.3722556786984365,1.0,5/11,23.18%,ACTN2;CAV1;CAB39;STK39;CASQ2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5692063130883679,-1.5396011885261502,0.05063291139240506,0.37882913174180066,1.0,5/16,12.73%,NOTCH2;BMPR2;NOTCH1;TGFB2;HEY2
prerank,phagolysosome assembly (GO:0001845),0.6845971465695335,1.5395734846937947,0.03893805309734513,0.7074036993022397,1.0,4/12,10.41%,RAB34;RAB20;SYT7;ARL8B
prerank,microvillus organization (GO:0032528),-0.5837858280015685,-1.5392790255646718,0.035211267605633804,0.37700996500620915,1.0,6/13,5.01%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6942321280318106,1.538184960563264,0.055846422338568937,0.7077032369008,1.0,3/11,1.70%,XCL1;CXCL10;WNT5A
prerank,nucleotide catabolic process (GO:0009166),-0.5572407758925325,-1.5380399672165235,0.039603960396039604,0.37752507657607076,1.0,9/16,19.98%,SAMHD1;DERA;NUDT3;XDH;VCP;GPX1;NT5E;GDA;NT5C1A
prerank,endothelial cell development (GO:0001885),0.5618195305781638,1.5357289477503455,0.0438871473354232,0.7133644587289383,1.0,3/25,2.43%,COL15A1;COL18A1;COL22A1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.46437766013203136,1.534365463899553,0.02165087956698241,0.7134147012788543,1.0,6/85,1.84%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5146207904263717,-1.53399546652879,0.024861878453038673,0.3857951647711142,1.0,14/22,36.55%,AEBP1;HSPA8;APOE;MAPT;GPX1;ARL2;CAMSAP2;PARK7;CAMSAP3;MAP1S;EFEMP2;PIK3CA;AKAP13;PRUNE1
prerank,negative regulation of cell migration (GO:0030336),-0.35302372597150183,-1.5333400420497747,0.0,0.3847857551581871,1.0,38/137,11.77%,PHLDB2;CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;TPM1;CDH1;CLDN5;DACH1;MAGI2;LIMCH1;MCTP1;IGFBP3;PTPRG;CYP1B1;KANK1;RAC1;SRGAP3;SRGAP2;ARHGDIB;TMEFF2;ACVRL1;ITGB1BP1;CITED2;IFITM1;SFRP1;SERPINE1;RNF41;DAG1;ARPIN;DLG5
prerank,positive regulation of immune system process (GO:0002684),-0.5517297320711836,-1.5327955210533932,0.05215419501133787,0.38348080706065013,1.0,4/16,9.97%,TGFB2;ANXA1;PIK3CB;PIK3CD
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4979363847012558,1.5327141806730868,0.020437956204379562,0.7151790963425949,1.0,8/51,9.06%,PTN;IL34;XCL1;CXCL10;EDN3;PTK2;PLA2G7;LGMN
prerank,supramolecular fiber organization (GO:0097435),0.4006935475366344,1.5309979444395156,0.0,0.717851112740009,1.0,66/333,12.94%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;RND3;LOXL4;COL23A1;GGA2;LUM;TGFBI;PLOD1;COL10A1;ERMN;ADAMTS14;HSPG2;MYO7A;MARCKS;COL22A1;COL7A1;NCKAP5L;COLGALT1;DPT;TNXB;TCHH;ELMO1;LOXL3;LOXL2;COLGALT2;PPP1R9A;RAC3;MFAP4;MYO1B;SORL1;COL12A1;COL26A1;NF1;CLIP3;ACTN1;CAPN3;CALCA;COL1A2;COL16A1;RHOBTB3;MYO6;CALB1;STMN2;CLRN1;COL4A2;P3H1;WDR73;ADAMTS2;STMN4;ZBED3;KATNA1;SLK;TGFBR1;IAPP;MYO1G;TUBGCP4;FIGNL1;CEP126;TRIOBP;CLIP2
prerank,axonogenesis (GO:0007409),0.4061842162152796,1.5292069002471687,0.003329633740288568,0.7200912014739168,1.0,67/237,16.74%,LAMA1;ROBO2;LAMA2;PIK3R1;ISL2;EPHA7;AUTS2;CTNNA2;WNT5A;PTEN;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;ANK3;EPHA6;UNC5A;ADGRB1;NEFH;DSCAM;RAB8A;CNTN4;IRS2;LLGL1;DAB1;DOCK7;DSCAML1;PTPRO;UNC5C;PTK2;RELN;PALLD;EPHB6;DCC;NRXN3;PRKCA;NEXN;CNTN6;OPHN1;LYPLA2;EPHA3;PPP3CB;PTPRA;DOK5;FYN;USP33;UNC5D;GFRA1;ARHGAP35;SH3KBP1;KIF5C;GFRA2;EPHA5;EVL;GDNF;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;ULK2;TUBB3;EFNA1;CYFIP1;SLITRK1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6601414961570788,-1.5289906592957072,0.030805687203791468,0.38812931326682876,1.0,7/10,28.28%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6601414961570788,-1.5289906592957072,0.030805687203791468,0.38812931326682876,1.0,7/10,28.28%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2;NSMAF
prerank,positive regulation of chemotaxis (GO:0050921),0.5109292564724994,1.5286970183857633,0.033478893740902474,0.7163290629900676,1.0,9/43,11.17%,PTN;NTRK3;XCL1;EDN3;SEMA5A;DSCAM;PRKD1;LGMN;P2RX4
prerank,dermatan sulfate metabolic process (GO:0030205),0.6607904910540581,1.5285204922178728,0.03873239436619718,0.7108862423537822,1.0,4/13,3.66%,DCN;BGN;DSE;VCAN
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6141057882466197,1.5276921043219516,0.04194630872483222,0.7086621603071959,1.0,4/17,2.66%,CASK;SULF1;TMEM204;ITGA3
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4676029825288248,-1.5273494091057218,0.013333333333333334,0.3894034010367416,1.0,20/36,29.02%,SGMS1;DEPTOR;TPD52L1;TMBIM6;FAS;CRADD;MADD;NR4A2;CX3CR1;CYLD;PPIA;CX3CL1;ING5;TRAF1;QARS1;TRIM39;RB1;ASAH2;BDNF;MAPK8IP2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4518183080091517,-1.5249579708327492,0.02694610778443114,0.3928553333819051,1.0,15/35,26.88%,PICALM;HIP1R;VTN;RAC1;B2M;RAB21;PIK3CB;SERPINE1;HIP1;HFE;HNRNPK;CCL19;FLOT1;BICD1;ARF1
prerank,bile acid biosynthetic process (GO:0006699),0.5718350496156559,1.5245625063216521,0.03827751196172249,0.7177841126925224,1.0,4/24,3.45%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,regulation of actin filament depolymerization (GO:0030834),0.6715796052277789,1.524452908426589,0.0587248322147651,0.7122758025626106,1.0,3/12,5.18%,PLEKHH2;SEMA5A;MTPN
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6753006273254166,1.5243915256352178,0.05851063829787234,0.7066263142194529,1.0,1/12,0.10%,IL33
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5288392599577323,-1.5227109138104356,0.03142857142857143,0.3959518318908665,1.0,11/20,10.22%,IGF1;SLIT2;IGFBP5;NRP1;IGFBP3;VTN;S100A11;ACE;PDGFA;SERPINE1;CCN4
prerank,Notch signaling involved in heart development (GO:0061314),-0.624265868470438,-1.5215418652086483,0.04954954954954955,0.3964158474150249,1.0,7/11,16.71%,RBPJ;NOTCH2;NOTCH1;GALNT11;HEYL;HEY2;SNAI1
prerank,cellular glucan metabolic process (GO:0006073),-0.6183257669503267,-1.5205986655022827,0.04954954954954955,0.39652774562594506,1.0,5/11,13.49%,PRKAG2;GBE1;GSK3B;UGP2;PPP1R3C
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5768591615395763,1.5194362874025926,0.04560260586319218,0.7238967194010925,1.0,7/21,8.88%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;AMPD2;ADCY7
prerank,regulation of plasminogen activation (GO:0010755),-0.5924896508228406,-1.5194323462929782,0.03333333333333333,0.39688944950045046,1.0,6/12,14.38%,THBS1;RUNX1;SERPINE1;ENO1;SERPINE2;CTSZ
prerank,response to purine-containing compound (GO:0014074),0.6106077961991131,1.519226658307801,0.05333333333333334,0.7189055074157987,1.0,10/17,23.93%,P2RY1;RYR2;DGKQ;TRPC3;P2RX4;TRPM2;NDUFS4;ABCC9;STAT1;P2RY6
prerank,regulation of lamellipodium organization (GO:1902743),-0.5827710972139233,-1.5190959996829834,0.052873563218390804,0.39524092841323494,1.0,9/14,21.82%,FER;RAC1;CAPZB;CDC42;CD44;PDPN;EPHA2;TWF2;DMTN
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5099300644484704,1.5185844268585615,0.04597701149425287,0.7159413014529707,1.0,13/41,16.57%,XCL1;ITPR1;GRIN2B;RYR2;HTR2B;GRIN2A;TRPV3;HTR2C;TRPM2;RYR3;F2R;CACNA2D1;CHERP
prerank,microvillus assembly (GO:0030033),-0.5684110121321022,-1.5164365197224245,0.03597122302158273,0.3996482487808922,1.0,6/14,5.01%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,regulation of neuroblast proliferation (GO:1902692),0.6347046664555878,1.5160939610502748,0.050761421319796954,0.721244544606599,1.0,4/15,5.91%,PTN;LRRK2;NF1;DISC1
prerank,endoderm development (GO:0007492),0.6603892545760037,1.5159646079619598,0.07606679035250463,0.7160730029521402,1.0,2/13,3.91%,LAMC1;DUSP1
prerank,negative regulation of nervous system development (GO:0051961),0.6184738211917711,1.515592243578996,0.04560810810810811,0.7120064743797782,1.0,4/17,9.09%,ROBO2;REST;SORL1;APPL2
prerank,cristae formation (GO:0042407),-0.4905510776540796,-1.5155319720440956,0.030470914127423823,0.3993991323679234,1.0,16/27,31.75%,APOOL;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;CHCHD3;LETM1;APOO;UQCC3;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5076295885184148,-1.5154461512741537,0.038781163434903045,0.3970080538664549,1.0,5/24,7.46%,LPGAT1;PLA2G4A;CDS2;PGS1;ABCA3
prerank,positive regulation of leukocyte activation (GO:0002696),0.602238646475204,1.5138355798255259,0.057432432432432436,0.714427476650128,1.0,5/18,9.41%,IL33;WNT5A;TSLP;TLR6;TLR4
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5739029335354213,1.5137937454695958,0.05289256198347107,0.7089800254359876,1.0,2/24,0.66%,RORA;SULF1
prerank,dendrite morphogenesis (GO:0048813),0.5302758591041077,1.5133545489442108,0.04242424242424243,0.7053562423743226,1.0,7/35,2.41%,PTN;DOCK10;CTNNA2;PTEN;EPHB1;FARP1;ABITRAM
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6059282931292018,1.513301217169838,0.046849757673667204,0.7001376917121512,1.0,7/18,6.20%,GRID2;GRID1;GRIK2;GRIK5;GRIK4;NAPB;GRIK1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.38049571762301787,-1.512792392902543,0.003875968992248062,0.4015686146430274,1.0,17/72,8.74%,HEG1;ARHGEF18;ROBO1;ARHGEF28;NET1;KANK2;F11R;NRP1;GPR4;KANK1;RASIP1;RAC1;PRAG1;APOE;ARHGDIB;RALBP1;EPS8L2
prerank,muscle cell migration (GO:0014812),-0.6322833061658617,-1.5105350772890795,0.04814004376367615,0.4054258774938009,1.0,5/10,11.86%,CCN3;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6023260705233586,1.5075618036544107,0.04878048780487805,0.7214254126990498,1.0,4/19,7.78%,ENPP1;TPST1;SLC35B3;PAPSS2
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6612553777280654,1.5072163406329284,0.05545927209705372,0.7175308220285334,1.0,4/12,14.06%,IL34;PTK2;IL12A;LYN
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.49829700646796005,-1.5060736569277282,0.029023746701846966,0.41585648505524736,1.0,8/22,15.54%,SLIT2;KANK3;HIP1R;GSN;KANK1;SSH1;TMSB4X;PRKCD
prerank,axonemal dynein complex assembly (GO:0070286),0.5346447183903188,1.5060693935444496,0.04915514592933948,0.717389662727986,1.0,7/27,9.67%,CCDC63;ODAD4;DNAAF4;DNAAF3;TTC12;DNAI4;CCDC65
prerank,pore complex assembly (GO:0046931),-0.520301825960807,-1.5045203934178983,0.0413625304136253,0.4174904207784317,1.0,9/19,15.32%,ANO6;AFDN;ADAM10;BAD;NUP98;NUP153;TMEM170A;P2RX7;NUP205
prerank,interstrand cross-link repair (GO:0036297),0.4814550890142303,1.5044992366990786,0.048295454545454544,0.7197473432658349,1.0,13/53,11.96%,FANCI;ERCC6L2;ERCC1;FAN1;USP1;FANCA;NEIL3;RPA1;ERCC4;RNF168;FAAP100;FAAP20;POLN
prerank,positive regulation of vascular permeability (GO:0043117),-0.5941199067378514,-1.5032821015816589,0.06944444444444445,0.4181558978393472,1.0,5/12,13.30%,TJP1;OCLN;PDE3A;TJP2;TRPV4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6737945197353479,1.5024461340187019,0.06039076376554174,0.7237500020693833,1.0,1/10,0.10%,IL33
prerank,regulation of nervous system process (GO:0031644),-0.5175109825714526,-1.5019443294105188,0.03731343283582089,0.4193230096317934,1.0,4/18,2.48%,ROCK2;SLC8A3;NOS3;APP
prerank,regulation of protein import into nucleus (GO:0042306),0.5220875236809037,1.5016815639461196,0.051908396946564885,0.7220720449725343,1.0,6/36,4.80%,APOD;PIK3R1;JUP;PIK3R2;ZIC1;MDFIC
prerank,negative regulation of GTPase activity (GO:0034260),-0.5049261282364015,-1.5014505571537986,0.0340632603406326,0.4178476154748295,1.0,8/22,11.17%,LRCH1;F11R;RDX;SH3BP4;WNK1;CPEB2;ARL2;GMIP
prerank,activation of protein kinase A activity (GO:0034199),0.6079211380236319,1.5014478335632937,0.056856187290969896,0.7177789774530062,1.0,7/16,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6476969781371124,1.5008585889887525,0.06747404844290658,0.7155663176683141,1.0,6/14,15.41%,AUTS2;KMT2E;KMT2A;WDR5;SNW1;PAXIP1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3712494322576615,-1.5008565745204707,0.01444043321299639,0.41680910788444286,1.0,18/82,10.62%,RANBP3L;CRIM1;SMOC1;IGF1;SMAD6;DDX5;MEF2C;BMPR2;NOTCH1;WNT4;SKI;IL6ST;CDK6;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3421737864853856,-1.500473844898773,0.0,0.4152829467131688,1.0,40/137,15.41%,PKP4;CD200;PICALM;RAPGEF2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;RASGRF1;S100A10;RAP1A;NDEL1;CAV2;SRGAP2;RAPGEF1;CALM1;GSK3B;MTMR9;RHOC;RSU1;RALBP1;PLXNB1;SGSM2;SFRP1;MAPRE2;CTSH;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;RAPGEF3;CX3CL1;EZH2;RAP1GDS1;RGS10
prerank,positive regulation of T cell migration (GO:2000406),0.5964961492107794,1.5001246461236275,0.05098684210526316,0.7136754840379425,1.0,4/20,1.70%,XCL1;CXCL10;TMEM102;WNT5A
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.37118939601781775,-1.4990751508575637,0.0,0.41660734778145975,1.0,29/86,14.56%,PLCE1;IGF1;ARHGEF18;DENND4A;ARHGEF28;KANK2;NOTCH2;RASGRF1;RDX;SHOC2;SQSTM1;NOTCH1;TGFB2;KANK1;DENND3;GABARAP;ARHGAP17;RAPGEF1;NGF;ARHGDIB;EPS8L2;MADD;EPHB2;STK19;MAPKAP1;BCR;DENND1A;DENND4C;GRB2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5789110503499173,1.4987013725993614,0.045234248788368334,0.7148511952779563,1.0,8/22,16.91%,DYNLL1;CDKN2A;CDKN2D;BMP7;TP53;ANKLE2;CDKN2C;PRKRIP1
prerank,regulation of protein kinase A signaling (GO:0010738),0.5834228899579282,1.4986492259548894,0.06741573033707865,0.7100369436373315,1.0,7/20,14.44%,AKAP5;ADGRV1;AKAP7;LRRK2;IAPP;AKAP6;PRKAR1A
prerank,regulation of vasculogenesis (GO:2001212),-0.5710861412714785,-1.4983493229502118,0.050761421319796954,0.41618885786290705,1.0,8/14,13.99%,RAPGEF2;KDR;RAP1A;CD34;XDH;CEACAM1;HEY2;RRAS
prerank,cellular response to glucagon stimulus (GO:0071377),0.5975443632544738,1.4978717070398573,0.054365733113673806,0.7085461399348373,1.0,7/17,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,regulation of BMP signaling pathway (GO:0030510),-0.38553941406464626,-1.497699766734776,0.007633587786259542,0.415367233294956,1.0,17/73,8.18%,CRIM1;SMAD6;RBPJ;BMPER;LEMD3;NBL1;XIAP;FSTL1;BMPR2;FOXD1;SKIL;NOTCH1;SKI;UBE2D3;CCN1;ACVRL1;SMURF2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6268821953821796,-1.49696993131283,0.058165548098434,0.4149387893816176,1.0,5/10,22.66%,MGRN1;PDE3A;PDE11A;CDC34;APLNR
prerank,apical protein localization (GO:0045176),-0.6316345769832022,-1.4963345552981369,0.04719101123595506,0.414074843378216,1.0,6/10,12.33%,ACTB;SHROOM3;GOPC;MAL;ATP8B1;SHROOM2
prerank,circulatory system development (GO:0072359),-0.357415624728514,-1.4960241613544312,0.004366812227074236,0.41244913153817325,1.0,41/118,15.84%,HEG1;PLCE1;FN1;TEK;CACNA1C;MEF2C;MICAL2;PDLIM5;CXADR;FOXC1;OSR1;MEF2A;FOXC2;NXN;RBP4;NOTCH1;TGFB2;GLI2;SOX4;TCF25;TBX1;SH3PXD2B;ACVR1;ACVRL1;SOX17;POU6F1;CRIP1;CASP8;FOXL1;CITED2;ZDHHC16;HEY2;TAB2;FLT4;RAMP2;CDH5;STRA6;CACYBP;CDKN1A;PCSK5;MKKS
prerank,bicellular tight junction assembly (GO:0070830),-0.41682150408411595,-1.493872387125805,0.03333333333333333,0.4159644706396642,1.0,21/46,27.36%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RAB13;ARL2;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP;PATJ;CLDN10;MARVELD2;ECT2;CLDN1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3105480618787338,-1.492383580614211,0.0,0.417714177890126,1.0,133/306,28.30%,MEF2A;RPS14;RPS9;RPS16;PTMA;ST3GAL4;RPLP1;RPL13;DRG1;TOP1;B4GALT5;RPL27A;RPS2;RPL37A;ALAS1;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;EXT1;RPS19;RPS24;RPS27;RPS15;APOE;RPL21;TBRG1;RPL10;EEF1G;RPL35A;LARGE1;RPS15A;RPL10A;RPS5;RPL11;ABCF1;RPL36A;PTMS;EEF1A1;RRAGC;RBBP8;ORC6;NR4A2;RECQL5;RPL34;POLR2B;ATR;RPLP2;RPS29;RPL32;RPL4;RPLP0;POLR2H;EEF2K;RPL30;RPL26;RPS4X;TERT;RPS21;RPL29;POLR2G;ATM;RPS8;EEFSEC;FUT9;EEF1D;POLR2C;POLE2;NBN;ING4;MRPS7;KAT5;RPL31;ST3GAL2;GCNT1;RPS23;ING5;RPL23A;GTPBP1;DONSON;SRBD1;MRPS17;AGO2;RPL19;HUS1;RPL36;HOXD3;ORC1;GSPT2;CREBL2;MCM6;MRPS18A;GAL3ST2;TYMS;MRPS18B;RPL17;RPL23;E2F1;MCM9;TOP1MT;MRPL24;RPS11;MRPL55;POLD2;MCM8;GSPT1;RPA2;RPL15;ATRIP;RPL38;RMI2;HARS2;CDC45;NT5M;BRCA1;PCLAF;BRIP1;MRPL36;MRPL35;RPL13A;POLR2I;RPS25;CHEK1;POLR2K;RHNO1;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.47947528810649054,-1.4922419147260118,0.064343163538874,0.41554146828502053,1.0,8/24,22.66%,RAPGEF2;MGRN1;PDE3A;PDE11A;PRKAR2A;PRKAR2B;CDC34;APLNR
prerank,presynapse assembly (GO:0099054),0.6073240923520403,1.4913375308828873,0.05792163543441227,0.7332403126305663,1.0,4/16,4.15%,WNT5A;PTEN;CEL;LRRTM3
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6481841305968856,1.4911164333865912,0.08303886925795052,0.7291765571305955,1.0,5/12,12.29%,BOD1;CENPE;RMDN1;CENPC;CDT1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.48801217154822063,-1.4905352601233608,0.03865979381443299,0.4178749758298499,1.0,12/24,24.35%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;TNFAIP3;UBA52;IKBKG;NOD2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6326283084892912,-1.4903062030015546,0.05995203836930456,0.4161518874808354,1.0,2/10,4.88%,NFKB1;SREBF2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.47055358906335254,-1.4892902059600936,0.03553299492385787,0.4163693876833509,1.0,12/26,21.22%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;TRPV4;MET;CDK5RAP2;NUMA1;FES;KATNB1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4577054687166097,-1.488557334053865,0.0392156862745098,0.41567945121719324,1.0,13/31,14.08%,PPP1R13B;HIP1R;YWHAB;GSK3B;YWHAG;CASP8;BAD;BAX;PPP3CC;PPP3R1;BID;BOK;ZNF205
prerank,bile acid metabolic process (GO:0008206),0.5533330545441566,1.4873380195920165,0.03940886699507389,0.7418907297781758,1.0,4/27,3.45%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.42845268143579146,-1.487104564450214,0.015015015015015015,0.417165338900655,1.0,20/39,28.61%,RPS14;RPS16;RPS7;DDX52;RPS19;RPS24;RPS27;RPS15;LSM6;RIOK1;RPS5;RIOK3;MRPS7;NPM1;NOL11;TSR3;PWP2;LTV1;RPS25;RRP36
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.48907270998477986,1.4868042586946335,0.03672316384180791,0.7391902293868903,1.0,6/48,8.66%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;PRKACA
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.4839432733777509,-1.4866323009547309,0.044270833333333336,0.41596447063966413,1.0,11/24,18.22%,SEMA3D;SEMA3C;SEMA7A;NRP1;MEGF8;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,regulation of fat cell differentiation (GO:0045598),0.4550799692923497,1.4863558752329826,0.03561643835616438,0.7363064262136071,1.0,19/74,18.49%,RORA;ENPP1;WNT5A;LRP3;PTPRQ;PPARD;RUNX1T1;ZBTB16;ZFP36L2;WDFY2;ZFPM2;FTO;CARM1;ASXL1;FERMT2;TAF8;FRZB;BMP2;ALOX5
prerank,protein localization to cell-cell junction (GO:0150105),-0.554841219271311,-1.485101049992358,0.04691358024691358,0.41798533080754824,1.0,8/15,8.03%,TJP1;ARHGEF18;ACTB;F11R;ACTG1;CGNL1;TJP2;LSR
prerank,protein hydroxylation (GO:0018126),0.617637102824887,1.4846423501307702,0.07084019769357495,0.738931791613125,1.0,8/15,17.94%,PLOD1;HIF1AN;VIPAS39;P3H1;P3H3;ASPH;VPS33B;PLOD2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.55395487282257,-1.4845645032322912,0.04895104895104895,0.4170301710701447,1.0,8/15,21.99%,RBPJ;EGFR;FER;CEACAM1;RHBDF2;ERBB2;EGF;MVB12B
prerank,inflammatory response (GO:0006954),0.40401259870081446,1.4839643323330642,0.006904487917146145,0.737104817956922,1.0,22/195,6.49%,SCUBE1;GGT5;IL1RN;IL2RA;XCL1;CXCL10;PTGFR;CXCL1;HSPG2;CD40;C5AR1;TPST1;MMP25;NFATC3;LOXL3;FOS;TLR6;CCL15;ADORA2A;ADORA1;PRDX5;ADCY8
prerank,lipoprotein transport (GO:0042953),0.6843073248469292,1.4832040331994487,0.07692307692307693,0.7356232410779799,1.0,7/10,24.91%,LRP1;UNC119;PRKCB;MIA3;UNC119B;ZDHHC17;VMP1
prerank,nervous system development (GO:0007399),0.38088987742809005,1.4825098530653977,0.0010471204188481676,0.7338021178671247,1.0,110/429,17.44%,CHST8;ROBO2;CHD7;PTN;ADGRL3;RBFOX1;NRG1;GPM6B;MERTK;TEAD1;ADGRV1;CXCL1;UNC119;MARCKS;PTEN;SEMA5A;ERBB4;EPHB1;SH3GL3;FARP1;ADGRA2;NRXN2;BTBD2;NRXN1;ZIC4;ASIC2;WDPCP;PCDHA5;VCAN;POU3F3;TBX3;DPYSL2;PCDHB16;SOX6;ZIC1;DCHS1;PRX;ZBTB16;APLP1;ADGRB2;ADGRB1;DSCAM;ADORA2A;NF1;CNTN4;ADORA1;GRIK1;LIMK1;PCDHB4;SZT2;HAPLN2;PCDHB11;RPS6KA6;NPAS2;DSCAML1;UTP11;NAV2;RELN;DHX30;AXL;NAV3;RAB29;TENM1;LSAMP;MBP;CNTN6;AHI1;LPAR1;OPHN1;SOX10;ALDH5A1;PRPS1;FGF12;RBFOX3;NDUFV2;FKTN;DLG4;TGFBR1;GFRA1;CBLN1;MYT1L;DPF2;ANKLE2;ATN1;SDCBP2;SCN2A;ADAM22;ATXN3;ARNT2;GFRA2;HAPLN3;FGF5;EVL;APBA2;NRSN2;KIRREL3;GDNF;TRIM3;HAPLN1;GLRB;NRCAM;IGF2BP3;CHERP;JAG1;SLITRK1;NHEJ1;ZIC5;CDK5;LDB2;LDB1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.5625940706885687,-1.481189139271733,0.06038647342995169,0.42429352634646705,1.0,9/15,28.48%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;ORMDL2;SPHK2;NSMAF;SAMD8
prerank,melanocyte differentiation (GO:0030318),0.6508127959601233,1.4802643103783681,0.072992700729927,0.739155053391678,1.0,2/11,1.49%,ENPP1;SLC24A5
prerank,carboxylic acid metabolic process (GO:0019752),-0.4424237610159766,-1.479583877154935,0.047619047619047616,0.4262344329798486,1.0,8/33,6.17%,DDO;CSGALNACT1;ST6GAL1;SLC2A1;PLA2G4A;PON3;ST3GAL1;CYB5R3
prerank,cellular response to alcohol (GO:0097306),0.5074099575152591,1.4792727282967177,0.05417276720351391,0.7388959219234424,1.0,14/42,14.53%,PTGFR;GRAMD1B;ADCY5;GPLD1;JUP;ADCY8;ADCY3;ADCY2;ADCY7;GLRA1;SPIDR;GLRA2;MAP4K1;GNG2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4578913768317893,-1.478874368056797,0.04986149584487535,0.42568792398419,1.0,11/29,15.54%,TJP1;SLIT2;SHANK3;KANK3;HIP1R;KANK1;SHANK1;SSH1;ARPIN;LIMA1;PRKCD
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5659737834527669,1.4785619543205448,0.05627009646302251,0.7371459323558773,1.0,9/24,16.57%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,intestinal lipid absorption (GO:0098856),0.6693061507015027,1.4783075504034575,0.07857142857142857,0.7336914074952289,1.0,3/11,10.30%,NPC1L1;CEL;SOAT2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6501125578572172,1.477857332608869,0.0727580372250423,0.7311395165497822,1.0,5/12,12.48%,MYCBP2;PTEN;EPHB1;EPHB6;ARHGAP35
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.5594122808795023,-1.4775614807973967,0.0663265306122449,0.42713660558421224,1.0,8/14,28.15%,THBS1;KLF4;NOTCH1;ITGB1BP1;MAP2K5;CARD10;DLL4;HDAC5
prerank,cGMP-mediated signaling (GO:0019934),0.624944224918073,1.477120648407909,0.0831918505942275,0.7297013647032751,1.0,4/13,9.08%,PDE9A;HTR2B;KCNC2;HTR2C
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5605511500939736,-1.47470040968227,0.046798029556650245,0.43216700712846656,1.0,2/14,0.41%,IGF1;CD200
prerank,"phagocytosis, engulfment (GO:0006911)",-0.43326981801523146,-1.4746481283418733,0.021406727828746176,0.430000205628688,1.0,8/36,5.90%,RHOBTB1;GULP1;DOCK1;THBS1;GSN;RHOBTB2;RAC1;CDC42
prerank,neuron migration (GO:0001764),0.48342603497833414,1.4729840221166126,0.042335766423357665,0.7442330221994622,1.0,12/48,8.43%,SH3RF1;ADGRL3;AUTS2;NTRK2;ASTN2;FGFR1;DNAAF4;LRP12;CDKL5;DISC1;ASTN1;RELN
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5518658442350863,1.4727373868305182,0.06873977086743044,0.7405240043828842,1.0,2/26,0.66%,RORA;SULF1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.610176356143717,1.4724522129504434,0.0670926517571885,0.737140465212081,1.0,6/16,9.37%,SEC16B;SEC16A;RYR2;GBF1;LRRK2;TAPT1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.4527928631690076,-1.4719645675178565,0.04142011834319527,0.43544327571340136,1.0,11/32,14.25%,HMBOX1;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;ATM;MAP3K4
prerank,response to progesterone (GO:0032570),-0.5234261707764651,-1.4718717334156022,0.05104408352668213,0.4333088219145132,1.0,5/18,9.86%,CAV1;THBS1;TGFB2;WBP2;ABHD2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5066293099339,-1.4708424963424187,0.07371007371007371,0.4338426187477613,1.0,8/19,12.73%,SMAD6;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;HEYL;HEY2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5895125069952656,1.4704515361049417,0.060810810810810814,0.7416715998208865,1.0,3/18,7.46%,APOD;MDFIC;POLR1A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6026634313388025,1.4703456184346915,0.07457627118644068,0.7375076806966413,1.0,5/15,11.50%,PDGFRA;EIF4A3;MTHFD1L;TWIST1;TGFBR1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.5603719213908984,-1.4698822732548964,0.05411764705882353,0.43409375259083954,1.0,7/14,16.72%,NCOA4;TRIM24;WBP2;SFRP1;ARID5A;SFR1;BCAS3
prerank,heart trabecula morphogenesis (GO:0061384),-0.5081524547570693,-1.468697933653325,0.06905370843989769,0.43506382572474417,1.0,7/18,4.36%,TEK;RBPJ;ADGRG6;S1PR1;RBP4;NOTCH1;TGFB2
prerank,positive regulation of embryonic development (GO:0040019),-0.5121624102746164,-1.4684715961934587,0.05398457583547558,0.43335478069150674,1.0,6/19,10.18%,PLCB1;OSR1;WNT4;B4GALT5;CFL1;NIBAN2
prerank,smooth muscle contraction (GO:0006939),-0.5541583960109312,-1.4677471023699957,0.06097560975609756,0.4332994339880029,1.0,6/14,12.34%,ROCK2;MYLK;EDNRA;BDKRB2;MYH11;ACTA2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6287421891018456,1.4672580233483714,0.06292517006802721,0.7466006488479215,1.0,3/14,1.52%,SULF1;SPRY4;SPRY1
prerank,diacylglycerol metabolic process (GO:0046339),-0.4800816448107321,-1.467053818219933,0.04904632152588556,0.43277326840846453,1.0,6/23,12.53%,PLCE1;DGKH;PGS1;DGKG;LIPE;DGKZ
prerank,cellular response to interleukin-12 (GO:0071349),-0.41421312077433947,-1.4663125026867603,0.017857142857142856,0.43243885169578516,1.0,20/48,23.30%,PLCB1;SIRPA;SOD2;CDC42;TALDO1;PITPNA;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4522543070755834,-1.4658095574907328,0.04310344827586207,0.43162856512147796,1.0,19/30,14.67%,TJP1;VCL;OCLN;PECAM1;ACTB;ITGB1;ESAM;F11R;CLDN5;JAM2;ACTG1;TJP2;LSR;DMD;SLC1A1;CLDN12;GJB6;MFSD2A;CDH5
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5292359594162952,-1.4654927415049186,0.05980861244019139,0.43031158100686817,1.0,5/17,4.26%,PBX1;RBPJ;MAML2;NOTCH3;NOTCH1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6357178608519191,1.4618670592696086,0.0855614973262032,0.7671866129682214,1.0,4/12,11.74%,PPARA;ITGAV;NR1H2;ABCA5
prerank,regulation of kinase activity (GO:0043549),0.4342169181283673,1.4614420313394132,0.03088803088803089,0.7646500326995456,1.0,19/89,10.40%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;NPRL2;EPHA6;ANKRD54;CAMKK2;IRS2;EPHB6;AXL;FGR;EPHA3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5808421759599258,1.4611228880465161,0.07855973813420622,0.7614803881988719,1.0,4/18,4.96%,PPARA;PAG1;TNFAIP8L2;PTPN22
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5443204252936921,1.4607707710549576,0.07716049382716049,0.7585479230465063,1.0,9/23,22.27%,XCL1;NR1H4;PDCD1LG2;AXL;TLR4;LGALS9;INHBA;DDIT3;HMGB1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4648020110847602,1.4595928549059682,0.03551136363636364,0.7592474013197165,1.0,18/59,15.59%,RUNX2;PTEN;TCF7L2;AGO4;CDKN2A;THRA;CDK8;MED12;MED6;TWIST1;TP53;MED10;AGO3;MED8;SOX9;MED1;MED25;TNRC6B
prerank,bicarbonate transport (GO:0015701),-0.46773544458122596,-1.4593986421348406,0.056,0.4456256130532014,1.0,11/25,24.81%,SLC4A10;SLC26A7;SLC39A8;SLC4A3;CA4;SLC4A8;CYB5R1;SLC26A6;CFTR;SLC4A7;CYB5R4
prerank,negative regulation of gene expression (GO:0010629),-0.3012634904646747,-1.4592997996547004,0.0,0.44359012284257077,1.0,84/302,17.86%,DAPK1;IGF1;PICALM;SLC24A3;ROCK2;FOXP1;ITGB8;MEF2C;OCLN;ROBO1;PPHLN1;NOTCH2;IGFBP5;APP;KLF4;NFKB1;KDM4A;CLDN5;SRGN;KDR;TMBIM6;WWP2;SAMD4A;NOTCH1;RUNX1;TGFB2;WNT4;CNOT10;SMO;LGR4;CD34;PRKAA2;ADAM10;ATP2B1;DICER1;APOE;LSM6;XDH;CELF1;ACVRL1;MAPT;CNOT8;BTG2;PTBP3;ATOH8;RPS6KA5;CITED2;SFRP1;GATA2;PPM1D;TNRC6A;PARP10;CPEB3;VHL;PARP9;SLC7A5;TARDBP;PAIP2;GAPDH;MAP2K2;RBM4;TLE5;TERT;TNRC6C;PTRH2;HEY2;YBX1;LSM2;JARID2;TOB1;DHFR;EZH2;ERN1;TRIM27;SIRT1;GPER1;PRKAA1;HAVCR2;ESR1;RBBP7;TWSG1;AGO2;PPP1R11;DNMT3B
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.49438164770627424,-1.4583939637158856,0.05063291139240506,0.4437981287105866,1.0,9/20,18.22%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,regulation of feeding behavior (GO:0060259),-0.5794249042090944,-1.4583165105749138,0.06872037914691943,0.4417548970820533,1.0,1/11,0.93%,LEPR
prerank,regulation of phospholipase C activity (GO:1900274),0.6115217800463627,1.4581081332715797,0.08376963350785341,0.7615580961927415,1.0,3/15,3.03%,PDGFRA;NTRK3;FGFR1
prerank,regulation of monooxygenase activity (GO:0032768),-0.47835233649207537,-1.4579652862201,0.06299212598425197,0.4404264050829445,1.0,13/23,22.05%,CAV1;EGFR;NOS3;ZDHHC21;NOSTRIN;CALM1;DDAH1;NOS1AP;AKT1;WASL;NOSIP;LYPLA1;DDAH2
prerank,regulation of establishment of protein localization (GO:0070201),0.6077879813078382,1.4559173305412902,0.09734513274336283,0.7672362507122039,1.0,5/13,11.64%,CORO2B;CEP295;CEP135;SCFD1;SPIDR
prerank,regulation of secretion (GO:0051046),0.6117721627700089,1.4532523220235625,0.07899159663865546,0.7751741946958514,1.0,5/13,15.57%,NRG1;GPLD1;MYO6;POFUT2;SGK1
prerank,neurotransmitter transport (GO:0006836),0.4473320027140872,1.4530942506171327,0.035422343324250684,0.7712713643589737,1.0,17/73,14.58%,SLC1A3;CASK;ATP1A2;SLC18A3;NRXN2;PTPRN2;NRXN1;VAMP2;CHAT;PPFIA2;SNPH;RIMS1;SLC29A1;DNAJC5;UNC13A;PPFIA4;SYN2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5256975299076463,-1.4527539182610056,0.07710280373831775,0.4525149147051093,1.0,8/16,25.49%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;DTX3L;KMT5C
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.519470713217314,-1.4523957159394176,0.06733167082294264,0.4513979582524009,1.0,5/19,6.17%,SLCO1C1;APP;KLF4;NFKB1;KLF2
prerank,regulation of multicellular organismal development (GO:2000026),0.5362966226223895,1.4515715071120459,0.07321131447587355,0.7735797096866248,1.0,5/25,10.89%,PTN;GBX1;CCSAP;KAT2A;DHX36
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5307886540278983,-1.4513454528884315,0.06474820143884892,0.4521120588945422,1.0,8/17,16.71%,RBPJ;NOTCH2;NOTCH1;ACVR1;GALNT11;HEYL;HEY2;SNAI1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5989698469900671,-1.4512763075024055,0.07551487414187644,0.45014500573328314,1.0,5/11,16.48%,MEF2C;EFNB2;TGFB2;GPER1;MYOCD
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6087975362229181,1.4512315899715322,0.08492201039861352,0.7706256148954617,1.0,3/15,4.06%,PPARA;PPARD;NR1H2
prerank,motile cilium assembly (GO:0044458),0.6367727840572639,1.4508960415778913,0.1012216404886562,0.7677254585700278,1.0,4/12,15.25%,RSPH9;E2F4;DNAAF3;CCDC39
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.37510383838274186,-1.4507965407369525,0.02681992337164751,0.44935835417187897,1.0,23/67,14.89%,FN1;DOCK5;LIMS2;DOCK1;VIT;NRP1;S100A10;RAC1;NEDD9;CDK6;CDC42;PPM1F;GSK3B;RSU1;ECM2;SFRP1;NPNT;ARL2;MDK;PLEKHA2;FLNA;PTK2B;CX3CL1
prerank,regulation of telomere capping (GO:1904353),-0.4861380713327823,-1.4506271558022805,0.035422343324250684,0.44765849205949065,1.0,8/23,14.36%,SMG6;TNKS2;NEK7;MAP2K7;RTEL1;ATM;MAP3K4;NBN
prerank,positive regulation of cell projection organization (GO:0031346),0.41741498677783556,1.4497114681534324,0.028151774785801713,0.768757770048012,1.0,28/115,14.06%,ROR1;ROBO2;PTN;NTRK3;PLXNC1;ROR2;TENM3;WNT5A;NTRK2;GRIP1;NGFR;CDKL5;CAPRIN1;PRKCI;CDKL3;CARMIL2;PRKD1;RELN;STMN2;P3H1;EPHA3;DLG4;PLXNB2;RETREG3;ARHGAP35;LRRC7;CUX2;LYN
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6462098900882867,1.4492255629505184,0.08717948717948718,0.7666617991799467,1.0,3/10,15.09%,C5AR1;SORL1;CLU
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.570606683635601,-1.4484885372449894,0.08254716981132075,0.45158126185414343,1.0,3/12,7.21%,PICALM;ROCK2;APOE
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6713904275909088,1.4475977237772515,0.09540636042402827,0.7698051667802895,1.0,4/10,12.54%,ENPP1;APPL2;PRKCB;GSK3A
prerank,heart morphogenesis (GO:0003007),0.4659240124773778,1.4469436419267492,0.05377906976744186,0.7684154455851191,1.0,11/50,12.87%,CHD7;FLRT2;DLC1;RYR2;TBX3;HTR2B;PTK2;MDM4;TGFBR1;SOX9;OLFM1
prerank,cardiac muscle tissue development (GO:0048738),0.471739294177999,1.4468449527269065,0.04525547445255475,0.7646131071306008,1.0,9/50,11.47%,TBX18;MSC;NRG1;SMAD5;GJA1;CACNA1G;BMP7;NDUFV2;MSX1
prerank,positive regulation of macrophage activation (GO:0043032),0.5809489332800993,1.4464413955211548,0.07482993197278912,0.762229370331876,1.0,4/17,9.41%,IL33;WNT5A;TLR6;TLR4
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.47181348490027764,-1.446169980260245,0.06005221932114883,0.4556808994467271,1.0,6/24,10.11%,ROCK2;PRKCH;FOXC1;RUNX1;ERRFI1;TRIM16
prerank,blood vessel endothelial cell migration (GO:0043534),-0.48466038528613387,-1.4453663096196807,0.04864864864864865,0.4558912937008705,1.0,11/22,17.86%,SLIT2;ROBO1;ID1;NRP1;EFNB2;KDR;EPHB4;NR4A1;CDH5;SOX18;AKT1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.41598355614784244,-1.445321715793311,0.03951367781155015,0.4538089423847532,1.0,14/41,22.48%,MEF2C;RBPJ;TPM1;CPE;NOTCH1;TGFB2;SOX4;HEYL;HEY2;SOX11;TGFBR3;PKP2;TGFBR2;SMAD7
prerank,positive regulation of chemokine production (GO:0032722),0.47836366091232313,1.4451106487690741,0.0695266272189349,0.7639782210303814,1.0,8/44,10.90%,IL33;WNT5A;TSLP;TWIST1;MBP;TLR4;EIF2AK2;PYCARD
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4468073020033833,1.4446404412194105,0.04016620498614958,0.7619298469512708,1.0,15/69,8.22%,PDGFRA;PLCL1;PIK3R1;OGT;PTEN;FGFR1;GAB2;PIK3R2;HTR2B;IRS1;NF1;IRS2;PI4KA;RPS6KB1;PLEKHA1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6642518234964732,1.4443508025179483,0.07853403141361257,0.7590298334691592,1.0,8/10,27.97%,HERPUD1;EIF2S1;HSPA5;EIF2AK3;CCL2;DDIT3;ATF4;QRICH1
prerank,cellular response to ionizing radiation (GO:0071479),-0.40199646697045044,-1.4426073887191113,0.02616279069767442,0.45897967617314195,1.0,22/47,27.76%,NET1;CRYAB;MAPK14;TLK2;INO80;ATR;RPL26;ATM;EEF1D;GRB2;CDKN1A;SIRT1;TMEM109;CLOCK;HUS1;RAD51;KDM1A;LIG4;ECT2;RHOB;RHNO1;GADD45A
prerank,negative regulation of biosynthetic process (GO:0009890),0.5906564217562873,1.4422534965618616,0.09310344827586207,0.7643769436490689,1.0,3/16,2.33%,PPARA;SLC30A10;ABCD2
prerank,ERBB2 signaling pathway (GO:0038128),0.5213457851510512,1.441796811677815,0.06717557251908397,0.762303245728094,1.0,7/31,8.66%,PIK3R1;NRG1;ERBB4;PTPRR;NRG2;NRG4;PRKCA
prerank,homotypic cell-cell adhesion (GO:0034109),-0.41369154784202644,-1.4404338538821186,0.05660377358490566,0.463078181174112,1.0,15/39,14.25%,FN1;VCL;PLPP3;ACTB;GNAS;MEGF11;ACTG1;TJP2;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,neutrophil chemotaxis (GO:0030593),0.468608196051981,1.4403006969487604,0.05858310626702997,0.7646963690014817,1.0,7/53,5.33%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6163833634174399,-1.4395769535701728,0.1,0.46318004550995984,1.0,7/10,22.29%,TUT7;UBB;NEDD8;ISG15;UBC;CHFR;UBA52
prerank,fatty acid transmembrane transport (GO:1902001),-0.5051787326878818,-1.4387303484006173,0.06860158311345646,0.4634026238438032,1.0,5/19,5.48%,PRKAG2;ABCD3;SLC2A1;ABCD4;PRKAA2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5912683957022992,-1.4385578464252404,0.0675990675990676,0.46173742992573263,1.0,7/11,24.44%,FOXO1;CAV1;FAS;ATP6V0A2;ATP6V1G1;CCDC115;TMEM199
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6324519722317383,1.4380917132869677,0.08925619834710743,0.7706107288385099,1.0,2/11,0.79%,TARM1;XCL1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6381319855217218,1.4379950762262572,0.08196721311475409,0.7669371259162503,1.0,3/12,8.15%,CDC14B;PTEN;GOLGA2
prerank,sensory perception (GO:0007600),0.48429054106778285,1.4373161112087753,0.06814814814814815,0.7658320358555752,1.0,10/45,11.17%,TRPA1;ADGRV1;MYO7A;NIPSNAP1;C5AR1;PDYN;ADORA2A;PTGES;CLRN1;P2RX4
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6323746132660898,1.4370431152848302,0.0967741935483871,0.7630457779558438,1.0,5/11,11.85%,DLC1;FAP;CIDEA;TP53;PTGIS
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4403576658831566,1.4367834184007526,0.057931034482758624,0.7601476088730078,1.0,16/68,17.67%,IL33;WNT5A;IL16;TSLP;TLR6;TLR8;TWIST1;MBP;TLR4;CYBA;PYCARD;F2R;DHX9;TIRAP;LGALS9;MYD88
prerank,oligosaccharide metabolic process (GO:0009311),-0.4031703292323319,-1.436290927322494,0.04398826979472141,0.4660801878273181,1.0,14/46,13.55%,B4GALT1;ST3GAL6;FUT8;ST8SIA4;B3GALT1;ST3GAL4;ST6GALNAC3;ST3GAL3;MANBA;MAN2C1;MPDU1;ST8SIA2;NAGA;FUT9
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4183219800441794,-1.4357955147741261,0.046583850931677016,0.4652293225779708,1.0,10/37,13.64%,CAV1;BCL2L1;BECN1;RPS7;NCK1;UBB;BAD;BAX;BID;BOK
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6046253218113204,1.4353645312876768,0.09863945578231292,0.7625903612807988,1.0,1/13,0.10%,IL33
prerank,hexose metabolic process (GO:0019318),0.4961512865048457,1.434754283258021,0.06606606606606606,0.7613054957366876,1.0,6/39,6.92%,APOD;GDPGP1;PPARD;IRS2;OMA1;ALDOB
prerank,protein ADP-ribosylation (GO:0006471),-0.44576967945220225,-1.4340868222059486,0.06084656084656084,0.46806026838176235,1.0,13/28,27.96%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;PARP4;SIRT1;SIRT5;PARP1;PARP2;PARP12;ARF4
prerank,sulfur compound catabolic process (GO:0044273),0.4868292148883844,1.4327818727562678,0.06736526946107785,0.7660964032574001,1.0,9/38,10.07%,DCN;GGT5;LUM;BGN;GGT7;VCAN;ADO;GNS;TXN2
prerank,epithelial structure maintenance (GO:0010669),-0.5816743928473165,-1.432749248271128,0.07982261640798226,0.46969346244778437,1.0,2/11,4.20%,CXADR;RBP4
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5394437889897049,1.4323894672116346,0.06593406593406594,0.7639686650299538,1.0,9/26,16.57%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.4415390992147939,-1.4323649015231368,0.05142857142857143,0.4685841734219775,1.0,12/30,23.43%,FLT1;MLLT3;KDR;ACE;SFRP1;FLT4;FLT3;ARMC6;CSF1R;BATF;FSTL3;SP7
prerank,positive regulation of synapse assembly (GO:0051965),0.5247262630660531,1.4319830577438706,0.071875,0.7619735154404953,1.0,10/27,17.98%,SRPX2;EPHB1;GRID2;NRXN1;SYNDIG1;IL1RAP;VSTM5;CUX2;IL1RAPL1;CLSTN1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.408415407435918,-1.4315340046026095,0.030395136778115502,0.4688594003579353,1.0,19/40,26.57%,MAGI2;INSR;VTN;DAB2;B2M;RAB21;SERPINE1;CD63;HIP1;HFE;HNRNPK;WASL;EGF;TBC1D5;CCL19;NTF3;GREM1;ARRB2;BICD1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5219882731686711,1.429601671540299,0.08763693270735524,0.7687443306271182,1.0,4/25,4.74%,ZFYVE28;PPARA;CBLB;CNRIP1
prerank,limb development (GO:0060173),0.5101244756628626,1.429023899670986,0.07596899224806201,0.7674564402472019,1.0,7/28,12.48%,CHD7;KDF1;SALL1;KREMEN1;KAT2A;GLI3;LNPK
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5245582193682228,-1.4289321873057432,0.0775,0.47415850380336094,1.0,5/16,10.60%,CAV1;INPP5F;PPP2R1A;PTPN2;VHL
prerank,regulation of cation transmembrane transport (GO:1904062),0.49892583473524565,1.4289054483124037,0.07407407407407407,0.7641721120958852,1.0,10/29,13.14%,DPP6;DPP10;SLC30A5;KCNIP1;KCNIP2;KCNAB1;KCNIP4;FGF12;KCNN2;KCNAB3
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4535296383411137,-1.4283392969808302,0.0449438202247191,0.47360009493224764,1.0,11/28,20.98%,OCLN;DRG1;RAC1;MAPT;GIT1;ARL2;SLAIN2;MET;CDK5RAP2;NUMA1;FES
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5737394808197679,1.4281855820894995,0.08319467554076539,0.7594227481446523,1.0,5/16,6.74%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5737394808197679,1.4281855820894995,0.08319467554076539,0.7594227481446523,1.0,5/16,6.74%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,intermediate filament organization (GO:0045109),-0.5225407204019175,-1.427335103121857,0.07159353348729793,0.47425883146541653,1.0,3/17,3.27%,VIM;MTM1;KLHL24
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5982133029346323,1.4270081376974377,0.1001669449081803,0.7609047048464013,1.0,3/13,9.31%,APOD;MDFIC;SP100
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.45906543761780644,-1.4266743971601294,0.07277628032345014,0.4740135213560549,1.0,8/26,10.77%,ROCK2;SHANK3;RDX;ACTG1;RAC1;CDC42;SHANK1;FHOD1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5726124307551034,1.4261775148143425,0.0958904109589041,0.7606035342324777,1.0,7/18,15.25%,ODAD4;ADCY10;NPHP3;DNAAF4;SPA17;CABYR;CCDC39
prerank,cellular response to purine-containing compound (GO:0071415),0.650941927818493,1.4256404660755058,0.11267605633802817,0.7591420206306011,1.0,4/10,13.68%,P2RY1;RYR2;TRPM2;RYR3
prerank,negative regulation of viral transcription (GO:0032897),-0.5571561128301208,-1.4252525801953497,0.08447488584474885,0.4762610230947312,1.0,6/13,19.19%,TRIM11;IFITM3;TRIM14;TRIM27;UBP1;HEXIM1
prerank,carboxylic acid catabolic process (GO:0046395),-0.5710420750007258,-1.4246784305880902,0.08980582524271845,0.47573050095767894,1.0,4/12,15.35%,ACOT8;PON3;RENBP;NPL
prerank,synapse assembly (GO:0007416),0.4367546342993129,1.424573849022755,0.04648074369189907,0.7602177858875635,1.0,16/67,11.41%,ADGRL3;WNT5A;PTEN;FARP1;NRXN2;GRID2;NRXN1;GABRA1;LRRTM3;PCDHB16;DSCAM;PCDHB4;PCDHB11;RAB29;GABRG2;PLXNB2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5327111596866345,1.424147850774,0.059748427672955975,0.7585529054441338,1.0,6/23,8.66%,PDE4B;RYR2;APLP1;LRRK2;SLC9A1;PRKACA
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.46901579202840094,-1.423841874850615,0.057291666666666664,0.47610731903659304,1.0,5/21,7.73%,CAV1;APC;DVL1;GSK3B;LRP6
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3698906003287141,-1.4236239769220191,0.0392156862745098,0.47454800371688693,1.0,20/63,15.14%,CXADR;SIPA1L1;FER;EZR;NRP1;RICTOR;PARVB;S1PR1;GSN;PHACTR1;MINK1;ANXA1;NEDD9;GAB1;CDC42BPB;PTPN1;TRPV4;FLNA;GRB2;CDC42BPG
prerank,response to glucagon (GO:0033762),0.5536000752030276,1.4222248283754055,0.08731466227347612,0.7631192232570092,1.0,7/19,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,ameboidal-type cell migration (GO:0001667),-0.3898928206343635,-1.421518015490282,0.03728813559322034,0.47855454993205243,1.0,22/51,20.74%,SEMA3D;SEMA3C;SEMA7A;AMOT;CCN3;GPC3;MEGF8;SRGAP2;SEMA6A;SEMA4B;TBX1;PHACTR4;SEMA5B;AMOTL2;SEMA6C;PKN2;AKT1;SEMA3G;SEMA6B;FAT2;AMOTL1;PKN3
prerank,morphogenesis of an epithelium (GO:0002009),0.5253928798183292,1.4214881754152702,0.08860759493670886,0.7627143445369893,1.0,7/25,12.02%,TBX18;KDF1;TRAF3IP1;PRKX;AHI1;SOX10;SOX9
prerank,limb morphogenesis (GO:0035108),-0.4919431686394519,-1.4213676835156446,0.06572769953051644,0.4769068978740441,1.0,6/20,7.73%,CYP26B1;MBNL1;TGFB2;SKI;MEGF8;LRP6
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4521369452136389,1.421087902058594,0.06128133704735376,0.7609491178464922,1.0,19/60,15.59%,RUNX2;PTEN;TCF7L2;AGO4;CDKN2A;CDK8;MED12;SRF;MED6;TP53;DHX36;MED10;AGO3;MED8;SOX9;MED1;MED25;PAXIP1;TNRC6B
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.6007318895624089,-1.4206535221445662,0.08695652173913043,0.4768178987086021,1.0,4/10,15.35%,ST6GAL1;ST3GAL1;RENBP;NPL
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4478574738822542,-1.420244900470292,0.058673469387755105,0.47585166910475823,1.0,5/26,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,acylglycerol catabolic process (GO:0046464),0.5102874139638827,1.4202135390285227,0.07208588957055215,0.7608523269796538,1.0,8/30,12.16%,LIPH;LIPC;FABP5;FABP4;ABHD16A;LYPLA2;ABHD12;FABP3
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5956413279426893,-1.4197641452021381,0.08076009501187649,0.4752804838462704,1.0,2/10,1.30%,CD200;SLIT2
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5032765450465752,-1.4196402228215144,0.0857843137254902,0.47364315377716143,1.0,3/18,3.83%,PRKAG2;OCLN;SLC2A1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5915625085176217,1.4194747123725535,0.09656301145662848,0.7602579588722217,1.0,6/16,15.41%,AUTS2;KMT2A;BCOR;WDR5;SNW1;PAXIP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4841668473307512,-1.4194093454458883,0.09523809523809523,0.47224560143310074,1.0,11/18,25.06%,EZR;RDX;DAB2;RAB21;MAP2K2;VPS11;MSN;SNX3;MTMR2;SRC;DNAJC13
prerank,aorta development (GO:0035904),0.59895710721112,1.419407926297993,0.09814814814814815,0.7569096571798546,1.0,2/14,0.48%,ROBO2;LRP1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5981427832159404,1.4192592876920278,0.1048951048951049,0.7540417167475048,1.0,3/14,7.70%,GHR;PIK3R1;PTK2
prerank,regulated exocytosis (GO:0045055),-0.3209241124437428,-1.419222720648614,0.0,0.47076044676592144,1.0,44/173,18.27%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;LHFPL2;ANXA5;APP;PCDH7;SPARC;ECM1;SRGN;SYT9;TGFB2;VEGFD;VEGFC;CD109;ARHGAP17;PDGFA;STX1A;CALM1;ENDOD1;RAB31;SERPINE1;TAGLN2;CD63;LGALS3BP;ITGB3;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;SYNGR2;ALDOA;CPLX2;LAMP2;CPLX1;EGF
prerank,negative chemotaxis (GO:0050919),-0.41708005988451435,-1.4186272230748078,0.0521978021978022,0.47033485949946424,1.0,9/33,6.77%,SEMA3D;SEMA3C;SLIT2;ROBO1;NTN1;SEMA7A;SEMA6A;SEMA4B;PDGFA
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.44681051779570125,-1.4183916074462537,0.075,0.4688908780089335,1.0,8/26,9.23%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;SLC35D2
prerank,cellular protein metabolic process (GO:0044267),-0.29041685958859986,-1.4181420950132617,0.0,0.4675570832611039,1.0,113/396,18.25%,FN1;ST3GAL6;IGF1;ST8SIA4;IGFBP6;RPS14;RPS9;IGFBP5;MSRB3;APP;FSTL1;PAPPA;CPE;CST3;UBE2G1;RPS16;IGFBP3;PRKDC;RPLP1;RPL13;WWP2;FDX1;DENND3;RPL27A;IGFBP2;RPS2;UBE2D3;GPC3;ST3GAL1;RPL37A;RPL5;RPL8;ADAM10;SERPIND1;RPS7;RPL41;RPS18;PRSS23;RPS20;FBXL2;RPS19;RPS24;LMCD1;RPS27;NUCB1;RPS15;APOE;CCN1;ABCA3;RPL21;RPL10;TNC;RPL35A;MSLN;LAMB2;RPS15A;MANBA;RPL10A;RPS5;RPL11;SPCS2;ABCF1;RPL36A;EEF1A1;SHISA5;RPL34;ST8SIA2;CTSH;RPLP2;RPS29;SEC11C;GALNT11;RPL32;RPL4;RPLP0;APH1A;RPL30;RPL26;RPS4X;RPS21;RPL29;CLN5;APH1B;MMP15;CSNK1G3;RPS8;GOLM1;GATA6;FURIN;MRPS7;USP25;F5;MMP1;RPL31;CHRDL1;FDXR;PARP4;PCSK5;RPS23;UBE2L6;RPL23A;NEDD8;SIAH2;YME1L1;TTF1;SRBD1;MRPS17;AGO2;YES1;RPL19;MFGE8;QPCT;RPL36
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4877283848918127,-1.4179332878451596,0.06561679790026247,0.4660851656475105,1.0,7/18,19.11%,EZR;RDX;VPS35;VPS11;VGLL4;MSN;WDR91
prerank,outer dynein arm assembly (GO:0036158),0.5772009763645811,1.4179142643512446,0.09515570934256055,0.7561115819225851,1.0,3/14,3.61%,CCDC63;ODAD4;DNAAF4
prerank,positive regulation of cell communication (GO:0010647),0.5159215822104254,1.417899165877738,0.09146341463414634,0.7526554310204074,1.0,10/28,18.61%,HCRT;EDN3;GRIK2;ANK3;RIMS2;RIMS1;DLG4;NMU;CLSTN1;SYT1
prerank,regulation of synapse assembly (GO:0051963),0.46919129771622764,1.4178316212122746,0.06360946745562131,0.7494486004813791,1.0,16/46,18.74%,ROBO2;SRPX2;EPHB1;GRID2;NRXN1;GPC4;SETD5;SYNDIG1;LRFN5;IL1RAP;CUX2;LHFPL4;IL1RAPL1;SLITRK1;CLSTN1;GPC6
prerank,epithelium development (GO:0060429),-0.34233540253337047,-1.417777260903978,0.014634146341463415,0.464553686680193,1.0,25/107,13.88%,ALDH1A2;VCL;OSR1;KANK2;KDR;WNT4;SMO;DVL1;CD34;SIX1;ERRFI1;TOLLIP;PGK1;TBX1;SOX17;BDH2;PTER;TBX2;TAGLN2;TAGLN;DAG1;PCNA;ALDOC;GATA6;MFSD2A
prerank,renal water homeostasis (GO:0003091),0.5315242410594597,1.4177048006163866,0.0736,0.746555743432653,1.0,7/23,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,positive regulation of glucose import (GO:0046326),-0.48317985073420877,-1.4176881478349068,0.06153846153846154,0.4628409288955922,1.0,6/21,4.57%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,embryonic eye morphogenesis (GO:0048048),-0.5907323136405737,-1.4173700710400545,0.08450704225352113,0.46174688348644743,1.0,6/11,22.73%,MFAP5;LRP6;TBX2;EFEMP1;MFAP2;KDM2B
prerank,modulation by symbiont of host process (GO:0044003),-0.5983031215905582,-1.4169700437725463,0.08207343412526998,0.46099576528958724,1.0,7/10,22.29%,UBB;B2M;PGK1;ENO1;UBC;MRC1;UBA52
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4101520774534832,1.4162841180539818,0.03850931677018633,0.7490406566733084,1.0,25/102,11.15%,ENPP1;LPIN3;PIK3R1;ADCY5;CPEB1;SLC30A10;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;ADCY8;ADCY3;ADCY2;PRKACB;RPS6KB1;PRKACA;ADCY7;GCK;SLC25A33;RAB15
prerank,negative regulation of transferase activity (GO:0051348),0.5087758704041521,1.4154448667571473,0.0899390243902439,0.7493753338893724,1.0,10/28,12.54%,NPRL2;FBXO5;IRS2;LIMK1;ERCC4;TERF1;EIF4A2;PIF1;TP53;GSK3A
prerank,cardiolipin metabolic process (GO:0032048),-0.5533067809497729,-1.4153473722501142,0.08505747126436781,0.46350657926947225,1.0,6/13,17.31%,PLA2G4A;PGS1;LCLAT1;PLA2G6;HADHA;PLSCR3
prerank,protein localization to cell junction (GO:1902414),-0.4765045381978342,-1.4147746848720162,0.082010582010582,0.4630656322420498,1.0,6/22,7.61%,HEG1;TJP1;ARHGEF18;CGNL1;TJP2;SHANK1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.6395554287081268,1.4139115867114231,0.10782608695652174,0.7523938212546838,1.0,5/10,21.42%,CD40;FGR;LYN;BAG6;BTLA
prerank,regulation of platelet activation (GO:0010543),0.5464852424609006,1.4137678621987537,0.08860759493670886,0.749488862944394,1.0,6/21,9.41%,PDGFRA;HRG;TXK;C1QTNF1;PRKCA;TLR4
prerank,diterpenoid metabolic process (GO:0016101),0.45065271545755514,1.4124047131355673,0.06438356164383562,0.751860971524846,1.0,7/55,4.65%,LRP1;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,negative regulation of response to external stimulus (GO:0032102),0.411254638783831,1.411951453897833,0.04949238578680203,0.7503292999378829,1.0,14/105,7.85%,RORA;CASK;PPARA;CTNNA2;PTEN;TRAF3IP1;GRID2;NR1H4;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,positive regulation of neuron migration (GO:2001224),-0.5765587881785614,-1.411697416147263,0.09360730593607305,0.46968229955441815,1.0,3/11,11.42%,RAPGEF2;SEMA6A;MDK
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.5169949033847656,-1.4110334602855343,0.10396039603960396,0.4696134533233894,1.0,5/16,4.82%,IGF1;IGFBP6;IGFBP5;IGFBP3;IGFBP2
prerank,lipoprotein localization (GO:0044872),0.6383389453640562,1.4105506165393187,0.11627906976744186,0.7530102168670739,1.0,3/11,9.16%,LRP1;UNC119;PRKCB
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5077653727152882,1.4102628944714053,0.08850931677018634,0.7508766275529045,1.0,11/31,15.80%,PDGFRA;EIF4A3;HOXC9;DSCAML1;TWIST1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.40686446862673936,-1.4099946474237044,0.036619718309859155,0.4703684079620739,1.0,11/39,8.29%,TSPAN5;RBPJ;ROBO1;MAML2;NOS3;NOTCH1;TGFB2;CCN3;IL6ST;EPN2;ITGB1BP1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5710494702946033,-1.4099365928035716,0.10208816705336426,0.46864755720971585,1.0,7/11,24.78%,KANK1;CD44;ENPP2;ARPIN;PDPN;CORO1B;SRC
prerank,negative regulation of macrophage activation (GO:0043031),-0.5139912465617397,-1.4098282232609383,0.07231920199501247,0.467097803303043,1.0,2/16,0.90%,CD200;IL31RA
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6350664626917724,1.4095720114731318,0.0948905109489051,0.7504158515130184,1.0,7/10,21.52%,GPR37L1;LRRK2;PYCR1;RIPK1;GPR37;STK26;PDE8A
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.40320186487254095,-1.4086177785481304,0.042105263157894736,0.46867703849526937,1.0,19/46,23.30%,PLCB1;SOD2;CDC42;TALDO1;PITPNA;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,response to organonitrogen compound (GO:0010243),0.481278417163702,1.408522350278499,0.06791907514450866,0.7516364163557248,1.0,16/38,19.56%,NR1H4;KYNU;SEL1L;MTOR;DNAJB12;GLRA3;GLRA1;RCN3;TRPM2;GLRA2;MEAK7;GLRB;BRSK2;UBXN6;KAT7;RHBDD1
prerank,potassium ion transport (GO:0006813),0.40274452077820366,1.4082364548232158,0.03286978508217446,0.7496360539753629,1.0,24/120,13.14%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNQ3;SLC9A9;KCNMA1;KCNIP2;SLC9A1;KCNG1;KCNH4;KCNAB1;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNK1;KCNN2;KCNH7;KCNJ8;KCNAB3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6227475135116811,1.4072700113697958,0.10582010582010581,0.74717661993008,1.0,2/11,3.37%,IL2RA;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.6227475135116811,1.4072700113697958,0.10582010582010581,0.74717661993008,1.0,2/11,3.37%,IL2RA;JAK1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6065437523029766,1.4070487387226152,0.10152284263959391,0.7448339435653596,1.0,2/14,1.27%,ECE1;EDN3
prerank,sterol homeostasis (GO:0055092),0.442945297355503,1.4062893539053238,0.058091286307053944,0.744890730675349,1.0,5/65,5.09%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,organelle fission (GO:0048285),0.5296719762585372,1.406153730058557,0.11442786069651742,0.7422086248320238,1.0,8/24,15.42%,SEC16B;MTFR2;OPA1;DNM1;WASHC5;PEX11A;MTFP1;PEX19
prerank,negative regulation of protein processing (GO:0010955),-0.5602316280849446,-1.4048084700676937,0.0825,0.4776633207386509,1.0,6/12,14.38%,THBS1;GAS1;SERPINE1;TMEM59;SERPINE2;CTSZ
prerank,regulation of hydrolase activity (GO:0051336),-0.3597570154534116,-1.4042773762246599,0.04597701149425287,0.47722444957452226,1.0,23/71,16.04%,PLXNA2;EPHA4;FGD5;CAV1;PLXNA4;CHN2;SIPA1L1;RAPGEF6;RDX;RASIP1;EFNA5;RALBP1;ITGB1BP1;PLXNB1;NGEF;ARHGAP12;ARHGAP27;NOS1;PRKG1;TBC1D10B;ARHGAP15;PLXNA1;ARHGAP44
prerank,cholesterol homeostasis (GO:0042632),0.4445591152415432,1.4039141751140463,0.060941828254847646,0.7484390888747949,1.0,5/64,5.09%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.48504674337707265,-1.403883594788032,0.09375,0.47649357777982954,1.0,5/19,20.49%,IGF1;GIT1;CX3CR1;CX3CL1;TNFAIP3
prerank,histone H3-K36 demethylation (GO:0070544),-0.5901630891695421,-1.4028612295616556,0.09656652360515021,0.4773796961115859,1.0,6/10,22.73%,KDM4A;KDM4C;RIOX2;PHF8;KDM4B;KDM2B
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5038719035720262,1.4028417565801214,0.0887218045112782,0.7496191162373708,1.0,3/32,1.71%,CXCL10;HRG;CXCL1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4478294596449708,-1.402765595730852,0.049868766404199474,0.4758033041336405,1.0,5/26,5.48%,PRKAG2;ADIPOR2;ERLIN1;LPGAT1;PRKAA2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5761448354030684,-1.4026565780569187,0.1162227602905569,0.4742965291356521,1.0,7/11,18.83%,ARL6IP5;MAP3K5;CYP1B1;PRODH;STK25;PRKCD;GSKIP
prerank,response to growth factor (GO:0070848),-0.404205526602095,-1.4021901497552456,0.04747774480712166,0.4736835346385464,1.0,21/41,23.68%,KLF4;BMPR2;ACVR1;ACVRL1;SFRP1;TBC1D7;NOS1;GATA6;CPNE3;PLK5;MAP2K5;EPHA2;ACVR2B;ERBB2;AKT1;CIB1;HDAC6;TGFBR2;TWF2;ACVR2A;EMD
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5225009359956152,-1.4017495547256729,0.10294117647058823,0.47314649227289823,1.0,10/16,20.26%,NPR3;SCARB1;APOE;GCH1;PIK3CB;TERT;NOS1AP;DHFR;AKT1;NUS1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.3567022632897287,-1.401423950324068,0.058823529411764705,0.4721592589679654,1.0,27/70,20.38%,BCL2L1;CASP8AP2;MCL1;FAS;TGFB2;GABARAP;CRADD;NGF;CASP2;GSK3B;HIPK1;IFI27;CASP3;SMAD3;CASP8;BAD;BAX;RNF41;BAG3;BID;BOK;P2RX7;TNFRSF1A;FGFR3;ERBB3;CIB1;TRADD
prerank,activation of phospholipase C activity (GO:0007202),0.49613757754543586,1.4009179765432125,0.07777777777777778,0.7547377184774178,1.0,7/29,12.36%,NTRK2;TXK;C5AR1;ARHGAP6;HTR2B;LPAR1;CD86
prerank,retinol metabolic process (GO:0042572),0.5922704237228477,1.4007073660345877,0.10332749562171628,0.7524407861589383,1.0,3/14,2.38%,ADH1A;RDH10;RDH11
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5730977596370226,-1.400638045837588,0.10256410256410256,0.4724665096241173,1.0,6/10,13.99%,RAPGEF2;KDR;RAP1A;CD34;CEACAM1;RRAS
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5382426884287146,1.4005024762732066,0.10714285714285714,0.75016680821231,1.0,4/21,8.27%,PPARA;SLC30A10;ABCD2;PINK1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4664017087647589,-1.3984949374207287,0.08222811671087533,0.4764533653449759,1.0,6/23,20.49%,IGF1;GIT1;CX3CR1;CEACAM1;CX3CL1;TNFAIP3
prerank,regulation of hippo signaling (GO:0035330),-0.5061532394478054,-1.3983369484907502,0.09004739336492891,0.4750156819118124,1.0,8/17,18.24%,MAPK14;MOB3B;SCHIP1;DLG5;AJUBA;MARK3;VGLL4;SOX11
prerank,cellular sodium ion homeostasis (GO:0006883),0.58648406580426,1.3981034710413254,0.09515859766277128,0.7570519859191901,1.0,3/15,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,lamellipodium organization (GO:0097581),-0.4380829654626517,-1.3976611934078458,0.05333333333333334,0.4750383890521682,1.0,8/29,11.40%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SPATA13;CCDC88A
prerank,potassium ion transmembrane transport (GO:0071805),0.3936619659581122,1.397187537613018,0.034782608695652174,0.7578528078240304,1.0,27/135,13.14%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNT2;KCNQ3;SLC12A6;SLC9A9;ATP1A3;KCNIP2;SLC9A1;KCNG1;KCNH4;KCNAB1;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNE4;KCNK1;KCNN2;KCNH7;KCNJ8;KCNAB3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6225891009363258,1.3959272541192755,0.11826086956521739,0.7601078001892833,1.0,2/10,0.85%,DCN;HRG
prerank,bone morphogenesis (GO:0060349),-0.5344829511737853,-1.3953207858190242,0.0737913486005089,0.47955126299167095,1.0,4/14,7.73%,CYP26B1;BMPR2;SKI;LRP6
prerank,response to ethanol (GO:0045471),0.591805190220551,1.3951320853861444,0.11208406304728546,0.7602859121636727,1.0,6/14,17.61%,GRIN2B;GRIN2A;ADCY7;GLRA1;GLRA2;GRIN3A
prerank,respiratory system development (GO:0060541),0.49272981457044446,1.3948912457775589,0.08268330733229329,0.7581409119592851,1.0,5/32,4.20%,CHD7;BASP1;ITGA3;NPHP3;LOXL3
prerank,positive regulation of kinase activity (GO:0033674),0.40819405917303564,1.3942478821365754,0.0364321608040201,0.7576487298770846,1.0,22/107,10.40%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;TRAF4;ERBB4;EPHB1;FGFR1;EPHA6;CENPE;MRNIP;PTK2;RELN;EPHB6;AXL;JTB;DAXX;CACUL1;EPHA3
prerank,regulation of synapse organization (GO:0050807),0.5098368516615228,1.3936935524078105,0.10832025117739404,0.7569051049458363,1.0,9/26,8.05%,ARHGAP22;CTNNA2;WNT5A;YWHAZ;CDKL5;NEDD4;SETD5;ABHD17C;ABHD17B
prerank,response to insulin (GO:0032868),0.4187729880535409,1.393482151764739,0.05958549222797927,0.7547434681317453,1.0,21/80,13.01%,ENPP1;LPIN3;PIK3R1;OGT;CPEB1;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;GCK;SLC25A33;ZBED3;RAB15;GSK3A;MEAK7
prerank,iron ion homeostasis (GO:0055072),-0.3718699369266129,-1.3933508087760222,0.03666666666666667,0.48324399659238165,1.0,25/58,24.44%,ABCG2;PICALM;NEO1;HMOX2;CUL1;TFRC;SCARA5;B2M;BDH2;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;TMEM199
prerank,steroid biosynthetic process (GO:0006694),0.4451701789741913,1.3928471515831498,0.07365439093484419,0.7541337647191507,1.0,6/56,6.24%,HSD11B1;CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D
prerank,positive regulation of phospholipase activity (GO:0010518),0.5385340332996718,1.3926099984043572,0.10383386581469649,0.7520392918097161,1.0,4/22,3.87%,PDGFRA;NTRK3;FGFR1;PDPK1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4445528116496507,-1.392355329799853,0.064343163538874,0.4842544620438557,1.0,6/26,4.57%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,regulation of viral entry into host cell (GO:0046596),-0.43037619045082987,-1.3923202848706222,0.049707602339181284,0.48254358263176544,1.0,16/30,29.49%,LY6E;GSN;TRIM25;TRIM5;TRIM11;IFITM3;TRIM14;IFITM1;TRIM27;CD74;SNX3;IFITM2;TRIM6;P4HB;CIITA;MID2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4181211647100491,-1.3914247049997048,0.060790273556231005,0.4833387237165281,1.0,12/32,15.22%,THBS1;KLF4;FOXC2;KDR;JCAD;NOTCH1;ANXA1;ITGB1BP1;GATA2;FGFBP1;MAP2K5;PTGS2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5938535515815185,1.390544158200896,0.11452991452991453,0.757690865919918,1.0,4/12,12.10%,DCN;HRG;ADAMTS12;IL12A
prerank,odontogenesis (GO:0042476),0.47936039219936744,1.3904006513985718,0.09145427286356822,0.7552129619055052,1.0,8/35,6.89%,LAMB1;EDA;HDAC1;ANKRD11;TUFT1;BCOR;COL1A2;AMELX
prerank,epiboly involved in wound healing (GO:0090505),-0.5039193634433741,-1.389878418486994,0.08816120906801007,0.4858008830911226,1.0,9/16,16.27%,CCN1;CD44;TMEFF2;RHOC;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6165891555832709,1.3896888870620288,0.13485113835376533,0.7551756142126235,1.0,3/10,9.11%,MAP4K4;IQSEC1;MTOR
prerank,microtubule-based transport (GO:0099111),0.5930281628333235,1.3896193559390964,0.1013745704467354,0.7525134878021441,1.0,4/12,11.25%,ADCY10;DNAAF4;SPA17;CABYR
prerank,positive regulation of positive chemotaxis (GO:0050927),0.571263049807122,1.3891347949536554,0.1035653650254669,0.7515491118828546,1.0,2/15,2.18%,NTRK3;IL16
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3652711406344773,-1.388953065745091,0.038910505836575876,0.4865601013898786,1.0,22/55,24.27%,CAV1;BCL2L1;TPD52L1;BECN1;TNFSF10;FAS;WWOX;CRADD;BAD;BAX;BID;CYLD;BOK;GPER1;ING5;PAK2;AGT;NUPR1;BCL10;TRIM39;HYAL2;BCL2L11
prerank,B cell differentiation (GO:0030183),-0.3881271948624344,-1.3889252549067639,0.056105610561056105,0.48488388335097554,1.0,20/46,28.15%,PTPRJ;FNIP1;TPD52;ITGB1;HDAC4;DNAJB9;PTPN2;IRF2BP2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK;KLF6;CLCF1;JAK3;ADGRG3;MSH2;HDAC5
prerank,negative regulation of lipid storage (GO:0010888),0.5341215088485439,1.3874587730473045,0.10771704180064309,0.7554931288318832,1.0,4/19,4.06%,PPARA;ITGAV;PPARD;NR1H2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5677692193510085,1.387380349075929,0.09666666666666666,0.7528440317754982,1.0,5/16,13.17%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.571182305828206,-1.3862796723340358,0.10407239819004525,0.4904469639300321,1.0,5/11,9.63%,THBS1;SEMA6A;KLF2;EPN2;PIK3CB
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43167643354514673,1.3862570279934074,0.07307171853856563,0.7546469003290595,1.0,22/65,18.74%,RORA;CPEB1;TBL2;EPAS1;EGLN2;HP1BP3;MDM4;TWIST1;PINK1;MTOR;AK4;BMP7;KCND2;TP53;PTGIS;FAM162A;SCN2A;MYC;TSC1;ADAM8;SUV39H2;HIF1A
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5586396023447097,1.3858142700805893,0.12286689419795221,0.7535640842704552,1.0,5/16,10.89%,RBM24;ZC3H12D;DND1;ZFP36L2;DHX36
prerank,regulation of anoikis (GO:2000209),-0.47979936781902294,-1.3856652695555274,0.105,0.49034106344275835,1.0,8/19,12.66%,CAV1;ITGB1;MCL1;NOTCH1;SIK1;MYBBP1A;TLE5;PTRH2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.394425542167912,-1.385617584649205,0.03666666666666667,0.4886962053280082,1.0,6/43,2.31%,IGF1;FOXP1;IL18;ADAMTS1;THBS1;IGFBP5
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.42158917614249886,1.3852165849903881,0.07094133697135062,0.7530354865142724,1.0,20/76,16.07%,FANCI;PRICKLE1;MYCBP2;GNL3;LRRK2;PSMD10;PINK1;TSPYL5;COMMD1;BIRC2;SAE1;NDFIP2;SPRTN;GSK3A;PTTG1IP;DCUN1D5;AXIN1;UBE2D1;PAXIP1;NDFIP1
prerank,regulation of muscle contraction (GO:0006937),-0.45001360861947126,-1.3850926716790841,0.0855614973262032,0.4883788324295003,1.0,7/26,13.26%,PLCE1;CAV1;TPM1;SRI;MYL9;PPP1R12B;ENO1
prerank,base-excision repair (GO:0006284),0.4488913010874642,1.3848812061447093,0.08658008658008658,0.7514805934120619,1.0,13/48,13.74%,POLG;LIG3;FEN1;POLQ;ERCC5;NEIL3;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,DNA packaging (GO:0006323),0.5698813295954164,1.3848168260509226,0.12307692307692308,0.7488009156658945,1.0,4/16,10.60%,NAA10;CHAF1B;NOC2L;TP53
prerank,endocardial cushion development (GO:0003197),-0.48244083946456384,-1.3845397786330917,0.07161125319693094,0.48809039771279705,1.0,8/21,11.63%,NOS3;BMPR2;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,rRNA processing (GO:0006364),-0.3112900137368902,-1.3839934786529773,0.0,0.48787044294877113,1.0,84/172,30.71%,NSA2;RPS14;RPS9;RPS16;PRKDC;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;LSM6;RPL21;PDCD11;RIOK1;RPL10;RPL35A;ERI1;DDX27;RPL10A;RPL11;RPL36A;RPL34;RPLP2;ESF1;UTP3;RIOK3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RPL31;IMP3;EXOSC3;RPL23A;SART1;RPL19;RPL36;WDR12;PES1;RRP15;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52;TSR3;WDR74;PWP2;RPL15;RPL38;MRM2;NOP2;RSL1D1;RPL13A;EXOSC4;RPS25;NHP2;RPL24;RPL18A;WDR75;RRP36;BMS1;PIH1D2;NOP53;RRP9;WDR46;RPL22
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5202241870039368,1.3834259990356,0.09904153354632587,0.7517171273879427,1.0,4/22,9.31%,APOD;MDFIC;LRRK2;SP100
prerank,mesenchymal cell differentiation (GO:0048762),-0.37991874375026413,-1.3831585017266261,0.046511627906976744,0.4884639026163245,1.0,12/51,7.73%,RANBP3L;ROCK2;DDX5;MEF2C;RBPJ;LEF1;FOXC1;NOTCH1;TGFB2;WNT4;GSK3B;LRP6
prerank,motor neuron axon guidance (GO:0008045),-0.5246326906776876,-1.3829283546874513,0.1036036036036036,0.48735167836155935,1.0,5/15,5.15%,EPHA4;SLIT2;NTN1;TMEFF1;RAC1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.4432008135833084,-1.3826108218231563,0.09192200557103064,0.48663722696163225,1.0,7/25,6.75%,EGFR;THBS1;APP;ITGA6;NRP1;PTGES3;FZD7
prerank,sulfur compound transport (GO:0072348),-0.436130241088625,-1.3823470924734076,0.09016393442622951,0.48562657951644167,1.0,6/27,7.78%,ABCG2;SLC13A4;SLC26A7;SLC6A6;SLC26A11;LRRC8D
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5114851331337136,-1.3823034041581759,0.1180722891566265,0.4840879378708908,1.0,5/15,28.42%,MOXD1;PAOX;SAT2;DDC;SRM
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5493993694887067,1.3822395910724234,0.11221122112211221,0.7535692740541776,1.0,7/19,5.53%,SCRIB;DLG3;FSCN1;MTCL1;PARD3B;DLG2;PRKCI
prerank,Wnt signaling pathway (GO:0016055),-0.33618863567159335,-1.3822380991304735,0.025,0.482603406813342,1.0,33/92,18.81%,LEF1;WNT5B;PLPP3;CPE;NXN;WNT9A;VPS35;WNT4;APC;DVL1;CUL1;WLS;FZD4;UBB;FZD7;ARL6;GSK3B;LRP6;WNT6;SFRP1;NR4A2;BCL9L;PLCG2;FZD3;CSNK1G3;CCDC88C;VPS29;WNT16;FZD8;UBC;CSNK1A1;WNT11;SNX3
prerank,response to axon injury (GO:0048678),0.5475633166391136,1.381815467576254,0.11853088480801335,0.7524755956847862,1.0,1/18,0.04%,APOD
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6251839759733328,1.3813330459713404,0.12844036697247707,0.7514955695289356,1.0,2/10,5.62%,DCN;LRRK2
prerank,regulation of protein kinase C signaling (GO:0090036),0.5703138952167206,1.3810840643695137,0.1234991423670669,0.7497159893725546,1.0,3/14,2.15%,ADGRV1;WNT5A;CD40
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5346807784399095,1.380759284010539,0.10869565217391304,0.7481752783699444,1.0,7/21,15.43%,LPIN3;CEL;PPARD;FAH;HOGA1;NUDT19;LPIN2
prerank,cardiac cell development (GO:0055006),-0.5578907410455067,-1.380748288982464,0.12183908045977011,0.485090643307642,1.0,3/11,9.16%,CXADR;NOTCH1;MYH11
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4336927432817393,-1.3802595923550853,0.08288770053475936,0.48475375980541174,1.0,10/27,8.02%,PHLDB2;TJP1;ARHGEF18;WASF2;SHANK3;F11R;CGNL1;SHANK1;TMEFF2;RHPN2
prerank,purine ribonucleotide transport (GO:0015868),-0.5015509755901165,-1.3797636878454915,0.11724137931034483,0.4844663986089589,1.0,4/16,7.78%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,sulfur amino acid catabolic process (GO:0000098),0.6329748486835003,1.379667067914158,0.11387900355871886,0.7497032245132186,1.0,4/10,10.07%,MTRR;BLMH;ADO;TXN2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4481192222142231,-1.3794899149936732,0.08498583569405099,0.4835867537180091,1.0,8/25,11.74%,ACTN2;ATP1B3;WNK4;WNK1;ANK2;STAC;DMD;TRPC6
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.49269785079492545,-1.3794403845761682,0.07769423558897243,0.48208684635311705,1.0,7/18,12.37%,SAMHD1;DERA;FUCA1;OGA;MANBA;NGLY1;NAGA
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4951216224500341,-1.3793450619327747,0.07751937984496124,0.48074582262452986,1.0,7/17,9.90%,SLIT2;ROBO1;NRP1;EFNB2;KDR;EPHB4;NR4A1
prerank,carbohydrate catabolic process (GO:0016052),-0.4035090643328585,-1.3792131311251687,0.058997050147492625,0.47946896236282976,1.0,19/38,20.82%,DERA;HK1;LDHA;PGK1;PFKFB2;HK2;TPI1;MANBA;MAN2C1;GAPDH;NAGA;PKM;ALDOC;ENO1;PFKL;ALDOA;MAN2B2;GAPDHS;PGM1
prerank,positive regulation of dendrite development (GO:1900006),0.6306171078684496,1.3787981856876177,0.09661016949152543,0.7504056328428477,1.0,2/10,9.69%,PTN;BMP7
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.36691154991935426,-1.3786027888953407,0.06206896551724138,0.47937736585148755,1.0,27/54,29.79%,NSA2;RPL5;RPL10;RPL35A;RPL10A;RPL11;RPLP0;RPL26;RPL23A;MRPL20;WDR12;PES1;NIP7;NPM1;PAK1IP1;RRP15;LAS1L;GTF3A;WDR74;NOP2;RSL1D1;RPF2;NHP2;LTO1;RPL24;NOP16;NOP53
prerank,myeloid leukocyte differentiation (GO:0002573),-0.36367681821945885,-1.378185078609833,0.04,0.47879886219588735,1.0,36/65,34.76%,FOXP1;PIR;IL31RA;LEF1;RUNX1;CDC42;RXRA;MAPK14;OSTM1;GLO1;CASP8;PIK3CD;CDKN1A;SIRT1;PDE1B;EPHA2;E2F1;TGFBR2;CSF1R;BATF;TYROBP;MYH9;CCL19;PARP1;SPI1;SBNO2;SNX10;CEBPA;PPARG;CSF1;MT1G;EFNA2;TREM2;BATF2;PML;DEK
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5773244585703681,1.37789560104634,0.10824742268041238,0.7511933010517416,1.0,4/15,3.66%,DCN;BGN;DSE;VCAN
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.44120937513843195,-1.3777414678918056,0.08719346049046321,0.4784672078902891,1.0,12/26,19.40%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;MTBP;ANXA1;HYAL1;CCND1;ANKRD17;AKT1;RGCC
prerank,negative regulation of immune effector process (GO:0002698),-0.5250461554663047,-1.3766190417594473,0.09722222222222222,0.4799077863504035,1.0,5/13,16.77%,FER;CD55;RPS19;RC3H1;HAVCR2
prerank,mesenchyme morphogenesis (GO:0072132),-0.5061602303444726,-1.3757698472949063,0.1066350710900474,0.48064388992335594,1.0,7/17,11.63%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,granulocyte chemotaxis (GO:0071621),0.4447745367271469,1.3756954052936228,0.08636977058029689,0.7573936208979201,1.0,7/55,5.33%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,positive regulation of cytokinesis (GO:0032467),0.48566993901850875,1.3753045148328051,0.08992248062015504,0.7561224489950602,1.0,3/32,0.93%,SVIL;CDC14B;RXFP3
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3586405322056377,-1.3752097195659803,0.056818181818181816,0.48056648201718827,1.0,19/62,14.67%,IGF1;ROBO1;NET1;NOTCH2;F11R;RASGRF1;GPR4;SHOC2;NOTCH1;RAC1;RAPGEF1;NGF;PRAG1;PIK3CB;STK19;MAPRE2;ALS2;GRB2;ADGRG1
prerank,positive regulation of reproductive process (GO:2000243),-0.4205818856454117,-1.3747286898252165,0.06460674157303371,0.48024575604780456,1.0,4/31,8.18%,PLCB1;LHFPL2;PDE3A;SMURF2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4550882185551874,-1.3746140203463586,0.08421052631578947,0.478983898364947,1.0,6/21,10.59%,FOXP1;PRKCH;ELF1;RUNX1;SLC39A10;ELF2
prerank,vitamin transport (GO:0051180),-0.431106789112468,-1.3739292303262427,0.0856269113149847,0.479237083636955,1.0,21/29,47.78%,ABCG2;SLC25A32;PDPN;CUBN;SLC52A3;AFM;SLC52A2;CD320;TCN2;SLC5A6;TTPA;SLC2A2;SLC23A1;TCN1;SLC27A1;SLC46A1;AMN;SLC2A6;SLC2A10;FOLR2;FOLR1
prerank,regulation of cholesterol storage (GO:0010885),0.5646056987519388,1.3733503290651676,0.12629757785467127,0.761405759858797,1.0,3/15,4.06%,PPARA;PPARD;NR1H2
prerank,pyruvate metabolic process (GO:0006090),-0.3812860122347918,-1.3729584917851436,0.04513888888888889,0.4801719388393591,1.0,21/52,20.82%,BSG;ME2;DLAT;HK1;LDHA;PGK1;PFKFB2;SLC16A1;HK2;GLO1;TPI1;ME1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;LDHB;GAPDHS;PGM1
prerank,long-term synaptic potentiation (GO:0060291),0.5302158488565767,1.3729513586248259,0.11945392491467577,0.7602342813930968,1.0,5/21,6.01%,GRIN2B;VAMP2;MPP2;CRHR2;GRIN2A
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5631006205841742,1.3725914608815863,0.14776632302405499,0.7590205932307301,1.0,11/14,28.48%,SEC24B;SAR1A;SCAP;SEC24A;SEC23A;MIA3;TBC1D20;SEC24C;SEC23B;SEC13;SEC24D
prerank,retinal metabolic process (GO:0042574),0.5967603277850093,1.3723213764970013,0.12908777969018934,0.7573763524548379,1.0,3/12,11.78%,RDH10;RDH11;ABCA4
prerank,regulation of myoblast differentiation (GO:0045661),-0.41701866041693725,-1.3722403131462915,0.08187134502923976,0.4803828447646298,1.0,7/32,6.48%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;NOTCH1;MAPK14
prerank,cell-cell junction organization (GO:0045216),-0.3447007936188582,-1.3722275459182518,0.03333333333333333,0.47882407916851955,1.0,16/79,9.74%,SDK1;PKP4;TJP1;LIMS2;OCLN;CXADR;AFDN;CDH1;CLDN5;CDH8;TGFB2;CTNND1;TJP2;SMAD3;PVR;GJC1
prerank,arachidonic acid metabolic process (GO:0019369),-0.4042338934305393,-1.371775350139944,0.06976744186046512,0.4784505081235182,1.0,14/35,25.42%,PTGDS;PTGS1;PTGES3;PLA2G4A;CYP1B1;MGLL;GPX1;PTGS2;CYP2U1;ALOX12;PLA2G4C;FAAH;CYP2S1;CBR1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5259483111579288,-1.3717469201813504,0.10588235294117647,0.47542016993851877,1.0,2/14,2.90%,ABCG2;HMOX2
prerank,heme catabolic process (GO:0042167),-0.5259483111579288,-1.3717469201813504,0.10588235294117647,0.47542016993851877,1.0,2/14,2.90%,ABCG2;HMOX2
prerank,defense response to fungus (GO:0050832),0.55269350809516,1.371431062025924,0.12155591572123177,0.7584620883161272,1.0,2/17,0.85%,CLEC4E;HRG
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.48075264088892167,-1.3711102812282847,0.12039312039312039,0.4756550782674714,1.0,8/18,18.37%,CTSC;EZR;RDX;VPS35;APOE;VPS11;VGLL4;MSN
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3875566451526179,-1.370964717788124,0.06666666666666667,0.47450065632575733,1.0,9/47,7.09%,RAPGEF2;ROCK2;CAV1;NFKB1;ERLIN1;SIRPA;WNT4;CD34;SIK1
prerank,Notch signaling pathway (GO:0007219),-0.3568064188396692,-1.370839180954612,0.024475524475524476,0.47328189941010107,1.0,16/59,13.77%,PBX1;RBPJ;SORBS2;MAML2;NOTCH3;NOTCH2;NOTCH1;ADAM10;MIB1;MDK;GALNT11;HEYL;APH1A;HEY2;APH1B;YBX1
prerank,O-glycan processing (GO:0016266),-0.378863587956119,-1.370259087227946,0.0364963503649635,0.4733783446107928,1.0,17/54,20.93%,ST6GAL1;GXYLT2;ST3GAL4;B4GALT5;ST3GAL1;ST6GALNAC2;C1GALT1C1;ST3GAL3;GALNT11;GALNT1;ST3GAL2;GCNT1;B3GNT2;GALNT6;GXYLT1;GALNT3;GALNT12
prerank,glutamate receptor signaling pathway (GO:0007215),0.47353022939380657,1.3699620506749366,0.09375,0.7616613946181726,1.0,17/37,21.36%,GRIA3;GRID2;GRIN2B;GRIK2;GRIA4;FMR1;GRIK4;GRIN2A;GRIK1;GRM5;GRM7;GRIN3A;GRM1;GRIA2;HOMER3;CDK5R1;HOMER2
prerank,sodium ion export across plasma membrane (GO:0036376),0.5928620545605712,1.3698916958584102,0.13074204946996468,0.7592561828296471,1.0,3/13,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5801723304977212,-1.369854176791191,0.13615023474178403,0.4728562368706215,1.0,7/10,34.23%,INPP5F;PPP2R1A;PTPN2;SOCS3;SOCS1;PPP2CA;NF2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.5512365902375637,1.3691000267970883,0.10956521739130434,0.7597471048101847,1.0,11/18,22.93%,LIG3;MCM7;GINS3;POLA1;RFC3;MCM4;POLE3;MCMDC2;POLE;RFC4;GINS1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3441381929605525,-1.3686622171902052,0.03260869565217391,0.47429197080852625,1.0,18/76,11.60%,TSPAN5;RBPJ;EGFR;MAML2;NOTCH3;NOS3;WWP2;NOTCH1;TGFB2;CCN3;SREBF2;IL6ST;EPN2;PRAG1;ITGB1BP1;GATA2;NIBAN2;GALNT11
prerank,amide transport (GO:0042886),-0.44114620945389715,-1.3681750651211515,0.0927536231884058,0.47396314078004476,1.0,13/26,31.25%,ABCG2;SLC25A32;CERT1;PLTP;SLC38A5;TAP2;PDPN;ABCB9;GLTP;DISP1;AQP11;SLC5A6;ABCA13
prerank,regulation of protein metabolic process (GO:0051246),-0.38302349576851613,-1.3675849228223165,0.0473186119873817,0.4740640563820112,1.0,14/44,18.15%,ROCK2;LTBP4;APP;KLF4;VPS35;ACE;KLF2;APOE;SSH1;FURIN;TRAF3;MAP2K5;NEDD8;TMEM9
prerank,striated muscle cell development (GO:0055002),-0.528173443380894,-1.3671368243065598,0.0995260663507109,0.4737380199638876,1.0,5/14,17.04%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.47838563587091465,-1.3651340764483555,0.10704960835509138,0.4773596708867636,1.0,8/20,15.67%,ANO6;ENTPD1;IL18;APP;TXNIP;NT5E;P2RX7;PSTPIP1
prerank,regulation of interleukin-1 production (GO:0032652),-0.5180037665465426,-1.3649848499661217,0.10421836228287841,0.4762363619210492,1.0,4/15,12.31%,FOXP1;SIRPA;ANXA1;CEACAM1
prerank,negative regulation of lyase activity (GO:0051350),0.5491534015436121,1.3642916650270704,0.12283737024221453,0.7764061558252693,1.0,3/16,5.81%,AKAP5;ADGRV1;MTRR
prerank,keratan sulfate metabolic process (GO:0042339),-0.4145950581719757,-1.3634697793042563,0.09195402298850575,0.47870397020251887,1.0,9/31,9.35%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;SLC35D2;HEXB
prerank,Golgi to plasma membrane transport (GO:0006893),0.4483140726517658,1.3631130423658067,0.09577464788732394,0.7785247008678974,1.0,12/47,11.20%,VAMP5;CCDC22;GGA2;STXBP6;RAB34;SPTBN1;ANK3;VAMP2;LLGL1;COMMD1;VAMP4;EXOC1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.462732154685142,-1.3627113007072251,0.09615384615384616,0.47912457487925736,1.0,4/20,10.61%,RAPGEF2;ADRA1B;ZDHHC21;LMBRD2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.4406244490321806,-1.3627086787971956,0.08746355685131195,0.477652012031654,1.0,16/25,35.25%,CSGALNACT1;B3GALT1;NDST1;NDST3;EXT1;B3GALNT1;FUT9;B3GNT2;HAS1;B3GNT9;NDST4;HAS2;B3GNT3;HAS3;B4GAT1;B3GNT6
prerank,serine family amino acid catabolic process (GO:0009071),0.6077284258438742,1.3623853079759043,0.13204225352112675,0.778670808805956,1.0,2/10,2.07%,THNSL2;GLDC
prerank,regulation of response to stress (GO:0080134),0.6202578674183354,1.3622500534610946,0.1425891181988743,0.7765858690660307,1.0,2/10,6.49%,CORO2B;ADCY8
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.546454420213734,-1.3621481056051181,0.1345707656612529,0.47772012746983067,1.0,4/12,4.87%,PLCB1;SLIT2;NBL1;CCN3
prerank,outflow tract septum morphogenesis (GO:0003148),-0.44714543449280825,-1.3613784040280823,0.10904255319148937,0.4781819673566546,1.0,10/24,9.88%,SMAD6;SEMA3C;ROBO1;NRP2;NRP1;BMPR2;TGFB2;TBX1;ACVR1;TBX2
prerank,positive regulation of bone resorption (GO:0045780),0.5985502595963954,1.3605322863403335,0.14690265486725665,0.7809127477573051,1.0,4/11,18.98%,SPP1;PRKCA;ADAM8;ATP6AP1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.38548085530899123,1.3605267058142054,0.050742574257425746,0.7781910035728296,1.0,22/138,10.40%,ROR1;PDGFRA;PTN;NTRK3;EPHA7;ROR2;MERTK;PTPRT;NTRK2;ERBB4;EPHB1;CD8B;FGFR1;EPHA6;PTPRU;PTK2;EFS;EPHB6;AXL;AHI1;FGR;EPHA3
prerank,regulation of response to biotic stimulus (GO:0002831),-0.42379627611024273,-1.3604163335608996,0.09014084507042254,0.4792666047087621,1.0,12/28,15.01%,FOXP1;XIAP;SAMHD1;CD55;ERAP1;TRIM5;CASP8;IRF1;ELMOD2;GATA6;CX3CL1;TRAF3
prerank,peptidyl-amino acid modification (GO:0018193),0.6216630420588339,1.3592545637932418,0.1445578231292517,0.7803544137451236,1.0,4/10,23.23%,METAP1D;ATP7A;FKBP10;FKBP7
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3959287585886867,1.3590775110524498,0.06606217616580311,0.7783411275516744,1.0,18/98,11.12%,CEMIP;LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;ANK3;YWHAZ;MTCL1;PRKCI;CLIP3;NECAB2;NKD2;EPHA3;TP53;FYN
prerank,ribosome assembly (GO:0042255),-0.3826001460800573,-1.3581334156015021,0.0670926517571885,0.4837294120590047,1.0,21/47,29.79%,RPS14;RPL5;RPS19;RPS27;RPS15;RPL10;RPS5;RPL11;RPLP0;MRPS7;RPL23A;MRPL20;NPM1;MPV17L2;PWP2;NOP2;RPF2;RPL24;EIF2A;MRPS2;NOP53
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3682381335355458,-1.3578268655516208,0.06397306397306397,0.4830577158321896,1.0,12/49,12.69%,LRCH1;F11R;CST3;ECM1;RDX;SH3BP4;WNK1;SH3RF2;CPEB2;ARL2;GMIP;NOS1
prerank,kidney development (GO:0001822),0.4249362174380087,1.3574811554034862,0.08448753462603878,0.7823362039886087,1.0,10/65,5.64%,ROBO2;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3;ZBTB16;PRKX;NF1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5117458293041912,1.357460575159852,0.10675039246467818,0.7797193945488862,1.0,1/23,0.02%,CEMIP
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.4384020106287754,-1.3573299404881458,0.09831460674157304,0.4828512732637859,1.0,12/27,24.34%,NFKB1;MAP3K5;CUL1;UBB;MAP2K7;MAP3K8;CCDC88C;UBC;UBA52;IKBKB;TAOK2;IKBKG
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.40264761099814256,-1.357127662942963,0.09550561797752809,0.4818848499008886,1.0,10/35,9.02%,FLT1;MEF2C;CAV1;THBS1;SPARC;COL4A3;CAV2;APOE;XDH;ATOH8
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.44276660831920445,-1.3564080687196916,0.09473684210526316,0.48243087040560645,1.0,14/26,26.54%,SPTLC2;NOS3;ACER2;CYP1B1;ACER3;CYB5R3;GCH1;NOS1;AKT1;SPHK2;DDAH2;ASAH1;NQO1;ASAH2
prerank,regulation of urine volume (GO:0035809),-0.5704173932175931,-1.3562592250841392,0.11832946635730858,0.4813479476816465,1.0,3/10,10.29%,NPR3;NPR1;ADCY6
prerank,positive regulation of intracellular protein transport (GO:0090316),0.38457577938728654,1.3559082004860654,0.05696969696969697,0.7834633483723177,1.0,26/144,12.93%,CEMIP;SEC16B;PIK3R1;AKAP5;MICALL2;TCF7L2;SEC16A;JUP;ANK3;PIK3R2;YWHAZ;ZIC1;VAMP2;MTCL1;SORL1;PINK1;RAB29;TENM1;TMEM30A;SAE1;SAR1A;TP53;FYN;HTRA2;GSK3A;CD81
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5812359392877243,1.3558220567474426,0.140597539543058,0.7811265115317654,1.0,7/13,23.58%,FGFR1;PDPK1;SIRT6;IGF2;SP1;HMGB1;ADAM17
prerank,positive regulation of synaptic transmission (GO:0050806),0.4141494067945299,1.355695550941147,0.09510869565217392,0.7789545290297833,1.0,17/72,11.37%,AKAP5;GRIN2B;NRXN1;CACNG3;GRIK2;VAMP2;FMR1;MPP2;CRHR2;GRIN2A;ADCY8;RIMS2;RELN;LGMN;CACNG4;RIMS1;DLG4
prerank,negative regulation of cell differentiation (GO:0045596),0.3715650910149701,1.3555957599223307,0.03773584905660377,0.7766876003095412,1.0,34/181,12.42%,RORA;ENPP1;PPARA;MEIS1;SPRY1;ADGRV1;WNT5A;PTEN;ITGAV;LRP3;NPHP3;MEIS2;NR1H2;SPRED1;REST;TBX3;RUNX1T1;ZBTB16;IL17RD;CNTN4;ADAMTS12;ZFP36L2;SPRED2;TWIST1;SOX2;BMP7;ZFPM2;TGFBR1;IQCB1;ABCA5;SOX9;TWIST2;PDCD4;IGF2
prerank,regulation of interferon-gamma production (GO:0032649),0.4136035947888045,1.3553539403714732,0.07640750670241286,0.7750688310867706,1.0,13/71,12.10%,XCL1;TXK;PDE4B;NR1H4;SCRIB;PTPN22;PDCD1LG2;CD276;TLR8;AXL;TLR4;PYCARD;IL12A
prerank,modulation of chemical synaptic transmission (GO:0050804),0.39042995572291045,1.3548257225329956,0.057285180572851806,0.7746426624055597,1.0,38/107,20.41%,HCRT;ATP1A2;PTEN;CHRNB4;GRID2;CEL;GRID1;GRIK2;GRIK5;ABR;FMR1;GRIK4;LRRK2;GRIK1;TMEM108;RIMS2;RELN;OPHN1;GRM5;LRRC4C;DGKI;RIMS1;DLG4;NRG3;PSMC5;UNC13A;DLGAP3;NMU;TPRG1L;GRM7;CDK5;CAMK2A;GRM1;CLSTN1;SYT1;USP46;NPTX2;PXK
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5513796947208376,1.3547221912312775,0.13095238095238096,0.7724426438590376,1.0,3/16,6.88%,LRP1;HDAC1;SRF
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4224158412284046,1.3543112191571203,0.09431345353675451,0.7715950128774002,1.0,25/62,21.85%,MEIS1;KMT2E;HDAC1;L3MBTL1;AGO4;MEIS2;KMT2A;ZBTB16;WDR5;PRKCB;AGO3;LYN;TNRC6B;HOXA9;MAFB;ASH2L;AGO1;CBFB;CDC73;KMT2C;HSPA9;RBM15;RBBP5;HOXA5;CREBBP
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.35015126098663973,-1.3537098413819255,0.042105263157894736,0.486213044582554,1.0,28/66,20.91%,PLCB1;EGFR;FHL1;ADAMTS1;KANK2;KLF4;RDX;CCND2;ANXA1;APC;CDK6;HYAL1;INO80;WEE1;FAM107A;PSME3;CCND1;PLK5;CDKN1A;ANKRD17;DCUN1D3;AKT1;DLG1;PSME2;RBL1;RGCC;RBL2;E2F1
prerank,muscle organ development (GO:0007517),0.4352707220121075,1.3531855483099757,0.09483960948396095,0.7735738417014364,1.0,12/54,11.73%,LAMA2;ITGA11;UTRN;CXCL10;VAMP5;SMTN;SGCE;SOX6;CAPN3;CHD2;FKTN;SPEG
prerank,vacuolar acidification (GO:0007035),-0.4601291184379577,-1.352927074380905,0.11450381679389313,0.4868677381094569,1.0,12/21,27.74%,ATP6V0A4;CLN5;ATP6AP2;ATP6V0E2;TMEM9;ATP6V0A2;ATP6V0D2;ATP6V0A1;CLN6;CCDC115;TMEM199;SLC11A1
prerank,positive regulation of locomotion (GO:0040017),-0.4343410595196295,-1.3529233078580973,0.1048158640226629,0.485417474429415,1.0,6/27,10.88%,CAVIN1;SPOCK2;NTN1;THBS1;PPM1F;STX3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4228561769321271,1.3516610315210509,0.07356948228882834,0.7768884108033155,1.0,22/72,20.54%,ENPP1;ERCC1;ANKLE1;FAN1;FEN1;POLK;ERCC5;PDE12;RPA1;ERCC4;RFC3;EDC3;GTF2H3;EDC4;ERCC2;GTF2H1;DXO;FBH1;REXO4;CUL4A;DDX1;DDB1
prerank,positive regulation of binding (GO:0051099),-0.3348424185431547,-1.3515266181995576,0.04484304932735426,0.48749551858581813,1.0,28/84,18.27%,IGF1;RAPGEF2;CAV1;FOXC1;HMBOX1;APP;CLDN5;HIP1R;VTN;SKI;NGF;B2M;APOE;GSK3B;RPL11;PARP9;RALB;TERT;HIPK2;CLN5;RAN;AMFR;DDX11;MARK3;MET;HFE;HMGB2;EGF
prerank,protein import (GO:0017038),0.40026848523971537,1.3506553650476458,0.07822685788787484,0.778407560016049,1.0,27/84,18.82%,PRICKLE1;CSE1L;ABCD2;PEX2;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;SLC25A17;HSPA4;CLU;PEX19;TNPO2;IPO9;PEX12;NUP155;PEX3;ALDH3A2;KPNB1;PEX14
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.43708150600580825,-1.3503772595643084,0.11311053984575835,0.48761917805994937,1.0,12/24,20.46%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,canonical glycolysis (GO:0061621),-0.43708150600580825,-1.3503772595643084,0.11311053984575835,0.48761917805994937,1.0,12/24,20.46%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4162482303327034,-1.3498236411283608,0.09444444444444444,0.4875704145312054,1.0,11/28,20.46%,CASP8AP2;GABARAP;CRADD;NGF;CASP8;BAX;BAG3;BID;TNFRSF1A;TRADD;ZDHHC3
prerank,adenine nucleotide transport (GO:0051503),-0.4866329620845778,-1.349692698207237,0.12259615384615384,0.48643571201778923,1.0,8/17,25.67%,ABCC4;LRRC8C;ABCC6;LRRC8D;SLC25A5;SLC35B2;SLC17A9;SLC25A4
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.46950226317554666,1.3493982144950851,0.11755725190839694,0.7809505047794573,1.0,6/36,4.67%,VAMP5;GGA2;RAB34;SPTBN1;ANK3;VAMP2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.42470839253059867,1.3491678639830758,0.09602194787379972,0.7792799061697023,1.0,9/70,2.28%,LAMC3;LAMC1;PIK3R1;LAMB1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5450831915251527,1.349039786629907,0.12769485903814262,0.7772559846640359,1.0,7/16,12.56%,PTN;RBM24;SOX6;NUDT21;DHX36;SOX9;HOXB4
prerank,regulation of nuclear division (GO:0051783),0.5302278653760102,1.348894347382532,0.1262135922330097,0.7752911297926767,1.0,6/20,11.27%,L3MBTL1;PKMYT1;FBXO5;CDK13;RCC1;MKI67
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.402755884093503,-1.34850752074299,0.08529411764705883,0.4882067089831584,1.0,12/35,14.25%,HMBOX1;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;RTEL1;ATM;MAP3K4
prerank,regulation of smooth muscle contraction (GO:0006940),-0.45786697183819525,-1.3483588184570536,0.09898477157360407,0.48715314909384083,1.0,4/20,6.34%,PLCE1;CAV1;ZDHHC21;ATP2B1
prerank,neuron fate commitment (GO:0048663),0.5721457399079118,1.3480200414084245,0.1388888888888889,0.7761892440143338,1.0,3/14,12.13%,ISL2;TGFBR1;MYT1L
prerank,intracellular lipid transport (GO:0032365),-0.44476027021219355,-1.3477899194477,0.0962566844919786,0.48726945467337096,1.0,5/21,5.48%,PRKAG2;ABCD3;ABCD4;CERT1;PRKAA2
prerank,DNA replication initiation (GO:0006270),0.4589626052181365,1.3477131738059185,0.1072463768115942,0.7749707955068458,1.0,13/37,15.55%,MCM7;CDC7;POLA1;GMNN;RPA1;POLE4;NOC3L;MCM4;CDT1;POLE3;MCM10;DBF4;ORC2
prerank,axon guidance (GO:0007411),0.36490121062772174,1.3473042330255898,0.03745743473325766,0.7741142244585382,1.0,45/201,12.73%,LAMA1;ROBO2;LAMA2;PIK3R1;EPHA7;PLXNC1;CHN1;WNT5A;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;EPHA6;UNC5A;DSCAM;CNTN4;IRS2;DAB1;DSCAML1;PTPRO;UNC5C;PTK2;RELN;PALLD;EPHB6;DCC;NRXN3;PRKCA;NEXN;CNTN6;OPHN1;LYPLA2;EPHA3;PTPRA;DOK5;FYN;USP33;UNC5D;PLXNB2;GFRA1;ARHGAP35;SH3KBP1;KIF5C
prerank,intraciliary retrograde transport (GO:0035721),0.5808648106222729,1.3469297052215194,0.13194444444444445,0.7731475002663603,1.0,4/12,16.55%,WDR35;DYNC2LI1;TTC21B;IFT43
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5810066841769431,1.3467670884772291,0.13787085514834205,0.7713543288015307,1.0,8/12,20.62%,MBTPS2;H6PD;DGKQ;CLCN2;SREBF1;KPNB1;ABCA2;MBTPS1
prerank,vascular transport (GO:0010232),0.4076333457601753,1.3462824756511635,0.08079470198675497,0.7708766399803022,1.0,9/81,2.36%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3
prerank,cellular lipid catabolic process (GO:0044242),0.4843720440598305,1.3461952550431941,0.11726384364820847,0.7687501194620925,1.0,7/27,15.43%,LPIN3;CEL;PPARD;ACADL;ABHD12;NUDT19;LPIN2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5548973643235343,-1.34540765615882,0.12440191387559808,0.49185282385552,1.0,7/11,19.18%,EZR;RDX;DAB2;RAB21;VPS11;MSN;MTMR2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4295786985454677,-1.3443523771952872,0.10410958904109589,0.49318020920224137,1.0,12/28,25.94%,PRKAG2;ADIPOR2;SIRPA;RAC1;PRKAA2;CX3CR1;NOS1AP;SIRT1;SIRT5;FITM2;PDK4;MFSD12
prerank,visual system development (GO:0150063),-0.39519925861015737,-1.3436291962321842,0.08033240997229917,0.4936445934510567,1.0,12/37,12.81%,SMOC1;PBX1;FOXC1;RBP4;TGFB2;PBX4;ATF6;SH3PXD2B;HIPK1;ZDHHC16;FREM2;HIPK2
prerank,telomere maintenance via recombination (GO:0000722),0.601745787530817,1.3432516731932662,0.1681260945709282,0.7779656781187052,1.0,3/11,7.73%,TEP1;ERCC1;ERCC4
prerank,cognition (GO:0050890),0.4523000503814856,1.3423785715505567,0.10650887573964497,0.778990595094763,1.0,17/42,21.05%,CHD7;C5AR1;SOBP;METTL23;NF1;SETD5;PTCHD1;RP9;GRM5;TUSC3;CUX2;LHCGR;CYFIP1;GPR155;MGAT3;BBS4;CTNS
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3506290479742003,-1.3422571050356709,0.0456140350877193,0.49570087821591396,1.0,22/65,19.03%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;INTS3;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;PSMC1;PABIR1;PSMB10;CHFR;PSME2
prerank,central nervous system myelination (GO:0022010),0.6103603175626374,1.3419826154958034,0.15356489945155394,0.7780434238634085,1.0,7/11,19.41%,PTEN;TENM4;SOX10;PLP1;MYRF;CLU;ABCA2
prerank,inositol lipid-mediated signaling (GO:0048017),0.4391218990807797,1.3419208371439335,0.101620029455081,0.7757886940015023,1.0,12/50,7.87%,PDGFRA;PLCL1;PIK3R1;OGT;FGFR1;GAB2;PIK3R2;IRS1;IRS2;ADAP2;PI4KA;RPS6KB1
prerank,ion homeostasis (GO:0050801),-0.4131320640112083,-1.3409502272493092,0.07309941520467836,0.4977238731350761,1.0,6/30,6.46%,SLC4A10;FHL1;CAMK2D;WNK4;WNK1;SLC4A3
prerank,mesoderm development (GO:0007498),-0.4609726606378688,-1.340685891678163,0.12987012987012986,0.49697055324868866,1.0,5/18,7.27%,FOXC2;TIE1;MESD;TBX1;BMX
prerank,regulation of acrosome reaction (GO:0060046),-0.5636540521229382,-1.3404100554218001,0.12240184757505773,0.49628194346563786,1.0,1/10,0.46%,PLCB1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3614878728817763,1.3399411128675196,0.035754189944134075,0.780849051487034,1.0,33/214,10.90%,ROR1;PDGFRA;NTRK3;EPHA7;XCL1;ROR2;SPRY1;SLC30A10;NTRK2;PTEN;ERBB4;C5AR1;EPHB1;PTPRR;P2RY1;CNKSR3;YWHAZ;SPRED1;GCNT2;HTR2B;PTPN22;CCL15;RPS6KA6;GLIPR2;NECAB2;SPRED2;GPR183;PRKCA;HTR2C;TLR4;MAP2K1;CCL25;PYCARD
prerank,mesenchymal to epithelial transition (GO:0060231),0.6138838086733129,1.3394769615687694,0.15579710144927536,0.780209365044842,1.0,2/10,2.53%,BASP1;SALL1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5997486034390664,1.33917179297854,0.13200723327305605,0.7790761917023484,1.0,1/10,0.11%,ENPP1
prerank,protein import into nucleus (GO:0006606),0.4150182757671226,1.3390497502040857,0.1044776119402985,0.7770862970367051,1.0,25/66,23.31%,PRICKLE1;CBLB;CSE1L;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;KPNA1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;TNPO2;IPO9;NUP54;NUP155;KPNB1;RANBP2;KPNA2;IPO4;IPO8;NUP35
prerank,purine ribonucleotide metabolic process (GO:0009150),0.41969385535415565,1.3382069888137023,0.09178082191780822,0.7780942585068666,1.0,18/68,16.64%,ENPP1;PDE9A;ACSF2;TPST1;LRRK2;AMPD2;AK4;OPA1;ACOT7;ACSL6;ACLY;MFN1;ENTPD7;AK3;SULT6B1;ACOT2;EFL1;ADSS1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5599047902150669,-1.3381481565116753,0.1473922902494331,0.5006026575418868,1.0,8/10,25.17%,RDX;CEACAM1;PRKG1;SERPINE2;PRKCD;CD9;ALOX12;ADAMTS18
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5029310770588319,-1.338103259894217,0.13793103448275862,0.4992859401959561,1.0,4/14,11.78%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5844956283234151,1.3372295489570887,0.14616755793226383,0.7795563040077956,1.0,4/12,9.80%,TLR6;ADGRB1;TLR4;CYBA
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5445248308454267,-1.3371746889447687,0.1366742596810934,0.5001957261510864,1.0,6/11,17.95%,ADIPOR2;KDR;CD34;GATA2;ITGB3;MCAM
prerank,amino acid import across plasma membrane (GO:0089718),0.4993866392074951,1.336680752280495,0.11235955056179775,0.7792572186810974,1.0,4/24,4.87%,SLC1A3;SLC1A5;SLC6A13;SLC7A8
prerank,phasic smooth muscle contraction (GO:0014821),0.6052374929878868,1.3365566312256694,0.13588850174216027,0.7772806411926347,1.0,2/10,4.84%,EDN3;HTR2B
prerank,regulation of blood coagulation (GO:0030193),-0.42313416273662696,-1.3361637091150718,0.10344827586206896,0.5012794837406784,1.0,11/27,15.37%,CAV1;THBD;THBS1;ST3GAL4;VTN;CD34;APOE;SERPINE1;EPHB2;SERPINE2;EDN1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5727908252340997,1.3358707036002941,0.15313653136531366,0.777674578022398,1.0,6/13,12.02%,PPARA;NFATC3;PPARD;REST;SRF;SOX9
prerank,alanine transport (GO:0032328),-0.5627954769466608,-1.335102833847295,0.1391509433962264,0.502756387139378,1.0,5/10,30.79%,SLC6A6;SLC6A17;SLC36A4;SLC7A10;SLC36A2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5162701334283464,-1.3344241842681777,0.14184397163120568,0.5032086549247474,1.0,4/13,7.09%,CAV1;CAMK2D;SRI;CALM1
prerank,negative regulation of defense response (GO:0031348),0.4048161628020112,1.3332793783737367,0.09103260869565218,0.7855632606124305,1.0,10/77,7.85%,RORA;PPARA;TRAF3IP1;NR1H4;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,neuron projection regeneration (GO:0031102),0.6001845398296354,1.3331433621113922,0.14495412844036698,0.7836761894733462,1.0,1/10,0.19%,PTN
prerank,fibrinolysis (GO:0042730),0.5756881254809885,1.332520739953009,0.16873889875666073,0.7838608704339232,1.0,2/13,8.21%,HRG;PLAU
prerank,prostanoid biosynthetic process (GO:0046457),-0.5002204896007021,-1.3322409129319184,0.13793103448275862,0.507900287514912,1.0,8/15,20.89%,PTGDS;PTGS1;PTGES3;PLA2G4A;PTGS2;EDN1;CD74;MIF
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4290897636699512,-1.3321638217744183,0.12073490813648294,0.5066547168464534,1.0,12/25,20.46%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,transport across blood-brain barrier (GO:0150104),0.39982678716453174,1.3320873234759305,0.08735332464146023,0.7832228535907027,1.0,11/83,5.83%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3;SLC7A8;FABP5
prerank,extracellular transport (GO:0006858),0.5622093282003375,1.3318611938559188,0.1494661921708185,0.7817247237574527,1.0,5/12,13.69%,ADCY10;DNAAF4;SPA17;CABYR;TSG101
prerank,pulmonary valve development (GO:0003177),-0.47302852316033017,-1.331652278666917,0.1262135922330097,0.5065762849900973,1.0,8/18,4.36%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;BMPR2;NOTCH1;TGFB2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5464308094861038,-1.330413689232151,0.15294117647058825,0.5084219330039047,1.0,4/11,4.87%,SLIT2;NBL1;RIN3;CCN3
prerank,retinoid metabolic process (GO:0001523),0.40946178513317055,1.3300488851583934,0.10215053763440861,0.7863364095600427,1.0,8/71,4.65%,LRP1;ADH1A;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3708537334209012,1.3298667347550353,0.05764705882352941,0.7846304546828974,1.0,22/151,10.90%,ROR1;PDGFRA;NTRK3;XCL1;ROR2;SLC30A10;NTRK2;ERBB4;C5AR1;P2RY1;GCNT2;HTR2B;PTPN22;CCL15;GLIPR2;NECAB2;GPR183;PRKCA;HTR2C;MAP2K1;CCL25;PYCARD
prerank,negative regulation of neurogenesis (GO:0050768),0.46379008196352556,1.3287704079309663,0.1297709923664122,0.786493047421486,1.0,7/34,9.09%,PTN;PTEN;NGFR;REST;SORL1;NF1;APPL2
prerank,membrane lipid biosynthetic process (GO:0046467),-0.348101825093394,-1.3286649166512468,0.04946996466431095,0.5118518923282677,1.0,20/58,15.79%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;ACER3;SGMS2;CERT1;DEGS2;SPNS2;VAPA;VAPB;ELOVL4;ELOVL7;SPTSSA;KDSR;ST3GAL2
prerank,positive regulation of viral genome replication (GO:0045070),0.47977952483672576,1.3280260625052693,0.12954186413902052,0.7870366239644158,1.0,10/29,17.72%,PPARA;PPID;TOP2B;PPIH;PDE12;STAU1;CNOT7;ADAR;HACD3;TOP2A
prerank,cellular potassium ion homeostasis (GO:0030007),0.5704142674551008,1.3271240429200588,0.1306532663316583,0.7883603348841896,1.0,3/13,5.33%,ATP1A2;ATP1A3;KCNMA1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5988049300588509,1.3269622218450359,0.14835164835164835,0.7866764926093586,1.0,2/11,1.20%,COLEC12;UNC93B1
prerank,nucleoside salvage (GO:0043174),-0.5479231724638767,-1.3267189890003117,0.1399548532731377,0.5156681135664966,1.0,7/10,39.15%,UPP2;TK2;DCK;CDA;TK1;UPP1;UCKL1
prerank,positive regulation of telomerase activity (GO:0051973),-0.4003858875269461,-1.3260319619230396,0.10144927536231885,0.5161341923611671,1.0,8/33,14.25%,HMBOX1;KLF4;PTGES3;PARN;NEK7;MAP2K7;CCT4;MAP3K4
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.44943683345933466,-1.3258376774595517,0.13227513227513227,0.5152622341247108,1.0,8/19,9.80%,TEK;PTPRJ;NRP1;S100A10;KDR;RAC1;PPM1F;SFRP1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.39901300036462456,-1.3253987792629285,0.11080332409972299,0.5149945472792344,1.0,13/33,12.85%,TJP1;BMPER;THBS1;KLF4;SEMA6A;KLF2;EPN2;PPP1R16B;FGF1;PIK3CB;CEACAM1;PKM;SMAD1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5560184003192173,-1.3252359906162092,0.14253897550111358,0.5140183945865017,1.0,5/10,21.47%,PODXL;DPP4;WNK1;SKAP1;PIEZO1
prerank,cGMP metabolic process (GO:0046068),0.5703308443635865,1.3251653413184583,0.17290552584670232,0.7914756738325782,1.0,1/12,0.28%,PDE9A
prerank,acidic amino acid transport (GO:0015800),0.533700798541776,1.324880793472345,0.1461794019933555,0.7903213683460109,1.0,4/17,8.61%,SLC1A3;SLC6A13;GJA1;SLC25A22
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3682084732172503,-1.3245904482264506,0.04950495049504951,0.5143382234380798,1.0,11/47,8.29%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;KANK1;RAC1;NEDD9;CDC42;EFNA5;ITGB1BP1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2983990302660948,-1.323070145422246,0.01775147928994083,0.5171798961715245,1.0,45/151,16.18%,FLT1;RAPGEF2;SOX5;MEF2C;EGFR;FOXC1;GAS1;KLF4;NRP1;BMPR2;MAGI2;IQGAP1;KDR;RAP1A;NOTCH1;WNT4;WWOX;ANXA1;PDE3A;SEMA6A;RAPGEF1;MAPK14;TBX1;CD44;ACVR1;ACVRL1;ITGB1BP1;MAPT;SMAD3;HYAL1;EEF1A1;SFRP1;NR4A1;RAB35;HSPB1;NOS1;NR3C1;FLT4;CPNE3;RAMP2;PLK5;MAP2K5;ERN1;KIDINS220;ZPR1
prerank,gliogenesis (GO:0042063),-0.4843164018355254,-1.3229139067951354,0.14460784313725492,0.5161956554508642,1.0,4/15,5.70%,NFIB;TGFB2;ANXA1;CDK6
prerank,cell projection organization (GO:0030030),-0.40024506532235815,-1.3222627782159837,0.11019283746556474,0.5166044231987177,1.0,8/30,6.77%,ITGB1;PACSIN2;PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4518575341846718,-1.3220960425749926,0.14871794871794872,0.5156739706868212,1.0,4/20,10.18%,IGF1;FOXC1;LAMTOR5;NIBAN2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.45455680241402735,1.321476929499187,0.12005856515373353,0.8015469291046614,1.0,11/35,21.17%,CDH6;PCDHB16;DCHS1;CDH11;PCDHB4;PCDHB11;CDH10;PCDHGB4;CDH9;ATP2C1;PCDHB14
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.41379889693383465,-1.3208045219251479,0.11428571428571428,0.517749535088731,1.0,9/27,15.82%,AHNAK;CAMK2D;CALM1;ANK2;DMD;JPH1;NOS1;JPH2;CACNB1
prerank,sodium ion homeostasis (GO:0055078),0.5119986701062902,1.3203226518821174,0.1349206349206349,0.8036365610988083,1.0,3/21,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,positive regulation of dendrite extension (GO:1903861),0.5307595897450628,1.319998966793677,0.17045454545454544,0.8025742812561243,1.0,7/17,18.61%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.5055713142190084,-1.3198339433867312,0.12009237875288684,0.5189607211098142,1.0,4/13,7.21%,DKK3;NFKB1;ERLIN1;APOE
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5093250119726049,1.319752351463354,0.1392,0.8012352710287564,1.0,6/21,15.41%,MED12;SRF;TWIST1;DHX36;MED1;PAXIP1
prerank,monocyte differentiation (GO:0030224),-0.5575213847500384,-1.318972342360619,0.13647058823529412,0.5197931300942485,1.0,7/10,30.89%,PIR;IL31RA;PDE1B;CSF1R;MYH9;PPARG;MT1G
prerank,female gamete generation (GO:0007292),0.46472857460230055,1.3189535402731183,0.14263565891472868,0.8022374106939748,1.0,3/29,6.86%,PTN;NANOS3;DIAPH2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.541156087892948,-1.318483593456956,0.1409090909090909,0.519672978967814,1.0,4/11,15.82%,CAMK2D;NOS1;NOS1AP;CACNB1
prerank,negative regulation of synaptic transmission (GO:0050805),0.4874817828466738,1.3179815835447952,0.1596774193548387,0.8037811226834293,1.0,4/23,12.09%,PTEN;PNKD;LRRK2;CBLN1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5816893655636157,1.3179484643961548,0.15964912280701754,0.8015784787825245,1.0,3/11,14.79%,IL34;PRKCA;RIPK1
prerank,neutrophil migration (GO:1990266),0.4240522032386187,1.317863119308602,0.11978465679676985,0.7996002536072621,1.0,7/58,5.33%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5963534310353646,1.316946884049548,0.15696649029982362,0.8009146027910967,1.0,1/10,0.31%,GHR
prerank,regulation of leukocyte activation (GO:0002694),-0.49679110898006085,-1.31687425611489,0.1393643031784841,0.5224662531372711,1.0,7/14,22.19%,CD200;GPER1;CD74;MFHAS1;MIF;SHPK;MYO18A
prerank,neural crest cell migration (GO:0001755),-0.39699324063347813,-1.3165384982570445,0.08459214501510574,0.5220428628494336,1.0,10/36,10.82%,FN1;SEMA3D;SEMA3C;SEMA7A;NRP1;SEMA6A;SEMA4B;TBX1;PHACTR4;SEMA5B
prerank,organelle transport along microtubule (GO:0072384),-0.409420001166489,-1.3164439097602194,0.07669616519174041,0.5209179399361251,1.0,15/31,26.57%,NDEL1;CDC42;UBB;MAPT;TRAK2;BICD2;BORCS5;RAB1A;RAB6A;DYNC1I1;TMEM201;BICDL1;KIF5B;COPG2;BICD1
prerank,negative regulation of cyclase activity (GO:0031280),0.5464492110581944,1.3158288128334796,0.1514629948364888,0.8030480653369755,1.0,2/14,1.67%,AKAP5;ADGRV1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.46753605169419227,-1.3154486146547877,0.12368421052631579,0.522216318248471,1.0,8/17,21.47%,PODXL;FOXC2;TGFB2;RET;SKAP1;CIB1;ADAM9;PIEZO1
prerank,negative regulation of catalytic activity (GO:0043086),-0.4343812403075197,-1.3151856460752462,0.14138817480719795,0.5214861623390403,1.0,13/24,24.21%,NOTCH1;NES;PARP9;NOS1;SIRT1;IFIT1;NOSIP;HDAC6;APBA3;CCAR2;OXA1L;PLN;MT3
prerank,synapse organization (GO:0050808),0.3743462940019831,1.3148466884392742,0.06303030303030303,0.8047296328337448,1.0,35/125,17.35%,PDZRN3;ADGRL3;PTEN;C5AR1;FARP1;NRXN2;NRXN1;GPC4;ANK3;REST;PCDHB16;NEDD4;DSCAM;LRRK2;PCDHB4;PCDHB11;C1QA;PPFIA2;LRFN5;C1QC;RAB29;CACNB4;GRM5;LRRC4C;CBLN1;UNC13A;PPFIA4;F2R;KIRREL3;NTNG1;NRCAM;CYFIP1;SLITRK1;CDK5;UNC13C
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5174626017370675,-1.3143071882849282,0.15639810426540285,0.5224564649702627,1.0,3/12,3.95%,IGF1R;UVRAG;INSR
prerank,rRNA metabolic process (GO:0016072),-0.29547067673156824,-1.313950307563306,0.023668639053254437,0.5219703193421718,1.0,57/160,22.29%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RPL10;RPL35A;MAPT;DDX27;RPL10A;RPL11;RPL36A;DIS3L;RPL34;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RPL31;IMP3;EXOSC3;NIFK;RPL23A;RPL19;RPL36;WDR12;PES1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4573203280484194,-1.3135336451958026,0.1570048309178744,0.521597070739839,1.0,8/20,23.30%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC;TTBK1;STOX1
prerank,positive regulation of heart contraction (GO:0045823),0.5175684565696186,1.313412006227136,0.1631663974151858,0.808085318808504,1.0,4/19,5.93%,EDN3;ATP1A2;RYR2;ATP2A2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4025035775857818,1.3132890771905965,0.1051912568306011,0.8062260434156696,1.0,8/72,3.03%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;FGFR1
prerank,positive regulation of secretion (GO:0051047),0.5901253428604423,1.3132658662455767,0.15480427046263345,0.8040133064810475,1.0,2/11,7.81%,GPLD1;TRH
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.38075727308307283,1.3130847218317383,0.06733167082294264,0.8024132386053194,1.0,27/117,17.12%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;CD81;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4
prerank,negative regulation of defense response to virus (GO:0050687),0.610322775860672,1.3129361416982748,0.16518650088809947,0.800718809679957,1.0,2/10,2.76%,TRAF3IP1;TSPAN6
prerank,neuromuscular junction development (GO:0007528),0.4963131301673057,1.3123654671967129,0.13015873015873017,0.8006202594714136,1.0,8/24,17.35%,PDZRN3;ANK3;NEDD4;LRRK2;CACNB4;UNC13A;F2R;UNC13C
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.426298708852886,-1.311891940506705,0.112565445026178,0.5246604040923522,1.0,10/25,17.86%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;NOS1AP;PTGS2;EDN1;AKT1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3838961923992705,1.311534932404356,0.08376288659793814,0.8015311142100011,1.0,16/100,8.25%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;PTEN;PIP4K2A;FGFR1;ENTPD5;NEDD4;IRS2;PTPN13;PTK2;TWIST1
prerank,chloride transmembrane transport (GO:1902476),0.4314569305465128,1.3111075555960705,0.11329305135951662,0.8009815472514005,1.0,13/48,13.84%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;LRRC8A
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4869758771460103,1.3107018271453743,0.14355628058727568,0.8003693155465792,1.0,11/27,18.61%,VAMP2;RIMS2;SYT3;SYT7;ARL8B;PPP3CB;RIMS1;SYT5;VAMP7;SYT6;SYT1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5001006051695625,-1.3106341767674126,0.15764705882352942,0.5265777251078417,1.0,7/13,28.32%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,transcription preinitiation complex assembly (GO:0070897),0.5695554012747507,1.3105587992236134,0.16341030195381884,0.7986848359529948,1.0,6/12,22.14%,TAF12;TAF1B;BDP1;TAF11;GTF2B;GTF2A2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.39806583016682606,-1.3100856954509355,0.11988304093567251,0.5265883002653705,1.0,12/31,17.83%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD;CDK9
prerank,epithelial cell migration (GO:0010631),-0.382648175996419,-1.3100686462463285,0.10857142857142857,0.5252658379546848,1.0,9/37,5.23%,KANK2;NOS3;FSTL1;NRP1;DPP4;ANLN;CYP1B1;KANK1;GIPC1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5899778140502356,1.3092564188918911,0.18641114982578397,0.8016273146633778,1.0,2/10,8.61%,SLC1A3;SLC25A22
prerank,response to light stimulus (GO:0009416),0.4308027219177138,1.309170335834657,0.09985096870342772,0.7997193066059763,1.0,13/55,15.54%,GPR88;COPS3;TYR;USP1;ERCC5;CDKN2D;ERCC4;UVSSA;GPR52;SPRTN;REV1;ERCC2;CRY2
prerank,response to hexose (GO:0009746),0.488558530781975,1.3082733271072957,0.1383147853736089,0.8009185139966063,1.0,6/25,10.48%,TCF7L2;GPLD1;VAMP2;EIF2B1;IRS2;ZBED3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5788993105142113,1.308084525327949,0.17137809187279152,0.7994456367921878,1.0,4/11,14.06%,JAK1;ANK3;PRKCA;LYN
prerank,response to glucose (GO:0009749),0.4386986040044143,1.3077902125558605,0.11079136690647481,0.7984143151958284,1.0,11/46,10.48%,ZBTB20;TCF7L2;TRA2B;GPLD1;VAMP2;EIF2B1;IRS2;ADCY8;PRKACA;GCK;ZBED3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.30518053101769965,-1.3071615866832687,0.043689320388349516,0.5317159950830795,1.0,24/108,9.83%,DAPK1;ROBO1;CASP8AP2;ARL6IP5;TNFSF10;ACER2;HIP1R;GSN;MAP3K5;FAS;UACA;COL4A3;EGLN3;CRADD;NGF;CASP2;PPM1F;XDH;VCP;MAPT;SMAD3;CASP8;BAD;BAX
prerank,glycolipid metabolic process (GO:0006664),-0.3667813133104078,-1.3070398936184378,0.1064516129032258,0.5307066788512045,1.0,21/47,28.69%,ST3GAL6;ST3GAL4;SMPD3;FUCA1;ST6GALNAC3;HEXB;UGCG;NAGA;B3GALNT1;ESYT3;SMPD1;ST3GAL2;GM2A;ARSA;PSAP;GLTP;ST8SIA6;ASAH1;PIGW;NEU1;SCCPDH
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5525347499047109,1.3061515935071504,0.17168141592920355,0.8025923747808877,1.0,2/13,1.67%,AKAP5;ADGRV1
prerank,protein trimerization (GO:0070206),0.564314686206435,1.305990110973456,0.16550522648083624,0.7988027668361027,1.0,3/14,7.39%,SLC1A5;CLYBL;ASIC1
prerank,protein homotrimerization (GO:0070207),0.564314686206435,1.305990110973456,0.16550522648083624,0.7988027668361027,1.0,3/14,7.39%,SLC1A5;CLYBL;ASIC1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.48432997647566145,-1.3054940815774319,0.15876777251184834,0.5334220553691147,1.0,2/15,0.90%,CD200;IL31RA
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5309691016788357,1.304866610128327,0.15650741350906094,0.8007333433502538,1.0,6/17,17.78%,GPLD1;SORL1;CIDEA;BSCL2;ADRA2A;PDE3B
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5028789320860497,1.3041395983313289,0.1484375,0.8014794327523099,1.0,4/20,6.00%,ATP1A2;ATP1A3;KCNMA1;SLC9A1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.45319318786805757,1.3033528900829612,0.1471861471861472,0.8022756608157732,1.0,10/34,12.54%,GRID2;GRIN2B;GABRA1;MPP2;LRRK2;GRIN2A;GABRG3;GABRG2;GLRA1;GSK3A
prerank,regulation of dendrite extension (GO:1903859),0.5230658288409186,1.3031898286404406,0.16666666666666666,0.8007040943523827,1.0,7/18,18.61%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,electron transport chain (GO:0022900),0.5288060344007242,1.30309225153296,0.1738382099827883,0.7988668617350364,1.0,2/15,4.16%,POR;SDHB
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.32953747414169976,-1.3019468834863626,0.045081967213114756,0.5414834067416616,1.0,17/74,10.45%,EYA2;IGF1;BCL2L1;EYA1;EYA4;NOS3;THBS1;ITGA6;MCL1;TNFSF10;FAS;GSK3B;ACVR1;CASP8;GPX1;SERPINE1;ICAM1
prerank,regulation of endothelial cell migration (GO:0010594),-0.32375918553569727,-1.3009811085636154,0.04219409282700422,0.5425750367370324,1.0,35/85,18.27%,ANXA3;ROCK2;FOXP1;TEK;BMPER;SLIT2;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;KDR;RAC1;SCARB1;APOE;AAMP;FGF1;ACVRL1;ITGB1BP1;ATOH8;PIK3CB;PIK3CD;ETS1;ITGB3;CEACAM1;FLT4;PTK2B;RRAS;EDN1;BCAS3;EPHA2;DNAJA4;AKT1;EGF
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.35686451169591854,-1.300461631176233,0.07342657342657342,0.5426616387780174,1.0,20/56,27.48%,SMAD6;BMPER;BMPR2;TGFB2;DAB2;SNX25;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;SMAD7;INHBB;ACVR2A;GREM1;SMAD4;EMILIN1;TTK
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5419111421482796,-1.3004196840447504,0.17660550458715596,0.5413880833932985,1.0,3/10,19.40%,NOTCH1;PPM1F;RGCC
prerank,negative regulation of phosphorylation (GO:0042326),0.383572050203681,1.3002119449419225,0.10863874345549739,0.8079521902692326,1.0,21/85,14.51%,DYNLL1;NTRK3;PPARA;PTEN;TRAF3IP1;CDKN2A;PFKFB1;NPRL2;LRRK2;IRS2;CBFA2T3;CDKN2D;PTPN13;BMP7;ZBED3;DNAJC10;ANKLE2;PIP5KL1;CDKN2C;LYN;ATG14
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5434797149590597,1.3000885608335995,0.16080402010050251,0.8062591897599757,1.0,6/15,15.81%,LRP1;FAP;FSCN1;CARMIL2;CLASP2;CLASP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4553798305330423,-1.2992780870412204,0.12339331619537275,0.5431765239435372,1.0,5/19,12.95%,TJP1;AFDN;NOTCH1;PPM1F;DENND6A
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.5669870820666556,1.2984087438256573,0.19932432432432431,0.8107624415234301,1.0,5/12,21.51%,TIPIN;GMNN;CDT1;KAT7;WDR18
prerank,negative regulation of anoikis (GO:2000811),-0.48188067878727614,-1.298285484207375,0.18867924528301888,0.5443155895150387,1.0,4/14,4.26%,CAV1;ITGB1;MCL1;NOTCH1
prerank,cellular response to cAMP (GO:0071320),-0.40506939996618063,-1.2980150759717433,0.10372340425531915,0.5435734960226403,1.0,11/30,23.30%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,regulation of focal adhesion assembly (GO:0051893),0.4141006646500365,1.2967610003690722,0.13191489361702127,0.8148290596675445,1.0,15/54,11.12%,APOD;DLC1;HRG;GPM6B;PEAK1;PTEN;MAP4K4;ARHGAP6;SLC9A1;DUSP22;COL16A1;PTK2;EPHA3;PTPRA;SLK
prerank,neuron development (GO:0048666),0.3654962609601908,1.2964185587103265,0.09952038369304557,0.8140814700946709,1.0,36/141,16.35%,NCDN;LAMB1;ISL2;ETV1;GPM6B;TENM3;NTRK2;MICALL2;CNTNAP2;LRP12;TENM4;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;TENM2;SRF;DOCK7;STMN2;NPY;TENM1;LGI4;OPHN1;PLP1;STMN4;MYT1L;GPRIN1;STMN1;ATP7A;LYN;EPHA5;PBX2;GDNF;TBC1D23;GPRIN3
prerank,mitotic recombination (GO:0006312),0.5276712340589361,1.2963777238654035,0.17152658662092624,0.8120788952634559,1.0,4/15,13.20%,TEP1;ERCC1;MSH3;RAD52
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3623916213820515,-1.2962059430285036,0.09841269841269841,0.5472385834237187,1.0,13/45,11.07%,CAMK2D;NCAM1;TRIM25;TRIM5;B2M;CD44;IRF2;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G
prerank,secondary palate development (GO:0062009),0.552009970793021,1.296068520249331,0.16903914590747332,0.8111010712405003,1.0,2/14,1.70%,CHD7;WNT5A
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4676179314555925,-1.2960173904389596,0.162227602905569,0.5463402318991001,1.0,7/18,11.63%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5052654371857717,1.295779135771847,0.16193656093489148,0.8101605176928397,1.0,7/19,11.66%,PTGFR;RYR2;STIMATE;PRKACA;ADGRL1;GRM5;TRPM2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4762673797569201,1.295596945392071,0.1495176848874598,0.8086941986365835,1.0,4/25,5.93%,TBX18;RYR2;JUP;ATP2A2
prerank,transepithelial transport (GO:0070633),0.530097177749647,1.2952787646362858,0.1689419795221843,0.8077945599601205,1.0,2/15,2.27%,SLC1A3;GPLD1
prerank,engulfment of apoptotic cell (GO:0043652),-0.47820033552849744,-1.2951655804106577,0.15827338129496402,0.5474785933018922,1.0,4/15,5.15%,RHOBTB1;THBS1;RHOBTB2;RAC1
prerank,negative regulation of centrosome duplication (GO:0010826),0.5744250090220311,1.2950248620008533,0.17345132743362832,0.8066857258547883,1.0,4/11,11.22%,MDM1;TRIM37;KAT2A;TMEM67
prerank,positive regulation of response to wounding (GO:1903036),-0.4295575936603011,-1.2941282009479262,0.13404825737265416,0.5489894124164336,1.0,8/24,5.81%,OCLN;MYLK;ITGB1;ACTG1;VTN;KANK1;ANXA1;SCARF1
prerank,granulocyte differentiation (GO:0030851),-0.4624707874710279,-1.2931107965916664,0.13636363636363635,0.5504803288472343,1.0,6/18,15.10%,LEF1;LBR;RXRA;JAGN1;TAL1;CDKN1A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.47482114080366644,-1.292858098020398,0.16290726817042606,0.5498326694971992,1.0,5/15,9.80%,RSPO3;WNT5B;CSNK1D;GPC3;SFRP1
prerank,regulation of exocytosis (GO:0017157),0.4274749396006188,1.292812843835337,0.14057971014492754,0.8132132445476947,1.0,15/46,18.98%,CADPS2;STXBP6;VAMP2;RAB8A;CADPS;RAB3C;RIMS2;RAB15;CLASP2;CLASP1;IL1RAPL1;STXBP5;RAB2B;SYT1;ATP6AP1
prerank,negative regulation of TOR signaling (GO:0032007),-0.39126410794834743,-1.292807708847812,0.12280701754385964,0.5486098400106961,1.0,12/36,16.15%,FNIP1;RNF152;DEPTOR;SESN1;PRKAA2;SH3BP4;UBR1;UBR2;TBC1D7;ATM;SIRT1;PRKAA1
prerank,positive regulation of histone methylation (GO:0031062),0.4850130779689275,1.2917122085420885,0.1752411575562701,0.8152675731209166,1.0,8/24,19.18%,AUTS2;OGT;KMT2A;WDR5;SNW1;PAXIP1;RIF1;CHTOP
prerank,tyrosine metabolic process (GO:0006570),0.5679073368542933,1.2916312420476082,0.18996415770609318,0.813479642479277,1.0,2/11,4.84%,TYR;FAH
prerank,negative regulation of T cell activation (GO:0050868),0.4532249414235484,1.2916202330418243,0.14977307110438728,0.8114239784958162,1.0,7/35,12.36%,PAG1;GLMN;TNFAIP8L2;PTPN22;PDCD1LG2;TNFRSF21;CD86
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.44209405171194205,-1.2910846214396705,0.10918114143920596,0.552030167875582,1.0,12/20,31.32%,PTGES3;PSMG2;NDUFAF1;MKKS;PSMG3;HOPX;HSPD1;PFDN6;HSPA1A;PTGES3L;BBS12;BBS10
prerank,positive regulation of cellular component movement (GO:0051272),-0.42062479198806607,-1.2908464298013376,0.1568627450980392,0.5512916396474961,1.0,10/24,23.89%,CAVIN1;SPOCK2;NTN1;RPS19;ETS1;PDPN;CCDC25;TUBB2B;CSF1R;CCL19
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5312540931459403,1.2908114031740516,0.1847457627118644,0.8125325900692018,1.0,5/15,12.04%,GGT5;GGT7;ABHD16A;HOGA1;ABHD12
prerank,regulation of complement activation (GO:0030449),0.4341879285890228,1.2904693459534353,0.14119359534206696,0.8118319637730854,1.0,9/40,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,protein localization to Golgi apparatus (GO:0034067),-0.40919785369282,-1.2903394271088415,0.13774104683195593,0.551277441457747,1.0,10/27,16.86%,CSNK1D;GBP5;ARFRP1;OPTN;GAK;BICD2;VPS13A;ARL1;VPS13D;RAB6A
prerank,protein-containing complex disassembly (GO:0032984),-0.3433907469250212,-1.2903306709743534,0.10309278350515463,0.54996255302257,1.0,12/54,9.94%,CAV1;UVRAG;HSPA8;GABARAP;EPG5;APC;DVL1;GABARAPL1;GSK3B;LRP6;VCP;PYM1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3632697684768373,-1.2902738382128949,0.09177215189873418,0.5487756625196977,1.0,25/49,30.17%,ACER2;NDRG1;MAPK14;ATR;BID;ATM;CDC5L;NBN;GRB2;CLOCK;DONSON;HUS1;E2F1;PRPF19;BATF;ATRIP;HINFP;CHEK2;BRIP1;CHEK1;RHNO1;GADD45A;SESN2;E2F7;TRIAP1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4613192440044292,-1.2901782689110939,0.13720316622691292,0.5476248896840217,1.0,7/18,8.88%,FN1;CD200;ITGB8;TGFB2;CD34;SMAD3;LRRC32
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.595396739946975,1.2900836153170827,0.17100371747211895,0.8113114764122361,1.0,3/10,11.67%,OGT;DGKQ;PDK2
prerank,regulation of lipid kinase activity (GO:0043550),0.577517133017952,1.2899108146415534,0.1872791519434629,0.8098552860671165,1.0,2/11,4.02%,PIK3R1;PIK3R2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4223311276092162,1.2893101123172743,0.1447178002894356,0.8102362476822412,1.0,16/46,18.61%,ATP1A2;NRXN1;CACNG3;LRRK2;GRIK1;RELN;OPHN1;CACNG4;GRM5;DGKI;UNC13A;TPRG1L;GRM7;CDK5;GRM1;SYT1
prerank,triglyceride metabolic process (GO:0006641),0.42766555827416075,1.289218162180852,0.13381294964028778,0.8085507354395413,1.0,11/48,15.43%,LPIN3;SEL1L;LIPH;LIPC;FABP5;FABP4;AGMO;GK;FABP3;GPAT3;LPIN2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4462945021229784,1.2891841578009593,0.1471927162367223,0.8066061612247969,1.0,6/33,5.41%,DCN;PTEN;NR2F2;PTPRR;MCC;ADGRB1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.39336202176564705,-1.2886976145035562,0.1069364161849711,0.5500994422812882,1.0,15/32,25.00%,SORBS1;PRKAG2;ADIPOR2;PRKAA2;APOE;CEACAM1;ASXL3;CREB1;GPER1;AKT1;CREBL2;FITM2;STAR;ASAH1;PDK4
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.47983757173479696,-1.2874518482910031,0.15384615384615385,0.5522150409338208,1.0,7/15,28.32%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,plasma membrane tubulation (GO:0097320),-0.5035917165685219,-1.2871852827009107,0.14925373134328357,0.5516330585308566,1.0,3/13,3.98%,FNBP1L;PACSIN2;CAVIN2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4195806877412961,-1.2869890376667892,0.11733333333333333,0.5508077287593952,1.0,10/26,17.86%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;NOS1AP;PTGS2;EDN1;AKT1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5931265250402262,1.2867101403236976,0.20035460992907803,0.8140922902743105,1.0,2/10,1.70%,XCL1;WNT5A
prerank,regulation of macrophage differentiation (GO:0045649),0.5278996091696099,1.2862173444591967,0.19834710743801653,0.813829267718131,1.0,3/15,8.66%,IL34;C1QC;PRKCA
prerank,inhibitory synapse assembly (GO:1904862),0.5587393561509398,1.2858719851039293,0.18055555555555555,0.8130407397019562,1.0,3/11,10.51%,WNT5A;GABRA1;GABRG2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3458392043878773,1.28531567511909,0.06997742663656885,0.8132130444526265,1.0,29/208,10.90%,RORA;ROR1;MAP3K14;EDA2R;CCDC22;WNT5A;TRAF4;CD40;TSPAN6;NR1H4;LURAP1;GJA1;PDPK1;HTR2B;TLR6;CAPN3;CARD19;TNFRSF19;PINK1;PRKD1;TRIM8;PRKCB;TLE1;BIRC2;IRAK1;LPAR1;NDFIP2;DHX36;PYCARD
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.37463233442355903,1.285297356871365,0.09079445145018916,0.8112484235647821,1.0,26/116,17.12%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4
prerank,insulin receptor signaling pathway (GO:0008286),-0.32900851535396797,-1.2851951079615265,0.08433734939759036,0.5544006760277511,1.0,14/69,7.28%,SORBS1;FOXO1;IGF1R;FER;ATP6V0A4;FOXC2;INSR;RHOQ;GRB14;APC;GRB10;CAV2;GAB1;GSK3B
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.580445447747249,1.2846161492293535,0.19366852886405958,0.8117990820878325,1.0,1/11,1.32%,RTP4
prerank,positive regulation of GTPase activity (GO:0043547),-0.28390553933076523,-1.28459649909498,0.0,0.5546780493948753,1.0,55/188,15.41%,PKP4;TBC1D4;PICALM;RAPGEF2;SIPA1L1;TIAM2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;SIPA1L2;RASGRF1;S100A10;TBC1D8;RAP1A;RAP1GAP2;NDEL1;ARHGAP42;TBC1D22B;CAV2;SRGAP2;RAPGEF1;GSK3B;ARHGEF15;RANGAP1;RUNDC1;RSU1;RALBP1;PLXNB1;NGEF;SGSM2;SFRP1;MAPRE2;GMIP;APC2;GRTP1;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;TBC1D22A;BCR;TBC1D10B;RAPGEF3;TBCK;CX3CL1;EZH2;RAP1GDS1;TBC1D13;RGS10
prerank,regulation of neuron projection development (GO:0010975),0.3548324658613791,1.2843359147070503,0.07801418439716312,0.8108061958499883,1.0,42/163,17.24%,ROR1;PTN;NTRK3;ROR2;CHN1;TENM3;CTNNA2;WNT5A;NTRK2;PTEN;CSMD3;CDKL5;PRKCI;LRRK2;DISC1;PTPRO;PPFIA2;TANC2;PRKD1;RELN;DCC;STMN2;P3H1;RAB29;LPAR1;EPHA3;LRRC4C;PLXNB2;RETREG3;ARHGAP35;GSK3A;LRRC7;LYN;NTNG2;NTNG1;BRSK2;NCS1;DENND5A;IL1RAPL1;CBFA2T2;RTN4RL1;CDK5
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4669417342565401,-1.2840810437458436,0.1491442542787286,0.5546679735851768,1.0,5/16,8.92%,CAV1;TRIM25;TRIM5;TRIM14;EXOC2
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5097236348341743,-1.2825555887723477,0.1674641148325359,0.5573546604421631,1.0,3/12,13.87%,EPHA4;NOTCH1;SERPINE2
prerank,pinocytosis (GO:0006907),0.5866463229084173,1.2822734804357656,0.19494584837545126,0.8166402345879809,1.0,3/10,11.55%,RAB34;PYCARD;MAPKAPK3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.46569079919081635,1.281744568829359,0.1578125,0.8165830421225672,1.0,8/28,12.54%,ENPP1;PIP4K2A;IRS1;RPS6KB1;APPL2;PRKCB;TNS2;GSK3A
prerank,signal peptide processing (GO:0006465),-0.511992977157335,-1.2815061251260254,0.17687074829931973,0.5589814550793185,1.0,5/11,15.69%,SPCS2;SEC11C;CLN5;FURIN;PCSK5
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4421380257583075,-1.2814494917198744,0.12468193384223919,0.5577982811026976,1.0,5/20,9.80%,NBL1;GLI2;ACVR1;ACVRL1;SFRP1
prerank,vasculogenesis (GO:0001570),-0.3874175411768865,-1.2811012416824277,0.13742690058479531,0.5575388092061794,1.0,13/32,22.66%,ITGB8;CAV1;KDR;NOTCH1;RASIP1;SOX17;HEY2;RAMP2;SOX18;RASA1;TGFBR3;TGFBR2;APLNR
prerank,clathrin-dependent endocytosis (GO:0072583),-0.40275398684971464,-1.2807473419098547,0.1509433962264151,0.5571922207043418,1.0,7/26,12.68%,PICALM;FNBP1L;INPP5F;GPR107;AP2A1;CLTB;GAK
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.305507760426312,-1.2797056642884561,0.06190476190476191,0.558563064709255,1.0,26/104,12.85%,CRIM1;SMAD6;CAV1;BMPER;LEMD3;NBL1;BMPR2;MAGI2;SKIL;NOTCH1;CCN3;SKI;UBE2D3;CD109;UBB;ASPN;SNX25;ACVR1;SMURF2;SMAD3;SNX6;PRDM16;BCL9L;SPRED3;HIPK2;SMAD1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4712420498656708,-1.279481428987707,0.1568627450980392,0.5577906911501528,1.0,12/16,37.32%,NOS3;GUCY1A1;APOE;NOS1;DDAH1;AGT;DDAH2;GUCY1B1;NDNF;MAFA;CD36;NOS2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3854062735086784,-1.278911759284721,0.1327683615819209,0.5580132436251659,1.0,13/33,19.40%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;ANXA1;HYAL1;PLCG2;CCND1;EZH2;ANKRD17;AKT1;RGCC
prerank,peptidyl-arginine modification (GO:0018195),-0.48349747201235316,-1.2788956027888865,0.15632183908045977,0.5567119403176973,1.0,13/15,47.90%,ART3;PRMT7;PRMT8;KRTCAP2;PADI2;PARK7;PRMT1;PRMT5;NDUFAF5;ART1;PADI1;PADI4;ART4
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3554347764396603,1.2785987298385544,0.09165687426556991,0.8268193950818679,1.0,33/152,17.33%,ADGRL3;CXCL10;PTGFR;ADCY5;AKAP5;CALCRL;GPR3;GPR37L1;ADGRB2;ADGRB1;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;LPAR3;ADGRB3;ADGRL1;ADCY7;GNA11;LPAR1;GPR26;IAPP;GNAO1;S1PR2;LGR5;LHCGR;GPR37;ADGRE5;PTGER4;ADRA2A
prerank,establishment of protein localization to organelle (GO:0072594),0.3944286174169843,1.27834154545945,0.13168724279835392,0.8257819470248363,1.0,21/72,18.72%,PRICKLE1;CSE1L;NUP214;RYR2;FAM53C;NUTF2;POM121;CD68;PINK1;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;PEX19;TNPO2;IPO9;NUP155;KPNB1
prerank,response to ATP (GO:0033198),0.5076572616905075,1.2780415224110167,0.1893687707641196,0.8249535263830113,1.0,6/18,13.68%,P2RY1;DGKQ;TRPC3;P2RX4;HSP90B1;RYR3
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4824402194862424,-1.2778318185224884,0.17733990147783252,0.558344618468656,1.0,7/13,36.65%,STX3;TYROBP;GPD1L;ABCA7;STX4;RANGRF;RIC3
prerank,aortic valve development (GO:0003176),-0.3779870651706979,-1.2776679035538785,0.11403508771929824,0.5574725588777746,1.0,8/34,4.26%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;BMPR2;TIE1;NOTCH1
prerank,negative regulation of blood coagulation (GO:0030195),0.43614793619807063,1.2768946041919984,0.1435114503816794,0.8273493612588686,1.0,6/38,9.62%,PDGFRA;HRG;KLKB1;C1QTNF1;PLAU;F8
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4511644691721093,-1.2767106001561461,0.16587677725118483,0.5585628175880611,1.0,6/17,17.38%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,negative regulation of protein binding (GO:0032091),-0.32290126072976766,-1.2763188403292067,0.08097165991902834,0.5582231953662247,1.0,23/71,18.23%,CAV1;ACTB;TMBIM6;DAB2;DVL1;MITD1;PTPRF;B2M;GSK3B;ITGB1BP1;NES;STYX;BAX;RALB;TLE5;ATP2A3;CTSZ;CDKN1A;DDX11;PRKCD;HFE;AKT1;IFIT1
prerank,regulation of phagocytosis (GO:0050764),0.4149375251031097,1.2747632649767706,0.15121255349500715,0.8336291457796997,1.0,9/53,10.90%,IL15RA;MERTK;ITGAV;TUB;LYAR;CYBA;FGR;SYT7;PYCARD
prerank,response to reactive oxygen species (GO:0000302),0.41237280018433026,1.2741467580696169,0.13915416098226466,0.833942356464484,1.0,6/54,6.14%,APOD;PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3829604038912938,-1.2738978660426272,0.14285714285714285,0.5633923245770479,1.0,10/30,14.56%,IGF1;NOTCH2;RASGRF1;SHOC2;NOTCH1;RAPGEF1;NGF;STK19;TGM2;GRB2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4732454806495014,-1.2738253658018655,0.19154228855721392,0.5622519952863574,1.0,7/15,27.79%,SAMHD1;PTPN2;NLRC5;ISG15;USP18;YTHDF2;TTLL12
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3532688024342602,1.273757457987693,0.08984830805134189,0.8334867773983172,1.0,34/159,12.68%,ROBO2;ADGRL3;TENM3;CDH6;PTPRT;GRID2;GPC4;MMP24;PCDHB16;TENM4;DCHS1;CDH11;DSCAM;CDH15;CDH3;CNTN4;PCDHB4;TENM2;PCDHB11;DSCAML1;LRFN5;PALLD;ADGRL1;NEXN;TENM1;CNTN6;AMIGO3;LRRC4C;CLDN15;UNC5D;PLXNB2;CBLN1;CDH10;CADM3
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5556100575837304,1.2732391328453438,0.19798657718120805,0.8335062219314705,1.0,3/12,5.51%,MYO7A;NKD1;DSCAM
prerank,positive regulation of coagulation (GO:0050820),-0.536821826105259,-1.2731225715924344,0.18140589569160998,0.5616020725637162,1.0,6/10,28.40%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.536821826105259,-1.2731225715924344,0.18140589569160998,0.5616020725637162,1.0,6/10,28.40%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5105747492486262,-1.2726300136545081,0.15632183908045977,0.5616450229501277,1.0,3/12,3.95%,SORBS1;IGF1;INSR
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.46484096014213405,-1.2724940601839985,0.1588785046728972,0.5606759569137265,1.0,6/17,19.40%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC
prerank,plasma membrane repair (GO:0001778),-0.49258822682681624,-1.2722005750218097,0.1585081585081585,0.5602175070949676,1.0,4/13,15.86%,MYOF;AHNAK2;SMPD1;DYSF
prerank,glycogen biosynthetic process (GO:0005978),-0.5029172146499711,-1.2712178623637547,0.1774193548387097,0.5602608241727097,1.0,6/12,13.49%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,glucan biosynthetic process (GO:0009250),-0.5029172146499711,-1.2712178623637547,0.1774193548387097,0.5602608241727097,1.0,6/12,13.49%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,regulation of mitotic nuclear division (GO:0007088),0.4113975992156962,1.2712068940209476,0.15988779803646563,0.8394053453254933,1.0,13/55,12.42%,EDN3;L3MBTL1;PHIP;DUSP1;PKMYT1;FBXO5;CDK13;BMP7;NME6;RCC1;MKI67;NUSAP1;IGF2
prerank,membrane assembly (GO:0071709),0.44062173804111954,1.2709941120061738,0.15987933634992457,0.8382161306455239,1.0,7/34,6.91%,PTEN;NRXN2;CEL;NRXN1;SPTBN1;ANK3;FLOT2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5435997982216431,1.2709321775334055,0.1815068493150685,0.8364243922482948,1.0,3/13,3.66%,DCN;BGN;VCAN
prerank,leukotriene biosynthetic process (GO:0019370),0.52691004535277,1.2703706988779713,0.18588640275387264,0.8365520367319718,1.0,2/14,2.23%,GGT5;GGT7
prerank,vasodilation (GO:0042311),-0.4912185367067293,-1.269571052483507,0.17114914425427874,0.5633367333331833,1.0,6/13,19.69%,NOS3;SOD2;KLF2;NOS1;GPER1;ADRB2
prerank,protein import into mitochondrial matrix (GO:0030150),0.49289454503411434,1.2695674394463354,0.1848184818481848,0.8376551685975356,1.0,6/18,20.82%,DNAJC19;TIMM44;DNAJC15;PAM16;GRPEL1;TIMM21
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.49769424621217256,-1.2685342582428145,0.16091954022988506,0.564885499452198,1.0,3/13,3.95%,SORBS1;IGF1;INSR
prerank,regulation of synapse maturation (GO:0090128),0.5731311537882929,1.2684654264985395,0.20642978003384094,0.84006317955628,1.0,4/10,8.81%,NRXN1;YWHAZ;RELN;ADGRL1
prerank,vesicle organization (GO:0016050),-0.3499222149418555,-1.2681481904450842,0.11285266457680251,0.5646813523078795,1.0,10/46,7.29%,CAV1;FNBP1L;LAPTM4B;SRGN;SQSTM1;CHMP2B;CD34;CAV2;VPS18;HOOK1
prerank,positive regulation of cell division (GO:0051781),0.4333474637834057,1.268047917044026,0.15327380952380953,0.8397955296621873,1.0,4/38,4.84%,SVIL;CDC14B;RXFP3;HTR2B
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5169797199454691,-1.2680120381093511,0.1876484560570071,0.5637375942801287,1.0,5/11,9.97%,RAPGEF2;MEF2C;ANXA1;PIK3CB;PIK3CD
prerank,positive regulation of organelle organization (GO:0010638),-0.3854323247205484,-1.2678365915244427,0.1274787535410765,0.56285687020339,1.0,18/32,32.93%,SORBS3;STX18;UVRAG;ANXA1;GSK3B;SURF4;P2RX7;SYNJ1;ATL3;LMAN1;ADRB2;SHCBP1L;PFDN2;LIG4;IRGM;AKT2;DOC2B;TREM2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4777499447872817,-1.267766579823829,0.16923076923076924,0.5617930212110527,1.0,7/15,16.70%,EGFR;IGF1R;KDR;BMX;PTK2B;TEC;AATK
prerank,positive regulation of cell adhesion (GO:0045785),-0.3194861440926448,-1.2677579771971095,0.08189655172413793,0.5605528541429424,1.0,21/74,13.13%,EPHA4;PTPRJ;AFDN;VIT;TPM1;FOXC2;TGFB2;RAC1;PPM1F;RSU1;ECM2;FRMD5;HYAL1;CITED2;NPNT;STX3;ARL2;MDK;RET;TGM2;ATM
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5383649251414423,-1.2676900118280514,0.2072072072072072,0.5594794824434995,1.0,6/10,22.71%,FN1;LAPTM4B;GATA6;FURIN;TSKU;TYROBP
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3738540072166179,1.2672279483515694,0.14010282776349614,0.8408996216195742,1.0,11/95,4.65%,CEMIP;DCN;LUM;HSPG2;BGN;DSE;GPC4;VCAN;B4GALT2;GCNT2;GPC5
prerank,regulation of hemopoiesis (GO:1903706),0.5824524032613037,1.2665370524470396,0.2182468694096601,0.8414694092114726,1.0,5/10,21.85%,PTN;PRKCB;MAFB;CBFB;CREBBP
prerank,cell-substrate junction assembly (GO:0007044),-0.383647325616296,-1.2664469454558782,0.146875,0.5616145124817492,1.0,13/33,13.62%,SORBS1;FN1;ACTN2;PTPRK;THSD1;ITGA6;PLEC;LAMA3;ITGB4;CD151;TRIP6;BCR;DST
prerank,eye development (GO:0001654),0.41001064719059804,1.2664454098343818,0.1411764705882353,0.8398094815546884,1.0,3/54,3.58%,LAMA1;MEIS1;MEIS2
prerank,cell differentiation in hindbrain (GO:0021533),0.5722512746654989,1.2663910797652929,0.20701754385964913,0.838058329702796,1.0,8/11,28.28%,GRID2;OPHN1;CBLN1;ATP7A;FAIM2;PROX1;AGTPBP1;KNDC1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.41414367517289774,1.2661782914290216,0.14866760168302945,0.8368139718383483,1.0,13/50,16.20%,RORA;RAB34;PTCH2;ZIC1;IFT81;GLI1;GLI3;GAS8;TXNDC15;HERC4;EVC;FGFR2;PDCL
prerank,regulation of immune effector process (GO:0002697),0.42308599454911655,1.2657749475609676,0.16448326055312956,0.8363379119907671,1.0,9/41,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,ear morphogenesis (GO:0042471),0.49837737144641275,1.2656696283149382,0.1867572156196944,0.8347590512686578,1.0,4/20,8.25%,CHD7;ZIC1;MYO6;TWIST1
prerank,energy reserve metabolic process (GO:0006112),-0.4503033275169849,-1.2655156810786778,0.1775,0.5629651145810565,1.0,11/19,28.50%,PRKAG2;LEPR;GBE1;GSK3B;UGP2;PPP1R3C;PID1;MRAP2;MT3;PHKG2;PYGL
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.49869693257766506,1.2651345603486475,0.1847457627118644,0.834750271678914,1.0,7/18,24.53%,C5AR1;GPLD1;LYN;BAG6;CMKLR1;SPG21;BCAR1
prerank,activation of adenylate cyclase activity (GO:0007190),0.4345449786118759,1.265027572434718,0.15555555555555556,0.8332131586087073,1.0,7/35,8.88%,ADORA2B;ADCY5;ADCY8;ADCY3;ACR;ADCY2;ADCY7
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.400336569570032,-1.264767248069832,0.14578005115089515,0.5636469828690982,1.0,8/24,8.02%,PHLDB2;TJP1;ARHGEF18;WASF2;F11R;CGNL1;TMEFF2;RHPN2
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.5371644281334522,-1.2646857862806153,0.18906605922551253,0.5625872971608167,1.0,5/10,17.68%,TSN;DICER1;DROSHA;TERT;AGO2
prerank,inorganic cation transmembrane transport (GO:0098662),0.33399785720305847,1.2646003920268196,0.05438401775804662,0.8328762091971094,1.0,47/268,13.68%,SLC1A3;KCNK2;KCNS2;TRPA1;SLC6A13;SLC6A8;ATP1A2;SLC24A5;SLC30A10;NALCN;MCOLN2;ITGAV;ASIC2;KCNQ3;SCN2B;SLC30A5;SLC39A7;SLC9A9;ATP1A3;ATP2A2;SLC9A1;CACNA1G;TRPV3;KCNG1;KCNH4;ASIC1;KCNAB1;TRPC3;KCNC2;TMEM175;HCN2;SLC30A3;HCN1;KCND2;HCN3;P2RX4;TRPM2;TRPC7;KCNK1;KCNN2;KCNH7;KCNJ8;ATP6V0E1;KCNAB3;SCN1A;SCN2A;RYR3
prerank,activation of protein kinase activity (GO:0032147),0.3655056998174224,1.262597101469704,0.11280101394169835,0.8383861051928534,1.0,19/106,10.04%,NTRK3;GHR;NRG1;ADCY5;WNT5A;MAP4K4;PDPK1;PRR5;TLR6;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;PINK1;PRKACA;ADCY7;MTOR;IRAK1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5035610457315223,1.2625806098505634,0.2006980802792321,0.8364865348971076,1.0,7/18,13.86%,PTEN;NRXN1;RIMS2;RELN;RIMS1;DLG4;CUX2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3821529773708747,-1.2622999999267541,0.15406976744186046,0.56756104028413,1.0,14/30,28.68%,DKK3;LTBP4;XIAP;FSTL1;SMURF2;SMAD3;TWSG1;SOX11;TGFBR3;SMAD7;FSTL3;SMAD4;TRIM33;FKBP1A
prerank,cell junction assembly (GO:0034329),-0.30202566736505576,-1.2622750237710354,0.09574468085106383,0.5663520052089256,1.0,17/100,8.10%,SDK1;PKP4;FN1;TJP1;LIMS2;SPOCK2;ACTB;SHANK3;CDH1;ITGA6;CLDN5;CDH8;ACTG1;CTNND1;CDC42;DNER;DNM3
prerank,transition metal ion homeostasis (GO:0055076),-0.4008484585635294,-1.262103513509264,0.15176151761517614,0.5655451645506615,1.0,6/28,8.27%,PICALM;XIAP;NEO1;HMOX2;B2M;BDH2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.48739192064548253,-1.2615636524174498,0.18080357142857142,0.5658069343142883,1.0,8/13,17.68%,BTG2;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,amino acid transmembrane transport (GO:0003333),-0.3616862049266934,-1.260911340628539,0.13782051282051283,0.5662937210514446,1.0,12/45,11.97%,SLC47A1;SLC16A2;SLC6A6;SLC38A11;SLC22A4;SLC7A1;SLC3A2;LRRC8D;SLC38A5;SLC38A10;SLC7A5;SFXN1
prerank,regulation of response to oxidative stress (GO:1902882),0.552214483896213,1.260396527436965,0.20363636363636364,0.8430196894021201,1.0,5/11,18.49%,ACOX2;GGT7;PINK1;AIFM2;ALOX5
prerank,development of primary male sexual characteristics (GO:0046546),-0.37593221297172336,-1.2602076131536755,0.12299465240641712,0.56692519526418,1.0,6/34,4.38%,KITLG;CSDE1;LHFPL2;TGFB2;WNT4;NCOA4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.35045769000416993,-1.2597716891237425,0.1396103896103896,0.5667644270603721,1.0,24/48,29.16%,BCL2L1;MCL1;PRKDC;CASP2;HIPK1;FNIP2;CRIP1;DYRK2;BAX;HIPK2;ATM;BOK;SIRT1;TMEM109;EPHA2;E2F1;IKBKE;BCL2L11;CHEK2;BRCA1;MSH2;SFN;DDIT4;TNFRSF1B
prerank,import into nucleus (GO:0051170),0.3851302875605599,1.2594772310875493,0.13648648648648648,0.8445912527340966,1.0,21/73,18.72%,PRICKLE1;CSE1L;GEMIN2;NUP214;FAM53C;NUTF2;POM121;SNUPN;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;SNRPF;TNPO2;IPO9;GEMIN8;NUP155;KPNB1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.49629542438501506,1.2593197880806035,0.19462025316455697,0.843237831971343,1.0,8/19,17.84%,CDKL5;CAPRIN1;CDKL3;RELN;DHX36;CUX2;IL1RAPL1;CUL7
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.43411090424467763,1.2587546003727015,0.1827637444279346,0.8433260719107117,1.0,10/35,14.68%,PDE9A;PDE7B;HTR2B;RIMS2;DGKQ;ADCY2;HTR2C;SOX9;AKAP6;EPHA5
prerank,membrane lipid catabolic process (GO:0046466),-0.5301003305878308,-1.2584996300828593,0.20665083135391923,0.5688674649005935,1.0,4/10,12.37%,CYP1B1;FUCA1;ENPP2;NAGA
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.41844834741977305,-1.2580860433612242,0.1503957783641161,0.5674641591654523,1.0,8/23,12.22%,PPP1R13B;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.41844834741977305,-1.2580860433612242,0.1503957783641161,0.5674641591654523,1.0,8/23,12.22%,PPP1R13B;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.3032755404860447,-1.2574494550032247,0.09465020576131687,0.567965220447328,1.0,20/88,9.97%,TEK;CAV1;THBS1;NRP2;NRP1;BMPR2;SPARC;TIE1;ECM1;KDR;VEGFD;VEGFC;CAV2;APOE;XDH;PPP1R16B;ACVRL1;ATOH8;NR4A1;PIK3CD
prerank,embryonic heart tube development (GO:0035050),-0.472009798295166,-1.257386669744476,0.1927710843373494,0.566888825090952,1.0,5/14,9.88%,MEGF8;ACVR1;SOX17;CITED2;TBX2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.509480576049415,-1.2572515703559568,0.19012345679012346,0.5648514914529259,1.0,8/11,39.74%,SRI;CALM1;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.509480576049415,-1.2572515703559568,0.19012345679012346,0.5648514914529259,1.0,8/11,39.74%,SRI;CALM1;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5148242783733242,-1.257089104610123,0.22693266832917705,0.5640686994003719,1.0,4/11,6.96%,MECOM;RUNX1;CD34;ETV6
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4110374048808301,1.2569943080218247,0.15177304964539007,0.8481248195721368,1.0,12/48,11.03%,ADCY5;ADCY10;SLC35B3;GMPS;COASY;ADCY8;ADCY3;ADCY2;PAPSS2;AMPD2;ADCY7;ACOT7
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3946941872793525,1.2568726944306188,0.1485557083906465,0.846600752766115,1.0,15/64,11.12%,CASK;UTRN;GPM6B;PEAK1;CDKN2A;MAP4K4;JUP;NF1;SLC9A1;PTK2;PLAU;EPHA3;CCL25;PTPRA;SLK
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5600155361428809,1.2566732409796464,0.21746880570409982,0.8454026774091582,1.0,4/10,17.28%,SCRIB;PDCD1LG2;PRKAR1A;LGALS9
prerank,myotube differentiation (GO:0014902),-0.449043935693617,-1.2563380404613238,0.15281501340482573,0.5648244268403845,1.0,4/17,4.92%,IGF1;MEF2C;JAM2;SKI
prerank,chondrocyte differentiation (GO:0002062),-0.3863446882272275,-1.2560148437772136,0.14893617021276595,0.5644990316746027,1.0,9/32,5.49%,NFIB;SOX5;MEF2C;WNT5B;OSR1;BMPR2;RUNX1;CCN3;SULF2
prerank,regulation of cellular component organization (GO:0051128),-0.28615569700313265,-1.2555608751399792,0.05649717514124294,0.5645591638401352,1.0,30/135,14.68%,PLCE1;SNCAIP;TJP1;PICALM;RAPGEF2;ROCK2;MLLT3;LTBP4;NET1;PACSIN2;MARK4;HIP1R;CAMK2D;RAP1A;HSPA8;SOCS2;TFRC;RAPGEF1;APOE;RAB5A;RAB5C;STK38L;FAM107A;PTPN1;NCLN;CEACAM1;SNX17;HIP1;AGTR1;ARHGEF11
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5000296669810875,-1.2554751891484908,0.19413092550790068,0.5636171264210456,1.0,5/13,10.77%,ROCK2;ACTG1;RAC1;CDC42;FHOD1
prerank,regulation of dendrite development (GO:0050773),0.42877558199701465,1.2549016847390142,0.15834522111269614,0.8501696973339886,1.0,10/37,16.69%,PTN;CSMD3;CDKL5;NEDD4;ADGRB3;DCC;BMP7;SDC2;TNIK;HECW1
prerank,negative regulation of bone mineralization (GO:0030502),0.5400704792239873,1.2540933208206901,0.22338568935427575,0.8513366295374275,1.0,2/13,6.36%,ENPP1;BCOR
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.45242283599462196,-1.253929519736924,0.18673218673218672,0.5664566359408799,1.0,9/18,26.77%,LBP;NMI;IFI35;KARS1;PLCG2;DYSF;DOCK2;TYROBP;SBNO2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.47745533075024044,-1.2539191328972306,0.18877551020408162,0.5652802913738663,1.0,4/13,2.72%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,presynaptic endocytosis (GO:0140238),0.4683493157064022,1.2538335980346245,0.18566775244299674,0.8503775291341428,1.0,9/24,19.48%,CEL;VAMP2;OPHN1;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.35105857103035437,1.2535516428667484,0.10653753026634383,0.8495413258959132,1.0,17/138,7.64%,RORA;PPARA;TEAD1;HDAC1;TAF9B;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;NR2C1;TAF3
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5258130051864844,1.2534555583962315,0.20863309352517986,0.8480446383956295,1.0,2/15,4.84%,KYNU;FAH
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4803330322469439,-1.2528811316024848,0.18357487922705315,0.5668827983072691,1.0,7/14,13.59%,MEF2C;SLIT2;IGFBP5;TPM1;IGFBP3;SERPINE1;PRKG1
prerank,carnitine metabolic process (GO:0009437),0.5419029024597087,1.252279762532562,0.1989247311827957,0.8507359008072731,1.0,7/12,26.26%,ACADL;CRAT;TMLHE;ALDH9A1;CPT1A;CPT1C;CROT
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.40180126964452045,1.251541850966666,0.16714285714285715,0.8516509520987722,1.0,13/52,10.40%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3;EPB41L2;GPSM2;NKD2;EPHA3
prerank,regulation of chemokine production (GO:0032642),0.43219652429106525,1.2514720846371625,0.17457886676875958,0.8500010418312455,1.0,6/36,10.90%,IL33;WNT5A;TSLP;TLR4;EIF2AK2;PYCARD
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.42628227701476357,1.2514252222170863,0.17559523809523808,0.8482686891610406,1.0,13/41,17.33%,IL34;NTRK2;UNC119;DLG3;DOCK3;RELN;GRM5;FYN;DLG4;CASS4;AREG;EFNA1;ADRA2A
prerank,negative regulation of kinase activity (GO:0033673),-0.32600026492324263,-1.2507848629160838,0.11068702290076336,0.571160031809594,1.0,24/62,23.73%,PRKAG2;PPM1E;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;LRP6;ITGB1BP1;MAPT;YWHAG;HSPB1;CEACAM1;PPIA;TRIM27;PRDX3;PAK2;AKT1;GSKIP;DUSP19;CAMK2N1;WWTR1;QARS1;DBNDD2
prerank,regulation of fibrinolysis (GO:0051917),0.5355180822780472,1.2506777751876255,0.210896309314587,0.8493156525971548,1.0,3/13,5.10%,HRG;FAP;KLKB1
prerank,peptide cross-linking (GO:0018149),-0.40577447275191997,-1.2502550194577813,0.1569620253164557,0.5713335186096655,1.0,3/25,5.01%,FN1;THBS1;ANXA1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3458830293887621,-1.250213663556676,0.13651877133105803,0.5702559997397756,1.0,9/48,5.90%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;PRKDC;RAC1;NEDD9;CDC42
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5768529441871248,1.2499885018430814,0.22540250447227192,0.8501770755809434,1.0,1/10,0.04%,APOD
prerank,blood vessel morphogenesis (GO:0048514),0.4016679509378551,1.249626095169553,0.16666666666666666,0.8496802900853138,1.0,3/54,2.79%,LAMA1;COL4A1;GLMN
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.582867015937377,1.2492095947780402,0.21228070175438596,0.849441272930419,1.0,3/10,6.25%,GPLD1;IRS1;IRS2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43254496256760755,1.2484773588024334,0.16043613707165108,0.8502367904896363,1.0,10/35,13.74%,POLG;LIG3;FEN1;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,receptor recycling (GO:0001881),0.582901117113792,1.2483906542386032,0.22939068100358423,0.8486985041591779,1.0,4/10,20.92%,PHETA2;SORL1;PHETA1;ARFGEF2
prerank,substantia nigra development (GO:0021762),0.4284190684820056,1.2482539381206375,0.18594436310395315,0.8473593420743469,1.0,9/37,14.38%,DYNLL1;GNB4;BASP1;SEC16A;MBP;PLP1;S100A1;HSPA5;NDRG2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.48331010741840175,1.2481833461568292,0.18494271685761046,0.8457420905774916,1.0,8/22,15.41%,MED12;SRF;PSMC4;TP53;DHX36;PSMC5;MED1;PAXIP1
prerank,positive regulation of lipid localization (GO:1905954),0.5614393876115463,1.2480773338287696,0.2264808362369338,0.8442564193320226,1.0,1/11,0.48%,LRP1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.49901722684038535,-1.2475645136686397,0.2,0.5764527100569575,1.0,5/11,16.48%,MEF2C;EFNB2;FZD7;FRS2;MYOCD
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4586400131762974,1.2468432695863427,0.1891891891891892,0.8470606114464286,1.0,5/29,8.14%,SPRY1;PTEN;SPRED1;IL17RD;SPRED2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4214765957711465,1.2468033880333902,0.17352941176470588,0.8453745899909023,1.0,7/39,7.26%,CASK;SPRY4;CORO2B;CDKN2A;MAP4K4;GCNT2;PTPRO
prerank,homeostasis of number of cells (GO:0048872),-0.5038004302812871,-1.246759033001738,0.20823798627002288,0.5773755854655463,1.0,5/12,11.32%,NOS3;NOTCH1;CCN3;CX3CR1;UBAP2L
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3211357130111752,-1.2467317640578481,0.1450381679389313,0.5762247502631717,1.0,22/67,14.62%,FLT1;ROCK2;DOCK1;WASF2;NRP2;NRP1;KDR;CLEC14A;VEGFD;RAC1;VEGFC;CDC42;NCK1;MAPK14;AAMP;PIK3CB;HSPB1;ITGB3;FLT4;PTK2B;BAIAP2;ELMO2
prerank,synaptonemal complex assembly (GO:0007130),0.5103031159477944,1.2465481350878385,0.1783783783783784,0.842654764799189,1.0,4/15,19.98%,STAG3;TEX11;BAG6;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.5103031159477944,1.2465481350878385,0.1783783783783784,0.842654764799189,1.0,4/15,19.98%,STAG3;TEX11;BAG6;TRIP13
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5422026910731416,1.2458526117273103,0.22664359861591696,0.8434797709508167,1.0,7/13,23.31%,CBLB;KPNA1;NUP54;KPNB1;RANBP2;KPNA2;NUP35
prerank,tRNA 5'-leader removal (GO:0001682),0.5150627815876468,1.2457079809912996,0.20650406504065041,0.8422187075067477,1.0,4/13,9.76%,RPP40;POP5;PRORP;POP7
prerank,protein localization to synapse (GO:0035418),0.5350246198869211,1.2453724383319724,0.19256756756756757,0.8417173674300082,1.0,5/12,18.59%,NRXN2;NRXN1;DLG4;PCLO;MPP4
prerank,midbody abscission (GO:0061952),-0.45576014720964075,-1.2448494392837122,0.16461916461916462,0.5798827553106222,1.0,13/17,38.38%,CHMP2B;MITD1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;CHMP4C;CHMP2A;CHMP6;VPS4A;KIF20A;CHMP3
prerank,negative regulation of nuclear division (GO:0051784),0.5583844583587314,1.2447711191169666,0.23104693140794225,0.8421777878957004,1.0,3/11,9.77%,FBXO5;BMP7;NME6
prerank,mRNA methylation (GO:0080009),-0.4594250071475564,-1.244580451184835,0.20293398533007334,0.57939015405603,1.0,4/15,8.67%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,myeloid cell development (GO:0061515),-0.43362534298691763,-1.2444550058529351,0.17233009708737865,0.5785206911232884,1.0,9/18,29.05%,FOXP1;APP;ALAS1;ABCB10;NRROS;DMTN;SRC;NCKAP1L;ALAS2
prerank,regulation of stem cell proliferation (GO:0072091),0.4936508672705616,1.243988935095352,0.19639934533551553,0.8432219950320629,1.0,4/17,11.21%,KDF1;GJA1;EIF2AK2;AGO3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.48166635450447254,1.2439583578223021,0.1977124183006536,0.8415358470049547,1.0,3/22,3.59%,GHR;ERBB4;TSLP
prerank,regulation of angiogenesis (GO:0045765),-0.2728828261137213,-1.2439423166623995,0.06666666666666667,0.578704322374918,1.0,58/192,17.68%,FLT1;ANXA3;ROCK2;TEK;ITGB8;BMPER;ADAMTS1;FOXC1;ITGB1;NOS3;THBS1;KLF4;SPARC;TIE1;ECM1;CLDN5;KDR;RUNX1;TGFB2;CYP1B1;AMOT;COL4A3;VEGFD;VEGFC;CD34;SEMA6A;GAB1;PGK1;HIPK1;HK2;PPP1R16B;FGF1;NPR1;HYAL1;STAB1;SFRP1;GATA2;SERPINE1;PIK3CD;NIBAN2;ETS1;CTSH;HSPB1;CEACAM1;HIPK2;GATA6;GTF2I;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6;SIRT1;EPHA2;NAXE;HHEX;ERBB2;AGO2
prerank,axon development (GO:0061564),0.37817285766796715,1.2438154056977342,0.15,0.8402794379912532,1.0,23/78,17.24%,ISL2;CTNNA2;SEMA5A;ANK3;ADGRB1;NEFH;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;PLP1;ARHGAP35;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;GRM7;SLITRK1;RTN4RL1;CDK5
prerank,metal ion export (GO:0070839),0.4364616734848831,1.2438143734846858,0.1827956989247312,0.8384799940293132,1.0,7/31,14.03%,ATP1A2;KCNT2;ATP1A3;KCNIP2;SLC9A1;KCNE4;ATP7A
prerank,regulation of protein binding (GO:0043393),-0.29163759399152406,-1.2437723127233147,0.054945054945054944,0.5779297227229586,1.0,32/114,15.54%,RAPGEF2;CAV1;ACTB;HDAC4;APP;CLDN5;HIP1R;TMBIM6;VTN;DAB2;DVL1;MITD1;B2M;PRMT7;GSK3B;ITGB1BP1;RPL11;NES;STYX;BAX;PRMT8;RALB;TLE5;TERT;HIPK2;RAN;AMFR;CTSZ;CDKN1A;DDX11;MARK3;PRKCD
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5397896997761051,1.2435509211471014,0.2208029197080292,0.8377231973224067,1.0,7/12,18.61%,RIMS2;SYT7;RIMS1;SYT5;UNC13A;UNC13C;SYT1
prerank,response to chemokine (GO:1990868),-0.4821571624847679,-1.243256719849474,0.2,0.5782214051200066,1.0,3/13,5.92%,LRCH1;FOXC1;WNK1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4547856368739494,-1.243206695144106,0.18225419664268586,0.5771595703854812,1.0,6/17,20.77%,LPGAT1;PLA2G4A;LCLAT1;PLAAT3;PLA2G4E;PLA2G4C
prerank,regulation of DNA binding (GO:0051101),-0.34972238329761085,-1.243156168976265,0.12063492063492064,0.5761327185384497,1.0,16/44,25.65%,IGF1;LEF1;FOXC1;SKI;SMO;NGF;NFKBIA;SUMO3;HMGB2;CSNK2B;EGF;E2F1;ILRUN;TXN;SUMO1;KDM1A
prerank,neuromuscular process controlling balance (GO:0050885),0.5474762039117494,1.2429800791909624,0.20216606498194944,0.8379633582660437,1.0,3/12,8.62%,MYO7A;NRXN1;CLRN1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3135350715145079,-1.2426826273744076,0.088,0.5761386117360682,1.0,24/73,13.82%,FN1;ITGB8;PLPP3;DOCK1;ADAMTS1;ITGB1;SEMA7A;ITGA10;ITGBL1;NRP1;FYB1;LAMA3;DAB2;NEDD9;ADAM10;CDC42;ITGB4;LAMA5;ITGB1BP1;ZYX;ITGB3;CEACAM1;DST;PTK2B
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3965788981362326,1.2420288815416782,0.16879432624113475,0.8396871218640052,1.0,11/59,11.95%,CYP7B1;ACOX2;OSBPL3;OSBPL6;LIPH;LIPC;PER2;HSD17B8;HOGA1;GAMT;ACLY
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4260556866779822,-1.2420105115183167,0.19036144578313252,0.5767516948029009,1.0,11/21,36.21%,OSBPL8;MBOAT1;PLA2G4A;PLAAT3;PLA1A;PLA2G4E;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4
prerank,negative regulation of secretion (GO:0051048),0.5592614822988651,1.2419517935584408,0.24263431542461006,0.8381594867555877,1.0,2/10,6.45%,NRG1;SPX
prerank,cell part morphogenesis (GO:0032990),-0.46853906081693925,-1.2418724963698995,0.19,0.5759449544652653,1.0,2/13,2.52%,MTM1;PACSIN2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.42492237986891745,-1.2413848621697645,0.19437340153452684,0.575976497518716,1.0,8/20,21.31%,GLYR1;PRKAA2;SOX4;RPS6KA5;NOS1;PRKAA1;TADA2B;RUVBL2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4900265848993396,1.2409991763978079,0.203125,0.8397610873827841,1.0,10/20,20.62%,MBTPS2;NR1H4;ACADL;DGKQ;SREBF1;LDLRAP1;ARV1;KPNB1;ABCA2;MBTPS1
prerank,excitatory postsynaptic potential (GO:0060079),0.49247267682130563,1.2409950544467434,0.20695102685624012,0.8379985077119998,1.0,5/19,6.01%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5180280143235805,1.2408294925791863,0.22491349480968859,0.8368222854542899,1.0,4/14,8.14%,ZEB1;SPRY1;SPRED1;SPRED2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5074788976958015,1.2408031053825392,0.22167487684729065,0.8351411976995906,1.0,5/15,11.17%,SEMA5A;FGFR1;PRKD1;LGMN;P2RX4
prerank,protein-containing complex subunit organization (GO:0043933),0.3587615918102962,1.2402295051452403,0.135678391959799,0.8354710978315887,1.0,22/109,12.05%,LAMC1;WIPF1;TEAD1;PPID;CD40;EPRS1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;LLGL1;CAPN3;WASF3;MDM4;KIFAP3;IL1RAP;TP53;RIMS1;DLG4;SOX9;TUBGCP4
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.3366749564578334,-1.2400357004976807,0.11145510835913312,0.5784825308204085,1.0,16/51,14.33%,HMBOX1;SMG6;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;STN1;SMG5;ATM;HNRNPC;MAP3K4;TEN1
prerank,muscle tissue morphogenesis (GO:0060415),-0.45604787616826215,-1.2399788780505967,0.1770573566084788,0.5774478726913302,1.0,5/16,19.16%,MYLK;NOTCH1;TBX1;HEY2;TGFBR3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.37288946841533926,-1.2398002781958457,0.14722222222222223,0.5766940484565939,1.0,6/30,6.76%,ROBO1;NET1;F11R;GPR4;RAC1;PRAG1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4003440622624347,-1.2388865118291954,0.18087855297157623,0.5779460856989684,1.0,11/24,16.48%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD
prerank,gene expression (GO:0010467),-0.25508703480746875,-1.2387633417470614,0.0,0.5771191592436854,1.0,136/348,28.47%,TSPAN5;MEF2A;RPS14;AGFG1;RPS9;SMG6;RPS16;PTMA;RPLP1;RPL13;DRG1;THOC2;RPL27A;THOC1;RPS2;RPL37A;RPL5;WDR33;RPL8;RPS7;RPL41;RPS18;NUP50;RPS20;RPS19;RPS24;RPS27;DROSHA;RPS15;RPL21;RPL10;RPL35A;HNRNPF;RPS15A;RPL10A;RPS5;RPL11;TSPAN17;ABCF1;ALKBH5;RPL36A;EEF1A1;SRSF3;RRAGC;LMF1;NR4A2;SNRNP40;RPL34;POLR2B;NUP98;RPLP2;RPS29;NUP153;RPL32;RPL4;THOC3;RPLP0;POLR2H;SRSF4;RBM4;RPL30;RPL26;RPS4X;HNRNPH1;RPS21;RPL29;SMG5;POLR2G;NOX4;ATXN1;RPS8;POLR2C;RNASEL;NUP43;MRPS7;RAE1;NUP205;RPL31;RPS23;SRSF7;RPL23A;SRSF2;NUFIP1;ALYREF;SRBD1;HNRNPK;HHEX;MRPS17;AGO2;RPL19;RPL36;HOXD3;SEH1L;GSPT2;CREBL2;CLP1;RBM15B;MRPS18A;MRPS18B;RPL17;RPL23;E2F1;RBM8A;NCBP2;DDX20;DDX39A;MRPL24;DDX25;RPS11;NXT1;MRPL55;HSPD1;GSPT1;MAGOH;RPL15;RPL38;HARS2;DUSP11;MRPL36;MRPL35;BICD1;RPL13A;POLR2I;RPS25;POLDIP3;U2AF2;POLR2K;RPS12;MRPS12;RBMS2;FARSB;TSPAN33;MRPL34;RPL24;RPL18A;FASTKD2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3457290607285,-1.2386293684550058,0.14242424242424243,0.5763055658344941,1.0,11/44,13.98%,ANO6;ACTN2;ATP1B3;WNK4;WNK1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5737477893114483,1.2385965743751304,0.23963963963963963,0.8380147353994125,1.0,3/10,6.86%,PPARA;PFKFB1;CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),0.5737477893114483,1.2385965743751304,0.23963963963963963,0.8380147353994125,1.0,3/10,6.86%,PPARA;PFKFB1;CBFA2T3
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.43675902238661335,-1.2381945717075882,0.17317073170731706,0.5762985194914465,1.0,5/18,16.99%,TMBIM6;NRDE2;PTBP3;TERT;ESR1
prerank,receptor catabolic process (GO:0032801),-0.3988080958551682,-1.2380751124907725,0.1931216931216931,0.5754300903370034,1.0,5/24,8.79%,BECN1;RNF43;UVRAG;SNX25;AP2A1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3367814761954954,1.2376991706647384,0.09883720930232558,0.8394986188761009,1.0,43/193,17.40%,PDGFRA;NTRK3;PIK3R1;NRG1;PPARA;NTRK2;PTEN;SEMA5A;TCF7L2;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PLEKHA1;PINK1;AXL;TSPYL5;RCN3;FYN;P2RX4;TGFBR1;IAPP;CD86;IGF2;CASS4;MYDGF;FERMT2;FGF5;AREG;FGFR2;HAX1;PIK3CG;MAZ;ADAM8;RHOG
prerank,filopodium assembly (GO:0046847),-0.44941376244240094,-1.2375325625215123,0.19,0.5756136592028788,1.0,5/16,10.42%,FGD5;EZR;SRGAP2;DNM3;SPATA13
prerank,negative regulation of inflammatory response (GO:0050728),0.3413682896352219,1.2374327008414407,0.10046728971962617,0.8387223595770513,1.0,29/182,12.45%,RORA;GGT5;ADORA2B;PPARA;ADCY5;CALCRL;NR1H4;TNFAIP8L2;PPARD;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ENPP3;ADCY2;PRKACB;LRFN5;CD200R1;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;PTGIS;GPR27;HTR4;FNDC4
prerank,metanephros development (GO:0001656),0.4554551637308729,1.2372248344776662,0.2144026186579378,0.837708472837868,1.0,4/26,9.69%,ROBO2;BASP1;NF1;BMP7
prerank,fat cell differentiation (GO:0045444),-0.3264260883537907,-1.2369961668594267,0.1180327868852459,0.5759601519456734,1.0,12/57,10.39%,SMAD6;FOXO1;WNT5B;BBS9;OSBPL8;KLF4;OSBPL11;ERAP1;PRDM16;NR4A1;FAM120B;NR4A2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.48262529443637214,1.236616827834359,0.22058823529411764,0.8381265106428506,1.0,4/18,9.78%,CORO2B;CCT5;CEP295;CEP135
prerank,positive regulation of transferase activity (GO:0051347),0.3466065180280786,1.236466308623202,0.12121212121212122,0.8369539507062036,1.0,30/142,15.69%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;SERINC1;EPHA6;SORL1;HNRNPA2B1;PARM1;PINK1;EPHB6;AXL;RFC3;EPHA3;POLG2;IGF2;GSK3A;DCUN1D5;AXIN1;SERINC5;EPHA5;HNRNPD;MYC;FGFR2
prerank,embryonic axis specification (GO:0000578),-0.4619117801632796,-1.236182649435638,0.17777777777777778,0.576906618331257,1.0,3/15,9.95%,SMAD6;COBL;CXXC4
prerank,aortic valve morphogenesis (GO:0003180),-0.37353840521126,-1.2361663675238204,0.1518324607329843,0.5757993883869552,1.0,7/30,4.26%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;TIE1;NOTCH1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.37984217967426787,1.2359390961329664,0.14795244385733158,0.8371630494766954,1.0,23/75,17.63%,ISL2;CTNNA2;FARP1;ABITRAM;ANK3;ADGRB1;NEFH;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;OPHN1;SDC2;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;SLITRK1;CDK5;CDHR1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3401301180557637,1.2358290677453638,0.12252042007001167,0.8358213150491475,1.0,50/173,20.27%,SEC16B;DYNLL1;KDELR3;COL7A1;COPA;SEC16A;KDELR2;DCTN3;GRIA1;SPTBN1;ANK3;GBF1;TMEM115;COPZ2;DCTN2;IER3IP1;TRAPPC2L;COPB1;CNIH4;GOLGA2;RAB29;COG6;DCTN4;F8;SEC24B;SAR1A;VAMP4;SCFD1;RAB2A;VAMP7;MCFD2;BGLAP;COG1;DYNLL2;TRIP11;AREG;ERGIC2;SEC24A;TMED3;SEC23A;TMED9;COPG1;MIA3;TRAPPC12;TBC1D20;CNIH3;TRAPPC2;TRAPPC5;COPB2;ACTR10
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.40026445950390344,-1.2357452765033883,0.1913265306122449,0.5758008270517985,1.0,8/24,13.82%,EPHA4;CTSC;UBB;APOE;TMF1;GPX1;PSME3;PTK2B
prerank,establishment of protein localization to extracellular region (GO:0035592),0.42069737046058436,1.2354784716960059,0.18358208955223881,0.8353705203030158,1.0,16/39,21.58%,STEAP3;SEL1L;RAB8A;RAB3C;RCN3;RAB15;TMEM167A;MTTP;TVP23B;LTBP2;COPG1;MIA3;SVBP;CANX;SCG2;TANGO6
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4173250823842796,-1.2352128345399522,0.17142857142857143,0.5760138190670716,1.0,9/20,23.65%,ACTN2;OSR1;CAMK2D;GOPC;CAB39;TCAF2;STK39;CASQ2;PLN
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5355319421860021,1.2341709256980222,0.2222222222222222,0.8384380340700187,1.0,2/13,2.72%,XCL1;MR1
prerank,regulation of lymphocyte activation (GO:0051249),0.5386702923344796,1.2341693676897376,0.2224168126094571,0.8367199653177749,1.0,2/12,9.77%,PAG1;KAT2A
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.515865639772052,-1.2339350037918946,0.21739130434782608,0.578224433436794,1.0,5/10,28.79%,APC;CDC42;RCC2;ECT2;SPAG5
prerank,positive regulation of neuron death (GO:1901216),0.4079660833557917,1.2339100040679265,0.1867816091954023,0.8360474374794636,1.0,13/46,15.09%,EPHA7;WNT5A;GRIN2B;REST;FOS;TLR6;NF1;C1QA;TLR4;DAXX;FYN;EIF2S1;CLU
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4408920183824019,-1.233749675907513,0.18414322250639387,0.5775447976359002,1.0,7/16,19.48%,SIK3;LAMTOR5;CLEC16A;PIP4P1;GPR137;SEH1L;RRAGB
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5700220200664167,1.233557735005626,0.22434782608695653,0.8356229773811467,1.0,1/10,0.33%,SH3RF1
prerank,phosphate ion transport (GO:0006817),-0.453365087018009,-1.2335100479873256,0.19444444444444445,0.5770023416543908,1.0,4/16,12.21%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.523865742789578,1.2334104405192412,0.215,0.8345225694058728,1.0,2/14,1.70%,XCL1;WNT5A
prerank,selective autophagy (GO:0061912),-0.32826242170809417,-1.233140614902165,0.15593220338983052,0.576830554805978,1.0,25/56,22.49%,VIM;RETREG1;BECN1;SQSTM1;ATG13;WDFY3;UBB;USP30;ATG2B;DYNC1H1;ATM;UBE2N;DYNC1I1;ATG2A;UBC;LGALS8;AMBRA1;ARL13B;DYNC1LI1;HDAC6;KLHL3;MAP1LC3B;CFTR;UBA52;UFM1
prerank,negative regulation of viral process (GO:0048525),-0.3336608403714946,-1.232182007164851,0.13745704467353953,0.578242728646629,1.0,18/57,20.88%,MAVS;TRIM5;TRIM11;IFITM3;TRIM14;ZC3HAV1;IFITM1;PARP10;SRPK1;RNASEL;PPIA;TRIM35;TRIM27;ISG15;UBP1;IFIT1;HEXIM1;IFITM2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.47479572827365296,-1.2317608625175518,0.22350230414746544,0.5781445458292453,1.0,4/13,13.27%,NOS3;PRODH;NOS1;DDAH1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.508550662075308,-1.2317572803890657,0.23370786516853934,0.5770252789537257,1.0,6/10,18.24%,NOTCH1;LRP6;PHACTR4;ARHGAP12;LIN7C;SOX11
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3969932296049765,-1.2313747047525248,0.1736842105263158,0.5767748781834352,1.0,5/25,15.71%,TMTC2;CAV1;CNNM2;CNNM4;JPH2
prerank,protein localization to cell periphery (GO:1990778),-0.2868245141339931,-1.2310018274387942,0.0670391061452514,0.5766487120338383,1.0,28/133,9.21%,TSPAN5;RAPGEF2;ROCK2;ACTN2;CAV1;BSG;LIN7A;RAPGEF6;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;PACS1;RAMP1;TTC7B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;TTC7A
prerank,response to ionizing radiation (GO:0010212),-0.317450980195266,-1.2303428010405264,0.13214285714285715,0.5773166273604445,1.0,33/70,29.74%,EYA1;NET1;ANXA1;MAPK14;RNF8;INTS3;INO80;BRCC3;ATM;EEF1D;GRB2;KAT5;CDKN1A;SMPD1;SIRT1;PRKAA1;CLOCK;DCUN1D3;HUS1;EYA3;FANCD2;RFWD3;RAD51;BRSK1;LIG4;BRCA1;ECT2;RHOB;RHNO1;GADD45A;MSH2;UIMC1;TANK
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4778622723744388,1.2302722726645738,0.19829059829059828,0.8441890225119436,1.0,9/20,21.61%,MEIS1;MEIS2;ZBTB16;HOXA9;MAFB;LDB1;CDC73;HSPA9;HOXA5
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.47960129983534644,1.2301642965345385,0.1972049689440994,0.8429184300223544,1.0,4/21,8.15%,CDC14B;PTEN;FBXO5;GOLGA2
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.3775232547808507,-1.2295080998268115,0.1671388101983003,0.5782419529667083,1.0,15/33,28.65%,GCLC;PRODH;SLC39A8;GOT2;RIMKLB;OAT;NIT2;DDAH1;DDAH2;CAD;GLUL;PYCR2;FPGS;PYCR3;GGT1
prerank,blood vessel diameter maintenance (GO:0097746),-0.36412957880489333,-1.2289387457571355,0.18152866242038215,0.5785581914758304,1.0,15/34,16.11%,ROCK2;EDNRA;NOS3;GCLC;ACE;KLF2;BDKRB2;ITGB1BP1;NPR1;ADCY6;SCPEP1;NOS1;AGTR1;EDN1;GPER1
prerank,positive regulation of ATPase activity (GO:0032781),0.40897883740445223,1.2283961357532551,0.20119225037257824,0.8476144965183693,1.0,11/41,19.18%,DYNLL1;RYR2;DNAJC24;MSH3;ALDOB;DNAJC10;DYNLL2;DHX9;MSH6;SSBP1;CHTOP
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5183067219494368,1.2281853402339218,0.22280701754385965,0.8466412574858435,1.0,6/13,19.01%,MBTPS2;NR1H2;USP19;CLU;ALOX5;EIF2AK3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.42990225764546064,1.2279735733220605,0.21013412816691504,0.8456456090394,1.0,7/33,8.22%,PIK3R1;PTEN;PIK3R2;HTR2B;IRS1;NF1;PLEKHA1
prerank,regulation of glucose import (GO:0046324),-0.38146830710365914,-1.2276689498809996,0.14697406340057637,0.5809667762727403,1.0,8/30,5.46%,SORBS1;PRKAG2;IGF1;OCLN;OSBPL8;INSR;RHOQ;GRB10
prerank,sphingosine metabolic process (GO:0006670),-0.43532540301651146,-1.227599931539345,0.1980440097799511,0.580005583482019,1.0,4/17,4.52%,SPTLC2;PLPP3;ACER2;ACER3
prerank,negative regulation of reproductive process (GO:2000242),0.4906764842346675,1.2275940651821542,0.22697368421052633,0.8453269630698229,1.0,3/17,3.91%,SULF1;GJA1;DUSP1
prerank,GPI anchor metabolic process (GO:0006505),0.4519862558190674,1.2271738046074872,0.21351766513056836,0.8451740097020971,1.0,6/26,13.17%,PIGV;GPLD1;PIGQ;PIGP;PIGA;PIGL
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4801691463408747,-1.2269116035969865,0.20945945945945946,0.5808063185690714,1.0,5/13,18.69%,NOS3;CALM1;GCH1;AKT1;PRKG2
prerank,alpha-amino acid catabolic process (GO:1901606),0.4438650236002387,1.2268507542668934,0.19904458598726116,0.844597505876287,1.0,7/29,10.21%,THNSL2;KYNU;FAH;ACADSB;MTRR;BLMH;HOGA1
prerank,sodium ion transmembrane transport (GO:0035725),0.3626181012249991,1.2265986537213085,0.14522292993630573,0.8438787237157486,1.0,16/84,13.61%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;SLC9A9;ATP1A3;SLC9A1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,regulation of gastrulation (GO:0010470),-0.46336669424291693,-1.226527406169903,0.23373493975903614,0.5807790071120176,1.0,2/14,2.04%,PHLDB2;OSR1
prerank,regulation of protein ubiquitination (GO:0031396),0.35251402542394694,1.2264905127551762,0.16120906801007556,0.8426134343380398,1.0,24/108,16.42%,FANCI;PRICKLE1;OGT;MYCBP2;PRMT3;ADGRB1;LRRK2;PSMD10;PER2;PINK1;TSPYL5;COMMD1;BIRC2;DAXX;NDFIP2;TGFBR1;SPRTN;GSK3A;PTTG1IP;AXIN1;UBE2D1;PAXIP1;NDFIP1;USP4
prerank,regulation of stem cell differentiation (GO:2000736),0.36305451382259124,1.225712367752184,0.16754617414248021,0.8438933554256118,1.0,27/89,19.21%,PDGFRA;PTN;PSMD1;RBM24;KMT2A;PSMD10;ZFP36L2;PSMA5;PSMB5;PSMC4;NUDT21;OCIAD1;EIF2AK2;PSMA4;PSMC5;HOXB4;PSMB9;SMYD5;PUS7;GDNF;PSMA7;JAG1;PSMD14;LDB1;PSMA2;PSMD11;CBFB
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5070659750351413,1.2254678263830237,0.2282793867120954,0.8431629552138704,1.0,4/17,6.86%,PPARA;PFKFB1;PDE12;CBFA2T3
prerank,nucleotide-excision repair (GO:0006289),0.35704960187452384,1.2253595495513887,0.1508452535760728,0.841834051622171,1.0,32/101,21.65%,COPS3;ERCC1;ISY1;LIG3;FAN1;POLK;ERCC5;POLA1;RPA1;ERCC4;POLL;UVSSA;XPC;COMMD1;BRCA2;RFC3;TP53;GTF2H3;XRCC1;POLB;COPS4;ATXN3;ERCC2;GTF2H1;MMS19;CUL4A;POLE;POLR2L;USP45;DDB1;CDK7;RFC4
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4885133004653003,1.2252182789176775,0.22696245733788395,0.8406811720734924,1.0,6/18,15.31%,POR;EDN3;FXN;PDP1;ATP7A;GDNF
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.371099371897808,1.2251600631998056,0.16870748299319727,0.839247116219339,1.0,23/82,19.98%,DYNLL1;ATF5;DCTN3;HAUS3;HAUS1;HMMR;DCTN2;HAUS8;PRKACA;CEP192;CEP135;TP53;SSNA1;CEP250;CEP152;CSNK1E;CENPF;CLASP1;ALMS1;PCM1;ATAD5;TUBA1A;CEP43
prerank,triglyceride biosynthetic process (GO:0019432),0.4935246719999155,1.2247603790087522,0.21818181818181817,0.8389645922085605,1.0,5/18,15.43%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.29700533378753957,-1.224657564610701,0.09745762711864407,0.5846902382655935,1.0,30/87,22.48%,SMAD6;ARHGEF18;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;TGFB2;SKI;UBB;ACVR1;ACVRL1;SMAD3;LRRC32;ZYX;PRKCZ;SMAD1;FURIN;CDH5;SIRT1;UBC;USP9X;TWSG1;TGFBR3;ADAM9;TGFBR2;NRROS;UBA52;SMAD7
prerank,negative regulation of apoptotic process (GO:0043066),-0.24962656799913346,-1.2244638802929926,0.0,0.5841425560305012,1.0,108/444,16.69%,IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;PRKCH;MEF2C;IL31RA;LEF1;CAV1;BCL2L1;FNIP1;EGFR;IGF1R;ITGB1;RETREG1;OSR1;XIAP;THBS1;NOTCH2;ANXA5;FSTL1;KLF4;NFKB1;MCL1;PTMA;KDR;SQSTM1;PRKDC;TMBIM6;CCND2;FAS;ARHGAP10;SOD2;NOTCH1;GCLC;SOCS2;ANXA1;DAB2;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;SIX1;HIPK3;CD38;BNIP2;UBB;NGF;CASP2;NRBP2;CAT;CARD14;TBX1;APOE;GSK3B;CD44;SH3RF2;GLO1;RPL10;CASP3;LAMTOR5;SNX6;CFL1;CITED2;GPX1;SFRP1;NFKBIA;KLHL20;BNIP3L;NIBAN2;RNF144B;NR4A2;CX3CR1;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;MDK;HSPB1;BAG3;BID;FOXQ1;PTRH2;FZD3;FLT4;GATA6;FLNA;PTK2B;TPT1;CX3CL1;ARL6IP1;MAP2K5;PRELID1;PRKCD;TRIM27;SIRT1;ANXA4;PRKAA1;PDPN;PRDX3;PAK2;SIAH2;YME1L1
prerank,regulation of cell communication (GO:0010646),0.4301494970691229,1.2244158143367707,0.20933734939759036,0.8386025989323599,1.0,3/35,3.83%,TBX18;MTCH1;RYR2
prerank,negative regulation of proteolysis (GO:0045861),-0.36971553538634616,-1.2241433541515574,0.1568627450980392,0.5838126946421687,1.0,12/34,22.17%,EPHA4;PTPN3;GAS1;CST3;ECM1;TMEM59;SERPINE2;AKT1;CLN8;TIMP3;HDAC6;CAMK2N1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4492563800637167,1.2236984063997545,0.1962025316455696,0.8394894759143026,1.0,7/27,12.54%,ENPP1;PIP4K2A;IRS1;RPS6KB1;PRKCB;TNS2;GSK3A
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.44550488857050013,-1.2236623937677908,0.2106537530266344,0.5839407488624471,1.0,10/16,28.50%,PYGB;PGM2L1;CALM1;GAA;PGM2;PHKG1;AOAH;PHKA2;PHKG2;PYGL
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4931826206398327,1.2234390332853498,0.21686746987951808,0.8388580396447691,1.0,7/17,15.14%,ATP1A2;GJA1;RYR2;ATP1A3;PRKACA;GJC3;GJA5
prerank,plasma membrane invagination (GO:0099024),-0.3838221687174092,-1.22319731499733,0.15472779369627507,0.5840635920781234,1.0,5/29,5.90%,GULP1;SNX18;DOCK1;GSN;CDC42
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3073900672426293,-1.2230353789168318,0.11363636363636363,0.5833138412882897,1.0,22/73,13.95%,ROBO1;CASP8AP2;TNFSF10;ACER2;HIP1R;FAS;COL4A3;EGLN3;CRADD;NGF;CASP2;XDH;VCP;MAPT;SMAD3;CASP8;BAD;BAX;BID;ATP2A3;BOK;HIP1
prerank,negative regulation of binding (GO:0051100),-0.3016728646964598,-1.2228569317523053,0.08968609865470852,0.5827127987334085,1.0,22/81,15.54%,LEF1;CAV1;ACTB;TMBIM6;SMO;DAB2;DVL1;MITD1;GSK3B;ITGB1BP1;NES;STYX;BAX;NFKBIA;ARHGAP28;SUMO3;RALB;TLE5;CTSZ;CDKN1A;DDX11;PRKCD
prerank,regulation of chemotaxis (GO:0050920),0.4347746105418069,1.2222229402777183,0.20955315870570107,0.8416124376141361,1.0,6/30,11.17%,PDGFRA;MYCBP2;ADGRA2;ZSWIM8;GPR183;P2RX4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.525940342929277,1.2218775389097638,0.23374340949033393,0.8412889232976738,1.0,2/13,2.01%,ZFYVE28;CBLB
prerank,positive regulation of cell differentiation (GO:0045597),-0.2593914355293612,-1.2217699748892346,0.02654867256637168,0.5846265762296652,1.0,50/237,12.31%,RANBP3L;IGF1;PLCB1;RAPGEF2;KITLG;CDON;SOX5;PRKCH;MEF2C;LEF1;BOC;IL18;FOXC1;CCN2;NBL1;MEF2A;SLC6A6;NFKB1;BMPR2;IGFBP3;KDR;RAP1A;CDS1;TGFB2;WNT4;DAB2;CD34;IL6ST;MAPK9;CDC42;MAPK14;BNIP2;NGF;CCN1;PKDCC;ACVR1;ACVRL1;SMAD3;IFITM1;SFRP1;CCN4;SPAG9;VHL;NPNT;BCL9L;RPS6KA1;MDK;HEYL;RBM4;CEACAM1
prerank,carnitine shuttle (GO:0006853),-0.5082715312262449,-1.2216760073486197,0.21261682242990654,0.5837839200602857,1.0,2/11,5.48%,PRKAG2;PRKAA2
prerank,skeletal muscle organ development (GO:0060538),0.4516089730758032,1.2216024638110075,0.20627062706270627,0.8406423920645713,1.0,3/26,2.11%,SVIL;MSC;BASP1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.44670892534481144,-1.2214229609649416,0.21671018276762402,0.5833514837271456,1.0,6/17,13.64%,BCL2L1;SOD2;BAD;BAX;BID;BOK
prerank,endodermal cell differentiation (GO:0035987),0.43211217681555625,1.2213043178738068,0.19783616692426584,0.8401034401024455,1.0,7/31,8.64%,LAMB1;ITGAV;COL7A1;ITGB5;COL12A1;RTF1;COL4A2
prerank,positive regulation of cellular component organization (GO:0051130),-0.2876656940543853,-1.2210444169599288,0.07608695652173914,0.5832428930286113,1.0,31/107,16.09%,TRABD2B;ATP10A;FNIP1;IGF1R;SHANK3;INSR;RUNX1;TGFB2;GPC3;DAB2;TFRC;APOE;GSK3B;VCP;RHOC;FNIP2;HYAL1;GPX1;BAX;CAMK2B;CD151;AJUBA;BID;SURF4;ABCB4;CDH5;TAL1;RAPGEF3;SMPD1;MMP1;LMAN1
prerank,extracellular matrix assembly (GO:0085029),0.4629205921415579,1.2209438452732384,0.1958266452648475,0.8397695290110582,1.0,4/23,4.93%,LAMB1;GPM6B;TNXB;MFAP4
prerank,regulation of developmental growth (GO:0048638),-0.3809967139273779,-1.2208880806050326,0.17827298050139276,0.5825264459016835,1.0,7/29,7.28%,IGF1;PLCB1;APP;INSR;SIX1;APOE;GSK3B
prerank,meiosis I (GO:0007127),0.4624664742792327,1.220798130766392,0.2204724409448819,0.8387026719420104,1.0,7/23,15.63%,SGO1;MEIKIN;ZCWPW1;SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3853814352638074,-1.2206804245762994,0.1937984496124031,0.5819685387464876,1.0,11/26,16.73%,FOXP1;KANK2;SMARCA4;DAB2;VPS18;SFRP1;HEYL;VPS11;SIRT1;PER1;CLOCK
prerank,canonical Wnt signaling pathway (GO:0060070),-0.31528866851444004,-1.2204964569549939,0.12692307692307692,0.581377894319745,1.0,17/68,10.93%,LEF1;WNT5B;CAV1;PLPP3;WNT9A;WNT4;APC;DVL1;FZD4;FZD7;GSK3B;LRP6;RAB5A;WNT6;SFRP1;NR4A2;BCL9L
prerank,regulation of microtubule-based process (GO:0032886),-0.36507341456913,-1.220330096461934,0.1404494382022472,0.5807013948992061,1.0,16/36,19.08%,PHLDB2;DIAPH1;MARK4;APC;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;CYLD;MACF1;BICD2;PRKAA1;ERBB2;MARK2
prerank,superoxide metabolic process (GO:0006801),-0.3803854761596119,-1.2200748652961282,0.1942257217847769,0.5802471665144459,1.0,14/29,27.12%,SH3PXD2A;NOS3;SOD2;SH3PXD2B;PRDX1;NOX4;SOD3;ALOX12;NRROS;CYBB;MT3;CYB5R4;NCF2;NOXO1
prerank,positive regulation of nervous system development (GO:0051962),0.414485888738061,1.2199544730589775,0.19020172910662825,0.8402814704316944,1.0,12/42,17.98%,SRPX2;EPHB1;GRID2;NRXN1;SERPINF1;SYNDIG1;IL1RAP;NAP1L1;SNW1;CUX2;IL1RAPL1;CLSTN1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4235264184352465,1.219888408252662,0.20150375939849624,0.8388999685550875,1.0,5/37,9.69%,CEMIP;SPRED1;DGKQ;SPRED2;BMP7
prerank,regulation of humoral immune response (GO:0002920),0.40468582386709484,1.219624290159964,0.19710144927536233,0.838216871959236,1.0,9/44,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.47592582908690745,1.218966346643076,0.245,0.8389316038558569,1.0,8/19,23.40%,IL34;PTK2;JAM3;AKIRIN1;CMKLR1;RARRES2;MAPK1;CAMK1D
prerank,regulation of peptide hormone secretion (GO:0090276),0.3796119005217196,1.2187441068083995,0.16527777777777777,0.8381775196059502,1.0,11/67,10.49%,CHD7;RAPGEF4;CACNA1E;ITPR1;PER2;PRKCA;KCNC2;HTR2C;SYT7;GCK;PPP3CB
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3948629232639688,1.2184791785341957,0.1957142857142857,0.8375014115218075,1.0,9/48,12.10%,TXK;PDE4B;SCRIB;PTPN22;CD276;TLR8;TLR4;PYCARD;IL12A
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.42218696334700034,-1.2184065670556765,0.20192307692307693,0.5834910451532516,1.0,8/19,15.15%,ELF1;KLF4;IRAK2;RUNX1;MAVS;PARP9;TLE5;MAP2K5
prerank,amino sugar metabolic process (GO:0006040),-0.513312024155886,-1.2180743848490436,0.23766816143497757,0.5832752952586939,1.0,3/10,5.10%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.39690449626562074,1.2179779603394276,0.19708029197080293,0.8377171531069085,1.0,9/43,6.88%,PPARA;TEAD1;GNL3;NFATC3;NGFR;PPARD;REST;FOS;SRF
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4946535836929963,-1.2177964814495135,0.24044943820224718,0.5829108297019572,1.0,5/11,21.49%,VCPIP1;STX18;VAPB;ARL6IP1;RTN4
prerank,regulation of transmembrane transport (GO:0034762),-0.3778054857852138,-1.217772889026985,0.19411764705882353,0.5818818769779359,1.0,8/31,12.29%,OCLN;ACTB;SLC2A1;WWP2;KCNJ13;CTTNBP2NL;KCNJ2;KCNJ12
prerank,double-strand break repair via homologous recombination (GO:0000724),0.36145887424561934,1.2175755935853971,0.16251638269986893,0.8375730570826143,1.0,26/95,18.20%,MORF4L1;LIG3;MCM7;FAN1;FEN1;POLQ;ERCC5;CDC7;RPA1;ERCC4;POLL;MMS22L;BRCA2;ZFYVE26;REV3L;MCM4;RECQL;SPIDR;POLN;XRCC1;RAD52;PSMD14;MCMDC2;HELQ;WRN;FBH1
prerank,regulation of secretion by cell (GO:1903530),0.3862970595417773,1.2174861371060843,0.17146776406035666,0.8362848538944764,1.0,14/54,12.83%,HCRT;CHRNB4;DNAJC1;VAMP2;FMR1;RAB8A;LLGL1;RAB3C;RIMS2;HTR1A;P3H1;RIMS1;RAB15;ARFIP1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.48077020001349013,1.2173613573485107,0.22296173044925124,0.8351373307581359,1.0,11/19,26.38%,PRDX5;MTOR;TENM1;ZC3H8;DHX36;CHD8;AR;MAF1;POLR3F;RPTOR;ELL
prerank,negative regulation of type I interferon production (GO:0032480),-0.353197564039946,-1.2169685844830904,0.16037735849056603,0.5828872149407784,1.0,17/40,22.94%,NPLOC4;SIRPA;MAVS;TRIM25;PCBP2;RNF125;CYLD;NLRX1;NLRC5;UBE2L6;TBK1;HAVCR2;ISG15;TNFAIP3;ILRUN;REL;IKBKE
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.35939810437602765,-1.2169030900485318,0.1661721068249258,0.581971903500191,1.0,6/37,4.25%,IGF1;MEF2C;ADAMTS1;IGFBP5;TPM1;SOD2
prerank,axoneme assembly (GO:0035082),0.43391130676962225,1.2166829183683654,0.2344213649851632,0.8359987936842526,1.0,8/30,18.52%,RSPH9;DNAAF3;TTC12;DNAI4;CCDC65;GAS8;CCDC39;SPEF1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4449758845028447,-1.2165785954852908,0.21739130434782608,0.5817358215830931,1.0,7/17,4.36%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;NOTCH1;TGFB2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.47438067403534345,-1.2162343896131218,0.22272727272727272,0.5815553061945615,1.0,6/14,23.89%,IL18;NFKBIZ;ANXA1;PRKCZ;SOCS5;CCL19
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5195508466224135,-1.2151378627358447,0.25,0.5833478137998926,1.0,3/10,7.13%,RARB;RXRA;TBX1
prerank,neuron projection morphogenesis (GO:0048812),0.34346435295497646,1.2138901361019259,0.16884661117717004,0.8445831507647861,1.0,35/137,17.24%,EPB41L3;ISL2;DOCK10;CTNNA2;PTEN;EPHB1;CNTNAP2;FARP1;ABITRAM;MAP4K4;ANK3;ADGRB1;NEFH;LRRK2;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;BMP7;DLG4;ATP7A;CTTN;SDC2;SGK1;NTNG2;NTNG1;TNIK;FGFR2;BRSK2;NRCAM;IMPACT;SLITRK1;CDK5
prerank,"wound healing, spreading of cells (GO:0044319)",-0.387476906626096,-1.2138011343528472,0.17647058823529413,0.586017080746842,1.0,10/24,16.27%,CCN1;CD44;TMEFF2;RHOC;ACVRL1;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,positive regulation of T cell proliferation (GO:0042102),-0.32807250435472446,-1.21333622937095,0.1736111111111111,0.5861629199409448,1.0,8/55,6.18%,IGF1;IL18;IGFBP2;ANXA1;IL6ST;SLC7A1;TFRC;NCK1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.29320533072167615,-1.2131637871318712,0.11059907834101383,0.5855412489712974,1.0,29/94,16.97%,DDX5;BCL2L1;PPP1R13B;ARL6IP5;MCL1;PRKDC;MAP3K5;CYP1B1;PRODH;CUL1;JMY;CASP2;PPM1F;FNIP2;CRIP1;BAD;BAX;MYBBP1A;HIPK2;ATP2A3;ATM;BOK;HINT1;CDKN1A;ERN1;PRKCD;CUL3;AIFM1;EPHA2
prerank,tRNA 5'-end processing (GO:0099116),0.49171814634094,1.2129170836853107,0.22607260726072606,0.846475482120825,1.0,8/15,23.77%,RPP40;POP5;PRORP;POP7;RPP21;POP4;TRMT10C;SSB
prerank,negative regulation of programmed cell death (GO:0043069),-0.25354243027031176,-1.212205996512925,0.05084745762711865,0.5868662826207592,1.0,115/355,22.66%,MECOM;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;IL31RA;LEF1;BCL2L1;EGFR;IGF1R;OSR1;KANK2;XIAP;THBS1;NOTCH2;ANXA5;FSTL1;NFKB1;MCL1;PTMA;KDR;SQSTM1;PRKDC;TMBIM6;CCND2;FAS;ARHGAP10;GCLC;SOCS2;ANXA1;DAB2;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;HIPK3;CD38;BNIP2;UBB;NGF;CASP2;CAT;CARD14;GSK3B;CD44;SH3RF2;GLO1;RPL10;CASP3;CFL1;CITED2;SFRP1;NFKBIA;KLHL20;BNIP3L;NIBAN2;RNF144B;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;HSPB1;BAG3;BID;FLT4;GATA6;FLNA;PTK2B;TPT1;CX3CL1;ARL6IP1;PRELID1;MET;SIRT1;ANXA4;PRKAA1;PDPN;PRDX3;PAK2;SIAH2;YME1L1;CD74;LAPTM5;UBC;HNRNPK;RASA1;AKT1;NUAK2;WNT11;HGF;NPM1;DCPS;DNAJC3;CIB1;SON;PIM2;ASNS;MIF;NAA35;CFLAR;BIRC3;MGMT;DDAH2;HIGD1A;NUPR1;MYO18A;UBA52;SIX4;UFM1;PPIF
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3649284629322782,1.2117528151654424,0.18361955085865259,0.8491313403527222,1.0,10/87,4.55%,PDGFRA;DLC1;LRP1;RND3;HRG;GPM6B;IQGAP3;CORO2B;FSCN1;RAC3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5088286532114451,1.2113297771212639,0.2563237774030354,0.8490184557184218,1.0,4/14,15.43%,LPIN3;CHKA;SELENOI;LPIN2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.39329331134612766,-1.2112371766629604,0.19554455445544555,0.5883375323490941,1.0,11/25,25.15%,RBPJ;AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;AGT;RTN4;DOK1;CNOT9
prerank,regulation of cellular response to heat (GO:1900034),-0.30469215690749646,-1.211105988552402,0.13846153846153847,0.5876275435128018,1.0,22/77,16.00%,PTGES3;CAMK2D;HSPA8;HSPH1;CD34;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;ATR;CAMK2G;NUP98;NUP153;BAG3;ATM;NUP43;HIKESHI;RAE1;NUP205;SIRT1
prerank,inorganic anion transport (GO:0015698),-0.32268229637780627,-1.2107801466312382,0.15547703180212014,0.5874187561872934,1.0,8/53,4.04%,CLIC4;SLC13A4;SLC4A10;ANO6;XPR1;SLC26A7;ANO1;SLC26A11
prerank,positive regulation of DNA binding (GO:0043388),-0.3801208233672838,-1.2103160636387476,0.19154929577464788,0.5875873825482097,1.0,11/31,26.33%,IGF1;FOXC1;SKI;NGF;NIBAN2;HMGB2;EGF;TXN;TRIM6;PARK7;RB1
prerank,platelet aggregation (GO:0070527),-0.36222720626610244,-1.2099694659423812,0.18154761904761904,0.5874241808280636,1.0,12/33,14.25%,FN1;VCL;ACTB;GNAS;ACTG1;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,skeletal system morphogenesis (GO:0048705),0.41061885157355793,1.2097692255060895,0.2044776119402985,0.8531508782096469,1.0,11/42,15.80%,PDGFRA;ANKRD11;FGFR1;HOXC9;DSCAML1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,negative regulation of cellular protein localization (GO:1903828),-0.36179552012500094,-1.2094138290796115,0.18885448916408668,0.5877463313372537,1.0,6/34,8.30%,PICALM;ROCK2;ACTN2;GOPC;GSK3B;MAPT
prerank,clathrin coat assembly (GO:0048268),-0.4520867963703794,-1.2081360763524887,0.2121951219512195,0.5900630997700351,1.0,7/15,23.01%,PICALM;HIP1R;CLTB;HIP1;CALY;AP2S1;PIK3C2A
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4400362177646025,1.207478181192825,0.23615635179153094,0.8597661163973069,1.0,10/26,13.86%,PTEN;NRXN1;LRRK2;TMEM108;RIMS2;RELN;RIMS1;DLG4;CBLN1;CUX2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3361568372842016,1.2071457298673398,0.15393794749403342,0.8593843849913806,1.0,37/150,17.40%,PDGFRA;PIK3R1;NRG1;SEMA5A;TCF7L2;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PINK1;AXL;TSPYL5;FYN;P2RX4;TGFBR1;IAPP;CD86;IGF2;CASS4;MYDGF;FERMT2;FGF5;AREG;FGFR2;HAX1;PIK3CG;MAZ;ADAM8;RHOG
prerank,T-helper cell differentiation (GO:0042093),-0.45970610569392956,-1.207059906350481,0.19809069212410502,0.5916770640788611,1.0,2/14,0.98%,FOXP1;LEF1
prerank,protein localization to phagophore assembly site (GO:0034497),0.540434556487363,1.207032659191729,0.27835051546391754,0.8581999217243681,1.0,6/11,21.07%,ATG9B;WDR45B;ATG9A;WIPI2;PACS2;MFN2
prerank,protein catabolic process (GO:0030163),-0.3200699206885691,-1.2068704255511726,0.14527027027027026,0.5910810933689338,1.0,25/59,25.43%,DDI2;UBE2G1;HSPA8;DENND3;TRIM24;OGA;APOE;VCP;MANBA;NGLY1;RNF41;CEACAM1;CLPX;CLN5;USE1;SIAH2;LAMP2;CLN8;STT3B;PRPF19;RNF5;PSMA8;CLN6;TPP1;CHEK2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3485650728500693,-1.2067747479327062,0.17507418397626112,0.5902410623965375,1.0,18/36,28.33%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;YAF2;BMI1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5358247508252927,1.2066257017229454,0.25402504472271914,0.8582043762725298,1.0,6/11,27.34%,REST;PINK1;NONO;HIF1A;ATF4;NR4A3
prerank,cellular response to chemokine (GO:1990869),0.39591639233058246,1.2064986268492963,0.21052631578947367,0.8570476173366369,1.0,5/46,5.33%,XCL1;CXCL10;CXCL1;DUSP1;CCL15
prerank,positive regulation of response to stimulus (GO:0048584),0.41508202365154107,1.2064715841448719,0.2235294117647059,0.8555244698441353,1.0,6/40,6.31%,ACOX2;WNT5A;CDKN2A;ANKLE1;FMR1;ECHDC3
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4320667586637416,-1.206339844554836,0.22443890274314215,0.5903051255285313,1.0,6/17,14.60%,CAV1;OSR1;KLF7;CEACAM1;APOLD1;MAFG
prerank,regulation of aerobic respiration (GO:1903715),0.4989054312299499,1.2059301220484,0.24283305227655985,0.8558683336711197,1.0,7/15,19.90%,CBFA2T3;PINK1;AK4;SLC25A33;ATP7A;COX7A2L;UQCC2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.296820801317987,-1.2058766303702178,0.10822510822510822,0.5905059829777736,1.0,23/86,18.29%,RBPJ;THBS1;BMPR2;FOXD1;NOTCH1;TGFB2;DAB2;GIPC1;CCN1;ACVR1;ACVRL1;CITED2;SH2B1;HIPK2;CDH5;TGFB1I1;GDF11;HFE;ACVR2B;TWSG1;CSNK2B;SOX11;SDCBP
prerank,COPII vesicle coating (GO:0048208),0.37543435608074693,1.2055311912386881,0.21016483516483517,0.8525314573890267,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.37543435608074693,1.2055311912386881,0.21016483516483517,0.8525314573890267,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,vesicle coating (GO:0006901),0.37543435608074693,1.2055311912386881,0.21016483516483517,0.8525314573890267,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,endoderm formation (GO:0001706),0.4157076660154637,1.2052501696734044,0.21568627450980393,0.8520010106251312,1.0,7/35,8.64%,LAMB1;ITGAV;COL7A1;ITGB5;DUSP1;COL12A1;COL4A2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.30852978858656915,-1.204919240887355,0.12962962962962962,0.5921048001251192,1.0,34/73,28.33%,ACTB;PPHLN1;HDAC4;DDX21;SF3B1;PRMT7;WBP2;GPX1;PPM1D;SMARCA5;MYO1C;MYBBP1A;POLR2H;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;CTCF;POLR1H;TAF1C;POLR1G;HDAC6;SPHK2;POLR1C;PHF2;PHF1;MTF2;CGGBP1;SPI1;ZFP57;POLR2K;HDAC5;BMI1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5467409865666548,1.2047603156728004,0.26949152542372884,0.8521721005940771,1.0,2/10,4.06%,ABCD2;NR1H2
prerank,multivesicular body assembly (GO:0036258),-0.37591419133707826,-1.2041690239692835,0.20670391061452514,0.5930174600948293,1.0,14/30,28.53%,VPS37A;CHMP2B;VPS37B;IST1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;VPS28;VPS36;CHMP4C;CHMP2A;RAB11A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5086736040821311,1.204164855036806,0.24695652173913044,0.8511614306304902,1.0,2/13,3.37%,IL15RA;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.5086736040821311,1.204164855036806,0.24695652173913044,0.8511614306304902,1.0,2/13,3.37%,IL15RA;JAK1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4510458671298646,1.2041440025910548,0.2327718223583461,0.8496821309282024,1.0,7/25,12.54%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A;GLRA1;GSK3A
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.41644747977644564,-1.2040208560749055,0.2044334975369458,0.5923660991314877,1.0,6/21,8.83%,TUT7;SAMD4A;CNOT10;PARN;PAN3;CNOT8
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2924663133428002,-1.2039093416056263,0.12280701754385964,0.5916051296071755,1.0,29/94,16.14%,PLCB1;NFKB1;IRAK2;PSMC6;SQSTM1;IL1R1;PELI1;PSMD9;PSMF1;PSMB7;CUL1;TOLLIP;UBB;PSMD8;RPS6KA5;PSMD12;NFKBIA;MAP3K8;TAB2;PSMA3;PSMA6;PSMD4;IRAK4;PSME3;PSMD7;UBE2N;PSMB6;PSMC1;PSMB10
prerank,intracellular protein transmembrane transport (GO:0065002),0.40593952009449535,1.2036802712596353,0.21676300578034682,0.8497846964107827,1.0,17/42,22.21%,DNAJC19;PEX2;PEX7;SEC63;SEC61B;TIMM44;DNAJC15;HSPA5;RTN2;PAM16;PEX12;PEX14;PEX6;GRPEL1;TIMM21;CHCHD4;C2CD5
prerank,regulation of inclusion body assembly (GO:0090083),-0.5001289091851485,-1.203657362912203,0.2524271844660194,0.5912937151615724,1.0,7/11,32.31%,SNCAIP;DNAJA4;DNAJB1;HSPA1A;DNAJB2;HSPA1B;HSPA2
prerank,negative regulation of immune response (GO:0050777),0.3388805467054608,1.203502584837286,0.14863258026159334,0.8489240217835329,1.0,31/154,17.39%,GGT5;ADORA2B;ADCY5;CALCRL;TRAF3IP1;ADORA2A;DHX58;CRHR2;ADCY8;ADCY3;CALCA;ENPP3;LYAR;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4;COL3A1
prerank,oxoacid metabolic process (GO:0043436),0.44530641797069276,1.2033571501793645,0.23613312202852615,0.8478875605928307,1.0,3/27,5.28%,ENPP1;TPST1;GRHPR
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.349227934925366,1.2031064112831822,0.17970660146699266,0.8472436717381896,1.0,27/110,17.33%,ADGRL3;CXCL10;PTGFR;ADCY5;CALCRL;GPR3;ADGRB2;ADGRB1;ADORA2A;ADCY8;ADCY3;CALCA;ADCY2;LPAR3;ADGRB3;ADGRL1;ADCY7;LPAR1;GPR26;IAPP;GNG2;S1PR2;LGR5;LHCGR;ADGRE5;PTGER4;ADRA2A
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.43696454243353783,-1.2030436807131861,0.2216624685138539,0.5918864884978589,1.0,4/17,5.48%,PRKAG2;CAV1;ADIPOR2;PRKAA2
prerank,ncRNA processing (GO:0034470),-0.2644294725789326,-1.2023766362266668,0.048,0.592533927591203,1.0,68/200,22.29%,RPS14;RPS9;DGCR8;RPS16;TUT7;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;DICER1;RPS27;DROSHA;RPP30;RPS15;RPL21;PDCD11;RPL10;RPL35A;INTS3;SMAD3;DDX27;RPL10A;RPL11;RPL36A;RPL34;KARS1;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;SMAD1;RPL29;EXOSC2;INTS9;INTS10;INTS1;RPL31;IMP3;EXOSC3;ADAT1;RPL23A;AGO2;RPL19;RPL36;WDR12;PES1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52
prerank,phosphate ion transmembrane transport (GO:0035435),-0.48253156946409337,-1.2020388131865398,0.24178403755868544,0.5924295249587616,1.0,4/12,12.21%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,mitochondrion distribution (GO:0048311),-0.4743473027003838,-1.2018864046279034,0.2161520190023753,0.591749074371954,1.0,5/12,17.36%,MEF2A;MTM1;MAPT;TRAK2;MSTO1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4310361454407465,-1.201423298125301,0.23058252427184467,0.5918613744939278,1.0,6/17,18.81%,COX15;COX6C;COX5B;AFG1L;COX4I1;COX6B1
prerank,microtubule depolymerization (GO:0007019),0.4802996671420815,1.2013985680329624,0.25,0.8517688686024022,1.0,6/17,15.36%,NCKAP5L;STMN2;CCSAP;STMN4;STMN1;KIF2A
prerank,T cell differentiation (GO:0030217),0.40971951666977136,1.2012502540260872,0.20833333333333334,0.850706115467989,1.0,7/40,11.91%,CHD7;MR1;RABL3;PTPN22;ZFP36L2;GLI3;LMBR1L
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2702340552481524,-1.2011511438514555,0.053691275167785234,0.5915527786528472,1.0,36/150,12.75%,PRKAG2;SMAD6;PPM1E;CAV1;OCLN;SLIT2;PLPP3;TRIB2;DEPTOR;SIRPA;PARD3;IGFBP3;PRKDC;NIBAN1;DVL1;ERRFI1;NCK1;CEP85;CALM1;PPM1F;MVP;SNX25;XDH;PRR5L;LRP6;ITGB1BP1;YWHAG;DMD;SFRP1;PPEF2;EPHB2;TARDBP;HSPB1;CEACAM1;SPRED3;PRKCZ
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.45842960548770195,1.200191314431666,0.2306451612903226,0.8529010956861565,1.0,5/22,9.69%,IL1RN;GCNT2;FLOT2;MBP;BMP7
prerank,regulation of macrophage migration (GO:1905521),-0.4961791323810625,-1.2000726381076505,0.23198198198198197,0.5933224695481032,1.0,4/10,13.82%,CD200;MTUS1;CX3CR1;PTK2B
prerank,embryonic skeletal system development (GO:0048706),0.4173473768156326,1.19963386201361,0.21351766513056836,0.8533558764207846,1.0,8/35,13.51%,PDGFRA;SULF1;WNT5A;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4
prerank,SNARE complex assembly (GO:0035493),0.5462772437515722,1.199433537752673,0.289568345323741,0.8524902250137131,1.0,3/10,10.81%,STXBP6;VAMP2;VAMP4
prerank,secretion (GO:0046903),-0.4496225064405529,-1.1990746793248397,0.22565320665083136,0.5948462353389503,1.0,4/14,9.39%,TPD52;SLC22A4;SLC22A6;NPR1
prerank,protein targeting to mitochondrion (GO:0006626),0.38466732176619217,1.1988356336277448,0.206993006993007,0.853042605907715,1.0,19/52,24.45%,TIMM10;DNAJC19;IMMP2L;PMPCA;PITRM1;TIMM44;AGK;DNAJC15;PAM16;HSPA4;IMMP1L;GRPEL1;TIMM21;MFN2;GDAP1;CHCHD4;FIS1;TOMM34;SAMM50
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5320642575442373,1.1980732475562217,0.26465364120781526,0.854232865333672,1.0,2/12,1.10%,CXCL10;TMEM102
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.301279852903498,-1.197613562948769,0.15471698113207547,0.5976433477726727,1.0,13/80,5.90%,PLCE1;DPYSL3;OCLN;FNBP1L;WASF2;NRP1;MARK4;ANLN;NDEL1;RHOQ;APC;RAC1;CDC42
prerank,regulation of macrophage cytokine production (GO:0010935),-0.47437104396408286,-1.197513996717107,0.23114355231143552,0.596879138800748,1.0,7/13,17.38%,SEMA7A;TGFB2;CUEDC2;PLCG2;SIRT1;CD74;LAPTM5
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3877022580517318,-1.1973770585410048,0.20107238605898123,0.5951741801784993,1.0,9/23,26.16%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3877022580517318,-1.1973770585410048,0.20107238605898123,0.5951741801784993,1.0,9/23,26.16%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,regulation of cholesterol transport (GO:0032374),0.4646103425327808,1.1970859753182201,0.26557377049180325,0.8562523040933007,1.0,3/20,4.06%,LRP1;OSBPL6;NR1H2
prerank,peroxisome organization (GO:0007031),0.4429740679383113,1.1969356511529332,0.23817034700315456,0.8552477105578378,1.0,10/25,18.90%,SEC16B;ABCD2;PEX2;PEX7;PEX11A;PEX19;PEX12;PEX3;PEX14;PEX6
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5248126423085505,1.1968012448655103,0.2534965034965035,0.8541582249917399,1.0,4/12,14.34%,KDELR3;KDELR2;TAPT1;HSPA5
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.36730273756267334,-1.1967393301160538,0.20414201183431951,0.5958957183413873,1.0,13/29,24.23%,CAV1;THBS1;TNFSF10;WWOX;SFRP1;RET;BID;CYLD;GPER1;PAK2;AGT;BCL10;HYAL2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.48990665412443624,-1.1954468442683688,0.2725118483412322,0.5983248849764703,1.0,1/10,0.26%,EPHA4
prerank,sensory perception of taste (GO:0050909),0.5401825094978916,1.1951142650256397,0.2577696526508227,0.858562542199195,1.0,2/10,7.39%,ASIC2;ASIC1
prerank,response to hydrogen peroxide (GO:0042542),-0.33451502891277246,-1.1945256501441888,0.16938110749185667,0.5997854047049146,1.0,21/45,27.34%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;CAT;GPX1;STK25;ANKZF1;PRKCD;SIRT1;PRDX3;APTX;TNFAIP3;ADAM9;HDAC6;PPIF;OSER1;PARK7;ECT2;RHOB
prerank,skeletal system development (GO:0001501),0.3345987780442113,1.1944357777459669,0.1614457831325301,0.8594044782861661,1.0,44/148,20.87%,COL13A1;CHD7;SULF1;TRPS1;COL10A1;WNT5A;ANKRD11;FGFR1;VCAN;GJA1;TBX3;SOX6;ZBTB16;CDH11;CREB3L2;HAPLN2;COL1A2;ALX4;PAPSS2;P3H1;BMP7;TGFBR1;SOX9;IGF2;BGLAP;ATP7A;TRIP11;EVC;HAPLN3;FBN1;HAPLN1;FGFR2;STC1;PTGER4;FRZB;BMP2;HHIP;EIF2AK3;DDRGK1;TRAPPC2;BMP5;PLS3;CMKLR1;RAB33B
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5084861386411093,1.19435524848922,0.25043478260869567,0.8582130544568959,1.0,2/14,6.08%,CCDC22;PSMD10
prerank,dendrite self-avoidance (GO:0070593),0.49513195664373266,1.1934628759912997,0.2517482517482518,0.8597985989367107,1.0,6/16,9.95%,DSCAM;CNTN4;DSCAML1;PALLD;NEXN;CNTN6
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3299960825237401,-1.1933805376877744,0.14705882352941177,0.6018139561133374,1.0,12/46,9.64%,MAP3K1;PIEZO2;CASP8AP2;NFKB1;F11R;FAS;CRADD;MAP2K4;CASP2;CASP8;BAD;IRF1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4515849589931086,1.1933273286348218,0.2401883830455259,0.8588030126471953,1.0,6/24,14.60%,NAA10;TTLL6;GGCX;AGBL4;TPGS1;VKORC1L1
prerank,lymphocyte migration (GO:0072676),0.4220964882431759,1.1933056866100569,0.23759398496240602,0.8573563406985728,1.0,8/32,20.39%,XCL1;MSMP;CCL15;CCL25;MYO1G;ADAM8;CCL2;CCL14
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.39304382585122594,-1.1930190744130384,0.21393034825870647,0.6018024751493685,1.0,6/22,17.38%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4444536659409158,-1.1922035409624725,0.20374707259953162,0.6028249365783128,1.0,9/15,17.68%,BTG2;TENT4A;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.39346541550424535,1.1921333918026067,0.24089635854341737,0.8599422631726062,1.0,10/46,9.97%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,positive regulation of blood coagulation (GO:0030194),-0.4271066980592313,-1.1920867572643914,0.2078239608801956,0.602133566632093,1.0,4/17,3.63%,ANO6;THBD;THBS1;ST3GAL4
prerank,neurotrophin signaling pathway (GO:0038179),-0.4048651036216075,-1.191757230674986,0.22531645569620254,0.6019777274551654,1.0,10/21,19.23%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF;CASP3;FRS2;GRB2;KIDINS220;SOS1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.39093904687502523,-1.1909051595534705,0.21798365122615804,0.6032713569953576,1.0,10/25,25.17%,EPHA4;PSMF1;RPL5;RPS7;RPL11;HIPK2;HFE;RPL23;TRIM39;ALAD
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4241354067019806,-1.1903057271062223,0.23013698630136986,0.603835241088499,1.0,2/17,3.21%,RAPGEF2;ADRA1B
prerank,sarcomere organization (GO:0045214),-0.3660117825180277,-1.1902506469566363,0.21333333333333335,0.6029700325655455,1.0,15/27,41.17%,ACTN2;TPM1;CSRP2;TNNT3;SIX4;MYOM2;KRT19;TTN;CASQ1;MYPN;MYLK3;TCAP;OBSCN;MYH6;CSRP1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.269789803342721,-1.1902254424353829,0.10493827160493827,0.6020237003773987,1.0,44/152,16.14%,RSPO3;WNT5B;CAV1;EGFR;XIAP;NFKB1;RNF146;SMARCA4;CSNK1D;PSMC6;PSMD9;RSPO2;KANK1;TBL1X;SKI;PSMF1;GPC3;PSMB7;LGR4;SULF2;WNK1;WLS;SOX4;TNKS2;VCP;SMURF2;PSMD8;PSMD12;SFRP1;GID8;TERT;PSMA3;DKK2;PSMA6;PSMD4;CSNK1G3;PSME3;MACF1;PSMD7;PSMB6;PSMC1;FAM53B;ATP6AP2;PSMB10
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.49605528401086474,1.1897530212499388,0.24872231686541738,0.8667904692565612,1.0,2/14,4.72%,ACOX2;CRAT
prerank,cytoskeleton organization (GO:0007010),-0.2835814268197594,-1.1896367983194067,0.0970873786407767,0.602576343915379,1.0,25/114,9.16%,PLCE1;RHOBTB1;MICAL2;MARK1;FGD5;SYNE3;LARP4;DIAPH1;TPM1;PACSIN2;LRCH3;BRWD3;ARHGAP10;RHOBTB2;RAC1;NEDD9;PLD2;CAPZB;ARAP3;SEMA6A;APOE;CDC42BPB;RHOC;MAST3;CFL1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.42971602711862944,-1.1895459641553725,0.23209876543209876,0.6018118905861596,1.0,4/16,4.38%,DDX5;RBFOX2;PPARGC1B;NCOA4
prerank,regulation of fibroblast migration (GO:0010762),-0.4057723884508244,-1.189536978403091,0.23940149625935161,0.6008095754366494,1.0,9/20,24.23%,ITGB1;THBS1;RAC1;PRR5L;ITGB1BP1;HAS1;RFFL;DMTN;HYAL2
prerank,catecholamine metabolic process (GO:0006584),-0.4421532562542405,-1.1895077292098084,0.22549019607843138,0.5998628166718067,1.0,1/14,0.20%,SNCAIP
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3455465571614006,-1.1894147590683775,0.18292682926829268,0.599115113300877,1.0,19/38,28.33%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;RHNO1;YAF2;BMI1
prerank,dendritic spine morphogenesis (GO:0060997),0.49368904822591364,1.1892964939384258,0.2672413793103448,0.86694455436905,1.0,3/15,2.25%,DOCK10;PTEN;EPHB1
prerank,digestive tract morphogenesis (GO:0048546),0.5073999744662807,1.1892152178388524,0.2656514382402707,0.8656752314973473,1.0,1/14,0.14%,PDGFRA
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4984618978795068,1.1886671799192845,0.2733333333333333,0.8661808761828107,1.0,3/14,6.25%,GPLD1;IRS1;IRS2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3413118373395958,1.188666658091034,0.1843088418430884,0.8646680936647702,1.0,31/124,17.24%,NCDN;LAMB1;GPM6B;MICALL2;CNTNAP2;WDPCP;LRP12;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;DOCK7;FAM161A;PLEKHA1;KIFAP3;STMN2;NPY;OPHN1;PLP1;STMN4;GPRIN1;FAM161B;STMN1;LYN;CTTN;GDNF;TBC1D23;GPRIN3;CYFIP1;CDK5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.46841912578389044,-1.1882990605296158,0.28699551569506726,0.6011012993412824,1.0,4/12,3.37%,PODXL;PROM1;MAGI2;IQGAP1
prerank,COPII-coated vesicle budding (GO:0090114),0.36500076723152974,1.1881214703563108,0.2100954979536153,0.8651585604965258,1.0,23/68,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;SAR1A;PPP6C;SCFD1;MCFD2;SCAP;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;MIA3;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,cyclooxygenase pathway (GO:0019371),-0.4842938730051205,-1.1880153592776574,0.24249422632794457,0.6007963793371246,1.0,3/10,3.06%,PTGDS;PTGS1;PTGES3
prerank,axon extension (GO:0048675),-0.3834794824941612,-1.187887579940928,0.21164021164021163,0.6001400178230855,1.0,4/23,2.72%,ALCAM;SLIT2;NRP2;NRP1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3282915340681498,1.1878702098968075,0.1617473435655254,0.8645978267931642,1.0,43/161,18.28%,TBX18;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CHD8;AMER2;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LZTS2;PSMA2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.43146569802345913,-1.1869755371014972,0.2222222222222222,0.6014728947585736,1.0,6/16,14.01%,THBS1;JCAD;PPP1R16B;GATA2;FGFBP1;AGTR1
prerank,recombinational repair (GO:0000725),0.3650623669328295,1.1869655172846554,0.20816326530612245,0.8663263728273239,1.0,22/77,18.20%,MORF4L1;LIG3;FAN1;FEN1;POLQ;ERCC5;RPA1;ERCC4;POLL;MMS22L;BRCA2;ZFYVE26;REV3L;RECQL;SPIDR;POLN;XRCC1;RAD52;PSMD14;HELQ;WRN;FBH1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3327380436795707,1.186454319229804,0.178743961352657,0.8666650177173613,1.0,22/142,11.67%,PDGFRA;PTGFR;ADCY5;ATP1A2;WNT5A;C5AR1;P2RY1;ACKR2;CCR9;RYR2;ADCY8;CALCA;C1QTNF1;CALB1;LPAR3;TRPC3;PRKACA;CCKBR;LPAR1;DLG4;IAPP;TRPC7
prerank,protein-containing complex assembly (GO:0065003),0.3142464803254896,1.1862845264792414,0.155902004454343,0.8657535638539722,1.0,75/259,19.85%,SEC16B;LAMC1;WIPF1;TEAD1;HDAC1;PPID;TCF7L2;CD40;COL7A1;PYGO1;SEC16A;EPRS1;RSPH9;GRIA1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;BCL9;LRRK2;TLE2;NOL3;SLC9A1;LLGL1;ADCY8;CAPN3;COL16A1;WASF3;TRAPPC2L;MDM4;GOLGA2;KIFAP3;OPA1;TLE1;IL1RAP;F8;SEC24B;DNAJB12;PPP6C;GSDMD;TP53;RIMS1;SCFD1;DLG4;WDCP;MCFD2;SOX9;TUBGCP4;CAND1;AXIN1;RIPK1;FERMT2;TFAP4;DHX9;AREG;MYC;DET1;PDZD11;FERMT3;TRAPPC10;PPP6R3;SEC24A;DNAJB14;SEC23A;ASH2L;TSPAN4;MDN1;PEX14;TBC1D20;ST13;CNIH3;TRAPPC2;TRAPPC5;CDC73
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.48253261000036285,1.1862602594476845,0.26755852842809363,0.864354980191594,1.0,4/16,11.46%,TRA2B;PRDX6;CELF4;SNW1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.4284571115041901,-1.1861835866461026,0.23604060913705585,0.6024707062408771,1.0,7/16,10.44%,PDGFD;PTPRJ;FER;NRP1;PDGFA;PDGFC;PTPN1
prerank,protein localization to plasma membrane (GO:0072659),-0.27751098605133556,-1.1858707620232,0.1276595744680851,0.6022418663518003,1.0,27/129,9.21%,TSPAN5;RAPGEF2;ROCK2;ACTN2;BSG;AFDN;RAPGEF6;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;PACS1;RAMP1;TTC7B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;TTC7A
prerank,neuron projection development (GO:0031175),0.3305794380360739,1.1854073293185916,0.17005988023952096,0.8658573124329492,1.0,39/168,16.35%,NCDN;EPB41L3;LAMB1;DOCK10;GPM6B;ADGRV1;MICALL2;PTEN;EPHB1;CNTNAP2;MAP4K4;LRP12;PPP1R9A;NEDD4;UNC5A;NEFH;LRRK2;CNTN4;TMEM108;DOCK7;STMN2;NPY;BMP7;OPHN1;PLP1;STMN4;DLG4;IFT88;GPRIN1;STMN1;ATP7A;LYN;CTTN;GDNF;SGK1;TNIK;TBC1D23;GRM7;GPRIN3
prerank,nuclear membrane organization (GO:0071763),-0.4050788391741268,-1.1852640918462827,0.2236180904522613,0.6027922874530012,1.0,12/19,36.77%,TARDBP;TOR1A;GPER1;CHMP4B;CHMP7;TOR1AIP1;EMD;CHMP2A;UBXN2A;NSFL1C;VPS4A;PLK1
prerank,negative regulation of JNK cascade (GO:0046329),-0.3700931022578725,-1.1848076702752675,0.2028169014084507,0.6029543342160608,1.0,8/31,16.20%,MECOM;SIRPA;HIPK3;SH3RF2;HDAC3;CYLD;MAPK8IP1;PER1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.36908832046465545,-1.1847050797726537,0.2005420054200542,0.6021962320651512,1.0,15/29,40.33%,TPM1;S1PR1;NOTCH1;TGFBR3;PKP2;SMAD7;FKBP1A;TTN;TNNC1;TNNI3;TBX20;NOG;TCAP;MYL3;MYH6
prerank,macrophage activation (GO:0042116),-0.3637417607399461,-1.1846979709764354,0.19117647058823528,0.601221359524345,1.0,11/34,18.27%,FOXP1;APP;LBP;NMI;CD93;IFI35;MAPT;PLCG2;CX3CL1;DYSF;IFNGR1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4648903001060679,1.1843290808000133,0.23717948717948717,0.8683061714138227,1.0,3/21,4.96%,PAG1;TNFAIP8L2;PTPN22
prerank,regulation of embryonic development (GO:0045995),-0.3541843889551735,-1.183963199095107,0.22160664819944598,0.6020583078288383,1.0,9/34,11.51%,PHLDB2;PLCB1;INSR;B4GALT5;TRIP12;SOX17;CFL1;NIBAN2;DAG1
prerank,negative regulation of T cell proliferation (GO:0042130),0.4278586941606138,1.1839380181952919,0.2572347266881029,0.8681821619812388,1.0,7/28,17.28%,GLMN;SCRIB;PDCD1LG2;TNFRSF21;CD86;PRKAR1A;LGALS9
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.42480042427793485,1.1838289029820528,0.23387096774193547,0.8670757891476212,1.0,4/35,2.23%,GGT5;ACSS3;PAM;GGT7
prerank,regulation of microtubule polymerization (GO:0031113),-0.3367496572803823,-1.183748672387996,0.1761194029850746,0.6016097702109015,1.0,13/40,20.98%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;CDH5;MET;CDK5RAP2;CAMSAP2;EML2;NUMA1;FES
prerank,synaptic vesicle exocytosis (GO:0016079),0.39946799869086214,1.1836465306099395,0.22153846153846155,0.8661879214083938,1.0,14/40,18.61%,VAMP2;SNAP23;RIMS2;SNPH;SNAP29;SYT7;RIMS1;SYT5;DNAJC5;UNC13A;PCLO;CDK5;UNC13C;SYT1
prerank,positive regulation of histone modification (GO:0031058),-0.35848329464177425,-1.1835626268460393,0.20738636363636365,0.6010994928003915,1.0,13/33,25.89%,GLYR1;RPS6KA5;SAP30BP;AKAP8;NOS1;UBE2N;CDK9;ZBTB7B;TADA2B;RUVBL2;APLNR;KDM1A;BRCA1
prerank,negative regulation of neuron differentiation (GO:0045665),0.46387299692819983,1.183504723243968,0.24247491638795987,0.8651899693709522,1.0,9/22,21.72%,REST;CNTN4;SOX2;BMP7;SOX9;MED1;CALR;HEY1;DTX1
prerank,negative regulation of axon extension (GO:0030517),-0.3648418915106532,-1.1833563650114634,0.20512820512820512,0.6006987913877007,1.0,14/30,28.07%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B;RTN4;MT3;SEMA3F;RTN4R;RNF6
prerank,multivesicular body organization (GO:0036257),-0.3690226065439836,-1.182939793808283,0.22093023255813954,0.6008766381673802,1.0,14/31,28.53%,VPS37A;CHMP2B;VPS37B;IST1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;VPS28;VPS36;CHMP4C;CHMP2A;RAB11A
prerank,ceramide transport (GO:0035627),-0.46830429635423715,-1.1828843498975323,0.24145785876993167,0.6000251039669485,1.0,5/12,20.98%,CERT1;PLTP;ABCB4;PSAP;GLTP
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.44917861867810227,-1.1824940432118147,0.25986078886310904,0.6001001508037952,1.0,12/14,54.23%,IL18;PAEP;IL17D;CD84;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.46617229637856694,-1.1819748707448159,0.25059665871121717,0.6005106991598791,1.0,5/12,25.14%,TNKS2;PARP10;PARP1;PARP2;PARP12
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4111969096806616,1.1819113700594293,0.24804992199687986,0.8693635341844003,1.0,7/34,10.09%,PDGFRA;PIK3R1;PIK3R2;IRS1;PTK2;PRKD1;FGR
prerank,cellular response to lipid (GO:0071396),0.3242608858472467,1.1818514370615218,0.1687715269804822,0.8681291908582994,1.0,35/191,14.06%,RORA;CXCL10;ADCY5;ATP1A2;WNT5A;CXCL1;GPLD1;PDE4B;NR1H4;NCOA3;PDCD1LG2;SPP1;ATP1A3;IRS1;ADCY8;ADCY3;CD68;ADCY2;AXL;TLR4;WNT3;PLAA;IRAK1;EPHA3;PYCARD;SNW1;SOX9;HTRA2;CD86;PDCD4;TESC;NRIP1;MED1;MAP4K1;LYN
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3392611146254525,1.1817933448416433,0.20124223602484473,0.8668457414939732,1.0,28/125,15.81%,DYNLL1;BUB1B;CENPU;EFHC1;DCTN2;SGO1;CENPE;SUN2;GPSM2;NSL1;PTPA;TBCE;SPDL1;RCC1;NUSAP1;RMDN1;CENPC;INCENP;CEP126;NUP107;EML1;BUB1;STMN1;DYNLL2;CLASP2;KIF2A;CENPF;CLASP1
prerank,positive regulation of signal transduction (GO:0009967),-0.250584241234737,-1.1817751258744729,0.054945054945054944,0.6000435451309549,1.0,60/238,16.38%,SORBS1;TSPAN5;IGF1;VWF;TEK;LIMS2;RBPJ;RSPO3;ROBO1;MAML2;NOS3;TPD52L1;SHANK3;NRP1;SMARCA4;VPS35;FAS;JCAD;NOTCH1;RSPO2;TGFB2;VTN;KANK1;CCN3;SKI;SMO;GRB10;SULF2;IL6ST;CAV2;CRADD;KLF2;EPN2;WLS;SHANK1;CCBE1;FGF1;ITGB1BP1;CITED2;SFRP1;BAX;TRIM16;MYO1C;CD63;DLG5;ITGB3;TERT;PRKCZ;TTC23;GKAP1;FLNA;MACF1;PTK2B;CDKN2AIP;ERN1;ESM1;SIRT1;ATP6AP2;GPER1;ING5
prerank,myelin assembly (GO:0032288),0.540678556512401,1.1816148963161621,0.2826086956521739,0.8659879902926781,1.0,2/10,4.49%,EPB41L3;TENM4
prerank,protein localization to cilium (GO:0061512),0.4124775774253767,1.1815822714499258,0.22955974842767296,0.8646549761416166,1.0,7/32,10.58%,ODAD4;WDR35;ZNF423;TUB;RAB29;TTC21B;TCTN2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.49055886552331973,-1.1811869179665895,0.23779193205944799,0.6006625134800251,1.0,4/10,10.36%,SHANK3;APP;RAB5A;CAMK2B
prerank,regulation of cell aging (GO:0090342),-0.4782760549113618,-1.1809144048505464,0.2575,0.6003878379739481,1.0,6/11,26.03%,NEK6;LMNA;VASH1;MIF;PNPT1;RSL1D1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.43673563076686284,1.1807697199686273,0.24610591900311526,0.8661685707519768,1.0,13/26,23.89%,GPR37L1;REST;LRRK2;NOL3;PYCR1;PINK1;FYN;HTRA2;GPR37;PDE8A;BAG5;MAPK7;ATF4
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2610709716963594,-1.180516699798694,0.08433734939759036,0.600489821139218,1.0,46/153,19.89%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;CAMK2D;PRKDC;TOP1;VRK3;TLK1;MAPK9;WNK1;HIPK3;MAPK14;GSK3B;HIPK1;TLK2;STK38L;MAST3;DYRK2;RPS6KA5;CAB39;ATR;RPS6KA1;MAP2K2;PRKCZ;HIPK2;ATM;CSNK1G3;ERN1;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;STK32B;AKT1;CSNK1A1;SBK1;VRK2;MARK2;ULK3;MKNK1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.40556824198163893,-1.180505980480946,0.23575129533678757,0.5995462416273883,1.0,8/20,13.64%,BCL2L1;MCL1;FAS;CASP2;GSK3B;CASP3;BAX;BOK
prerank,xenobiotic transport (GO:0042908),-0.425873512211435,-1.1802182271107506,0.25,0.5994129051811263,1.0,6/17,10.69%,ABCG2;SLC47A1;SLC22A4;ABCA3;SLC22A18;SLC7A5
prerank,phospholipid biosynthetic process (GO:0008654),-0.35352078004142506,-1.1802086867587593,0.21364985163204747,0.5984721067023515,1.0,14/36,29.95%,SGMS1;MBOAT1;SGMS2;AGPAT4;CPNE3;FDPS;NUS1;PIP5K1A;DOLPP1;SPHK2;FITM2;AGPAT5;SAMD8;MVD
prerank,positive regulation of biosynthetic process (GO:0009891),0.3978748503860381,1.1800905561036605,0.2529411764705882,0.8671607727779821,1.0,10/40,9.80%,ZBTB20;PPARA;TLR6;MTPN;LARP6;ADGRB1;AMELX;MTOR;TLR4;CYBA
prerank,calcium-mediated signaling (GO:0019722),0.346163820642945,1.1800834409817476,0.20516129032258065,0.865715063003403,1.0,20/93,11.66%,PTGFR;ACKR2;CCR9;RYR2;PDPK1;PPP1R9A;HTR2B;CAMKK2;LRRK2;STIMATE;ATP2A2;SLC9A1;PRKACA;ADGRL1;KSR2;PPP3CB;GRM5;RCAN3;P2RX4;TRPM2
prerank,sterol metabolic process (GO:0016125),-0.3085288073047416,-1.1799748059353785,0.15467625899280577,0.5981073373619685,1.0,20/60,21.56%,PRKAG2;CYP26B1;LBR;CYP39A1;CYP1B1;FDX1;RXRA;APOE;LIPA;PIP4P1;SOAT1;PMVK;FDXR;CYP51A1;INSIG1;INSIG2;CLN8;OSBPL1A;EBP;TSKU
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4589479470674246,-1.1799285586104473,0.23702031602708803,0.5972773080031735,1.0,5/13,18.43%,ANO6;AZIN1;P2RX7;ACSL5;SLC26A6
prerank,regulation of neuron differentiation (GO:0045664),0.35943610958665523,1.1796087876490216,0.21903520208604954,0.8658867138857195,1.0,18/76,18.45%,ZEB1;ZFHX3;TCF4;FGFR1;REST;LRRK2;CNTN4;BEND6;SOX2;BMP7;MED1;NRCAM;IMPACT;BRINP1;CALR;BMP2;HEY1;RHOA
prerank,histone lysine demethylation (GO:0070076),-0.37338913127677087,-1.1791584587724728,0.23869346733668342,0.5984360665697246,1.0,10/25,25.65%,KDM4A;KDM4C;RIOX2;PHF8;HR;KDM4B;KDM3B;PHF2;KDM2B;KDM1A
prerank,inner mitochondrial membrane organization (GO:0007007),-0.33519224523056507,-1.178813582639054,0.1650485436893204,0.5983631981642217,1.0,20/47,24.23%,APOOL;MICOS10;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;TIMM9;ATP5MC2;GHITM;ATP5F1D;ATP5MC1;TIMM13;CHCHD3;TIMM8B;ROMO1;LETM1;NDUFA13;APOO;UQCC3;TIMM10B
prerank,mammary gland development (GO:0030879),0.45979712370044046,1.1787636397978885,0.26533996683250416,0.8673675543238973,1.0,5/21,12.48%,NRG1;ERBB4;TBX3;WNT3;ARHGAP35
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.34397824239338476,1.1786665775153982,0.21794871794871795,0.8662691918165502,1.0,10/101,6.08%,CEMIP;IL34;EDN3;WNT5A;CD40;FGFR1;HTR2B;LRRK2;MTCP1;PSMD10
prerank,nucleosome disassembly (GO:0006337),-0.4542763652470939,-1.1784395465887625,0.2809278350515464,0.59742395269642,1.0,11/14,42.40%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,chromatin disassembly (GO:0031498),-0.4542763652470939,-1.1784395465887625,0.2809278350515464,0.59742395269642,1.0,11/14,42.40%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.45920925170754356,-1.1782686458366924,0.26126126126126126,0.5968745145509723,1.0,9/12,50.62%,IL18;PAEP;IL17D;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.38258849263473305,-1.17819276373558,0.2276657060518732,0.5961333488521671,1.0,11/24,29.54%,CAMK2D;SRI;CALM1;DMD;JPH1;NOS1;JPH2;GSTO1;CASQ2;FKBP1A;JPH3
prerank,mitotic cytokinetic process (GO:1902410),-0.4068332607494279,-1.1779548333793408,0.228287841191067,0.5957848215634922,1.0,14/20,38.38%,CHMP2B;MITD1;KLHDC8B;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;CHMP4C;CHMP2A;CHMP6;VPS4A;KIF20A;CHMP3
prerank,maturation of LSU-rRNA (GO:0000470),-0.3834127312597027,-1.177633192594758,0.21179624664879357,0.5956912715819551,1.0,11/26,27.54%,NSA2;RPL10A;NIFK;WDR12;PES1;RRP15;LAS1L;NOP2;RSL1D1;RPF2;NHP2
prerank,regulation of actin filament-based process (GO:0032970),0.36307391253205995,1.1775594456934801,0.2161422708618331,0.8687289199210724,1.0,9/70,4.55%,DLC1;LRP1;RND3;HRG;GPM6B;IQGAP3;CORO2B;FSCN1;RAC3
prerank,epithelial tube morphogenesis (GO:0060562),-0.3586329985320627,-1.1774462334031623,0.21676300578034682,0.595320971104682,1.0,9/32,8.00%,MEF2C;SLIT2;PODXL;RASIP1;GLI2;MEGF8;ACVR1;ACVRL1;SOX17
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3519175720821895,1.1774090856539858,0.21438082556591212,0.8677600911413915,1.0,18/80,16.07%,FANCI;PRICKLE1;MYCBP2;LRRK2;PSMD10;PINK1;TSPYL5;COMMD1;BIRC2;NDFIP2;SPRTN;GSK3A;PTTG1IP;DCUN1D5;AXIN1;UBE2D1;PAXIP1;NDFIP1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4079843110285607,1.177089888232067,0.2289348171701113,0.8674500935858831,1.0,16/34,22.62%,PTPRT;PTPRQ;DUSP1;PTPN22;DUSP22;PTPRO;PTPN13;TNS2;UBASH3B;DUSP8;PTPN18;PTPN11;DUSP10;DUSP6;PTPRZ1;DUSP7
prerank,positive regulation of growth (GO:0045927),-0.30785399417186504,-1.1766420982163908,0.20384615384615384,0.5963388092093596,1.0,21/64,20.47%,PLCB1;EGFR;INSR;TGFB2;ADAM10;CDC42;PPM1F;HYAL1;SFRP1;INO80;RPS6KA1;EXOSC2;MFSD2A;CDKN2AIP;PABIR1;ZPR1;ERBB2;AKT1;SDCBP;CIB1;LGI1
prerank,regulation of cellular component size (GO:0032535),-0.36215017721127013,-1.1764285411166489,0.226890756302521,0.5959333997945628,1.0,7/30,8.25%,PICALM;EZR;RDX;RIN3;RAP1GAP2;RAC1;LAMTOR5
prerank,regulation of interleukin-6 production (GO:0032675),0.34335820653528326,1.1762793455556788,0.19220779220779222,0.8686953789102675,1.0,13/96,10.90%,IL33;WNT5A;IL16;TSLP;PTPN22;TLR6;TLR8;TWIST1;CD200R1;MBP;TLR4;CYBA;PYCARD
prerank,regulation of cation channel activity (GO:2001257),0.3483643192813391,1.1759035665242341,0.20861372812920592,0.8686021748329027,1.0,20/89,11.37%,KCNS2;GRIA3;GRIN2B;CACNG3;GRIA4;GRIA1;DLG3;ANK3;VAMP2;DLG2;GRIN2A;KCNG1;KCNAB1;RELN;PRKACA;CACNB4;CACNG4;SHISA6;FGF12;DLG4
prerank,RNA catabolic process (GO:0006401),0.39187697557573636,1.175780862463166,0.2511144130757801,0.8675821497564858,1.0,13/46,17.91%,RNASEH2C;AGO4;FEN1;ZC3H12D;ZFP36L2;AGO3;MTREX;RNASEH2B;DIS3L2;HNRNPD;RNASEH1;PPP1R8;DXO
prerank,dendritic spine organization (GO:0097061),0.42793834049335255,1.1755277753879714,0.2611464968152866,0.8670319189559901,1.0,7/26,11.37%,DOCK10;PTEN;EPHB1;ITGA3;LGMN;FYN;DLG4
prerank,regulation of cell motility (GO:2000145),-0.2768585155321056,-1.174482329150615,0.10362694300518134,0.6000896699448441,1.0,37/121,18.67%,PLXNA2;LMO4;ROCK2;CAVIN1;PLXNA4;EGFR;SPOCK2;NTN1;DIAPH1;AMOT;MINK1;RAC1;INPP5F;CDK6;PRAG1;FGF1;PLXNB1;FRMD5;ARHGAP18;ENPP2;SPATA13;ROBO4;LMNA;CEACAM1;AMOTL2;FLNA;MACF1;SERPINE2;TMSB4X;PLXNA1;PKN2;CCDC25;ERBB2;AKT1;EGF;SPINT2;ERBB3
prerank,actin filament organization (GO:0007015),-0.2721467474881595,-1.174213616731234,0.09580838323353294,0.599888547535218,1.0,37/151,14.62%,NEBL;TMOD3;RHOBTB1;BAIAP2L1;DPYSL3;SHROOM4;SHROOM3;TPM1;MYO1D;HIP1R;GSN;RUFY3;RHOBTB2;RAC1;NEDD9;CGNL1;ARHGAP17;COBL;CDC42;VILL;INPPL1;RHOC;FHOD1;MYO1C;MYO1E;ARHGAP12;CD2AP;LMOD1;SHROOM2;TMOD1;TRPV4;FLNA;DSTN;SHROOM1;HIP1;BAIAP2;ELMO2
prerank,visual perception (GO:0007601),0.3523055521862615,1.1740589564973998,0.19922879177377892,0.8706713180815938,1.0,7/84,3.76%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,ribosome biogenesis (GO:0042254),-0.26251641080220484,-1.173635704409819,0.07874015748031496,0.6003742552899107,1.0,86/187,30.71%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RIOK1;RPL10;RPL35A;DDX27;RPL10A;RPL11;RPL36A;RPL34;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RAN;RPL31;IMP3;EXOSC3;RPL23A;RPL19;RPL36;WDR12;PES1;NIP7;NPM1;PAK1IP1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52;GTF3A;GLUL;WDR74;PWP2;RPL15;RPL38;MRM2;LTV1;LSG1;RPF2;MRPL36;RPL13A;EXOSC4;RPS25;LTO1;RPL24;RPL18A;WDR75;RRP36;NOP16;BMS1;EIF2A;PIH1D2;NOP53;RRP9;WDR46;RPL22
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2992828457009397,-1.1731490362842536,0.15413533834586465,0.6006229278977792,1.0,24/72,22.17%,SLIT2;SHANK3;KANK3;HIP1R;ATXN7;HSPA8;KANK1;APC;CRYAB;APOE;SHANK1;SSH1;APC2;ARPIN;LIMA1;CDH5;PRKCD;CAMSAP2;EML2;CHADL;CIB1;KATNB1;TWF2;PFDN4
prerank,regulation of protein phosphorylation (GO:0001932),-0.24994839816990272,-1.1725159550316142,0.04950495049504951,0.6013838559281397,1.0,42/256,8.11%,PLCE1;FN1;ROCK2;TEK;LEPR;OCLN;BMPER;SLIT2;PECAM1;FNIP1;EGFR;KRAS;PLPP3;FER;APP;CSNK1D;SIRPA;LIMCH1;IGFBP3;KDR;PRKDC;NIBAN1;CCND2;INSR;FAS;VEGFD;RAC1;DAB2;VEGFC;MAVS;TFRC;EFNA5;PDGFA;CARD14;TBX1;CCN1;XDH;PRR5L;LRP6;FGF1;FNIP2;RALBP1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.28617467254198065,-1.1716457514591108,0.12719298245614036,0.6025867248687252,1.0,30/88,24.23%,PRKAG2;PTPRB;PPM1E;CAV1;SLC8A3;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;MVP;LRP6;ITGB1BP1;YWHAG;PTPN1;HSPB1;CEACAM1;PPIA;CDKN1A;TRIM27;PAK2;AKT1;GSKIP;NPM1;DUSP19;CAMK2N1;WWTR1;QARS1;DBNDD2;HYAL2
prerank,zinc ion transmembrane transport (GO:0071577),0.4545512721760183,1.1715621327290284,0.26174496644295303,0.8778851487534025,1.0,7/22,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A13;SLC39A14
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.49521324633969277,1.1715395689306103,0.27871621621621623,0.8765174344580916,1.0,5/13,14.93%,WNT5A;TSLP;AXL;TRIM44;DHX9
prerank,organic cation transport (GO:0015695),-0.4064145707267432,-1.171111733398066,0.24757281553398058,0.6029741307026734,1.0,4/20,8.11%,SLC47A1;SLC22A4;SLC22A18;RALBP1
prerank,zinc ion transport (GO:0006829),0.4536713613516468,1.1710451950782939,0.26554621848739496,0.8767880710493519,1.0,7/21,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A13;SLC39A14
prerank,negative regulation of blood pressure (GO:0045776),-0.4525774744954888,-1.170972171313405,0.27884615384615385,0.6023719417863759,1.0,4/13,12.69%,NOS3;BMPR2;SCPEP1;NOS1
prerank,amyloid fibril formation (GO:1990000),-0.3178287726391491,-1.1709578685305424,0.1936619718309859,0.6014587734165229,1.0,17/51,18.01%,TSPAN5;SNCAIP;APP;CST3;GSN;ADAM10;UBB;B2M;MAPT;APH1A;APH1B;FURIN;UBE2L6;SIAH2;UBC;USP9X;MFGE8
prerank,transport along microtubule (GO:0010970),-0.45250631278927417,-1.1705627223585326,0.28169014084507044,0.6015568955191928,1.0,10/13,31.52%,APP;CDC42;BAG3;BORCS5;DYNC1I1;SPG11;COPG2;APBA1;CAMSAP3;DYNC1I2
prerank,ERBB signaling pathway (GO:0038127),0.36850986999222174,1.1703987220186352,0.22623828647925034,0.8775561816560317,1.0,13/64,13.05%,PIK3R1;NRG1;SLC30A10;ERBB4;PTPRR;NRG2;PDPK1;NRG4;PTK2;PRKCA;SOX9;CUL5;GAREM1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.3903707488536623,-1.1703360025393246,0.2560646900269542,0.6011772611045226,1.0,3/21,2.31%,IGF1;ADAMTS1;IGFBP5
prerank,magnesium ion transport (GO:0015693),-0.4671408923693207,-1.1702444667448197,0.2850678733031674,0.600479714664834,1.0,4/12,12.39%,SLC41A1;NIPAL2;MRS2;CNNM4
prerank,positive regulation of TOR signaling (GO:0032008),-0.3364938493985861,-1.1701276671129588,0.2070063694267516,0.5998515015068026,1.0,12/40,19.48%,FNIP1;RICTOR;SIK3;LAMTOR5;RRAGC;CLEC16A;PIP4P1;HDAC3;LAMTOR3;GPR137;SEH1L;RRAGB
prerank,cellular defense response (GO:0006968),0.39462274090993865,1.1697641505239995,0.2469879518072289,0.8783203358530456,1.0,5/40,5.63%,ADORA2B;CLEC5A;C5AR1;CCR9;ADORA2A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5149931925439798,1.1693034929279158,0.29462738301559793,0.8785310109174582,1.0,4/11,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4530488048045016,1.1684406835778982,0.2637729549248748,0.880064859632987,1.0,3/20,2.62%,PTEN;NR2F2;CDKN2A
prerank,glycolytic process (GO:0006096),-0.37202342131527644,-1.1680890121266119,0.23631123919308358,0.6040446796362577,1.0,14/28,20.82%,HK1;LDHA;PGK1;PFKFB2;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS;PGM1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.47770278492015206,-1.1678467747953625,0.28442437923250563,0.6036271962991715,1.0,2/10,8.32%,ANO6;RAB31
prerank,chemokine-mediated signaling pathway (GO:0070098),0.39320105311730225,1.1677636488995442,0.2503617945007236,0.8809705405486797,1.0,4/42,5.33%,XCL1;CXCL10;CXCL1;CCL15
prerank,negative regulation of protein secretion (GO:0050709),-0.34008532898187915,-1.167701498900366,0.21637426900584794,0.6030830042656216,1.0,12/38,22.58%,CD200;PSMD9;CCN3;APOE;KCNB1;SFRP1;RHBDF2;CYP51A1;CHGA;RAB11FIP1;RAB11FIP5;INHBB
prerank,embryonic limb morphogenesis (GO:0030326),0.40565563205522986,1.1676834821604143,0.2671875,0.8798236455933832,1.0,7/34,9.85%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3
prerank,regulation of cholesterol esterification (GO:0010872),-0.49941734945686,-1.1664510855381056,0.29205607476635514,0.6051555837194107,1.0,4/10,20.22%,APOE;STARD4;AGTR1;AGT
prerank,negative regulation of transposition (GO:0010529),-0.429077093034499,-1.1661347166279565,0.24752475247524752,0.6050925562358564,1.0,4/16,11.79%,TUT7;MYBL1;TEX15;UBR2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3069266867693902,-1.1656273149029643,0.19858156028368795,0.6054937092277284,1.0,17/60,19.55%,HMBOX1;KLF4;PTGES3;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;PCNA;ATM;MAP3K4;HGF;RGCC;HNRNPA1
prerank,protein localization to lysosome (GO:0061462),0.4240037079953587,1.1654186588698652,0.25996810207336524,0.8862317062069701,1.0,8/28,12.93%,SORL1;NEDD4;SZT2;SNX16;AP3M1;RNF128;HGS;CD81
prerank,cGMP biosynthetic process (GO:0006182),-0.4949600051104066,-1.1652885770234584,0.27472527472527475,0.6054379516789518,1.0,4/10,28.00%,GUCY1A1;NPR1;GUCY2C;GUCY1B1
prerank,tryptophan metabolic process (GO:0006568),0.5217581323864835,1.1651930874370833,0.30035971223021585,0.8855924830544185,1.0,3/11,17.55%,KYNU;ATP7A;KMO
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.2721876045800146,-1.1646323569445458,0.11848341232227488,0.6061198197124867,1.0,31/112,17.62%,SMAD6;SOX5;ARHGEF18;MEF2C;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;TGFB2;WNT4;WWOX;SKI;PDE3A;UBB;ACVR1;ACVRL1;SMAD3;LRRC32;SFRP1;ZYX;PRKCZ;SMAD1;NR3C1;FURIN;CDH5;SIRT1;UBC;USP9X;TWSG1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5170099115230609,1.164558220794058,0.2956989247311828,0.8863518338849055,1.0,3/10,10.89%,CPEB1;NUDT21;DHX36
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.46123552275052915,1.1644278485529167,0.2786885245901639,0.8839760651848901,1.0,9/21,20.54%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.46123552275052915,1.1644278485529167,0.2786885245901639,0.8839760651848901,1.0,9/21,20.54%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,positive regulation of lipid transport (GO:0032370),0.5033625178291848,1.1643682482831192,0.27419354838709675,0.882724320798961,1.0,2/12,5.26%,LRP1;SPP1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4755924467746209,1.164111705582888,0.2761437908496732,0.8821942298138159,1.0,7/16,18.60%,MCM7;RPA1;MCM4;RECQL;MCMDC2;WRN;SSBP1
prerank,mitotic spindle organization (GO:0007052),0.3272795126996066,1.1633252537952474,0.20689655172413793,0.8836707915173115,1.0,34/153,15.81%,DYNLL1;BUB1B;CENPU;CCDC61;LSM14A;EFHC1;AAAS;DCTN2;SGO1;CENPE;SUN2;GPSM2;GOLGA2;CEP192;NSL1;PTPA;TBCE;SPDL1;RCC1;RMDN1;CENPC;INCENP;CEP126;NUP107;EML1;BUB1;MAP9;STMN1;DYNLL2;CLASP2;KIFC2;KIF2A;CENPF;CLASP1
prerank,protein localization to chromatin (GO:0071168),-0.4099975854229171,-1.1624025584350726,0.25118483412322273,0.610748147296215,1.0,8/18,28.38%,PPHLN1;ESR1;CHMP7;MCM9;RUVBL2;MCM8;MSH2;SGF29
prerank,positive regulation of lipid storage (GO:0010884),-0.3958267879700054,-1.1618429320792467,0.27735368956743,0.611187372686949,1.0,4/21,6.66%,NFKB1;OSBPL11;SREBF2;SCARB1
prerank,postsynaptic membrane organization (GO:0001941),0.4633090261227603,1.1614671365490177,0.2830508474576271,0.8886490970452502,1.0,5/17,15.66%,NRXN2;CEL;NRXN1;DLG4;LHFPL4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3895920910982416,1.1613134657962898,0.24017467248908297,0.8877906009927015,1.0,11/43,12.54%,ENPP1;OGT;PIP4K2A;SORL1;IRS1;RPS6KB1;PRKCB;TNS2;ERFE;IGF2;GSK3A
prerank,regulation of macrophage activation (GO:0043030),0.40949424961874414,1.1612745441823884,0.2811550151975684,0.8865092925062823,1.0,5/30,9.41%,IL33;WNT5A;TLR6;LRFN5;TLR4
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5217284715076418,1.160607333930397,0.2927272727272727,0.8874317487724919,1.0,6/10,22.12%,CDC7;WIZ;CDT1;DBF4;SSBP1;ATRX
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3199150783363479,1.1595345044797378,0.21505376344086022,0.8896920242707079,1.0,30/166,15.28%,RORA;PPARA;TEAD1;HDAC1;TAF9B;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;POLR1A;NR2C1;TAF3;TBPL1;TAF1D;TAF1B;SNW1;GTF2H3;ESR2;HDAC10;MED1;ERCC2;NRBF2;GTF2H1;AR
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4881538243425773,1.1595142256257287,0.2889273356401384,0.8883666057568416,1.0,4/13,16.57%,PRICKLE1;TBX3;SOX9;SRA1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.43697331165292846,-1.159056414302204,0.2546728971962617,0.6175640115969577,1.0,5/15,7.89%,RAI2;RICTOR;TGFB2;STOX2;CELF1
prerank,protein heterooligomerization (GO:0051291),0.46094720194249084,1.1590181125064334,0.2832764505119454,0.8886411670772058,1.0,4/17,10.19%,GRIN2B;KCNC2;HSD17B8;NUDT21
prerank,histone H3-K4 methylation (GO:0051568),0.42855410175938363,1.1589031857916245,0.25326797385620914,0.8875970982306689,1.0,13/26,24.07%,OGT;KMT2A;CXXC1;WDR5;DYDC2;PAXIP1;ASH2L;SETD4;MEN1;KMT2C;RBBP5;KDM6A;TET2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.45047821201854465,-1.1588248297957318,0.2860520094562648,0.6172284234882687,1.0,2/13,3.21%,CAV1;ADRA1B
prerank,regulation of cellular pH (GO:0030641),-0.36616494379468906,-1.1585670584714023,0.22285714285714286,0.616957821037851,1.0,9/29,18.67%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;LACC1;SLC4A8;SLC9A5;SLC26A6;SLC9B1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3960889101173854,-1.1583590675990123,0.2776349614395887,0.6165114561072098,1.0,14/20,37.20%,SLC8A3;MICU1;MCUB;SMDT1;YME1L1;MCUR1;LETM1;MCU;SLC8B1;MICU2;PMPCB;STOML2;SLC25A23;SPG7
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4129927104931654,-1.1578785633788913,0.2603092783505155,0.6167698274288635,1.0,8/18,21.31%,EGFR;LCOR;SFRP1;KAT5;GPER1;ESR1;CCDC62;RUVBL2
prerank,stem cell differentiation (GO:0048863),-0.33916777905588646,-1.1577571567807103,0.21406727828746178,0.616158410314024,1.0,7/39,9.80%,MLLT3;MEF2C;OSR1;TGFB2;ACE;LRP6;SFRP1
prerank,regulation of gene expression (GO:0010468),-0.22284310392280812,-1.1575837893165544,0.0,0.6156984405494853,1.0,225/903,18.77%,BNC2;PRDM6;FN1;IGF1;PICALM;APBB2;SLC24A3;ROCK2;FOXP1;ITGB8;ERC1;MEF2C;DENND4A;RBPJ;LEF1;OCLN;ROBO1;LARP4;KRAS;MBNL1;AFDN;FOXC1;HDAC4;OSR1;EZR;FOXN3;NOS3;NOTCH2;PPARGC1B;APP;CDH1;GTF2IRD1;AHNAK;KLF4;NFKB1;ZNF462;GPBP1L1;KDM4A;KAT6B;FOXD1;ESRRG;CLDN5;RDX;PRRX2;SIRPA;SMARCA2;KDR;VPS35;GSN;YBX3;AHNAK2;INSR;WWP2;NOTCH1;RUNX1;TGFB2;WNT4;ACTG1;NFKBIZ;TDRD7;TAPBP;ASCC2;SMO;DVL1;RPL5;CD34;PRKAA2;MAPK9;NFYC;TFRC;CDK6;ADAM10;PRDM2;SLC39A8;SIX1;MEGF8;RPS7;PPP2R1A;TRIM5;TRIM11;MOG;AFF4;MAPK14;SOX4;NGF;PRDM11;FZD7;CRABP2;DICER1;NOVA2;TRIM14;PPM1F;APOE;GSK3B;PLAG1;IRF2;XDH;CELF1;FGF1;ACVRL1;SOX17;HNRNPF;PCBP2;LAMTOR5;MAPT;SMAD3;ANK2;WNT6;CRIP1;GZF1;RPL11;VSX1;ACTR8;PTBP3;ATOH8;CASP8;RPS6KA5;RC3H1;CITED2;PIK3CB;GPX1;MYBL1;SFRP1;GATA2;HMG20B;PIK3CD;RFX3;MYCBP;CCN4;ETS1;EPHB2;CASZ1;NFYA;TNRC6A;PARP10;VHL;PARP9;SLC7A5;UBAP2;MBNL2;CTSH;GCFC2;TARDBP;MZF1;MAP2K2;AJUBA;MYBBP1A;FASTK;ACTA2;TLE5;FUS;TERT;TNRC6C;HNRNPH1;PTRH2;PLCG2;HNRNPDL;HEY2;SMAD1;NR3C1;TMEM119;ATM;ATXN1;ACTR5;YBX1;MSL3;HINT1;NOS1AP;ZNF205;PTHLH;WNT16;RAMP2;TICAM1;P2RX7;CDH5;CIAO3;CAVIN4;TOB1;ZNF219;TRAF3;EZH2;NFYB;POGZ;CHD3;TRIM27;SRRM4;SIRT1;MATR3;GPER1;PRKAA1;ZPR1;PER1;MED23;TRRAP;NFKB2;CLOCK;HAVCR2;BTN3A3;FAM50A;ESR1;DNAJA4;HFE;CD74;HNRNPK;ACVR2B;BHLHE40;AGO2;SOX18;AKT1;DNMT3B;SOX11;OGG1;IFNGR1;EGF;SLC22A2;MSN;ACE2;PQBP1;SUFU;HOXD3;CTCF;EFEMP1;PID1;APBB1;WNT11
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.31743836358759125,-1.1574201299569455,0.20317460317460317,0.6151913085000786,1.0,18/47,25.13%,FOXO1;EGFR;IGF1R;ARL6IP5;FAS;TGFB2;MAPK8IP3;MAP2K2;PPIA;MAPK8IP1;STK25;PER1;TGFBR3;MID1;QARS1;TAOK2;NOD2;GREM1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5085464043970527,1.1572294303656747,0.298932384341637,0.8922639951305127,1.0,2/11,8.61%,MERTK;AXL
prerank,negative regulation of metabolic process (GO:0009892),0.3735186459552883,1.1571405348504604,0.26433566433566436,0.8911636779521638,1.0,10/54,9.97%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,sensory perception of pain (GO:0019233),0.4542208190699927,1.1568315769907842,0.2926829268292683,0.8907666773714047,1.0,4/21,11.17%,TRPA1;NIPSNAP1;PTGES;P2RX4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3998731765267051,1.1567658811990091,0.26259541984732826,0.8895869343205414,1.0,10/37,16.58%,ENTPD2;RNASEH2C;ENTPD5;NUDT9;MTREX;RNASEH2B;ENTPD7;HNRNPD;RNASEH1;PPP1R8
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4395218927909215,1.1566514356620101,0.290625,0.8885468718330284,1.0,14/25,28.99%,HTATSF1;SETD5;ZNF326;EAF2;CCNK;THOC5;LDB1;KAT7;DDX39B;CCNT2;EAF1;ELL;WDR43;HMGN1
prerank,organophosphate biosynthetic process (GO:0090407),-0.3420695448945495,-1.1565893105705973,0.22781065088757396,0.6163319781300416,1.0,7/37,7.94%,MBOAT1;TPK1;ITPKB;AGPAT4;NFS1;IP6K2;TPI1
prerank,neuropeptide signaling pathway (GO:0007218),0.36738321216281455,1.1565884715539934,0.2593123209169054,0.8873633828590279,1.0,11/58,16.06%,RXFP3;SORCS3;PDYN;SORL1;NPY;GLRA3;GLRA1;GLRA2;NMU;GLRB;GPR37
prerank,positive regulation of RNA splicing (GO:0033120),0.417400701885248,1.1563629255178098,0.2697160883280757,0.8867448861402011,1.0,8/29,17.90%,PIK3R1;TRA2B;PRDX6;CELF4;SNW1;RBM20;HNRNPLL;HABP4
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4506484709311584,-1.1560589539582777,0.26573426573426573,0.6167785637746973,1.0,5/12,16.96%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.31470122436788744,-1.1557746675531326,0.22758620689655173,0.6165230343171483,1.0,23/55,27.96%,THBS1;CYP1B1;RAC1;MAPK14;XDH;RNF41;AGTR1;GRB2;CDKN1A;ACE2;PID1;SIRT5;MPV17;AGT;ROMO1;TGFBR2;SPHK2;MT3;CBR1;BRCA1;NOXO1;GADD45A;ARF4
prerank,eye morphogenesis (GO:0048592),0.4560782014253071,1.1557483395428378,0.2854757929883139,0.8875115217600978,1.0,3/19,5.64%,TENM3;NKD1;NF1
prerank,heart development (GO:0007507),0.32326454923483894,1.1546720491625413,0.1997533908754624,0.8898751087786311,1.0,24/150,12.50%,SCUBE1;CHD7;ECE1;FLRT2;DLC1;NTRK3;PTEN;ERBB4;SALL1;DNAAF4;HTR2B;NF1;BCOR;ADAP2;SRF;PTK2;BMP7;KAT2A;FGF12;ZFPM2;NDUFV2;TGFBR1;SOX9;RBM20
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.29585117962113705,-1.1546404537343085,0.17753623188405798,0.6185883194832532,1.0,28/71,23.08%,CTSC;DDI2;UBB;VCP;NGLY1;CASP8;CTSO;RNF41;CTSH;CLPX;PSMA6;CTSZ;NEDD8;YME1L1;ISG15;CTSS;CHMP4B;UBC;USP9X;CHFR;CLPP;PDCD6IP;TNFAIP3;HDAC6;PRPF19;UBA52;PSMA8;CHMP4C
prerank,early endosome to late endosome transport (GO:0045022),-0.39023054787934863,-1.1546206942302015,0.2617801047120419,0.6177211244901845,1.0,4/20,7.81%,EEA1;BECN1;HOOK1;RAB5A
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.4799457959888415,1.154525443982856,0.29391304347826086,0.8889735456968982,1.0,6/14,21.50%,IL34;PTK2;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.46015292707114486,-1.1545053987576468,0.31263383297644537,0.6170785780471395,1.0,3/12,4.21%,DPYSL3;CTPS1;CTPS2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.298160234027742,-1.1544415093106108,0.1799163179916318,0.6162993661887516,1.0,22/80,12.46%,EPHA4;PICALM;ROCK2;VIM;LARP4;THBS1;ELAVL1;PRKDC;NIBAN1;SAMD4A;SMPD3;LARP4B;RPL5;SIRT3;SOX4;CASP3;PYM1;CPEB3;PLA2G6;RPL26;EIF3D;RPS4X
prerank,cellular response to copper ion (GO:0071280),-0.42483400021791556,-1.1541006199679604,0.2631578947368421,0.6162623151239709,1.0,12/16,37.35%,MT2A;MT3;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;HSF1;AQP1
prerank,sensory organ development (GO:0007423),0.3743485333100895,1.1539737334529125,0.25755395683453236,0.8895589671118488,1.0,8/51,10.06%,CHD7;ECE1;MEIS1;MYO7A;MEIS2;SIPA1L3;SOX2;AHI1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4096536830020525,1.153792199194254,0.2578125,0.8888074056880877,1.0,2/33,1.89%,APOD;PTEN
prerank,positive regulation of translational initiation (GO:0045948),0.4566109464829268,1.1534084864280736,0.2838283828382838,0.8886833626667912,1.0,8/18,24.63%,BOLL;RPS6KB1;MTOR;HABP4;KHDRBS1;YTHDF1;EIF2B5;POLR2D
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3462730818705973,-1.1529833851385625,0.23661971830985915,0.6182407960528403,1.0,10/36,18.05%,MECOM;FOXO1;EZR;SIRPA;SH3RF2;HDAC3;CYLD;PPIA;PER1;DLG1
prerank,synaptic membrane adhesion (GO:0099560),0.4903088618163833,1.1528897915453908,0.3076923076923077,0.889162241522997,1.0,6/14,18.74%,GPC4;LRFN5;LRRC4C;NTNG1;SLITRK1;GPC6
prerank,heme biosynthetic process (GO:0006783),-0.3874732506453319,-1.1526790102612892,0.25699745547073793,0.6180556526256461,1.0,7/22,12.56%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5234987556725156,1.1524911992494298,0.30701754385964913,0.8891664635985158,1.0,5/10,19.12%,TLR6;CD68;TLR4;MYD88;MIA3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30388482634149294,1.1524573917720509,0.16416309012875535,0.8878937549113909,1.0,47/308,12.02%,IL33;PTN;GHR;LRP1;HCRT;OGT;WNT5A;TXK;GPR3;PLA2R1;THRA;GLMN;LURAP1;GJA1;LOXL2;REST;ACADL;FBXO5;GCNT2;SOX6;NCOA3;HTR2B;ZBTB16;SORL1;SIRT6;EPAS1;FABP5;FABP4;OMA1;GLIPR2;HMCES;PER2;BSCL2;TWIST1;G0S2;APPL2;MTOR;TAPT1;KAT2A;KSR2;FGR;EIF2AK2;ZBED3;SMTNL2;TGFBR1;VAMP7;SOX9
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.47822517250471264,-1.1524350482959798,0.29550827423167847,0.6177957493063878,1.0,5/11,21.67%,RNF185;VCP;TOR1A;RNF5;UGGT1
prerank,endothelial cell differentiation (GO:0045446),0.5030659658565179,1.1522256831034638,0.306368330464716,0.887331195014832,1.0,1/12,0.06%,SCUBE1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2990103043694546,-1.151858064642327,0.20357142857142857,0.618422473005208,1.0,24/59,22.73%,ROCK2;CAMK2D;PRKDC;WNK1;HIPK3;GSK3B;HIPK1;ACVR1;CDC42BPB;DYRK2;HIPK2;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;AKT1;CSNK2B;SBK1;MARK2;TGFBR2;TTBK1;STK39;CAD
prerank,negative regulation of wound healing (GO:0061045),-0.3605001455826379,-1.1514575100806987,0.23333333333333334,0.6184887787333325,1.0,7/28,9.85%,PHLDB2;THBD;VTN;CD34;CD109;APOE;SERPINE1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3708378415318379,1.1511433786991723,0.2531824611032532,0.8898532111606308,1.0,12/53,20.38%,CALCRL;HTR2B;HTR5A;LPAR3;HTR1A;NPY;HTR2C;HTR4;LHCGR;HTR6;CHRM2;CCL2
prerank,regulation of lymphocyte migration (GO:2000401),-0.48766293618937606,-1.1509622594265905,0.2837528604118993,0.6187706712728112,1.0,6/10,31.46%,JAM2;AKT1;WASL;MSN;SLC8B1;STK10
prerank,cytoplasmic translational initiation (GO:0002183),-0.42255847288049087,-1.1509115185732532,0.291970802919708,0.6179744104502123,1.0,6/17,16.94%,EIF5;EIF2S2;MCTS1;RBM4;EIF3D;EIF4H
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.31603147464953996,-1.1507206005712571,0.2,0.6175560884895567,1.0,18/55,16.14%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;PSMC1;PSMB10
prerank,nucleoside catabolic process (GO:0009164),-0.4584307736253917,-1.150522234640423,0.2747747747747748,0.6171426362982061,1.0,4/11,10.80%,UPP2;DERA;UPB1;NT5E
prerank,cytosolic transport (GO:0016482),-0.27499352720843606,-1.1502687948974708,0.18396226415094338,0.6168831034636791,1.0,31/108,19.93%,ERC1;VTI1A;EEA1;BECN1;MYO1D;VPS35;DOP1B;HOOK1;RAB5A;SNX32;AP2A1;ARFRP1;SNX6;KLHL20;SPAG9;MON2;GAK;CLN5;TBC1D10B;VPS51;VPS29;VPS13A;TRIM27;ARL1;TMEM87B;RAB6A;LAPTM5;VPS54;WDR91;PLEKHJ1;TBC1D5
prerank,glucan catabolic process (GO:0009251),-0.431899525742444,-1.1496760655455311,0.28502415458937197,0.6174884026669812,1.0,9/15,28.50%,PYGB;PGM2L1;CALM1;GAA;PGM2;PHKG1;PHKA2;PHKG2;PYGL
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4749175561659557,-1.1494131330990143,0.2912621359223301,0.6172925650172079,1.0,4/11,20.56%,NRP1;RAC1;HGF;MST1R
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2844532777795745,-1.1486236192501806,0.1744186046511628,0.6184891717417094,1.0,30/87,19.40%,FBXL7;FHL1;KANK2;KLF4;PSMC6;PSMD9;PSMF1;APC;PSMB7;AVEN;CUL1;CDK6;PSMD8;PSMD12;WEE1;FAM107A;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;CDKN1A;PSMC1;PSMB10;DCUN1D3;DLG1;PSME2;RBL1;RGCC
prerank,nuclear migration (GO:0007097),-0.441007802484806,-1.1479635539923687,0.271264367816092,0.619306363324956,1.0,3/13,3.79%,SYNE2;SYNE3;CLMN
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5299686801115229,1.1478003360087548,0.3029197080291971,0.8973190512339364,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,t-circle formation (GO:0090656),0.5299686801115229,1.1478003360087548,0.3029197080291971,0.8973190512339364,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5299686801115229,1.1478003360087548,0.3029197080291971,0.8973190512339364,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,cellular response to amyloid-beta (GO:1904646),0.3971968891426511,1.1474812891631307,0.26356589147286824,0.8970498961438446,1.0,11/35,11.12%,LRP1;GJA1;NGFR;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;GRM5;FYN
prerank,positive regulation of protein binding (GO:0032092),-0.30226557900928486,-1.147477584584568,0.2181208053691275,0.6195725446208052,1.0,16/56,15.42%,RAPGEF2;CAV1;APP;CLDN5;HIP1R;VTN;B2M;APOE;GSK3B;RPL11;RALB;TERT;HIPK2;RAN;AMFR;MARK3
prerank,negative regulation of cellular senescence (GO:2000773),0.4963196468596993,1.1474686477991296,0.29310344827586204,0.8957186745756158,1.0,4/13,8.25%,SLC30A10;FBXO5;ZKSCAN3;TWIST1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.26363363405154383,-1.1472555202554429,0.14,0.6192198369749546,1.0,34/118,19.63%,PHLDB2;EPHA4;MEF2C;PDLIM5;BMPER;SIPA1L1;LARP4;SHANK3;SPARC;RUFY3;CAPZB;EFNA5;TBX1;GSK3B;MAPT;CFL1;RC3H1;SFRP1;ETS1;BCL9L;DAG1;CEACAM1;FLT4;LFNG;LZTS3;ARHGAP44;PAK2;EPHA2;ERBB2;EPHB3;PID1;MARK2;VASH1;SARM1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4380604382543387,1.147084232271973,0.29555895865237364,0.8956221218191422,1.0,2/23,2.16%,GHR;ERBB4
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3308051930804605,1.1467744289449027,0.2397003745318352,0.8953607955533627,1.0,20/117,11.03%,GGT5;ADH1A;PPARA;SLC6A8;ACSF2;PPARD;MCCC1;KYNU;GRHPR;ACADSB;ABAT;ECHDC3;MTHFD1L;PER2;FA2H;PDHX;CKM;HOGA1;GAMT;ACOT7
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5100795578910304,1.146621829551183,0.30344827586206896,0.8944928386803261,1.0,1/11,0.79%,XCL1
prerank,regulation of transferase activity (GO:0051338),-0.4099998464816116,-1.1463529780520887,0.2607594936708861,0.6206892162912133,1.0,6/17,20.36%,HMBOX1;SMG6;ATM;NLRC5;PARP4;JMJD8
prerank,protein phosphorylation (GO:0006468),-0.22634604228091673,-1.1456967693823383,0.0,0.6213942640901529,1.0,122/479,19.18%,FLT1;PRKAG2;DAPK1;EPHA4;MAP3K1;ROCK2;TEK;ERC1;PRKCH;MARK1;ERG;DCLK1;EGFR;TRIB2;IGF1R;FER;APP;BMPR2;RICTOR;CSNK1D;MARK4;NEK6;IGFBP3;KDR;CAMK2D;PRKDC;MAP3K5;INSR;GTF2H5;TOP1;TGFB2;SIK3;MINK1;WNK4;EPHB4;VRK3;PRKAA2;TLK1;MAPK9;CDK6;ADAM10;CDK17;SNRK;WNK1;HIPK3;MAPK14;PRAG1;NRBP2;SIK1;BMX;GSK3B;PKDCC;HIPK1;ACVR1;CDC42BPB;ACVRL1;FNIP2;TLK2;NEK7;STK38L;MAST3;DYRK2;RPS6KA5;LIPE;CDK19;PIK3CD;CAB39;CAMK2B;EPHB2;STK19;ATR;CDKL2;RPS6KA1;RET;EEF2K;FASTK;SRPK1;PRKCZ;HIPK2;PRKAG3;ATM;CSNK1G3;FLT4;BCR;PRKG1;PTK2B;RNASEL;STK25;TBCK;STK17B;CDC42BPG;CREB1;ERN1;MARK3;PRKCD;FLT3;TEC;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;AATK;MAP3K10;ACVR2B;ERBB2;STK32B;CDK9;AKT1;CSNK2B;EPHB3;FGFR3;NUAK2;EFEMP1;CSNK1A1;PRKG2;SBK1;WNT11;VRK2;MARK2;TGFBR3;MAP4K3
prerank,regulation of bone mineralization (GO:0030500),0.37024405405676164,1.145382914240226,0.28448275862068967,0.8972837992394102,1.0,4/55,1.67%,ENPP1;PTN;GPM6B;ADGRV1
prerank,positive regulation of autophagy (GO:0010508),-0.29091561744870564,-1.1453133544181193,0.20784313725490197,0.6214908109448711,1.0,23/81,16.45%,DAPK1;FOXO1;RNF152;KDR;SESN1;ATF6;PRKAA2;SH3BP4;TRIM5;TRIM14;GSK3B;BAD;PIK3CB;BNIP3L;OPTN;TMEM59;PAFAH1B2;TICAM1;KAT5;TRIM27;SIRT1;PRKAA1;TBK1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5178311667304287,1.1452949674773178,0.32578397212543553,0.8962419670186982,1.0,2/10,9.91%,WNT5A;WNT3
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3757211207337654,1.1452871845537722,0.25323741007194245,0.8948989935739483,1.0,22/52,22.83%,RBFOX1;TRA2B;NOVA1;RBM24;REST;FMR1;KHDRBS3;WTAP;CELF4;SMU1;DDX17;RBFOX3;ZBTB7A;RBM5;HNRNPL;SRSF6;KHDRBS1;FXR1;RBM15;RBM25;SRSF12;CELF6
prerank,regulation of oxidative phosphorylation (GO:0002082),0.46238120877356376,1.1452405759164308,0.2857142857142857,0.8937199537559285,1.0,7/16,19.90%,PDE12;PINK1;AK4;SLC25A33;ATP7A;COX7A2L;UQCC2
prerank,negative regulation of ossification (GO:0030279),-0.3717587368978246,-1.1452221739234894,0.26448362720403024,0.6208220363834361,1.0,6/23,4.26%,SMAD6;MEF2C;RBPJ;ECM1;SRGN;NOTCH1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42930334069151377,-1.1443663128752255,0.2907801418439716,0.6220265726781453,1.0,6/15,12.85%,TJP1;BMPER;KLF4;FGF1;PKM;SMAD1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2678596112893474,-1.143684253354979,0.2,0.6229453698926617,1.0,41/129,19.03%,CAV1;EGFR;XIAP;NFKB1;RNF146;CSNK1D;PSMC6;PSMD9;KANK1;TBL1X;PSMF1;GPC3;PSMB7;LGR4;WNK1;WLS;SOX4;TNKS2;VCP;SMURF2;PSMD8;PSMD12;SFRP1;GID8;PSMA3;DKK2;PSMA6;PSMD4;CSNK1G3;PSME3;PSMD7;PSMB6;PSMC1;FAM53B;ATP6AP2;PSMB10;HHEX;TMEM9;EGF;GSKIP;PSME2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.44336257185361805,-1.1436667809618974,0.2733990147783251,0.6220936439823036,1.0,4/13,26.02%,MAPT;PRKCD;TYROBP;ITGB2
prerank,embryonic organ morphogenesis (GO:0048562),0.38553569063776616,1.1435464805845428,0.274310595065312,0.8983405440204794,1.0,10/42,15.80%,PDGFRA;RYR2;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4;FBN1;FGFR2;HOXA9
prerank,regulation of platelet aggregation (GO:0090330),-0.41300806774464965,-1.1429830264795142,0.26854219948849106,0.6229099478102581,1.0,10/17,25.17%,F11R;CEACAM1;PRKG1;SERPINE2;PRKCD;PDPN;CD9;ALOX12;DMTN;ADAMTS18
prerank,urogenital system development (GO:0001655),-0.4685055738341403,-1.1427072369924816,0.3109048723897912,0.6227099843990841,1.0,4/11,17.97%,OSR1;ANXA1;EPHB2;EPHB3
prerank,proteoglycan metabolic process (GO:0006029),0.4129115432726721,1.1424759108242215,0.2854938271604938,0.9008266262229561,1.0,2/26,0.66%,CHST8;SULF1
prerank,keratinocyte differentiation (GO:0030216),-0.35659856478617585,-1.1424326909852314,0.23746701846965698,0.6225230278191947,1.0,13/29,25.19%,CLIC4;ANXA1;TXNIP;CASP3;UGCG;BCR;WNT16;EPHA2;ADAM9;PIP5K1A;ASAH1;DSP;EXPH5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.506542909460315,1.1416154259547178,0.3137931034482759,0.902447746205327,1.0,7/11,23.89%,MBTPS2;TP53;HSPA5;CREB3L1;ATF6B;DDIT3;ATF4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.2942244617242526,-1.1413526189935828,0.22,0.6242930259648366,1.0,21/73,16.14%,KITLG;FOXC1;PSMC6;PRKDC;LMO2;PSMD9;RUNX1;PSMF1;PSMB7;PSMD8;PSMD12;GATA2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;TAL1;PSMB6;PSMC1;PSMB10
prerank,negative regulation of cell aging (GO:0090344),0.47129390725480064,1.1413470057111614,0.295,0.9019840093781054,1.0,6/16,15.64%,SLC30A10;FBXO5;ZKSCAN3;TWIST1;FOXM1;MAP3K3
prerank,sphingolipid metabolic process (GO:0006665),-0.27068800442469193,-1.141202303141168,0.16666666666666666,0.6237926122445903,1.0,35/108,21.50%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;SMPD3;ACER3;SGMS2;CERT1;PPP2R1A;DEGS2;SPNS2;VAPA;ST6GALNAC3;VAPB;HEXB;ENPP2;ELOVL4;UGCG;B3GALNT1;ELOVL7;ESYT3;SPTSSA;KDSR;SMPD1;GM2A;CLN8;ARSA;ORMDL2;CERS2;PSAP;GLTP;SPHK2
prerank,gland development (GO:0048732),-0.3061454601886294,-1.1405139580540586,0.21454545454545454,0.6246926406174248,1.0,20/59,19.16%,DKK3;CAV1;EZR;ARID5B;WNT4;ANXA1;COBL;GLI2;SIX1;TBX1;LSR;CITED2;MDK;STRA6;MET;EPHB3;MSN;HOXD3;WNT11;TGFBR3
prerank,T cell mediated immunity (GO:0002456),-0.4494450644704818,-1.140401374532292,0.3064516129032258,0.6240712192520693,1.0,5/13,20.48%,CD55;CTSH;GNL1;BTN3A3;CD46
prerank,positive regulation of mRNA processing (GO:0050685),0.4372611008093791,1.1396663793111617,0.2977346278317152,0.9064252788911857,1.0,5/21,11.46%,TRA2B;PRDX6;CELF4;DHX36;SNW1
prerank,B cell receptor signaling pathway (GO:0050853),-0.3418934288558464,-1.1394811930883497,0.2535211267605634,0.6253880355969251,1.0,9/32,18.49%,MEF2C;CD38;BMX;BAX;PIK3CD;PLCG2;TEC;SH2B2;BLNK
prerank,regulation of receptor binding (GO:1900120),-0.48351861816393016,-1.1391362302860781,0.3173076923076923,0.6254190094136977,1.0,5/10,17.14%,PTPRF;B2M;ATP2A3;GREM2;HFE
prerank,brain morphogenesis (GO:0048854),0.489806537246931,1.1389366655684487,0.30866425992779783,0.9076169513050002,1.0,2/12,1.89%,CTNNA2;PTEN
prerank,homologous chromosome segregation (GO:0045143),0.4496788043272665,1.1388801657696381,0.2972972972972973,0.9064233545934666,1.0,4/20,12.24%,SGO1;MEIKIN;ZCWPW1;CENPC
prerank,focal adhesion assembly (GO:0048041),-0.3825052758986237,-1.1386624085906787,0.2849604221635884,0.6256662069104129,1.0,4/21,2.45%,SORBS1;ACTN2;PTPRK;THSD1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3484452892642527,1.1385978954312899,0.25885558583106266,0.9061078389961271,1.0,15/72,15.08%,COPS3;ERCC1;ISY1;LIG3;POLK;ERCC5;RPA1;ERCC4;UVSSA;RFC3;GTF2H3;XRCC1;COPS4;ERCC2;GTF2H1
prerank,regulation of neuron projection arborization (GO:0150011),0.4747682147350879,1.1380507517414928,0.32006920415224915,0.9066117181117601,1.0,8/15,20.74%,WNT5A;GRIP1;DLG4;NTNG2;NTNG1;DVL3;MAP3K13;DVL2
prerank,positive regulation of protein modification process (GO:0031401),-0.249425685265678,-1.1380131408501741,0.13846153846153847,0.6264957424452854,1.0,50/203,16.11%,TRABD2B;ROCK2;TEK;LEPR;PECAM1;FNIP1;EGFR;KRAS;APP;CSNK1D;LIMCH1;KDR;NIBAN1;CCND2;INSR;FAS;VEGFD;RAC1;DAB2;VEGFC;MAVS;ACE;TFRC;PPP1R7;EFNA5;RAMP1;CARD14;CALM1;TBX1;CCN1;PPP1R16B;FGF1;RALBP1;HDAC3;ITGB3;CAMTA1;RALB;TMEM119;FLT4;NOS1AP;PPIA;UBE2N;CCND1;CDH5;KAT5;RAPGEF3;SMPD1;PRKCD;SIRT1;GPER1
prerank,establishment of protein localization to membrane (GO:0090150),-0.2927994799118478,-1.1379595292106701,0.18681318681318682,0.6257674388546942,1.0,14/66,12.72%,SYNE3;EGFR;AFDN;VPS37A;NACA;PARD3;ZDHHC21;VPS37B;ARL6;FRMPD1;MYO1C;RAB3IP;BID;ZDHHC14
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3443074727655576,-1.137521705947415,0.24166666666666667,0.6260358620949258,1.0,11/32,16.30%,DDX5;PPP1R13B;JMY;HIPK1;DYRK2;MYBBP1A;HIPK2;BOK;HINT1;SIRT1;TMEM109
prerank,regulation of protein kinase activity (GO:0045859),-0.276353497018743,-1.1373430438505967,0.20540540540540542,0.6256127881995562,1.0,30/106,17.97%,PRKAG2;PLCE1;RAPGEF2;PPM1E;TRIB2;DEPTOR;IQGAP1;RAP1A;UVRAG;DVL1;CEP85;PPM1F;CCN1;LRP6;ITGB1BP1;YWHAG;HSPB1;ALS2;CEACAM1;TAB2;PTK2B;PPIA;RAP2C;CDKN1A;TRIM27;SIRT1;PAK2;AKT1;RAP2B;LCP2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.45321233891208035,-1.137300219663953,0.3014018691588785,0.6248276869441007,1.0,7/12,36.41%,GCLC;BDH2;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,cardiac muscle cell differentiation (GO:0055007),-0.388311267410657,-1.1371592866153764,0.27249357326478146,0.6243133377471884,1.0,7/21,16.48%,MEF2C;CXADR;SIK1;ACVR1;MYH11;CBY1;MYOCD
prerank,regulation of cytoskeleton organization (GO:0051493),-0.27093196344739984,-1.1371133185377809,0.22624434389140272,0.6235566456712157,1.0,25/108,9.47%,PHLDB2;CLIC4;TJP1;RHOBTB1;ROCK2;SORBS3;EZR;DIAPH1;F11R;RICTOR;IQGAP1;HIP1R;RHOQ;RHOBTB2;RAC1;PRKAA2;ARHGAP17;EFNA5;PDGFA;GSK3B;RHOC;MAPT;TRIM36;PLXNB1;ARHGAP18
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4084131139798284,1.1369793270656565,0.27899686520376177,0.908829216733425,1.0,10/32,23.10%,LPIN3;CHAT;CHKA;STARD10;LPIN2;CSNK2A2;SLC44A1;PCYT1A;ABHD3;SLC44A5
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4341750297089425,1.1368734201875128,0.30250783699059564,0.9078293526401928,1.0,6/23,12.54%,PPARA;PFKFB1;CBFA2T3;GCK;ERFE;GSK3A
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.23495021442291153,-1.1365718313584547,0.015151515151515152,0.6240279994550113,1.0,108/341,23.64%,FBXL7;WWP1;NPLOC4;VPS37A;RNF146;UBE2G1;ASB2;PSMC6;SQSTM1;RNF43;RNF185;PELI1;PSMD9;WWP2;ARIH1;CDC23;TBL1X;UBE2D3;PSMF1;PSMB7;TRIP12;TRIM25;ANAPC10;PTTG1;TOLLIP;VPS37B;IFI27;RNF8;VCP;UBE2H;MIB1;SMURF2;PCBP2;UBA6;KCTD21;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;KLHL20;RNF11;GID8;RNF144B;RNF114;SPSB4;RCHY1;KCTD6;PSMA3;PSMA6;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;PSMB6;KAT5;UCHL1;ELOC;PSMC1;SIAH3;UBE2L6;SIRT1;PSMB10;HECTD3;TGFB1I1;FBXL14;NEDD8;SIAH2;CUL3;CLOCK;ANAPC16;ANAPC11;USP9X;ANAPC15;PPP1R11;RAD23B;BUB3;CHFR;ANKIB1;PSME2;WDR91;KLHL25;KCTD2;FZR1;CDC34;TNFAIP3;MAEA;KLHL3;ANAPC2;PSMC3;RNF166;KBTBD7;RNF5;VPS28;TNFAIP1;RFFL;FBXO22;MVB12B;ZFAND2B;PSMA8;ADRM1;FBXO10;SMURF1;RLIM;RNF111
prerank,endochondral bone morphogenesis (GO:0060350),0.5139380146786445,1.1363818467839117,0.31464737793851716,0.9080922745048242,1.0,1/11,0.07%,COL13A1
prerank,mitotic spindle assembly (GO:0090307),0.38708119274047337,1.1363531525504595,0.2850877192982456,0.9068231398649299,1.0,20/42,25.51%,CCDC61;LSM14A;AAAS;GOLGA2;CEP192;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;RHOA;KPNB1;SMC3;KIF11;KIF23;TPX2;TOGARAM1;STAG1;KIFC1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5049855479546675,1.136328368989635,0.3049645390070922,0.9055797730211093,1.0,4/11,15.73%,TLR6;CYBA;LYN;TIRAP
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3977907760807522,-1.1361956672823192,0.2702702702702703,0.6241160110891257,1.0,7/19,14.15%,CSGALNACT1;NDST1;NDST3;EXT1;UGDH;GLCE;HS3ST3B1
prerank,mRNA splice site selection (GO:0006376),0.4052722690252419,1.1361046087672722,0.30243161094224924,0.905068587931781,1.0,13/30,22.83%,ISY1;NOL3;CELF4;SLU7;LUC7L2;SRSF10;SRSF9;SF3A3;SRSF6;PRPF39;LUC7L3;SRSF12;CELF6
prerank,prostaglandin biosynthetic process (GO:0001516),-0.39883892357944084,-1.135940680757746,0.3092269326683292,0.6239506075365556,1.0,4/18,4.08%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,fluid transport (GO:0042044),-0.4608486665321207,-1.1358921723058415,0.29439252336448596,0.6232211603584256,1.0,8/12,53.64%,PDPN;SLC26A6;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3111668962392939,1.1355922992159646,0.22916666666666666,0.9055210559054268,1.0,27/199,9.97%,TBX18;PLCL1;HOXC10;ALDH1A1;SPRY1;PTEN;PTPRR;NR1H4;NOVA1;MCC;GJA1;NR1H2;SPRED1;LOXL2;ZNF423;IL17RD;TRPV3;SPX;SRF;DOCK7;RPS6KA6;PTPRO;CIDEA;SPRED2;TLR4;BRCA2;NRDC
prerank,ceramide catabolic process (GO:0046514),-0.43615764839653026,-1.1354768753379463,0.27294685990338163,0.623448264828264,1.0,8/14,28.37%,ACER2;ACER3;HEXB;NAGA;GM2A;ASAH1;ASAH2;NEU1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4649141916469162,1.1353999777083956,0.33172302737520126,0.9048337538058967,1.0,5/15,11.17%,HRG;SEMA5A;PRKD1;LGMN;P2RX4
prerank,regulation of TORC1 signaling (GO:1903432),-0.3421262323419005,-1.135015080995901,0.25142857142857145,0.6237748904559711,1.0,11/33,19.48%,RNF152;SIK3;SESN1;LAMTOR5;RRAGC;CLEC16A;PIP4P1;ATM;GPR137;SEH1L;RRAGB
prerank,protein import into peroxisome membrane (GO:0045046),0.43120703555790985,1.1349153390038922,0.28802588996763756,0.9051064888699781,1.0,10/22,23.26%,ABCD2;PEX2;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;GDAP1;FIS1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.29410395915560245,-1.1348508043303567,0.22105263157894736,0.6233125625201784,1.0,19/65,18.27%,AFAP1L2;PTPRJ;EGFR;FER;PTPN3;HIP1R;CDC42;ERRFI1;MVP;ITGA1;PTPN2;CCDC88A;CEACAM1;RHBDF2;HIP1;GRB2;GPER1;AKT1;EGF
prerank,cellular response to virus (GO:0098586),0.4096063715603729,1.1346639592492114,0.2981366459627329,0.9045938871204635,1.0,9/30,19.67%,CXCL10;GBF1;FMR1;IL12A;MAPK11;LGALS9;RRP1B;HIF1A;GSDME
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.40200426979978127,1.1344106771973397,0.2876712328767123,0.9041661351270477,1.0,12/31,22.09%,DNAJC19;PEX2;PEX7;TIMM44;DNAJC15;PAM16;PEX12;PEX14;PEX6;GRPEL1;TIMM21;CHCHD4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4546230004543215,1.134059321223867,0.3175438596491228,0.9040686620746315,1.0,8/17,25.07%,CTNNA2;FCHSD2;WASF3;ARFIP1;CYFIP1;GMFB;ARFIP2;ABI2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4084109300031675,-1.1334870467116545,0.2697201017811705,0.6259562710250555,1.0,3/18,4.82%,IGF1;IL18;IGFBP2
prerank,histone deacetylation (GO:0016575),0.38039211776118287,1.133152119164847,0.27729885057471265,0.9058966660762265,1.0,8/43,7.97%,MIER2;HDAC1;MORF4L1;REST;SIRT6;BRMS1L;BRMS1;PER2
prerank,cellular response to hypoxia (GO:0071456),0.32212660316174674,1.1328459632059564,0.2440251572327044,0.905660355869255,1.0,35/126,19.13%,RORA;CPEB1;HIF1AN;PSMD1;TBL2;EPAS1;PSMD10;EGLN2;HP1BP3;PSMA5;PSMB5;MDM4;TWIST1;PINK1;MTOR;AK4;BMP7;PSMC4;KCND2;TP53;PSMA4;PSMC5;PTGIS;FAM162A;PSMB9;SCN2A;MYC;PSMA7;PSMD14;ADAM8;SUV39H2;PSMA2;HIF1A;PSMD11;ARNT
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.32685410483697813,-1.132802655766943,0.2245508982035928,0.6268008187071256,1.0,9/39,10.62%,SLIT2;NRP1;TIE1;KDR;RASIP1;GLI2;SIX1;LRP6;NPNT
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.38551243519282297,-1.1327724395795933,0.29333333333333333,0.6260168174206887,1.0,10/20,28.60%,ROCK2;RHOQ;RAB13;FHOD1;LLGL2;DLG1;STRIP1;IKBKB;FMNL1;NCKAP1L
prerank,cytosolic calcium ion transport (GO:0060401),-0.3551469450576213,-1.1321828701337777,0.27298050139275765,0.6266000032086927,1.0,9/28,15.71%,CACNA1C;SLC35G1;ATP2B1;MICU1;MCUB;SMDT1;JPH1;ATP2A3;JPH2
prerank,modification-dependent protein catabolic process (GO:0019941),-0.25192572030193755,-1.1316779197374642,0.140625,0.6270325923502739,1.0,67/193,23.97%,FBXL7;NPLOC4;RNF146;UBE2G1;ASB2;SQSTM1;RNF43;RNF185;PSMD9;ARIH1;CDC23;PSMF1;TRIP12;TRIM25;ANAPC10;PTTG1;TOLLIP;UBB;RNF8;UBE2H;MIB1;SMURF2;UBA6;KCTD21;RC3H1;UBE2A;RNF125;RNF11;RNF144B;RNF114;SPSB4;RCHY1;KCTD6;FBXL4;AMFR;ELOC;UBE2L6;FBXL14;NEDD8;SIAH2;CUL3;ANAPC16;ISG15;ANAPC11;UBC;ANAPC15;PPP1R11;BUB3;CHFR;ANKIB1;WDR91;KLHL25;FZR1;CDC34;KLHL3;ANAPC2;RNF166;RNF5;RFFL;FBXO22;UBA52;ADRM1;FBXO10;SMURF1;RLIM;RNF111;RNF20
prerank,regulation of keratinocyte proliferation (GO:0010837),0.42992086654328654,1.131547461902947,0.3305785123966942,0.9088903707262369,1.0,7/22,17.43%,CASK;CDH3;PRKD1;MED1;AREG;FGFR2;SRSF6
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.39430465076299953,1.1315257407358241,0.283987915407855,0.9076576384726105,1.0,10/40,15.90%,CCDC22;PTEN;GLMN;PDCL3;PTK2;COMMD1;AXIN1;CLU;ARAF;CSNK2A2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.31813760351446235,-1.1313907970607784,0.2616822429906542,0.6268893889867975,1.0,8/46,3.64%,IGF1;FOXP1;OGN;IL18;THBS1;IGFBP5;IGFBP3;PRKDC
prerank,cell differentiation in spinal cord (GO:0021515),0.5072403074122432,1.1312125964572808,0.30111524163568776,0.9073892892853719,1.0,2/10,4.52%,MDGA2;SOX6
prerank,regulation of phospholipid metabolic process (GO:1903725),0.5125098618942387,1.1308115117735789,0.3357142857142857,0.9074212113422072,1.0,3/10,6.30%,DNAJC19;MTMR4;MTMR1
prerank,positive regulation of telomere capping (GO:1904355),-0.4070453860647171,-1.1294870996504907,0.29292929292929293,0.6306863847555017,1.0,5/17,14.25%,TNKS2;NEK7;MAP2K7;RTEL1;MAP3K4
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.4343361013188452,-1.129379381898222,0.31678486997635935,0.6300951423927228,1.0,3/13,6.45%,DDO;ACOT8;GOT2
prerank,regulation of viral release from host cell (GO:1902186),-0.37669226069165584,-1.1281410168596926,0.2889447236180904,0.6323717900403925,1.0,5/21,6.69%,CHMP2B;TRIM25;TRIM5;TRIM11;VPS37B
prerank,Rho protein signal transduction (GO:0007266),0.3648326367742127,1.1281103806680446,0.29213483146067415,0.9154425218481034,1.0,19/53,19.37%,ARHGEF3;RHOJ;ARHGAP6;NGFR;CTNNAL1;LIMK1;COL1A2;EPS8L1;ARHGAP4;ARHGAP1;RTKN;CDC42EP1;CDC42EP4;ADRA2A;RHOG;ARHGAP29;CDC42EP3;RHOA;PLEKHG5
prerank,regulation of ion transmembrane transport (GO:0034765),-0.33473708583773565,-1.127998769847273,0.26744186046511625,0.6318682959256295,1.0,8/33,14.64%,ANO6;WWP2;KCNJ13;WNK1;KCNJ2;KCNQ1;KCNJ12;P2RX7
prerank,cartilage development (GO:0051216),-0.31639205910818363,-1.1272592357555589,0.24918032786885247,0.6329473948195289,1.0,10/49,7.33%,NFIB;SOX5;ITGB8;MEF2C;WNT5B;OSR1;RUNX1;CCN3;SULF2;CD44
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2509210932887602,-1.1264650748997074,0.14634146341463414,0.6341812767634595,1.0,49/166,19.47%,SORBS1;IGF1;VIM;LARP4;EGFR;THBS1;KLF4;LPGAT1;ELAVL1;PRKDC;NIBAN1;INSR;SAMD4A;GIPC1;LARP4B;RPL5;GLI2;KLF2;SOX4;SCARB1;SMAD3;DYRK2;PYM1;STARD4;PTPN2;CPEB3;RPL26;EIF3D;RPS4X;PTH1R;PCNA;STN1;ASS1;DDAH1;MFSD2A;NOS1AP;ZNF205;PTGS2;EDN1;SIRT1;EIF3E;EPM2AIP1;ERBB2;AKT1;ABCB10;EGF;HGF;RGCC;NPM1
prerank,endocrine system development (GO:0035270),-0.38761737962552,-1.1260954626660378,0.319693094629156,0.634253253579647,1.0,9/21,18.77%,DKK3;WNT4;GLI2;SIX1;TBX1;MDK;STRA6;HOXD3;WNT11
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4618898842467841,-1.1260018026746061,0.3188405797101449,0.6336501445646694,1.0,5/12,15.09%,CYP26B1;DHRS3;KLF2;TRIM16;EZH2
prerank,activation of protein kinase B activity (GO:0032148),0.40594000012543546,1.1259267543881037,0.304,0.9218259304282352,1.0,7/29,9.11%,NTRK3;NRG1;WNT5A;PDPK1;PRR5;PINK1;MTOR
prerank,atrioventricular valve development (GO:0003171),-0.43658604802149564,-1.1258304098384857,0.3195402298850575,0.6331635409491425,1.0,5/14,11.63%,BMPR2;NOTCH1;TGFB2;ACVR1;HEYL
prerank,carbohydrate transport (GO:0008643),-0.4625936395267267,-1.1253012390440358,0.3169164882226981,0.633683623812431,1.0,9/11,46.94%,SLC26A6;AQP11;SLC2A2;SLC23A2;SLC23A1;AQP1;SLC50A1;SLC2A5;AQP9
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.45186560681365473,-1.1252303501289742,0.30917874396135264,0.6330214184397976,1.0,5/12,26.94%,TMEFF2;AP2A1;EDN1;SELENOS;TAF7
prerank,cellular response to osmotic stress (GO:0071470),-0.37634532844926083,-1.1251893712722882,0.2716049382716049,0.6322466155984783,1.0,5/21,13.30%,MYLK;YBX3;LRRC8D;CAB39;TRPV4
prerank,regulation of intracellular protein transport (GO:0033157),-0.3432997835118301,-1.1250333091646958,0.26865671641791045,0.631803191029898,1.0,10/32,17.60%,PTPN14;RUFY3;NDEL1;IFI27;PRR5L;CEP290;PTPN1;OAZ1;BCAS3;OAZ2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4670764736604294,1.1249430287477429,0.3361774744027304,0.9239227391762553,1.0,6/15,17.33%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,regulation of wound healing (GO:0061041),-0.32495355067995774,-1.1247246739338828,0.26245847176079734,0.6318072398346306,1.0,11/42,10.44%,CAV1;OCLN;MYLK;ITGB1;ACTG1;VTN;KANK1;ANXA1;CD109;SERPINE1;EPHB2
prerank,endothelial cell proliferation (GO:0001935),-0.41441761728393367,-1.1245360708452647,0.2819277108433735,0.6314895909106372,1.0,6/17,8.29%,TEK;BMPER;BMPR2;CD34;ACVRL1;ITGB1BP1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.43023824601413085,1.1245325915947042,0.3126934984520124,0.9239721140130346,1.0,7/25,12.02%,TRA2B;GEMIN2;BCAS2;MPHOSPH10;SLU7;DBR1;SRSF10
prerank,regulation of protein autophosphorylation (GO:0031952),0.3932032420128857,1.1237716940975073,0.31610044313146235,0.9252622685251751,1.0,2/36,0.66%,ENPP1;EPHA7
prerank,protein modification process (GO:0036211),-0.2814591223549077,-1.123750663412312,0.22140221402214022,0.6327255205324991,1.0,31/76,27.55%,ST3GAL6;ST8SIA4;CPE;PRKDC;WWP2;UBE2D3;ST3GAL1;FBXL2;MANBA;ST8SIA2;MMP15;CSNK1G3;USP25;PARP4;UBE2L6;NEDD8;YES1;QPCT;MCRS1;CDC34;ICMT;FBXO22;UBA52;PHEX;FBXW2;PARP1;BAP1;ADPRH;NAGPA;PHKA2;RABGGTA
prerank,peptide metabolic process (GO:0006518),-0.28687652138849884,-1.1233875850313166,0.22807017543859648,0.6328018311182886,1.0,29/75,30.40%,AEBP1;CPE;CPD;ERAP1;ACE;SPCS2;DMD;GPX1;SEC11C;ETHE1;CLN5;FURIN;GSTA4;APEH;PCSK5;GSTT1;TRHDE;ABCB9;GSTM5;MME;BACE2;TPP1;PSEN2;GGT1;CARNMT1;THOP1;GSTK1;SPPL3;CPZ
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4149231043908084,1.1233183312638202,0.3262642740619902,0.9255108414215172,1.0,3/23,4.06%,TXK;JAK1;NR1H2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.364660844251873,1.1231624363419987,0.2829912023460411,0.9247273729452716,1.0,9/52,6.24%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,response to amyloid-beta (GO:1904645),0.3704034736425935,1.1230933538227612,0.2913616398243045,0.9236338283462402,1.0,11/44,11.12%,LRP1;GJA1;NGFR;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;GRM5;FYN
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.27984120899527976,-1.122775932068877,0.2145922746781116,0.6334219282745146,1.0,14/79,6.24%,CRIM1;SMAD6;BMPER;SLIT2;LEMD3;NBL1;THBS1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SULF2;EPN2
prerank,negative regulation of hippo signaling (GO:0035331),-0.45949970014629077,-1.122751762227578,0.32662192393736017,0.6326272138179405,1.0,5/12,16.76%,MAPK14;DLG5;AJUBA;MARK3;VGLL4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.33672379953704895,-1.1224665127352635,0.26047904191616766,0.6325053083915355,1.0,11/37,16.15%,PHLDB2;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;MAPRE2;CYLD;BICD2;PRKAA1
prerank,regulation of dendritic spine development (GO:0060998),-0.38834282866246106,-1.1223177357160263,0.31773399014778325,0.6320214189068512,1.0,7/19,11.77%,MEF2C;SHANK3;APOE;SHANK1;CAMK2B;CPEB3;DLG5
prerank,regulation of actin filament polymerization (GO:0030833),-0.2909696196460118,-1.1222816196320646,0.2425531914893617,0.6312566671946594,1.0,17/69,15.54%,BAIAP2L1;SLIT2;FER;ESAM;KANK3;HIP1R;KANK1;NCK1;SSH1;ARHGAP18;COTL1;ARHGAP28;LMOD1;PTK2B;PLEKHG2;BAIAP2;PRKCD
prerank,bone development (GO:0060348),-0.31715829602840695,-1.1217809646989085,0.273015873015873,0.631655890722222,1.0,8/39,7.73%,RANBP3L;CYP26B1;GNAS;RPL13;SKI;SULF2;SH3PXD2B;LRP6
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.49965183302883476,1.1217328737227852,0.34111310592459604,0.9269900192012067,1.0,3/11,5.40%,GHR;PIK3R1;IRS1
prerank,negative regulation of protein transport (GO:0051224),-0.3598340452540994,-1.1209310027660961,0.28940568475452194,0.6329628187714386,1.0,7/25,18.81%,WWP2;PPM1F;APOE;PKDCC;RHBDF2;CYP51A1;SNX3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4598913475239447,-1.1205679094771193,0.32891832229580575,0.6330429583179452,1.0,2/10,1.78%,ROCK2;IL18
prerank,response to thyroid hormone (GO:0097066),-0.429479290401698,-1.1204888893876612,0.31220657276995306,0.6324261998179501,1.0,5/13,16.96%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.44979325021434435,1.120101681642081,0.3288590604026846,0.9314534776310066,1.0,5/17,15.28%,ATP1A2;ATP1A3;BMP7;MED1;AR
prerank,cell-matrix adhesion (GO:0007160),0.3256087022123478,1.1199765377744835,0.28608923884514437,0.9305660568108032,1.0,12/95,7.55%,COL13A1;DLC1;ITGA11;ITGA8;PEAK1;ITGAV;ITGA3;ITGB5;SGCE;ACTN1;ADAMTS12;PPFIA2
prerank,negative regulation of endocytosis (GO:0045806),-0.35953585003237215,-1.1194999986577643,0.2830188679245283,0.634157204606607,1.0,4/24,5.15%,PICALM;CAV1;MCTP1;RAC1
prerank,potassium ion homeostasis (GO:0055075),0.4183947955255046,1.1193948707468395,0.31746031746031744,0.9312837928433996,1.0,4/23,5.33%,ATP1A2;SLC12A6;ATP1A3;KCNMA1
prerank,autonomic nervous system development (GO:0048483),-0.4127884177218411,-1.1193344911085592,0.31865284974093266,0.6337826439026414,1.0,4/17,10.02%,FN1;NRP1;SOX4;PHACTR4
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.38704677410373456,-1.1189751227454319,0.2918781725888325,0.6338629153472524,1.0,13/19,38.38%,DRG1;CHMP2B;CHMP4B;PDCD6IP;CHMP1A;CHMP4C;HSPA1A;CHMP2A;HSPA1B;TPR;PLK1;HNRNPU;CHMP3
prerank,response to retinoic acid (GO:0032526),-0.2938144216781321,-1.118852771565591,0.26171875,0.6333370153099181,1.0,16/59,15.29%,WNT5B;ACER2;WNT9A;RBP4;RXRA;FZD4;FZD7;TBX1;WNT6;TRIM16;CTSH;RET;ATM;GATA6;PTK2B;CREB1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4054869383967383,1.118827734165191,0.32171156893819336,0.9319035779969636,1.0,8/29,11.21%,AGO4;SPOUT1;ZC3H7B;LIN28B;HNRNPA2B1;MRPL44;SRRT;AGO3
prerank,in utero embryonic development (GO:0001701),0.4133658660403763,1.118151775927367,0.3291139240506329,0.9328971567707112,1.0,7/25,18.02%,CHD7;PTPRR;TGFBR1;IGF2;ARNT2;FGFR2;BMP2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4422727814251898,-1.118144191961965,0.3261904761904762,0.6343344197761627,1.0,5/12,13.00%,HDAC4;NOTCH1;CCN3;HDAC3;TMEM119
prerank,regulation of viral transcription (GO:0046782),-0.32979832679101667,-1.1180620664856982,0.26865671641791045,0.6336798980362045,1.0,17/39,29.49%,TRIM11;IFITM3;TRIM14;POLR2B;POLR2H;POLR2G;POLR2C;TRIM27;UBP1;CDK9;NELFCD;HEXIM1;GTF2F2;CTDP1;POLR2I;POLR2K;MID2
prerank,heterochromatin organization (GO:0070828),-0.41428055237655936,-1.1177160740758807,0.3211009174311927,0.633732075119069,1.0,6/14,16.93%,MECOM;PRDM16;SMCHD1;SIRT1;SNAI1;BAHD1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4649769751513379,1.117319679863464,0.3173758865248227,0.9344727952219171,1.0,3/13,7.03%,GPR37L1;LRRK2;PYCR1
prerank,neuromuscular process (GO:0050905),0.4469360765896956,1.1172118757074798,0.31960461285008235,0.9335328346706302,1.0,2/16,3.00%,MYCBP2;NRXN1
prerank,retinoic acid metabolic process (GO:0042573),-0.41498414006392054,-1.117190933484501,0.31116389548693585,0.6342039269175932,1.0,2/14,1.57%,ALDH1A2;CYP26B1
prerank,steroid metabolic process (GO:0008202),0.34603808135155245,1.116832013768544,0.2941952506596306,0.9335131210367941,1.0,2/72,0.29%,HSD11B1;CYP7B1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.31572436833988426,-1.1167444045779094,0.2551928783382789,0.6345211890510575,1.0,16/47,20.22%,APP;KLF4;NFKB1;VPS35;APOE;RPL10;SSH1;TCOF1;NFKBIA;EIF2B4;NOLC1;AGTR1;EDN1;AKT1;WDR91;AGT
prerank,positive regulation of MAPK cascade (GO:0043410),0.29689134353536417,1.1166144374276576,0.23937360178970918,0.932961758478218,1.0,33/245,10.90%,ROR1;PDGFRA;NTRK3;IL34;XCL1;ROR2;EDN3;SLC30A10;NTRK2;CD40;ERBB4;C5AR1;P2RY1;FGFR1;GPR37L1;GCNT2;HTR2B;PTPN22;CCL15;LRRK2;GLIPR2;NECAB2;GPR183;PRKCA;SOX2;HTR2C;TENM1;MAP2K1;IRAK1;LPAR1;EIF2AK2;CCL25;PYCARD
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3401170859310884,-1.1165269271076401,0.28059701492537314,0.6342185147461363,1.0,17/36,27.52%,ATR;ATM;CDC5L;NBN;CLOCK;DONSON;SETMAR;HUS1;E2F1;PRPF19;ATRIP;CDC45;HINFP;CHEK2;BRIP1;CHEK1;RHNO1
prerank,prostaglandin metabolic process (GO:0006693),-0.3568703310532656,-1.1161545844720868,0.3022598870056497,0.6342892360400397,1.0,4/26,4.08%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,cellular response to type I interferon (GO:0071357),-0.3215198852276221,-1.1159057161929564,0.25507246376811593,0.6332519558976515,1.0,10/41,9.69%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IRF1;IFITM1
prerank,type I interferon signaling pathway (GO:0060337),-0.3215198852276221,-1.1159057161929564,0.25507246376811593,0.6332519558976515,1.0,10/41,9.69%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IRF1;IFITM1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2813408638293157,-1.1157396781793114,0.2235294117647059,0.6328552814111724,1.0,29/74,23.30%,RBPJ;PSMC6;PSMD9;NOTCH1;EGLN3;PSMF1;HIF3A;PSMB7;UBB;PSMD8;CITED2;PSMD12;VHL;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;ELOC;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;PSMA8;STOX1
prerank,negative regulation of heart contraction (GO:0045822),0.5013561988569982,1.1157320750909137,0.33276450511945393,0.9346283687894261,1.0,2/11,6.45%,ATP1A2;SPX
prerank,mitochondrial protein processing (GO:0034982),0.5024087727624643,1.1155957816514204,0.31316725978647686,0.9337798317545811,1.0,4/11,17.56%,OMA1;IMMP2L;PMPCA;IMMP1L
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.46792083135990803,1.1150337888252726,0.3396551724137931,0.9344850973574699,1.0,5/15,11.47%,EDA;HDAC1;ANKRD11;AMELX;MSX1
prerank,regulation of DNA repair (GO:0006282),-0.3098607123280341,-1.114846201130184,0.2884012539184953,0.6344148907499848,1.0,12/44,17.83%,EYA2;EYA1;EGFR;EYA4;TRIP12;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;SIRT1;CDK9
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.43636734070673,-1.1143814622454498,0.3080459770114943,0.6347580788573903,1.0,7/13,25.13%,NBL1;FSTL1;GREM2;CHRDL1;CD46;NRROS;GREM1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3574571686430919,-1.1141635357442745,0.2869318181818182,0.6344885278410047,1.0,3/26,0.60%,EPHA4;PICALM;ROCK2
prerank,phosphorylation (GO:0016310),-0.22670892746829002,-1.1137862233717162,0.10638297872340426,0.6345985609685122,1.0,101/385,19.18%,PRKAG2;DAPK1;MAP3K1;ROCK2;PRKCH;MARK1;ERG;DCLK1;TRIB2;FER;APP;BMPR2;CSNK1D;MARK4;NEK6;IGFBP3;CAMK2D;PRKDC;MAP3K5;DGKH;INSR;TOP1;TGFB2;SIK3;MINK1;WNK4;HK1;PRKAA2;TLK1;MAPK9;CDK6;ADAM10;CDK17;SNRK;WNK1;HIPK3;TOLLIP;PRAG1;NRBP2;SIK1;PGK1;BMX;GSK3B;HIPK1;ACVR1;CDC42BPB;ACVRL1;FNIP2;TLK2;DGKG;NEK7;STK38L;DYRK2;RPS6KA5;LIPE;CDK19;PIK3CB;PIK3CD;GNPTAB;CAMK2B;EPHB2;STK19;CDKL2;RET;FASTK;SRPK1;DGKZ;PRKCZ;HIPK2;PRKAG3;ATM;BCR;PRKG1;PTK2B;RNASEL;STK25;TBCK;STK17B;CDC42BPG;CREB1;ERN1;MARK3;PRKCD;TEC;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;AATK;ACVR2B;ERBB2;CDK9;AKT1;NUAK2;CSNK1A1;PRKG2;WNT11;VRK2;MARK2;MAP4K3
prerank,regulation of phosphatase activity (GO:0010921),0.41858438592131464,1.113710200445134,0.32189542483660133,0.9377986545123739,1.0,9/24,18.02%,GPATCH2;PPP6R2;PTPA;PPP1R26;HSP90B1;ZCCHC9;TSC1;PPP6R3;BMP2
prerank,regulation of myelination (GO:0031641),0.4140974202180953,1.1136908278315054,0.3161397670549085,0.9365428364245926,1.0,5/25,13.88%,PTN;TENM4;LGI4;TNFRSF21;MYRF
prerank,cation transport (GO:0006812),-0.24932828521672631,-1.1136573776159568,0.15942028985507245,0.6340900012264735,1.0,25/167,12.29%,TRPM3;TRPM6;SLC47A1;ANO6;PIEZO2;SLC8A3;KCNK5;SLC6A6;ANO1;SLC9B2;SLC22A4;KCNJ13;KCNQ4;SLC7A1;SLC3A2;SLC41A1;SLC22A18;SLC38A5;KCNK9;KCNJ2;SCN7A;SLC6A17;TRPC6;SLC1A1;KCNJ12
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4051469768156397,1.1134899467059833,0.29337539432176657,0.9359035903650047,1.0,8/26,17.33%,ADCY5;GPLD1;NR1H4;ADCY8;PPP3CB;EPHA5;BRSK2;ADRA2A
prerank,positive regulation of cytokine production (GO:0001819),0.29319890102889024,1.1134081168199923,0.23725055432372505,0.934867012700595,1.0,34/292,10.90%,RORA;IL33;SULF1;XCL1;WNT5A;TXK;PLA2R1;CD40;IL16;PDE4B;GLMN;NR1H4;LURAP1;TSLP;SCRIB;SPTBN1;HTR2B;PTPN22;TLR6;SORL1;CD276;DHX58;TLR8;TWIST1;MBP;TLR4;DDX41;KAT2A;CYBA;IRAK1;FGR;EIF2AK2;DHX36;PYCARD
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.4472497000809599,-1.1132880793169386,0.33966745843230406,0.6342388598897337,1.0,3/11,4.00%,PICALM;ACTN2;GOPC
prerank,sensory perception of light stimulus (GO:0050953),0.3323681291961905,1.1132840960733636,0.2805662805662806,0.933964170159585,1.0,7/87,3.76%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,positive regulation of endocytosis (GO:0045807),-0.3102154717455393,-1.1131904911280242,0.2764505119453925,0.633650177429674,1.0,16/45,17.52%,ANO6;VTN;GPC3;DAB2;CDC42;B2M;RAB21;APOE;RAB31;SERPINE1;CD151;HIP1;TOR1A;SMPD1;HFE;HNRNPK
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.336123835537798,-1.1127110872858954,0.2672672672672673,0.6341151932734733,1.0,7/35,7.66%,NR3C2;DDX5;RBFOX2;PPARGC1B;NCOA4;TMF1;WBP2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4629478806980186,-1.1125264160877695,0.3215077605321508,0.6337652660275263,1.0,5/10,19.84%,APOE;ABCA3;ABCB4;PRELID1;DBI
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5062412102939374,1.1123864016093195,0.3327433628318584,0.9331505949790371,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.5062412102939374,1.1123864016093195,0.3327433628318584,0.9331505949790371,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5062412102939374,1.1123864016093195,0.3327433628318584,0.9331505949790371,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,nuclear pore complex assembly (GO:0051292),-0.46711381454829826,-1.1117510190597095,0.35064935064935066,0.6349616355166204,1.0,5/10,21.49%,NUP98;NUP153;TMEM170A;NUP205;RTN4
prerank,renal absorption (GO:0070293),-0.4640242711388601,-1.111561867152604,0.32629107981220656,0.6346546579400263,1.0,6/10,28.60%,GSN;WNK4;KCNQ1;KLHL3;HYAL2;HAS2
prerank,regulation of protein localization to centrosome (GO:1904779),-0.46773612594960523,-1.1113049382825213,0.3441108545034642,0.6344856980225049,1.0,3/10,7.28%,MARK4;APC;GSK3B
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.45858941433807987,1.1112638650894202,0.3388581952117864,0.9343525743006019,1.0,6/15,15.59%,NANOS3;ZFP36L2;DHX36;CNOT1;CNOT7;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.45858941433807987,1.1112638650894202,0.3388581952117864,0.9343525743006019,1.0,6/15,15.59%,NANOS3;ZFP36L2;DHX36;CNOT1;CNOT7;TNRC6B
prerank,positive regulation of cell cycle process (GO:0090068),0.33005995716221703,1.1107139151738963,0.28763440860215056,0.9349164965539984,1.0,13/91,12.42%,SVIL;CDC14B;RXFP3;EDN3;PHIP;FEN1;CDC7;CEP295;GPSM2;WIZ;NUSAP1;USP19;IGF2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.45735512865208355,-1.1104589288004216,0.32505643340857787,0.6357466474306205,1.0,4/11,25.14%,PARP10;PARP9;PARP4;PARP12
prerank,regulation of cytoplasmic translation (GO:2000765),0.46543140219349427,1.109990451880079,0.3435374149659864,0.9361883126953876,1.0,5/14,14.93%,CPEB1;RBM24;FMR1;DHX36;DHX9
prerank,central nervous system neuron differentiation (GO:0021953),0.394091169366361,1.109985957225335,0.3210445468509985,0.9348971237803352,1.0,7/33,14.03%,NTRK2;GRID2;MDGA2;NPY;OPHN1;CBLN1;ATP7A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.4494235382518025,-1.1099683251340307,0.32339449541284404,0.6361799252553344,1.0,5/11,26.23%,ANXA1;RC3H1;SOCS5;SMAD7;JAK3
prerank,acylglycerol metabolic process (GO:0006639),-0.3333770388012345,-1.1095106903951883,0.2616822429906542,0.6364960563194647,1.0,10/37,14.46%,CAV1;DGKH;MGLL;PGS1;APOE;DGKG;ABHD2;LMF1;DGKZ;PLAAT3
prerank,negative regulation by host of viral transcription (GO:0043922),0.4928213254917737,1.1094345757017052,0.34532374100719426,0.9355822947805563,1.0,2/12,4.28%,HDAC1;REST
prerank,"transcription, DNA-templated (GO:0006351)",-0.2413258047816755,-1.1093182178293124,0.14516129032258066,0.6361938418293537,1.0,61/207,24.09%,SOX5;PIR;MLLT3;DDX5;GLIS3;KLF13;TSC22D1;MEF2A;NFKB1;PTMA;ELOA;DDX21;GTF2H5;DRG1;TRIM24;HIPK3;AFF4;SNAPC3;CRCP;RRAGC;UBTF;RBMX;NR4A2;NFYA;MAF;SMARCA5;POLR2B;RPAP1;POLR2H;POLR3G;POLR2G;POLR2C;ELOC;CEBPD;GTF2E2;BTF3;TTF1;GMEB2;MLLT1;PMF1;CDK9;NELFCD;HOXD3;GTF3C6;CREBL2;ZBTB7B;TAF1C;GTF2H4;LEO1;E2F1;POLRMT;POLR1C;NCBP2;POLR3K;GTF3A;TAF2;TWNK;GTF2F2;CTDP1;HSF2BP;PARP1
prerank,base conversion or substitution editing (GO:0016553),0.4918215295731726,1.1092463860583015,0.3469750889679715,0.9349055885045333,1.0,2/11,15.51%,ADARB2;ADAR
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2811863982852609,-1.1090283708234767,0.2222222222222222,0.6361048527233074,1.0,21/71,15.29%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ACER3;SGMS2;CERT1;DEGS2;SPNS2;VAPA;LARGE1;VAPB;ELOVL4;ELOVL7;ST3GAL5;SPTSSA;KDSR;SMPD1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.43571448384524514,-1.108927640741967,0.30900243309002434,0.635571143932912,1.0,4/12,10.59%,ELF1;RUNX1;RC3H1;ELF2
prerank,positive regulation of transport (GO:0051050),0.3355632435017826,1.1088723162479104,0.29770992366412213,0.9349194351461653,1.0,14/85,10.90%,IL15RA;LRP1;MERTK;GPLD1;KMT2A;FMR1;TUB;CDH3;CLIP3;LYAR;CYBA;PLAA;KCTD7;PYCARD
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4783323919531699,-1.1088297534645333,0.33111111111111113,0.6350087496352635,1.0,4/10,24.21%,HDAC6;AOC3;OXA1L;MT3
prerank,epithelial cell differentiation (GO:0030855),0.33275216657783874,1.108807015832324,0.28495339547270304,0.9338679897982302,1.0,9/88,9.06%,SCUBE1;HDAC1;BASP1;ERBB4;SCRIB;CASP6;E2F4;EDF1;GLI1
prerank,male gonad development (GO:0008584),-0.3310909586756139,-1.1086451394652355,0.3005464480874317,0.6346894374589156,1.0,5/34,4.38%,KITLG;CSDE1;TGFB2;WNT4;NCOA4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4017909500685528,-1.1085948055146264,0.2963917525773196,0.6340049815461745,1.0,5/16,27.36%,CLDN5;CLDN12;CLDN11;CLDN10;CLDN1
prerank,monocyte chemotaxis (GO:0002548),0.39480768523870396,1.1079153312822496,0.33384615384615385,0.9356854178994304,1.0,6/32,10.56%,XCL1;MSMP;CCL15;CALCA;PTPRO;CCL25
prerank,muscle tissue development (GO:0060537),-0.436646118876162,-1.1078110555741727,0.3253588516746411,0.6351213641300463,1.0,4/13,14.79%,PGM5;SMO;CSRP2;STRA6
prerank,pancreas development (GO:0031016),0.4810836099885878,1.1076337470627817,0.3487544483985765,0.9353444262664558,1.0,2/12,3.13%,TCF7L2;NPHP3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.39062519192472794,1.1072053847011092,0.32978723404255317,0.9355635363023237,1.0,5/35,5.15%,DLC1;SPRY4;SPRY1;ITGA3;ARHGAP24
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.43536532103462666,1.107119016671094,0.33503401360544216,0.9345707967234379,1.0,4/18,10.50%,NRXN1;CACNG3;RELN;CACNG4
prerank,kinetochore organization (GO:0051383),0.467811974528605,1.1070712522015325,0.36254295532646047,0.9334506318835937,1.0,5/13,15.58%,CENPE;CENPC;CDT1;CENPW;CENPF
prerank,sodium ion transport (GO:0006814),0.3277933859577256,1.1067914257374518,0.27676240208877284,0.9331312707233741,1.0,14/85,13.61%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;CATSPER3;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,regulation of microtubule-based movement (GO:0060632),0.4937659078422796,1.1065416367152405,0.34535104364326374,0.9327282385165832,1.0,3/11,9.67%,NEFH;TTC21B;CCDC65
prerank,tube closure (GO:0060606),0.39076239375290606,1.1062859512487615,0.33182503770739064,0.9322763642826257,1.0,4/31,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,protein localization to membrane (GO:0072657),-0.24499756227050493,-1.1060391233196574,0.2,0.6387554904756004,1.0,35/187,9.21%,TSPAN5;RAPGEF2;ROCK2;ACTN2;CAV1;BSG;SYNE3;LIN7A;RAPGEF6;EZR;SHANK3;CDH1;F11R;CPE;RDX;MAGI2;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;DVL1;PACS1;RAMP1;TTC7B;SH3PXD2B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;FRMPD1;TTC7A
prerank,primary neural tube formation (GO:0014020),0.39365058124102853,1.1059786004225962,0.3424657534246575,0.9320715444916176,1.0,4/30,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,positive regulation of cell death (GO:0010942),0.35305849196278544,1.1056308144938625,0.3047619047619048,0.9319977342293689,1.0,13/59,15.09%,LRP1;SLC6A13;ACOX2;WNT5A;GRIN2B;FOS;LRRK2;C1QA;DAXX;FYN;EIF2S1;RIPK1;CLU
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2732826571698948,-1.1055648008962855,0.250936329588015,0.6391496067330653,1.0,20/79,15.79%,ST3GAL6;IGF1;CSGALNACT1;ST8SIA4;B3GALT1;BMPR2;ST3GAL4;B4GALT5;ST6GALNAC2;CHST11;ST3GAL3;MGAT1;LARGE1;FOXL1;ST8SIA2;B3GALNT1;FUT9;ST3GAL5;ST3GAL2;GCNT1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.2998461963889915,-1.1052322610023173,0.2847457627118644,0.6392178572038482,1.0,17/54,21.80%,RNF152;RNF146;UBE2G1;PELI1;UBE2D3;IFI27;RNF8;UBE2H;UBE2A;AMFR;CUL3;CDC34;TNFAIP3;KLHL3;KBTBD7;RNF5;RFFL
prerank,ESCRT complex disassembly (GO:1904896),-0.4691852544620276,-1.1052227065634386,0.3438202247191011,0.6376302833047118,1.0,5/10,27.10%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),-0.4691852544620276,-1.1052227065634386,0.3438202247191011,0.6376302833047118,1.0,5/10,27.10%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3786982877835813,1.104980072895898,0.31268882175226587,0.9329130152023429,1.0,5/36,5.41%,DCN;HRG;NR2F2;JUP;ADGRB1
prerank,cellular component disassembly (GO:0022411),0.3592037623170049,1.1045434084477856,0.3319559228650138,0.9331138272884466,1.0,2/53,0.41%,SCUBE1;LAMC1
prerank,cellular response to fatty acid (GO:0071398),0.4866811917699665,1.1041393667640862,0.3472222222222222,0.9332196071826179,1.0,2/12,5.40%,NR1H4;IRS1
prerank,embryonic digestive tract development (GO:0048566),0.4481850103806224,1.1034589018704672,0.3427620632279534,0.9342191449395313,1.0,2/18,2.53%,PDGFRA;SALL1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.34763181195041,1.1034449556278516,0.3052486187845304,0.932994491159433,1.0,14/57,13.79%,GRIA3;GRIN2B;CACNG3;GRIA4;GRIA1;DLG3;DLG2;GRIN2A;RELN;CACNG4;SHISA6;DLG4;LRRC7;DLGAP3
prerank,water transport (GO:0006833),-0.4437938655129837,-1.1027174922267367,0.3252212389380531,0.6431551505469586,1.0,8/12,55.32%,PDPN;CFTR;AQP11;AQP1;AQP9;AQP6;AQP7;SLC5A1
prerank,chromatin assembly (GO:0031497),0.3791076432447905,1.102535283457395,0.3075780089153046,0.9347832693720033,1.0,10/38,12.74%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;NOC2L;DAXX;TP53;NAP1L1;SOX9;POLE3
prerank,positive regulation of phosphorylation (GO:0042327),0.2946077476233397,1.102142766133842,0.25112107623318386,0.934863902235,1.0,31/240,10.56%,ROR1;PDGFRA;NTRK3;IL34;ZBTB20;EPHA7;ROR2;MERTK;NTRK2;CD40;ERBB4;EPHB1;PFKFB1;GLMN;P2RY1;FGFR1;ENTPD5;EPHA6;FMR1;DSCAM;CAMKK2;LRRK2;CLIP3;PTK2;PINK1;EPHB6;AXL;RB1CC1;DAXX;EPHA3;WDFY2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4268183539961185,1.102009516966586,0.3274478330658106,0.9340867727200785,1.0,6/20,18.74%,EPAS1;PINK1;DAXX;TGFBR1;DCUN1D5;HIF1A
prerank,positive regulation of cellular process (GO:0048522),0.28240652671363764,1.1018518040709062,0.22657054582904224,0.9333750005578058,1.0,97/565,15.69%,PDGFRA;PTN;COLEC12;NTRK3;IL34;IL15RA;LRP1;ZFHX3;NRG1;MERTK;TMEM102;HOXC10;PTGFR;EDN3;MEIS1;ACOX2;HDAC1;WNT5A;NTRK2;TAF9B;PTEN;PHIP;ERBB4;ITGAV;FLT3LG;FGFR1;ANKLE1;GAB2;MEIS2;TSLP;TIPIN;RYR2;POU3F3;TBX3;FBXO5;TENM4;GCNT2;HTR2B;CDC7;FMR1;TUB;MTPN;IRS1;CDH3;PSMD10;IRS2;ECHDC3;SRF;FXN;LYAR;PTK2;TRPC3;HTR1A;CDK13;PRKCA;CCKBR;GLI1;LGMN;TSPYL5;TLR4;CYBA;CACUL1;SLC25A33;DHX36;PYCARD;POFUT2;RTKN2;NAP1L1;P2RX4;TGFBR1;ACLY;SOX9;IL12A;EXOSC9;CD86;IGF2;FAM98B;CD81;GAREM1;AKAP6;DHPS;MYRF;LYN;DOT1L;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;AREG;AR;GDNF;CNOT7;MYC;N6AMT1;FGFR2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42317756576568144,1.1016243332672435,0.337152209492635,0.9329155145047403,1.0,3/21,3.66%,DCN;BGN;VCAN
prerank,T cell migration (GO:0072678),0.4740318384326172,1.1014591177086261,0.34536082474226804,0.9322563020048499,1.0,4/13,16.96%,CXCL10;GPR183;MYO1G;PIK3CG
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3650744112126642,1.1008031418578337,0.33715925394548063,0.9333024065330073,1.0,9/44,14.06%,SPRY4;SPRY1;DUSP1;PTPN22;SORL1;NF1;BMP7;PDCD4;LYN
prerank,amyloid-beta metabolic process (GO:0050435),-0.4067479482271323,-1.1006882523335333,0.35714285714285715,0.6475792941897627,1.0,7/16,25.69%,ACE;APH1A;APH1B;APEH;MME;BACE2;PSEN2
prerank,receptor metabolic process (GO:0043112),-0.3005383745118527,-1.0998691712681683,0.26640926640926643,0.6487484642202364,1.0,11/53,8.32%,PICALM;CAV1;ITGB1;BECN1;UVRAG;ACKR3;TFRC;RAMP1;SNX25;DNM3;RAB31
prerank,striated muscle tissue development (GO:0014706),-0.33884038317012904,-1.0998180513396716,0.32020997375328086,0.6480767510401516,1.0,7/29,5.87%,MEF2C;CAV1;PGM5;BMPR2;MYL6;RBP4;SIX1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4524745807058637,1.0998084832018657,0.34,0.9354072484642584,1.0,5/16,17.72%,TOP2B;ERCC4;HFM1;EME2;TOP2A
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.4493592034928541,-1.099756907674088,0.3574766355140187,0.6474145015975813,1.0,5/11,22.48%,TGFB2;ACVR1;TGFBR3;TGFBR2;SMAD7
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4688302250768652,-1.0995993588736994,0.3456221198156682,0.6469791951369769,1.0,4/10,23.43%,KLF4;TLE5;MAP2K5;SIGIRR
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3716829401551791,-1.0993124903254996,0.3183023872679045,0.6468786008513249,1.0,7/22,6.94%,IGF1;ROCK2;MEF2A;CAMK2D;NOTCH1;IL6ST;LMCD1
prerank,regulation of NMDA receptor activity (GO:2000310),0.3880578492549871,1.0989243480165887,0.3296875,0.9371678213725135,1.0,10/32,12.92%,GRIA3;GRIN2B;GRIA4;GRIA1;DLG3;DLG2;GRIN2A;RELN;DLG4;LRRC7
prerank,chordate embryonic development (GO:0043009),0.3491087345330147,1.0987964316421206,0.3129445234708393,0.9363553718149497,1.0,5/55,3.03%,CHD7;SULF1;WNT5A;PTPRR;FGFR1
prerank,cellular response to interleukin-7 (GO:0098761),0.4446650209620909,1.0987532550916133,0.358974358974359,0.9339998263639264,1.0,4/17,6.25%,JAK1;TSLP;IRS1;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4446650209620909,1.0987532550916133,0.358974358974359,0.9339998263639264,1.0,4/17,6.25%,JAK1;TSLP;IRS1;IRS2
prerank,regulation of autophagy (GO:0010506),-0.23363145572648789,-1.0980046913919945,0.19083969465648856,0.6494191055102917,1.0,52/216,16.15%,PRKAG2;DAPK1;FOXO1;LEPR;RNF152;FOXK1;KDM4A;MCL1;ACER2;EXOC4;VPS35;ATG13;RASIP1;SREBF2;ATF6;PRKAA2;SH3BP4;TRIM5;FBXL2;TRIM14;GSK3B;MTMR9;SNX32;CASP3;DAPL1;LAMTOR5;MAPT;TLK2;SNX6;BAD;EEF1A1;PIK3CB;RRAGC;OPTN;TMEM59;PIP4K2C;GAPDH;HSPB1;TAB2;PRKAG3;LAMTOR3;ATM;BOK;VPS29;RAB39B;TICAM1;KAT5;UCHL1;ERN1;MET;TRIM27;PRKAA1
prerank,cellular response to cadmium ion (GO:0071276),-0.36074583382255854,-1.0979123084420936,0.3224043715846995,0.6488436195385409,1.0,16/24,33.25%,EGFR;MAPK9;MT2A;AKT1;MT3;SUMO1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;JUN;HSF1
prerank,cellular amino acid catabolic process (GO:0009063),0.3262406309639996,1.0978867250577204,0.31836195508586523,0.9356452494388261,1.0,15/87,10.90%,GLDC;SLC25A21;MCCC1;KYNU;FAH;ACADSB;MTRR;ABAT;BLMH;HNMT;ASPA;DLST;HOGA1;ALDH5A1;BCAT1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.47797320787866027,1.0973206184102244,0.38419117647058826,0.9363095169938922,1.0,4/11,18.96%,REST;PINK1;FYN;STK26
prerank,positive regulation of protein secretion (GO:0050714),-0.27991249079827984,-1.0972944610488273,0.25830258302583026,0.6495403217474294,1.0,16/69,14.25%,IGF1;MYRIP;EZR;PSMD9;RBP4;TGFB2;UNC13B;WLS;SOX4;NNAT;BAD;CD2AP;ACSL4;MYH10;GOLPH3L;PPIA
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.44978917410650787,1.0966076730774714,0.3684210526315789,0.9374164707008658,1.0,5/16,22.59%,VAMP2;ARL8B;VAMP7;PLEKHM2;ULBP1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.45199001169050235,1.096606083870154,0.34759358288770054,0.9361789772109682,1.0,5/15,13.81%,ENTPD2;ENTPD5;AK4;ENTPD7;AK8
prerank,chromatin assembly or disassembly (GO:0006333),0.49578566714638406,1.0965600390278003,0.34929078014184395,0.9350829249006931,1.0,5/11,21.09%,CHAF1B;NOC2L;TP53;SUV39H2;HIRIP3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3266618100614054,1.0965547739328336,0.3109987357774968,0.9338609905902784,1.0,16/90,9.82%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;SIRT6;EPAS1;FABP5;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.42716734832962305,-1.0965247596528835,0.34772182254196643,0.6507000336404954,1.0,5/12,22.73%,UPP2;TK2;DCK;CDA;CAD
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4856099551295771,1.0956744717582367,0.3639705882352941,0.9356256118443611,1.0,5/11,14.92%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,purine nucleotide catabolic process (GO:0006195),-0.4269420407943197,-1.095178395138808,0.33413461538461536,0.6534390375244122,1.0,6/13,19.98%,XDH;GPX1;NT5E;HINT1;GDA;NT5C1A
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.44856123166513995,1.0950172961125186,0.35842880523731585,0.9367112575703155,1.0,4/16,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,protein heterotetramerization (GO:0051290),0.4703901040911491,1.0948460136459635,0.36528028933092227,0.9360669437523942,1.0,3/13,10.19%,GRIN2B;HSD17B8;NUDT21
prerank,positive regulation of nervous system process (GO:0031646),0.43707458228391705,1.0942887785401765,0.3536379018612521,0.9366721938750691,1.0,5/18,13.88%,HCRT;TENM4;RIMS2;RIMS1;MYRF
prerank,extracellular matrix disassembly (GO:0022617),0.35886644415875846,1.0938307557808231,0.33379310344827584,0.9370119864093821,1.0,2/53,0.41%,SCUBE1;LAMC1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4864110279513036,1.0938209497608269,0.36329588014981273,0.9358096906538936,1.0,4/10,17.18%,GALNT13;POGLUT3;POGLUT2;GALNT2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.30291154537592313,-1.0936697590387545,0.3194444444444444,0.6563006104632397,1.0,22/48,27.47%,ACTB;DDX21;SF3B1;WBP2;SMARCA5;MYO1C;MYBBP1A;POLR2H;SERTAD1;ARID1B;POLR1H;TAF1C;POLR1G;SPHK2;POLR1C;PHF2;SMARCD1;ELOF1;PADI2;CDCA4;CHEK1;POLR2K
prerank,cellular response to interleukin-4 (GO:0071353),0.4931338843102981,1.0935142574147065,0.36462093862815886,0.935569825918962,1.0,1/10,0.79%,XCL1
prerank,regulation of membrane repolarization (GO:0060306),-0.423811196315776,-1.0931556364400496,0.35194174757281554,0.6567892447072345,1.0,3/13,10.98%,CAV1;KCNJ2;KCNQ1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.49503936178134156,1.093039501460997,0.3512014787430684,0.9359529633134467,1.0,5/10,14.92%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,cellular response to ketone (GO:1901655),0.37932162642919237,1.0929768801573407,0.35942028985507246,0.9349510755096478,1.0,10/35,17.12%,PTGFR;ADCY5;SPP1;ADCY8;ADCY3;ADCY2;MAP4K1;GNG2;AR;PTGER4
prerank,regulation of potassium ion transport (GO:0043266),0.3904020409454205,1.0927759887568553,0.35944700460829493,0.9344000594313585,1.0,9/31,13.14%,DPP6;DPP10;ANK3;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3
prerank,regulation of inflammatory response (GO:0050727),0.2989887906895149,1.0926803123506847,0.3014018691588785,0.9334980097658052,1.0,21/190,9.55%,RORA;IL33;XCL1;PPARA;WNT5A;IL16;NR1H4;TSLP;TNFAIP8L2;PPARD;VAMP2;CASP4;ADAMTS12;ENPP3;BCL6;LRFN5;PTGES;PLA2G7;CD200R1;TLR4;BIRC2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4352302076996575,-1.0926536294500409,0.3574766355140187,0.6572474773108883,1.0,5/12,21.36%,CSGALNACT1;FUT8;UGP2;EXTL2;GFUS
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4753138971615435,1.0924413922391858,0.34991119005328597,0.9319055505248286,1.0,2/11,8.79%,PTEN;INPP5J
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4753138971615435,1.0924413922391858,0.34991119005328597,0.9319055505248286,1.0,2/11,8.79%,PTEN;INPP5J
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.22864950121754404,-1.0922366462769013,0.2,0.6575281140837272,1.0,91/348,18.77%,FN1;IGF1;SLC24A3;ROCK2;ITGB8;MEF2C;RBPJ;LEF1;OCLN;ROBO1;KRAS;AFDN;PPHLN1;OSR1;EZR;NOS3;APP;KLF4;FOXD1;CLDN5;RDX;MAGI2;VPS35;GSN;INSR;NOTCH1;ACTG1;SMO;INPP5F;RPL5;CD34;MAPK9;TFRC;RPS7;KLF2;MAPK14;NGF;PPM1F;GSK3B;CELF1;FGF1;LAMTOR5;SMAD3;ANK2;WNT6;RPL11;CITED2;PIK3CB;GATA2;PIK3CD;ETS1;PTPN1;EPHB2;TNRC6A;ATF7IP;CTSH;CD63;ACTA2;TNRC6C;PLCG2;HEY2;SMAD1;TMEM119;ATM;NOS1AP;WNT16;RAMP2;TICAM1;P2RX7;CDH5;MAP2K5;GPER1;PRKAA1;ZPR1;MED23;DNAJA4;HFE;CD74;LAPTM5;AGO2;AKT1;DNMT3B;SOX11;IFNGR1;EGF;SLC22A2;MSN;HOXD3;CTCF;PID1;WNT11
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2845837064797424,-1.0920077229319862,0.3064516129032258,0.6573099777019754,1.0,23/59,24.34%,ROCK2;ERC1;IRAK2;UBB;AZI2;NFKBIA;NKIRAS1;TAB2;TICAM1;TBK1;TNFRSF1A;UBC;AKT1;TIFA;LY96;TRADD;BIRC3;TLR7;UBA52;REL;BCL10;IKBKB;IKBKG
prerank,miRNA metabolic process (GO:0010586),-0.37337334111296827,-1.0917752148924496,0.34293193717277487,0.6571107478469105,1.0,5/20,6.98%,DGCR8;TUT7;PARN;DICER1;DROSHA
prerank,nucleic acid-templated transcription (GO:0097659),-0.3096166575131189,-1.0917028616181164,0.3081761006289308,0.6564946544216297,1.0,13/42,20.91%,MEF2A;PTMA;DRG1;RRAGC;NR4A2;POLR2B;POLR2H;TERT;POLR2G;POLR2C;HOXD3;CREBL2;E2F1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.417806847726906,-1.0916480254793532,0.35903614457831323,0.6558067877592041,1.0,5/13,29.18%,ITGB1;SREBF2;CD9;ITGB2;PPARG
prerank,glucose homeostasis (GO:0042593),-0.27247942452226004,-1.0914462814870975,0.29739776951672864,0.6554805160198212,1.0,16/83,10.31%,FOXO1;LEPR;IGF1R;FOXK1;ADIPOR2;KLF7;INSR;RBP4;HK1;PRKAA2;SOX4;HK2;KCNB1;LRRC8D;BAD;PTPN2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.43819829594671444,1.091175366941672,0.3613861386138614,0.9348700655808918,1.0,7/18,18.02%,COLGALT1;FSCN1;IER3IP1;CARMIL2;CLASP2;CLASP1;BMP2
prerank,neutrophil activation (GO:0042119),0.4926970537347355,1.0910156989713085,0.36548223350253806,0.9342190011379675,1.0,2/12,13.18%,KMT2E;PREX1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4047162517676007,-1.0907326650263587,0.3425,0.6564679910518362,1.0,4/16,4.26%,IGF1;MEF2C;RBPJ;NOTCH1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2641824703736356,-1.0907115490301451,0.2651162790697674,0.6557142320107708,1.0,36/95,23.64%,SMAD6;DKK3;CAV1;LEMD3;LTBP4;THBS1;SKIL;SKI;DAB2;GIPC1;CD109;UBB;ASPN;SNX25;SMURF2;SMAD3;SNX6;PRDM16;CITED2;BCL9L;SPRED3;HIPK2;SIRT1;TGFB1I1;UBC;HTRA4;SOX11;SDCBP;TGFBR3;VASN;ADAMTSL2;TGFBR2;UBA52;SMAD7;SMURF1;RNF111
prerank,regulation of postsynapse organization (GO:0099175),0.38984289566429137,1.0902744257909387,0.3471337579617834,0.9355198640586291,1.0,8/28,8.22%,ARHGAP22;WNT5A;CDKL5;LRRK2;PPFIA2;ABHD17C;ABHD17B;TANC2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3748364131427614,1.0897302912909415,0.3323397913561848,0.9361583759030592,1.0,11/37,13.50%,TENM3;GRID2;TENM4;DCHS1;TENM2;ADGRL1;TENM1;AMIGO3;CBLN1;CADM3;NECTIN3
prerank,regulation of telomere maintenance (GO:0032204),0.4035534024395077,1.0895684431113029,0.333843797856049,0.9355182783409868,1.0,8/26,15.40%,GNL3;ERCC1;SIRT6;ERCC4;PIF1;DHX36;HNRNPD;MYC
prerank,cellular response to interferon-gamma (GO:0071346),-0.2692131450680955,-1.0893797012762083,0.2606837606837607,0.6583278025143686,1.0,20/88,11.59%,DAPK1;GBP7;SIRPA;CAMK2D;NCAM1;TRIM25;GBP5;TRIM5;B2M;CD44;IRF2;GBP4;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G;GAPDH;GBP6
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.38411400010744395,-1.089326303263939,0.35714285714285715,0.6576646649860136,1.0,3/18,4.84%,FLT1;MEF2C;COL4A3
prerank,receptor internalization (GO:0031623),-0.30791812236589655,-1.0891068742883272,0.3018181818181818,0.6574775598167322,1.0,12/44,14.58%,PICALM;CAV1;ITGB1;ACKR3;TFRC;RAMP1;RAB5A;DNM3;RAB31;CEACAM1;GRB2;RAMP2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.48605611569212426,1.0890494921905916,0.3767857142857143,0.9360598045255724,1.0,2/11,8.18%,LIPC;PLA2G7
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.24539368143191595,-1.0889110849666217,0.2214765100671141,0.6571925119962111,1.0,40/151,17.89%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;PLA2G4A;ACER3;B4GALT5;SGMS2;CERT1;ALAS1;NFS1;DEGS2;SPNS2;VAPA;APOE;LARGE1;GCH1;VAPB;DMD;ELOVL4;ASS1;ELOVL7;MFSD2A;FURIN;MOCS1;CHKB;SPTSSA;KDSR;GSTA4;PCSK5;ST3GAL2;GCNT1;GSTT1;ESD;PCTP;CSNK2B
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3005443837184449,1.088374662907822,0.302491103202847,0.9370715395841501,1.0,33/149,17.81%,ROR1;EDA2R;EDA;WNT5A;CD40;IL18RAP;TLR6;MTPN;PRKCI;CAPN3;FLOT2;TRIM37;PRKD1;TRIM8;PRKCB;TLR4;IL1RAP;IRAK1;EIF2AK2;PYCARD;RTKN2;RNF31;UBE2V1;RIPK1;DHX9;CLU;AR;TIRAP;ZBTB7A;LGALS9;ADAM8;MYD88;CAMK2A
prerank,regulation of ruffle assembly (GO:1900027),-0.3585952729778774,-1.088316550509915,0.33665835411471323,0.6578909550448092,1.0,5/23,8.74%,CAV1;RDX;NDEL1;KANK1;EPS8L2
prerank,regulation of Rac protein signal transduction (GO:0035020),0.44902835291389204,1.0881828681714723,0.35823429541595925,0.9364886761561657,1.0,3/16,5.15%,AUTS2;OGT;ARHGAP24
prerank,positive regulation of response to external stimulus (GO:0032103),0.30787707781736356,1.0880150394532178,0.3236040609137056,0.9358514450336759,1.0,13/128,9.80%,IL33;PTN;HRG;WNT5A;IL16;TSLP;DHX58;TLR8;AKIRIN2;PLA2G7;PRKCA;TLR4;CYBA
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.29932453741897336,-1.0880063318916726,0.2975778546712803,0.6578356411372612,1.0,10/49,13.64%,SGMS1;CAV1;BCL2L1;BECN1;MCL1;BAD;BAX;BID;CYLD;BOK
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.38832384675371057,1.0872722651128728,0.32142857142857145,0.9371173211433628,1.0,3/29,7.14%,STAG3;ZCWPW1;TEX11
prerank,B cell activation (GO:0042113),-0.27947123882060365,-1.087270875649028,0.2743682310469314,0.6589297974334595,1.0,17/68,18.49%,MEF2C;PTPRJ;TPD52;ITGB1;HDAC4;CTPS1;CASP8;DNAJB9;PIK3CD;PTPN2;EPHB2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.30595468006571636,1.0871094904568293,0.3180169286577993,0.936425195179945,1.0,19/140,11.57%,PDGFRA;PTGFR;ADCY5;C5AR1;P2RY1;ACKR2;CCR9;RYR2;ADCY8;CALCA;C1QTNF1;LPAR3;TRPC3;CCKBR;HTR2C;LPAR1;P2RX4;DLG4;IAPP
prerank,response to cAMP (GO:0051591),-0.31593095178562036,-1.0868338460553069,0.33783783783783783,0.6592349113053598,1.0,11/37,23.30%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.22534473751560413,-1.0863842697235073,0.13846153846153847,0.6595588451051692,1.0,85/348,18.29%,PDGFD;PRKAG2;IGF1;RAPGEF2;ROCK2;TEK;LEPR;CAV1;PTPRJ;PECAM1;FNIP1;EGFR;KRAS;APP;NRP1;BMPR2;CSNK1D;IQGAP1;LIMCH1;CSPG4;KDR;NIBAN1;RAP1A;CCND2;INSR;FAS;TGFB2;VTN;VEGFD;RAC1;DAB2;VEGFC;MAVS;TFRC;EFNA5;NGF;PDGFA;CARD14;CALM1;TBX1;CCN1;CD44;ACVR1;FGF1;ACVRL1;FNIP2;RALBP1;PDGFC;RPS6KA5;ENPP2;CAB39;CX3CR1;HDAC3;ITGB3;RALB;ALS2;PLCG2;NOS1;TAB2;TMEM119;FLT4;PTK2B;PPIA;NBN;CCND1;RAPGEF3;CX3CL1;RAP2C;CDKN1A;TEC;SIRT1;GPER1;TBK1;PAK2;GDF11;HFE;CD74;TWSG1;ERBB2;CDK9;AKT1;CSNK2B;LCP2;EGF;SDCBP
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3837298006134525,1.0861344253644718,0.35285285285285284,0.93849849331552,1.0,4/30,3.66%,DCN;BGN;DSE;VCAN
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3728063799427679,-1.0860828165838012,0.3403141361256545,0.6595032805310241,1.0,5/21,7.54%,MEF2C;MAGI2;CALM1;MTMR9;ITGA1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.3749575247495967,-1.085995742930002,0.3422330097087379,0.6589134908376417,1.0,6/21,16.22%,SNTA1;ANK2;KCNQ1;FLNA;NOS1AP;SCN4B
prerank,regulation of myotube differentiation (GO:0010830),-0.35747202532940386,-1.0859576707894423,0.3333333333333333,0.6582111886392022,1.0,12/24,28.15%,HDAC4;NOTCH1;CCN3;MAPK14;SIK1;HDAC3;TMEM119;PIEZO1;FBXO22;BHLHE41;BDNF;HDAC5
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.45123727010725323,-1.085879853350294,0.3598233995584989,0.6576363631332358,1.0,5/10,20.94%,PRKCH;FOXC1;TRIM16;NUMA1;ETV4
prerank,positive regulation of stem cell proliferation (GO:2000648),0.43933368692635366,1.0853739531300093,0.35426731078904994,0.9398839628365961,1.0,6/17,18.55%,GJA1;N4BP2L2;FERMT2;KAT7;LTBP3;CCNE1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.41651839712515415,1.0849047431857006,0.34105960264900664,0.9402589545194192,1.0,3/22,2.62%,PTEN;NR2F2;CDKN2A
prerank,positive regulation of macrophage migration (GO:1905523),0.4281754918049487,1.0848919090036697,0.34868421052631576,0.9390940165057113,1.0,7/19,21.50%,IL34;PTK2;P2RX4;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,glutamate metabolic process (GO:0006536),-0.39217462596875763,-1.0847820450883738,0.3300970873786408,0.6596771954506669,1.0,4/19,9.05%,GCLC;PRODH;GOT2;OAT
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.31033220921609556,-1.084697743103833,0.31683168316831684,0.6591109514520824,1.0,5/41,4.78%,PTGS1;PLA2G4A;CYP1B1;ACOT8;MGLL
prerank,skeletal muscle tissue development (GO:0007519),0.3779247129729516,1.0845583054830974,0.33699059561128525,0.9389895731745402,1.0,2/32,0.73%,SVIL;MSC
prerank,negative regulation of protein modification process (GO:0031400),-0.27052965717366506,-1.084492515417097,0.31512605042016806,0.6588325302087866,1.0,24/79,16.15%,OCLN;SLIT2;PLPP3;SNTA1;SIRPA;IGFBP3;PRKDC;NIBAN1;PRKAA2;YWHAB;GSK3B;XDH;PRR5L;LRP6;PPP1R16B;MAPT;DMD;EPHB2;TARDBP;CRTAP;PPIA;CDYL;SIRT1;PRKAA1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.3640779858526954,-1.084366444798454,0.33159268929503916,0.6583476424374735,1.0,6/21,11.65%,PGM2L1;DERA;HK1;TALDO1;HK2;PGM2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4691296127914685,1.0841115185477022,0.3613013698630137,0.9392381933130376,1.0,3/12,5.31%,NUP214;AAAS;NEDD4
prerank,neuronal action potential (GO:0019228),0.40678989025310475,1.0836341796678823,0.3564516129032258,0.9395966360005639,1.0,6/22,21.35%,ANK3;CACNA1G;SCN1A;SCN2A;SCN8A;CACNA1I
prerank,regulation of vasoconstriction (GO:0019229),-0.34464281410205677,-1.0835932135500055,0.32456140350877194,0.6595205044385575,1.0,7/27,6.34%,CAV1;BMPR2;ADRA1B;ZDHHC21;ACE;BDKRB2;ATP2B1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3034182365995063,-1.0834863635903011,0.3023255813953488,0.659015141989168,1.0,15/44,17.68%,ROCK2;PRR5L;ZC3HAV1;CELF1;CNOT8;BTG2;RC3H1;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;GTPBP1;AGO2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.43588308672666287,1.0821187784881845,0.3559322033898305,0.9433661870140088,1.0,6/17,19.03%,ERCC5;NEIL3;TERF1;MUTYH;MBD4;TERF2IP
prerank,positive regulation of programmed cell death (GO:0043068),-0.23157114674253398,-1.0819254056769811,0.1619047619047619,0.6621532822024685,1.0,79/272,22.61%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;ITGA6;MCF2L;TNFSF10;MARK4;HIP1R;IGFBP3;SQSTM1;MAP3K5;FAS;CYP1B1;UNC13B;APC;ATF6;CRADD;JMY;UBB;SOX4;IP6K2;NGF;CASP2;CASP3;NGEF;CASP8;BAD;SFRP1;BAX;BNIP3L;TNFAIP8;ADAMTSL4;BID;APH1A;TGM2;GADD45B;APH1B;ATM;BOK;PLEKHG2;ING4;ARHGEF11;STK17B;TRIM35;SMPD1;SIRT1;GPER1;ING5;AIFM1;DCUN1D3;LAPTM5;UBC;MAP3K10;TFPT;APBB1;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;RASGRF2;GADD45G;TRADD;ARHGEF12;HDAC6;E2F1;SPHK2;CCAR2;DDX20;UBA52;TIAM1;ARHGEF1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3612364871795317,1.0817045117988067,0.3684210526315789,0.9435983990954371,1.0,6/44,7.97%,CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D;PER2
prerank,peptidyl-asparagine modification (GO:0018196),0.38346257764208125,1.0816516342715823,0.3494539781591264,0.9425877290576273,1.0,7/31,12.21%,HIF1AN;RPN2;OSTC;DAD1;ALG5;MCFD2;TUSC3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3888533369328943,1.0810410513844082,0.3439878234398782,0.9433654213693369,1.0,8/29,15.31%,RBM24;FMR1;DND1;TAF15;PAIP1;TENT5A;EIF4ENIF1;GDNF
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.2827547926972402,-1.0808061799979178,0.31316725978647686,0.6642190809772163,1.0,15/66,9.80%,NFIB;CAV1;ROBO1;PTPRK;THBS1;SPARC;TGFB2;CAV2;CDK6;B2M;APOE;XDH;ATOH8;KLF9;SFRP1
prerank,ncRNA transcription (GO:0098781),-0.4208903729009773,-1.0807852538464084,0.33413461538461536,0.6634655044541482,1.0,5/13,22.51%,CAVIN1;SNAPC3;NIFK;POLR1G;GTF3A
prerank,innate immune response in mucosa (GO:0002227),-0.442308839348261,-1.0806820574157323,0.35362997658079626,0.662944530953914,1.0,8/10,53.59%,RPL39;RNASE3;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,regulation of centriole replication (GO:0046599),0.4461128378435903,1.0806529607615096,0.36300174520069806,0.9434463876629918,1.0,4/17,9.77%,MDM1;CEP295;TRIM37;KAT2A
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.377590173285806,-1.0806087877786652,0.3553921568627451,0.6623464784538584,1.0,8/18,14.28%,HIP1R;GSK3B;BAX;BID;BOK;SLC25A5;ZNF205;ACAA2
prerank,neurotransmitter secretion (GO:0007269),0.36265088081888447,1.0804013972130904,0.3465648854961832,0.9430174230497437,1.0,14/44,18.61%,NRXN2;PTPRN2;NRXN1;VAMP2;RIMS2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,positive regulation of immune effector process (GO:0002699),-0.3428820012639032,-1.0803215282814975,0.2985507246376812,0.6622930154734359,1.0,4/27,6.56%,PTPRJ;DDX60;LBP;RPS19
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.3854289259405272,-1.0802914970942044,0.33078880407124683,0.6615851177883765,1.0,5/19,4.27%,MEF2C;RBPJ;RBP4;NOTCH1;RUNX1
prerank,organelle fusion (GO:0048284),-0.3586196107995091,-1.0802655925227953,0.34540389972144847,0.6608494518201996,1.0,8/22,20.96%,EEA1;VPS18;MIEF1;USP30;BAX;VPS11;CHCHD3;MIGA1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4306712161710666,-1.0802056990493156,0.3576158940397351,0.6601978926886185,1.0,6/11,25.67%,YBX3;PELI1;CASP8;BIRC3;NUPR1;SLC25A4
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3633039750511454,-1.0801666977536633,0.34375,0.659502338591567,1.0,11/23,36.21%,MBOAT1;PLA2G4A;PLA2G6;PLAAT3;PLA2G4E;PLA2G4C;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4
prerank,fatty acid beta-oxidation (GO:0006635),0.3491245056246426,1.0798614512350462,0.34870317002881845,0.9435704850146274,1.0,7/51,6.33%,ACOX2;ABCD2;PEX2;PPARD;ACADL;CRAT;ACADS
prerank,toxin transport (GO:1901998),0.4892724983184519,1.0796390377650613,0.37158469945355194,0.9431074537400445,1.0,3/10,8.89%,ANTXR2;RAB40B;RAB29
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2654125416809422,-1.0790807355687604,0.2761904761904762,0.6614304239475344,1.0,25/101,12.98%,VIM;LARP4;EZR;THBS1;KLF4;ELAVL1;RDX;VPS35;PRKDC;NIBAN1;SAMD4A;LARP4B;RPL5;SOX4;CASP8;BAD;NFKBIA;PYM1;PERP;IST1;CPEB3;RPL26;EIF3D;RPS4X;VPS11
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.42472031942446303,-1.078686553468078,0.3508771929824561,0.6616334243633968,1.0,10/12,54.23%,SLC11A1;CCR2;ZBTB1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,regulation of cartilage development (GO:0061035),0.43747045686624164,1.078467142930381,0.39767054908485855,0.945778691957039,1.0,6/18,12.02%,TRPS1;SOX6;ZBTB16;TAPT1;KAT2A;SOX9
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4197035445525681,-1.0778265969458265,0.3584070796460177,0.6629879522184875,1.0,6/12,16.00%,FOXP1;SMARCA4;DAB2;SFRP1;HEYL;SIRT1
prerank,vasoconstriction (GO:0042310),0.4685184367624515,1.0773503318688744,0.375609756097561,0.9482425409201547,1.0,2/11,4.84%,EDN3;HTR2B
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.2931513905684818,-1.0773452527361231,0.30633802816901406,0.6634810509461977,1.0,27/57,29.31%,RPS16;RPL5;RPS7;RPS19;RPS24;RPS15;RIOK1;RPL35A;RPL11;RPL26;WDR12;PES1;NIP7;NPM1;PAK1IP1;GTF3A;GLUL;WDR74;RPL38;LTV1;RPF2;MRPL36;RPS25;LTO1;RRP36;NOP16;TGS1
prerank,protein polyubiquitination (GO:0000209),-0.22416107821091946,-1.0770845097080854,0.1282051282051282,0.6633830079418633,1.0,88/297,23.60%,FBXL7;WWP1;RNF152;LMO7;UNKL;RNF146;UBE2G1;PSMC6;PELI1;PSMD9;WWP2;ARIH1;CDC23;UBE2D3;PSMF1;PSMB7;TRIP12;CUL1;ANAPC10;TRIM5;UBB;TRIM14;TNKS2;IFI27;HERC6;RNF8;UBE2H;SMURF2;TRIM36;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;KLHL20;ZFP91;RNF144B;RNF41;RNF114;UBR2;PSMA3;PSMA6;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;UBE2N;PSMB6;TRAF3;PSMC1;FBXO32;TRIM27;ANAPC13;UBE2L6;PSMB10;FBXL14;SIAH2;CUL3;ANAPC11;UBC;CHFR;ANKIB1;PSME2;FZR1;CDC34;TNFAIP3;KLHL3;ANAPC2;PSMC3;RNF166;PRPF19;KBTBD7;RNF5;TRAF1;RFFL;FBXO22;FBXL8;MKRN1;UBA52;FBXW2;FBXL18;PSMA8;FBXO10;SMURF1;RLIM
prerank,positive regulation of hormone secretion (GO:0046887),0.44197048613457135,1.0770726195850442,0.36541598694942906,0.9479736515567226,1.0,3/17,11.81%,EDN3;SPP1;VAMP7
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3984373741282964,1.076872352972429,0.3555900621118012,0.9474465020220559,1.0,5/23,13.64%,ENPP1;PTCH2;GLI3;HERC4;RFX4
prerank,cellular response to ATP (GO:0071318),0.45079824058244755,1.0766463363499965,0.37137989778534924,0.9469880392406571,1.0,4/14,13.68%,P2RY1;P2RX4;HSP90B1;RYR3
prerank,neuromuscular synaptic transmission (GO:0007274),0.4279301915714492,1.0760474597030083,0.3616666666666667,0.94777331901783,1.0,4/18,10.19%,CHRNB4;CHAT;FCHSD2;ERC2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.29794022378141777,-1.0752863051070036,0.34172661870503596,0.6671155548796897,1.0,16/53,16.00%,EYA2;DDX5;EYA1;EGFR;EYA4;RNF8;ATR;SPRED3;PCNA;BRCC3;ATM;SMCHD1;UBE2N;NSMCE4A;PRKCD;SIRT1
prerank,positive regulation of histone acetylation (GO:0035066),-0.3517526076667081,-1.074985099248537,0.34574468085106386,0.6670717480229289,1.0,9/23,26.16%,GLYR1;WBP2;RPS6KA5;NOS1;TADA2B;RUVBL2;SPHK2;BRCA1;SMAD4
prerank,cilium assembly (GO:0060271),0.28303089278378646,1.074622341548423,0.32786885245901637,0.9512446755808397,1.0,77/296,20.83%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;DCTN3;HAUS3;DYNC2LI1;RSPH9;HAUS1;GBF1;CCDC57;DCTN2;RAB8A;DISC1;E2F4;DNAAF3;IFT81;HAUS8;FAM161A;KIFAP3;PRKACA;CEP192;TTC21B;SNAP29;CCDC65;CEP135;AHI1;RPGRIP1;TCTN2;IFT74;SSNA1;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;IQCB1;GAS8;SSX2IP;RFX2;TNPO1;IFT88;RAB11FIP3;CEP126;SCLT1;TXNDC15;ACTR2;DYNLL2;TRIP11;CEP250;KIF3C;CEP152;CCDC39;CSNK1E;PTPDC1;CLASP1;IFT43;CLUAP1;ALMS1;BBS1;PCM1;ATP6V0D1;WDR90;MKS1;CEP19;TUBA1A;CEP43;NUDCD3;DZIP1L;UNC119B;KIF3A;TTC39C;BBS4;ABLIM3
prerank,response to zinc ion (GO:0010043),0.39935630364564856,1.0739763430911766,0.36436597110754415,0.9521894090156765,1.0,6/25,12.98%,PAM;SLC30A5;SLC30A3;GLRA1;P2RX4;GLRA2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4302098044464123,1.0737952447495576,0.3852739726027397,0.9515921793949474,1.0,8/16,17.43%,CDK13;CELF4;DDX17;SLU7;RBM17;DHX9;SRSF9;SRSF6
prerank,DNA-dependent DNA replication (GO:0006261),0.30237073814830046,1.0737371606346637,0.33906633906633904,0.950583932481468,1.0,36/128,18.81%,POLG;PSMD1;MCM7;CDC7;GINS3;PSMD10;POLA1;GMNN;PSMA5;RPA1;PSMB5;POLE4;RFC3;PSMC4;NOC3L;REV3L;MCM4;PSMA4;RECQL;TEFM;PSMC5;CDT1;POLG2;POLB;POLE3;PSMB9;MCM10;DBF4;ORC2;PSMA7;PSMD14;MCMDC2;WRN;PSMA2;SSBP1;PSMD11
prerank,fatty acid catabolic process (GO:0009062),0.3307692184635919,1.0734952844758159,0.33146853146853145,0.9501875433307384,1.0,17/67,18.89%,LPIN3;ABCD2;CEL;PEX2;PPARD;ACADL;ACADS;ACAT2;SLC25A17;NUDT19;LPIN2;PECR;MMAA;MMUT;MCEE;ALDH3A2;ECI2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4039646668203786,1.0725037577725156,0.36492890995260663,0.9524290477270482,1.0,5/24,6.84%,PIK3R1;HRG;MAP4K4;IQSEC1;COL16A1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4168845135819682,-1.0722792634627145,0.36519607843137253,0.6731748290651867,1.0,5/13,24.33%,PARP10;PARP9;PTGS2;NAXE;NAPRT
prerank,protein deneddylation (GO:0000338),0.4777022983972169,1.0722416797935028,0.36906854130052724,0.9520894513482143,1.0,2/10,12.53%,COPS3;COPS4
prerank,response to cholesterol (GO:0070723),0.4296298895000129,1.0721020877650382,0.39862542955326463,0.9513273389032352,1.0,2/17,2.27%,GRAMD1B;GPLD1
prerank,positive regulation of exocytosis (GO:0045921),0.3689974086322302,1.071706898617257,0.3623853211009174,0.9515147262267409,1.0,12/35,18.98%,CADPS2;CADPS;RAB15;HGS;TSG101;CLASP2;SNF8;CLASP1;STXBP5;VPS4B;RAB2B;ATP6AP1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.38746649644282893,1.071589932405861,0.34379905808477235,0.9507573455964828,1.0,3/27,3.66%,DCN;BGN;VCAN
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.46829020666521315,1.0714921657674643,0.3888888888888889,0.9499236812509729,1.0,2/12,5.48%,GNL3;CCT5
prerank,determination of left/right symmetry (GO:0007368),-0.315136163178267,-1.0711952002832823,0.33707865168539325,0.6751385707893729,1.0,15/36,21.05%,NOTCH1;OFD1;SMO;MEGF8;ARL6;TBX1;CITED2;RFX3;GALNT11;ZIC3;MKKS;DNAH11;ENKUR;BBS7;DNAH5
prerank,regulation of cellular response to stress (GO:0080135),-0.25090252222381276,-1.0711610456945486,0.29064039408866993,0.6744249556337069,1.0,29/115,16.00%,ROCK2;MCL1;PTGES3;NEK6;CAMK2D;ARMT1;HSPA8;HSPH1;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;ATR;CAMK2G;NUP98;NUP153;AJUBA;BAG3;CHCHD2;ATM;AMFR;NUP43;HIKESHI;RAE1;NUP205;MANF;SIRT1
prerank,N-terminal protein amino acid modification (GO:0031365),0.4447308404494249,1.0709818664690616,0.3780687397708674,0.9503868931656645,1.0,3/14,9.92%,NAA10;METAP1D;NAA50
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3407990297379501,1.070787695649234,0.35410764872521244,0.9498654251120143,1.0,17/56,18.45%,CECR2;UNC119;DCTN3;SPTBN1;ANK3;EFHC1;SEPTIN9;JTB;NUSAP1;INCENP;RTKN;STMN1;CEP55;STAMBP;SPIRE1;CUL7;RHOA
prerank,regulation of macroautophagy (GO:0016241),-0.2545586911019733,-1.0705784993303684,0.2672811059907834,0.6751370067906497,1.0,33/105,22.25%,PRKAG2;EXOC4;KDR;VPS35;ATG13;SESN1;PRKAA2;NRBP2;SNX32;CASP3;LAMTOR5;SNX6;RRAGC;CLEC16A;BNIP3L;GAPDH;PAFAH1B2;PRKAG3;LAMTOR3;UCHL1;ERN1;SIRT1;PRKAA1;TBK1;ATP6V0E2;AKT1;ATP6V0A2;RRAGB;EXOC8;HDAC6;ATG101;ATP6V0D2;ATP6V0A1
prerank,nucleus organization (GO:0006997),-0.2952220174374493,-1.0704419948319073,0.31545741324921134,0.6746915672658901,1.0,16/47,20.04%,LEMD3;ATXN7;CHMP2B;RPS19;NUP98;REEP3;TOR1A;TMEM170A;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;NUMA1;PDCD6IP;CHMP1A
prerank,GTP metabolic process (GO:0046039),0.44727450110715883,1.0702547074117765,0.3872053872053872,0.950416099270866,1.0,9/15,21.60%,LRRK2;AK4;OPA1;MFN1;ENTPD7;AK3;EFL1;IMPDH2;GNAI3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.35156641918796616,-1.0702038353519066,0.3404255319148936,0.6745017890583922,1.0,7/23,16.48%,IGF1;MEF2C;EFNB2;MAPK14;NIBAN2;EDN1;MYOCD
prerank,spindle assembly (GO:0051225),0.3366199605274148,1.069927888020139,0.35365853658536583,0.9503347726214028,1.0,21/67,18.72%,CCDC61;HAUS3;HAUS1;LSM14A;AAAS;STARD9;HAUS8;GOLGA2;CEP192;RCC1;TUBGCP4;MAP9;CLASP2;TUBGCP6;KIFC2;KIF2A;CLASP1;GOLGA8B;SMC1A;RHOA;KPNB1
prerank,positive regulation of cell population proliferation (GO:0008284),0.2780150266183603,1.0696713036459766,0.3242392444910808,0.9500387200586546,1.0,86/423,17.40%,PDGFRA;PTN;NTRK3;IL34;LAMC1;LAMB1;NRG1;HOXC10;PTGFR;EDN3;MEIS1;HDAC1;WNT5A;NTRK2;PTEN;TCF7L2;PHIP;ERBB4;C5AR1;ITGAV;FLT3LG;FGFR1;GAB2;MEIS2;TSLP;TIPIN;GJA1;POU3F3;TBX3;FBXO5;GCNT2;HTR2B;CDC7;IRS1;PRKCI;SIRT6;IRS2;FXN;PTK2;HTR1A;CDK13;CCKBR;GLI1;LGMN;TSPYL5;CACUL1;SLC25A33;ZFPM2;RTKN2;NAP1L1;TGFBR1;SOX9;CD86;IGF2;FAM98B;CD81;GAREM1;DHPS;PIM1;LYN;NME1;DOT1L;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;DHX9;AREG;AR;GDNF;CNOT7;MYC;MAP3K3;FGFR2;NDUFS4;GDF9;NOX1;CCPG1;STAMBP;MAZ;CALR;ADRA2A;ASH2L;RHOG
prerank,cellular response to organonitrogen compound (GO:0071417),-0.26086631125649334,-1.0695897005427766,0.3004115226337449,0.675269062118149,1.0,18/99,10.98%,RAPGEF2;MEF2C;SLIT2;ACTB;EZR;DIAPH1;IGFBP5;CDH1;RAP1A;SH3BP4;PDE3A;RAPGEF1;LAMTOR5;SSH1;SFRP1;RRAGC;CPEB3;KCNQ1
prerank,pre-miRNA processing (GO:0031054),0.4526853930424596,1.0695423384060836,0.38738738738738737,0.9493151295155688,1.0,6/14,17.42%,AGO4;LIN28B;MRPL44;AGO3;ADAR;AGO1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4031344583449197,-1.0694721545470138,0.37346437346437344,0.6747860541790444,1.0,5/14,19.69%,RAPGEF2;PRKAR2A;PRKAR2B;SIRT1;ADRB2
prerank,cellular response to peptide (GO:1901653),0.33825960216547596,1.0692663354925043,0.35816618911174786,0.9490613776012324,1.0,13/56,11.12%,LRP1;GJA1;NGFR;PTPN22;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;TP53;GRM5;FYN
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3030460021260411,-1.0690084259990411,0.326984126984127,0.6752095370238749,1.0,13/42,22.66%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,inorganic anion transmembrane transport (GO:0098661),0.3364027955840913,1.0688818416299575,0.3574468085106383,0.9491580751244884,1.0,16/63,15.70%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;SLC25A30;GABRB1;LRRC8A;SLC25A14;GLRB
prerank,response to cadmium ion (GO:0046686),-0.34545156183051573,-1.0685159532150754,0.3522727272727273,0.6756507560854895,1.0,16/26,33.25%,EGFR;MAPK9;MT2A;AKT1;MT3;SUMO1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;JUN;HSF1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2965999321300029,1.068454200781092,0.3286219081272085,0.9494112396791331,1.0,36/158,20.19%,ROR1;MAP3K14;EDA2R;CCDC22;CD40;TSPAN6;LURAP1;GJA1;HTR2B;TLR6;TNFRSF19;PINK1;PRKD1;TRIM8;PRKCB;BIRC2;IRAK1;LPAR1;NDFIP2;DHX36;LGALS1;RNF31;UBE2V1;F2R;RIPK1;MAP3K3;TIRAP;NDFIP1;LGALS9;MYD88;RHOA;ATP2C1;TERF2IP;PLEKHG5;GPR89A;DDX1
prerank,regulation of cellular protein localization (GO:1903827),-0.30233491977185933,-1.0681704797825005,0.3356643356643357,0.6757241790537177,1.0,16/45,18.27%,VCPIP1;NDEL1;GPC3;DVL1;PRKAA2;PPM1F;VCP;MAPT;PTPN1;SUMO3;RALB;TOR1A;KCNAB2;PRKAA1;HFE;EGF
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3917330307445445,-1.0680554204219816,0.37777777777777777,0.6752601223645248,1.0,6/17,16.11%,MEF2C;TPM1;SOD2;PRKG1;CDKN1A;GPER1
prerank,negative regulation of cell death (GO:0060548),-0.26186173712862854,-1.0676830025921595,0.28688524590163933,0.6753854872648634,1.0,26/88,19.90%,MECOM;CD200;CCN2;KANK2;BECN1;VPS35;CCN3;CD34;SRGAP2;NCK1;SOX4;CCN5;CCN1;GSK3B;BNIP3L;CCN4;NENF;WNT16;TMEM109;CHMP4B;CHMP4A;AKT1;SOX11;WNT11;CHGA;DCPS
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4357082268992971,-1.0670651857347844,0.3839080459770115,0.6761870962674179,1.0,4/11,18.31%,FOXO1;NOTCH1;LMNA;GLRX3
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.32054047629522736,-1.0670102674527124,0.3556231003039514,0.6755422893159961,1.0,7/33,8.29%,MEF2C;THBS1;KLF4;NOTCH1;APOE;ACVRL1;ITGB1BP1
prerank,sterol transport (GO:0015918),0.4279672180310229,1.066959028837214,0.38449111470113084,0.9530827284892491,1.0,8/19,26.01%,NPC1L1;LDLRAP1;ARV1;OSBP;NPC2;OSBPL5;MSR1;LCAT
prerank,cellular response to pH (GO:0071467),0.4300084522326031,1.0668771252871818,0.38235294117647056,0.9522098509129309,1.0,5/17,17.53%,GPLD1;SLC9A1;ASIC1;IMPACT;MCOLN1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3194542099732033,-1.0664123459161363,0.35755813953488375,0.6762860972054267,1.0,15/33,27.34%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;ANKZF1;PRKCD;SIRT1;TNFAIP3;HDAC6;PPIF;OSER1;PARK7;ECT2;RHOB
prerank,response to interleukin-4 (GO:0070670),0.4859080720017338,1.0662433623415672,0.3777372262773723,0.9531662591994221,1.0,1/10,0.79%,XCL1
prerank,regulation of ossification (GO:0030278),0.37995731012257405,1.0660657144431103,0.37767584097859325,0.9526125504223696,1.0,4/36,5.18%,ENPP1;PTN;WNT5A;ZBTB16
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4178926895402376,-1.065898340181271,0.3759213759213759,0.6768253611858259,1.0,5/12,12.69%,ATP1B3;WNK4;WNK1;DMD;NOS1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.32071437469599356,1.0657322867449903,0.3552278820375335,0.9525863783878931,1.0,28/84,22.86%,RBFOX1;TRA2B;NOVA1;RBM24;REST;PRDX6;FMR1;KHDRBS3;WTAP;CELF4;SMU1;DDX17;CWC22;RBFOX3;SNW1;SRSF10;ZBTB7A;SRSF9;RBM5;HNRNPL;SRSF6;KHDRBS1;FXR1;RBM15;RBM25;SRSF12;CELF6;DAZAP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.37798055019474386,1.0657281089473682,0.37738619676945667,0.951450287407925,1.0,11/32,17.84%,CDKL5;NEDD4;CAPRIN1;CDKL3;ADGRB3;CUX2;SDC2;TNIK;IL1RAPL1;HECW1;CUL7
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4544215541721547,1.0655065153157603,0.3772954924874791,0.9509636482564043,1.0,7/13,16.16%,LRRK2;AK4;OPA1;MFN1;ENTPD7;AK3;EFL1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2853328947648631,-1.0654873943059908,0.30141843971631205,0.6770865970665888,1.0,18/54,20.15%,FIGN;EZR;HOOK1;MAPT;TUBGCP5;KATNAL2;FIGNL2;CRIPT;CCDC88A;SLAIN2;DYNC1H1;TRPV4;CCDC88C;DST;DLG1;CAMSAP2;NUMA1;CIB1
prerank,positive regulation of protein polymerization (GO:0032273),-0.27709473724420364,-1.064389543649934,0.3046875,0.6790416728716867,1.0,14/65,15.68%,BAIAP2L1;OCLN;FER;DRG1;RAC1;NCK1;MAPT;ARL2;SLAIN2;LMOD1;PTK2B;BAIAP2;TPPP3;MET
prerank,negative regulation of receptor binding (GO:1900121),-0.4476700192169777,-1.0637085950494611,0.3680555555555556,0.680034270190143,1.0,4/10,17.14%,PTPRF;B2M;ATP2A3;HFE
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.33101425473709684,-1.063511566103683,0.36797752808988765,0.6797691163075453,1.0,8/30,11.63%,FOXP1;DDX5;KDM4C;SMARCA4;DAB2;KLK2;SFRP1;HEYL
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.24290477742658526,-1.0633290965043811,0.26865671641791045,0.6794023154886903,1.0,42/128,23.64%,SMAD6;DDX5;ARHGEF18;ITGB1;PTPRK;ID1;F11R;BMPR2;CLDN5;PARD3;TGFB2;SKI;MEGF8;UBB;ACVR1;ACVRL1;SMURF2;SMAD3;LRRC32;ZYX;SLC33A1;PRKCZ;SMAD1;FURIN;CDH5;SIRT1;TGFB1I1;HFE;UBC;USP9X;ACVR2B;TWSG1;TGFBR3;ADAM9;TGFBR2;NRROS;UBA52;SMAD7;INHBB;ACVR2A;SMURF1;RNF111
prerank,import into cell (GO:0098657),0.3612757133524951,1.0631602303123906,0.38472622478386165,0.9573684264489095,1.0,5/41,4.87%,SLC1A3;SLC6A13;ATP1A2;SLC12A6;SLC7A8
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.39137001598054355,1.0631533512969673,0.3814756671899529,0.9562442954823224,1.0,7/28,15.09%,CCDC22;PTEN;FMR1;PTK2;PSMC5;AXIN1;CLU
prerank,cardiac myofibril assembly (GO:0055003),0.44436350942358965,1.062984561683228,0.38290598290598293,0.9556134721474734,1.0,1/15,0.14%,PDGFRA
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4329148291456505,1.0629086038540712,0.3610648918469218,0.9547375917727849,1.0,5/16,21.23%,BOD1;SGO1;NAA50;SMC1A;MAU2
prerank,regulation of insulin secretion (GO:0050796),0.307005955373875,1.0628325408511359,0.35400516795865633,0.9538356385438727,1.0,17/101,10.49%,RAPGEF4;ADCY5;CACNA1E;TCF7L2;ITPR1;NR1H4;REST;IRS1;TM7SF3;IRS2;TRH;PER2;PRKCA;KCNC2;SYT7;GCK;PPP3CB
prerank,cell-cell junction assembly (GO:0007043),-0.283738252704248,-1.062761477897437,0.3253012048192771,0.6800690765791244,1.0,24/63,19.87%,PKP4;TJP1;VCL;ACTB;CLDN5;CDH8;ACTG1;GJB2;CTNND1;RHOC;GJC1;GJD3;CLDN12;GJB6;TRPV4;RAMP2;CDH5;CTNNA1;PAK2;PKN2;CD9;CLDN11;PKP2;CNTNAP1
prerank,UV-damage excision repair (GO:0070914),0.4492670587417634,1.0627195041638573,0.4006908462867012,0.9530661354221679,1.0,3/12,9.10%,ERCC1;POLA1;XPC
prerank,response to endoplasmic reticulum stress (GO:0034976),0.30906402194335064,1.062697954606723,0.3518987341772152,0.9520007354253087,1.0,33/107,21.56%,PIK3R1;ITPR1;MBTPS2;SEC16A;PIK3R2;SEL1L;CREB3L2;ATP2A2;CASP4;HERPUD1;TMX1;DNAJB12;TP53;RCN3;DNAJC10;USP19;HSP90B1;EIF2S1;HSPA5;CREB3L1;BAK1;BAG6;BRSK2;UBXN6;BBC3;EIF2AK3;DDRGK1;RHBDD1;MBTPS1;TNFRSF10B;ATG10;ATF6B;DDIT3
prerank,cholesterol biosynthetic process (GO:0006695),0.37831960756340266,1.0622632223053914,0.3812405446293495,0.9522293203837351,1.0,7/31,11.95%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4493853769954918,1.0615108536723967,0.37543859649122807,0.9535675812421623,1.0,1/13,0.10%,IL33
prerank,histone H4 deacetylation (GO:0070933),0.4805518067891543,1.0612498451359191,0.3960216998191682,0.9533041349077894,1.0,2/10,4.28%,HDAC1;REST
prerank,positive regulation of cell development (GO:0010720),-0.32732067865051173,-1.0610530389654327,0.3514285714285714,0.683562553229976,1.0,13/31,26.31%,PDE3A;BAD;RFX3;NIBAN2;CX3CR1;TGM2;GPER1;SOX11;TYROBP;MME;SPEN;LIG4;NUMB
prerank,cell projection assembly (GO:0030031),-0.34809485586738365,-1.0609706010993394,0.365,0.6829973617789575,1.0,6/22,6.77%,PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.44265657400801905,-1.060965923893949,0.39198218262806234,0.6822341243987823,1.0,3/10,4.26%,CST3;DPP4;NOTCH1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.46125779285294005,1.0608406616514876,0.4045138888888889,0.953445389979237,1.0,4/12,14.03%,ODC1;HNMT;TRH;ATP7A
prerank,regulation of neuroinflammatory response (GO:0150077),0.4130809533903528,1.0607009020022502,0.3853820598006645,0.9527718800330448,1.0,1/19,0.10%,IL33
prerank,negative regulation of signal transduction (GO:0009968),0.28549733809596195,1.060561976428024,0.35714285714285715,0.9520524251762289,1.0,39/249,14.69%,APOD;ENPP1;DCN;LRP1;SULF1;HRG;SPRY4;PTPRT;SPRY1;PTEN;HIF1AN;PIP4K2A;NKD1;PTCH2;NEDD4;IRS1;LRRK2;ADAMTS12;RPS6KB1;LRRC14;BEND6;DCC;LGMN;PRKCB;TLE1;NKD2;GLI3;TNS2;UBASH3B;CBLN1;IL12A;HGS;GSK3A;CNOT1;HERC4;LYN;CTNNBIP1;CREB3L1;ASXL1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.383199539171322,-1.0605341235066696,0.3459715639810427,0.6825147643838904,1.0,8/15,33.08%,JMY;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4;WHAMM;ACTR3
prerank,positive regulation of developmental process (GO:0051094),0.2937853202456603,1.0604053641811588,0.367103694874851,0.9514028172513762,1.0,25/164,9.69%,PTN;DCN;EDN3;WNT5A;BASP1;NRXN1;FGFR1;PHLDB1;GRIP1;GJA1;REST;FBXO5;SOX6;NCOA3;FOXO6;FMR1;ZBTB16;SORL1;SRF;HMCES;PINK1;RELN;ADGRL1;TAPT1;BMP7
prerank,cellular response to organic cyclic compound (GO:0071407),0.2981439767304474,1.0604053429106963,0.3537331701346389,0.9502742255345894,1.0,28/141,13.82%,RORA;ADCY5;ATP1A2;NR1H4;P2RY1;JUP;NCOA3;CASP6;SPP1;ATP1A3;LRRK2;PDE12;ADCY8;ADCY3;ADCY2;HCN2;HCN1;GABRG2;HCN3;P2RX4;SPIDR;TRPM2;HSP90B1;AKAP6;NRIP1;RYR3;MED1;GABRB1
prerank,autophagy of nucleus (GO:0044804),0.42896219487132853,1.0600558446651729,0.39862542955326463,0.9502688913095797,1.0,6/16,17.76%,ATG9B;WDR45B;RB1CC1;ATG9A;ULK2;WIPI2
prerank,tetrapyrrole metabolic process (GO:0033013),0.4191104772303639,1.059883637889416,0.3921901528013582,0.9497420041917783,1.0,5/18,17.19%,MMAB;MTRR;ABCB6;MMAA;MMUT
prerank,neutrophil degranulation (GO:0043312),-0.21832585797262868,-1.0598325831699367,0.25,0.6835705439461222,1.0,119/425,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,regulation of cell morphogenesis (GO:0022604),-0.3259918348132132,-1.059267266237427,0.35942028985507246,0.6842449291488891,1.0,10/30,16.27%,LARP4;SPARC;CAPZB;EFNA5;CD44;CFL1;BCL9L;MACF1;MFSD2A;PDPN
prerank,mesonephric tubule development (GO:0072164),0.44225648840310783,1.0589798616032888,0.38178633975481613,0.9515210739727376,1.0,2/15,2.53%,ROBO2;SALL1
prerank,lipoxygenase pathway (GO:0019372),-0.4083730206157171,-1.058685436210358,0.360381861575179,0.6850219238654902,1.0,4/14,19.42%,PON3;GPX1;PTGS2;ALOX12
prerank,neuron remodeling (GO:0016322),-0.45214601460325415,-1.0585478022221215,0.4327354260089686,0.6845770021140652,1.0,3/10,5.81%,ANKS1A;APP;SCARF1
prerank,regulation of telomerase activity (GO:0051972),-0.3002256897281286,-1.0584320136399532,0.32919254658385094,0.6841007934433704,1.0,11/45,15.68%,HMBOX1;KLF4;PTGES3;SMG6;PARN;NEK7;MAP2K7;CCT4;ATM;MAP3K4;PARP4
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.40420222931728766,-1.0582578198534403,0.3793911007025761,0.6837967705473889,1.0,5/14,13.58%,LIMS2;ITGB1BP1;PHACTR4;CD63;FLNA
prerank,regulation of chondrocyte differentiation (GO:0032330),0.39656773996416605,1.0581667729882651,0.3876582278481013,0.9530639991436122,1.0,7/24,12.02%,TRPS1;LOXL2;SOX6;ZBTB16;ADAMTS12;TGFBR1;SOX9
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.45386270165745013,1.057926862231246,0.377326565143824,0.9527109701934989,1.0,2/13,3.59%,PTPRT;TSLP
prerank,cellular iron ion homeostasis (GO:0006879),-0.2882641121327305,-1.0579189083799165,0.31986531986531985,0.6839277270152425,1.0,21/55,24.44%,ABCG2;HMOX2;CUL1;TFRC;SCARA5;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;TMEM199
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.3914604374450657,-1.0576216439018393,0.3842239185750636,0.6838932631868321,1.0,2/17,4.08%,LPGAT1;PLA2G4A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2722965534853099,-1.057590859213805,0.3486590038314176,0.6832019185449096,1.0,20/70,16.14%,FOXC1;PSMC6;PRKDC;LMO2;PSMD9;RUNX1;PSMF1;PSMB7;PSMD8;PSMD12;GATA2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;TAL1;PSMB6;PSMC1;PSMB10
prerank,positive regulation of axon extension (GO:0045773),-0.35293074772867744,-1.0575631974640933,0.36187845303867405,0.6825093385654967,1.0,8/22,13.68%,NTN1;SEMA7A;NRP1;RUFY3;MEGF8;MAPT;GOLGA4;MACF1
prerank,endothelial cell migration (GO:0043542),-0.30798829746059264,-1.0573111472914651,0.347953216374269,0.6823789617627245,1.0,10/37,10.26%,NOS3;ID1;FSTL1;NRP1;DPP4;CYP1B1;CCN3;GIPC1;NR4A1;RAB13
prerank,positive regulation of chromosome organization (GO:2001252),0.44692449133804685,1.0571818016617571,0.3953488372093023,0.9539416945332183,1.0,4/15,10.89%,GNL3;FEN1;SIRT6;DHX36
prerank,potassium ion export across plasma membrane (GO:0097623),0.4530138530932869,1.0570370675411782,0.39572192513368987,0.9533021139603935,1.0,3/13,10.96%,KCNT2;KCNIP2;KCNE4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.37231719593176027,-1.056854692754276,0.38095238095238093,0.6827824246930011,1.0,7/18,13.00%,HDAC4;NOTCH1;CCN3;FZD7;FRS2;HDAC3;TMEM119
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.2719224056915589,-1.0567868358317924,0.3485915492957746,0.6821956191085191,1.0,18/67,13.71%,CAV1;TBC1D19;PODXL;FER;RABEP2;RDX;TBC1D8;RAC1;TBC1D22B;CAPZB;CDC42;PPP1R16B;RAB5A;ATP8B1;IFT140;TBC1D22A;CYLD;TBC1D10B
prerank,neutrophil activation involved in immune response (GO:0002283),-0.21802035996723582,-1.0565843032954936,0.2826086956521739,0.6819339873433358,1.0,119/428,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,DNA methylation (GO:0006306),0.3982946982094657,1.0561257606621186,0.39158576051779936,0.9550849340431997,1.0,9/23,22.91%,KMT2E;FOS;MTRR;DMAP1;N6AMT1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3072217724986254,-1.0560262642001852,0.3625,0.6825865037936834,1.0,7/36,14.64%,CAV1;MYLK;ATP2B1;ORAI1;ANK2;TRPC6;P2RX7
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4113788334162021,-1.0555334315843565,0.4088785046728972,0.6831141317626993,1.0,3/13,4.26%,RBPJ;CPE;NOTCH1
prerank,positive regulation of ossification (GO:0045778),0.36440360944866745,1.0554540260772138,0.3780487804878049,0.9562105919277818,1.0,5/39,5.18%,PTN;GPM6B;ADGRV1;WNT5A;ZBTB16
prerank,positive regulation of neuron differentiation (GO:0045666),0.35647189364760246,1.0553895113957654,0.3805970149253731,0.9552913727356018,1.0,15/40,25.26%,ZEB1;TCF4;FGFR1;REST;BEND6;NRCAM;IMPACT;BRINP1;BMP2;RHOA;MMD2;TRIM32;ZC4H2;CPNE1;VWC2
prerank,amino acid import (GO:0043090),0.4039236974717686,1.055208261090332,0.38235294117647056,0.9547743360408336,1.0,3/21,4.87%,SLC1A3;SLC6A13;SLC7A8
prerank,gastrulation (GO:0007369),-0.39185084204327114,-1.0550001785891765,0.37528604118993136,0.6836752129230624,1.0,4/15,15.84%,GPC3;MEGF8;UGDH;MKKS
prerank,positive regulation of protein transport (GO:0051222),-0.27176200684310625,-1.054903232359561,0.3686274509803922,0.683150186493341,1.0,19/67,22.19%,IGF1;EZR;CNST;RUFY3;TGFB2;UNC13B;PRR5L;CEP290;CD2AP;MYH10;GOLPH3L;PPIA;OAZ1;BCAS3;OAZ2;APBB1;ADAM9;VPS28;MYO18A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4167728806750442,-1.0532784021073613,0.3900709219858156,0.6865130805010875,1.0,6/12,25.89%,SMCHD1;CDYL;PCGF5;RBM15B;RLIM;BRCA1
prerank,cellular response to starvation (GO:0009267),-0.24225247560178462,-1.0532147221584875,0.30177514792899407,0.6859128880996854,1.0,44/147,23.55%,PRKAG2;FOXO1;XPR1;FNIP1;RNF152;BMPR2;BECN1;MAP3K5;FAS;HSPA8;SREBF2;GABARAP;SESN1;PRKAA2;GABARAPL1;SIK1;DAPL1;LAMTOR5;SFRP1;RRAGC;CLEC16A;MYBBP1A;RALB;PRKAG3;LAMTOR3;MFSD2A;CDKN1A;SIRT1;PRKAA1;ATP6V0E2;MAP1LC3A;LAMP2;NUAK2;SEH1L;RRAGB;HNRNPA1;ASNS;MAP1LC3B;WDR45;ATP6V0D2;INHBB;KLF10;NPRL3;ATP6V1G1
prerank,regulation of immune response (GO:0050776),0.29672010731269743,1.0530277026407302,0.3624242424242424,0.9606230314860608,1.0,17/135,10.09%,COLEC12;TREML4;CD40;CD8B;PIANP;PTPN22;CD276;DHX58;SH2D1A;COL1A2;OSCAR;BCL6;CD200R1;ADCY7;APPL2;BIRC2;FGR
prerank,negative regulation of protein polymerization (GO:0032272),-0.33096454291187166,-1.0528683117970934,0.3675675675675676,0.6859732532844312,1.0,9/27,21.46%,SLIT2;KANK3;HIP1R;KANK1;SSH1;CDH5;PRKCD;EML2;TWF2
prerank,Golgi localization (GO:0051645),-0.4196973463877556,-1.052845531546812,0.37383177570093457,0.6852468782215388,1.0,4/11,14.84%,UVRAG;CDC42;ARCN1;STK25
prerank,mRNA modification (GO:0016556),-0.3548518829958448,-1.0528111086076553,0.3699731903485255,0.6845840384550668,1.0,4/22,8.67%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2254131459725166,-1.0526614268480197,0.33,0.684231939752094,1.0,47/259,11.91%,ABLIM1;RAPGEF2;ABCC4;ANO6;FGD5;ACTN2;VCL;FNBP1L;BBS9;EXOC6;MYLK;RAPGEF6;ITGB1;NTN1;EZR;CDC14A;NRP1;PARVB;S1PR1;EXOC4;FXYD5;GSN;RAP1A;RAB23;NOTCH1;EXOC5;MINK1;OFD1;RAC1;SRGAP2;ARL6;KIF24;CYS1;DNM3;CEP290;CEP162;EHD4;EXOC2;RFX3;IFT140;SPATA13;RAB3IP;CCDC88A;GALNT11;RP2;CD2AP;TMEM237
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3478300933110175,1.0525159548685703,0.3788098693759071,0.9611235919984327,1.0,8/46,9.41%,SPRY1;PTEN;PTPRR;CNKSR3;SPRED1;RPS6KA6;SPRED2;TLR4
prerank,response to lipid (GO:0033993),-0.25015002279479026,-1.0521967702264197,0.3592233009708738,0.684615185067229,1.0,21/105,13.46%,SMAD6;FOXO1;FOXP1;FER;NOS3;LBP;ACER2;PELI1;RBP4;SOCS2;ANXA1;RXRA;ALPL;IFNAR1;PAQR7;GCH1;TRIM16;CTSH;NOS1;TAB2;GATA6
prerank,cellular response to insulin stimulus (GO:0032869),0.2988744912852212,1.0521547538454694,0.38405797101449274,0.9611716100600006,1.0,22/124,13.09%,ENPP1;LPIN3;PIK3R1;CPEB1;PHIP;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;GCK;SLC25A33;RAB15;PDK2;IGF2;GSK3A;ATP6V0E1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2846272826845933,1.0519957252093335,0.3613348676639816,0.9605376716036849,1.0,42/184,18.28%,DYNLL1;CDC14B;BUB1B;PSMD1;DCTN3;HAUS3;HAUS1;FBXO5;HMMR;DCTN2;CENPE;CDC16;PSMD10;ZFP36L2;PSMA5;PSMB5;HAUS8;PRKACA;CEP192;APPL2;XPC;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;CEP250;TFAP4;CEP152;CSNK1E;CENPF;CLASP1;PSMA7;PSMD14;ALMS1;CDC26;PCM1;PSMA2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.41333622039103385,1.0519107099336857,0.38102893890675243,0.9597099003595141,1.0,7/19,16.74%,CAMKK2;PINK1;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.38497570363276135,1.051892236945878,0.39546191247974066,0.958659659697626,1.0,5/24,8.47%,NAT10;ERCC4;TERF1;PIF1;TENT4B
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.33978912964207497,-1.0518662159801133,0.37815126050420167,0.6846588224076914,1.0,12/26,30.23%,ST3GAL4;B4GALT5;TPI1;LARGE1;RRM2B;ST3GAL2;GCNT1;GAL3ST2;ST8SIA6;SCCPDH;RRM1;GK5
prerank,water-soluble vitamin metabolic process (GO:0006767),0.32569218239737385,1.0517435255394538,0.377027027027027,0.9579793573582515,1.0,7/68,6.65%,ENPP1;MMAB;PDXK;MCCC1;GSTO2;MTRR;MTHFD1L
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.38012773015689333,1.0516004469515687,0.404320987654321,0.9572945828025159,1.0,6/31,13.42%,CDC14B;PTEN;GOLGA2;PINK1;DCUN1D5;AXIN1
prerank,regulation of cytokine production (GO:0001817),0.29659787004672356,1.0508337234395118,0.37682926829268293,0.9587286812646899,1.0,17/126,11.37%,IL33;TXK;PLA2R1;GLMN;LURAP1;ICOSLG;DTX4;HTR2B;CD276;TRIM56;POLA1;BCL6;CIDEA;KAT2A;FGR;EIF2AK2;ASB1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3887611026042598,-1.0507420669909355,0.39371980676328505,0.6867408978068157,1.0,6/17,20.48%,IL18;CD55;BACH2;GNL1;BTN3A3;CD46
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4072163164436491,1.0505704951283121,0.40589198036006546,0.958393743456505,1.0,2/19,0.85%,DCN;HRG
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.40555440654535285,1.0501678995355057,0.39718804920913886,0.9585741109868098,1.0,4/19,8.47%,NAT10;TERF1;PIF1;TENT4B
prerank,peptidyl-serine modification (GO:0018209),-0.23129437619669158,-1.050080319375295,0.31756756756756754,0.6876866517134826,1.0,49/166,21.19%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;CAMK2D;PRKDC;TOP1;VRK3;TLK1;MAPK9;WNK1;HIPK3;MAPK14;NTMT1;GSK3B;HIPK1;TLK2;STK38L;MAST3;DYRK2;RPS6KA5;CAB39;ATR;RPS6KA1;PRKCZ;HIPK2;ATM;CSNK1G3;GALNT1;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;STK32B;AKT1;CSNK1A1;SBK1;VRK2;MARK2;ULK3;MKNK1;GALNT3;PKN3;TGFBR2
prerank,error-prone translesion synthesis (GO:0042276),0.39966153209381766,1.050009677501711,0.36363636363636365,0.9579349752379223,1.0,7/21,14.01%,POLK;RPA1;RFC3;REV3L;POLH;REV1;POLI
prerank,histone H4-K16 acetylation (GO:0043984),0.42119321439266816,1.0498687046008004,0.42996742671009774,0.957271245600965,1.0,6/19,11.31%,OGT;KMT2A;WDR5;MSL1;KANSL1;JADE1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3255997262441952,1.049560821012055,0.3748271092669433,0.9571648610833478,1.0,13/70,15.90%,LPIN3;GPLD1;NR1H2;CHAT;LIPC;PLA2G7;CHKA;MBOAT7;STARD10;PLA2G12A;LPIN2;ABHD4;CSNK2A2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.29955920195624963,-1.0494438034901434,0.33440514469453375,0.6885332658666287,1.0,14/42,14.89%,TEK;PTPRJ;NRP1;S100A10;KDR;RAC1;CDK6;PPM1F;GSK3B;SFRP1;PLEKHA2;PTK2B;RRAS;CX3CL1
prerank,cellular component assembly (GO:0022607),0.28087758482174513,1.049002776640007,0.3744394618834081,0.9578659775910265,1.0,40/253,12.05%,LAMC1;GPM6B;WIPF1;TEAD1;PPID;WNT5A;CD40;STAG3;RHOJ;EPRS1;RSPH9;SPTBN1;ANK3;FSCN1;TEAD2;YWHAZ;LRRTM3;RAC3;KMT2A;VAMP2;FANCA;PPIH;MYO1B;NEFH;LLGL1;CAPN3;WASF3;TEX11;MDM4;CHAF1B;KIFAP3;NOC2L;IL1RAP;OPHN1;TP53;RIMS1;DLG4;GAS8;SOX9;TUBGCP4
prerank,neutrophil mediated immunity (GO:0002446),-0.21687346257821866,-1.0489708961257185,0.23255813953488372,0.6890107074366131,1.0,121/432,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;ACE;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;IRAK4;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,regulation of establishment of planar polarity (GO:0090175),0.3095854991850143,1.048921630363511,0.40425531914893614,0.9570457483267601,1.0,22/88,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;NPHP3;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMA7;PSMD14;PSMA2;RHOA;SPEF1;PSMD11
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4056564736616959,1.0488919489349013,0.40404040404040403,0.9560517508725168,1.0,5/20,11.21%,AGO4;SPOUT1;ZC3H7B;MRPL44;AGO3
prerank,hepaticobiliary system development (GO:0061008),-0.3579630950503014,-1.0488333940475003,0.38461538461538464,0.6885950723969961,1.0,8/20,22.23%,ARID5B;WNT4;COBL;LSR;CITED2;MET;TGFBR3;PHF2
prerank,apoptotic DNA fragmentation (GO:0006309),0.42617212635895146,1.0488122892178913,0.3912280701754386,0.9551896271077002,1.0,1/16,0.46%,CECR2
prerank,cellular protein modification process (GO:0006464),-0.20341268132820398,-1.0487226191543009,0.0,0.6881490143649189,1.0,298/983,24.43%,PRKAG2;FN1;DAPK1;ST3GAL6;PTPRB;FBXL7;MAP3K1;ROCK2;PRKCH;PPM1E;MARK1;PTPRJ;ERG;ST8SIA4;B3GALT1;DCLK1;TRIB2;FER;PTPRK;LMO7;THBS1;PTPN3;IGFBP5;GAN;MTM1;APP;FSTL1;CPE;PTP4A2;CST3;BMPR2;KLHL13;CSNK1D;ASB2;PTPN4;MARK4;PSMC6;NEK6;IGFBP3;CAMK2D;PPM1L;ST3GAL4;PRKDC;MAP3K5;PTPN14;INSR;PSMD9;WWP2;PTPRG;TGFB2;ART3;SOCS2;B4GALT5;EGLN3;UBE2D3;SIK3;MINK1;ANXA1;PSMF1;HIF3A;WNK4;GPC3;ST3GAL1;PSMB7;PRKAA2;TLK1;MAPK9;CUL1;CDK6;ADAM10;CDK17;SERPIND1;SNRK;WNK1;PPP2R1A;HIPK3;OGA;PTPRF;ST6GALNAC2;PRSS23;FBXL2;SIRT3;PRAG1;NRBP2;NUCB1;SIK1;PPM1F;TNKS2;APOE;CCN1;BMX;GSK3B;HIPK1;ACVR1;ZC3HAV1;RAB5A;UBE2F;CDC42BPB;UST;ACVRL1;TNC;FNIP2;MSLN;ST3GAL3;MGAT1;LARGE1;LAMB2;TLK2;NEK7;MANBA;NGLY1;STK38L;KLHL11;CTTNBP2NL;DCAF8;PSMD8;DYRK2;SSH1;PIGU;RPS6KA5;LIPE;FBXL19;CDK19;PSMD12;PPM1D;PIK3CD;ASB5;KLHL20;PPEF2;SHISA5;RAB13;CAMK2B;PTPN1;PARP10;VHL;PARP9;PPP3CC;ST8SIA2;STK19;CUL9;CDKL2;NEURL2;SPSB4;UGCG;GPAA1;LHPP;RET;FASTK;SRPK1;TGM2;KCTD6;B3GALNT1;PRKCZ;PSMA3;LOXL1;HIPK2;PSMA6;PRKAG3;ATM;MMP15;PSMD4;CSNK1G3;PSME3;FBXL4;GOLM1;BCR;FUT9;PRKG1;RAB38;PPP2R5D;PTK2B;PSMD7;RNASEL;ST3GAL5;USP25;PSMB6;F5;STK25;TBCK;STK17B;CDC42BPG;ELOC;CREB1;ERN1;PSMC1;MARK3;PRKCD;CHRDL1;FBXO32;PARP4;TEC;ST3GAL2;SBF1;UBE2L6;SIRT1;PSMB10;PRKAA1;RAB1A;DYRK1B;TBK1;PAK2;PKN2;FBXL14;NEDD8;CUL3;AATK;FNTB;ISG15;DCUN1D3;OARD1;ASB7;ACVR2B;RBBP7;ERBB2;MAN2A1;NAA80;YES1;B3GNT2;CDK9;AKT1;MFGE8;PPP1CB;QPCT;NUAK2;PPP2R5B;CSNK1A1;PRKG2;CCDC8;WNT11;SIRT5;VRK2;PSME2;STT3B;MARK2;MAP4K3;MTMR2;KLHL25;PTPN5;MCRS1;MKNK1;DNAJC3;MACROD1;NUS1;CDC34;RAB1B;ASB8;GPS1;PKN3;PIM2;SOCS5;KLHL3;ASB6;TGFBR2;PSMC3;WDR45;ICMT;PIGK;KBTBD7;PENK;FBXO22;NEK10;B3GNT9;CDKL4;FBXL8;UBA52;TTBK1;PHEX;FBXW2;PASK;STK39;CISH;FBXL18;PSMA8;IKBKE;ACVR2A;FSTL3;FBXO10;SOCS3;CTDP1;ST8SIA6;BRD2;F13A1;CDK16;PLK4;IKBKB;FN3K;PAK4;PTPRE;MPI;COQ8A;GRK4;TAOK2;PARP1;MT3;PARP2;BAP1;RSKR;PTPN6
prerank,regulation of cell development (GO:0060284),-0.3076588014114696,-1.048265805973998,0.3627760252365931,0.6885831157128084,1.0,15/36,26.25%,FOXO1;NOTCH2;RPS19;CX3CR1;HEYL;HEY2;CX3CL1;CLOCK;BHLHE40;HMGB2;AKT1;FBXO22;BHLHE41;YTHDF2;HES6
prerank,response to peptide hormone (GO:0043434),-0.2946872715247414,-1.0480833063261537,0.3680555555555556,0.6882712768172966,1.0,13/43,19.16%,ROCK2;CAV1;IGFBP5;ANXA1;TRIM16;EIF2B4;CREB1;SIRT1;GPER1;EPM2AIP1;AKT1;ZBTB7B;TGFBR3
prerank,positive regulation of heart rate (GO:0010460),0.42120651144444154,1.0479034032392323,0.4135702746365105,0.9569343188145656,1.0,3/17,5.93%,EDN3;RYR2;ATP2A2
prerank,determination of bilateral symmetry (GO:0009855),-0.3402590528424878,-1.0477959460555586,0.35904255319148937,0.688199125268592,1.0,10/24,21.05%,NOTCH1;ARL6;TBX1;CITED2;GALNT11;ZIC3;MKKS;DNAH11;BBS7;DNAH5
prerank,DNA strand elongation (GO:0022616),0.4219206518960718,1.0477195158869517,0.41778523489932884,0.9563854608400997,1.0,5/18,10.71%,MCM7;GINS3;POLA1;RFC3;MCM4
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.399055427909354,1.0474025610124769,0.3872549019607843,0.9563057761773107,1.0,2/19,6.58%,CHRNB4;COLQ
prerank,regulation of receptor internalization (GO:0002090),-0.31763755667356464,-1.0473146582069128,0.3669724770642202,0.688627677471612,1.0,14/35,26.88%,MAGI2;RIN3;INSR;CD63;EGF;SDCBP;MTMR2;TBC1D5;ANKRD13D;NTF3;GREM1;FLOT1;ARRB2;ARF1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.39539787222773193,-1.047266374678053,0.4055299539170507,0.688002449891696,1.0,6/14,15.11%,ELAVL1;YBX3;MAPK14;TARDBP;HNRNPC;ANGEL2
prerank,vasculature development (GO:0001944),0.42924092078573756,1.047222411157126,0.38747884940778343,0.9557827045947548,1.0,1/16,0.14%,PDGFRA
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.34251622102493984,-1.047165077188786,0.39361702127659576,0.6875315364518185,1.0,8/25,23.08%,LAPTM4B;CHMP2B;VCP;CHMP4B;CHMP4A;CHMP7;CHMP1A;CHMP4C
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.23464205903368257,-1.04716432603869,0.2893081761006289,0.6867831267441151,1.0,35/170,15.94%,PRDM6;IGF1;ROCK2;FOXP1;APP;CDH1;ZNF462;SIRPA;YBX3;NFKBIZ;TAPBP;CDK6;PRDM2;MEGF8;TRIM5;TRIM11;AFF4;PRDM11;NOVA2;TRIM14;APOE;MTMR9;PCBP2;CRIP1;HMG20B;UBAP2;TARDBP;HNRNPDL;YBX1;PTHLH;CIAO3;CAVIN4;TOB1;POGZ;TRIM27
prerank,neutral amino acid transport (GO:0015804),0.371998381100486,1.047050257441925,0.3830769230769231,0.9552102750579459,1.0,3/28,4.87%,SLC1A5;SLC43A1;SLC7A8
prerank,negative regulation of MAPK cascade (GO:0043409),0.3132940235043282,1.0467742866401777,0.38817480719794345,0.9549767611573222,1.0,15/87,9.69%,SPRY4;SPRY1;PTEN;PTPRR;DUSP1;CNKSR3;PIK3R2;SPRED1;SORL1;NF1;PSMD10;RPS6KA6;SPRED2;TLR4;BMP7
prerank,cellular response to gamma radiation (GO:0071480),-0.3761206364043096,-1.0467100014510795,0.4013921113689095,0.6871883942014061,1.0,6/17,16.30%,CRYAB;TLK2;ATR;RPL26;ATM;TMEM109
prerank,regulation of ATP metabolic process (GO:1903578),0.3336545704680883,1.0464952325429802,0.3974358974358974,0.9547398228247835,1.0,20/54,23.31%,OGT;NUP214;AAAS;POM121;PINK1;AK4;GCK;SLC25A33;NUP42;NUP107;ATP7A;COX7A2L;ZBTB7A;NUP54;NUP155;HIF1A;UQCC2;RANBP2;FIS1;NUP35
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3701601787695891,1.0464071507255368,0.38330757341576505,0.9539087592726556,1.0,4/30,10.90%,XCL1;TSLP;TLR4;PYCARD
prerank,maturation of SSU-rRNA (GO:0030490),-0.32118774979733605,-1.0463415250134935,0.4046920821114369,0.6873607323150549,1.0,9/34,13.28%,RPS14;RPS16;DDX52;RPS19;LSM6;RIOK1;UTP3;RIOK3;RPS8
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4493649657282905,1.0461371997182989,0.4203152364273205,0.953662717471388,1.0,1/12,0.21%,COLEC12
prerank,metanephric mesenchyme development (GO:0072075),-0.4445133358528158,-1.0460813416940538,0.4021505376344086,0.6872240848048756,1.0,3/10,5.87%,OSR1;WNT4;SIX1
prerank,regulation of cell projection organization (GO:0031344),0.4545018586659289,1.0460603588198276,0.40808823529411764,0.9528258894631206,1.0,4/13,18.87%,ERMN;NTNG2;NTNG1;SPRY2
prerank,cellular response to drug (GO:0035690),-0.3429513407662385,-1.0455976172549177,0.38095238095238093,0.6877069781843649,1.0,7/25,10.98%,PPM1E;MEF2C;ACER2;TFRC;PPM1F;RBM22;KCNQ1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.40165567342207636,1.0448500559124347,0.40032414910858993,0.955554692578689,1.0,7/21,19.98%,BUB1B;FBXO5;TEX14;BUB1;CENPF;KLHL22;TRIP13
prerank,cellular response to hormone stimulus (GO:0032870),0.3234969906801547,1.0447832079726858,0.38858695652173914,0.9546989340721188,1.0,7/69,6.46%,ROBO2;GHR;ATP1A2;NCOA2;NCOA3;ATP1A3;BRD8
prerank,cellular response to light stimulus (GO:0071482),0.32537368258615723,1.044722481313395,0.39207650273224043,0.953839216087392,1.0,12/66,15.40%,GPR88;POLK;FMR1;NEDD4;ERCC4;NOC2L;GPR52;TP53;DHX36;EIF2S1;BAK1;MYC
prerank,negative regulation of growth (GO:0045926),-0.24438851519005822,-1.044701760835443,0.34574468085106386,0.6891099592399375,1.0,60/121,30.92%,APBB2;PTPRJ;SLIT2;FHL1;NOTCH2;BMPR2;SMARCA4;OSGIN2;SMARCA2;NOTCH1;TGFB2;CCN3;SH3BP4;PPP2R1A;IP6K2;PRDM11;ACVRL1;SOX17;SMAD3;MT2A;NPR1;HYAL1;SFRP1;ENO1;CDKN2AIP;ING4;CDKN1A;SIRT1;ING5;VGLL4;DCUN1D3;RBBP7;FGFR3;APBB1;WNT11;RERG;RTN4;SPHK2;CCAR2;BTG1;NDUFA13;CDA;PNPT1;MT3;HYAL2;HSPA1A;SMAD4;RB1;DNAJB2;SESN2;HSPA1B;MINAR1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,monocarboxylic acid transport (GO:0015718),0.33741442957393714,1.0445985389093648,0.39628040057224606,0.9531590222192408,1.0,6/51,3.46%,ABCC3;SLC6A13;SLC6A8;SLC16A12;NR1H4;NCOA2
prerank,negative regulation of cell adhesion (GO:0007162),0.32068151426042596,1.0443694501259981,0.37402597402597404,0.9528135681271543,1.0,12/72,8.20%,PLXNC1;HRG;TGFBI;SEMA5A;CORO2B;SIPA1;DUSP1;GCNT2;DSCAM;PTPRO;PTK2;JAM3
prerank,carboxylic acid transport (GO:0046942),-0.2825552837589212,-1.0441353996419465,0.3835125448028674,0.6898678191175523,1.0,17/55,16.17%,SLC13A3;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC7A1;SLC3A2;SLC16A1;SLC16A4;SLC38A5;SLC7A5;SLC6A17;SLC1A1;SLC6A7;SLC16A9;SLC36A4;LLGL2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.2956685833282354,-1.0434902147872673,0.3885135135135135,0.6907139400243055,1.0,14/43,22.66%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;ACVR1;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,positive regulation of protein metabolic process (GO:0051247),-0.24823826076518116,-1.0434860110788047,0.3382352941176471,0.6899752644209566,1.0,34/110,23.52%,FOXO1;ROCK2;WWP1;IL18;APP;KLF4;WWP2;GPC3;APC;KLF2;APOE;GSK3B;VCP;SMURF2;NFKBIA;ASB5;RNF41;APC2;AGTR1;MAP2K5;OAZ1;PAEP;RAB1A;OAZ2;AKT1;ABCB10;FZR1;AGT;RAB1B;TNFAIP3;VPS28;NDUFA13;BCL10;SMURF1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.36789506239676983,1.0433759008412027,0.38316400580551524,0.9547957712828451,1.0,4/33,3.87%,PPARA;SEMA5A;TCF7L2;PDPK1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.41812706144246786,-1.0432797963874638,0.40326340326340326,0.6897576829131294,1.0,7/11,20.48%,CD200;THBS1;CD34;GATA6;PTGS2;ATP6AP2;CD46
prerank,activin receptor signaling pathway (GO:0032924),-0.3860805932458662,-1.0431916939541144,0.41531322505800466,0.6892396401359088,1.0,5/15,22.99%,ACVR1;SMAD3;ACVR2B;INHBB;ACVR2A
prerank,regulation of lipid metabolic process (GO:0019216),0.3129238386662373,1.0431623738041944,0.37466666666666665,0.9544199188591634,1.0,25/88,21.85%,RORA;PPARA;NCOA2;PPARD;C1QTNF2;SC5D;IRS2;CHD9;EDF1;NCOA1;HMGCS1;MBOAT7;CARM1;MED1;SREBF1;ELOVL6;IDI1;NR1D2;PANK2;NPC2;SP1;BBS4;RARRES2;ACACA;CREBBP
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34103991767769015,1.0430893046605525,0.3877551020408163,0.9535946456846,1.0,15/49,21.55%,KMT2E;HDAC1;L3MBTL1;AGO4;KMT2A;WDR5;AGO3;TESC;TNRC6B;ASH2L;AGO1;CBFB;KMT2C;RBM15;RBBP5
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3495146663179511,-1.043081029422858,0.4040920716112532,0.6887721468862754,1.0,11/22,20.81%,DDX5;RPS7;RPS20;UBB;RPS15;ATR;SPRED3;ATM;EEF1E1;HEXIM1;RPL23
prerank,antibacterial humoral response (GO:0019731),-0.37663462115887636,-1.0430698644295553,0.3972602739726027,0.6880520879034097,1.0,6/16,36.37%,PLA2G6;RNASE7;RPL39;SLPI;RNASE3;JCHAIN
prerank,DNA replication (GO:0006260),0.3060501460763488,1.0429636686918398,0.40359897172236503,0.9529361044598704,1.0,21/105,14.03%,RBMS1;POLG;TIPIN;MCM7;FEN1;CDC7;POLA1;RPA1;PIF1;POLL;RFC3;REV3L;MCM4;TOP3A;NAP1L1;POLG2;POLB;POLE3;REV1;MCM10;DBF4
prerank,regulation of interleukin-4 production (GO:0032673),-0.35257767721628475,-1.042558224221467,0.39948453608247425,0.6886600670208403,1.0,4/21,16.77%,LEF1;SLC7A5;PRKCZ;HAVCR2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.32935104901541157,-1.0423917277666799,0.37719298245614036,0.6883252116150989,1.0,13/29,27.79%,SAMHD1;MAVS;PTPN2;PTPN1;RNASEL;NLRC5;ISG15;USP18;PTPN6;YTHDF2;TRIM6;ZBP1;TTLL12
prerank,heart looping (GO:0001947),-0.30045819806223256,-1.0417037178425765,0.36503067484662577,0.6891776974903481,1.0,12/39,22.66%,MEF2C;MICAL2;NOTCH1;SMO;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,mitotic DNA replication (GO:1902969),0.4750350518615871,1.0415352857543991,0.41421143847487,0.9564246670538851,1.0,7/10,27.84%,GINS3;POLA1;MCM4;MCMDC2;GINS1;MCM3;MCM2
prerank,response to organophosphorus (GO:0046683),0.4214134343767115,1.0412178820139555,0.39344262295081966,0.956356279005153,1.0,7/16,23.87%,DGKQ;TRPC3;RFC3;P2RX4;NDUFS4;ABCC9;STAT1
prerank,chromatin organization (GO:0006325),-0.23541954060074552,-1.041176145056346,0.3602150537634409,0.6897333471083297,1.0,43/132,26.33%,MECOM;HDAC4;PBRM1;KDM4A;KDM4C;SMARCA4;SMARCA2;CBX3;TOP1;PRDM16;INO80;HDAC8;HDAC3;SMARCA5;SMARCC2;JARID2;EZH2;DDX11;SIRT1;SNAI1;BAZ1A;FAM50A;ESR1;BAZ2B;INO80C;CHD1;HMGB2;KDM4B;TADA2B;NPM1;CHD1L;SMARCD3;RUVBL2;PHF1;MTF2;HDAC11;SMARCD1;MYSM1;TAF6L;PADI2;ACTL6B;SPI1;RB1
prerank,regulation of fatty acid oxidation (GO:0046320),0.4238753385620548,1.0411419060275289,0.4134948096885813,0.9555490622312985,1.0,5/16,12.16%,PPARA;ACADL;APPL2;SOX9;FABP3
prerank,dephosphorylation (GO:0016311),0.29131056200851235,1.0405674837939802,0.38705738705738707,0.9562558979191373,1.0,23/147,10.69%,CDC14B;PTPRT;THNSL2;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;PLPPR3;PTPRU;PTPRO;PTPN13;SSH2;PLPPR2;PPP2R2A;PPP2R3A;PPP6C;PPP3CB;PLPP6;PDP1;PTPRA
prerank,response to muscle stretch (GO:0035994),0.4348753067663286,1.0402598313485751,0.42333333333333334,0.956221883295079,1.0,3/15,7.70%,RYR2;SLC9A1;PTK2
prerank,cellular glucose homeostasis (GO:0001678),0.35522378366950386,1.0402583899952964,0.39544807965860596,0.9551645829600485,1.0,8/41,10.39%,PIK3R1;ZBTB20;TRA2B;NGFR;PIK3R2;ADCY8;PRKACA;GCK
prerank,nitrogen compound transport (GO:0071705),0.2929927173246614,1.0400466587880044,0.3812423873325213,0.9547969267941107,1.0,19/141,12.95%,SLC1A5;SLC48A1;HRG;SLC6A13;SLC6A8;LRP1B;CALCRL;SLC7A11;SLC43A1;VAMP2;SLC7A8;RUFY1;ABCB6;TMEM30A;SEC14L1;RCN3;SLC7A3;HSP90B1;SLC25A29
prerank,nuclear pore organization (GO:0006999),-0.39098293752275387,-1.0396522876783578,0.3911007025761124,0.6928033169137284,1.0,6/14,21.49%,NUP98;NUP153;TMEM170A;NUP205;SEH1L;RTN4
prerank,DNA biosynthetic process (GO:0071897),0.4241703001275515,1.0396515837132951,0.4076655052264808,0.9549686721502778,1.0,7/16,19.87%,POLA1;CDKN2D;POLL;RFC3;POLH;WRN;POLE
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4609948790585601,1.0395026855153566,0.43109540636042404,0.9543789365383887,1.0,8/12,29.19%,AMPD2;PRPS1L1;PRPS1;MTHFD1;HPRT1;PRPSAP2;GART;PRPSAP1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.26665855422577617,1.0394069442414977,0.37631027253668764,0.9536149182006878,1.0,59/390,14.06%,ROR1;COL4A6;PDGFRA;FLRT2;NTRK3;GHR;PIK3R1;EPHA7;SULF1;NRG1;ROR2;CHN1;MERTK;PTPRT;NTRK2;PHIP;ERBB4;EPHB1;GPLD1;ITGAV;CD8B;GRIN2B;FGFR1;NGFR;PIK3R2;ELMO1;SPRED1;EPHA6;IRS1;IRS2;ANKS1B;PTK2;EFS;SPRED2;PRKD1;EPHB6;AXL;COL4A2;ITSN1;CYBA;AHI1;FGR;EPHA3;FYN;MAPKAPK3;PDK2;UBASH3B;DNM1;IGF2;GSK3A;CASS4;MTSS1;ATP6V0E1;ACTR2;CRK;STMN1;GFRA2;SH2D2A;LYN
prerank,protein localization to kinetochore (GO:0034501),-0.39530131807660274,-1.039029008196187,0.40047961630695444,0.6936257356775166,1.0,7/14,27.48%,MTBP;ZW10;CENPT;BUB3;RCC2;IK;TTK
prerank,negative regulation of microtubule polymerization (GO:0031115),0.45157398013750527,1.0388887701766938,0.4370629370629371,0.9541767458422544,1.0,3/12,13.83%,CLIP3;STMN2;STMN1
prerank,cell chemotaxis (GO:0060326),0.33229090211227313,1.0386879714142094,0.4085872576177285,0.9537419456894979,1.0,5/60,3.26%,PDGFRA;SEMA5A;EPHB1;ACKR2;CCR9
prerank,protein-DNA complex disassembly (GO:0032986),-0.3877303496434326,-1.038658439689908,0.39466666666666667,0.6937576001986158,1.0,12/16,42.40%,ARID2;SMARCA4;SMARCC2;SMARCD3;RPL23;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,sympathetic nervous system development (GO:0048485),-0.38744253765197506,-1.0385577428339159,0.39901477832512317,0.6933162394665267,1.0,5/15,18.24%,NRP2;NRP1;SOX4;FZD3;SOX11
prerank,DNA methylation or demethylation (GO:0044728),0.4069226576929288,1.037964451661677,0.41264559068219636,0.953775240726676,1.0,8/19,22.91%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,DNA alkylation (GO:0006305),0.4069226576929288,1.037964451661677,0.41264559068219636,0.953775240726676,1.0,8/19,22.91%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,positive regulation of macroautophagy (GO:0016239),-0.28467273557908096,-1.037774233473628,0.37987012987012986,0.6945544869656796,1.0,16/48,16.60%,SPTLC2;KDR;UVRAG;SESN1;PRKAA2;HSPB8;BNIP3L;OPTN;PIP4K2C;BAG3;RALB;PAFAH1B2;SLC25A5;SIRT1;TBK1;VPS13D
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3585210540830216,1.0376491706935462,0.4086181277860327,0.9536752580466044,1.0,10/39,15.08%,ERCC1;FAN1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,T cell activation involved in immune response (GO:0002286),-0.4108323817979561,-1.0373296468893076,0.4231678486997636,0.6949358128369607,1.0,5/12,35.38%,ICAM1;MDK;CD74;SLC11A1;LILRB1
prerank,mitochondrion localization (GO:0051646),-0.36027507685242105,-1.0370752150780496,0.41192411924119243,0.6948296263915165,1.0,3/19,2.47%,MARK1;MEF2A;MTM1
prerank,acute inflammatory response (GO:0002526),-0.34205620972959005,-1.0367631772091115,0.391304347826087,0.6949015377449425,1.0,2/23,2.85%,ANO6;LBP
prerank,regulation of axon regeneration (GO:0048679),0.45910680306688884,1.0365799689468325,0.4448462929475588,0.9560433958893555,1.0,1/12,0.19%,PTN
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3800689141782997,1.0364573352231317,0.40923076923076923,0.9553916152626709,1.0,3/25,3.80%,PDE4B;GLMN;SPTBN1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3094186362142234,-1.0364533037475252,0.3956043956043956,0.6949496053154742,1.0,4/34,0.60%,EPHA4;IGF1;PICALM;ROCK2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3760069750476446,1.0364218250346124,0.387987012987013,0.9544495974774023,1.0,6/28,9.06%,PTN;AKAP5;ADCY8;CALB1;RELN;LGMN
prerank,regulation of microtubule nucleation (GO:0010968),-0.43617096633715624,-1.0362322508070347,0.418013856812933,0.6947714293366595,1.0,6/10,35.55%,GIT1;EML2;HSPA1A;HSPA1B;RANGRF;MECP2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3377944116034771,-1.0362249558380567,0.40443213296398894,0.6940538300289177,1.0,10/25,19.65%,RBPJ;BMPR2;FOXD1;NOTCH1;CCN1;ACVRL1;CDH5;ACVR2B;SOX11;NUMA1
prerank,cardiac muscle cell development (GO:0055013),0.40977241954092314,1.0359550493495506,0.41518578352180935,0.9548259820829565,1.0,1/20,0.14%,PDGFRA
prerank,synaptic vesicle recycling (GO:0036465),0.36893146179356723,1.0358242820190702,0.4208,0.954195813966805,1.0,10/31,19.48%,CEL;VAMP2;OPHN1;SYT7;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.40543679333275273,-1.0358090098509534,0.3981042654028436,0.6943532329350732,1.0,7/12,38.41%,SETMAR;HUS1;ORC1;CHEK2;HUS1B;CDC6;TICRR
prerank,heterochromatin assembly (GO:0031507),0.4072616794584179,1.0356482685136759,0.4355108877721943,0.9537033287286476,1.0,3/20,5.03%,HDAC1;CDKN2A;RRP8
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.398183259221768,1.0356416501506254,0.4169435215946844,0.9526873100508603,1.0,10/21,18.45%,GPM6B;PEAK1;SLC9A1;PTK2;EPHA3;PTPRA;SLK;CLASP1;LDB1;RHOA
prerank,regulation of axonogenesis (GO:0050770),0.33406429921919006,1.0356416110841409,0.40173410404624277,0.9516449825781569,1.0,6/51,3.83%,ROBO2;PLXNC1;CHN1;NTRK2;PTEN;NGFR
prerank,negative regulation of developmental growth (GO:0048640),0.36878231606703976,1.0355449470130347,0.4214618973561431,0.9508813916423509,1.0,4/30,8.53%,PTEN;NKD1;CDKL3;DCC
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.2974904388236185,-1.0354888022712514,0.36464088397790057,0.6944868663367165,1.0,8/39,7.11%,PODXL;CDH1;KLF4;RDX;FXYD5;NOTCH1;WNK1;PPM1F
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3293953327260696,1.0347032165975574,0.4014184397163121,0.9514466056238704,1.0,24/56,25.64%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFV2;NDUFAF7;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFAF2;NDUFB6;DMAC1;NDUFB8
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3293953327260696,1.0347032165975574,0.4014184397163121,0.9514466056238704,1.0,24/56,25.64%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFV2;NDUFAF7;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFAF2;NDUFB6;DMAC1;NDUFB8
prerank,chromosome organization (GO:0051276),0.30529068341221377,1.0346752527472922,0.41486486486486485,0.950485925300849,1.0,25/99,20.54%,HDAC1;L3MBTL1;TCF7L2;COPS3;TOP2B;MSH3;SOX2;XPC;HMGN3;CDT1;COPS4;POLE3;CENPW;HDAC10;DOT1L;MYC;ZBTB7A;LDB1;TOP2A;SAFB;MSH6;NUP155;CUL4A;GATAD1;DDB1
prerank,renal filtration (GO:0097205),0.4716965558353483,1.0342499707097896,0.4236111111111111,0.9506992973779147,1.0,3/10,9.55%,SULF1;ITGA3;TBC1D8B
prerank,generation of neurons (GO:0048699),0.2813132079168985,1.034243611315612,0.3928157589803013,0.9496867156079386,1.0,26/190,11.41%,SH3RF1;ADGRL3;RUNX2;AUTS2;WNT5A;NTRK2;ASTN2;FGFR1;DNAAF4;MYEF2;LRP12;CDKL5;MTPN;DISC1;DOCK7;ASTN1;SNPH;PER2;RELN;OLIG2;BHLHE22;WNT3;MAP2K1;OPHN1;SMARCA1;PLXNB2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3683327372243496,1.0340302530569363,0.41935483870967744,0.9493087049478105,1.0,8/31,12.92%,SCRIB;DLG3;MTCL1;PARD3B;DLG2;PRKCI;OPHN1;LRRC7
prerank,chloride transport (GO:0006821),0.31668822294623505,1.0337891043864509,0.3786407766990291,0.9489777122254677,1.0,16/74,13.84%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;SLC4A1;CLCN6;GLRA2;GABRB1;LRRC8A
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2823844047787158,-1.0336829157558967,0.4090909090909091,0.6983096088404426,1.0,18/47,26.02%,THBS1;MAPK14;XDH;MAPT;RNF41;PLCG2;AGTR1;GRB2;CDKN1A;PRKCD;ACE2;PID1;AGT;ROMO1;TGFBR2;TYROBP;CBR1;ITGB2
prerank,positive regulation of cyclase activity (GO:0031281),-0.39584286404039026,-1.0335188032893599,0.43099273607748184,0.6979771185955838,1.0,5/14,12.69%,CACNA1C;NOS3;MAPK14;ORAI1;NOS1
prerank,regulation of cellular respiration (GO:0043457),-0.3642223262497981,-1.0331953845938031,0.4164588528678304,0.6980385747799158,1.0,6/17,16.31%,IL10RB;IFNAR1;VCP;PRDM16;PRELID1;NOA1
prerank,regulation of endopeptidase activity (GO:0052548),-0.2743933542277303,-1.0331213642691734,0.3800738007380074,0.6974799843389328,1.0,21/59,22.79%,PICALM;SPOCK2;VTN;SERPIND1;SERPINE1;SERPINI1;SERPINA2;GAPDH;APH1A;PSMA3;APH1B;PSME3;SERPINE2;FURIN;PRELID1;AKT1;PSME2;TIMP3;AGT;BIRC3;SERPINB8
prerank,central nervous system neuron development (GO:0021954),0.43329467898856694,1.0324460655986518,0.43666666666666665,0.9520755668802081,1.0,5/15,14.03%,NTRK2;PTEN;NPY;ARHGAP35;ATP7A
prerank,protein O-linked mannosylation (GO:0035269),-0.3629876382939519,-1.0324321999967936,0.40512820512820513,0.6985404809433525,1.0,4/18,8.23%,TMTC2;TMTC1;TMTC4;LARGE1
prerank,regulation of superoxide anion generation (GO:0032928),-0.39239368815894915,-1.0322253361256266,0.3768844221105528,0.6983654268617357,1.0,9/14,50.89%,MAPT;PRKCD;TYROBP;ITGB2;AATF;CRP;GSTP1;F2RL1;CD177
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.42668463882186597,1.0318140723335758,0.41652613827993257,0.95299917121124,1.0,6/15,22.76%,TLR6;TLR4;EIF2AK2;MYD88;DHX33;NLRP2B
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.26652538433797796,-1.0317861130630244,0.3840304182509506,0.6988165118113575,1.0,27/69,25.76%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFS6;NDUFA8;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;COA6;NDUFA1;NDUFS2;NDUFS8
prerank,negative regulation of chemotaxis (GO:0050922),0.35874753419618866,1.031765884091161,0.3984615384615385,0.9521136245212803,1.0,3/31,1.98%,ROBO2;HRG;SEMA5A
prerank,defense response to tumor cell (GO:0002357),0.46959197711463646,1.0317531135836702,0.43703703703703706,0.9511286062331654,1.0,2/10,4.92%,DLEC1;RBMS3
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4077620143520351,1.0317092451145509,0.42105263157894735,0.9502413615962546,1.0,4/22,9.77%,IL2RA;FANCA;BCL6;KAT2A
prerank,regulation of apoptotic process (GO:0042981),-0.20641350294843974,-1.0316469708697134,0.17647058823529413,0.6984076043434728,1.0,192/676,22.66%,PAWR;DAPK1;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;ARHGEF18;MEF2C;IL31RA;ANO6;LEF1;ACTN2;SLIT2;TIAM2;BCL2L1;EGFR;IGF1R;ITGB1;NET1;OSR1;PPP1R13B;XIAP;THBS1;ARL6IP5;NOTCH2;ANXA5;FSTL1;GAS1;NFKB1;ITGA6;MCL1;MCF2L;TNFSF10;ACER2;PTMA;HIP1R;IGFBP3;KDR;SQSTM1;PRKDC;MAP3K5;TMBIM6;CCND2;FAS;NDRG1;ARHGAP10;CYP1B1;GCLC;SOCS2;UNC13B;EGLN3;ANXA1;APC;DAB2;TRIM24;ATF6;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;CRADD;HIPK3;JMY;CD38;DDX42;BNIP2;UBB;SOX4;IP6K2;NGF;CASP2;CAT;CARD14;GSK3B;CD44;SH3RF2;VCP;GLO1;RPL10;CASP3;NGEF;CFL1;CASP8;MADD;BAD;CITED2;SFRP1;BAX;NFKBIA;KLHL20;PERP;BNIP3L;NIBAN2;RNF144B;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;TARDBP;HSPB1;ADAMTSL4;BAG3;BID;APH1A;TGM2;GADD45B;APH1B;ATM;FLT4;GATA6;FLNA;BOK;PTK2B;PLEKHG2;TPT1;HIP1;PPIA;ING4;ARHGEF11;CX3CL1;PLK5;ARL6IP1;STK17B;TRIM35;PRELID1;SMPD1;FLT3;SIRT1;GPER1;ANXA4;PRKAA1;PDPN;ING5;PRDX3;PAK2;SIAH2;YME1L1;AIFM1;DCUN1D3;CD74;PLSCR3;UBC;MAP3K10;HNRNPK;RASA1;AKT1;NUAK2;TFPT;APBB1;WNT11;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;HGF;NPM1;DNAJC3;CIB1;RASGRF2;AGT;GADD45G;TRADD;SON;ARHGEF12;PIM2;ASNS;MIF;E2F1;NAA35;CFLAR;RTN4;SPHK2;CCAR2;BIRC3;DDX20;MGMT;DDAH2;HIGD1A;NUPR1;MYO18A;UBA52;SIX4;TIAM1;UFM1;ARHGEF1;PPIF
prerank,cellular protein catabolic process (GO:0044257),-0.2745554613934857,-1.0315789290170239,0.3767123287671233,0.6978671311134788,1.0,19/59,22.87%,CTSC;UBE2G1;DENND3;AP2A1;CASP8;BNIP3L;CTSO;CTSH;CLPX;PSMA6;CTSZ;AFG1L;SIAH2;YME1L1;CTSS;CLPP;AP2S1;RNF5;AP2B1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.28625055851378944,-1.0314748042039763,0.40192926045016075,0.6966846342312044,1.0,21/51,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.28625055851378944,-1.0314748042039763,0.40192926045016075,0.6966846342312044,1.0,21/51,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,Ras protein signal transduction (GO:0007265),-0.23743085709707454,-1.0311830511097688,0.3485714285714286,0.6966925062090853,1.0,31/137,16.27%,PLCE1;IGF1;RAPGEF2;ROCK2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;RAP1A;RAC1;RASGRP3;RAPGEF1;MAPK14;ARHGDIB;EPS8L2;CFL1;PHACTR4;RGL2;RALB;RRAS;AGTR1;GRB2;ADGRG1;ARHGEF11;RAPGEF3;RAP2C;CDKN1A;GRAP;PDPN
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.46351401784518625,1.031080862799267,0.4237588652482269,0.951176075463979,1.0,5/11,15.69%,WNT5A;SOX9;CTNNBIP1;MYC;FGFR2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.43399113338564477,-1.03100583959113,0.4593967517401392,0.6957344142943999,1.0,3/10,22.87%,AP2A1;AP2S1;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.43399113338564477,-1.03100583959113,0.4593967517401392,0.6957344142943999,1.0,3/10,22.87%,AP2A1;AP2S1;AP2B1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.37616868497111294,-1.030857025595442,0.39351851851851855,0.6953678167281271,1.0,3/16,4.37%,VIM;RUNX1;WNT4
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3811801079960212,-1.0304891914988572,0.40714285714285714,0.6956566964122795,1.0,5/15,5.51%,IGF1;ROCK2;MEF2A;CAMK2D;IL6ST
prerank,positive regulation of cell junction assembly (GO:1901890),0.32941801429249706,1.0304730203316748,0.4129834254143646,0.9519515775202666,1.0,10/56,9.52%,HRG;SRPX2;EPHB1;CNTNAP2;GRID2;NRXN1;MAP4K4;COL16A1;SYNDIG1;IL1RAP
prerank,protein export from nucleus (GO:0006611),0.3805021041642583,1.0304533041176451,0.41812400635930047,0.9509803171663342,1.0,9/27,17.09%,CSE1L;ANKLE1;NUP214;NUTF2;NUP42;RANBP3;STRADB;CALR;XPO6
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.34512664169157115,-1.0297075274525562,0.4037940379403794,0.696816593945692,1.0,9/21,22.59%,SLC8A3;MICU1;MCUB;SMDT1;TGM2;RAP1GDS1;MCUR1;LETM1;MCU
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.38388120894316485,1.0295735694377988,0.40425531914893614,0.9527758327016694,1.0,8/24,16.56%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1;ACTR2;AKIRIN1;CYFIP1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.40369034361639816,1.029542804205794,0.42454394693200664,0.9518309550879133,1.0,4/22,9.11%,ZBTB20;PPARA;PPARD;MTOR
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.37688053037156344,-1.029412443701282,0.41975308641975306,0.6968705809131758,1.0,6/16,23.08%,CHMP4B;CHMP4A;CHMP7;VPS28;VPS36;CHMP4C
prerank,synaptic vesicle endocytosis (GO:0048488),0.35774583665213516,1.0290163941401642,0.41203703703703703,0.9524524268099103,1.0,13/33,21.14%,CEL;VAMP2;ITSN1;OPHN1;SYT5;DNM1;CDK5;DNAJC6;AMPH;FCHO2;SYT1;CANX;SNAP91
prerank,regulation of multicellular organism growth (GO:0040014),0.41465784179138737,1.0286604565774478,0.4204355108877722,0.9525653350531913,1.0,1/15,0.31%,GHR
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.3438601840016253,-1.0282599627196012,0.3979591836734694,0.6990148297849416,1.0,9/21,25.69%,ERAP1;ADAM10;RBMX;DAG1;APH1A;ADAM9;MYH9;BACE2;PSEN2
prerank,regulation of protein localization to membrane (GO:1905475),0.38101701661678333,1.0278872602310674,0.4190938511326861,0.9539451921581164,1.0,10/28,18.74%,GPC4;SPTBN1;GPC5;NECAB2;FYN;AR;LDLRAP1;ZDHHC2;CDK5;GPC6
prerank,membrane depolarization during action potential (GO:0086010),0.37519493611639576,1.0277609577235256,0.4292527821939587,0.9532817172260769,1.0,9/26,21.35%,ATP1A2;SCN2B;CACNA1G;HCN2;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,ceramide metabolic process (GO:0006672),-0.2836861586874728,-1.0277226977935987,0.4106583072100313,0.6995913696465405,1.0,9/49,7.43%,SGMS1;SPTLC2;PLPP3;ACER2;ACER3;SGMS2;PPP2R1A;DEGS2;ST6GALNAC3
prerank,calcineurin-mediated signaling (GO:0097720),0.46605874502441,1.0276734703996062,0.4293286219081272,0.9514900842730822,1.0,3/10,10.49%,NFATC3;ADGRB2;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.46605874502441,1.0276734703996062,0.4293286219081272,0.9514900842730822,1.0,3/10,10.49%,NFATC3;ADGRB2;PPP3CB
prerank,positive regulation of viral process (GO:0048524),0.3288586925796927,1.0266800948135462,0.4232424677187948,0.9534475029760712,1.0,17/60,22.34%,PPARA;PPID;MDFIC;PPIH;PDE12;STAU1;AXL;NELFA;DHX9;CNOT7;ADAR;HACD3;TBC1D20;POLR2L;DDB1;NELFB;KPNA2
prerank,myelination in peripheral nervous system (GO:0022011),-0.4027854050935623,-1.0264163446183274,0.43,0.7021514779748524,1.0,4/13,6.78%,ADGRG6;PARD3;SKI;DICER1
prerank,phospholipid dephosphorylation (GO:0046839),0.34899436122922667,1.025809192369428,0.4149560117302053,0.9551408989608844,1.0,8/37,10.68%,PTEN;SACM1L;MTMR4;PLPPR3;MTMR1;INPP5J;PLPPR2;PLPP6
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3228503560656302,-1.0257428450258848,0.40700808625336926,0.7031411338644398,1.0,9/27,21.18%,CDC23;UBE2D3;ANAPC10;UBE2H;UBE2A;ANAPC13;ANAPC11;FZR1;ANAPC2
prerank,response to gamma radiation (GO:0010332),-0.3436203704395747,-1.0256899387731726,0.4482758620689655,0.7025562429044685,1.0,11/24,25.78%,CRYAB;TLK2;ATR;RPL26;ATM;PRKAA1;TMEM109;DCUN1D3;FANCD2;KDM1A;LIG4
prerank,negative regulation of insulin secretion (GO:0046676),-0.37988938238138403,-1.0254393825254577,0.41578947368421054,0.7024927771181403,1.0,5/17,9.80%,KLF7;PSMD9;CCN3;KCNB1;SFRP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.25343472167349523,-1.0254178625340773,0.4366812227074236,0.7018178244234093,1.0,21/80,16.65%,DAPK1;FNIP1;XIAP;THBS1;ARL6IP5;KLF4;TNFSF10;MAP3K5;UACA;NGF;PPM1F;CD44;LAMTOR5;BAD;GPX1;RPS6KA1;ARL6IP1;MAP2K5;SIRT1;GPER1;SIAH2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3101349652877705,1.0253233638180086,0.41434262948207173,0.9555651188297157,1.0,26/83,20.52%,CDK14;CDKN2A;FBXO5;CDC7;POLA1;CDKN2D;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CDT1;CUL5;CDKN2C;DBF4;MYC;KLF11;CDK5;CAMK2A;CCNE1;KHDRBS1;CUL4A;TFDP1;POLE;LATS2;INHBA
prerank,positive regulation of protein import (GO:1904591),0.3664559668241757,1.0248603423631424,0.42834890965732086,0.9559026177908455,1.0,4/30,4.57%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.47136668080796473,1.024587466951209,0.4390681003584229,0.9557139637931312,1.0,3/10,15.04%,ADGRV1;IFT88;PDZD7
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4000722570874416,1.0245569669667962,0.4194053208137715,0.954783509966934,1.0,5/20,8.66%,ATP1A2;RYR2;ATP2A2;SLC9A1;PRKACA
prerank,protein transport (GO:0015031),0.266567524854236,1.0236099043107072,0.43797195253505933,0.9566440670679007,1.0,78/332,20.54%,LRP1;VAMP5;STEAP3;UNC93B1;GGA2;LRP1B;CALCRL;UNC119;RAB34;RAB20;RABGAP1L;TBC1D16;RABL3;COPA;SPTBN1;NGFR;ANK3;VAMP2;SEL1L;COPZ2;RAB8A;NAPB;RUFY1;RAB3C;MYO6;SYNDIG1;VIPAS39;TBC1D1;TRIM23;VPS26C;RAB29;PRKCB;TBC1D8B;SLU7;RAB24;SAR1A;VAMP4;RCN3;RAB15;SCFD1;HSP90B1;ARHGAP1;ARFIP1;ATP6V0E1;AP3D1;TBC1D9;CTTN;TMEM167A;CLU;CENPF;VPS33B;MTTP;SCAMP2;USP6NL;TMED3;TMED9;TBC1D17;MCOLN1;BBS1;TVP23B;ATP6V0D1;LTBP2;ATP6V1G2;COPG1;ATP6AP1;MIA3;SVBP;VPS45;CANX;RAB3GAP2;SCAMP3;ARL5C;COPB2;ARL4A;SCG2;UNC119B;NAPG;KIF3A
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3184490084478006,-1.022971347096895,0.3951367781155015,0.7073281263603605,1.0,10/31,14.15%,IGF1;CSGALNACT1;BMPR2;NDST3;EXT1;UGDH;CHST11;FOXL1;GLCE;HS3ST3B1
prerank,regulation of store-operated calcium entry (GO:2001256),0.46178822903760364,1.0227116463317916,0.44765342960288806,0.9582250217658125,1.0,4/10,21.36%,GRAMD2A;STIM1;HOMER3;HOMER2
prerank,calcium ion transport (GO:0006816),0.2933774653980901,1.0208171362032032,0.41729323308270677,0.9629290933403011,1.0,18/113,11.67%,TRPA1;SLC24A5;CACNA1E;NALCN;CALCRL;MCOLN2;ITGAV;ITPR1;CACNG3;RYR2;ATP2A2;CACNA1G;TRPV3;TRPC3;FYN;P2RX4;TRPM2;TRPC7
prerank,ventricular septum morphogenesis (GO:0060412),-0.33155661662117175,-1.02046224292107,0.41944444444444445,0.7128997334997038,1.0,15/27,22.66%,SLIT2;ROBO1;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;CITED2;HEYL;HEY2;SOX11;TGFBR3;TGFBR2;SMAD7;APLNR
prerank,response to interferon-gamma (GO:0034341),0.31611163935728165,1.0203362756177952,0.42704149933065594,0.9633034531672194,1.0,10/67,10.56%,XCL1;WNT5A;CD40;EPRS1;KYNU;CCL15;PDE12;SP100;TLR4;CCL25
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3525211035457093,-1.0195604506468292,0.45012787723785164,0.7144361660702052,1.0,4/19,5.90%,EZR;CYTH1;PARD3;CDC42
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3519133147292189,-1.0195111268949426,0.4020618556701031,0.7138420181656865,1.0,7/18,15.22%,FOXC2;KDR;JCAD;ANXA1;GATA2;FGFBP1;PTGS2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3717861484428178,1.019112305965951,0.4407051282051282,0.9660521898062889,1.0,4/28,4.57%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,Fc receptor signaling pathway (GO:0038093),-0.24404417788971705,-1.0191024717864998,0.3891625615763547,0.7141688010654088,1.0,34/110,19.23%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;RAC1;PSMB7;MAPK9;CUL1;MAP2K4;CALM1;MAP2K7;PSMD8;PSMD12;PIK3CB;PPP3R1;PLCG2;TAB2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;GRB2;PSMB6;PSMC1;TEC;PSMB10;PAK2;LCP2;VAV1;PSME2;SOS1
prerank,apoptotic cell clearance (GO:0043277),0.36210873765149476,1.0187313116731385,0.4418960244648318,0.9661598612237537,1.0,5/30,7.90%,LRP1;ITGAV;TXNDC5;ADGRB1;XKR6
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.33607206348293966,-1.0184392079503666,0.44,0.7151268879662562,1.0,6/21,9.65%,CACNA1C;CAMK2D;SRI;CALM1;ANK2;DMD
prerank,regulation of osteoclast differentiation (GO:0045670),0.3568663244773639,1.0180470807062705,0.4368340943683409,0.9672810043446125,1.0,9/33,17.82%,MTOR;TLR4;CAMK4;UBASH3B;BGLAP;LRRC17;FBN1;MAFB;GPR137B
prerank,detection of calcium ion (GO:0005513),0.44074071077755483,1.0180261795702787,0.4621710526315789,0.966322478478083,1.0,4/13,18.61%,RYR2;KCNIP2;STIM1;SYT1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.33748301233731437,1.0179258688451538,0.40822320117474303,0.9655976494857343,1.0,6/46,5.31%,PIK3R1;TCF7L2;JUP;PIK3R2;ZIC1;NEDD4
prerank,response to cytokine (GO:0034097),-0.23122297631766545,-1.0179230022207797,0.4177215189873418,0.7156786114975807,1.0,23/141,10.31%,ALDH1A2;DPYSL3;LEF1;BCL2L1;HDAC4;APP;MCL1;IRAK2;PTPN4;PTPN14;IL1R1;ANXA1;IL6ST;ADAM10;IFITM3;CASP3;GCH1;SMAD3;MAP2K7;CASP8;IFITM1;KLHL20;PTPN2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.3736232982126356,-1.0171904019208085,0.42105263157894735,0.7167750390300872,1.0,3/15,7.21%,PLTP;SCARB1;APOE
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.42703398430686357,1.0170976933609248,0.44714038128249567,0.9670857997166645,1.0,5/14,19.46%,XCL1;PTPN22;CD81;LGALS9;RASAL3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3330709458150801,-1.0169117150460205,0.39947780678851175,0.7167647641515021,1.0,6/23,14.38%,NMI;UACA;CCN3;IFI35;CYLD;TMSB4X
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.24372366896081754,-1.016864209769103,0.37850467289719625,0.7161503910717074,1.0,34/109,19.23%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;RAC1;PSMB7;MAPK9;CUL1;MAP2K4;CALM1;MAP2K7;PSMD8;PSMD12;PIK3CB;PPP3R1;PLCG2;TAB2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;GRB2;PSMB6;PSMC1;TEC;PSMB10;PAK2;LCP2;VAV1;PSME2;SOS1
prerank,regulation of intracellular signal transduction (GO:1902531),0.26092114094081315,1.0166523134312728,0.43067226890756305,0.967335642463402,1.0,90/420,18.88%,DLC1;NTRK3;CHN1;ARHGAP22;ARHGAP32;AKAP5;TAGAP;FBXO9;HDAC1;L3MBTL1;WNT5A;NTRK2;TAF9B;PTEN;TRAF4;ARHGEF3;ITGAV;PIP4K2A;RHOJ;TAF12;AKAP7;ABR;MAP4K4;ARHGAP6;PDPK1;PIK3R2;SPRED1;ENTPD5;RAC3;PRR5;PTPN22;ARHGAP24;ANKRD54;CHD4;LRRK2;CAPN3;MBD3;TAF15;ARHGEF6;RPA1;TAF3;PTPN13;MDM4;NOC2L;MTOR;ITSN1;BIRC2;DAXX;RFC3;ARAP2;OPHN1;ARHGAP4;TP53;PYCARD;RCN3;TOP3A;ARHGAP31;ARHGAP35;SSRP1;ARHGAP1;FAM13B;PREX1;AKAP6;CRK;LYN;ARHGEF19;GPAT3;PRKAR1A;RRS1;ARAF;SGK1;TNIK;CSNK2A2;FGD2;MAPK11;CDK5;PAK5;RHOG;A2M;CASTOR1;WRN;TTI1;TAF10;SYDE1;ARHGAP29;BRD7;RHOA;WWC1;ULK4;KALRN
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.3729171019080365,-1.0166449174100785,0.4325581395348837,0.7159349758430332,1.0,5/17,16.22%,SNTA1;ANK2;KCNQ1;NOS1AP;SCN4B
prerank,glycerolipid metabolic process (GO:0046486),-0.41804637648277765,-1.0163599434351174,0.44638949671772427,0.7159129741515745,1.0,5/11,20.57%,DGKG;DGKZ;PGP;PNPLA3;PIP5K1A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.35574305409270085,1.01611791572777,0.43119266055045874,0.9679632248270593,1.0,3/34,4.96%,XCL1;WNT5A;PTPN22
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4093657396489018,1.0156559989960225,0.44013490725126475,0.9684169121240329,1.0,3/17,9.06%,CXCL10;PLA2G7;LGMN
prerank,negative regulation of catabolic process (GO:0009895),0.3365314175890417,1.0155000922052781,0.43043478260869567,0.9678760645094555,1.0,7/47,8.09%,PPARA;PFKFB1;ADGRB1;CBFA2T3;MDM4;CIDEA;BSCL2
prerank,protein-DNA complex assembly (GO:0065004),0.2917833780833899,1.0154486851890945,0.41718555417185554,0.9669955234334654,1.0,32/116,18.81%,TCF4;PSMD1;MCM7;NAP1L3;ERCC5;PSMD10;ASF1A;GMNN;PSMA5;RPA1;PSMB5;CHAF1B;SPTY2D1;XPC;DAXX;PSMC4;MCM4;PSMA4;NAP1L1;PSMC5;GTF2H3;SOX9;CDT1;PSMB9;ERCC2;GTF2H1;ORC2;PSMA7;PSMD14;PSMA2;CUL4A;PSMD11
prerank,cellular response to UV-A (GO:0071492),0.4406924594645252,1.0154050425549561,0.43386243386243384,0.9661168168180505,1.0,1/11,1.67%,PPID
prerank,response to glucocorticoid (GO:0051384),0.37354688927886875,1.015369090870489,0.4326923076923077,0.965210088672699,1.0,3/26,7.16%,IL1RN;REST;ZFP36L2
prerank,neural tube closure (GO:0001843),0.35431276710953313,1.015336043436159,0.44510385756676557,0.9643070528433747,1.0,4/34,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4022985964516329,-1.0153271553269554,0.4247191011235955,0.7177608488658089,1.0,4/12,22.66%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,bile acid and bile salt transport (GO:0015721),0.3813031456326763,1.01530143393152,0.43926788685524126,0.9634022817785406,1.0,4/24,9.04%,ABCC3;NR1H4;NCOA2;NCOA1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3619044452280079,1.0149838632137282,0.4310077519379845,0.9633614497881434,1.0,6/32,6.62%,HCRT;CHRNB4;PNKD;FMR1;LRRK2;RIMS2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2576436019683057,-1.0147785376238847,0.3916349809885932,0.7183487737646101,1.0,28/72,24.72%,ELF1;IRAK2;RUNX1;OTULIN;HIPK1;CASP8;MADD;PTPN2;PTPN1;CYLD;RNASEL;TNFRSF1A;CD74;IFNGR1;VRK2;TRADD;TNFAIP3;AGPAT2;USP18;CFLAR;TRAF1;BIRC3;SOCS3;IKBKB;SIGIRR;IKBKG;PTPN6;SUMO1
prerank,cellular metal ion homeostasis (GO:0006875),0.298781615917158,1.0147022737697584,0.4315403422982885,0.9632774638314527,1.0,13/102,9.08%,EDN3;ATP1A2;SLC24A5;CD40;RYR2;HTR2B;ATP1A3;KCNMA1;CCL15;ATP2A2;SLC9A1;ATP13A3;HTR2C
prerank,regulation of catabolic process (GO:0009894),0.3978142207622721,1.014147576560162,0.4273789649415693,0.9640782254377631,1.0,8/18,22.97%,FAP;ODC1;HGS;SNF8;ZDHHC2;CENATAC;RARRES2;FAF1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.265481534274418,-1.0141107689434505,0.42160278745644597,0.719291361249857,1.0,22/61,19.03%,PRKAG2;CAV1;PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;SIRT1;PSMB10;OAZ2;SIRT5;PSME2
prerank,regulation of neuron death (GO:1901214),0.31031467452733935,1.0138053385213888,0.4418300653594771,0.9640826670992345,1.0,19/82,13.29%,WNT5A;EPHB1;GRID2;GRIN2B;REST;FOS;SORL1;DHCR24;LRRK2;EGLN2;C1QA;CD200R1;DCC;RAB29;DAXX;FYN;HTRA2;EIF2S1;TRIM2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.36006838887988285,-1.013357202486999,0.41025641025641024,0.7204405620583011,1.0,3/17,4.37%,VIM;RUNX1;WNT4
prerank,placenta development (GO:0001890),0.44637772793070796,1.0131691353120882,0.46539792387543255,0.9649860098517886,1.0,3/12,17.84%,ADAM19;PTK2;CUL7
prerank,positive regulation of neurogenesis (GO:0050769),0.3142005626895492,1.0130806842404603,0.4306864064602961,0.9642619691673998,1.0,12/68,11.46%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;CAPRIN1;SERPINF1;DISC1;CDKL3;NAP1L1;PLXNB2;SNW1
prerank,protein kinase A signaling (GO:0010737),-0.39952316904058605,-1.0129898430713218,0.4679334916864608,0.7206374823922082,1.0,3/12,10.26%,EZR;RDX;RAB13
prerank,regulation of endocytosis (GO:0030100),-0.2683604668107823,-1.0124169027296412,0.43727598566308246,0.721408164459908,1.0,18/61,19.99%,PICALM;PACSIN2;HIP1R;MCTP1;GPC3;DAB2;APOE;RAB5A;RAB5C;PTPN1;CD151;SNX17;HIP1;SMPD1;MTMR2;RAB4A;CALY;AP2S1
prerank,calcium import into the mitochondrion (GO:0036444),-0.42124767096134036,-1.0123980486255446,0.43231441048034935,0.7207245542347556,1.0,5/10,22.59%,MICU1;MCUB;SMDT1;MCUR1;MCU
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.3360971060827702,-1.012212556380342,0.43842364532019706,0.7204827088533344,1.0,14/23,44.40%,TPM1;TGFBR3;PKP2;HOPX;SMAD7;DSG2;FKBP1A;TNNC1;TNNI3;IRX3;MYL3;MYH6;ID2;ISL1
prerank,negative regulation of cytokine production (GO:0001818),0.27922051562379785,1.0119994640156027,0.447831184056272,0.966572029105571,1.0,23/163,12.41%,APOD;XCL1;PPARA;TRAF3IP1;ABCD2;NR1H4;PTPN22;PDCD1LG2;TLR6;DHX58;TLR8;CIDEA;CD200R1;AXL;NAV3;ADCY7;APPL2;TLR4;TNFRSF21;PYCARD;ASB1;IL12A;PDCD4
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2576020104401267,1.011849424008285,0.4556701030927835,0.9660734462788023,1.0,120/497,19.41%,ENPP1;ZEB1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;HDAC1;L3MBTL1;WNT5A;NR2F2;TCF7L2;BASP1;EIF4A3;SALL1;NANOS3;CDKN2A;THRA;EPRS1;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;LSM14A;SCML4;MDFIC;RUNX1T1;ZNF423;FMR1;ZBTB16;CAPRIN1;TLE2;FOXS1;BCOR;CAPN3;CALCA;CBFA2T3;GMNN;BRMS1;PAX9;BCL6;TERF1;ZKSCAN3;PER2;TWIST1;L3MBTL4;TLE1;DAXX;BMP7;GLI3;EIF2AK2;EIF2AK1;TP53;ZC3H8;MPHOSPH8;DHX36;ZFPM2;SNW1;DAP;EPC1;ZNF318;SOX9;TWIST2;PDCD4;GSK3A;DPF2;HIC2;BTAF1;CNOT1;PHC1;PRDM5;ZMYND15;MALSU1;HDAC10;EIF4ENIF1;PUS7;KDM5C;TSPYL2;CREB3L1;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;CNOT7;CRY2;CENPF;ZHX3;SPINDOC;TSC1;ZBTB7A;CBFA2T2;IGF2BP3;NONO;MBTD1;CIART;NR1D2;CALR;CDK5;MBD2;LDB1;SUV39H2;BMP2;MBD1;KAT7;HEY1;BRD7;ILF3;KHDRBS1;DEDD2;PEX14;THAP7;EIF2AK3;CREBZF;FXR1;NACC1;IKZF4
prerank,gene silencing by miRNA (GO:0035195),0.3588887389620797,1.0117459572652647,0.4274447949526814,0.9653836112452164,1.0,11/32,19.88%,AGO4;SPOUT1;ZC3H7B;AGO3;CNOT1;CNOT7;WTIP;ADAR;TNRC6B;AGO1;ZC3H7A
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3595855219013714,-1.0115606354872122,0.41131105398457585,0.7213674507342364,1.0,3/18,0.60%,EPHA4;PICALM;ROCK2
prerank,metal ion homeostasis (GO:0055065),-0.2903542913565648,-1.0115220914384742,0.4194528875379939,0.7207346412033673,1.0,3/40,1.13%,TMTC2;SLC12A7;CAV1
prerank,sulfur compound biosynthetic process (GO:0044272),0.29507369025328417,1.01151003286742,0.43403205918618987,0.9650829287243553,1.0,13/104,7.78%,DCN;GGT5;LUM;BGN;GGT7;DSE;SLC35B3;VCAN;B4GALT2;GSTO2;B4GALT3;GSTA3;PAPSS2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.30734896455598637,1.0113772223425834,0.4475806451612903,0.9645169044762673,1.0,22/76,19.81%,PRICKLE1;CCDC22;PTEN;RNF180;LRRK2;PSMD10;CBFA2T3;PTK2;NKD2;ZYG11B;HECTD1;GSK3A;AXIN1;DDA1;CLU;CSNK1E;DET1;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2889669504046754,-1.0111141313677339,0.4117647058823529,0.7210535615504922,1.0,13/40,20.69%,LBP;GBP7;DROSHA;GBP4;GBP2;PGLYRP1;GBP6;RNASE7;MPEG1;HMGB2;PPP1R11;CHGA;ROMO1
prerank,peptidyl-lysine modification (GO:0018205),0.29617276412645466,1.011041477815426,0.43316195372750643,0.9644887634265379,1.0,25/99,19.67%,LOXL4;PLOD1;NUP214;LOXL3;LOXL2;AAAS;VCPKMT;POM121;VIPAS39;PIAS2;SAE1;NUP42;NUP107;P3H3;HDAC10;ATP7A;SENP6;NDUFAB1;VPS33B;NUP54;PLOD2;NUP155;USPL1;ATPSCKMT;SUMO2
prerank,7-methylguanosine RNA capping (GO:0009452),-0.31135137508056693,-1.011009177323633,0.45879120879120877,0.7198620944635195,1.0,12/31,28.25%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;POLR2K;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.31135137508056693,-1.011009177323633,0.45879120879120877,0.7198620944635195,1.0,12/31,28.25%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;POLR2K;CMTR2
prerank,cellular response to calcium ion (GO:0071277),0.3178075732103893,1.0106454617170173,0.43134535367545074,0.9646886868267962,1.0,22/67,18.99%,ADGRV1;WNT5A;GPLD1;ADCY8;CAPN3;RASGRP2;SYT3;LGMN;SYT7;CPNE7;TRPM2;SYT5;CPNE4;RYR3;CPNE8;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1
prerank,replication fork processing (GO:0031297),-0.2955662546432046,-1.010455238213669,0.4329268292682927,0.7205452949416462,1.0,16/38,27.97%,SAMHD1;THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;ALYREF;CDK9;SETMAR;RFWD3;ZRANB3;RAD51;CENPX;GEN1
prerank,histone methylation (GO:0016571),-0.3186194842501314,-1.0104390599894546,0.4293785310734463,0.7198742407523236,1.0,6/26,15.09%,SMYD3;NTMT1;PRMT7;SMYD2;PRMT8;EZH2
prerank,mesoderm formation (GO:0001707),0.3982278624743163,1.010306796889202,0.43333333333333335,0.9647111427309826,1.0,2/17,2.66%,ITGA8;ITGA3
prerank,regulation of phosphorylation (GO:0042325),0.2914934445662145,1.010212296816975,0.45165238678090575,0.964007378499799,1.0,30/120,17.44%,DYNLL1;OGT;PHIP;SRPX2;CDKN2A;GLMN;NUP214;MCM7;AAAS;DSCAM;POM121;CDKN2D;PTK2;BMP7;GCK;GRM5;NUP42;PLXNB2;ANKLE2;NUP107;CDKN2C;LYN;ATG14;AR;NDUFS4;ZBTB7A;PRKRIP1;NUP54;LDB2;LDB1
prerank,lipid transport (GO:0006869),0.30000441509553594,1.010177435785385,0.4423076923076923,0.9631372346876522,1.0,8/97,4.00%,ABCA9;NPC1L1;ABCC3;ABCA6;ABCD2;NR1H4;NCOA2;PPARD
prerank,hemopoiesis (GO:0030097),-0.24677144720204647,-1.0099250972349005,0.40271493212669685,0.7204853199961696,1.0,13/87,7.46%,FLT1;MECOM;KITLG;TEK;NOTCH2;KDR;RUNX1;TGFB2;CD34;SNRK;MFAP5;ETV6;HIPK1
prerank,cholesterol transport (GO:0030301),0.3378887454688091,1.0099229953100044,0.43923865300146414,0.962919049544549,1.0,11/45,19.35%,NPC1L1;CEL;LIPC;SOAT2;ABCA5;RELCH;SERAC1;CLU;LDLRAP1;OSBP;NPC2
prerank,adipose tissue development (GO:0060612),-0.40996203285220034,-1.009821696149121,0.4423963133640553,0.7200487567738678,1.0,3/11,7.13%,SPTLC2;ARID5B;SH3PXD2B
prerank,embryonic organ development (GO:0048568),0.31885019248466984,1.0097647616184993,0.4361111111111111,0.9624150950501053,1.0,6/61,4.58%,COL13A1;TEAD1;FLT3LG;SALL1;TEAD2;KMT2A
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3189197503018353,1.0095948089598796,0.44942196531791906,0.9619387232286731,1.0,10/56,12.46%,CLEC4E;UNC93B1;TLR6;TLR8;LGMN;TLR4;IRAK1;MAPKAPK3;S100A1;HSP90B1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4112485750456193,1.0091719751006314,0.43084260731319557,0.9622653889982409,1.0,6/16,20.07%,NECAB2;PRKCA;GSK3A;MRAP;SLC39A14;PDE6H
prerank,glutathione biosynthetic process (GO:0006750),-0.41237486576798665,-1.00908778510857,0.45605700712589076,0.7212096159103598,1.0,6/11,36.41%,GCLC;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,histone lysine methylation (GO:0034968),0.34931080489182376,1.009022483887814,0.45925925925925926,0.9617221149493652,1.0,14/33,23.21%,KMT2A;CXXC1;WDR5;DYDC2;PRDM5;DOT1L;PAXIP1;N6AMT1;ASH2L;SUV39H2;EHMT2;MEN1;RBBP5;KDM6A
prerank,protein processing (GO:0016485),0.29527048187749716,1.0088948142358674,0.44358974358974357,0.9611252281538427,1.0,15/102,12.41%,ECE1;ECE2;OGT;PCSK2;KLKB1;ADAM19;CASP4;OMA1;CPM;FXN;LGMN;PITRM1;SEC11A;HTRA2;SPRTN
prerank,positive regulation of bone mineralization (GO:0030501),0.35521951099818755,1.0086286552760408,0.4660493827160494,0.9609589003027192,1.0,3/35,1.67%,PTN;GPM6B;ADGRV1
prerank,protein deacylation (GO:0035601),0.38042917940006593,1.0085445416055805,0.43167701863354035,0.9602530248845227,1.0,6/23,13.60%,HDAC1;SIRT6;ABHD17C;ABHD17B;LYPLA2;HDAC10
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3675903902598212,1.008244907759394,0.4416403785488959,0.9602022949293942,1.0,2/25,1.70%,XCL1;WNT5A
prerank,regulation of hormone secretion (GO:0046883),0.418206317105582,1.0077157267105996,0.4682274247491639,0.960802965252181,1.0,2/15,4.67%,EDN3;VAMP2
prerank,response to fatty acid (GO:0070542),0.41563933326605296,1.0075934769361974,0.4677685950413223,0.9602065092447598,1.0,4/17,12.02%,GLDC;NR1H4;IRS1;SOX9
prerank,positive regulation of filopodium assembly (GO:0051491),0.3669447531429732,1.0073600248865018,0.44568690095846647,0.9599226524740718,1.0,5/24,9.15%,PIK3R1;FSCN1;FMR1;TENM2;TENM1
prerank,phospholipid homeostasis (GO:0055091),0.45383750243708926,1.0073412098603354,0.46265938069216755,0.9590093182513609,1.0,3/11,21.46%,RCN3;FABP3;TLCD1
prerank,signal release from synapse (GO:0099643),0.34101058105288695,1.0073194601689686,0.4453004622496148,0.9581214594735276,1.0,13/43,18.61%,NRXN2;PTPRN2;NRXN1;VAMP2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.28968071873421364,-1.0072631335696558,0.3976945244956772,0.7251287076056285,1.0,10/43,10.62%,IGF1;MEF2C;BMPR2;WNT4;IL6ST;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2965190441680018,-1.0067433580268825,0.4553314121037464,0.725769194876198,1.0,20/35,38.38%,DRG1;CHMP2B;DYNC1H1;RAE1;CHMP4B;NUMA1;PDCD6IP;CHMP1A;CHMP4C;TACC3;HSPA1A;CHMP2A;FSD1;HSPA1B;NUP62;TPR;PLK1;HNRNPU;PSRC1;CHMP3
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2500779767377468,-1.0062040677867026,0.4474708171206226,0.7264578020720349,1.0,25/82,18.29%,EPHA4;ROCK2;ANKS1A;SIPA1L1;ACTB;ARHGEF28;EFNB2;ACTG1;EPHB4;RAC1;CDC42;EFNA5;EFNB1;AP2A1;NGEF;GIT1;EPHB2;APH1A;APH1B;EPHA2;YES1;RASA1;WASL;EPHB3;SDCBP
prerank,P-body assembly (GO:0033962),0.43754093709744046,1.0059173936547718,0.4546979865771812,0.9612713107844217,1.0,4/12,13.86%,LSM14A;LSM4;EDC3;EIF4ENIF1
prerank,mammary gland epithelium development (GO:0061180),0.42598661289728934,1.005813363947872,0.47332185886402756,0.9606162262584589,1.0,3/14,9.91%,ERBB4;SCRIB;WNT3
prerank,membrane organization (GO:0061024),-0.21778652773487372,-1.0057542261769485,0.41284403669724773,0.7269143433339412,1.0,68/227,23.27%,MYOF;PICALM;FNBP1L;LEMD3;EGFR;ACTB;AGFG1;PACSIN2;STX18;HIP1R;SYT9;HSPA8;ACTG1;CERT1;DAB2;CHMP2B;TFRC;MITD1;EPN2;FZD4;VAPA;UBB;RAB5A;DNM3;ANK2;AP2A1;VAPB;NAPA;CLTB;GAPVD1;CCDC88A;USO1;GAK;GCA;HIP1;REEP3;TOR1A;IGF2R;GRB2;TMEM170A;SYNJ1;DYSF;CHMP4B;CHMP4A;CHMP7;UBC;SYNGR2;WASL;REPS1;EGF;SNX3;ADRB2;PDCD6IP;AP2S1;CHMP1A;GLTP;A4GALT;TOR1AIP1;COX18;CFTR;UBA52;TMEM33;AP2B1;ARPC5;PIK3C2A;CHMP4C;ARPC4;OXA1L
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24400353159746327,-1.0051884503672501,0.48,0.7276497408047888,1.0,33/108,18.83%,TRABD2B;RSPO3;APP;SMARCA4;NXN;RNF43;RUNX1;RSPO2;OTULIN;KANK1;WWOX;SKI;GPC3;GRB10;SULF2;PPP2R1A;WLS;FZD7;FOXL1;SFRP1;CXXC4;TMEM237;TERT;MACF1;CBY1;FAM53B;ATP6AP2;VGLL4;ESR1;HHEX;TAX1BP3;SNX3;GSKIP
prerank,lipid translocation (GO:0034204),-0.3355732046134076,-1.004838711496244,0.4631578947368421,0.7278480987551673,1.0,4/21,8.54%,ATP10A;ATP8A1;ATP11B;ATP8B1
prerank,anion transmembrane transport (GO:0098656),0.3120246131310255,1.0048146224093273,0.4452054794520548,0.9626357422740041,1.0,6/67,4.87%,SLC1A3;SLC6A13;SLC6A8;SLC16A12;SLC25A21;SLC7A8
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2807930253365708,1.0047328673572913,0.45982694684796044,0.9619056206500375,1.0,25/140,13.18%,DLC1;CHN1;ARHGAP22;ARHGAP32;TAGAP;ARHGEF3;ITGAV;RHOJ;RABL3;ABR;ARHGAP6;PIK3R2;RAC3;ARHGAP24;ARHGEF6;RELN;ITSN1;ARAP2;OPHN1;ARHGAP4;ARHGAP31;ARHGAP35;ARHGAP1;FAM13B;PREX1
prerank,membrane repolarization (GO:0086009),0.41266900438242726,1.0046478456182806,0.458041958041958,0.9611848013567528,1.0,3/15,10.96%,ATP1A2;KCNIP2;KCNE4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45730816413473696,1.0043451345916186,0.45233968804159447,0.9611354375725567,1.0,3/10,18.50%,HNMT;DMGDH;SLC44A1
prerank,substrate-dependent cell migration (GO:0006929),-0.3836710614152121,-1.004030957283783,0.47785547785547783,0.7291702781399719,1.0,6/14,11.76%,ANKS1A;NTN1;NRP1;VEGFC;ITGB1BP1;CD2AP
prerank,mRNA destabilization (GO:0061157),0.33652251717234516,1.0040001212027438,0.45588235294117646,0.9611696229988373,1.0,10/38,15.33%,RBM24;ZC3H12D;DND1;PDE12;ZFP36L2;DHX36;DIS3L2;CNOT1;FTO;RC3H2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.29803143570731583,1.0039349774839563,0.45917001338688085,0.9604247786343826,1.0,25/84,19.24%,NTRK2;EIF4A3;NANOS3;EPRS1;LSM14A;FMR1;SORL1;CAPRIN1;EIF2AK2;DHX36;CNOT1;MALSU1;EIF4ENIF1;PUS7;RTN2;CLU;CNOT7;TSC1;IGF2BP3;RTN3;CALR;ORMDL3;ILF3;EIF2AK3;FXR1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2837462182628756,-1.0039153240388141,0.44660194174757284,0.7287351453272793,1.0,13/39,20.49%,TEK;ANO6;THBS1;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5;GPER1;RGCC;ECSCR;TNFAIP3
prerank,androgen metabolic process (GO:0008209),0.4037684928618462,1.00346776535508,0.45874587458745875,0.9608456607147546,1.0,3/18,17.23%,SPP1;MED1;HSD17B11
prerank,ganglioside metabolic process (GO:0001573),-0.3496498646165622,-1.0033350683917859,0.44611528822055135,0.729501426766709,1.0,8/20,23.37%,ST8SIA4;ST6GALNAC3;HEXB;ST8SIA2;ST3GAL5;GM2A;ST8SIA6;CLN6
prerank,signal transduction by p53 class mediator (GO:0072331),-0.30809075755367016,-1.003190442491022,0.46437994722955145,0.7291808772619881,1.0,9/30,14.36%,DDX5;PPP1R13B;ACER2;NDRG1;JMY;MYBBP1A;BOK;HINT1;NBN
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.33739982105087263,-1.0029100415614456,0.44221105527638194,0.7292199251919705,1.0,3/21,6.91%,FOXP1;PRKCH;SLC39A10
prerank,regulation of cell growth (GO:0001558),-0.2164149441169935,-1.002623477469825,0.4435483870967742,0.7292601199517927,1.0,68/204,24.38%,PLCE1;APBB2;PTPRJ;SLIT2;EGFR;FHL1;LTBP4;NET1;BMPR2;SMARCA4;OSGIN2;SMARCA2;CAMK2D;TGFB2;SOCS2;CCN3;SH3BP4;TFRC;ADAM10;CDC42;PPP2R1A;IP6K2;PRDM11;ACVRL1;SOX17;SMAD3;NPR1;HYAL1;SFRP1;INO80;FAM107A;RPS6KA1;CEACAM1;ENO1;EXOSC2;MFSD2A;AGTR1;CDKN2AIP;ARHGEF11;CDKN1A;SIRT1;PABIR1;VGLL4;OGFR;DCUN1D3;RBBP7;ERBB2;AKT1;SDCBP;APBB1;WNT11;RERG;CIB1;AGT;LGI1;RTN4;SPHK2;CCAR2;BTG1;NDUFA13;CDA;CISH;NUBP1;PAK4;TAOK2;MT3;HYAL2;BAP1
prerank,peroxisomal membrane transport (GO:0015919),0.36444814328883807,1.002612633274248,0.4559505409582689,0.9623733152672653,1.0,12/27,23.26%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;PEX6;GDAP1;FIS1
prerank,DNA double-strand break processing (GO:0000729),-0.3513877113565864,-1.0025953243743042,0.43942992874109266,0.7285959507525787,1.0,10/18,32.44%,RBBP8;ATM;NBN;UBE2N;KAT5;SETMAR;BRCA1;RNF138;RAD50;BARD1
prerank,negative regulation of cell population proliferation (GO:0008285),0.2591336605331665,1.002393444680766,0.4719222462203024,0.9620554774423817,1.0,69/351,16.57%,APOD;DLC1;COL18A1;KDF1;ATF5;HRG;ROR2;WNT5A;CXCL1;PTEN;ERBB4;GPLD1;CDKN2A;GLMN;FAP;PEX2;MCC;DLG3;REST;TBX3;TMEM115;ADGRB1;NF1;CBFA2T3;CDKN2D;PTPRU;MDM4;PER2;IFNLR1;P3H1;SOX2;APPL2;TENM1;MAP2K1;TNS2;EIF2AK2;TP53;FKTN;GAS8;SPEG;SOX9;IL12A;FABP3;HGS;ST18;DIS3L2;MTSS1;TESC;BNIPL;P3H3;CDKN2C;B4GALT7;LYN;NME1;MED25;THAP12;WNK2;CTNNBIP1;F2R;TFAP4;AR;CNOT7;MYC;KLF11;MN1;CDK10;TSC1;RBM5;CHERP
prerank,telomere organization (GO:0032200),-0.28503201025768377,-1.0023768852217336,0.43465045592705165,0.7284229164971927,1.0,27/43,37.10%,PTGES3;PRKDC;ATR;RTEL1;TERT;PCNA;STN1;ATM;NBN;RAD51D;DCLRE1B;HUS1;POLD2;PARP1;RPA2;ACD;LTO1;POLD4;POLD1;CTC1;RAD50;H3-3A;TINF2;HUS1B;MRE11;RPA3;APEX1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4491790442265009,1.001980684739422,0.46303501945525294,0.9623238440307572,1.0,4/10,11.54%,THRA;PSMC4;TP53;PSMC5
prerank,carbohydrate derivative transport (GO:1901264),-0.3591321603062577,-1.0019099595633107,0.4505208333333333,0.72887624165197,1.0,4/18,13.88%,LBP;PLTP;SCARB1;MFSD2A
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.25440695861254614,-1.0018013686052223,0.43700787401574803,0.7284131239841232,1.0,22/75,18.27%,TEK;NRP2;NRP1;BMPR2;ECM1;KDR;JCAD;VEGFD;VEGFC;PPP1R16B;GATA2;NR4A1;PIK3CD;FGFBP1;MDK;ITGB3;FLT4;AGTR1;SIRT1;HMGB2;AKT1;EGF
prerank,protein localization to nucleus (GO:0034504),0.2950074271431085,1.0016393454078139,0.46183699870633893,0.9624171306413699,1.0,26/102,18.72%,PRICKLE1;CSE1L;NUP214;FAM53C;NUTF2;POM121;TAF3;APPL2;FAM53A;BMP7;MSX1;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;RRS1;ZBTB7A;TNPO2;CALR;TAF8;IPO9;CTDNEP1;WRN;NUP155;KPNB1
prerank,tryptophan catabolic process (GO:0006569),0.4475241913740486,1.0011681690188508,0.47802197802197804,0.9628969604631877,1.0,2/11,17.55%,KYNU;KMO
prerank,cellular response to glucose stimulus (GO:0071333),0.36390240269941754,1.0009423351318745,0.4560862865947612,0.9626419555433486,1.0,5/30,8.66%,ZBTB20;TRA2B;PTPRN2;ADCY8;PRKACA
prerank,mRNA stabilization (GO:0048255),0.3380873960954555,1.00055971610505,0.4086826347305389,0.9628164941219495,1.0,12/40,17.67%,RBM24;DND1;BOLL;ELAVL4;TAF15;PAIP1;TENT5A;EIF4ENIF1;DHX9;GDNF;TIRAP;MYD88
prerank,aerobic electron transport chain (GO:0019646),-0.25947029794881854,-1.0003975830821745,0.44274809160305345,0.731168639864378,1.0,26/68,25.76%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFS6;NDUFA8;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;NDUFA1;NDUFS2;NDUFS8
prerank,regulation of water loss via skin (GO:0033561),0.4173819821855418,1.0002258933622639,0.452991452991453,0.9619289771668823,1.0,3/15,13.83%,KDF1;FA2H;STMN1
prerank,establishment of skin barrier (GO:0061436),0.4173819821855418,1.0002258933622639,0.452991452991453,0.9619289771668823,1.0,3/15,13.83%,KDF1;FA2H;STMN1
prerank,stress-activated MAPK cascade (GO:0051403),-0.26372660037469237,-0.9998045528876472,0.42857142857142855,0.7319744339161905,1.0,22/61,24.35%,NFKB1;IRAK2;MAP3K5;MINK1;MAPK9;CUL1;MAP2K4;MAPK14;UBB;MAP2K7;MAP3K8;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKB;TAOK2;IKBKG;NOD2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3338421496839714,-0.9997958446245787,0.4659400544959128,0.7312738292582615,1.0,11/23,20.46%,IGF1;APP;NFKB1;INSR;PRKAA2;PFKFB2;P2RX7;PRKAA1;EGF;PRXL2C;GAPDHS
prerank,telomere capping (GO:0016233),-0.3725297017489404,-0.9997680283755446,0.4794188861985472,0.7306280276627972,1.0,6/16,15.81%,PRKDC;DCLRE1A;STN1;TEN1;NBN;DCLRE1B
prerank,cardiac ventricle development (GO:0003231),0.39352922231896387,0.9996863874778008,0.4713804713804714,0.9625538022229351,1.0,7/20,18.37%,SALL1;TMEM65;MDM4;HECTD1;DAND5;GJA5;HEY1
prerank,negative regulation of viral genome replication (GO:0045071),-0.28633425367687304,-0.9994135843992928,0.43125,0.7308193469726656,1.0,12/40,25.63%,MAVS;IFITM3;ZC3HAV1;IFITM1;PARP10;SRPK1;RNASEL;ISG15;IFIT1;IFITM2;BANF1;TRIM6
prerank,mitochondrion morphogenesis (GO:0070584),-0.3998170040154988,-0.999328128146551,0.46365914786967416,0.7303425026057312,1.0,7/11,43.10%,MTM1;PID1;PNPT1;DNM1L;NUBPL;WASF1;SLIRP
prerank,dopaminergic neuron differentiation (GO:0071542),-0.34590819369677356,-0.9988954211635465,0.4564102564102564,0.7307129219064433,1.0,3/19,15.36%,LRP6;NR4A2;MANF
prerank,regulation of filopodium assembly (GO:0051489),0.3357432150144312,0.9987915022167232,0.46676737160120846,0.9642766457698017,1.0,8/38,11.66%,PIK3R1;ABITRAM;MYO10;FSCN1;FMR1;TENM2;TENM1;TRPM2
prerank,response to organic cyclic compound (GO:0014070),0.32733115828944115,0.99874550129863,0.45211267605633804,0.9634457009721074,1.0,7/52,7.11%,GGT5;GLDC;GGT7;KYNU;SPP1;LRRK2;CDKN2D
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.380330997420903,-0.9983437862065176,0.46731234866828086,0.7313293757407159,1.0,4/13,10.98%,CACNA1C;ANK2;GJC1;KCNQ1
prerank,proteolysis (GO:0006508),0.26549600039969845,0.9983296832277282,0.4854260089686099,0.9637271824647776,1.0,31/252,12.41%,ECE1;GGT5;PGPEP1L;ECE2;OGT;ADGRV1;ATG4A;FAP;MMP24;MMP25;PCSK2;CAPN5;HTRA3;CASP6;CPQ;KLKB1;ADAM19;CASP4;CAPN3;CPM;ADAMTS12;PSMB5;PLAU;LGMN;CAPN6;PSMC4;PITRM1;ERMP1;HTRA2;ENDOU;SPRTN
prerank,protein targeting to peroxisome (GO:0006625),0.3544341763720076,0.9979900721938954,0.4575757575757576,0.963764267713236,1.0,12/29,23.26%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;PEX6;GDAP1;FIS1
prerank,regulation of cell differentiation (GO:0045595),0.2784605289593609,0.9979206799169331,0.4715151515151515,0.9630208976677037,1.0,34/148,17.12%,ZFHX3;TRPS1;RUNX2;EDN3;PTPRQ;FGFR1;PHLDB1;ST7;REST;NF1;SRF;FLOT2;BCL6;PTK2;PRKACA;PRKCB;DDX17;BIRC2;OCIAD1;EPHA3;EIF2AK2;MCRIP1;TGFBR1;IGF2;SMYD5;CLASP2;AR;GDNF;FGFR2;CLASP1;MAFB;TRIP4;NR1D2;TAF8
prerank,cell cycle G1/S phase transition (GO:0044843),0.3136789669845312,0.9975734608961492,0.4465753424657534,0.9631098381873977,1.0,21/61,21.60%,CDKN2A;CDC7;CDKN2D;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CUL5;CDKN2C;DBF4;CCNA2;MYC;CAMK2A;CCNE1;KHDRBS1;CUL4A;POLE;LATS2;INHBA;CDK7
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.29171854238875716,-0.9967560245615565,0.4634920634920635,0.7346599379437043,1.0,15/41,25.90%,TJP1;PODXL;PLPP3;AFDN;CD44;CITED2;MDK;DENND6A;CX3CL1;SKAP1;PIEZO1;SMAD7;FSTL3;MAGI1;FLOT1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3378280333319063,-0.9967288824317162,0.4300254452926209,0.7340158194401343,1.0,4/21,6.14%,ROCK2;KLF7;RUNX1;ERRFI1
prerank,membrane depolarization (GO:0051899),0.3513629982651615,0.9963782199993864,0.45245398773006135,0.9656102261903446,1.0,12/32,22.80%,CACNA1E;CACNA1G;CACNB4;CACNG4;P2RX4;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I;CACNA1A;ABL1
prerank,manganese ion transport (GO:0006828),0.41662538557964945,0.9963395983403722,0.47018739352640543,0.9647777484840071,1.0,6/14,19.43%,SLC30A10;TRPC3;TRPC7;SLC39A14;ATP2C1;TRPC1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3774043498550713,0.9960897957892918,0.46481178396072015,0.9645760835285345,1.0,5/23,8.79%,PTEN;SACM1L;MTMR4;MTMR1;INPP5J
prerank,aminoglycan catabolic process (GO:0006026),0.35905741404237407,0.9960875812417015,0.46261682242990654,0.9636382252580031,1.0,7/28,15.44%,HSPG2;GPC4;GPC5;GNS;GUSB;IDUA;SDC2
prerank,glial cell differentiation (GO:0010001),-0.3140775820577355,-0.995197729159807,0.44477611940298506,0.7370574816730224,1.0,3/28,1.55%,NFIB;SLC8A3;ADGRG6
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.35211230375265173,-0.9950352023683042,0.4755784061696658,0.7367460403768227,1.0,8/19,23.79%,RENBP;UGDH;UAP1;UGP2;UAP1L1;PMM1;NANS;MPI
prerank,negative regulation of DNA binding (GO:0043392),-0.313285107414993,-0.9949272786259491,0.4588235294117647,0.7362967756985854,1.0,10/28,25.65%,LEF1;SMO;NFKBIA;SUMO3;HEY2;SOX11;E2F1;ILRUN;SUMO1;KDM1A
prerank,thymus development (GO:0048538),-0.3811528490438757,-0.9947114972598526,0.4889975550122249,0.7361009191404099,1.0,3/13,17.97%,SIX1;TBX1;EPHB3
prerank,cellular response to organic substance (GO:0071310),-0.23462367979119195,-0.9945937199639506,0.49261083743842365,0.7356951988978938,1.0,42/116,23.68%,DPYSL3;LEF1;SLIT2;IL18;ARL6IP5;IGFBP5;KLF4;BMPR2;PTPN4;PTPN14;CYP1B1;SOCS2;RAMP1;ACVR1;ACVRL1;SMAD3;SFRP1;PTPN2;SLC1A1;NOS1;CPNE3;RAMP2;PLK5;MAP2K5;FLT3;TBK1;ACVR2B;ERBB2;CDK9;NDOR1;PID1;PTPN5;DCPS;CIB1;HDAC6;TGFBR2;TWF2;CSF1R;ACVR2A;MME;SIGIRR;EMD
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3559069456578527,0.994561661949406,0.4589905362776025,0.9670876675238559,1.0,12/29,21.85%,HDAC1;TCF7L2;PYGO1;BCL9;TLE2;TLE1;MYC;ASH2L;CDC73;MEN1;RBBP5;CREBBP
prerank,regulation of lamellipodium assembly (GO:0010591),0.34525158467924116,0.9941413240262758,0.46551724137931033,0.9673919811252931,1.0,6/34,8.62%,PIK3R1;HRG;AUTS2;FSCN1;CARMIL2;CLRN1
prerank,RNA transport (GO:0050658),0.3064677861291413,0.9940552946059895,0.46613545816733065,0.9667009101264986,1.0,17/71,19.18%,RBFOX1;EIF4A3;NUP214;FMR1;POM121;THOC7;HNRNPA2B1;SRSF11;SLU7;CASC3;KIF5C;SLBP;SRSF9;THOC5;SRSF6;NUP155;CHTOP
prerank,endothelial tube morphogenesis (GO:0061154),-0.4118922059613777,-0.993699968149983,0.4715261958997722,0.7371614180618491,1.0,3/10,17.89%,RBPJ;ACVRL1;CSNK2B
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3370467868776059,-0.9930219334162079,0.4772727272727273,0.7381211933929395,1.0,8/21,13.93%,AMPD3;NUDT3;NUDT4;XDH;NUDT7;NT5E;ACAT1;HINT1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.27788491253643677,-0.9929087612844537,0.4517241379310345,0.7377075097490209,1.0,15/44,20.63%,FNIP1;XIAP;THBS1;KLF4;NGF;CD44;LAMTOR5;GPX1;RPS6KA1;ARL6IP1;MAP2K5;SIAH2;AKT1;HGF;CAST
prerank,lipoprotein catabolic process (GO:0042159),0.4414609099686021,0.9925950115814285,0.43828264758497315,0.9700127358586095,1.0,3/11,10.31%,ABHD17C;ABHD17B;LYPLA2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4507413069445708,0.9925311429991587,0.4782608695652174,0.9692535914362879,1.0,3/10,21.56%,TLR4;IL12A;DDIT3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.38331610924747966,-0.9923566357858937,0.4560975609756098,0.7384518833608366,1.0,7/14,17.38%,SEMA7A;MAVS;PLCG2;TICAM1;SIRT1;CD74;LAPTM5
prerank,response to amino acid (GO:0043200),0.3540130301842086,0.992314261171621,0.4500768049155146,0.9689517018576822,1.0,10/31,18.69%,CPEB1;MTOR;GLRA3;GLRA1;GLRA2;MEAK7;GLRB;RRAGA;RRAGD;CAPN2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.36723385527552066,0.9921221082124869,0.45813586097946285,0.9685169242253386,1.0,5/26,9.06%,MEIS2;CCDC57;RPS6KB1;PRKCA;LGMN
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3790340474174392,-0.9920949255527856,0.4738095238095238,0.7384093138620693,1.0,4/13,13.55%,ZDHHC21;ETS1;MDK;FUT9
prerank,histone H3-K4 trimethylation (GO:0080182),0.43726567755629925,0.9919002750519356,0.4628975265017668,0.9681775140221127,1.0,2/11,4.58%,OGT;KMT2A
prerank,hippo signaling (GO:0035329),-0.3179471519403011,-0.9918738230772972,0.4659400544959128,0.7382509651664676,1.0,10/26,20.19%,TJP1;AMOT;TEAD4;YWHAB;TJP2;CASP3;AMOTL2;MOB1B;NPHP4;AMOTL1
prerank,sensory perception of chemical stimulus (GO:0007606),0.41909257295320435,0.9918171407385331,0.4672413793103448,0.967460193011552,1.0,2/15,6.49%,C5AR1;ADCY3
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.4475383419018393,0.9915439236798944,0.4772313296903461,0.9673094599336608,1.0,3/10,10.51%,GABRA1;GABRG3;GABRG2
prerank,regulation of MAPK cascade (GO:0043408),0.27647039883175634,0.991423796544761,0.46875,0.9667180694633349,1.0,15/157,6.08%,ROR1;NTRK3;EPHA7;ROR2;NTRK2;EPHB1;FGFR1;MAP4K4;GPR37L1;DUSP1;PIK3R2;YWHAZ;SPRED1;NF1;PSMD10
prerank,indolalkylamine catabolic process (GO:0046218),0.45480227722515026,0.9913910030763033,0.4927007299270073,0.9658865441845756,1.0,2/10,17.55%,KYNU;KMO
prerank,protein autophosphorylation (GO:0046777),0.27439160332434875,0.991304868373569,0.47368421052631576,0.9652204023299369,1.0,35/157,16.05%,PDGFRA;NTRK2;PEAK1;TXK;ERBB4;EPHB1;FGFR1;PDPK1;CDKL5;PRKX;CAMKK2;LRRK2;PTK2;PINK1;PRKD1;MTOR;IRAK1;FGR;CAMK4;EIF2AK2;EIF2AK1;SLK;MAPKAPK3;STK16;MAP4K1;MELK;PIM1;LYN;WNK2;RIPK1;VRK1;TNIK;MAP3K3;FGFR2;ULK2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.4487678898554084,0.9911821425956789,0.4627949183303085,0.9637050408323652,1.0,2/10,9.26%,IL1RN;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.4487678898554084,0.9911821425956789,0.4627949183303085,0.9637050408323652,1.0,2/10,9.26%,IL1RN;MBP
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3038815862777604,0.9911256709226611,0.46303501945525294,0.9629340570380777,1.0,19/77,17.00%,SH3RF1;TCF7L2;PHIP;ITGAV;NOL3;PSMD10;HERPUD1;FXN;PINK1;NOC2L;OPA1;RTKN2;BCL2L2;TGFBR1;RIPK1;CLU;AR;CSNK2A2;MAZ
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.31861796281840005,0.9910303723059349,0.4889196675900277,0.962254915169546,1.0,14/54,16.88%,DPP6;DPP10;KCNIP1;NEDD4;KCNMA1;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3;AKAP6;GNG2;GABBR2;KCNJ10
prerank,cellular response to interleukin-1 (GO:0071347),-0.2266102368415897,-0.9909749477663063,0.4840764331210191,0.7397957545954171,1.0,35/143,15.39%,PLCB1;NFKB1;IRAK2;PSMC6;SIRPA;SQSTM1;IL1R1;PELI1;PSMD9;PSMF1;PSMB7;CUL1;TOLLIP;UBB;GBP2;PSMD8;RPS6KA5;RC3H1;HYAL1;PSMD12;SFRP1;NFKBIA;RBMX;MAP3K8;TAB2;PSMA3;PSMA6;PSMD4;IRAK4;PSME3;PSMD7;UBE2N;PSMB6;CX3CL1;PSMC1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.30364617674162186,-0.9906368997311998,0.45108695652173914,0.7399308379912884,1.0,5/29,7.68%,IL31RA;FER;NMI;SOCS2;IFNAR1
prerank,response to calcium ion (GO:0051592),0.29350299879586367,0.990608029322218,0.47876447876447875,0.9625466562678842,1.0,29/102,19.43%,ADGRV1;WNT5A;GPLD1;RYR2;NEDD4;KCNMA1;KCNIP2;ADCY8;CAPN3;RASGRP2;SYT3;TRPC3;LGMN;SYT7;CPNE7;TRPM2;SYT5;CPNE4;RYR3;CPNE8;STIM1;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1;TRPC1
prerank,calcium ion transmembrane transport (GO:0070588),0.29224448285315674,0.9903348059357413,0.4766977363515313,0.962375225117763,1.0,16/86,11.67%,TRPA1;SLC24A5;NALCN;MCOLN2;ITGAV;GRIN2B;ATP2A2;GRIN2A;CACNA1G;TRPV3;TRPC3;MICU3;PMPCA;P2RX4;TRPM2;TRPC7
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3436717644963066,0.9900663251413547,0.5,0.9622308186220913,1.0,6/33,10.60%,TEAD1;GNL3;NGFR;FOS;SRF;TP53
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.35883074779471624,0.989967710254427,0.48942598187311176,0.9615666237027263,1.0,4/29,4.06%,ZBTB20;PPARA;GPLD1;NR1H2
prerank,cellular response to oxidative stress (GO:0034599),0.2832625648622039,0.9899576676415205,0.4732142857142857,0.9606738926257727,1.0,23/118,14.60%,PDGFRA;ETV5;PLA2R1;ERCC6L2;FOS;PRDX6;ALDH3B1;CAMKK2;LRRK2;PRDX5;CCS;PYCR1;PINK1;PRKD1;CYBA;TP53;ERMP1;PDK2;HTRA2;EIF2S1;RAD52;LONP1;VKORC1L1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2487427907346057,0.9896041452236243,0.5262096774193549,0.9607303392242503,1.0,141/834,16.89%,RORA;IL33;LPIN3;DCN;PIK3R1;ZFHX3;ATF5;ETV1;CXCL10;RUNX2;PPARA;HOXC10;AUTS2;MEIS1;TEAD1;OGT;ETV5;HDAC1;GNL3;WNT5A;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;SALL1;THRA;SMAD5;NR1H4;CDK8;MAML3;NCOA2;MEIS2;PGR;NFATC3;NGFR;MED12;THAP3;METTL23;JUP;PPARD;PIK3R2;NR1H2;REST;TBX3;FOS;NCOA3;KMT2A;MYCN;BCL9;EPAS1;HLF;SSBP4;SLC9A1;E2F4;BRD8;CRTC2;GLIS1;SRF;CSRNP3;NPAS2;MYO6;AKIRIN2;FIZ1;CSRNP2;MED6;TWIST1;PRKD1;PFKM;CDK13;SOX2;NCOA1;GLI1;TLR4;DDX17;KAT2A;GLI3;AHI1;ZBED3;PPP3CB;TP53;SMARCA1;DHX36;ZFPM2;MED10;SNW1;EPC1;FOXJ2;SOX9;IGF2;TFEB;HOXB4;ST18;DPF2;KDM1B;CD81;ACTR2;NRIP1;NFIX;HOXC4;MYDGF;RFX4;PEG3;MED1;SREBF1;ZFP64;ARNT2;MED25;DOT1L;SSBP2;ELK1;BPTF;ASXL1;RIPK1;CHD8;FOXM1;DHX9;EAF2;PBX2;AR;GDNF;ATF2;MYC;PAXIP1;LPIN2;PRDM10;LAGE3;FOXJ3;FGFR2;PLAC8;AKIRIN1;ONECUT2;DVL3;CCNK;USP16;JAG1;HAX1;TOX2;ATMIN
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3253132798866889,0.9893476370756871,0.45689655172413796,0.9605406877836927,1.0,4/49,3.59%,GHR;CD40;ERBB4;TSLP
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.35741096203945305,0.988857691118704,0.4696969696969697,0.9609873731286362,1.0,13/29,24.05%,COPA;COPZ2;COPB1;COG6;COG1;TRAPPC10;GOLGA5;COPG1;COPB2;NAPG;RAB33B;COPZ1;GOSR1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.24861457318064542,-0.9885699250468782,0.5150214592274678,0.7445069133545207,1.0,19/86,15.68%,BAIAP2L1;OCLN;FER;APP;DRG1;RAC1;NCK1;APOE;MAPT;GPX1;ARL2;SLAIN2;LMOD1;TRPV4;PTK2B;BAIAP2;CX3CL1;EDN1;MET
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3951233657421469,-0.9885566915796863,0.46731234866828086,0.7438328706090591,1.0,1/12,0.01%,SORBS1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.44733229225439086,0.9883414827053018,0.46846846846846846,0.9615601136610272,1.0,5/10,16.07%,CORO2B;TERF1;NDFIP2;SNX12;NDFIP1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3217130322734248,-0.9882285686743342,0.46701846965699206,0.7439696383829144,1.0,5/25,8.64%,MEF2C;SHANK3;MINK1;SHANK1;CACNG2
prerank,cell-cell junction maintenance (GO:0045217),-0.4054485708070852,-0.9881389914393054,0.49029126213592233,0.7434874144865928,1.0,1/11,0.33%,TJP1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.26905135392552726,0.9880499588787802,0.4797687861271676,0.9614381646043614,1.0,26/198,10.49%,ENPP1;EPHA7;PLA2G2C;THNSL2;PTEN;PIP4K2A;PFKFB1;DUSP12;HTR2B;LRRK2;IPMK;NADK;GFPT2;PLPPR3;ALDOB;ENPP3;PI4KA;PFKM;INPP5J;MTOR;PLPPR2;ACYP2;PLAA;GCK;GK;PPP3CB
prerank,establishment of spindle localization (GO:0051293),0.40857997972320337,0.9879372345257829,0.4957410562180579,0.9608296533479816,1.0,6/14,18.72%,LLGL1;ZBED3;NUSAP1;CLASP2;CLASP1;KPNB1
prerank,positive regulation of cilium assembly (GO:0045724),0.39504777034909017,0.9878442865499655,0.4752475247524752,0.9601718473197955,1.0,5/18,12.99%,SEPTIN9;TAPT1;CEP135;ARHGAP35;ENTR1
prerank,ion transport (GO:0006811),0.28504530562064,0.9877473133186792,0.4810126582278481,0.9595384284933568,1.0,17/111,14.33%,SLC1A3;SLC15A1;VDAC2;TRPA1;SLC24A5;CHRNB4;SLC12A6;SLC9A9;SLC9A1;PLP2;SLC25A22;GLRA1;SLC4A1;KCNN2;GABRB1;LRRC8A;SLC25A26
prerank,cellular response to superoxide (GO:0071451),-0.41358145141666763,-0.9874065831634147,0.4955947136563877,0.7446647628980851,1.0,4/10,16.03%,NOS3;SOD2;PRDX1;SOD3
prerank,cellular response to cytokine stimulus (GO:0071345),0.2547843053850542,0.9872763363746789,0.520042194092827,0.9599950777597736,1.0,54/416,12.54%,RORA;GHR;IL34;PIK3R1;ZEB1;IL1RN;IL2RA;XCL1;CXCL10;PTPRT;WNT5A;CXCL1;IL1R2;CD40;IL16;FLT3LG;EPRS1;GAB2;JAK1;DUSP1;FSCN1;YWHAZ;FOS;CCL15;SMPD4;PDE12;COL1A2;ADAMTS12;ZFP36L2;BCL6;PTPN13;IL5;UBE2G2;TWIST1;PLP2;AXL;PRKACA;IFNLR1;SOX2;TLR4;IL1RAP;IRAK1;TNFRSF21;CCL25;TP53;PYCARD;FYN;PTGIS;SOX9;IL12A;HTRA2;CD86;HSP90B1;GSK3A
prerank,protein polymerization (GO:0051258),-0.2684984172056222,-0.9869627298744847,0.44285714285714284,0.7450800763158201,1.0,15/55,17.92%,DIAPH1;GSN;RAC1;COBL;ARL6;MAPT;GAS7;FAM107A;MAP7D3;TRPV4;TPPP3;PSTPIP1;CHMP4B;CHMP4A;WASL
prerank,primary alcohol metabolic process (GO:0034308),0.3696005340674979,0.9858873221594242,0.5,0.9630182758544055,1.0,3/25,2.38%,ADH1A;RDH10;RDH11
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4337043913144862,0.9856855990180293,0.4809027777777778,0.9626781132471699,1.0,1/12,0.79%,XCL1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.25986556256351484,-0.9852264680967182,0.4647887323943662,0.7486989823763558,1.0,18/56,23.51%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;CDC23;ANXA1;HYAL1;CCND1;RAD51C;ANKRD17;CUL3;ANAPC11;AKT1;RGCC;RCC2;STOX1;LSM10
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2931724895625329,0.9850518780251186,0.4748677248677249,0.9635371419113886,1.0,24/94,19.98%,DYNLL1;DCTN3;HAUS3;HAUS1;DCTN2;HAUS8;PRKACA;CEP192;CEP135;AHI1;TCTN2;SSNA1;TMEM67;IQCB1;SCLT1;CEP250;CEP152;CSNK1E;CLASP1;ALMS1;PCM1;MKS1;TUBA1A;CEP43
prerank,coenzyme A metabolic process (GO:0015936),0.416534623319096,0.9847943080591159,0.48911222780569513,0.9633476310943151,1.0,5/14,21.63%,COASY;ACOT7;ACLY;PANK2;SLC25A16
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.4099787921324125,0.9847354020198592,0.4905982905982906,0.9626088135370408,1.0,4/14,12.97%,ENTPD2;ENTPD5;NUDT9;ENTPD7
prerank,regulation of MAP kinase activity (GO:0043405),0.29182146213161453,0.9846480183459136,0.4713541666666667,0.9619600426543523,1.0,11/92,5.64%,IL34;SPRY4;EDN3;SPRY1;CD40;FGFR1;DUSP1;HTR2B;SORL1;LRRK2;NF1
prerank,ureteric bud development (GO:0001657),0.3995678106739283,0.984484402392599,0.46826758147512865,0.9614683094658659,1.0,2/17,2.53%,ROBO2;SALL1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.35776662224945044,-0.9844454716428698,0.46329113924050636,0.7500206008601717,1.0,5/17,13.00%,NPR3;CCN1;PLXNB1;SFRP1;TMEM119
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2952157431925748,0.9843608417391868,0.4849279161205767,0.9609086821151106,1.0,20/88,14.46%,CCDC22;STXBP6;TXNDC5;GBF1;VAMP2;MYO1B;SORL1;EPS15;LLGL1;SNAP23;COMMD1;AP1S1;SCFD1;EXOC1;VAMP7;HGS;ACBD3;CLVS1;RABIF;SH3D19
prerank,tRNA metabolic process (GO:0006399),0.39078078446618203,0.9841598694790838,0.4774624373956594,0.9605588331070353,1.0,8/17,23.77%,POP5;DTD1;POP7;SARS1;RPP21;DTD2;AARS1;SSB
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3531615592529035,-0.9841405657016365,0.46859903381642515,0.7500809543616997,1.0,6/17,24.35%,ARL6IP5;TGFB2;STK25;MID1;TAOK2;NOD2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4229313688252933,0.9839816140392887,0.4931740614334471,0.960145039512685,1.0,3/12,10.49%,GPLD1;ADCY8;PPP3CB
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.39034174629482465,0.9839802937901595,0.45292207792207795,0.9592459155126304,1.0,6/17,15.21%,UBL4A;EMC2;EMC9;EMC8;BAG6;GET3
prerank,positive regulation of integrin activation (GO:0033625),-0.39059816635754335,-0.9837676256922971,0.45390070921985815,0.7503218545009634,1.0,5/11,24.78%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC
prerank,positive regulation of innate immune response (GO:0045089),-0.3105318627176843,-0.9837484734666049,0.44571428571428573,0.749658668038996,1.0,10/30,15.90%,LBP;NMI;MAVS;GBP5;RPS19;IFI35;RIOK3;POLR3G;NLRC5;POLR3D
prerank,chromatin remodeling (GO:0006338),-0.23288247171298948,-0.9837377797351571,0.5049019607843137,0.7489755284897135,1.0,30/100,21.31%,ACTB;HDAC4;PBRM1;KDM4A;KDM4C;SMARCA4;SMARCA2;CBX3;TOP1;ACTR8;INO80;SMARCA5;HNRNPC;ACTR5;SMARCC2;JARID2;CHD3;SIRT1;ARID1B;BAZ1A;BAHD1;ESR1;BAZ2B;INO80C;KDM4B;TADA2B;NPM1;CHD1L;SMARCD3;RUVBL2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3135044252527536,-0.9835982016771677,0.4648648648648649,0.7486057055770424,1.0,6/26,12.66%,IGF1;LMCD1;GSK3B;DYRK2;CAMTA1;PLCG2
prerank,protein prenylation (GO:0018342),0.4528063240429214,0.9835645254227013,0.4831858407079646,0.9594887413994183,1.0,3/10,14.63%,PTAR1;PGGT1B;CHML
prerank,negative regulation of cell projection organization (GO:0031345),-0.2758757862002276,-0.9834471297431147,0.4681528662420382,0.7482612870002994,1.0,10/48,13.30%,EPHA4;RAPGEF2;DPYSL3;EFNB2;KANK1;PRAG1;APOE;ADCY6;GAK;TRPV4
prerank,atrial septum development (GO:0003283),-0.3857610810453356,-0.9833329786356464,0.47706422018348627,0.7478611118185718,1.0,5/13,12.73%,NOTCH2;BMPR2;TGFB2;ANK2;HEY2
prerank,positive regulation of metabolic process (GO:0009893),0.2878738383934243,0.9827393668261366,0.48860759493670886,0.9609518490086042,1.0,16/103,9.82%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;SIRT6;EPAS1;FABP5;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2
prerank,myelination (GO:0042552),0.32592063386545916,0.9826892365731564,0.47307132459970885,0.9601750712037895,1.0,12/46,13.88%,EPB41L3;ABCD2;NF1;SBF2;MBP;DEGS1;LGI4;SOX10;PLP1;TNFRSF21;SCN2A;MYRF
prerank,regulation of cellular metabolic process (GO:0031323),0.3269763958306013,0.9826135867707382,0.48104956268221577,0.95949090805472,1.0,12/45,19.51%,PPARA;TBC1D16;PINK1;PDK2;ACLY;MBOAT7;FOXM1;PANK2;COQ7;NPC2;ABCA2;PDK3
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.25831883473448536,-0.9825379642744405,0.46946564885496184,0.7490878032238666,1.0,12/66,14.89%,IGF1;FOXP1;APP;SIRPA;GBP5;CASP8;GIT1;TRIM16;CX3CR1;HSPB1;P2RX7;CX3CL1
prerank,smooth muscle tissue development (GO:0048745),-0.4083621899680275,-0.9822265335463095,0.5058548009367682,0.7491661770536258,1.0,3/10,14.79%,MYLK;SMO;STRA6
prerank,ganglion development (GO:0061548),-0.40140516029610773,-0.9821386150173205,0.4841628959276018,0.7486643289371704,1.0,3/11,13.11%,NRP2;NRP1;FZD3
prerank,regulation of vacuole organization (GO:0044088),-0.34074327114596537,-0.9821094385441221,0.4639175257731959,0.7480381573136741,1.0,8/20,25.09%,MTM1;LAPTM4B;RAB5A;ENO1;TBC1D14;RAB1B;NPRL3;ADPRH
prerank,histone monoubiquitination (GO:0010390),0.3700805583924848,0.9820889314026783,0.4688995215311005,0.9601302349716524,1.0,4/24,9.24%,RNF40;BCOR;TRIM37;RNF168
prerank,regulation of cytoplasmic transport (GO:1903649),0.4301617804033029,0.9818897719484407,0.45868465430016864,0.9598040393615199,1.0,5/11,21.55%,LRRK2;MAP2K1;ATP9A;MAPK1;DENND10
prerank,regulation of interleukin-2 production (GO:0032663),0.32253122946180945,0.9818334709046626,0.4738372093023256,0.9590669469524719,1.0,4/43,3.80%,XCL1;PDE4B;GLMN;SPTBN1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3933780366891022,0.98152639803191,0.48625429553264604,0.9589896737468597,1.0,6/18,15.40%,PEX2;NF1;TP53;B4GALT7;MED25;MYC
prerank,regulation of phosphate metabolic process (GO:0019220),0.40136708056585324,0.9811927532506093,0.4956521739130435,0.9590551284987587,1.0,2/16,3.65%,SRPX2;MCM7
prerank,positive regulation of defense response (GO:0031349),0.29152132707403294,0.981177342072108,0.4881578947368421,0.9582050507448235,1.0,10/89,9.80%,IL33;WNT5A;IL16;TSLP;TLR8;NPAS2;AKIRIN2;PLA2G7;TLR4;CYBA
prerank,glycine metabolic process (GO:0006544),0.4257358625439971,0.9810750501368727,0.4882154882154882,0.9576023776588422,1.0,2/12,13.25%,GLDC;AMT
prerank,positive regulation of ion transport (GO:0043270),-0.27194136865330804,-0.9808914743369785,0.4790996784565916,0.7502905188817898,1.0,12/48,19.73%,ANO6;ACTN2;FHL1;MYLK;ATP2B1;ORAI1;ANK2;TRPC6;P2RX7;SCN4B;DLG1;PKP2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.34250292928333204,0.9804114254158751,0.4908256880733945,0.9585705301762064,1.0,6/40,9.69%,PTN;GPM6B;ADGRV1;FBXO5;AMELX;BMP7
prerank,positive regulation of potassium ion transport (GO:0043268),-0.2869825778920577,-0.9803727899507904,0.5045045045045045,0.7508769526792035,1.0,8/38,13.98%,ACTN2;FHL1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP
prerank,organic hydroxy compound transport (GO:0015850),-0.2931709066355377,-0.980309875445018,0.49014084507042255,0.7503251834081971,1.0,7/36,8.54%,ABCC4;SLCO1C1;RBP4;RXRA;SLC16A1;RALBP1;ATP8B1
prerank,regulation of monocyte differentiation (GO:0045655),0.4172583278117397,0.980272089911291,0.47231833910034604,0.9580880917184119,1.0,1/14,0.31%,IL34
prerank,glycerophospholipid metabolic process (GO:0006650),0.29766796799752115,0.9802354393556416,0.47950819672131145,0.9572960926571104,1.0,15/75,13.98%,PIGV;GPLD1;PIGQ;SERINC1;PRDX6;SMPD4;PIGP;ENPP6;PLA2G7;CPNE7;ABHD12;AGK;PIGA;PIGL;SERINC5
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3009878617141269,0.9801418488750336,0.4768211920529801,0.9566795779189468,1.0,8/75,5.46%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;ADGRB1;SERPINF1
prerank,aerobic respiration (GO:0009060),0.38221780368559316,0.980052223626183,0.4780564263322884,0.9560722537253322,1.0,6/20,15.03%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14
prerank,plasma membrane organization (GO:0007009),0.30583407536874746,0.9800389658508064,0.4860724233983287,0.9552175737560711,1.0,9/61,10.41%,PLSCR4;EPB41L3;ABCD2;SPTBN1;ANK3;DEGS1;FA2H;SYT7;ARL8B
prerank,fatty acid transport (GO:0015908),0.39607263761211975,0.9799769418429084,0.5024875621890548,0.9545106919079919,1.0,5/17,14.47%,PPARD;FABP5;FABP4;FABP3;SLC25A17
prerank,positive regulation of axonogenesis (GO:0050772),0.3251520303571313,0.979761270191913,0.47293447293447294,0.9542481812883693,1.0,6/43,6.34%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;LIMK1
prerank,regulation of glycolytic process (GO:0006110),0.3037015190363139,0.9797605956006994,0.4911080711354309,0.9533702842831132,1.0,9/68,6.86%,ZBTB20;PPARA;OGT;PFKFB1;NUP214;ENTPD5;AAAS;POM121;CBFA2T3
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.4062442019509972,-0.9793497032056389,0.4786516853932584,0.752051175622259,1.0,2/10,5.23%,RAPGEF2;GIPC1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.32535693854722164,-0.9790833710156724,0.46511627906976744,0.7519735999152684,1.0,5/24,10.50%,ERAP1;TAPBP;ACE;B2M;TAP2
prerank,positive regulation of DNA repair (GO:0045739),-0.27154291889483123,-0.9786312032943265,0.5064935064935064,0.7524107303068683,1.0,11/46,16.00%,EYA2;EYA1;EGFR;EYA4;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;DDX11;SIRT1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.32456995572022357,-0.9784585230571619,0.5157894736842106,0.7521329145106063,1.0,7/24,12.56%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,regulation of lipid catabolic process (GO:0050994),0.3813431773685147,0.9781833793221149,0.46321070234113715,0.9568243613210976,1.0,6/19,22.61%,CIDEA;BSCL2;ADRA2A;PDE3B;RARRES2;TYSND1
prerank,regulation of protein localization (GO:0032880),-0.2598436668107674,-0.9780433304810436,0.4734982332155477,0.7524737937275351,1.0,8/58,8.31%,PICALM;AFDN;DVL1;TRIM25;TRIM5;TRIM14;PPM1F;CEP290
prerank,glycogen catabolic process (GO:0005980),-0.37757712721144643,-0.977793738670258,0.4641975308641975,0.7523438726392467,1.0,5/15,11.65%,PYGB;PGM2L1;CALM1;GAA;PGM2
prerank,digestive tract development (GO:0048565),0.3508684128954257,0.9776795946540031,0.5142857142857142,0.9573072542403421,1.0,8/32,15.69%,CLMP;SALL1;NPY;GLI1;GLI3;CHD8;CCDC39;FGFR2
prerank,sphingosine biosynthetic process (GO:0046512),-0.39614731808258685,-0.9770999124256786,0.4762979683972912,0.7525702642728536,1.0,3/11,4.52%,SPTLC2;ACER2;ACER3
prerank,sphingoid biosynthetic process (GO:0046520),-0.39614731808258685,-0.9770999124256786,0.4762979683972912,0.7525702642728536,1.0,3/11,4.52%,SPTLC2;ACER2;ACER3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3603801678274269,-0.9767441972853229,0.4798994974874372,0.7527635991274236,1.0,4/16,10.80%,DPYSL3;UPP2;UPB1;NT5E
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.24876887529694852,0.9766326238490763,0.5614583333333333,0.9592990956827604,1.0,107/509,19.20%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;MAP3K14;NRG1;ROR2;EDA2R;CCDC22;ADGRV1;WNT5A;NTRK2;SEMA5A;TCF7L2;CD40;ERBB4;ITGAV;FLT3LG;NRG2;TSPAN6;FGFR1;GAB2;LURAP1;GPR37L1;GJA1;PDPK1;PIK3R2;GCNT2;HTR2B;TLR6;NEDD4;IRS1;DHX58;IRS2;NRG4;WDR24;PTK2;TNFRSF19;PINK1;PRKD1;RELN;AXL;SOX2;TRIM8;PRKCB;TSPYL5;TLR4;BIRC2;IRAK1;LPAR1;FGR;NDFIP2;EIF2AK2;TP53;DHX36;RTKN2;FYN;RPL37;P2RX4;TGFBR1;IAPP;SOX9;CD86;PDCD4;IGF2;CASS4;LGALS1;TRIM44;MYDGF;RNF31;LYN;UBE2V1;F2R;RIPK1;FERMT2;FGF5;AREG;MIOS;MAP3K3;FGFR2;TIRAP;GPR37;NDFIP1;ZCCHC3;HAX1;PIK3CG;RRAGA;MAZ;HTR6;LGALS9;ADAM8;ADRA2A;RHOG;MYD88;BMP2;RRAGD;NFAT5;RHOA;BBC3;WWC1;SPRY2;ATP2C1;TERF2IP;RNF13;KSR1;PDGFRB
prerank,response to tumor necrosis factor (GO:0034612),0.2892934294716618,0.9766124063382678,0.507323568575233,0.9584765104973059,1.0,11/91,10.90%,GGT5;XCL1;CD40;GGT7;CCL15;SMPD4;ADAMTS12;ZFP36L2;TNFRSF21;CCL25;PYCARD
prerank,regulation of interleukin-10 production (GO:0032653),0.3228290118259919,0.976481613293669,0.4746008708272859,0.9580178338632361,1.0,6/44,10.90%,XCL1;TSLP;PDCD1LG2;TLR4;TNFRSF21;PYCARD
prerank,cellular response to metal ion (GO:0071248),0.27878064468071717,0.9760862136959598,0.5280487804878049,0.9582673820404555,1.0,32/123,18.99%,ADGRV1;WNT5A;GPLD1;ANK3;FOS;DLG2;LRRK2;ADCY8;CAPN3;RASGRP2;SYT3;ADCY7;LGMN;DAXX;SYT7;GLRA1;CPNE7;P2RX4;DLG4;TRPM2;SYT5;GLRA2;CPNE4;RYR3;CPNE8;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1
prerank,regulation of protein sumoylation (GO:0033233),0.39146494086533934,0.9760786466043537,0.4724025974025974,0.9574113530231697,1.0,3/17,10.22%,GNL3;CAPN3;SAE1
prerank,regulation of T cell activation (GO:0050863),0.3335654615033971,0.9760655553270667,0.4906204906204906,0.9565752007484642,1.0,5/42,10.90%,PAG1;TNFAIP8L2;PTPN22;KAT2A;PYCARD
prerank,phospholipid translocation (GO:0045332),-0.3046730472315138,-0.9759253762359991,0.5144508670520231,0.7541709634058996,1.0,10/28,18.60%,ATP10A;ANO6;ATP8A1;ATP11B;ATP8B1;MFSD2A;ABCB4;P2RX7;PLSCR3;ATP8A2
prerank,myoblast differentiation (GO:0045445),0.4110043740410861,0.9753737858274475,0.4845890410958904,0.9575857020036442,1.0,5/14,9.54%,NRG1;TCF7L2;REST;EPAS1;DDX17
prerank,protein insertion into ER membrane (GO:0045048),0.33339676592403655,0.9752681207142094,0.5022900763358779,0.9569884998558067,1.0,16/37,24.06%,VAMP2;UBL4A;EMC2;SEC61B;EMC9;TRAM2;EMC8;BAG6;GET3;ALDH3A2;EMC10;TRAM1L1;SERP1;UBE2J2;CCDC47;EMC4
prerank,positive regulation of cation channel activity (GO:2001259),-0.2851290897412065,-0.9748245834894117,0.5,0.7561268703890345,1.0,12/40,22.01%,ACTN2;SHANK3;CALM1;ANK2;STAC;EPHB2;LRRC38;TMSB4X;JPH2;CTSS;ADRB2;GSTO1
prerank,L-amino acid transport (GO:0015807),0.35482219226946576,0.9747084591582826,0.4873417721518987,0.9576832036061919,1.0,4/28,12.38%,SLC1A3;SLC7A8;SLC25A22;SLC7A3
prerank,peripheral nervous system development (GO:0007422),0.35992351149064195,0.9741328704471829,0.48661417322834644,0.9584281934182878,1.0,8/23,20.24%,ASIC2;ADGRB2;ADGRB1;NF1;SOX10;GDNF;ALDH3A2;SCN8A
prerank,regulation of biomineral tissue development (GO:0070167),0.36065696190275076,0.9738641739013467,0.48942598187311176,0.9582898705450221,1.0,3/26,8.25%,ENPP1;FBXO5;TWIST1
prerank,cellular response to nutrient levels (GO:0031669),-0.2544743171239562,-0.9737523019758899,0.4883720930232558,0.7581218481934732,1.0,22/62,22.74%,FOXO1;FNIP1;BMPR2;HSPA8;SREBF2;PRKAA2;KCNB1;SFRP1;RRAGC;CLEC16A;FAM107A;RALB;MFSD2A;SIRT1;PRKAA1;MAP1LC3A;LAMP2;RRAGB;MAP1LC3B;WDR45;INHBB;KLF10
prerank,artery development (GO:0060840),0.3655991544730457,0.9737156475904457,0.48688524590163934,0.9578430404394543,1.0,5/23,15.14%,ROBO2;NF1;TGFBR1;HECTD1;GJA5
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.29026798589513214,-0.9736002339132976,0.49572649572649574,0.757762618889409,1.0,12/33,19.24%,IGF1;BCL2L1;TFRC;MAPT;GPX1;SLC25A5;ACAA2;ADCK1;PRELID1;GHITM;AKT1;HGF
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.38312865127494733,-0.9735313177061838,0.4806378132118451,0.7572392837552893,1.0,4/12,7.35%,ACTB;ACTG1;LAMA3;LAMA5
prerank,diol biosynthetic process (GO:0034312),-0.36503943150322726,-0.9733558583332133,0.4861111111111111,0.7569770899995347,1.0,4/15,8.26%,SPTLC2;ACER2;ACER3;GCH1
prerank,histone H3 deacetylation (GO:0070932),0.40242082030849424,0.9732932120554412,0.49146757679180886,0.9581642642446502,1.0,3/15,7.97%,HDAC1;SIRT6;PER2
prerank,regulation of autophagosome maturation (GO:1901096),-0.37704404836810684,-0.9732127448412142,0.5081967213114754,0.7566360240803823,1.0,6/13,32.17%,UVRAG;CLEC16A;TMEM39A;ADRB2;IRGM;PHF23
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4125697805460596,0.9731525310863253,0.5008347245409015,0.957692282469093,1.0,1/13,0.70%,COL4A1
prerank,organic acid transport (GO:0015849),0.28706142389840666,0.9731250630949466,0.5051282051282051,0.9569029762525815,1.0,9/94,4.87%,SLC1A5;ABCC3;SLC6A13;NR1H4;NCOA2;PPARD;SLC7A11;SLC43A1;SLC7A8
prerank,positive regulation of apoptotic process (GO:0043065),-0.20790474708450526,-0.9730976710005972,0.5729166666666666,0.7561680448189667,1.0,85/293,22.61%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;TPD52L1;ITGA6;MCF2L;TNFSF10;HIP1R;IGFBP3;SQSTM1;MAP3K5;FAS;TGFB2;CYP1B1;UNC13B;APC;ATF6;CRADD;JMY;UBB;SOX4;IP6K2;NGF;PRDM11;CASP2;SIK1;CASP3;NGEF;CASP8;BAD;SFRP1;BAX;BNIP3L;TNFAIP8;ADAMTSL4;MYBBP1A;BID;APH1A;TGM2;TLE5;GADD45B;PTRH2;APH1B;ATM;BOK;PLEKHG2;ING4;ARHGEF11;STK17B;TRIM35;SMPD1;SIRT1;GPER1;ING5;AIFM1;DCUN1D3;UBC;MAP3K10;TFPT;APBB1;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;RASGRF2;GADD45G;TRADD;ARHGEF12;E2F1;SPHK2;CCAR2;BTG1;DDX20;NUPR1;UBA52;TIAM1;ARHGEF1
prerank,regulation of cardiac conduction (GO:1903779),0.3106999644318167,0.9730923774036933,0.5200553250345782,0.9561245683326187,1.0,12/54,15.14%,ATP1A2;ITPR1;RYR2;TMEM65;ATP1A3;ATP2A2;PRKACA;FXYD4;RYR3;ASPH;STIM1;GJA5
prerank,defense response to bacterium (GO:0042742),-0.23291410027419057,-0.9729990244067648,0.51931330472103,0.755700932185813,1.0,23/105,17.80%,ANXA3;LBP;GBP7;MAVS;RPS19;DROSHA;GBP4;GBP2;PGLYRP1;STAB1;SERPINE1;OPTN;PLA2G6;GBP6;RPL30;RNASE7;PRKCD;ANKRD17;MPEG1;RAB1A;ISG15;HMGB2;PPP1R11
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3317192949681886,-0.9729768673323025,0.4748603351955307,0.7550477337097021,1.0,3/22,0.60%,EPHA4;PICALM;ROCK2
prerank,protein localization to cell surface (GO:0034394),-0.3042991581723633,-0.9728580537513046,0.5136612021857924,0.7546501264103309,1.0,10/26,23.52%,VCL;PTPRK;MESD;ANK2;PIGU;FLNA;UNC50;WNT11;PIGK;SMURF1
prerank,regulation of dephosphorylation (GO:0035303),-0.3664138713968139,-0.9727449484854711,0.510250569476082,0.7542360811583121,1.0,5/15,12.96%,SMG6;PPP1R16A;MTMR9;PPP1R16B;SMG5
prerank,protein modification by small protein conjugation (GO:0032446),-0.20026996451754098,-0.9725293604554416,0.6,0.7540435452666618,1.0,78/361,17.49%,FBXL7;WWP1;EYA1;RNF152;LMO7;GAN;MGRN1;VCPIP1;KLHL13;UBE2G1;ASB2;KLHL24;RNF43;PRKDC;WWP2;ARIH1;OTULIN;CDC23;UBE2D3;HIF3A;TRIM24;HLTF;CUL1;TRIM5;NUP50;TRIM11;FBXL2;UBB;STX1A;VPS18;TRIM14;RANGAP1;RNF8;VCP;MSL2;UBE2F;UBE2H;MIB1;SMURF2;UBR1;UBA6;FBXO25;TSPAN17;UBE2A;ASB5;KLHL20;VHL;CUL9;RNF41;NUP98;NUP153;SPSB4;UBR2;SUMO3;RCHY1;PCNA;HERC2;VPS11;TRIM63;AMFR;NUP43;UBE2N;CAND2;RAE1;TRIM35;ELOC;NUP205;FBXO32;TRIM27;SIRT1;NEDD8;CUL3;ANAPC16;ISG15;DCUN1D3;ANAPC11;UBC;USP9X
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.361162942999803,0.9723912656938408,0.4759535655058043,0.9572555653824485,1.0,6/24,12.35%,LIG3;POLK;RPA1;RFC3;XRCC1;POLB
prerank,RNA metabolic process (GO:0016070),0.2768132814319449,0.9716451049122844,0.5270440251572327,0.95846089011767,1.0,35/127,21.15%,RBMS1;RNASEH2C;AGO4;NOVA1;ADARB2;ELAVL4;PCBP3;HNRNPA2B1;MRPL44;MPHOSPH10;WTAP;DDX17;NOL9;DHX36;AGO3;MTREX;TENT2;RNASEH2B;FTO;HNRNPUL1;HNRNPD;DHX9;RNASEH1;ADAR;LAGE3;RBM5;PPP1R8;HNRNPL;AGO1;DEDD2;RBM6;POLR2L;TFIP11;DDX39B;RBPMS
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2942245918355544,0.9714398054176862,0.507227332457293,0.9581205769398532,1.0,28/79,26.41%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.32631851552912255,0.9712650024895231,0.5114613180515759,0.9577297915153999,1.0,5/47,5.46%,HRG;RECK;SPOCK3;SORL1;SERPINF1
prerank,protein modification by small protein removal (GO:0070646),0.25675127472118525,0.9711657302168001,0.5480984340044742,0.9571064917633508,1.0,57/252,18.81%,IL33;STAMBPL1;OGT;TAF9B;PTEN;COPS3;MBD6;PSMD1;USP1;PSMD10;UCHL3;OTULINL;PSMA5;USP42;PSMB5;MDM4;BIRC2;KAT2A;RNF128;PSMC4;TP53;PSMA4;USP33;JOSD1;TGFBR1;PSMC5;USP19;HGS;POLB;COPS4;PSMB9;KDM1B;ATXN3;UBE2D1;SENP6;CCNA2;ASXL1;RIPK1;AR;MYC;YOD1;USP34;USP4;PSMA7;USP21;USP16;USP13;STAMBP;PSMD14;USP49;INO80E;TAF10;PSMA2;USP14;RHOA;HIF1A;PSMD11
prerank,cAMP-mediated signaling (GO:0019933),0.3663500378211683,0.97108413449809,0.5057660626029654,0.9564505816659663,1.0,7/24,14.68%,PDE7B;RIMS2;DGKQ;ADCY2;SOX9;AKAP6;EPHA5
prerank,protein deacetylation (GO:0006476),0.33199584098815765,0.970972598797733,0.49343065693430654,0.9559024563635755,1.0,6/41,7.08%,MIER2;HDAC1;MORF4L1;SIRT6;BRMS1L;BRMS1
prerank,peptidyl-threonine modification (GO:0018210),-0.24797379635174216,-0.970932388686295,0.5092936802973977,0.7572314844778169,1.0,27/66,22.73%,ROCK2;CAMK2D;PRKDC;WNK1;HIPK3;GSK3B;HIPK1;ACVR1;CDC42BPB;DYRK2;GALNT11;HIPK2;GALNT1;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;AKT1;CSNK2B;SBK1;MARK2;GALNT3;TGFBR2;TTBK1;STK39;CAD
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3561146197148171,0.9708287073594323,0.4983974358974359,0.9554398968664787,1.0,5/27,15.67%,LPIN3;CHKA;SELENOI;LPIN2;ABHD4
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3448740709939475,0.970547231696349,0.5083459787556904,0.95531617831635,1.0,9/34,16.96%,PDE4B;RYR2;ATP2A2;SLC9A1;PRKACA;P2RX4;GJA5;STC1;PIK3CG
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2876151199817221,0.9703007536427195,0.5157068062827225,0.955130144449683,1.0,34/87,25.64%,TIMMDC1;DMAC2;OMA1;IMMP2L;NDUFS7;TMEM126A;NDUFS5;BCS1L;SLC25A33;NDUFV2;NDUFAF7;COX16;NDUFV3;NDUFC2;SURF1;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;UQCC2;TMEM126B;TIMM21;NDUFA10;CHCHD4;LYRM7;NDUFS1;NDUFAF2;COX17;NDUFB6;SAMM50;DMAC1;NDUFB8
prerank,Golgi organization (GO:0007030),0.2826533407015688,0.9702727615182088,0.5261194029850746,0.9543602415100069,1.0,29/112,19.53%,SEC16B;SEC16A;YWHAZ;GBF1;DNAJC28;LRRK2;GOLGA2;PRKD1;RAB30;RAB29;VAMP4;RAB2A;SYNE1;COG1;TRIP11;CLASP2;VRK1;HACE1;CLASP1;USP6NL;UBXN2B;TMED3;TMED9;GOLGA8B;GOLGA5;CUL7;TRAPPC12;TBC1D20;PLEKHM2
prerank,negative regulation of hormone secretion (GO:0046888),0.4480752422637592,0.9699503150333177,0.5064220183486239,0.954335365234528,1.0,2/10,12.63%,GJA1;RAB11FIP3
prerank,positive regulation of phagocytosis (GO:0050766),0.32264395665963325,0.969943289474303,0.5076708507670851,0.953494271849931,1.0,7/47,10.90%,IL15RA;MERTK;TUB;LYAR;APPL2;CYBA;PYCARD
prerank,actin filament capping (GO:0051693),0.3811622661185608,0.9698754189185871,0.47854785478547857,0.9519706913307869,1.0,1/18,0.32%,SVIL
prerank,barbed-end actin filament capping (GO:0051016),0.3811622661185608,0.9698754189185871,0.47854785478547857,0.9519706913307869,1.0,1/18,0.32%,SVIL
prerank,regulation of gluconeogenesis (GO:0006111),0.3538097184932496,0.9694601295683954,0.4825949367088608,0.9522341715607606,1.0,5/27,11.67%,OGT;DGKQ;GCK;ERFE;PDK2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.29451212640651575,0.969180915723946,0.5,0.9513292960403112,1.0,28/78,26.41%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.29451212640651575,0.969180915723946,0.5,0.9513292960403112,1.0,28/78,26.41%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,MAPK cascade (GO:0000165),0.25391991470814257,0.9689585364475637,0.5428881650380022,0.9511072136154854,1.0,69/295,19.20%,PDGFRA;PIK3R1;IL2RA;NRG1;ERBB4;ITGAV;FLT3LG;NRG2;GRIN2B;FGFR1;JAK1;PSMD1;MAP4K4;SPTBN1;DLG3;PIK3R2;SPRED1;HTR2B;DLG2;IRS1;IL17RD;CAMKK2;LRRK2;NF1;PSMD10;IRS2;NRG4;ZFP36L2;PSMA5;ABHD17C;PTK2;PSMB5;IL5;ABHD17B;MBP;MAP2K1;PSMC4;PTPRA;PSMA4;FYN;DLG4;PSMC5;GFRA1;SOX9;PSMB9;LRRC7;GFRA2;FGF5;AREG;GDNF;MYC;ARAF;TNIK;MAP3K3;FGFR2;MAPK11;PSMA7;PTGER4;PSMD14;LGALS9;CAMK2A;CCM2;RASA3;PSMA2;ZDHHC9;MAPK12;PSMD11;KSR1;PDGFRB
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.24255268987647594,-0.9688072781701516,0.5309734513274337,0.7617618441784827,1.0,24/86,17.88%,IGF1;PTPRJ;PECAM1;EGFR;APP;NRP1;CSPG4;VTN;EFNA5;PDGFA;CD44;ACVR1;ENPP2;SFRP1;ITGB3;PLCG2;PRKCZ;PTK2B;RAP2C;PRKCD;TEC;PAK2;CD74;RAP2B
prerank,double-strand break repair via break-induced replication (GO:0000727),0.42402049953715004,0.9686652331466663,0.5084459459459459,0.9510575228186233,1.0,4/12,17.83%,MCM7;CDC7;MCM4;MCMDC2
prerank,negative regulation of peptidase activity (GO:0010466),0.32632525937125,0.9685720221804498,0.5078236130867709,0.9504436265694096,1.0,4/47,5.46%,LRP1;HRG;SPOCK3;SERPINF1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.24761836942064067,0.9677339209828418,0.5611285266457681,0.951960703203584,1.0,97/417,18.84%,ZEB1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;HDAC1;L3MBTL1;WNT5A;NR2F2;TCF7L2;BASP1;SALL1;CDKN2A;THRA;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;SCML4;MDFIC;RUNX1T1;ZNF423;ZBTB16;TLE2;FOXS1;BCOR;CAPN3;CALCA;CBFA2T3;GMNN;BRMS1;PAX9;BCL6;ZKSCAN3;EIF4A2;PER2;TWIST1;L3MBTL4;TLE1;DAXX;BMP7;GLI3;TP53;ZC3H8;MPHOSPH8;ZFPM2;SNW1;DAP;EPC1;ZNF318;SOX9;TWIST2;PDCD4;DPF2;HIC2;BTAF1;PHC1;PRDM5;ZMYND15;HDAC10;KDM5C;CREB3L1;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;CNOT7;CRY2;CENPF;ZHX3;SPINDOC;ZBTB7A;CBFA2T2;NONO;MBTD1;CIART;NR1D2;CALR;CDK5;MBD2;LDB1;SUV39H2;BMP2;MBD1;KAT7;HEY1;BRD7;ILF3;KHDRBS1;DEDD2;PEX14;THAP7
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4179665132578406,0.9676590791261771,0.48704663212435234,0.9513138698432391,1.0,2/13,10.09%,GAB2;FGR
prerank,iron ion transmembrane transport (GO:0034755),0.4376198524423336,0.9676412036923325,0.5104364326375711,0.9505122406945001,1.0,4/10,17.97%,SLC25A37;ABCB6;ABCB7;SLC39A14
prerank,response to X-ray (GO:0010165),-0.3605050559898592,-0.9673066955364181,0.5076586433260394,0.7647143998547297,1.0,8/14,40.73%,ANXA1;BRCC3;ATM;LIG4;MSH2;XRCC4;XRRA1;XRCC5
prerank,peptidyl-tyrosine modification (GO:0018212),-0.25967240943130465,-0.9672028124085859,0.5,0.7642565414126442,1.0,7/56,3.95%,FLT1;EPHA4;TEK;EGFR;FER;KDR;INSR
prerank,positive regulation of peptidase activity (GO:0010952),-0.3217952875205825,-0.9671618762986971,0.4936708860759494,0.7636492408810286,1.0,10/20,29.74%,VCP;CTSH;APH1A;APH1B;PSME3;PRELID1;PSME2;NDUFA13;VSIR;TANK
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.263936238200416,-0.9667332784040942,0.5,0.7640121729958579,1.0,18/50,19.03%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;PSMB10;OAZ2;PSME2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.38066102019810166,-0.9663708071964537,0.508235294117647,0.7642073860145105,1.0,4/12,17.22%,FOXP1;KLF4;MAP2K5;CD74
prerank,nucleosome assembly (GO:0006334),0.3445734381357625,0.9662730818192885,0.5045731707317073,0.9534722114512448,1.0,8/31,12.02%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;NAP1L1;UBN1;SOX9
prerank,regulation of cellular senescence (GO:2000772),0.3544312144896163,0.9658847910104472,0.5121212121212121,0.9536464842846912,1.0,5/28,8.25%,SLC30A10;CDKN2A;FBXO5;ZKSCAN3;TWIST1
prerank,regulation of cell population proliferation (GO:0042127),0.24385772448309362,0.9658707167732877,0.6004056795131846,0.9528456891030632,1.0,131/691,17.40%,PDGFRA;PTN;DLC1;NTRK3;IL34;COL18A1;ATF5;CXCL10;NRG1;HRG;ROR2;HOXC10;PTGFR;EDN3;MEIS1;HDAC1;GNL3;CXCL1;NTRK2;PTEN;TCF7L2;PHIP;ERBB4;GPLD1;ITGAV;FLT3LG;CDKN2A;GLMN;FGFR1;GAB2;MEIS2;TSLP;TIPIN;DLG3;JUP;POU3F3;REST;TBX3;FBXO5;GCNT2;TMEM115;HTR2B;CDC7;IRS1;ADGRB1;IRS2;DUSP22;CBFA2T3;AMELX;FXN;HP1BP3;CDKN2D;PTPRU;BCL6;PTK2;MDM4;HTR1A;CDK13;IFNLR1;P3H1;CCKBR;GLI1;LGMN;TENM1;TSPYL5;BIRC2;CACUL1;MAP2K1;TNS2;SLC25A33;EIF2AK2;TP53;RTKN2;FKTN;NAP1L1;AGO3;TGFBR1;GAS8;SPEG;SOX9;FABP3;HGS;CD86;IGF2;ST18;DIS3L2;FAM98B;CD81;MEAK7;TESC;GAREM1;BNIPL;P3H3;CDKN2C;DHPS;LYN;NME1;DOT1L;THAP12;WNK2;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;TFAP4;CLU;AREG;AR;GDNF;CNOT7;MYC;SGK1;FGFR2;KLF11;CDK10;TSC1;RBM5;CHERP;GDF9;JAG1;NOX1;CCPG1;STAMBP;IGFBP7;MAZ;CALR;ADRA2A;ASH2L;RHOG
prerank,negative regulation of response to stimulus (GO:0048585),0.3068794861543585,0.9657913715772666,0.5083798882681564,0.9522232435134687,1.0,16/60,18.72%,CASK;SLC30A10;GGT7;NR1H2;FBXO5;ZKSCAN3;TWIST1;APPL2;UBASH3B;LYN;CLU;MAP3K3;ADRA2A;COL3A1;ALOX5;HHIP
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2747544314038164,-0.9656691565922817,0.5079365079365079,0.7652753483875967,1.0,13/40,19.24%,IGF1;BCL2L1;TNFSF10;BAD;GPX1;BAX;BID;PRELID1;GPER1;GHITM;PLSCR3;AKT1;HGF
prerank,regulation of translational initiation (GO:0006446),0.3010457774393826,0.9653762699695198,0.5062413314840499,0.9525172899174716,1.0,23/63,24.63%,EIF4G3;EIF3H;FMR1;BOLL;RPS6KB1;EIF4A2;GLE1;PAIP1;IMPACT;EIF5B;MTIF2;HABP4;KHDRBS1;YTHDF1;EIF2AK3;CTIF;DDX1;NCK2;EIF4B;EIF2B5;ATF4;MIF4GD;POLR2D
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.37667273493079034,-0.9652090910613771,0.508235294117647,0.7656947823226564,1.0,5/13,17.21%,PRR5L;ZC3HAV1;CNOT8;RC3H1;GTPBP1
prerank,microtubule polymerization (GO:0046785),-0.302366407770721,-0.9651895077624149,0.4959349593495935,0.7650424772643043,1.0,8/28,15.48%,CSNK1D;NDEL1;MAPT;TUBGCP5;MAP7D3;SLAIN2;TRPV4;TPPP3
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.23252317044810228,-0.9649295114788297,0.5601851851851852,0.764998259781797,1.0,38/109,23.01%,PLCB1;PITPNM2;MTM1;LPGAT1;PLA2G4A;CDS1;PIK3C2B;INPP5F;INPP4B;INPP5D;BMX;MTMR9;RAB5A;INPPL1;PIK3CB;LCLAT1;PIK3CD;PIP4P1;PIP4K2C;PLEKHA2;PLCG2;VAC14;PLAAT3;SYNJ1;PIK3R6;INPP5B;SBF1;MTMR14;MTMR2;RAB4A;PLA2G4E;PIP5K1A;PLA2G4C;PIP5K1B;CSF1R;PITPNM1;MTMR11;PIK3C2A
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3478047112688828,0.964805827524615,0.5,0.9532608129674798,1.0,5/27,10.09%,PDGFRA;IRS1;PTK2;PRKD1;FGR
prerank,regulation of protein polymerization (GO:0032271),-0.2835354896567831,-0.9646991880067194,0.5290322580645161,0.7648636241204073,1.0,16/35,31.13%,ESAM;MAPT;ARHGAP18;ARL2;COTL1;ARHGAP28;PLEKHG2;TPPP3;RASA1;CAMSAP2;TTBK1;FCHSD1;TPPP;HCLS1;CAMSAP3;PFN2
prerank,intracellular protein transport (GO:0006886),0.25307610057408747,0.9645476691917426,0.5698447893569845,0.9531199374604403,1.0,72/304,20.15%,PRICKLE1;UNC93B1;GGA2;RAB20;CSE1L;RABGAP1L;TBC1D16;CACNG3;RABL3;ANKLE1;COPA;SEC16A;NUP214;NGFR;COPZ2;FAM53C;SORL1;NUTF2;POM121;NAPB;CLIP3;MYO6;SYNDIG1;VIPAS39;TBC1D1;TRIM23;VPS26C;RAB29;APPL2;FAM53A;TBC1D8B;BCS1L;SLU7;RAB24;SRPRA;SAR1A;NUP42;SCFD1;RANBP3;TNPO1;PTTG1IP;ARFIP1;NUP107;AKAP6;AP3D1;EIF4ENIF1;NXT2;TBC1D9;STRADB;SNF8;RTN2;CTTN;VPS33B;USP6NL;TNPO2;CALR;XPO6;TMED3;IPO9;TMED9;TBC1D17;NUP155;LTBP2;KPNB1;KIF13B;HOMER3;VPS45;RAB3GAP2;XPO1;ARL5C;COPB2;ARL4A
prerank,RNA stabilization (GO:0043489),0.33664143622095155,0.9641430693408618,0.5030581039755352,0.9533886519553326,1.0,9/33,15.31%,RBM24;DND1;TAF15;PAIP1;TENT5A;DHX36;TENT2;EIF4ENIF1;GDNF
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2529178792109217,0.963790706100405,0.5490196078431373,0.9534707836626911,1.0,47/291,14.06%,RORA;PDGFRA;CXCL10;CPEB1;WNT5A;CXCL1;GPLD1;ERCC6L2;PDE4B;NR1H4;P2RY1;FOS;NCOA3;PDCD1LG2;IRS1;CAMKK2;PRDX5;CD68;PRKD1;AXL;KCNC2;MTOR;TLR4;HCN2;WNT3;HCN1;PLAA;IRAK1;EPHA3;HCN3;GLRA1;DHX36;PYCARD;P2RX4;SNW1;PDK2;SOX9;HTRA2;CD86;PDCD4;HSP90B1;GLRA2;TESC;AKAP6;NRIP1;RYR3;LYN
prerank,regulation of ERAD pathway (GO:1904292),0.43138117513776647,0.9636784688521047,0.5089928057553957,0.9529291265564308,1.0,5/11,16.69%,HERPUD1;USP19;ATXN3;BAG6;USP13
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.33530739632109635,0.9634641532169022,0.516566265060241,0.9526957651506022,1.0,9/37,15.08%,ERCC1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.39764083853584437,0.9634584347368611,0.5217391304347826,0.9518715840649526,1.0,1/16,0.79%,XCL1
prerank,natural killer cell activation (GO:0030101),-0.3129184974859672,-0.9633009356558938,0.5454545454545454,0.767607865133237,1.0,5/23,12.23%,PBX1;ELF4;CASP8;PIK3CD;PRDX1
prerank,protein homotetramerization (GO:0051289),-0.2659638854083368,-0.9632755345386123,0.5090361445783133,0.7669742608847454,1.0,13/49,17.60%,ALDH1A2;SAMHD1;SOD2;GBP5;B2M;UPB1;KCNJ2;CBR4;KCNJ12;ACOT13;CBY1;ACACB;ALDOA
prerank,cytokine-mediated signaling pathway (GO:0019221),0.24642024035373403,0.9632535722660404,0.5975485188968335,0.9515785055355183,1.0,61/532,12.56%,RORA;IL33;GHR;IL34;IL15RA;PIK3R1;ZEB1;IL1RN;MAP3K14;IL2RA;XCL1;CXCL10;EDA2R;EDA;CXCL1;IL1R2;CD40;IL16;FLT3LG;IL18RAP;GAB2;JAK1;PSMD1;TSLP;FSCN1;YWHAZ;FOS;CCL15;IRS1;IFIT2;PSMD10;IRS2;COL1A2;PSMA5;BCL6;HNRNPA2B1;PSMB5;IL5;TWIST1;PLP2;PRKACA;IFNLR1;SOX2;TRIM8;APPL2;SP100;IL1RAP;BIRC2;IRAK1;PSMC4;CCL25;TP53;PSMA4;PYCARD;FYN;PSMC5;IL12A;CD86;PDCD4;HSP90B1;ST18
prerank,regulation of T cell differentiation (GO:0045580),0.3461798211242144,0.9629535411373296,0.5077881619937694,0.951507072758286,1.0,4/33,10.11%,IL2RA;FANCA;KAT2A;CAMK4
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.40505858018236585,-0.9627823545851106,0.4909090909090909,0.7675421590051906,1.0,5/10,25.89%,JARID2;SIRT1;DNMT3B;KDM1A;BRCA1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3389939674243998,-0.9624806699849473,0.5099009900990099,0.7676390146005156,1.0,3/19,4.37%,VIM;RUNX1;WNT4
prerank,endodermal cell fate commitment (GO:0001711),0.43535775530475646,0.96246237589523,0.5225563909774437,0.9519309705480233,1.0,2/10,8.78%,RTF1;SOX2
prerank,lytic vacuole organization (GO:0080171),0.34266384374542397,0.9624600925897863,0.5154798761609907,0.9511019728988408,1.0,8/32,15.59%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,ncRNA catabolic process (GO:0034661),0.346001864452328,0.96243282594512,0.5250379362670713,0.950347435860513,1.0,10/28,19.04%,LIN28B;TENT4B;MTREX;EXOSC9;DIS3L2;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2394854161738771,-0.962404886381279,0.5546218487394958,0.7671433664249538,1.0,24/84,20.53%,FOXO1;WWP1;EZR;RDX;VPS35;WWP2;GPC3;APC;APOE;GSK3B;VCP;SMURF2;ASB5;RNF41;APC2;VPS11;FURIN;OAZ1;VGLL4;OAZ2;MSN;FZR1;TNFAIP3;ADAM9
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4365901183195234,0.9623947101997111,0.5227272727272727,0.9496268917734199,1.0,3/10,17.28%,XCL1;CD81;LGALS9
prerank,male meiosis I (GO:0007141),0.39523636765874987,0.9621772444967251,0.4966996699669967,0.9494033592383988,1.0,4/16,15.63%,SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.34059702442193385,-0.9614300962528309,0.49144254278728605,0.7688717692876339,1.0,5/18,16.99%,DDX5;EGFR;MAP2K2;TERT;ESR1
prerank,positive regulation of protein depolymerization (GO:1901881),0.4236381639050899,0.9612536175640182,0.504302925989673,0.9510022068861901,1.0,2/11,8.58%,SEMA5A;STMN2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.32897814999526814,0.9612526071297745,0.5142450142450142,0.9501761169965373,1.0,12/40,19.24%,ANKLE1;USP1;FBXO5;FMR1;NPAS2;UBE2V2;POLH;UBE2V1;MYC;WDR76;FEM1B;FXR1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.24674988955553034,-0.961186597973255,0.5317725752508361,0.7687412206135974,1.0,28/69,28.08%,MEF2C;RETREG1;SOD2;SIX1;NGF;NRBP2;APOE;SNX6;CX3CR1;MDK;FOXQ1;PTK2B;CX3CL1;ZPR1;RASA1;ERBB3;SIX4;KDM2B;CLCF1;MT3;NTF3;CRLF1;LIG4;PARK7;VSTM2L;BDNF;NDNF;MSH2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2221143089992481,-0.9610660282099343,0.5846994535519126,0.768326779704006,1.0,46/132,27.62%,RPS14;PTGES3;PRKDC;EIF5;SF3B1;RPL5;EIF2S2;SCAF11;RPS19;DICER1;PRMT7;RPS27;KHDC4;RPS15;MCTS1;CELF1;RPL10;RPS5;RPL11;SNRPC;GCFC2;SNRPE;RPLP0;SRPK1;SNRNP200;MRPS7;SNRPD1;RPL23A;SART1;EIF4H;MRPL20;CLP1;PRPF19;DDX20;PUF60;SF3A2;USP39;CELF5;PWP2;RPL38;SMN1;NOP2;RPF2;CPSF6;CPSF7;STRAP
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2407678868384732,0.9605454532611997,0.6472945891783567,0.9512066281919597,1.0,196/1082,17.02%,RORA;IL33;LPIN3;DCN;PIK3R1;ZFHX3;ATF5;ETV1;CXCL10;RUNX2;PPARA;HOXC10;AUTS2;MEIS1;TEAD1;RGMB;OGT;ETV5;KMT2E;HDAC1;WNT5A;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;ERBB4;SALL1;THRA;SMAD5;NR1H4;CDK8;MAML3;NCOA2;MEIS2;PGR;NFATC3;MED12;THAP3;METTL23;JUP;POU3F3;PPARD;PIK3R2;NR1H2;TEAD2;REST;TBX3;FOS;NCOA3;ZIC1;KMT2A;MDFIC;ZNF423;ZBTB16;CXXC1;SPP1;MYCN;CAMKK2;BCL9;EPAS1;HLF;CREB3L2;SSBP4;SLC9A1;SERTAD2;E2F4;BRD8;CRTC2;ASF1A;CAPN3;GLIS1;TRIM56;TAF15;SRF;CSRNP3;NPAS2;MYO6;AKIRIN2;LYAR;SPIN1;FIZ1;CSRNP2;ZKSCAN3;MED6;TWIST1;PRKD1;PFKM;SOX2;BICRAL;EDF1;NCOA1;GLI1;XPC;MTOR;SP100;TLR4;DDX17;BRCA2;BMP7;KAT2A;NSD1;GLI3;ENY2;MAP2K1;AHI1;CAMK4;SOX10;ZBED3;PPP3CB;TP53;ZC3H8;SMARCA1;DHX36;ZFPM2;MED10;SNW1;TGFBR1;PSMC5;EPC1;ZNF318;FOXJ2;ESR2;SOX9;UTP15;CD86;IGF2;TFEB;HOXB4;ST18;DPF2;KDM1B;HIVEP3;CD81;TESC;ACTR2;TRIM44;NRIP1;NFIX;AXIN1;HOXC4;MYDGF;RFX4;PEG3;BICRA;MED1;SREBF1;MYRF;ZFP64;ARNT2;MED25;DOT1L;SSBP2;ELK1;BPTF;UBE2V1;ASXL1;F2R;RIPK1;CHD8;FOXM1;HNRNPD;TFAP4;DHX9;EAF2;PBX2;GTF2H1;PRMT2;AR;GDNF;ATF2;MYC;LPIN2;PRDM10;LAGE3;FOXJ3;FGFR2;MAFB;MMS19;PLAC8;AKIRIN1;ONECUT2;TRIP4;DVL3;CCNK;THOC5;USP21;USP16;JAG1;HAX1;TOX2;ATMIN;MAZ;NR1D2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.350460758605397,-0.9603825701201384,0.530562347188264,0.7692696137061862,1.0,7/16,21.96%,RBM22;SNRPC;CWC15;SNRNP200;SART1;DCPS;NCBP2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3102122077484223,-0.9603784277031664,0.5139664804469274,0.7685864026443952,1.0,10/25,21.67%,RNF185;VCP;NGLY1;TOR1A;CUL3;YME1L1;CLPP;HDAC6;RNF5;UGGT1
prerank,defense response to virus (GO:0051607),0.282646529364623,0.9603670537107092,0.5311688311688312,0.950859937870876,1.0,12/100,11.68%,MAP3K14;CXCL10;RTP4;CD40;IFIT2;TLR8;PDE12;TRIM56;IFNLR1;EIF2AK2;PYCARD;AGBL4
prerank,snRNA 3'-end processing (GO:0034472),0.37961500354108807,0.9599554485793312,0.5234113712374582,0.951163161765008,1.0,5/19,15.88%,INTS8;INTS14;EXOSC9;EXOSC8;EXOSC5
prerank,cellular response to dsRNA (GO:0071359),0.3950838165470635,0.959451788563712,0.5017182130584192,0.9517165969006133,1.0,2/15,6.47%,COLEC12;PDE12
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.34020923909702666,-0.9593965466807202,0.4987012987012987,0.7703258551640277,1.0,5/16,9.65%,CACNA1C;CAMK2D;CALM1;ANK2;DMD
prerank,organic substance transport (GO:0071702),0.2767223565343349,0.9591198064830998,0.5584577114427861,0.951804250089808,1.0,7/121,2.33%,ABCA9;SLC48A1;HRG;ABCA6;LRP1B;CALCRL;ABCD2
prerank,regulation of organelle assembly (GO:1902115),-0.24314670662072083,-0.9586569648196985,0.5402298850574713,0.7715093896854771,1.0,21/72,20.44%,TBC1D19;EZR;RABEP2;STX18;RDX;GSN;TBC1D8;TBC1D22B;RAB5A;IFT140;VPS11;TBC1D22A;CYLD;TBC1D10B;TBC1D13;MSN;NPM1;TBC1D14;PDCD6IP;TBC1D5;RAB1B
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3149987623126189,0.9585119577339263,0.5022354694485842,0.9526027027872607,1.0,13/45,17.91%,PIK3R1;MYCN;LIN28B;NMD3;MAP2K1;TP53;UTP15;RBM20;DIMT1;RIPK1;HNRNPLL;HABP4;DXO
prerank,negative regulation of axonogenesis (GO:0050771),0.35376315019794324,0.9582411004810749,0.5082781456953642,0.952521456557171,1.0,9/27,22.35%,PTEN;NGFR;CDKL3;DCC;ULK2;RHOA;EFNB3;MCF2;GDI1
prerank,hemidesmosome assembly (GO:0031581),-0.3966353570093135,-0.9571463433656836,0.5402010050251256,0.7745600443101481,1.0,7/11,17.05%,ITGA6;PLEC;LAMA3;ITGB4;CD151;DST;LAMC2
prerank,cilium-dependent cell motility (GO:0060285),0.3657047945884006,0.9571107653462018,0.5299003322259136,0.9546809001439457,1.0,5/22,15.25%,RSPH9;EFHC1;CCDC65;GAS8;CCDC39
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3406971803739407,-0.9561543135135964,0.5223097112860893,0.7763139872437499,1.0,7/18,22.29%,RNF185;UBB;AMFR;UBC;RNF5;UGGT1;UBA52
prerank,regulation of cell-substrate adhesion (GO:0010810),0.31839802300969283,0.9560274409617627,0.5109170305676856,0.9566952375460012,1.0,6/42,7.70%,FBLN2;CORO2B;GCNT2;NF1;PTPRO;PTK2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.38085451419032323,0.9558361410770235,0.4906303236797274,0.9563800099103781,1.0,4/17,9.46%,ATP1A2;SCN2B;CACNA1G;HCN2
prerank,camera-type eye morphogenesis (GO:0048593),0.43814070846381226,0.9556809708095425,0.5126353790613718,0.9560000184190863,1.0,2/10,5.64%,TENM3;NF1
prerank,activation of GTPase activity (GO:0090630),0.286166647441114,0.9551814385793024,0.5297927461139896,0.9565297096971638,1.0,12/89,7.41%,NTRK3;ARHGAP22;RABGAP1L;TBC1D16;SIPA1;ABR;SCRIB;GARNL3;ARHGAP24;SIPA1L3;DOCK7;TBC1D1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.282533959537833,0.9548688133058187,0.5428954423592494,0.9565556565898531,1.0,20/85,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMA7;PSMD14;PSMA2;RHOA;PSMD11
prerank,RNA polyadenylation (GO:0043631),-0.30084121286861204,-0.9547350064797585,0.5272206303724928,0.7783250539884194,1.0,10/26,26.26%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,mRNA polyadenylation (GO:0006378),-0.30084121286861204,-0.9547350064797585,0.5272206303724928,0.7783250539884194,1.0,10/26,26.26%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.33898940648663184,0.954709504653037,0.5076687116564417,0.9561472952183832,1.0,10/31,23.40%,REST;CACNA1G;SYT3;SYT7;SYT5;ADRA2A;SYT6;SYT1;CACNA1I;SYT4
prerank,regulation of double-strand break repair (GO:2000779),0.3267774212540769,0.9545593498715393,0.5168869309838473,0.9556663242841826,1.0,13/39,20.56%,SIRT6;ZCWPW1;MRNIP;TWIST1;SLF1;SPIDR;FIGNL1;ACTR2;FOXM1;SLF2;SPIRE1;TERF2IP;PPP4R2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3678063638768039,0.9539941996753694,0.5025553662691652,0.9563110817391719,1.0,4/22,8.58%,NTRK3;NTRK2;TMEM108;STMN2
prerank,nucleotide metabolic process (GO:0009117),0.3591798835992405,0.9537756989011714,0.5217391304347826,0.9560667854856019,1.0,7/23,13.81%,NMNAT3;ENPP3;AK4;FHIT;DCTD;RNASEH2B;AK8
prerank,secondary alcohol biosynthetic process (GO:1902653),0.34334358928576353,0.9537187118635171,0.5238828967642527,0.955413267037505,1.0,6/30,11.95%,NPC1L1;DHCR24;ACAT2;PLPP6;HMGCS1;ACLY
prerank,glucose import (GO:0046323),-0.36276339541780456,-0.9535162746761842,0.5220588235294118,0.7806089279364898,1.0,8/13,48.85%,SLC2A1;SLC2A4;RAB4B;SLC27A4;SLC27A1;SLC2A3;SLC2A10;TRARG1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2754832716336156,0.9533567005911604,0.5477075588599752,0.9555473927343673,1.0,12/113,8.66%,PTN;LAMC1;LAMB1;WNT5A;SEMA5A;TCF7L2;C5AR1;HTR2B;CDH3;PDCL3;PRKD1;PRKCA
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3199451155154954,-0.9531227755716273,0.5286458333333334,0.7809243318497555,1.0,2/22,4.15%,ALDH1A2;RBP1
prerank,cellular response to alkaloid (GO:0071312),0.3863297228412754,0.9529422280545619,0.5317324185248714,0.9558645292376212,1.0,4/17,13.68%,RYR2;CASP6;SPIDR;RYR3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.31069797438377,-0.9525354084306755,0.5219638242894057,0.7816172361379163,1.0,6/24,9.10%,SORBS1;IGF1;INSR;PPP1R3B;GSK3B;DYRK2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2577887931694231,-0.952473594160189,0.5401929260450161,0.7810890615048187,1.0,18/53,19.03%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;PSMB10;OAZ2;PSME2
prerank,regulation of translation (GO:0006417),0.2613826235269705,0.9524521266143141,0.5728155339805825,0.9563448561663812,1.0,44/173,19.24%,EIF4G3;PRR16;PLD1;NAT10;EIF4A3;NANOS3;EPRS1;EIF3H;LSM14A;FMR1;MTPN;LARP6;CAPRIN1;RPS6KB1;EIF4A2;GLE1;PAIP1;MTOR;MTRF1;EIF2AK2;GRM5;DHX36;PLXNB2;CNOT1;MALSU1;EIF4ENIF1;RBM4B;PUS7;HNRNPD;DHX9;CNOT7;IMPACT;TSC1;IGF2BP3;CYFIP1;EIF5B;CALR;MTIF2;EIF3C;ILF3;YTHDF1;EIF2AK3;CTIF;FXR1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.3841663922647845,-0.9521488582796457,0.5077605321507761,0.7811612154058756,1.0,2/11,1.60%,DDX5;EGFR
prerank,autophagy of peroxisome (GO:0030242),-0.38140877550459795,-0.9519976535680673,0.5148063781321185,0.7808240283107059,1.0,5/12,26.78%,SQSTM1;USP30;ATM;MAP1LC3B;PEX5
prerank,nucleic acid metabolic process (GO:0090304),0.2988956096337914,0.9518769201321982,0.52400548696845,0.9570229042257924,1.0,7/69,8.80%,ENPP1;POLG;ANKLE1;FEN1;PDE12;HNRNPA2B1;WTAP
prerank,cellular response to hexose stimulus (GO:0071331),0.36471060680740897,0.9518454966992166,0.5039745627980922,0.95627849004312,1.0,4/23,8.66%,ZBTB20;TRA2B;ADCY8;PRKACA
prerank,oligodendrocyte differentiation (GO:0048709),0.37614134888932765,0.9518365666564457,0.5127334465195246,0.9554826413959282,1.0,9/19,23.37%,SOX6;EIF2B1;SOX10;SOX9;MYRF;CDK5;PTPRZ1;NSUN5;EIF2B5
prerank,protein localization to organelle (GO:0033365),-0.22079106563525275,-0.9518311536650617,0.5691489361702128,0.7805838385118941,1.0,32/133,17.91%,BBS9;APP;PACSIN2;CSNK1D;VPS35;DVL1;GBP5;SIX1;TOLLIP;VAPA;ARL6;STX1A;UBAC2;GBP2;ANK2;RPL11;ARFRP1;TSPAN17;IFT140;OPTN;RAB35;LMNA;GAK;YBX1;TOR1A;BICD2;CROCC;ARL1;RAB6A;ISG15;HHEX;LAMP2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3974333663135974,-0.951791901423208,0.5033112582781457,0.7799876252082093,1.0,5/10,34.72%,TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,regulation of protein export from nucleus (GO:0046825),-0.31842571470454323,-0.9517880026030789,0.5194805194805194,0.7792995709853779,1.0,7/23,14.82%,PTPN14;RBM22;GSK3B;IFI27;RANGAP1;BAG3;RAPGEF3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3875193919457998,0.9516249129303673,0.5182608695652174,0.9552295940096088,1.0,5/16,8.66%,PDE9A;MTPN;SLC9A1;TRPC3;PRKCA
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4159357411279545,0.9515494861291265,0.5197934595524957,0.9546190409563162,1.0,5/12,17.70%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,proteasome assembly (GO:0043248),-0.3835715529510795,-0.951459369779617,0.5187793427230047,0.77940504388925,1.0,5/11,22.98%,PSMD9;PSMG2;PSMD4;POMP;ADRM1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.25614270339168227,0.9514098945754604,0.5862831858407079,0.9541524328329953,1.0,59/248,18.28%,PRICKLE1;HDAC1;WNT5A;LYPD6;CDK14;SEMA5A;TCF7L2;BICC1;ADGRA2;RNF220;NKD1;NPHP3;PSMD1;MCC;JUP;GPC5;RBMS3;CDH3;LRRK2;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;ZBED3;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;WNK2;DAAM2;LGR5;CHD8;CSNK1E;AMER2;FGFR2;USP34;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LRRK1;LZTS2;PSMA2
prerank,apoptotic process (GO:0006915),0.25768720024363834,0.95127750311146,0.5630733944954128,0.9537169511153384,1.0,42/203,15.40%,DLC1;IL2RA;MAGI3;OGT;FAP;NGFR;PPARD;ELMO1;CASP6;ZBTB16;IFIT2;DHCR24;ADORA2A;CASP4;CAPN3;ARHGEF6;KREMEN1;TNFRSF19;DCC;MTOR;DDX41;TNFRSF21;PYCARD;JADE1;IAPP;DAP;CASP12;PDCD4;FAM162A;DPF2;MRPS30;BNIPL;ATN1;SCN2A;MELK;ERCC2;BAK1;RIPK1;BAG6;YARS1;AIFM2;MYC
prerank,inorganic ion transmembrane transport (GO:0098660),0.41433285854872204,0.9503270662409492,0.5203539823008849,0.9553400875675572,1.0,3/12,21.24%,ASIC2;KCNJ8;ABCC9
prerank,cellular protein localization (GO:0034613),0.25016483492468944,0.9502142542563327,0.5960698689956332,0.9548171876313725,1.0,38/285,10.36%,EPB41L3;UNC93B1;GGA2;RTP4;WNT5A;MYO7A;ATG9B;RAB20;CNTNAP2;RABGAP1L;TBC1D16;GRID2;RABL3;COPA;WDR45B;GJA1;NGFR;COPZ2;LRRK2;SEPTIN9;NAPB;CAPN3;CEP68;MYO6;PTPRU;SYNDIG1;VIPAS39;TBC1D1;TRIM23;JAM3;VPS26C;RAB29;ITSN1;TBC1D8B;SLU7;RAB24;AHI1;SAR1A
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3438256596966622,0.9497785497539408,0.5086887835703001,0.955217581947655,1.0,3/26,7.50%,TRAF3IP1;DHX58;LYAR
prerank,regulation of extracellular matrix organization (GO:1903053),0.39495940513330635,0.949614543637851,0.544839255499154,0.9548143781264289,1.0,2/15,2.80%,LRP1;FAP
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.27570838517990426,0.9496028431592017,0.538647342995169,0.9540457304945418,1.0,27/113,15.73%,NRG1;ERCC1;FSCN1;ERCC5;TLR6;RPA1;ERCC4;IL5;TERF1;MPP7;TLR4;PSMC4;SLF1;TP53;ASAP1;PSMC5;SPIDR;GTF2H3;CDT1;ERCC2;MED25;BAK1;FERMT2;GTF2H1;CLU;SLF2;TIRAP
prerank,positive regulation of translation (GO:0045727),-0.230705961485972,-0.9491506912009126,0.6153846153846154,0.7842422351089574,1.0,20/94,13.78%,VIM;LARP4;THBS1;RPS9;ELAVL1;PRKDC;NIBAN1;YBX3;SAMD4A;LARP4B;RPL5;SOX4;PYM1;CPEB3;RPL26;EIF3D;RPS4X;PKM;POLR2G;NGRN
prerank,RNA interference (GO:0016246),-0.3384649189031546,-0.9491413315845447,0.5514018691588785,0.7835588504232206,1.0,8/17,19.19%,TSN;DICER1;DROSHA;NRDE2;CELF1;TERT;AGO2;CLP1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.31245913348520166,-0.9488920681846427,0.5439560439560439,0.7834673928973103,1.0,4/23,8.34%,DKK3;LTBP4;SMURF2;SMAD3
prerank,protein deubiquitination (GO:0016579),0.25121460357921,0.9483182547655561,0.58006718924972,0.9566399280484709,1.0,55/242,18.81%,IL33;STAMBPL1;OGT;TAF9B;PTEN;MBD6;PSMD1;USP1;PSMD10;UCHL3;OTULINL;PSMA5;USP42;PSMB5;MDM4;BIRC2;KAT2A;ENY2;RNF128;PSMC4;TP53;PSMA4;USP33;JOSD1;TGFBR1;PSMC5;USP19;HGS;POLB;PSMB9;KDM1B;ATXN3;UBE2D1;CCNA2;ASXL1;RIPK1;AR;MYC;YOD1;USP34;USP4;PSMA7;USP21;USP16;USP13;STAMBP;PSMD14;USP49;INO80E;TAF10;PSMA2;USP14;RHOA;HIF1A;PSMD11
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3237487273687232,-0.9480542582717504,0.5424657534246575,0.7848427581535783,1.0,9/22,22.29%,RNF185;UBB;AMFR;UBC;EDEM1;MAN1A2;RNF5;UGGT1;UBA52
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2367597470351301,0.9478696943296336,0.741,0.9569932996325203,1.0,289/1668,17.44%,TBX18;RORA;IL33;GBX1;ZNF367;LPIN3;DCN;PIK3R1;ZEB1;ZBTB20;ISL2;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;PKNOX2;CXCL10;RUNX2;ARID3A;PPARA;HOXC10;AUTS2;MEIS1;MIER2;TEAD1;OGT;ETV5;TEF;HDAC1;PPID;WNT5A;TAF9B;PTEN;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;SALL1;AGO4;CDKN2A;THRA;SMAD5;NR1H4;PEX2;CDK8;ZFHX4;MAML3;ZIC4;PER3;HTATSF1;NCOA2;MEIS2;PGR;NFATC3;ZNF740;MED12;THAP3;METTL23;MYT1;JUP;POU3F3;PPARD;PIK3R2;NR1H2;TEAD2;LOXL2;REST;TBX3;FOS;ZBTB24;SOX6;NCOA3;ZIC1;KMT2A;FOXO6;HOXC9;ZBTB16;CHD4;IFRD1;MYCN;DMRTA2;BCL9;ZFP37;RTF1;SIRT6;EPAS1;HLF;CREB3L2;SSBP4;SLC9A1;FOXS1;PSMD10;BCOR;E2F4;ZBTB46;BRD8;CRTC2;GLIS1;DUSP22;TENM2;SRF;CSRNP3;BRMS1L;BRMS1;NPAS2;PAX9;ZBTB2;TRIM37;MYO6;AKIRIN2;LYAR;BCL6;FIZ1;DGKQ;ALX4;NR2C1;TAF3;CSRNP2;ZKSCAN3;MDM4;PER2;MED6;PIAS2;TWIST1;PRKD1;PFKM;CDK13;CHD2;SOX2;MXI1;NOC2L;NCOA1;PHF6;GLI1;OLIG2;PRKCB;TTC21B;SP100;TLR4;WIZ;DDX17;BHLHE22;KAT2A;NSD1;GLI3;ZBTB43;ENY2;HOXC8;AHI1;SOX10;ZBED3;PPP3CB;TP53;N4BP2L2;SMARCA1;DHX36;ZFPM2;MED10;AGO3;ZNF292;ZBTB39;ZNF25;MED8;SNW1;MSX1;PSMC5;HOXB9;ZBTB26;EPC1;RFX2;GTF2H3;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TWIST2;IGF2;TFEB;HOXB4;ST18;SAP30;DPF2;ELP4;PPIL4;KDM1B;HIVEP3;CD81;HIC2;CNOT1;DMRTA1;ACTR2;PRDM5;ATN1;NRIP1;NFIX;HOXC4;MYDGF;ZFP1;HDAC10;RFX4;CRK;PEG3;MED1;SREBF1;CUX2;ZFP64;ARNT2;UBE2D1;MED25;DOT1L;SSBP2;ELK1;BPTF;ZSCAN18;PRKAR1A;SNF8;CREB3L1;ASXL1;ZBTB32;MYNN;RIPK1;CHD8;FOXM1;CIAO1;HOXC5;TFAP4;DHX9;EAF2;DMAP1;PBX2;GTF2H1;ZBTB25;SAFB2;AR;GDNF;ATF2;MYC;LPIN2;PRDM10;CRY2;ORC2;TNRC6B;LAGE3;FOXJ3;ZHX3;DCAF1;FGFR2;KLF11;HOXA9;MAFB;ZKSCAN5;KDM2A;IMPACT;PLAC8;EFNA1;AKIRIN1;ZBTB7A;AASS;ZNF467;ONECUT2;ZNF3;DVL3;CCNK;SRA1;USP16;ZFP62;JAG1;HAX1;TOX2;ATMIN;ZIC5;MAZ;NR1D2;CALR;ZBTB12;DNMT3A;SARS1;CREG1;MBD2;AGO1;LDB2;LDB1
prerank,protein targeting to lysosome (GO:0006622),0.3691197640297592,0.9478426510001478,0.5433333333333333,0.9562497427874064,1.0,6/20,15.09%,SORL1;NEDD4;SNX16;AP3M1;HGS;CLU
prerank,nuclear membrane reassembly (GO:0031468),-0.2587251061782933,-0.9478028957254776,0.5526315789473685,0.7847833272842375,1.0,21/54,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3088276626178675,0.9477367089224479,0.5342857142857143,0.9557159506880362,1.0,13/52,19.63%,KDELR3;FKBP14;CXXC1;EXTL3;SRPRA;GSK3A;TATDN2;MYDGF;HSPA5;TSPYL2;CUL7;ATP6V0D1;SSR1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.349002131855383,0.9472601552874664,0.5202492211838006,0.956105152128563,1.0,8/26,19.60%,OGT;KMT2A;VCPKMT;SETD5;SMYD5;SUV39H2;SETD4;ATPSCKMT
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.26487705355533364,-0.9472031219272196,0.5304878048780488,0.7855901272997233,1.0,12/45,22.99%,BMPR2;TGFB2;DAB2;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;INHBB;ACVR2A
prerank,negative regulation of cellular component movement (GO:0051271),0.3922620144620413,0.946876848862912,0.5183946488294314,0.9562371655799241,1.0,5/15,18.39%,SPOCK3;ACTN1;SP100;CRK;FBLN1
prerank,mitotic cell cycle phase transition (GO:0044772),0.2570595293433986,0.9467256792586791,0.5778032036613272,0.9558328909444462,1.0,53/203,21.66%,DYNLL1;CDK14;CDKN2A;CCNJ;DCTN3;HAUS3;PKMYT1;HAUS1;CDC7;CCDC57;DCTN2;CDC16;CDKN2D;HAUS8;RPS6KB1;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;CACUL1;PPP6C;BCAT1;SSNA1;RCC1;CUL5;CDKN2C;MELK;DBF4;CLASP2;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;MYC;BRSK2;CLASP1;ALMS1;CAMK2A;PCM1;CCNE1;KHDRBS1;CUL4A;TUBA1A;POLE;CEP43;LATS2;INHBA;FBXL22;CCND3;CDK7;BTRC
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2445614276916791,0.9466463211883615,0.627906976744186,0.9552610027573157,1.0,95/476,17.02%,RORA;ZFHX3;ATF5;RUNX2;PPARA;TEAD1;RGMB;KMT2E;HDAC1;WNT5A;NR2F2;TCF4;PHIP;ERBB4;SALL1;SMAD5;NR1H4;MED12;POU3F3;PPARD;NR1H2;TEAD2;REST;FOS;ZIC1;KMT2A;MDFIC;ZNF423;ZBTB16;CXXC1;SPP1;MYCN;CAMKK2;CREB3L2;CAPN3;TRIM56;TAF15;NPAS2;SPIN1;ZKSCAN3;SOX2;BICRAL;EDF1;NCOA1;GLI1;XPC;SP100;BRCA2;BMP7;KAT2A;NSD1;GLI3;ENY2;MAP2K1;CAMK4;SOX10;PPP3CB;TP53;SMARCA1;TGFBR1;PSMC5;EPC1;ZNF318;ESR2;SOX9;CD86;TFEB;HIVEP3;TESC;TRIM44;AXIN1;BICRA;MED1;MYRF;ARNT2;ELK1;UBE2V1;F2R;CHD8;FOXM1;HNRNPD;TFAP4;GTF2H1;PRMT2;AR;MYC;MAFB;MMS19;TRIP4;DVL3;USP21;USP16;ATMIN;MAZ;NR1D2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3084147914766273,-0.9464127505148607,0.5693215339233039,0.7867886431226345,1.0,7/24,14.67%,TEK;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2388226251608316,-0.946410819494683,0.5658914728682171,0.7860967587817747,1.0,23/80,19.93%,ERC1;VTI1A;VPS35;SNX32;ARFRP1;SNX6;SGSM2;SPAG9;SURF4;CLN5;TBC1D10B;VPS51;VPS29;TRIM27;LMAN1;ARL1;TMEM87B;RAB6A;SNX3;VPS54;PLEKHJ1;TBC1D14;TBC1D5
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.26730945520411725,0.9461333963874178,0.5635220125786163,0.9558042703250568,1.0,30/124,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;TCF7L2;AGO4;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PPP3CB;PSMA4;AGO3;PSMC5;GNAO1;PSMB9;ARHGEF19;GNG2;TNRC6B;DVL3;PSMA7;PSMD14;AGO1;CAMK2A;FRZB;PSMA2;RHOA;PSMD11
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3542020564842907,-0.9458194934063805,0.5240506329113924,0.7868969687574664,1.0,3/15,7.21%,APP;CRYAB;APOE
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4014187844871837,0.9457872084157266,0.5549828178694158,0.9558732712585406,1.0,1/15,0.79%,XCL1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.39406373544910034,-0.9457459318279298,0.5183585313174947,0.7863683096350109,1.0,3/10,9.80%,MLLT3;ACE;SFRP1
prerank,apoptotic nuclear changes (GO:0030262),0.35165699445585047,0.9457051838119209,0.5144694533762058,0.9553013299501003,1.0,5/24,18.80%,CECR2;KPNA1;TOP2A;KPNB1;DEDD2
prerank,regulation of acute inflammatory response (GO:0002673),0.3730738981021281,0.9454594583463273,0.5132890365448505,0.9551139381273015,1.0,4/18,21.68%,KLKB1;PTGES;ADAM8;OSMR
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2783207877238101,-0.9453117753220135,0.536741214057508,0.7867499415783664,1.0,22/36,43.15%,LEF1;GLI2;SOX4;MDK;SART1;SOX12;CD46;RHOH;PNP;VSIR;NCKAP1L;IL7;SOCS1;NKAP;IL4I1;VNN1;ZBTB1;ZAP70;GATA3;TESPA1;IL12RB1;IL4
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3364314569376321,0.945267796407318,0.5259026687598116,0.954799347232844,1.0,7/29,14.51%,PDGFRA;IRS1;PTK2;PRKD1;FGR;CD81;ATG14
prerank,fatty acid elongation (GO:0030497),-0.3662591184419848,-0.9449885600927721,0.5164319248826291,0.7867875953091649,1.0,4/13,13.29%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2586426658908086,0.944411689455773,0.58698224852071,0.9562769817003426,1.0,23/175,12.86%,MAP3K14;XCL1;EDA2R;EDA;CD40;PSMD1;CCL15;SMPD4;PSMD10;ADAMTS12;ZFP36L2;PSMA5;PSMB5;BIRC2;PSMC4;TNFRSF21;CCL25;TP53;PSMA4;PYCARD;PSMC5;ST18;PSMB9
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3183884053874909,-0.9443495374053037,0.532133676092545,0.7876237016417983,1.0,6/20,31.04%,FDX1;FDXR;STAR;HSD17B10;CYP46A1;TSPO
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3212330022878833,-0.9442003414608193,0.5278514588859416,0.7872992653347711,1.0,9/21,24.36%,COX15;PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L;COA6
prerank,positive regulation of cell growth (GO:0030307),-0.2311029694027524,-0.9437532253317639,0.5734597156398105,0.787727805869574,1.0,24/96,18.29%,IGF1;EGFR;NTN1;SEMA7A;RUFY3;TGFB2;ADAM10;CDC42;NGF;MAPT;HYAL1;SFRP1;INO80;RPS6KA1;GOLGA4;EXOSC2;MACF1;MFSD2A;CDKN2AIP;EDN1;PABIR1;ERBB2;AKT1;SDCBP
prerank,regulation of mRNA catabolic process (GO:0061013),-0.22885141612700197,-0.9437103887567708,0.6294416243654822,0.7871194925564696,1.0,34/121,18.20%,VIM;ELAVL1;PSMC6;PSMD9;SAMD4A;HSPA8;PSMF1;PSMB7;YWHAB;PARN;UBB;PRR5L;ZC3HAV1;CNOT8;PSMD8;RC3H1;PSMD12;HSPB1;PSMA3;PSMA6;PSMD4;PSME3;EXOSC2;PSMD7;PSMB6;PSMC1;PRKCD;EXOSC3;PABPC1;PSMB10;GTPBP1;UBC;AKT1;SERBP1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3825183868813157,0.9436459487079072,0.5058043117744611,0.9573993408014858,1.0,2/17,5.09%,NR1H2;LIPC
prerank,regulation of interleukin-13 production (GO:0032656),-0.36908209015973314,-0.9431666319414069,0.5287081339712919,0.7877303113051884,1.0,2/13,1.78%,LEF1;IL18
prerank,second-messenger-mediated signaling (GO:0019932),0.27949721429712027,0.9429385631616851,0.5357607282184655,0.9583998978660901,1.0,12/82,11.17%,EDN3;ACKR2;CCR9;RYR2;PDPK1;PPP1R9A;HTR2B;CAMKK2;LRRK2;KSR2;RCAN3;P2RX4
prerank,negative regulation of stem cell differentiation (GO:2000737),0.41684415507839534,0.9428197031292839,0.5210526315789473,0.957912227021777,1.0,5/12,21.32%,REST;ZFP36L2;N4BP2L2;JAG1;NELFB
prerank,regulation of membrane depolarization (GO:0003254),-0.33755287645280674,-0.9426702237967062,0.5392405063291139,0.7882563152354389,1.0,3/18,3.59%,FHL1;PTPN3;CAMK2D
prerank,modulation by host of viral genome replication (GO:0044827),-0.35428634840594386,-0.9426682954854376,0.5268065268065268,0.7875752479218143,1.0,3/13,7.47%,FBXL2;VAPA;IFI27
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.29677975037556725,0.9426382112342745,0.5506849315068493,0.9575886316457485,1.0,12/59,13.50%,ROBO2;TENM3;PTPRT;DSCAM;CNTN4;DSCAML1;PALLD;NEXN;CNTN6;PLXNB2;CADM3;NECTIN3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3222450253796302,0.9425527523781246,0.5461309523809523,0.9569850007664072,1.0,7/36,14.79%,WNT5A;TXK;TSLP;CASP4;AXL;TRIM44;RIPK1
prerank,leukotriene metabolic process (GO:0006691),0.3750118571117528,0.9421846882587227,0.5272108843537415,0.9571806609399628,1.0,1/19,0.52%,GGT5
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2749202495871803,0.9421688868371468,0.5545796737766625,0.9564242069744533,1.0,27/100,19.93%,PRICKLE1;OGT;GLMN;EIF3H;RNF180;LRRK2;PSMD10;HERPUD1;CBFA2T3;COMMD1;NKD2;FHIT;ZYG11B;HECTD1;GSK3A;DDA1;BAG6;CLU;CSNK1E;DET1;ARAF;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A;XPO1
prerank,response to exogenous dsRNA (GO:0043330),0.37635194844826475,0.9420847592893007,0.5216666666666666,0.9558628269185804,1.0,1/18,0.21%,COLEC12
prerank,covalent chromatin modification (GO:0016569),0.4076028478350328,0.9415283944387327,0.542907180385289,0.9564512983866301,1.0,2/14,5.93%,HDAC1;SETD5
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3416970848332307,0.9411374785147035,0.5482866043613707,0.9566474737907082,1.0,5/27,12.95%,SLC1A3;SLC7A8;SLC25A22;SLC7A3;SLC25A29
prerank,regulation of JNK cascade (GO:0046328),-0.23277920585951384,-0.9408581021037321,0.5497835497835498,0.7911794249368092,1.0,35/101,24.82%,MECOM;PLCB1;EGFR;IGF1R;CCN2;TPD52L1;APP;SIRPA;MAP3K5;MAPK8IP3;MINK1;FZD7;SH3RF2;HDAC3;GADD45B;HIPK2;CYLD;FLT4;PTK2B;WNT16;MAPK8IP1;TRAF3;PER1;MAP3K10;SDCBP;TGFBR3;MFHAS1;GADD45G;DUSP19;TRAF1;CCL19;EDAR;TAOK2;NOD2;CD27
prerank,Golgi inheritance (GO:0048313),0.42092088356759644,0.9408338035980967,0.5227655986509275,0.9566694684197303,1.0,4/11,15.36%,YWHAZ;GBF1;GOLGA2;VRK1
prerank,positive regulation of type 2 immune response (GO:0002830),0.3857024844693252,0.9404429915790447,0.542314335060449,0.9569026188023052,1.0,3/14,12.93%,XCL1;CD86;CD81
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.33642202806965305,0.9401135410248832,0.5338461538461539,0.9570100688526216,1.0,9/30,17.07%,ACOX2;ABCD2;PEX2;ELOVL2;ACSL6;ACOT2;ELOVL6;ELOVL1;HACD3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.34201871643049186,0.9397106913536887,0.5360501567398119,0.9572634196481494,1.0,9/27,15.59%,FMR1;MYCN;MAP2K1;TP53;EIF4ENIF1;RIPK1;DHX9;WTIP;TNRC6B
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.3006053021207168,-0.9396349784196486,0.5583333333333333,0.7934745472065579,1.0,7/27,15.33%,KHNYN;NYNRIN;PARN;DICER1;RPP30;RNASE4;ERN1
prerank,RNA splicing (GO:0008380),0.28065590016182806,0.9390271752068344,0.5691906005221932,0.95824470241081,1.0,28/95,22.42%,TRA2B;GEMIN2;NOVA1;SNRNP35;ZRSR2;NOL3;LSM4;BCAS2;SRSF11;MPHOSPH10;SMU1;RP9;SLU7;DBR1;SNRNP48;SRSF10;PRPF18;SNRPF;NONO;SF3A3;PPIG;ZCRB1;LUC7L3;PRPF8;DDX39B;DHX15;WBP4;HNRNPH3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.29331303358999095,0.9386941732924264,0.5300546448087432,0.9583184484548264,1.0,10/67,11.12%,PDGFRA;GHR;TXK;ERBB4;FGFR1;PTK2;RELN;FGR;EPHA3;FYN
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3936329987580536,-0.9386720567664218,0.5414746543778802,0.7950839648108056,1.0,6/11,27.35%,CYC1;UQCRB;UQCRQ;UQCRC2;UQCC3;UQCRC1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3855701915580425,-0.9385195597517156,0.5279642058165548,0.7947923791903966,1.0,5/10,25.66%,UPP2;UPB1;NT5E;NT5C1A;NT5M
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.228471185079415,-0.9384119240760834,0.5821596244131455,0.7943833775246788,1.0,32/98,21.19%,SLCO1C1;THBS1;KLF4;MAGI2;INSR;IL10RB;INPP5F;MAPK14;APOE;XDH;IFNAR1;NFKBIA;STARD4;RNF41;CD63;CHCHD2;AGTR1;GRB2;CDKN1A;PRELID1;RAB1A;ACACB;GHITM;AKT1;EGF;ACE2;PID1;TBC1D5;AGT;RAB1B;ROMO1;TGFBR2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3492137049979652,0.9380168681102066,0.5339652448657188,0.9593187738942639,1.0,2/27,1.70%,PDGFRA;WNT5A
prerank,lipid droplet formation (GO:0140042),-0.392986778681761,-0.9379842487878502,0.5661605206073753,0.7946776979342601,1.0,4/10,23.41%,CDS1;CDS2;PLA2G4C;FITM2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.26878472004899506,-0.9379156933985593,0.6086956521739131,0.7941453092637484,1.0,11/41,22.02%,IGF1;LBP;SIRPA;CD34;DICER1;CX3CL1;TRIM27;HAVCR2;TNFAIP3;SELENOS;ILRUN
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.40049686056592,0.9378910968234291,0.5503472222222222,0.9588629177311312,1.0,1/13,1.01%,VDAC2
prerank,regulation of innate immune response (GO:0045088),-0.25055001490781553,-0.9378614539153268,0.5612244897959183,0.7935944242978159,1.0,14/57,15.90%,XIAP;SAMHD1;ERAP1;NMI;GBP5;IFI35;CASP8;IRF1;PTPN1;PARP9;RIOK3;POLR3G;RNASEL;POLR3D
prerank,cellular senescence (GO:0090398),0.34630870281059445,0.9378419874584206,0.5390505359877489,0.9581971230753522,1.0,5/27,9.96%,CDKN2A;TBX3;SRF;OPA1;MAP2K1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4314495363944984,0.9375707487322523,0.5492700729927007,0.9580701733642977,1.0,4/10,12.02%,LOXL2;SOX6;ZBTB16;SOX9
prerank,positive regulation of cellular respiration (GO:1901857),-0.38061802018795876,-0.9374666238254218,0.5290023201856149,0.7938735693240665,1.0,6/11,26.33%,IL10RB;IFNAR1;VCP;PRELID1;NUPR1;PARK7
prerank,T cell homeostasis (GO:0043029),-0.39692791698958485,-0.9372344165135841,0.5431235431235432,0.7937224343758045,1.0,7/10,35.61%,FAS;AKT1;PPP2R3C;JAK3;NCKAP1L;FADD;PMAIP1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3833283195200802,0.9371017958330435,0.5199335548172758,0.9584857462903226,1.0,3/16,9.12%,PPARA;PINK1;AK4
prerank,B cell proliferation (GO:0042100),-0.32543574526884456,-0.9370042506303535,0.5746268656716418,0.7935715618146052,1.0,2/17,3.05%,MEF2C;CTPS1
prerank,cellular response to glucose starvation (GO:0042149),-0.2711812604756104,-0.9368682549946109,0.5510204081632653,0.7931962107947615,1.0,11/41,20.89%,PRKAG2;BECN1;SESN1;PRKAA2;SIK1;MYBBP1A;PRKAG3;PRKAA1;NUAK2;HNRNPA1;ASNS
prerank,regulation of signal transduction (GO:0009966),0.256785286805976,0.9366401212436012,0.5995397008055235,0.95886989651241,1.0,28/190,11.70%,RORA;SULF1;TMEM204;MTCH1;OGT;TSPEAR;SEMA5A;ITGA3;RGS20;ZIC1;MDFIC;ANKRD54;LRRK2;TMEM108;LLGL1;IFT81;KCTD8;DGKQ;PRKD1;RGS8;GLI1;SP100;IRAK1;DOK5;FYN;USP33;SNW1;UBASH3B
prerank,regulation of defense response (GO:0031347),-0.23189719541378156,-0.9364670154723507,0.6271186440677966,0.7935080390987576,1.0,38/76,30.15%,FOXP1;XIAP;SEMA7A;SAMHD1;IL1R1;ERAP1;MGLL;ANXA1;APOE;CELF1;CASP8;IRF1;LACC1;ELMOD2;PSMA6;CYLD;AGTR1;TMSB4X;TRAF3;PTGS2;ACE2;USP18;SHPK;BIRC3;BCL6B;NOD2;PIK3AP1;TKFC;HCK;PARK7;SBNO2;ZBP1;CASP1;FCGR2B;GGT1;LRP8;LRRC19;CCR2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.27117997316932474,-0.936413926677448,0.5773480662983426,0.7929541269233308,1.0,18/40,23.64%,LEF1;FOXC1;NOTCH1;TGFB2;DAB2;SMAD3;BCL9L;MDK;EZH2;PDPN;TGFB1I1;SNAI1;SDCBP;RGCC;TGFBR2;TIAM1;WWTR1;AXIN2
prerank,regulation of coagulation (GO:0050818),0.42004575753017837,0.9362208307019971,0.5618729096989966,0.9591519880055909,1.0,3/11,14.71%,HRG;F2R;HS3ST5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3744655792872804,-0.9361814025461512,0.5364238410596026,0.7928291090255533,1.0,2/12,10.91%,PPHLN1;ATF7IP
prerank,positive regulation of interleukin-1 production (GO:0032732),0.30258531147199574,0.9361214227969294,0.5568022440392707,0.9586150125048748,1.0,7/51,10.90%,WNT5A;IL16;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.29179180680746575,-0.9360778528546888,0.5623100303951368,0.7924149768011581,1.0,8/28,18.27%,EGFR;NOTCH3;WWP2;GATA2;NIBAN2;LFNG;AKT1;EGF
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.23471770450950147,-0.9359582455076473,0.5991379310344828,0.7920657999599355,1.0,24/88,19.75%,TRABD2B;FNIP1;STX18;SMPD3;TFRC;GSK3B;VCP;RHOC;FNIP2;SMAD3;HYAL1;BAX;SDC4;AJUBA;BID;CDH5;TAL1;CX3CL1;MMP1;SDC1;SDCBP;RGCC;CHGA;PDCD6IP
prerank,positive regulation of ATP metabolic process (GO:1903580),0.33077304780377986,0.9359454766419534,0.5415430267062314,0.9582735958735362,1.0,5/32,8.27%,ZBTB20;PPARA;PFKFB1;ENTPD5;PINK1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.27689729903986704,-0.9357651737055003,0.5391566265060241,0.7918199211899003,1.0,11/33,22.71%,PICALM;ACTN2;GOPC;STX3;TOR1A;KCNAB2;HFE;EGF;TAX1BP3;RAB11FIP5;TYROBP
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3861211089008851,0.9356817203310495,0.533106960950764,0.9581892465734836,1.0,4/15,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.38273958585954654,0.9356436704070014,0.560064935064935,0.9574998884401114,1.0,3/17,12.02%,KDF1;AHI1;SOX9
prerank,positive regulation of protein sumoylation (GO:0033235),0.42476689092709946,0.9349679931826369,0.541958041958042,0.9584548887038306,1.0,2/10,10.22%,GNL3;SAE1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.4080533070555187,0.9348873572017213,0.5526770293609672,0.9578794536583186,1.0,2/12,8.42%,DOCK10;GPR183
prerank,amide biosynthetic process (GO:0043604),0.3089053576186447,0.9344099274410496,0.5647743813682679,0.9583361586651578,1.0,12/47,17.21%,PAM;CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;CERS6;SLC25A2;SLC25A15
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.4133460921530737,0.9343534853015255,0.5292035398230088,0.9577057006048729,1.0,1/11,1.70%,WNT5A
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.42996037289507805,0.9343429244093282,0.5540308747855918,0.956952190048655,1.0,2/10,7.93%,SEMA5A;CARMIL2
prerank,sensory perception of smell (GO:0007608),0.4184933347471492,0.9342163646876649,0.5420240137221269,0.9564797479416992,1.0,3/11,22.63%,ADCY3;BBS4;UBR3
prerank,regulation of mononuclear cell migration (GO:0071675),0.35406812163878415,0.9339777122594266,0.5218800648298217,0.9563138791713081,1.0,8/23,21.50%,IL34;PTK2;LYN;AKIRIN1;BMP5;CMKLR1;RARRES2;MAPK1
prerank,glycerophospholipid catabolic process (GO:0046475),0.341159846286866,0.9338108042947229,0.5368589743589743,0.9559827713329362,1.0,7/27,12.04%,PRDX6;LIPC;SMPD4;ENPP6;PLA2G7;ABHD16A;ABHD12
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.28845687076368826,0.9337882839211954,0.5728021978021978,0.9552507801816673,1.0,19/74,16.15%,SPRY1;PTEN;PHLDB1;SPRED1;LOXL2;GCNT2;IL17RD;GLIPR2;SPRED2;TWIST1;MTOR;EPHA3;MCRIP1;TGFBR1;OLFM1;CLASP2;FERMT2;CLASP1;EFNA1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.37228332541223463,-0.9335500551918675,0.5497737556561086,0.7963050762132406,1.0,4/12,10.44%,NFIB;EPHA4;GLI2;EPHB2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2517175684879679,-0.9334644279839684,0.6045627376425855,0.795830642235946,1.0,9/57,10.08%,DAPK1;ARL6IP5;TNFSF10;MAP3K5;UACA;PPM1F;CASP8;BAD;PERP
prerank,protein acetylation (GO:0006473),-0.2899434676783394,-0.9334613948156232,0.5446927374301676,0.7951574989804635,1.0,12/30,22.75%,FOXO1;NAA40;MAPT;ESCO1;ING4;KAT5;SIRT1;ING5;CLOCK;NAA80;NAA35;NAT9
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3558675206469884,0.9330557184062274,0.5413290113452188,0.9563030177371094,1.0,3/23,6.74%,ZFYVE28;CBLB;DUSP22
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.24570663218252317,-0.9330494994739745,0.6510791366906474,0.7954492367769462,1.0,16/61,19.40%,EYA2;EYA1;EGFR;EYA4;RNF8;RTEL1;PCNA;BRCC3;SMCHD1;NBN;UBE2N;SIRT1;USP9X;PPP1R10;HGF;RGCC
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.29072144676118694,-0.9327693484602665,0.5555555555555556,0.7954049510861148,1.0,11/27,25.61%,CTPS1;CTPS2;DTYMK;AK2;RRM2B;GUK1;TYMS;AK6;AK5;TXNRD1;AK7
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.26793373964072464,-0.93268313385894,0.5786163522012578,0.7949158909364875,1.0,12/41,20.84%,ACTN2;ANK2;STAC;KCNJ2;KCNQ1;KCNJ12;NOS1;FLNA;NOS1AP;CTSS;ACE2;KCNJ15
prerank,AMP metabolic process (GO:0046033),-0.35696680049284885,-0.9324728946762173,0.5412621359223301,0.7947370966155344,1.0,4/13,10.80%,AMPD3;ADSS2;XDH;NT5E
prerank,protein secretion (GO:0009306),0.294727244719841,0.9320852059364464,0.5773638968481375,0.9579913923912593,1.0,17/56,21.58%,STEAP3;SEL1L;RAB8A;RAB3C;RIMS2;RCN3;RAB15;TMEM167A;MTTP;TVP23B;LTBP2;COPG1;MIA3;SVBP;CANX;SCG2;TANGO6
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.25358074462703006,0.932043118921683,0.6041426927502876,0.9573441542456925,1.0,25/190,11.89%,RORA;PPARA;CCDC22;PTEN;ITPR1;TSPAN6;NR1H4;DUSP1;PIK3R2;SPRED1;NPRL2;NF1;PSMD10;HERPUD1;CARD19;PLEKHA1;TWIST1;PINK1;NOC2L;TLE1;BMP7;PYCARD;RTKN2;BCL2L2;TRIM59
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.2884220782585465,-0.9319559478117242,0.5543175487465181,0.7953447933910474,1.0,7/31,10.36%,EPHA4;PDLIM5;SIPA1L1;SHANK3;NGEF;CFL1;CAMK2B
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.2281991541655128,-0.9315976171056373,0.6190476190476191,0.7954419285675273,1.0,35/86,27.19%,PSMC6;PSMD9;EGLN3;PSMF1;HIF3A;PSMB7;KLF2;UBB;PSMD8;PSMD12;INO80;VHL;BAG3;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;ELOC;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;PSMA8;STOX1;DNAJB1;BACH1;HSPA1A;LIMD1;ATF3;CHEK1
prerank,sphingolipid catabolic process (GO:0030149),-0.35007947463046934,-0.9314812929567248,0.547911547911548,0.7950382971498496,1.0,7/15,26.54%,ACER2;ACER3;ENPP2;SMPD1;SMPDL3A;ASAH1;ASAH2
prerank,aorta morphogenesis (GO:0035909),-0.33418385578556137,-0.9311291527944587,0.5524475524475524,0.7951853335629215,1.0,6/17,12.73%,RBPJ;MYLK;TBX1;ACVRL1;TBX2;HEY2
prerank,UV protection (GO:0009650),0.4278411780972966,0.9311290931325905,0.5346715328467153,0.9588253663306324,1.0,3/10,4.93%,FEN1;ERCC5;MFAP4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2692323190998117,0.9309222492019036,0.5935897435897436,0.958541696483028,1.0,16/114,12.86%,MAP3K14;EDA2R;EDA;CD40;PSMD1;PSMD10;PSMA5;PSMB5;BIRC2;PSMC4;TP53;PSMA4;PYCARD;PSMC5;ST18;PSMB9
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.2615303942031478,-0.9307800703436224,0.5959595959595959,0.7953850579790347,1.0,18/48,20.26%,NOS3;THBS1;FOXC2;ATP5F1B;KDR;JCAD;ANXA1;MAPK14;GATA2;ETS1;FGFBP1;HSPB1;TMSB4X;PTGS2;SIRT1;AKT1;CIB1;NUS1
prerank,lymphocyte differentiation (GO:0030098),-0.24242762238671664,-0.930638334409636,0.5725490196078431,0.7950787752842466,1.0,20/68,21.24%,PBX1;LEPR;PTPRJ;TPD52;ITGB1;HDAC4;SOX4;DNAJB9;PIK3CD;PTPN2;PLCG2;SLC25A5;LFNG;FLT3;VCAM1;HHEX;BLNK;NFIL3;KLF6;RHOH
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.23268060222268488,0.9304124654319729,0.803,0.9590581350469438,1.0,341/1646,19.90%,TBX18;RORA;CHD7;GBX1;ZNF367;ZEB1;ZBTB20;ISL2;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;XCL1;PKNOX2;NRG1;RUNX2;ARID3A;PRICKLE1;PPARA;HOXC10;MEIS1;TEAD1;RGMB;OGT;ETV5;TEF;KMT2E;HDAC1;L3MBTL1;WNT5A;CDK14;NR2F2;TCF7L2;TCF4;PHIP;BASP1;ERBB4;SALL1;CDKN2A;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;HTATSF1;NCOA2;MEIS2;PGR;NFATC3;ZNF740;MED12;MYT1;POU3F3;PPARD;NR1H2;TEAD2;LOXL3;LOXL2;REST;TBX3;FOS;FBXO5;ZBTB24;SCML4;SOX6;ZIC1;KMT2A;FOXO6;MDFIC;RUNX1T1;HOXC9;ZNF423;RRP8;ZBTB16;FOXN2;CXXC1;SPP1;CHD4;IFRD1;MYCN;DMRTA2;CAMKK2;ZFP37;EPAS1;HLF;TLE2;CREB3L2;SETD5;FOXS1;BCOR;E2F4;ZBTB46;CAPN3;GLIS1;TRIM56;CALCA;TAF15;POLA1;CBFA2T3;SRF;GMNN;CSRNP3;HP1BP3;BRMS1;NPAS2;PAX9;ZBTB2;SPIN1;BCL6;DGKQ;ALX4;NR2C1;CSRNP2;ZKSCAN3;MDM4;PER2;MED6;PIAS2;TWIST1;SPTY2D1;CHD2;SOX2;MXI1;BICRAL;L3MBTL4;EDF1;NCOA1;PHF6;GLI1;XPC;OLIG2;TENM1;PRKCB;TTC21B;SP100;TLE1;WIZ;DDX17;BHLHE22;DAXX;SRRT;BRCA2;BMP7;KAT2A;NSD1;GLI3;ZBTB43;ENY2;MAP2K1;HOXC8;CAMK4;SOX10;PPP3CB;TP53;ZC3H8;NFXL1;MPHOSPH8;SMARCA1;DHX36;ZFPM2;ZNF292;ZBTB39;ZNF25;MED8;SNW1;MSX1;TGFBR1;PSMC5;DAP;HOXB9;ZBTB26;EPC1;RFX2;ZNF318;FOXJ2;ESR2;PROX2;SOX9;SRSF10;MYT1L;ZNF112;CDT1;TWIST2;CD86;PDCD4;IGF2;TFEB;HOXB4;ST18;SAP30;DPF2;ELP4;HIVEP3;HIC2;BTAF1;NUP107;TESC;PHC1;DMRTA1;TRIM44;ZNF628;PRDM5;ZMYND15;NFIX;AXIN1;CARM1;HOXC4;ZFP1;HDAC10;RFX4;CRK;PEG3;BICRA;MED1;SREBF1;CUX2;MYRF;ARNT2;SSBP2;ZNF326;ELK1;BPTF;ZSCAN18;TGFBRAP1;KDM5C;PRKAR1A;UBE2V1;SNF8;CREB3L1;F2R;ZBTB32;MYNN;CHD8;FOXM1;CIAO1;HOXC5;HNRNPD;TFAP4;DHX9;DMAP1;PBX2;GTF2H1;ZBTB25;SAFB2;PRMT2;MLF1;AR;ATF2;CNOT7;MYC;WTIP;CRY2;CENPF;FOXJ3;ZHX3;KLF11;HOXA9;MAFB;ZKSCAN5;MMS19;KDM2A;SPINDOC;ZBTB7A;ZNF467;ONECUT2;TRIP4;ZNF3;CBFA2T2;DVL3;CCNK;NONO;SRA1;USP21;USP16;USP13;ZFP62;MBTD1;TOX2;ATMIN;ZIC5;CIART;MAZ;NR1D2;CALR;ZBTB12;CREG1;CDK5;MBD2;ZBTB11;RHOG;LDB1;SMARCAL1;SAFB;PHF20L1;ZNF32;MLF2;RAI1;SUV39H2;ZXDB;BMP2;MBD1;KAT7;NFAT5;RNF187;SKOR2;HDGFL2;HEY1;BRD7;CCNE1;ILF3;REXO4;KHDRBS1;HIF1A;WWC1;DEDD2;PEX14;THAP7;ZNF711;CARF;TERF2IP;CREBZF;ARNT;CBFB;NR2C2;TFDP1;NACC1;ABCA2;IKZF4;SP1;E2F5;OLIG1;TASP1;MTA3;TRAPPC2;CNBP;HIVEP2;LRRFIP1;HOXB2;MAP3K2
prerank,response to interferon-beta (GO:0035456),-0.31405385920869344,-0.9302309380442733,0.5314285714285715,0.7953723209952073,1.0,10/22,29.09%,IFITM3;IRF1;IFITM1;CDC34;IFITM2;NDUFA13;IKBKE;PNPT1;TRIM6;IRGM
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2786175990360244,0.929866085794717,0.5660377358490566,0.9596334705965354,1.0,13/73,17.31%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;CD86;RIPK1;DHX9;CLU;TIRAP;LGALS9;ADAM8
prerank,cortical cytoskeleton organization (GO:0030865),0.3096169477970598,0.9298038660151886,0.5614285714285714,0.9590142022371885,1.0,6/41,7.23%,EPB41L3;RND3;RAC3;LLGL1;FMNL2;RHOBTB3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.33010437526736547,-0.9296441151834091,0.5617715617715617,0.7960761806110334,1.0,6/17,16.15%,ERLIN1;SREBF2;APOE;FGF1;RAN;PRKAA1
prerank,endoplasmic reticulum organization (GO:0007029),0.28452498503293,0.9291872987514767,0.578875171467764,0.9597724623533506,1.0,10/72,12.48%,SEC16B;REEP2;SEC16A;VAMP2;LRRK2;SMPD4;ZBED3;SEC61B;TRAM2;LNPK
prerank,regulation of protein processing (GO:0070613),-0.3153500082999618,-0.9291687811127023,0.5773480662983426,0.7965139924177902,1.0,5/21,13.87%,GAS1;RUNX1;CCBE1;TMEM59;SERPINE2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.35027826375104304,0.9287061141856205,0.551779935275081,0.9602596033342473,1.0,3/22,5.64%,AKAP5;ADGRV1;NF1
prerank,inositol phosphate catabolic process (GO:0071545),0.3968474873323656,0.9286732735582872,0.5219683655536028,0.9595621750230475,1.0,2/12,8.79%,PTEN;INPP5J
prerank,cobalamin metabolic process (GO:0009235),0.3723319012041495,0.9285035597374418,0.5411764705882353,0.9592277181112984,1.0,4/17,17.19%,MMAB;MTRR;MMAA;MMUT
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.32956589373686096,0.9282825830561272,0.5580693815987934,0.9589728244227298,1.0,6/33,16.74%,IL34;PRKCA;TESC;CTNNBIP1;RIPK1;HAX1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3801963002340663,0.9281788588017488,0.5673758865248227,0.9584549024277221,1.0,5/14,20.84%,XCL1;HMCES;PAXIP1;RIF1;NECTIN2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.4213421353060074,0.9278654140926139,0.5608465608465608,0.9584894011365339,1.0,3/10,10.96%,ANK3;KCNAB1;KCNE4
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2539684434227314,0.9275605124643411,0.6214622641509434,0.9585008219152358,1.0,31/172,15.90%,LPIN3;PIK3R1;PLD1;PTEN;PIP4K2A;SACM1L;PIK3R2;MTMR4;CHAT;LIPH;MTMR1;RUFY1;PI4KA;DGKQ;PTPN13;CDIPT;PLEKHA1;INPP5J;CHKA;CPNE7;AGK;PTDSS2;MBOAT7;SELENOI;TAMM41;STARD10;GPAT3;PLA2G12A;LPIN2;ABHD4;CSNK2A2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.29437620659662683,0.9272358323405312,0.57001414427157,0.9585073447207193,1.0,15/53,20.27%,GLMN;DNAAF4;FMR1;PINK1;PRKACA;COMMD1;OPHN1;PSMC5;USP19;ARAF;PSMD14;USP14;DDRGK1;XPO1;PRKCG
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3420084422062941,0.9269786436697448,0.5474339035769828,0.9583794257895917,1.0,2/26,2.01%,ZFYVE28;CBLB
prerank,positive regulation of behavior (GO:0048520),-0.3914953217770957,-0.9268868893718261,0.5393518518518519,0.8012230063680368,1.0,1/10,0.87%,MEF2C
prerank,positive regulation of protein deacetylation (GO:0090312),-0.35464070971589573,-0.9263663302678607,0.5799086757990868,0.8017578797686263,1.0,4/14,22.66%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,spermatid development (GO:0007286),0.32565454301616836,0.926286606745011,0.5569044006069803,0.9594028584327648,1.0,5/32,13.34%,CCDC63;SYCP3;RFX2;DPY19L2;ZMYND15
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.25148385573732507,-0.9259906209407678,0.6233333333333333,0.8019813601974953,1.0,12/52,12.98%,PPP1R13B;ATG13;SREBF2;UBE2D3;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID;VPS11
prerank,linoleic acid metabolic process (GO:0043651),0.36956775275349696,0.9259750453327414,0.5480132450331126,0.9594044714301561,1.0,4/17,21.94%,ELOVL2;ELOVL1;ALOX5;ELOVL5
prerank,regulation of adaptive immune response (GO:0002819),-0.329719442290897,-0.9252670011709027,0.5491803278688525,0.8030026246936613,1.0,10/18,35.60%,IL6ST;IRF1;TRIM27;SIRT1;SKAP1;FCGR2B;IRF7;SAMSN1;FADD;IL4I1
prerank,cilium organization (GO:0044782),0.2497583144347488,0.9250347512020725,0.6245733788395904,0.9610709779073682,1.0,52/209,20.83%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;GBF1;CCDC57;RAB8A;DISC1;IFT81;FAM161A;KIFAP3;SNAP29;CCDC65;AHI1;TCTN2;IFT74;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;IQCB1;SSX2IP;RFX2;IFT88;RAB11FIP3;CEP126;SCLT1;TXNDC15;ACTR2;FAM161B;DYNLL2;CEP250;PTPDC1;IFT43;CLUAP1;BBS1;PCM1;ATP6V0D1;WDR90;MKS1;CEP19;NUDCD3;DZIP1L;UNC119B;KIF3A;TTC39C;BBS4;ABLIM3
prerank,ATP transport (GO:0015867),-0.38289869827617196,-0.9249007107094966,0.5742793791574279,0.8031700346995252,1.0,4/10,25.67%,ABCC6;SLC25A5;SLC17A9;SLC25A4
prerank,regulation of centrosome cycle (GO:0046605),0.35256707703302925,0.9248979729058511,0.532258064516129,0.9606616131851031,1.0,2/21,2.23%,ATF5;NAT10
prerank,negative regulation of response to wounding (GO:1903035),-0.3272955899728713,-0.9248274901319959,0.5497382198952879,0.8026726267115224,1.0,6/19,11.42%,EPHA4;INPP5F;CD109;GIT1;SERPINE1;MDK
prerank,regulation of cell killing (GO:0031341),-0.34771473783402246,-0.9244255655637924,0.6081730769230769,0.8029333873496877,1.0,5/16,10.45%,CD55;TGFB2;RAC1;FZD7;ICAM1
prerank,glycolipid biosynthetic process (GO:0009247),0.31539553083897065,0.9242343980429892,0.5609397944199707,0.9615571625514764,1.0,6/38,13.17%,ST8SIA1;PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,entry into host (GO:0044409),-0.3615131836744777,-0.9240847618911401,0.5615763546798029,0.8030826146176265,1.0,5/13,15.68%,CDH1;CTNND1;PPIA;GRB2;MET
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4154882847148429,0.9239925153496824,0.5464285714285714,0.9613768198226703,1.0,2/10,6.33%,ACADL;ACADS
prerank,cellular response to unfolded protein (GO:0034620),-0.2903753379644623,-0.9234226045344623,0.5710382513661202,0.8039436569169279,1.0,12/26,25.77%,TMBIM6;HSPA8;HSPB8;BAX;PTPN1;OPTN;BAG3;ERN1;ABCB10;HSPD1;HSPA14;HSPA1A
prerank,response to estradiol (GO:0032355),0.3240334920490785,0.9229721993363652,0.54337899543379,0.9631666613501301,1.0,3/31,4.54%,GGT5;GGT7;NCOA3
prerank,heart process (GO:0003015),-0.3567865103872305,-0.9226559444090958,0.5741626794258373,0.8050836473665399,1.0,3/14,12.99%,ACE;GPX1;NOX4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2601796878124629,-0.9226493882076818,0.60062893081761,0.8044225963875561,1.0,11/43,22.02%,IGF1;LBP;SIRPA;CD34;DICER1;CX3CL1;TRIM27;HAVCR2;TNFAIP3;SELENOS;ILRUN
prerank,osteoclast differentiation (GO:0030316),-0.31021397357062286,-0.9225258838382072,0.5685279187817259,0.8040478107136383,1.0,13/22,32.93%,FOXP1;MAPK14;OSTM1;GLO1;EPHA2;CSF1R;TYROBP;SRC;SBNO2;SNX10;CSF1;EFNA2;TREM2
prerank,autophagy of mitochondrion (GO:0000422),-0.2724103580571613,-0.9223893873401697,0.595166163141994,0.803733143000284,1.0,15/38,21.26%,BECN1;SQSTM1;ATG13;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;AMBRA1;MARK2;MAP1LC3B;WDR45
prerank,long-term memory (GO:0007616),-0.3276786212636098,-0.9207481729516379,0.5644329896907216,0.8070019072762745,1.0,4/19,10.54%,RASGRF1;APOE;SHANK1;CPEB3
prerank,negative regulation of transport (GO:0051051),0.29910839285379665,0.9207060437002016,0.5810616929698709,0.9680971647323185,1.0,10/51,16.07%,NRG1;PTEN;ITGAV;NR1H2;PRKD1;EPHA3;NDFIP2;SNX12;PACSIN3;NDFIP1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.26659467400567455,0.9205803640176934,0.6099110546378653,0.9676478782056606,1.0,17/119,8.79%,PIK3R1;PIGV;PTEN;PIP4K2A;PIGQ;SACM1L;PIK3R2;MTMR4;EFR3A;MTMR1;RUFY1;PIGP;PI4KA;PTPN13;CDIPT;PLEKHA1;INPP5J
prerank,glycerolipid catabolic process (GO:0046503),-0.32151997986443404,-0.9205745829885889,0.5666666666666667,0.8067738455884015,1.0,5/19,9.86%,GPCPD1;PLA2G4A;MGLL;GDPD3;ABHD2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.36007786872122055,-0.9205272967835713,0.5615763546798029,0.8061943078858491,1.0,1/13,0.01%,SORBS1
prerank,negative regulation of B cell activation (GO:0050869),-0.30943324854283827,-0.9204925828152778,0.6240963855421687,0.8056126221731807,1.0,10/21,33.49%,RC3H1;SFRP1;ATM;LAPTM5;TNFAIP3;TYROBP;FCGR2B;BANK1;SAMSN1;FOXJ1
prerank,positive regulation of receptor internalization (GO:0002092),-0.30867460671806,-0.920359601253023,0.5631578947368421,0.8052626268441715,1.0,8/22,26.26%,MAGI2;INSR;CD63;EGF;TBC1D5;NTF3;GREM1;ARRB2
prerank,regulation of type I interferon production (GO:0032479),-0.23224749823056912,-0.9201476912534625,0.6425855513307985,0.805105319430482,1.0,28/84,22.94%,NPLOC4;NFKB1;PRKDC;POLR3E;MAVS;TRIM25;CRCP;PCBP2;IRF1;RNF125;GAPDH;POLR2H;POLR3G;CYLD;NLRX1;TRAF3;NLRC5;POLR3D;UBE2L6;TBK1;NFKB2;ISG15;PQBP1;TNFAIP3;POLR1C;ILRUN;POLR3K;IKBKE
prerank,T cell activation (GO:0042110),0.28625483716776995,0.9199574346338818,0.6016371077762619,0.9683905870382604,1.0,9/69,11.91%,CHD7;CD8B;SCRIB;ICOSLG;PTPN22;CD276;RAB29;PPP3CB;LMBR1L
prerank,positive regulation of ERAD pathway (GO:1904294),-0.3537522625350292,-0.9194807314368159,0.5445544554455446,0.8060729452381705,1.0,2/13,3.70%,CAV1;RNF185
prerank,regulation of lipase activity (GO:0060191),-0.35496507476246614,-0.919154936063527,0.5781637717121588,0.8061194435857852,1.0,4/13,15.69%,RHOC;LMF1;FURIN;PCSK5
prerank,protein ubiquitination (GO:0016567),-0.1843362529126496,-0.9187685860675219,0.8333333333333334,0.8063512697334095,1.0,101/471,17.49%,FBXL7;WWP1;RNF152;LMO7;UNKL;GAN;MGRN1;VCPIP1;RNF146;KLHL13;UBE2G1;ASB2;KLHL24;PSMC6;RNF43;PRKDC;RNF185;PELI1;PSMD9;WWP2;ARIH1;OTULIN;CDC23;UBE2D3;PSMF1;HIF3A;PSMB7;TRIM24;HLTF;TRIP12;TRIM25;CUL1;TRIM5;TRIM11;FBXL2;UBB;VPS18;TRIM14;TNKS2;SH3RF2;HERC6;RNF8;VCP;MSL2;UBE2H;MIB1;SMURF2;UBR1;TRIM36;UBA6;FBXO25;TSPAN17;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;ASB5;KLHL20;RNF11;RNF144B;VHL;CUL9;RNF41;RNF114;SPSB4;UBR2;RCHY1;PCNA;HERC2;PSMA3;VPS11;PSMA6;TRIM63;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;UBE2N;CAND2;PSMB6;TRIM35;ELOC;PSMC1;FBXO32;TRIM27;UBE2L6;SIRT1;PSMB10;FBXL14;NEDD8;SIAH2;CUL3;ANAPC16;ISG15;ANAPC11;UBC;USP9X
prerank,negative regulation of complement activation (GO:0045916),0.42062172304608436,0.9186743258704851,0.5600706713780919,0.9708478829268161,1.0,3/10,17.51%,SUSD4;CR2;A2M
prerank,regulation of cellular component movement (GO:0051270),0.30114813688191205,0.9186091359859698,0.5811373092926491,0.9702305268623704,1.0,11/49,14.06%,NRG1;MYCBP2;ERBB4;NRG2;ZSWIM8;ACTN1;NRG4;SP100;TGFBR1;MEMO1;LYN
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3786695488226161,-0.9185608704410456,0.5617433414043583,0.8061677058293794,1.0,2/11,3.97%,GSN;FAS
prerank,cardiac muscle cell action potential (GO:0086001),0.3270311041868072,0.9184898763455738,0.5619967793880838,0.9697306508400199,1.0,8/30,15.77%,ATP1A2;SCN2B;KCNIP2;CACNA1G;HCN2;FGF12;SCN1A;CACNA2D1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.37382034787673135,-0.9184095078413602,0.5547445255474452,0.8058252033237602,1.0,2/12,1.54%,FOXP1;FNIP1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3561846400557653,0.9182483270811499,0.5681444991789819,0.9680253266479666,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3561846400557653,0.9182483270811499,0.5681444991789819,0.9680253266479666,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3561846400557653,0.9182483270811499,0.5681444991789819,0.9680253266479666,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,negative regulation of cell activation (GO:0050866),0.3894913512255205,0.9182053390027898,0.5536332179930796,0.9673672884725341,1.0,1/14,0.14%,PDGFRA
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.36770562615588576,0.9180386067020325,0.5625,0.9670158410045777,1.0,2/18,2.66%,DLC1;ITGA3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3146218964924994,0.9179569345715037,0.5865102639296188,0.9664522604483907,1.0,10/38,16.74%,MICALL2;LRRK2;PINK1;SAE1;HTRA2;GSK3A;RNF31;SREBF1;CSNK2A2;HAX1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4230134769755324,0.9175305150792529,0.5721925133689839,0.9667369071229259,1.0,1/10,1.47%,ATP1A2
prerank,C-terminal protein amino acid modification (GO:0018410),0.40676318257499827,0.9169639938432376,0.5563380281690141,0.9673485392737923,1.0,3/11,15.83%,GPLD1;AGBL4;FOLH1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3675781459198452,0.9169316631206847,0.5707070707070707,0.9666703527510276,1.0,8/18,23.86%,CRTC2;ADCY8;PRKD1;RELN;EPHA5;CRTC3;CAMK1D;ADCY1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.22583779316665603,-0.9164591174704615,0.7172131147540983,0.8097049080864341,1.0,46/91,33.11%,ABCG2;APP;HMOX2;CUL1;TFRC;SLC39A8;SLC31A2;SCARA5;SLC39A10;MT2A;ACO1;CYB561A3;SLC30A9;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;MT3;TMEM199;SMAD4;ARF1;ATOX1;SLC11A1;ALAS2;LCN2;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;IREB2;HMOX1;BMP6;SLC30A1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3382315477428152,0.9160823655201562,0.5784313725490197,0.9680580200483541,1.0,5/25,8.36%,ITGAD;ITGAV;JUP;JAM3;CD200R1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2543083060859613,0.9159669665236363,0.6236559139784946,0.9675757924794167,1.0,33/145,18.81%,DYNLL1;PSMD1;DCTN3;HAUS3;HAUS1;FBXO5;CDC7;HMMR;DCTN2;PSMD10;PSMA5;PSMB5;HAUS8;PRKACA;CEP192;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;PSMB9;CEP250;CEP152;CSNK1E;CENPF;CLASP1;PSMA7;PSMD14;VPS4B;ALMS1;PCM1;PSMA2;PSMD11
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3359205926630772,-0.9157018909176029,0.5725,0.8107887825448433,1.0,8/15,22.66%,IGF1;BCL2L1;GPX1;PRELID1;GHITM;AKT1;HGF;PPIF
prerank,response to prostaglandin E (GO:0034695),-0.3798169610949836,-0.9156341875261819,0.5632183908045977,0.8102772227000176,1.0,4/10,23.89%,SFRP1;ADCY6;TGFBR3;CCL19
prerank,regulation of cell cycle phase transition (GO:1901987),0.273100179168646,0.9155521774650797,0.606020942408377,0.9678591214088298,1.0,24/91,18.81%,BUB1B;PSMD1;FBXO5;CDC16;PSMD10;PSMA5;PSMB5;XPC;PSMC4;TP53;PSMA4;PSMC5;ANAPC5;PSMB9;UBE2D1;DBF4;ERCC2;TFAP4;MN1;PSMA7;PSMD14;CDC26;PSMA2;PSMD11
prerank,neuron projection organization (GO:0106027),0.3816057260741513,0.9154809647219505,0.6013864818024264,0.9672700004076509,1.0,3/15,9.06%,ABCD2;ATP1A3;LGMN
prerank,histone H4-K8 acetylation (GO:0043982),0.3867148805950431,0.9152107306399447,0.575809199318569,0.9664515039213961,1.0,4/15,11.31%,OGT;WDR5;KANSL1;JADE1
prerank,histone H4-K5 acetylation (GO:0043981),0.3867148805950431,0.9152107306399447,0.575809199318569,0.9664515039213961,1.0,4/15,11.31%,OGT;WDR5;KANSL1;JADE1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3217580480610087,0.9151805188094407,0.5628930817610063,0.9657743338134265,1.0,5/32,8.62%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1
prerank,cellular amide metabolic process (GO:0043603),-0.22193029485416402,-0.9145670621333029,0.6682027649769585,0.8120081093477463,1.0,12/102,6.66%,AEBP1;ST6GAL1;PLPP3;CPE;CPD;SLC25A32;PCCA;SMPD3;ACOT8;ST3GAL1;PPP2R1A;AASDHPPT
prerank,histone modification (GO:0016570),-0.22121578661417146,-0.9144115949413877,0.6666666666666666,0.8116920414842819,1.0,24/109,16.63%,EYA2;EYA1;HDAC4;EYA4;KDM4A;KAT6B;SIN3B;ATXN7;TBL1X;NTMT1;PRMT7;MIER1;PHF20;RPS6KA5;UBE2A;PRMT8;MIER3;MSL3;UBE2N;KAT5;EZH2;PRKCD;SIRT1;TRRAP
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3680108439248514,-0.9143308357524111,0.5333333333333333,0.8112077572554531,1.0,5/11,26.10%,MAVS;TICAM1;TYROBP;ITGB2;SPI1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.314640360171941,-0.9141370199436654,0.5772946859903382,0.8109956827059142,1.0,4/20,6.80%,IL18;IL1R1;CD55;B2M
prerank,GPI anchor biosynthetic process (GO:0006506),0.32774880443803683,0.9139679735256782,0.5939849624060151,0.9679590796856075,1.0,5/30,13.17%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3208246176390145,-0.9139333101650318,0.5816831683168316,0.8108188844792272,1.0,3/17,7.54%,MAGI2;CALM1;ITGA1
prerank,regulation of cholesterol efflux (GO:0010874),-0.2815240210207414,-0.9137849679181117,0.5705882352941176,0.8105099794210286,1.0,7/30,9.84%,CAV1;SREBF2;PLTP;RXRA;APOE;ABCA3;NFKBIA
prerank,positive regulation of insulin secretion (GO:0032024),0.31575537949627214,0.9136669640950307,0.5984615384615385,0.9679043516851705,1.0,8/36,10.49%,TCF7L2;GPLD1;TM7SF3;IRS2;ADCY8;TRH;GCK;PPP3CB
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.41015300023955203,0.9136147452283734,0.5740740740740741,0.9672697392069706,1.0,4/11,19.24%,FMR1;DHX9;WTIP;FXR1
prerank,regulation of peptidase activity (GO:0052547),-0.31596636644221326,-0.9136070218333525,0.622107969151671,0.8102631156195556,1.0,6/19,14.02%,CAV1;CST3;ECM1;CTSH;PSMA3;FURIN
prerank,gonad development (GO:0008406),0.30597343214241857,0.9134466263242288,0.5802098950524738,0.9669218046081958,1.0,4/41,2.53%,WNT5A;NR2F2;BASP1;SALL1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3056964000899566,-0.9129730300734391,0.5858310626702997,0.811041316458869,1.0,4/25,5.15%,PICALM;APP;RIN3;RAC1
prerank,receptor-mediated endocytosis (GO:0006898),0.26169116221636646,0.9127940080538443,0.6115802171290712,0.9677949249421248,1.0,12/132,6.29%,COLEC12;LRP1;LRP1B;HSPG2;CALCRL;MASP1;LRP3;SORL1;NEDD4;FCHSD2;EPS15;TMEM108
prerank,negative regulation of translation (GO:0017148),0.27331670125715885,0.9126094626382913,0.600263852242744,0.9674986159467,1.0,23/87,19.24%,CPEB1;EIF4A3;NANOS3;EPRS1;RBM24;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;CNOT1;FTO;MALSU1;EIF4ENIF1;PUS7;CNOT7;TSC1;IGF2BP3;CALR;ILF3;YTHDF1;EIF2AK3;FXR1
prerank,regulation of fibroblast proliferation (GO:0048145),0.30364736871489845,0.9120800038861491,0.5894134477825465,0.9680117908103291,1.0,10/45,16.18%,PDGFRA;WNT5A;PEX2;NF1;TP53;B4GALT7;MED25;DHX9;MYC;NDUFS4
prerank,regulation of cell cycle (GO:0051726),-0.19576739228945528,-0.9116536747345158,0.8,0.8134204954746052,1.0,76/271,22.17%,MECOM;APBB2;AFAP1L2;PTPRK;PPP1R13B;XIAP;THBS1;CDC14A;NOTCH2;MAGI2;IQGAP1;NEK6;NOTCH1;TGFB2;APC;CDK6;ADAM10;JMY;PRCC;PRDM11;SIK1;LRP6;TBRG1;PLAGL1;SMAD3;RPS15A;NEK7;MADD;CITED2;IRF1;SFRP1;NR4A1;PHACTR4;TARDBP;LIN52;MYBBP1A;GADD45B;HIPK2;ZBTB49;ATM;CYLD;GATA6;NBN;ING4;CCND1;CDKN1A;ERN1;ANKRD17;TRNP1;SIRT1;GPER1;DCUN1D3;CDK9;SETMAR;SDCBP;JUNB;WDR12;APBB1;PES1;RGCC;TXLNG;GADD45GIP1;CHMP1A;HBP1;GADD45G;SON;PIM2;RPL23;MIF;MAEA;RPRD1B;ZBTB17;BIRC3;FBXL8;NUPR1;CAMK2N1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.26146459391191956,0.9116432827177605,0.6276729559748427,0.9683178407804691,1.0,33/122,19.24%,IL33;SLC25A37;PRR16;PLD1;NAT10;EIF4A3;FMR1;MTPN;LARP6;IRS1;IRS2;RPS6KB1;NMD3;GLI1;MTOR;TLR4;GCK;PLXNB2;CDT1;IGF2;HNRNPD;DHX9;AR;MYC;NOX1;PPP1R3E;LDB1;EIF3C;KAT7;YTHDF1;ATAD5;PDGFRB;FXR1
prerank,negative regulation of angiogenesis (GO:0016525),0.27633633849314926,0.9115536193084957,0.6213720316622692,0.967807539220797,1.0,8/84,5.46%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;ADGRB1;SERPINF1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.239519912314066,-0.9108600789013879,0.6792452830188679,0.8145354546496337,1.0,8/63,6.18%,MEF2C;IL18;ANXA1;IL6ST;SLC7A1;TFRC;CD38;NCK1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2603258305720379,-0.9108398714733859,0.6024464831804281,0.8139109673716343,1.0,13/41,21.65%,RNF152;UBE2G1;PELI1;WWP2;TRIM5;RNF8;ZFP91;UBE2N;TRAF3;TRIM27;PRPF19;RNF5;TRAF1
prerank,myeloid cell differentiation (GO:0030099),-0.25841284577868795,-0.9105672214420814,0.6274509803921569,0.8138441067578681,1.0,24/47,32.47%,RPS14;RUNX1;SNRK;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;PRDX3;MFHAS1;KAT8;NCOA6;SPI1;JAK3;RASGRP4;KAT6A;ALAS2;CEBPA;HCLS1;EPO;ATP5IF1;CDKN2B
prerank,phospholipid catabolic process (GO:0009395),-0.3019089464175933,-0.910368306645092,0.589873417721519,0.8136273515363064,1.0,8/24,20.77%,GPCPD1;PLA2G4A;GDPD3;ENPP2;SMPD1;SMPDL3A;PLA2G4E;PLA2G4C
prerank,response to steroid hormone (GO:0048545),-0.27733182574776705,-0.9103544009634604,0.6174142480211082,0.8129908773192601,1.0,7/31,12.91%,CAV1;THBS1;TGFB2;WBP2;PAQR7;ABHD2;NR3C1
prerank,positive regulation of vacuole organization (GO:0044090),0.4135097214999882,0.9103492962548096,0.5708955223880597,0.9699727256355485,1.0,1/10,2.30%,PIP4K2A
prerank,positive regulation of cell killing (GO:0031343),0.3912190076236572,0.9098360520454382,0.5637707948243993,0.9704668631125264,1.0,4/13,20.74%,WNT5A;CYBA;NOX1;DVL2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.34711427130997335,0.9097510543764589,0.5874587458745875,0.969930455578866,1.0,6/22,16.72%,NUBP2;FXN;CIAO1;ABCB7;MMS19;ISCA1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2676411768969331,0.9096353902120161,0.6517285531370038,0.9694811334138969,1.0,14/101,12.41%,CXCL10;WNT5A;CXCL1;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,cation transmembrane transport (GO:0098655),-0.2613442029565512,-0.9093760951227278,0.6257861635220126,0.814587558657753,1.0,7/44,11.97%,TRPM3;TRPM6;SLC7A1;SLC3A2;SLC38A5;SLC7A5;SFXN1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.30648049036122116,-0.909192508529482,0.5743073047858942,0.8143666552225738,1.0,9/22,29.86%,MINK1;XDH;GADD45B;MAP3K4;MFHAS1;GADD45G;SPI1;GADD45A;AGER
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38642760245488506,0.9088428932671018,0.5539823008849557,0.9706370653367306,1.0,4/13,9.06%,AKAP5;ADCY8;RELN;LGMN
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.27150781284102066,-0.9087657707047088,0.5961538461538461,0.8147217879866858,1.0,6/33,12.53%,PTPRJ;EZR;RC3H1;PTPN2;CEACAM1;DGKZ
prerank,regulation of cell adhesion (GO:0030155),0.2600679713496239,0.9087542609679158,0.636038186157518,0.9701004259676598,1.0,15/129,8.66%,EPHA7;PLXNC1;ZFHX3;HRG;TMEM102;TGFBI;SEMA5A;ITGAV;SIPA1;DUSP1;PRKX;DSCAM;PTK2;PLAU;PRKCA
prerank,telomere maintenance (GO:0000723),-0.25065951625650346,-0.9084874352212571,0.6032786885245902,0.814723697117374,1.0,24/50,30.56%,PTGES3;PRKDC;ATR;RTEL1;TERT;PCNA;STN1;ATM;TEN1;NBN;RAD51D;DCLRE1B;HUS1;POLD2;PARP1;RPA2;ACD;RAD51;LTO1;POLD4;POLD1;CTC1;RAD50;XRCC3
prerank,nuclear membrane disassembly (GO:0051081),0.3861682147452974,0.90830427143675,0.5854483925549916,0.9704338925308456,1.0,5/14,17.70%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,positive regulation of dendritic spine development (GO:0060999),0.35181341196506266,0.9081034139221786,0.5652892561983471,0.9701521702622347,1.0,6/20,13.86%,FOXO6;FMR1;CAPRIN1;RELN;DHX36;CUX2
prerank,regulation of mast cell activation (GO:0033003),0.42141247747090155,0.9080090002643256,0.5735849056603773,0.9696379574298079,1.0,5/10,28.65%,TSLP;LYN;NECTIN2;MILR1;PLSCR1
prerank,positive regulation of gene expression (GO:0010628),0.23420201550182568,0.9078575677930968,0.7216931216931217,0.9692425879443434,1.0,96/442,19.53%,IL33;SEC16B;NTRK3;PIK3R1;PRR16;WNT5A;NTRK2;PLD1;TXK;PLA2R1;NAT10;LRP3;EIF4A3;AGO4;GLMN;LURAP1;GJA1;POU3F3;RBM24;ANK3;HTR2B;RBMS3;PTPN22;FMR1;TLR6;LARP6;MYCN;CDH3;ADAM19;RIMS2;ELAVL4;PDCL3;C1QTNF1;POLR1A;DGKQ;RPS6KB1;TWIST1;TENT4B;MTOR;TLE1;TLR4;BMP7;KAT2A;WNT3;MAP2K1;FGR;TAF1D;EIF2AK2;TP53;TAF1B;DHX36;RIMS1;AGO3;PLXNB2;TGFBR1;SOX9;HGS;RBM20;GSK3A;FAM98B;OLFM1;TESC;MED1;CUX2;ACTG2;SNF8;RIPK1;FGF5;HNRNPD;CLU;AR;ATF2;MYC;TNRC6B;HNRNPLL;MAPK11;PIK3CG;MAZ;PTGER4;LGALS9;ADRA2A;AGO1;EIF3C;MYD88;HABP4;BMP2;HEY1;YTHDF1;HIF1A;SPRY2;MBIP;EIF2AK3;FXR1;PIK3R3;SP1;DDRGK1
prerank,positive regulation of proteolysis (GO:0045862),0.29109801018807585,0.9078475020326954,0.6138613861386139,0.9685174094675162,1.0,15/55,19.56%,OGT;GPLD1;CAPN3;PINK1;NKD2;NRDC;RCN3;ASPH;SH3D19;BAK1;PACSIN3;ADAM8;ADRA2A;MAPK12;RHBDD1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3071009346652622,0.9074560025308301,0.6062874251497006,0.9687590616165015,1.0,11/41,18.74%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34913989310522975,0.9070555420478934,0.5680672268907563,0.9689541677001375,1.0,2/20,2.78%,RUNX2;SMAD5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3268845019281362,-0.9069570715224332,0.5980392156862745,0.8176886146157847,1.0,4/17,5.90%,BAIAP2L1;TEK;NRP1;CDC42
prerank,regulation of neuron migration (GO:2001222),0.33106569564609684,0.9067500239956009,0.5741626794258373,0.9689102570949413,1.0,9/26,18.79%,IGSF10;CTNNA2;PLAA;PLXNB2;NTNG2;NTNG1;COL3A1;CAMK2A;ULK4
prerank,neuron maturation (GO:0042551),-0.32771408432822724,-0.9062530798679851,0.5945273631840796,0.818581950537648,1.0,7/18,15.96%,ANKS1A;APP;B4GALT5;SCARF1;CLN5;CX3CL1;SRRM4
prerank,regulation of cilium assembly (GO:1902017),-0.23719876809738732,-0.9058206170762504,0.6394557823129252,0.8188939520369146,1.0,14/62,15.41%,TBC1D19;RABEP2;MARK4;TBC1D8;TBC1D22B;IFT140;CCDC88A;TBC1D7;EVI5L;TBC1D22A;CYLD;TBC1D10B;CROCC;TBC1D13
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2854167155376709,-0.9057784614714899,0.6097560975609756,0.8183170982675915,1.0,14/33,22.33%,FHL1;KANK2;KLF4;APC;CDK6;WEE1;FAM107A;PLK5;CDKN1A;DCUN1D3;DLG1;RBL1;RBL2;CDK2AP2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3754165417137916,-0.9057422304922925,0.558891454965358,0.8177442226296981,1.0,2/10,5.90%,EZR;CDC42
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2466341265246137,0.9056123919603511,0.6862068965517242,0.9708996241793898,1.0,46/186,18.97%,LRP1;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CTNNBIP1;CHD8;AMER2;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LZTS2;PSMA2;PSMD11;APCDD1
prerank,aggrephagy (GO:0035973),-0.290388014337159,-0.9055622202271054,0.5904255319148937,0.817484768368632,1.0,13/27,22.29%,VIM;SQSTM1;WDFY3;UBB;DYNC1H1;UBE2N;DYNC1I1;UBC;ARL13B;DYNC1LI1;HDAC6;CFTR;UBA52
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.33532041076394087,0.9055358776298288,0.5705024311183144,0.9703281813039883,1.0,5/23,18.72%,CECR2;KPNA1;FBH1;REXO4;KPNB1
prerank,negative regulation of neuron death (GO:1901215),-0.22212313623881252,-0.9054390165824804,0.6935483870967742,0.8170903353684981,1.0,35/93,28.08%,CD200;MEF2C;RETREG1;VPS35;SOD2;CD34;SIX1;NGF;NRBP2;APOE;GSK3B;SNX6;MDK;FOXQ1;NENF;PTK2B;CHMP4B;CHMP4A;RASA1;AKT1;ERBB3;CHGA;SIX4;KDM2B;CLCF1;MT3;IKBKG;NTF3;CRLF1;LIG4;PARK7;VSTM2L;BDNF;NDNF;MSH2
prerank,gas transport (GO:0015669),0.4127278088956463,0.9054032462722287,0.574430823117338,0.9699277347685529,1.0,2/10,15.40%,MB;MYC
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3582536965039488,-0.905401335532667,0.5823665893271461,0.816511781158871,1.0,3/13,13.13%,RNF152;SESN1;ATM
prerank,regulation of mRNA metabolic process (GO:1903311),0.3950367190306925,0.9053234489505197,0.5512104283054003,0.9693859118022267,1.0,4/11,17.80%,DHX9;SAFB2;IWS1;SAFB
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3181449941353223,0.9051800708988182,0.5808383233532934,0.9689774754587315,1.0,2/35,0.27%,PDGFRA;NTRK3
prerank,mononuclear cell differentiation (GO:1903131),-0.29964787082611444,-0.90502466516742,0.5944444444444444,0.8166756479882304,1.0,2/24,0.90%,PIR;IL31RA
prerank,endosome organization (GO:0007032),-0.25994842301266324,-0.9049830966849385,0.6227544910179641,0.8161094596120706,1.0,15/41,26.07%,EEA1;LAPTM4B;SQSTM1;CHMP2B;VPS18;HOOK1;ALS2;VPS11;TMEM9;SNX3;PLEKHJ1;EXOC8;DNAJC13;WASHC4;ALS2CL
prerank,carbohydrate homeostasis (GO:0033500),-0.24236809073414542,-0.9047472792278225,0.675,0.8160054780370004,1.0,11/67,10.31%,LEPR;IGF1R;ADIPOR2;KLF7;INSR;RBP4;PRKAA2;SOX4;KCNB1;BAD;PTPN2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3584476662841114,0.9046814612392031,0.6116666666666667,0.9694409372608523,1.0,4/19,10.49%,EDN3;NFATC3;ADGRB2;PPP3CB
prerank,regulation of axon guidance (GO:1902667),0.4092932414313685,0.9046341333730598,0.5974955277280859,0.9688029618189742,1.0,2/10,5.13%,MYCBP2;ZSWIM8
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.37239299630187356,-0.9044687483311661,0.6042105263157894,0.8159791549186726,1.0,8/11,34.43%,ITM2A;SOAT1;AGO2;ITM2B;BACE2;NECAB3;ITM2C;ABCA7
prerank,negative regulation of platelet activation (GO:0010544),0.37905239474916724,0.9043676827477266,0.6044905008635578,0.9686976290695923,1.0,1/16,0.14%,PDGFRA
prerank,regulation of spindle assembly (GO:0090169),-0.2893716893533145,-0.9042992308027941,0.6216931216931217,0.8157105386411307,1.0,16/25,38.38%,DRG1;CHMP2B;DYNC1H1;CHMP4B;NUMA1;PDCD6IP;CHMP1A;CHMP4C;HSPA1A;CHMP2A;SPAG5;HSPA1B;TPR;PLK1;HNRNPU;CHMP3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2666581633940856,0.9041392373491733,0.6347150259067358,0.9684988224995287,1.0,13/95,12.41%,CXCL10;WNT5A;CXCL1;PDE4B;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,erythrocyte differentiation (GO:0030218),-0.25588246002703524,-0.9040744058816743,0.6600660066006601,0.8155277596115742,1.0,13/44,21.82%,RPS14;ALAS1;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;ABCB10;TGFBR3;MFHAS1;DMTN
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.27572216116437587,-0.9037450219590385,0.6151603498542274,0.8156113139401653,1.0,11/31,29.48%,NFS1;GCH1;MOCS1;FDXR;CYP51A1;NOXRED1;PYCR2;STAR;MOCS3;PYCR3;FDFT1
prerank,ncRNA metabolic process (GO:0034660),-0.26922012528786987,-0.903709730884508,0.6283185840707964,0.8150477320606214,1.0,10/37,19.81%,DGCR8;TUT7;PARN;DICER1;DROSHA;MAPT;RAN;NIFK;AGO2;MEPCE
prerank,cellular response to interleukin-6 (GO:0071354),-0.2946063693055936,-0.9035501209501029,0.6301369863013698,0.8147586869465702,1.0,4/26,5.51%,ST3GAL6;FER;NFKB1;IL6ST
prerank,regulation of epithelial cell proliferation (GO:0050678),0.27103441004336576,0.9034496482068761,0.636604774535809,0.969366011845591,1.0,6/85,3.69%,LAMC1;LAMB1;TCF7L2;C5AR1;PEX2;MCC
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.24131243767126856,0.9033271744754277,0.6901565995525727,0.9689156977835744,1.0,45/234,17.81%,ROR1;EDA2R;EDA;WNT5A;PTEN;CD40;MBTPS2;IL18RAP;TAF12;JUP;TLR6;MTPN;PRKCI;CRTC2;ADCY8;CAPN3;SRF;FLOT2;TRIM37;PRKD1;RELN;TRIM8;PRKCB;TLR4;IL1RAP;IRAK1;EIF2AK2;PYCARD;RTKN2;ESR2;RNF31;UBE2V1;EPHA5;RIPK1;DHX9;CLU;AR;ATF2;TIRAP;ZBTB7A;TRIM26;LGALS9;ADAM8;MYD88;CAMK2A
prerank,positive regulation of catabolic process (GO:0009896),-0.23856421563231986,-0.9033120625936063,0.6823529411764706,0.814640360696126,1.0,11/65,11.30%,FOXO1;WWP1;WWP2;GPC3;APC;GSK3B;VCP;SMURF2;ASB5;RNF41;APC2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3312486705536501,0.9032583226350241,0.5779967159277504,0.9683607234820812,1.0,7/27,12.81%,PLA2R1;SPRED1;PSMD10;SPRED2;TWIST1;MSX1;PTTG1IP
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2829844880876848,0.9030010237637796,0.6068965517241379,0.9682581148223224,1.0,14/71,14.06%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,nuclear export (GO:0051168),0.27290166275706507,0.9029422072829804,0.6174142480211082,0.9676641311630537,1.0,22/80,20.64%,CSE1L;EIF4A3;ANKLE1;NUP214;NUTF2;POM121;THOC7;SRSF11;SLU7;NUP42;RANBP3;CASC3;STRADB;SRSF9;THOC5;CALR;XPO6;SRSF6;NUP155;CHTOP;XPO1;DDX39B
prerank,DNA metabolic process (GO:0006259),0.2378530444122909,0.9027050558353044,0.6968026460859978,0.9675390716701477,1.0,72/270,22.46%,TCF7L2;POLG;ERCC1;LIG3;MCM7;FAN1;FEN1;POLK;POLQ;TOP2B;ERCC5;FANCA;CDC7;MSH3;ASF1A;NEIL3;POLA1;GMNN;RPA1;ERCC4;TERF1;POLL;XPC;SP100;POLE4;RFC3;UBE2V2;NOC3L;MCM4;POLH;RECQL;TOP3A;GTF2H3;MUTYH;CDT1;XRCC1;POLB;POLE3;RAD52;ALKBH3;MBD4;LONP1;POLI;MCM10;DBF4;DOT1L;RNASEH1;GTF2H1;CSNK1E;ORC2;MMS19;SMARCAL1;TOP2A;SMC1A;MSH6;WRN;REXO4;RIF1;TERF2IP;CNBP;POLE;USP45;MEN1;DDB1;ORC5;RFC4;TOPBP1;RAD54L;PWWP3A;HMGB1;KPNA2;FANCC
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28657737795894683,0.9025268868962948,0.6075949367088608,0.9672563322285932,1.0,17/58,18.77%,ERCC1;LIG3;POLQ;POLA1;ERCC4;POLL;RNF168;UBE2V2;POLB;CYREN;PAXIP1;KDM2A;ZBTB7A;NHEJ1;PSMD14;SMARCAL1;RIF1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.34415327120380645,0.9020646445014083,0.5673076923076923,0.9676479254640674,1.0,1/21,0.11%,ENPP1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2838219123854766,0.9018533175488574,0.6094839609483961,0.9673839996410798,1.0,14/70,14.06%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3320830782041983,0.9018187776116496,0.604133545310016,0.9667158224696302,1.0,4/24,7.73%,ERCC1;KMT2A;MSH3;ERCC4
prerank,regulation of mitochondrion organization (GO:0010821),0.2919555600646363,0.901794643197959,0.6,0.9660394380953413,1.0,10/47,16.74%,TMEM102;LRRK2;OMA1;PINK1;IAPP;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.2913393924836156,-0.9016532481473154,0.6129032258064516,0.8177764157262783,1.0,4/24,6.17%,RBPJ;NOTCH1;ATF6;KLF2
prerank,response to interleukin-6 (GO:0070741),-0.39081107589939656,-0.9015286687925542,0.6173708920187794,0.8173828831117742,1.0,2/10,2.62%,ST3GAL6;NFKB1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3519421610999608,0.9015158456468484,0.5882352941176471,0.9659839550323963,1.0,3/20,5.53%,PLA2R1;CD40;PRKCI
prerank,response to muramyl dipeptide (GO:0032495),-0.3607658108574925,-0.9014928107141518,0.5775280898876405,0.8168141500100704,1.0,1/12,1.09%,VIM
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.302385594881976,-0.9014079743582911,0.6136363636363636,0.8163231984878836,1.0,13/24,32.92%,PPHLN1;PPM1D;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;PHF1;MTF2;SPI1;BMI1;H3-3A;PHF19
prerank,negative regulation of RNA splicing (GO:0033119),-0.3148895462194862,-0.9011996301005891,0.5775,0.8161452398037577,1.0,5/19,16.15%,TMBIM6;PTBP3;RBMX;SRSF4;SRSF7
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3841463672788699,0.9010064657162048,0.5938566552901023,0.9664079069699888,1.0,4/14,14.26%,ANK3;SLC9A1;TESC;WNK2
prerank,RNA processing (GO:0006396),0.2483893393932972,0.9008285355395416,0.6510538641686182,0.9660782398270126,1.0,49/176,22.68%,RBMS1;GEMIN2;NOVA1;ADARB2;SNRNP35;ZRSR2;NOL3;LIN28B;LSM4;ELAVL4;BCAS2;HNRNPA2B1;MRPL44;SRSF11;MPHOSPH10;TENT4B;PRKACA;SMU1;DDX17;RP9;SLU7;NUDT21;NOL9;SNRNP48;TENT2;PRPF18;HNRNPUL1;HNRNPD;SNRPF;ADAR;SRSF9;RBM5;NONO;HNRNPL;SF3A3;PPIG;DEDD2;ZCRB1;RBM6;LUC7L3;PRPF8;TFIP11;DDX39B;RBPMS;DHX15;RNGTT;WBP4;HNRNPH3;LSM3
prerank,intestinal absorption (GO:0050892),0.3793727893137809,0.9003203088557531,0.5746140651801029,0.966563852654616,1.0,1/13,0.61%,NPC1L1
prerank,protein mannosylation (GO:0035268),-0.3029345254852136,-0.9002413663123751,0.5737265415549598,0.8175711795184708,1.0,6/22,14.78%,TMTC2;TMTC1;TMTC4;LARGE1;FKRP;DPY19L4
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3753997521259809,-0.9002369429883113,0.5767543859649122,0.8169184792441194,1.0,3/10,12.13%,CCT3;CCT4;CCT7
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3035766550978837,0.8997286394130849,0.6002949852507374,0.967258014746251,1.0,11/42,14.01%,POLK;POLA1;CDKN2D;RPA1;RFC3;POLH;FAAP20;POLN;SPRTN;REV1;POLI
prerank,negative regulation of neuron projection development (GO:0010977),-0.2435797278588624,-0.8996030560061125,0.6415094339622641,0.8177663696387776,1.0,11/56,13.30%,EPHA4;DPYSL3;EFNB2;RUFY3;KANK1;PRAG1;APOE;NGEF;ADCY6;GAK;TRPV4
prerank,rRNA modification (GO:0000154),0.3443895042868256,0.8993584524941113,0.6038961038961039,0.9674345465929981,1.0,10/21,30.64%,NAT10;DIMT1;NSUN3;MTERF4;METTL5;ZCCHC4;NOP10;DKC1;NSUN4;FTSJ3
prerank,glycoprotein metabolic process (GO:0009100),-0.24767747163977905,-0.899346687597539,0.6632302405498282,0.8176544394825304,1.0,17/53,20.55%,FUT8;ST8SIA4;ST3GAL4;B4GALT5;OGA;ST6GALNAC3;LARGE1;MANBA;NGLY1;MGAT4B;ST8SIA2;ST3GAL2;GCNT1;MAN2A1;STT3B;GAL3ST2;MAN1A2
prerank,protein kinase B signaling (GO:0043491),-0.29497463335720475,-0.8993085923301559,0.5916230366492147,0.8170926526254517,1.0,2/23,3.58%,IGF1;KDR
prerank,pharyngeal system development (GO:0060037),-0.33578185255057097,-0.8991850899481164,0.5815085158150851,0.8167173930885677,1.0,3/15,7.13%,BMPR2;TGFB2;TBX1
prerank,B cell homeostasis (GO:0001782),0.40874514017568975,0.8991304678391532,0.5676625659050967,0.9672642811559828,1.0,1/10,0.78%,DOCK10
prerank,transcription by RNA polymerase I (GO:0006360),-0.27320897615880424,-0.8989163501705227,0.6392961876832844,0.8166779852124298,1.0,11/34,21.86%,CAVIN1;GTF2H5;TCOF1;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,histone H4 acetylation (GO:0043967),0.29707947606279456,0.8987377065433895,0.6176890156918687,0.9674778532091483,1.0,12/47,15.32%,OGT;MORF4L1;KMT2A;BRD8;WDR5;MSL1;BRCA2;KANSL1;JADE1;EPC1;DMAP1;ATF2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.34075136923830807,0.8981058349722459,0.6066115702479339,0.9682843568380878,1.0,4/21,8.73%,SULF1;HS6ST3;HS6ST2;EXTL3
prerank,sodium ion import across plasma membrane (GO:0098719),0.35948040508051937,0.8978916078099215,0.5692041522491349,0.9681014182767544,1.0,3/17,9.46%,SLC9A9;SLC9A1;HCN2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2794772932233321,0.8971691621987733,0.6191780821917808,0.9690237995038362,1.0,14/73,14.06%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,response to metal ion (GO:0010038),0.28037007553811344,0.8969873373396013,0.6283783783783784,0.9687263738241263,1.0,9/67,9.59%,PAM;LOXL2;SLC30A5;NEDD4;KCNMA1;CAPN3;FXN;TRPC3;SLC30A3
prerank,negative regulation of cell development (GO:0010721),-0.2915374379661566,-0.8969353583413323,0.6072423398328691,0.8204552691253189,1.0,4/25,7.28%,IGF1;NOTCH1;B2M;GSK3B
prerank,positive regulation of cellular catabolic process (GO:0031331),0.25404072184607923,0.8968242482833994,0.6600985221674877,0.9683987447578966,1.0,22/132,13.02%,DCN;ZBTB20;PPARA;GPLD1;ABCD2;PFKFB1;TPCN1;NPRL2;ENTPD5;ZSWIM8;IRS1;LRRK2;LIN28B;IRS2;TWIST1;PRKD1;TRIM8;NRDC;TFEB;GSK3A;PTTG1IP;CNOT1
prerank,DNA conformation change (GO:0071103),0.35855311561083925,0.8967296337244443,0.593698175787728,0.9678995762839718,1.0,6/17,22.80%,NAA10;TOP2B;TOP3A;TOP2A;HMGB1;ABL1
prerank,membrane protein proteolysis (GO:0033619),-0.26252435263010493,-0.8966828277241112,0.5935672514619883,0.8203327257429575,1.0,9/37,13.03%,NFKB1;ERAP1;ADAM10;RBMX;CTSH;DAG1;RET;APH1A;APH1B
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.35210053461292634,0.8966803883411056,0.5987361769352291,0.9672891590373159,1.0,6/21,16.20%,RAB34;GLI1;GAS8;TXNDC15;EVC;PDCL
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2361571287730571,-0.8966677427552188,0.6934865900383141,0.8197136525712224,1.0,22/62,27.47%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;GTF2F2;CTDP1;ELOF1;TCEA1;POLR2I;POLR2K
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.38456163974689567,0.8964668956104789,0.6046511627906976,0.9670804594302467,1.0,4/13,11.47%,PLA2R1;SPRED1;SPRED2;MSX1
prerank,neuron differentiation (GO:0030182),0.24941671981396837,0.8962550960371831,0.6810551558752997,0.9668298110334079,1.0,21/165,12.13%,ISL2;RUNX2;TENM3;WNT5A;NTRK2;MYO7A;MYEF2;TENM4;MTPN;TENM2;SRF;SNPH;OLIG2;TENM1;BHLHE22;WNT3;MAP2K1;OPHN1;SMARCA1;TGFBR1;MYT1L
prerank,calcium ion transport into cytosol (GO:0060402),0.3415057341312521,0.8957760195543133,0.5921052631578947,0.9672324687200812,1.0,5/21,15.77%,GRIN2B;RYR2;GRIN2A;TRPM2;CACNA2D1
prerank,positive regulation of sodium ion transport (GO:0010765),0.3964972479023048,0.8956670631673944,0.6197916666666666,0.9667607047280276,1.0,2/12,3.99%,CNKSR3;ANK3
prerank,actin nucleation (GO:0045010),-0.29917538891561735,-0.8951749814241501,0.6333333333333333,0.8224156339100163,1.0,7/21,23.23%,JMY;LMOD1;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4
prerank,cellular response to UV (GO:0034644),0.2711344904104638,0.8950333479192073,0.6373477672530447,0.9675481487236012,1.0,15/76,16.01%,PPID;ERCC1;POLK;MFAP4;FMR1;NEDD4;ERCC4;NOC2L;XPC;TP53;DHX36;EIF2S1;BAK1;MYC;IMPACT
prerank,cellular response to oxygen levels (GO:0071453),-0.3789976120476677,-0.8949198343575949,0.5916473317865429,0.8223412172127145,1.0,5/10,24.98%,ATP6V0A2;ATP6V1G1;CCDC115;TMEM199;NDUFS2
prerank,stem cell development (GO:0048864),0.35981716457404206,0.8941517023674775,0.5951219512195122,0.9689068050231213,1.0,2/16,9.37%,NRG1;TAPT1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.27135095387666697,0.8941287705118466,0.6216577540106952,0.9682295123476871,1.0,9/78,6.24%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,glutathione metabolic process (GO:0006749),0.3097215078756286,0.8938288379342944,0.6284875183553598,0.9682276776285076,1.0,3/38,7.44%,GGT5;GGT7;GSTA3
prerank,regulation of mitochondrial fission (GO:0090140),0.3280418687470288,0.8936792407688914,0.593698175787728,0.967903101103888,1.0,3/24,8.27%,DCN;LRRK2;PINK1
prerank,female gonad development (GO:0008585),0.35039333811008233,0.8936116097821519,0.5861513687600645,0.9673204865180034,1.0,5/19,23.37%,NR2F2;NUP107;LHCGR;INHBA;EIF2B5
prerank,lymphocyte mediated immunity (GO:0002449),-0.3635621600409517,-0.8935501639263619,0.5944700460829493,0.8247238840133432,1.0,4/12,20.48%,CD55;GNL1;BTN3A3;CD46
prerank,copper ion transport (GO:0006825),0.39970082238984506,0.8933998099193758,0.5794392523364486,0.967113959975164,1.0,5/11,25.21%,STEAP3;ATP7A;STEAP2;COX17;CUTC
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3618973777457941,-0.8929865220463831,0.6038961038961039,0.8252859140120355,1.0,4/11,16.40%,CAT;GPX1;PRDX1;PRDX3
prerank,response to UV (GO:0009411),0.26257086118573447,0.8928173491158232,0.6330390920554855,0.9677460395198804,1.0,21/95,15.40%,FEN1;POLK;USP1;ERCC5;MFAP4;FMR1;NEDD4;CDKN2D;ERCC4;UVSSA;NOC2L;TP53;POLH;DHX36;IL12A;SPRTN;REV1;EIF2S1;ERCC2;BAK1;MYC
prerank,regulation of proteolysis (GO:0030162),-0.24833742362266703,-0.8925528175660813,0.6375404530744336,0.8256016460397845,1.0,16/48,24.69%,CAV1;LTBP4;CST3;CASP8;BAD;PERP;IST1;SERPINE2;TRAF3;NEDD8;AKT1;CLN8;HDAC6;CAMK2N1;CLN6;CYFIP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.37316635018849403,-0.892354056643134,0.6142241379310345,0.8247211733247578,1.0,2/10,5.90%,APC;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.37316635018849403,-0.892354056643134,0.6142241379310345,0.8247211733247578,1.0,2/10,5.90%,APC;CDC42
prerank,mitotic chromosome condensation (GO:0007076),-0.27999430499980155,-0.8922787027692679,0.6289473684210526,0.8242323319453899,1.0,12/26,31.56%,SMC2;PHF8;TENT4A;PHF13;CSNK2B;CHMP1A;NCAPH2;SMC4;RB1;NCAPG2;TTN;SET
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2607876244486233,-0.8919225551442904,0.6430868167202572,0.8244044624032056,1.0,11/40,18.66%,BCL2L1;ARL6IP5;UBB;VCP;MAPT;BAD;BAX;PRELID1;PRDX3;AKT1;PID1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.34235999523753613,-0.8917326246458703,0.5825,0.8241610788077883,1.0,8/13,27.19%,SERTAD1;ARID1B;SMARCD1;ELOF1;PADI2;SPI1;CDCA4;CHEK1
prerank,lipid homeostasis (GO:0055088),0.2869883809619281,0.8911981926074506,0.6264044943820225,0.9708076714169126,1.0,10/57,19.41%,ZBTB20;ACOX2;TLCD3B;IRS2;RCN3;FABP3;ABHD4;NR1D2;ORMDL3;ABCA2
prerank,icosanoid biosynthetic process (GO:0046456),-0.37268448883869104,-0.8911307240739444,0.6086956521739131,0.8248420708885185,1.0,5/10,36.41%,PLA2G4A;MGST3;PLA2G5;ALOX5AP;MGST2
prerank,ether lipid metabolic process (GO:0046485),0.3796772128713566,0.8908865193764601,0.5993150684931506,0.9707710700410992,1.0,3/14,9.68%,PEX7;PLA2G7;AGMO
prerank,dendritic cell migration (GO:0036336),0.3667308824048317,0.8904584520851911,0.6064400715563506,0.9709676176026081,1.0,6/16,25.54%,GPR183;TRPM2;PIK3CG;ALOX5;HMGB1;CCR5
prerank,negative regulation of cell growth (GO:0030308),0.2529110872484444,0.8900713812856834,0.66375,0.9711703085123871,1.0,18/121,12.54%,ENPP1;HRG;CDKN2A;SIPA1;GJA1;NAIF1;SERTAD2;CDKN2D;CDKL3;BCL6;DCC;NME6;NDRG3;TP53;JADE1;MSX1;ESR2;GSK3A
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3450919089218009,-0.8892947385492571,0.6037296037296037,0.8281222083540986,1.0,4/13,13.29%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,response to lipopolysaccharide (GO:0032496),0.25129998281397087,0.8892074116453983,0.6594464500601684,0.9724194311708093,1.0,19/138,12.41%,GGT5;CXCL10;WNT5A;CXCL1;GGT7;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;LIAS;MAPKAPK3;IL12A;CD86;PDCD4
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2618153886976754,0.8885739994323864,0.6763959390862944,0.9731141743110968,1.0,11/93,9.83%,NTRK3;PTEN;CNKSR3;SH2D3C;MTCP1;DOCK7;PINK1;PRKD1;INPP5J;TENM1;NSD1
prerank,ruffle organization (GO:0031529),-0.3300645245429674,-0.8882567280136051,0.6094527363184079,0.8297264232991177,1.0,6/16,23.71%,TPM1;RAC1;LIMA1;PIP5K1A;CSF1R;CORO1B
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3252305769306523,0.8879891790381437,0.6040061633281972,0.9737590988015202,1.0,5/26,8.28%,KCNS2;VAMP2;NEDD4;KCNG1;KCNAB1
prerank,positive regulation of telomere maintenance (GO:0032206),0.3186280907498222,0.8877307962582598,0.6285714285714286,0.9736749325508383,1.0,7/31,17.17%,GNL3;ERCC1;SIRT6;HNRNPA2B1;DHX36;HNRNPD;PKIB
prerank,lipid droplet organization (GO:0034389),0.33974930851017315,0.8875983422516069,0.5853658536585366,0.9732562576952062,1.0,3/22,8.09%,PPID;CIDEA;BSCL2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3365175098180866,-0.887519590366646,0.6118251928020566,0.830623543326166,1.0,2/15,2.98%,LEF1;SMARCA4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.2269529209340973,-0.887477667436051,0.7224489795918367,0.8300476782237853,1.0,12/76,14.38%,NR3C2;EGFR;EZR;APP;NMI;UACA;CCN3;IFI35;NFKBIA;TRIP6;CYLD;TMSB4X
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3328951894070236,-0.8873072751511093,0.6560196560196561,0.8297560556207366,1.0,3/15,6.13%,NEK6;CDC23;PTTG1
prerank,autophagosome organization (GO:1905037),-0.24369595378352535,-0.8873042085249319,0.6794871794871795,0.8291085618816072,1.0,17/50,21.26%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;RAB1A;ATG12;ATG2A;MAP1LC3A;AMBRA1;ULK3;RAB1B;ATG101;MAP1LC3B;WDR45
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3179771663927628,0.8872880128407375,0.6128,0.9732565028754326,1.0,6/30,12.21%,RPN2;OSTC;DAD1;ALG5;MCFD2;TUSC3
prerank,protein stabilization (GO:0050821),-0.19681376432609207,-0.8871225350294465,0.8188976377952756,0.8288591071857446,1.0,59/168,27.14%,EPHA4;IGF1;PLPP3;PTGES3;HIP1R;ATP1B3;TBL1X;CTNND1;DVL1;RPL5;CRYAB;RPS7;SOX4;RAB21;MTMR9;TBRG1;SOX17;CCT3;ANK2;RPL11;VHL;ATF7IP;GAPDH;CRTAP;NCLN;BAG3;CCT4;CCT7;FLNA;GLMP;HIP1;CDKN1A;CREB1;PRKCD;USP9X;LAMP2;AFM;CREBL2;PIM2;RPL23;RTN4;SMAD7;TYROBP;BAG2;TMEM88;HSPD1;SUGT1;MCM8;TRIM39;MT3;SUMO1;COG3;CHEK2;GOLGA7;HSPA1A;FLOT1;PARK7;ATP1B2;STK3
prerank,innate immune response (GO:0045087),0.24009733962360366,0.8867340187659702,0.7165354330708661,0.973866136959792,1.0,21/217,10.09%,COLEC12;CLEC4E;CXCL10;CLEC5A;CD40;MASP1;KYNU;MFAP4;DHX58;TLR8;TRIM56;PTK2;IFNLR1;TRIM8;MBL2;SP100;TLR4;CYBA;CR2;IRAK1;FGR
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.35326429833647227,-0.8863910413431777,0.63718820861678,0.8298781458687755,1.0,1/11,4.55%,NFKBIZ
prerank,lysosome organization (GO:0007040),0.3091375632998158,0.8862515929388995,0.6202143950995406,0.9742350074554622,1.0,8/36,15.59%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2924265523601419,0.8860486213086977,0.6212121212121212,0.9739993166039856,1.0,11/45,16.56%,NANOS3;SPOUT1;GCNT2;MTPN;ZC3H7B;NUDT21;GRM5;RBM4B;ATG14;TSC1;CYFIP1
prerank,mitochondrion transport along microtubule (GO:0047497),0.3748826206144219,0.885853040384366,0.6,0.9737390626540683,1.0,4/13,18.74%,LRPPRC;OPA1;SYBU;HIF1A
prerank,glycosphingolipid metabolic process (GO:0006687),-0.25318510101206043,-0.8855542217853575,0.6735905044510386,0.831065050320465,1.0,16/42,24.76%,SMPD3;ST6GALNAC3;LARGE1;HEXB;UGCG;B3GALNT1;ESYT3;ST3GAL5;SMPD1;GM2A;ARSA;PSAP;GLTP;A4GALT;CLN6;ASAH1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3479487107240029,-0.8855088011996163,0.6084905660377359,0.8305178266739629,1.0,4/13,9.88%,MEF2C;RBPJ;NOTCH1;TBX2
prerank,transcription by RNA polymerase II (GO:0006366),0.23260938070956866,0.8848062957044112,0.7420042643923241,0.9754462306715507,1.0,52/305,17.12%,RORA;PPARA;TEAD1;HDAC1;TAF9B;C5AR1;INTS8;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;RTF1;LSM11;TAF15;NR2C1;TAF3;CDK13;SRRT;TBPL1;NUDT21;NELFA;ZC3H8;SNAPC5;INTS14;SNW1;GTF2H3;ESR2;SSRP1;ELP4;NFIX;ELL2;HDAC10;MED1;TRIP11;ERCC2;NRBF2;SLBP;EAF2;SNRPF;GTF2H1;AR;SYMPK;CCNK;IWS1;MAZ;NR1D2;TAF8
prerank,regulation of neurotransmitter transport (GO:0051588),0.3650817207698946,0.8847938615821669,0.637987012987013,0.9747669221561841,1.0,3/16,5.01%,HCRT;CHRNB4;FMR1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.22108042821884136,-0.8845057743460799,0.7669491525423728,0.8319658932091593,1.0,32/93,24.82%,PLCB1;CCN2;ARL6IP5;TPD52L1;APP;MAP3K5;TGFB2;MINK1;FZD7;SH3RF2;XDH;GADD45B;HIPK2;FLT4;PTK2B;WNT16;MAP3K4;MAPK8IP1;STK25;TRAF3;MAP3K10;SDCBP;MFHAS1;GADD45G;DUSP19;TRAF1;MID1;CCL19;EDAR;TAOK2;NOD2;CD27
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.35554392131230156,-0.8842441098896491,0.6302325581395349,0.8318550953380518,1.0,7/12,31.26%,ACO1;ACO2;ASS1;IDH3B;IDH3A;IDH2;IREB2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2666315740249847,0.8841763500163131,0.6460296096904441,0.9754970405291215,1.0,10/69,15.73%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;RIPK1;DHX9;CLU;TIRAP
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.39022171951734935,0.884054884880012,0.6104347826086957,0.9750543180040224,1.0,1/12,0.55%,PIK3R1
prerank,cellular response to heat (GO:0034605),-0.26429326873465225,-0.8836306039794303,0.6787878787878788,0.8325338096316128,1.0,8/35,14.34%,THBS1;ANO1;VCP;FGF1;MAPT;BAG3;TRPV4;HIKESHI
prerank,mitochondrion organization (GO:0007005),-0.1970305882722965,-0.8833995191219256,0.8387096774193549,0.8323819950397185,1.0,55/165,26.65%,CXADR;BCL2L1;MEF2A;NOS3;MTM1;ATP5F1B;ALAS1;CAV2;SIRT3;HK2;DNM3;MIEF1;USP30;BAX;BNIP3L;TIMM9;BID;CHCHD2;TERT;PYROXD2;TRAK2;RAB38;ADCK1;MTFR1L;AFG1L;PRDX3;VPS13D;YME1L1;AIFM1;ATP5F1D;MSTO1;TIMM13;CHCHD3;TOMM22;PID1;SIRT5;TIMM8B;MPV17;MIGA1;POLRMT;HIGD1A;FANCG;TWNK;OXA1L;VPS13C;HSPD1;PNPT1;PARP1;TIMM10B;TOMM5;FMC1;MIEF2;SLC25A4;PARK7;HSD17B10
prerank,JNK cascade (GO:0007254),-0.25208829739915356,-0.8824584133881727,0.6756756756756757,0.8337756064076794,1.0,16/40,24.35%,IRAK2;MAP3K5;MINK1;MAPK9;MAP2K4;UBB;MAP2K7;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKG;NOD2
prerank,cellular zinc ion homeostasis (GO:0006882),0.32697184581927563,0.8822181696174893,0.6288492706645057,0.9786130762985973,1.0,3/26,4.66%,SLC30A10;SLC30A5;SLC39A7
prerank,regulation of mRNA stability (GO:0043488),0.2476954571612719,0.8820137147443192,0.7070457354758962,0.9783842922717061,1.0,39/145,19.93%,NUP214;PSMD1;RBM24;YWHAZ;FMR1;DND1;PSMD10;PDE12;TAF15;ZFP36L2;PSMA5;PSMB5;PAIP1;PRKCA;TENT5A;PSMC4;PSMA4;DHX36;PSMC5;CSDC2;TNPO1;EXOSC9;PSMB9;FTO;EIF4ENIF1;HNRNPD;GDNF;RC3H2;EXOSC8;EXOSC5;PSMA7;IGF2BP3;PSMD14;PSMA2;YTHDF1;PSMD11;FXR1;ZC3H14;XPO1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.23302871837117653,-0.8812662739736872,0.6754098360655738,0.8357685537085748,1.0,15/57,16.11%,TNFSF10;HIP1R;KDR;VPS35;GSK3B;RALBP1;MIEF1;BAD;BAX;BID;DDHD1;BOK;ZNF205;ADCK1;GPER1
prerank,regulation of mRNA processing (GO:0050684),0.3103641960935535,0.8809317678860543,0.6088328075709779,0.9802305398696665,1.0,8/32,18.67%,KHDRBS3;CWC22;SRSF10;DHX9;SAFB2;IWS1;SAFB;KHDRBS1
prerank,regulation of exit from mitosis (GO:0007096),0.3016582895925704,0.8807900204636169,0.6065573770491803,0.9798466105320529,1.0,3/38,6.02%,CDC14B;BUB1B;CDC16
prerank,regulation of cytokinesis (GO:0032465),0.26667319120337707,0.8805803630243685,0.6631158455392809,0.97963709684795,1.0,3/78,0.93%,SVIL;CDC14B;RXFP3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.40354080867849884,0.8796401545605815,0.6286231884057971,0.981155027715188,1.0,2/10,8.66%,PRKACB;PRKACA
prerank,mitochondrion disassembly (GO:0061726),-0.26597933229103154,-0.8793211039364413,0.6810344827586207,0.8392924547709688,1.0,14/34,21.26%,BECN1;SQSTM1;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;AMBRA1;MARK2;MAP1LC3B;WDR45
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3618519756778823,0.8790808171544708,0.616580310880829,0.9817153027048138,1.0,2/15,3.83%,NTRK2;NGFR
prerank,I-kappaB phosphorylation (GO:0007252),-0.3735082951951232,-0.8790300993778685,0.6186046511627907,0.8392712372473373,1.0,1/10,0.80%,ERC1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.258246129468034,0.8782019715331663,0.6946847960444994,0.9830623647478791,1.0,12/107,9.08%,EDN3;SLC24A5;SLC30A10;CD40;RYR2;SLC30A5;SLC39A7;HTR2B;CCL15;ATP2A2;ATP13A3;HTR2C
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3082722785683532,-0.8778462903466178,0.6379746835443038,0.841087095168957,1.0,2/19,0.43%,IGF1;PICALM
prerank,neurogenesis (GO:0022008),-0.2490701344819686,-0.8777560299385017,0.68125,0.8406531660431981,1.0,9/43,13.35%,TGFB2;THOC2;ANXA1;CDK6;SIX1;MAPT;WDR62;CLN5;TRAK2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.27346685940053395,-0.8777482793473244,0.6582633053221288,0.8400163285760668,1.0,7/29,13.28%,RPS14;RPS16;RPS19;UTP3;RPS21;NOP9;RPS8
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3162445175269485,0.8775736281337453,0.6169230769230769,0.9838152955446267,1.0,12/27,25.72%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,regulation of metal ion transport (GO:0010959),0.35004771380454036,0.8773889113586871,0.5959933222036727,0.9835366441455152,1.0,2/16,2.18%,SLC30A10;IL16
prerank,T cell receptor signaling pathway (GO:0050852),0.2457884661548291,0.8772206478234149,0.687192118226601,0.9832034362803156,1.0,19/138,11.54%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;ICOSLG;PDPK1;PIK3R2;PTPN22;EIF2B1;CD276;PSMD10;PSMA5;PSMB5;PSMC4;TNFRSF21;PSMA4;FYN;PSMC5
prerank,purine-containing compound catabolic process (GO:0072523),-0.3386127092879325,-0.8764991936377228,0.6305882352941177,0.8419787349809548,1.0,5/13,19.98%,XDH;GPX1;NT5E;GDA;NT5C1A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3267235501024419,0.8764468269456157,0.6287519747235387,0.9842361762065147,1.0,4/26,6.02%,DUSP1;FBXO5;CENPE;CDC16
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3650243861768733,0.876414817058685,0.5857385398981324,0.983593840409887,1.0,3/14,11.24%,EARS2;SLC25A33;TEFM
prerank,tRNA wobble uridine modification (GO:0002098),0.37136589738571674,0.8763380854925719,0.6302521008403361,0.983055816370495,1.0,4/14,17.74%,CTU1;ELP1;ELP4;TRMU
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.21228582947285435,-0.8761005133762071,0.8049792531120332,0.8421664868125875,1.0,23/87,20.39%,RBFOX2;SHOC2;TBX1;CD44;FGF1;HNRNPF;ITGB1BP1;HYAL1;SFRP1;NR4A1;FRS2;POLR2B;FGFBP1;POLR2H;HNRNPH1;POLR2G;POLR2C;GRB2;FGFR3;FGFRL1;FLRT1;HNRNPA1;GALNT3
prerank,protein dephosphorylation (GO:0006470),0.24621894935143307,0.8760651247901735,0.6958128078817734,0.9829525800978551,1.0,21/135,10.69%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;DUSP22;PTPRU;PTPRO;PTPN13;SSH2;PPP2R2A;TNS2;PPP2R3A;PPP6C;PPP3CB;PDP1;PTPRA
prerank,negative regulation of immune system process (GO:0002683),-0.32420960314443115,-0.8758890660071216,0.601010101010101,0.8419833444039667,1.0,1/16,0.41%,CD200
prerank,regulation of cellular localization (GO:0060341),0.2904061976663698,0.875714231052457,0.6602658788774003,0.9830578425822073,1.0,10/46,16.45%,ADCY5;TRIM67;NR1H4;LRRK2;PINK1;LYN;EPHA5;CSNK1E;BRSK2;DVL3
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2445145272535328,-0.8753402317761405,0.673469387755102,0.8425045659440266,1.0,12/48,20.68%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;PLA2G6;DGKZ;DDHD1;DDHD2;PNPLA3;AGPAT2
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.2521087853714387,-0.8751827116054395,0.6845238095238095,0.8421561341352454,1.0,10/39,17.14%,MYRIP;PSMD9;RBP4;SOX4;NNAT;BAD;ACSL4;SELENOT;GPER1;HFE
prerank,positive regulation of glycolytic process (GO:0045821),0.34040284469872756,0.8751294947912946,0.632258064516129,0.9830309499258258,1.0,3/20,4.54%,ZBTB20;PFKFB1;ENTPD5
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.34040284469872756,0.8751294947912946,0.632258064516129,0.9830309499258258,1.0,3/20,4.54%,ZBTB20;PFKFB1;ENTPD5
prerank,positive chemotaxis (GO:0050918),0.3557122635852259,0.8746704283850091,0.6190476190476191,0.9833934443081592,1.0,2/17,3.60%,SEMA5A;SCRIB
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.28812738084300216,0.8746537038860931,0.6546762589928058,0.9827198158285795,1.0,14/46,24.01%,TIMM10;DNAJC19;PINK1;PITRM1;TIMM44;DNAJC15;PAM16;GRPEL1;TIMM21;MFN2;GDAP1;CHCHD4;FIS1;TOMM34
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.266920015943455,0.8741652922198514,0.6922060766182299,0.9831528833118671,1.0,12/76,11.85%,CCDC22;CDKN2A;PSMD10;BRMS1;TRIM37;LRRC14;COMMD1;BMP7;IRAK1;PYCARD;DAP;PTGIS
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24166728051565106,-0.8738192904166517,0.6972789115646258,0.844414679602504,1.0,5/50,7.95%,NR3C2;EGFR;APP;NMI;IFI35
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3679117236965419,-0.8737251745875916,0.6267605633802817,0.8439357594764729,1.0,4/10,16.48%,PRKAA2;SIRT1;PRKAA1;MYOCD
prerank,receptor signaling pathway via STAT (GO:0097696),0.3202580997889814,0.8729021977863872,0.6282051282051282,0.9853132236293679,1.0,1/25,0.31%,GHR
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2196406424179012,0.8727067051021797,0.8606060606060606,0.9850599014974909,1.0,172/807,19.41%,IL33;ZEB1;ZFHX3;TRPS1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;PPARA;MIER2;ETV5;HDAC1;L3MBTL1;PPID;WNT5A;TAF9B;NR2F2;TCF7L2;BASP1;SALL1;CDKN2A;THRA;NR1H4;PEX2;PER3;MEIS2;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;SCML4;MDFIC;RUNX1T1;ZNF423;ZBTB16;ZFP37;RTF1;SIRT6;TLE2;FOXS1;PSMD10;PRDX5;BCOR;CAPN3;GLIS1;CALCA;DUSP22;TENM2;CBFA2T3;GMNN;BRMS1L;BRMS1;PAX9;ZBTB2;TRIM37;LYAR;BCL6;NR2C1;TAF3;ZKSCAN3;MDM4;PER2;TWIST1;SOX2;MXI1;NOC2L;L3MBTL4;PHF6;SP100;TLE1;DAXX;BMP7;NSD1;GLI3;SOX10;TP53;N4BP2L2;ZC3H8;MPHOSPH8;ZFPM2;ZNF25;SNW1;DAP;EPC1;ZNF318;ESR2;SOX9;MYT1L;TWIST2;PDCD4;IGF2;SAP30;DPF2;KDM1B;HIC2;BTAF1;CNOT1;PHC1;PRDM5;ATN1;ZMYND15;NRIP1;NFIX;HDAC10;PEG3;MED1;CUX2;UBE2D1;MED25;BPTF;KDM5C;CREB3L1;ZBTB32;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;AR;CNOT7;MYC;CRY2;ORC2;CENPF;ZHX3;DCAF1;FGFR2;KLF11;KDM2A;IMPACT;SPINDOC;EFNA1;ZBTB7A;AASS;ZNF3;CBFA2T2;NONO;MBTD1;CIART;MAZ;NR1D2;CALR;DNMT3A;SARS1;CDK5;MBD2;LDB2;LDB1;SUV39H2;BMP2;MBD1;KAT7;SKOR2;HEY1;BRD7;ILF3;KHDRBS1;WWC1;RIF1;DEDD2;PEX14;THAP7;CREBZF;CBFB;EHMT2;NR2C2;NACC1;IKZF4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.33042955281915176,-0.8724037779528913,0.6314553990610329,0.846055191606871,1.0,8/13,38.05%,UPP2;OGG1;NEIL1;NT5M;NTHL1;SMUG1;NEIL2;DCTPP1
prerank,liver development (GO:0001889),-0.2671819281383384,-0.8723701676340525,0.6704225352112676,0.8454722646829812,1.0,8/32,15.68%,ARID5B;WNT4;ANXA1;COBL;LSR;CITED2;ZIC3;MET
prerank,stabilization of membrane potential (GO:0030322),0.36310319747801145,0.8723294681282171,0.6188034188034188,0.9852024677673968,1.0,1/16,0.58%,KCNK2
prerank,epithelial to mesenchymal transition (GO:0001837),0.2859559715969495,0.8721480516675765,0.6390532544378699,0.9848964326511438,1.0,15/47,18.74%,WNT5A;FGFR1;LOXL3;LOXL2;TBX3;AMELX;DDX17;BMP7;TGFBR1;SOX9;OLFM1;CUL7;BMP2;HEY1;HIF1A
prerank,response to interleukin-1 (GO:0070555),-0.2184111116269418,-0.8721464198522217,0.7629310344827587,0.8453009631251854,1.0,12/73,10.33%,HDAC4;APP;NFKB1;IRAK2;SIRPA;IL1R1;ANXA1;GBP2;RC3H1;HYAL1;SFRP1;RBMX
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3383464385558945,0.8720941959033406,0.6196513470681458,0.9843077448418712,1.0,8/21,17.28%,ITGAV;HTR2B;ZFP36L2;MAP2K1;SOX9;MYC;PTGER4;LGALS9
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2647480563345928,0.8720432727536832,0.6742021276595744,0.9837242742069261,1.0,8/75,5.64%,SPRY4;SPRY1;PTEN;NR2F2;CDKN2A;DUSP1;SORL1;NF1
prerank,negative regulation of cellular process (GO:0048523),0.22193161436506742,0.8718100767739287,0.8199791883454735,0.9835516299780633,1.0,96/521,16.57%,ENPP1;DLC1;CASK;COL18A1;PLXNC1;ATF5;HRG;ROR2;TGFBI;CXCL1;PTEN;SEMA5A;ERBB4;GPLD1;CDKN2A;SIPA1;GLMN;SUSD2;GJA1;DLG3;DUSP1;NR1H2;REST;FBXO5;TMEM115;HTR2B;ADGRB1;DSCAM;NAIF1;SERTAD2;ACTN1;PDE12;CBFA2T3;DUS2;GMNN;NPAS2;CDKN2D;PTPRU;BCL6;MDM4;PRKD1;IFNLR1;P3H1;APPL2;TENM1;SP100;BMP7;NME6;MAP2K1;TNS2;NDRG3;EIF2AK2;TNFRSF21;TP53;FKTN;JADE1;PLXNB2;MSX1;GAS8;SPEG;ESR2;HTRA2;FABP3;HGS;PDCD4;ST18;DIS3L2;TESC;SMYD5;BNIPL;P3H3;MALSU1;CDKN2C;TDRD9;ADAM22;LYN;NME1;THAP12;WNK2;TSPYL2;F2R;FERMT2;FOXM1;TFAP4;CLU;AR;CNOT7;MYC;KLF11;RNF167;IMPACT;CDK10;BRINP1;TSC1;RBM5;CHERP
prerank,dicarboxylic acid transport (GO:0006835),0.31543323548479424,0.8718030663276769,0.6365054602184087,0.9828616588637252,1.0,2/28,3.74%,SLC1A3;GJA1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.31808912769954206,0.8717674308931695,0.6178736517719569,0.9822505690577614,1.0,3/27,4.06%,PPARA;ITGAV;NR1H2
prerank,regulation of intracellular pH (GO:0051453),-0.25767990397041424,-0.8717033833395215,0.6855524079320113,0.8455374641097482,1.0,10/34,22.36%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;SLC4A8;SLC9A5;SLC26A6;SLC9B1;CFTR;SLC4A7
prerank,regulation of response to external stimulus (GO:0032101),0.25002362898969205,0.8709483957519927,0.7034813925570228,0.9833571123002447,1.0,17/121,13.07%,PDGFRA;XCL1;HRG;WNT5A;ADGRA2;PTPN22;DHX58;CASP4;ADAMTS12;BCL6;PTGES;APPL2;BIRC2;FGR;P2RX4;CASP12;AREL1
prerank,protein maturation (GO:0051604),0.25799947455023164,0.8707778615503082,0.7120622568093385,0.9830172191491504,1.0,9/95,6.96%,ECE1;ECE2;OGT;NAA10;PCSK2;SORL1;ADAM19;CCS;CPM
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.2755113997290358,-0.8707271379424316,0.6506666666666666,0.8469962282460931,1.0,9/27,23.89%,MAP3K1;IRAK2;UBB;TAB2;IRAK4;UBC;LY96;UBA52;HSPD1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.39475845566243,0.8704647401870798,0.6112115732368897,0.9830409432302887,1.0,3/10,17.61%,FMR1;GNB5;GPR35
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.36011952862908947,0.8702352931571458,0.6510067114093959,0.982872634652368,1.0,2/15,4.54%,KDF1;NCOA3
prerank,establishment of mitotic spindle localization (GO:0040001),0.31133573714259144,0.8701063617511495,0.6203554119547657,0.982459306539464,1.0,9/28,18.72%,GJA1;GPSM2;SPDL1;NUSAP1;INSC;CLASP2;CLASP1;UBXN2B;KPNB1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.3992844204051049,0.8697835439498715,0.6325088339222615,0.9824660049362228,1.0,2/10,5.31%,ATP1A2;NEDD4
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.29078846601018055,-0.8695828988055396,0.6222222222222222,0.8487364356140161,1.0,11/23,24.27%,BAD;BAX;TIMM9;TIMM13;TOMM22;TIMM8B;ROMO1;COX18;NDUFA13;TIMM10B;BCL2L11
prerank,response to unfolded protein (GO:0006986),-0.24181492981678354,-0.8693228271817492,0.7218543046357616,0.8486118258146311,1.0,17/48,25.84%,TMBIM6;HSPA8;HSPH1;HSPB8;BAX;PTPN1;OPTN;HSPB1;BAG3;ERN1;STT3B;DNAJB5;DNAJB1;HSPD1;HSPA14;HSPA1A;HSPB2
prerank,replicative senescence (GO:0090399),0.380007864379957,0.8691664903825053,0.629757785467128,0.9831286808414867,1.0,3/12,10.60%,PLA2R1;CDKN2A;TP53
prerank,immunoglobulin mediated immune response (GO:0016064),0.39709634105182207,0.8688354434497442,0.6451612903225806,0.983156578015246,1.0,2/10,12.93%,TLR8;CD81
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3319413437108457,0.8686861056108488,0.6247933884297521,0.9828005671905746,1.0,2/21,7.70%,IL34;PTK2
prerank,cell cycle checkpoint signaling (GO:0000075),0.3787945877969028,0.8686083420543533,0.6397941680960549,0.9822687331634234,1.0,1/12,0.92%,BUB1B
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2778792688261862,0.8684759047122407,0.6503496503496503,0.9818730549557517,1.0,4/57,3.59%,GHR;CD40;ERBB4;TSLP
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.3082751671124525,-0.8684568431539981,0.6658163265306123,0.8497215198973579,1.0,6/18,12.78%,RAP1A;SYN1;VPS18;GSK3B;RAB5A;SLC4A8
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.28360728761488707,0.8684386892124407,0.6661931818181818,0.9812530519023483,1.0,8/54,8.66%,HRG;CD40;FGFR1;PDPK1;JUP;NF1;PRKD1;PRKCA
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.22671440950415334,0.8683828124248995,0.8008474576271186,0.9806715899240784,1.0,94/366,22.82%,RORA;CHD7;ZFHX3;MSC;ATF5;NANOS3;RABL3;NCOA2;MYT1;TEAD2;REST;FBXO5;SOX6;ZNF423;MTPN;FOXN2;CXXC1;ZFP37;GMNN;HP1BP3;SPIN1;SPTY2D1;SOX2;EDF1;DAXX;SRRT;BRCA2;NSD1;TP53;GRM5;NFXL1;TGFBR1;ESR2;SRSF10;IGF2;TFEB;SAP30;NUP107;ZNF628;CARM1;HDAC10;ARNT2;SSBP2;RBM4B;TGFBRAP1;CCNA2;UBE2V1;HNRNPD;MLF1;ATF2;WTIP;MAFB;ZKSCAN5;TSC1;TRIP4;NONO;CYFIP1;USP13;NR1D2;CALR;ZBTB11;LDB1;MLF2;BMP2;KAT7;SKOR2;REXO4;HIF1A;WWC1;THAP7;TERF2IP;EHMT2;NR2C2;SP1;TRAPPC2;CNBP;SMC3;DVL2;ORC5;HCFC2;GON4L;UTP4;APBB3;ASCC1;DDIT3;CREBBP;LIN54;SERTAD3;ATRX;MLLT6;NLK;RREB1;ABL1;HOXB7
prerank,endocytic recycling (GO:0032456),0.2761799696938506,0.8682952239959855,0.6444759206798867,0.9801834950881084,1.0,10/50,16.11%,CCDC22;MICALL2;EPS15;VPS39;VPS26C;RAB11FIP3;ENTR1;SNF8;SNX12;VPS52
prerank,pyroptosis (GO:0070269),0.35613047679387433,0.8681766718063054,0.596551724137931,0.9797602093865279,1.0,4/15,19.67%,CASP4;GSDMD;DHX9;GSDME
prerank,protein import into peroxisome matrix (GO:0016558),0.38918156114203745,0.8680231677385215,0.6221033868092691,0.9793763361235099,1.0,5/12,18.90%,PEX2;PEX7;PEX12;PEX14;PEX6
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3051263320381832,0.8675140213057058,0.6458635703918723,0.9798074909866284,1.0,6/35,14.70%,GHR;ERBB4;OCIAD1;HGS;DOT1L;F2R
prerank,polyamine metabolic process (GO:0006595),0.37670481534664063,0.8674327766002694,0.6289752650176679,0.9793109310328947,1.0,3/13,13.65%,ODC1;HDAC10;DHPS
prerank,polyol biosynthetic process (GO:0046173),-0.32067544213176835,-0.8672875690719248,0.6634615384615384,0.8515709310003021,1.0,3/16,6.65%,ACER3;ITPKB;IP6K2
prerank,cellular response to retinoic acid (GO:0071300),-0.24442005813701945,-0.8671521775493187,0.6870748299319728,0.8512130336075905,1.0,10/42,15.29%,WNT5B;WNT9A;FZD4;FZD7;TBX1;WNT6;RET;ATM;PTK2B;CREB1
prerank,N-glycan processing (GO:0006491),0.34775697220352086,0.8671443265227976,0.6144578313253012,0.9792281946295602,1.0,4/18,10.38%,ST8SIA1;PRKCSH;MAN1C1;MAN1B1
prerank,wound healing (GO:0042060),0.2696235543847225,0.8670738270696902,0.6826265389876881,0.9786946575116707,1.0,9/62,11.50%,PDGFRA;NRG1;WNT5A;NF1;SRF;EVPL;SYT7;ARL8B;TGFBR1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2624843777383072,0.8668945286925543,0.6649145860709592,0.9783828763154914,1.0,27/80,23.69%,KDELR3;COPA;KDELR2;GBF1;TMEM115;COPZ2;DNAJC28;CENPE;COPB1;KIFAP3;SCFD1;ATP9A;RINT1;KIF3C;KIF2A;ERGIC2;TMED3;TMED9;COPG1;COPB2;KIF3A;KIF11;KIF15;BNIP1;KIF23;COPZ1;KDELR1
prerank,amino acid transport (GO:0006865),0.2821438711005886,0.8668696598343354,0.6581920903954802,0.9777513079362342,1.0,4/49,4.87%,SLC1A5;SLC7A11;SLC43A1;SLC7A8
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.32538046744272614,0.8667999838370709,0.639344262295082,0.9772033893301424,1.0,2/24,5.64%,EPHA7;NF1
prerank,fatty acid biosynthetic process (GO:0006633),0.270273317115898,0.866713664887344,0.6713091922005571,0.9767052507848696,1.0,18/63,21.94%,LIPH;LIPC;DEGS1;ELOVL2;HSD17B8;ACOT7;LIAS;ACLY;NDUFAB1;ELOVL6;ELOVL1;HACD3;ALOX5;ACSBG1;ABHD3;SCD5;ACACA;ELOVL5
prerank,regulation of histone modification (GO:0031056),-0.3292509276005082,-0.8662815775030221,0.6611374407582938,0.8523400614609827,1.0,5/13,17.83%,AKAP8;MTHFR;UBE2N;MYOCD;CDK9
prerank,mRNA export from nucleus (GO:0006406),0.25618920242106835,0.8660740866665384,0.6922094508301405,0.9774088837336301,1.0,28/102,21.20%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;DDX19A;ENY2;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;IWS1;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,isotype switching (GO:0045190),-0.3738261227828676,-0.8660346864740834,0.6413043478260869,0.8521570691373437,1.0,6/10,28.08%,RNF8;EXOSC3;BATF;HSPD1;LIG4;MSH2
prerank,cell proliferation in forebrain (GO:0021846),0.39376826419889976,0.8657873845649631,0.6373626373626373,0.9773627623382825,1.0,4/10,25.77%,DOCK7;PCM1;KIF14;NUMBL
prerank,protein O-linked glycosylation (GO:0006493),0.25272081556642,0.8657490896497383,0.682704811443433,0.9767714216549149,1.0,12/96,11.10%,GALNTL6;PLOD1;OGT;GALNT18;POMT1;GALNT13;GALNT15;RXYLT1;B3GNT8;GALNT10;POFUT2;FKTN
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.32571075096583363,-0.865505257895385,0.6287128712871287,0.8525757482431239,1.0,2/15,5.26%,CD55;HSPH1
prerank,organelle organization (GO:0006996),0.22339794917320535,0.8653291938102836,0.8082627118644068,0.9770428574472638,1.0,91/388,19.29%,SEC16B;CECR2;PPID;PHIP;RAB34;MTFR2;ABCD2;SIPA1;PEX2;SEC16A;WDPCP;GBF1;DPYSL2;IRAG2;PRKCI;DNAJC28;LRRK2;PEX7;SMPD4;SIPA1L3;EPS15;FMNL2;WASF3;FAM161A;CIDEA;BSCL2;GOLGA2;FGD6;PINK1;PRKD1;PALLD;KIFAP3;RAB30;RAB29;MTX3;OPA1;WDR73;BCS1L;SAR1A;SLC25A33;ARHGAP4;RAB2A;POLG2;LNPK;SH3KBP1;KIF5C;CENPW;PEX11A;SYNE1;KIF9;FAM161B;COG1;LONP1;ATP7A;PCLO;TRIP11;CLASP2;SH3D19;PACSIN3;HACE1;MYC;PEX19;WTIP;TNIK;CLASP1;CEP55;FGD2;USP6NL;HAX1;UBXN2B;TMED3;PAK5;VPS4B;TMED9;GOLGA8B;GOLGA5;MCOLN1;PEX12;PDZD8;CUL7;MAST1;PEX3;SSBP1;YTHDF1;PEX14;PEX6;EIF2AK3;MIA3;TRAPPC12;TBC1D20;NIPSNAP2
prerank,zinc ion homeostasis (GO:0055069),0.3169113862809972,0.8646514219544466,0.6439024390243903,0.977845610940199,1.0,3/28,4.66%,SLC30A10;SLC30A5;SLC39A7
prerank,chromosome condensation (GO:0030261),-0.25141846113245164,-0.864312936726495,0.7177177177177178,0.8544519682485751,1.0,15/36,29.13%,SMC2;PHF8;TENT4A;PHF13;GPER1;AIFM1;CSNK2B;CHMP1A;NCAPH2;BANF1;SMC4;RB1;NCAPG2;DFFB;TTN
prerank,detection of visible light (GO:0009584),0.35239984379229805,0.8641781892188718,0.6214788732394366,0.9781903341672793,1.0,3/16,14.50%,GNA11;ABCA4;CEP250
prerank,mRNA transport (GO:0051028),0.2546291280489114,0.8641200165361336,0.6984732824427481,0.9776232363126091,1.0,27/101,21.20%,EIF4A3;NUP214;AAAS;FMR1;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;KIF5C;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.24554059438878562,0.8640424195703527,0.7053020961775586,0.9771160220980796,1.0,23/128,15.81%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;SSNA1;MELK;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;BRSK2;CLASP1
prerank,DNA repair (GO:0006281),0.22698776964161926,0.8638861580018234,0.7958740499457112,0.9767830081983702,1.0,66/284,20.54%,FANCI;ERCC6L2;ERCC1;LIG3;FAN1;FEN1;POLK;POLQ;USP1;ERCC5;FANCA;MSH3;ASF1A;NEIL3;POLA1;CDKN2D;RPA1;ERCC4;POLL;XPC;RNF168;FAAP100;COMMD1;BRCA2;RFC3;UBE2V2;TEX264;TP53;POLH;RECQL;FAAP20;GTF2H3;POLN;MUTYH;XRCC1;POLB;SPRTN;RAD52;FTO;ALKBH3;MBD4;ATXN3;POLI;ERCC2;DOT1L;EME2;UBE2V1;GTF2H1;CSNK1E;MMS19;APEX2;SMARCAL1;SMC1A;MSH6;WRN;FBH1;REXO4;TRAIP;POLE;TRIP13;MLH1;MTA1;DDX1;USP45;MEN1;DDB1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.31296490229758717,-0.8634648524613674,0.6240786240786241,0.8555664284757478,1.0,5/17,16.12%,KLF4;ANXA1;TMSB4X;MAP2K5;ANXA4
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3585987831809988,0.8631704512225782,0.6173913043478261,0.977710271654414,1.0,4/14,15.02%,NMNAT3;AK4;AK8;AK3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.35378453924623765,-0.8631249975990585,0.6451612903225806,0.8556042822583019,1.0,4/11,13.66%,CTPS2;TPK1;DCK;SLC19A3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.29282200360123245,0.8631080231826358,0.6836581709145427,0.9771420563694032,1.0,11/41,18.74%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.32560588926921874,0.8629877168629727,0.6553945249597424,0.9767343973266736,1.0,7/24,19.13%,TMEM204;NEDD4;PRKCB;HGS;ITGA5;HIF1A;ARNT
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31168492597025527,0.862927241799878,0.6527331189710611,0.9761913315274026,1.0,8/30,15.77%,GJA1;RYR2;SCN2B;CACNA1G;FGF12;KCNE4;SCN1A;CACNA2D1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.21822254255171514,-0.8628881690081804,0.7803030303030303,0.8554289668526905,1.0,12/75,13.30%,SLC12A7;SLC9A2;SLC8A3;KCNJ13;ATP1B3;SLC39A8;SLC39A10;KCNK9;KCNJ2;SLC12A8;KCNJ12;TRPV4
prerank,regulation of transposition (GO:0010528),-0.3395717553848223,-0.8627919054114173,0.6261904761904762,0.8549813448045902,1.0,3/13,11.79%,MYBL1;TEX15;UBR2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.34014140387614894,-0.86275413612293,0.6326034063260341,0.8544161910502566,1.0,7/13,33.33%,RUNX1;ZBTB7B;TGFBR2;PNP;NCKAP1L;SOCS1;NKAP
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.342813424750651,0.8626524773901088,0.6354679802955665,0.9761161153768347,1.0,5/18,20.59%,DDX19B;DDX19A;ENY2;IWS1;MCM3AP
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.29630963809141553,-0.8626229756583048,0.6839237057220708,0.8540456229495027,1.0,10/23,25.69%,DIAPH1;CAMK2D;ANK2;NOS1;PTK2B;NOS1AP;CACNB1;CBARP;CASQ2;PSEN2
prerank,"phototransduction, visible light (GO:0007603)",0.3596692951592454,0.8624115459490608,0.6505190311418685,0.9759773542239097,1.0,2/14,11.78%,GNA11;ABCA4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3124812117340988,0.8619877129412336,0.6351145038167939,0.9762440446912446,1.0,12/28,25.42%,ITPR1;CASP4;DNAJC10;BAK1;BAG6;BRSK2;BBC3;TNFRSF10B;DDIT3;TMEM117;ATF4;SELENOK
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3692039675002698,0.8619851546901923,0.6017391304347826,0.9755696571133068,1.0,7/13,27.04%,UBE2G2;YOD1;BRSK2;EDEM2;UBE2J1;OS9;BCAP31
prerank,homocysteine metabolic process (GO:0050667),0.38415664027305574,0.8615891173233369,0.6286701208981001,0.9757818169532579,1.0,4/11,17.19%,MTRR;BLMH;DPEP1;MMUT
prerank,regulation of dopamine secretion (GO:0014059),0.32000766464011265,0.8615523737556166,0.6539074960127592,0.9751902967219707,1.0,6/25,18.61%,SYT3;SYT7;SYT5;GDNF;SYT6;SYT1
prerank,inner dynein arm assembly (GO:0036159),0.3888407366600437,0.8615046081415216,0.6610169491525424,0.974606243533743,1.0,2/10,15.25%,DNAAF4;CCDC39
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3553300039823195,-0.8614905723547909,0.665158371040724,0.8557143113569369,1.0,3/10,11.86%,VTN;GRB10;ITGB3
prerank,ribosomal large subunit assembly (GO:0000027),-0.28440929451115027,-0.8614361990822911,0.6722689075630253,0.8551819710480323,1.0,11/24,29.79%,RPL5;RPL10;RPL11;RPLP0;RPL23A;MRPL20;NOP2;RPF2;RPL24;FASTKD2;NOP53
prerank,primary miRNA processing (GO:0031053),-0.36087462539039317,-0.8610094033877957,0.6602870813397129,0.8554461972701375,1.0,4/10,12.85%,DGCR8;DROSHA;SMAD3;SMAD1
prerank,response to copper ion (GO:0046688),-0.2972574189906465,-0.8609749391248375,0.6684350132625995,0.8548734162904453,1.0,15/20,37.95%,MT2A;ATP5F1D;MT3;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;HSF1;ATP7B;AQP1;IL1A
prerank,adherens junction organization (GO:0034332),0.28767166012693485,0.860949364207304,0.6633941093969145,0.9750920901100015,1.0,12/48,14.84%,CDH6;CADM2;JUP;DCHS1;CDH11;CDH15;CDH3;JAM3;CDH10;CADM3;NECTIN3;FERMT2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.34354156502069405,0.8604657977252388,0.6056782334384858,0.9754849659018827,1.0,3/18,9.42%,ATP1A2;SLC43A1;COMMD1
prerank,regulation of regulated secretory pathway (GO:1903305),0.30389598360564163,0.8604492797285895,0.65284178187404,0.9748494775473924,1.0,10/34,19.47%,LRRK2;RIMS2;SYT3;SYT7;RIMS1;RAB15;SYT5;SYT6;SYT1;RIMS4
prerank,protein K63-linked deubiquitination (GO:0070536),0.3054506949265213,0.860237570913152,0.6789137380191693,0.9746106525464099,1.0,8/31,17.14%,STAMBPL1;USP33;ATXN3;YOD1;USP16;USP13;STAMBP;PSMD14
prerank,regulation of immunoglobulin production (GO:0002637),-0.29010479442143167,-0.8593928046125647,0.6898395721925134,0.8573987378366853,1.0,3/23,10.44%,RBP4;DNAJB9;EPHB2
prerank,positive regulation of inflammatory response (GO:0050729),0.2570394208599253,0.8591571881296282,0.7046979865771812,0.9762732477859654,1.0,13/86,17.31%,IL33;WNT5A;IL16;TSLP;PLA2G7;TLR4;VAMP7;PDCD4;CD81;RIPK1;DHX9;PTGER4;ADAM8
prerank,protein N-linked glycosylation (GO:0006487),0.2662138287029384,0.8590018650177758,0.6690340909090909,0.975913453032068,1.0,14/66,14.57%,RPN2;OSTC;ENTPD5;DAD1;ALG6;GFPT2;MAN1C1;ALG13;ALG5;MCFD2;TUSC3;TMEM258;B4GALT7;PMM2
prerank,cholesterol metabolic process (GO:0008203),0.26662043587480755,0.858615696267896,0.6828929068150209,0.9760759619013631,1.0,13/68,16.30%,NPC1L1;CEL;PPARD;DHCR24;SOAT2;ACAT2;PLPP6;HMGCS1;ABCA5;ACLY;SCAP;LDLRAP1;IDI1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.31894731239149204,-0.8582055208150943,0.6842105263157895,0.859167672255997,1.0,4/15,6.99%,KHNYN;NYNRIN;DICER1;RPP30
prerank,regulation of isotype switching (GO:0045191),-0.33124238047447796,-0.8581308927628503,0.663594470046083,0.8586601112282255,1.0,3/14,9.89%,KMT5B;TFRC;SHLD2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.27556357167164247,0.8579761450747754,0.6589595375722543,0.9767801168046962,1.0,13/54,15.44%,HSPG2;GPC4;GCNT2;GPC5;HS6ST2;GNS;GUSB;B4GALT7;IDUA;HS3ST6;HS3ST5;HEXA;SDC2
prerank,sterol biosynthetic process (GO:0016126),0.3015115176477974,0.8578849166990553,0.6882530120481928,0.9763006517072336,1.0,7/33,11.95%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,anterior/posterior axis specification (GO:0009948),-0.32099204651128926,-0.8575730762965746,0.6390243902439025,0.8591376726741027,1.0,2/15,6.38%,SKI;WLS
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.22574173129870995,-0.8575065293584757,0.7638376383763837,0.8586468582836735,1.0,14/64,22.05%,PLA2G4A;CYP1B1;ACOT8;MGLL;AIG1;GPX1;ACSL4;ACSL5;PTGS2;ALOX12;PNPLA3;PLA2G4C;SLC27A2;FAAH
prerank,cell cycle G2/M phase transition (GO:0044839),0.24259541546919972,0.8572827152496043,0.7331701346389229,0.9769340895644707,1.0,23/129,15.81%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;SSNA1;MELK;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;BRSK2;CLASP1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.24753687427616666,-0.8570652750124332,0.7120743034055728,0.8588976860067863,1.0,18/38,30.78%,PTPRJ;MAGI2;XDH;PIK3CB;DAG1;PHLPP2;SIRT1;GPER1;EPHA2;AKT1;PPP2R5B;CIB1;HYAL2;ARRB2;PPP2R5C;TRIB3;NOP53;BANK1
prerank,eye photoreceptor cell development (GO:0042462),0.3547486360901154,0.8569091057161675,0.6401384083044983,0.9770546802056718,1.0,2/15,10.28%,MYO7A;RPGRIP1
prerank,chemical homeostasis (GO:0048878),0.2700553102292292,0.8568498711610262,0.699290780141844,0.9765119148425188,1.0,10/61,17.02%,ZBTB20;ACOX2;TLCD3B;IRS2;SLC66A1;TENT4B;SLC4A1;WNK2;ABHD4;NR1D2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.34287221442036214,0.8566822663980208,0.6397415185783522,0.9761902094301517,1.0,5/18,16.69%,PIK3R1;ATXN3;BAK1;BAG6;USP13
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3169447186912754,0.856593894647276,0.6571428571428571,0.9757128002396829,1.0,6/25,12.95%,ADK;GMPS;AMPD2;PRPS1L1;PRPS1;DGUOK
prerank,regulation of mitotic cell cycle (GO:0007346),0.23700796278309494,0.8562987370417783,0.745005875440658,0.9756748706243744,1.0,38/171,18.28%,BUB1B;L3MBTL1;PSMD1;MEIS2;SCRIB;PKMYT1;GBF1;FBXO5;RNF40;CCDC57;CDC16;PSMD10;PSMA5;PSMB5;RPS6KB1;CDK13;PRKCA;LGMN;XPC;PSMC4;PSMA4;TTC28;RCC1;MKI67;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;TFAP4;CDK10;BRINP1;PSMA7;SRA1;PSMD14;CDC26;CUL7;PSMA2
prerank,regulation of transport (GO:0051049),0.2963718418149445,0.8562872751808654,0.6858877086494689,0.9750252141189467,1.0,7/36,11.18%,TMEM102;VAMP2;LRRK2;MYO6;PINK1;POFUT2;SCFD1
prerank,regulation of epithelial cell migration (GO:0010632),0.2762673301080033,0.8561765033256773,0.6749633967789166,0.9745883956936001,1.0,6/51,7.70%,PTN;PTPRR;RHOJ;MCC;GLIPR2;PTK2
prerank,regulation of T cell cytokine production (GO:0002724),0.356173342494557,0.8560883151130417,0.6439522998296422,0.9741265222062874,1.0,1/15,0.79%,XCL1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.22876522065928853,0.8557267934810489,0.7865786578657866,0.9742495692219437,1.0,71/264,22.68%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNUPN;SNRPB2;CDK13;CELF4;SMU1;DDX17;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;SRSF10;SYF2;CLNS1A;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;GEMIN8;CTNNBL1;ZCRB1;RBM6;POLR2L;DDX1;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,response to nutrient levels (GO:0031667),0.3482159966410277,0.8556286795682936,0.6650246305418719,0.9737986897463702,1.0,4/17,13.01%,CD68;RPS6KB1;MTOR;MEAK7
prerank,cellular response to amino acid starvation (GO:0034198),0.26300557828929944,0.8555561468802599,0.6749311294765841,0.9732740036105213,1.0,19/71,19.01%,NPRL2;SZT2;WDR24;PRKD1;MTOR;EIF2AK2;DAP;TFEB;ATP6V0E1;EIF2S1;ATF2;MIOS;IMPACT;RRAGA;CASTOR1;ATP6V0D1;RRAGD;ATP6V1G2;EIF2AK3
prerank,cellular response to amino acid stimulus (GO:0071230),0.2992084625461183,0.8549479926526694,0.6676970633693973,0.9739001454121557,1.0,10/33,18.69%,CPEB1;MTOR;GLRA1;FYN;GLRA2;RRAGA;CASTOR1;KLHL22;RRAGD;CAPN2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.34097963313893137,-0.8541045760968368,0.669833729216152,0.8643436314507094,1.0,2/12,1.13%,CACNA1C;CAV1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.231406153839702,-0.8539326218129041,0.7725752508361204,0.8641028335225817,1.0,25/54,31.37%,CAV1;NXN;SQSTM1;RPL5;SOX4;SH3RF2;RPL11;HDAC8;ISG15;DCUN1D3;AKT1;COPS9;TNFAIP3;VPS28;SMAD7;BAG2;SENP2;HSPA1A;ARRB2;PARK7;U2AF2;PRR7;HSPA1B;MINAR1;CAMLG
prerank,regulation of cell size (GO:0008361),0.3217218974304246,0.853901187935132,0.6544,0.9754761639732542,1.0,4/23,9.11%,PRR16;PTEN;MTPN;MTOR
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3155307614330187,-0.8536433439868992,0.6413301662707839,0.8640186649946879,1.0,7/16,23.28%,ST8SIA4;ST6GALNAC3;LARGE1;ST8SIA2;ST3GAL5;A4GALT;ST8SIA6
prerank,positive regulation of double-strand break repair (GO:2000781),-0.249622740908594,-0.8534890358320817,0.7237237237237237,0.8636793633762213,1.0,14/39,25.49%,ARID2;PRKDC;KMT5B;SHLD2;PARP9;FUS;SMCHD1;DDX11;SETMAR;MGMT;WDR48;PARP1;DTX3L;KMT5C
prerank,protein homooligomerization (GO:0051260),0.24259676520461354,0.8530997285567076,0.7465495608531995,0.9765051709116129,1.0,16/114,11.66%,SLC1A5;TRPA1;POLQ;MPP2;ADCY8;CLYBL;ASIC1;GOLGA2;KCNC2;APPL2;HCN1;GLRA3;GSDMD;VSTM5;PYCARD;TRPM2
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.1757392750380282,-0.852976272229812,0.9876543209876543,0.8641039075601116,1.0,108/336,26.43%,FOXO1;FOXP1;BCL2L1;XIAP;SAMHD1;VCPIP1;MCL1;ACER2;CBX3;PRKDC;UVRAG;KMT5B;APC;TRIP12;MAPK14;CASP2;RNF8;VCP;NRDE2;FNIP2;INTS3;TLK2;UBA6;CRIP1;PAXX;BTG2;DYRK2;BAX;UBE2A;RBBP8;INO80;RECQL5;ATR;CBX1;ZDHHC16;RTEL1;BID;OTUB1;RNF169;HERC2;WDHD1;ETAA1;ATM;BOK;GNL1;LIG1;POLE2;NBN;CDKN2AIP;CCND1;GRB2;PLK5;RAD51D;CDKN1A;NSMCE4A;DDX11;ENDOV;RAD51C;PARP4;SIRT1;NSMCE3;TRRAP;EPHA2;OARD1;APTX;HUS1;MUS81;OGG1;XRCC2;APBB1;USP3;NPM1;GTF2H4;MACROD1;CIB1;CHD1L;E2F1;MCM9;MGMT;PHF1;BATF;FANCG;WDR48;IKBKE;RFWD3;ZRANB3;TAOK2;PARP1;MCM8;PARP2;BCL2L11;IKBKG;ATRIP;SUMO1;RMI2;RAD51;BACH1;DTX3L;BRSK1;HINFP;CHEK2;NCOA6;KMT5C;TIGAR;BRCA1;PCLAF;PARK7;CHRNA4
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.22439024279997485,-0.852726015972077,0.7831325301204819,0.8639349698252607,1.0,23/64,28.66%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;GTF2F2;CTDP1;ELOF1;TCEA1;POLR2I;POLR2K;TCEA2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3187280439878576,0.852706273770049,0.6529968454258676,0.9767115914201403,1.0,3/25,11.17%,ITPR1;LRRK2;P2RX4
prerank,response to amino acid starvation (GO:1990928),0.2618191640691847,0.8525530634171948,0.6790123456790124,0.9763676832142651,1.0,19/72,19.01%,NPRL2;SZT2;WDR24;PRKD1;MTOR;EIF2AK2;DAP;TFEB;ATP6V0E1;EIF2S1;ATF2;MIOS;IMPACT;RRAGA;CASTOR1;ATP6V0D1;RRAGD;ATP6V1G2;EIF2AK3
prerank,regulation of protein transport (GO:0051223),0.3111465676990028,0.8522666657789872,0.6666666666666666,0.9763189441220564,1.0,9/27,17.32%,DNAJC1;LLGL1;P3H1;NDFIP2;SCFD1;ARFIP1;SNX12;NDFIP1;STXBP5
prerank,defense response to protozoan (GO:0042832),-0.34243325990745543,-0.8520403215268443,0.677570093457944,0.8646618778268347,1.0,4/12,11.59%,GBP7;GBP4;GBP2;GBP6
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.26218726614892396,0.8517734531196487,0.7013698630136986,0.976733055696294,1.0,20/78,22.24%,PTEN;NR2F2;CDKN2A;CCNJ;PKMYT1;PSMD10;CDKN2D;CCNB2;CDKN2C;CCNA2;TFAP4;GTF2H1;CCNK;CCNE1;LATS2;MEN1;CDK5R1;CCND3;CDK7;CCNT2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.29973495854664695,0.8517035543602524,0.6744186046511628,0.9762157436460288,1.0,11/33,17.78%,HRG;RAC3;PTK2;JAM3;PLAU;TESC;LYN;EFNA1;FERMT3;PIK3CG;PDE3B
prerank,photoreceptor cell development (GO:0042461),0.356379709770581,0.8516363791983723,0.658578856152513,0.9757020946341695,1.0,3/14,17.63%,MYO7A;AHI1;CDHR1
prerank,neural crest cell differentiation (GO:0014033),0.3355594956948471,0.8514838340832294,0.6515397082658023,0.9753706871108527,1.0,3/18,9.37%,NRG1;HTR2B;TAPT1
prerank,regulation of intracellular transport (GO:0032386),0.2940341678997893,0.8513256150644798,0.6591928251121076,0.9750403211177264,1.0,11/38,19.60%,NUP214;AAAS;NEFH;LRRK2;TTC21B;SCFD1;ATP9A;RINT1;CAPN10;WWC1;ATPSCKMT
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.33207487622555937,-0.8510025118119483,0.691566265060241,0.8660094743903074,1.0,5/13,16.99%,NR3C2;ABHD2;NR3C1;GPER1;ESR1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.28116104397535424,-0.8505419868191018,0.6871657754010695,0.8662279237537026,1.0,9/23,23.21%,WNT5B;SMO;SIX1;PIK3CD;MDK;EGF;AGT;SIX4;SOX8
prerank,positive regulation of MAP kinase activity (GO:0043406),0.26441076919278417,0.850366593918304,0.7050754458161865,0.9764790732927727,1.0,7/66,5.62%,IL34;EDN3;CD40;FGFR1;HTR2B;TLR6;LRRK2
prerank,regulation of protein secretion (GO:0050708),0.24353862054870795,0.8502447348940478,0.7459119496855345,0.9760675542463451,1.0,17/119,12.83%,RAPGEF4;PPID;CACNA1E;ITPR1;DNAJC1;LLGL1;IER3IP1;PER2;PRKCA;P3H1;KCNC2;SYT7;GCK;PPP3CB;EXOC1;IL12A;ARFIP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3095736319020391,0.8502065547426124,0.6498422712933754,0.9754814409710139,1.0,10/27,18.79%,CTNNA2;PTEN;DISC1;GSK3A;NTNG2;NTNG1;BRSK2;NCS1;IL1RAPL1;ULK4
prerank,microtubule bundle formation (GO:0001578),0.28842760839275283,0.8497417949242599,0.6871428571428572,0.9758066520589737,1.0,6/42,11.65%,NCKAP5L;RSPH9;AAAS;MTCL1;CAPN6;GAS8
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.35877603641235595,-0.8492177932003246,0.6365795724465558,0.8682006156926831,1.0,1/10,0.55%,RAPGEF2
prerank,regulation of protein dephosphorylation (GO:0035304),0.2925513730240601,0.8486206447360514,0.6983655274888558,0.9774901077236358,1.0,9/37,16.59%,DLC1;PPP6R2;PTPA;HSP90B1;ANKLE2;SYMPK;TSC1;PPP1R8;PPP6R3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.277793201125188,-0.8485727516581751,0.6767955801104972,0.8688495939358787,1.0,9/24,21.55%,BCL2L1;ACKR3;CD44;TPT1;SIRT1;SNAI1;CD74;MIF;CCAR2
prerank,regulation of necroptotic process (GO:0060544),-0.2751088161489241,-0.8473984439918618,0.6844919786096256,0.8705682808547865,1.0,12/23,26.98%,YBX3;PELI1;CASP8;CYLD;SDCBP;MLKL;PDCD6IP;CFLAR;BIRC3;SLC25A4;FLOT1;ZBP1
prerank,regulation of sodium ion transport (GO:0002028),0.2952036445116751,0.8472513811405127,0.6763803680981595,0.9797174503822833,1.0,7/34,11.17%,NKAIN1;CNKSR3;ANK3;NKAIN2;NEDD4;FGF12;P2RX4
prerank,regulation of mRNA polyadenylation (GO:1900363),0.34158261418025765,0.8469653271442358,0.660958904109589,0.9796662524443874,1.0,3/17,10.19%,CPEB1;RNF40;NUDT21
prerank,protein autoubiquitination (GO:0051865),0.2640846248369668,0.8460202755241287,0.7132867132867133,0.9809416657438699,1.0,5/61,7.21%,SH3RF1;SH3RF3;RNF220;BFAR;TRIM37
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.35420425108254566,0.8459282962825809,0.659016393442623,0.9804773911331686,1.0,3/15,12.81%,TAF9B;ARMC10;PTTG1IP
prerank,establishment of melanosome localization (GO:0032401),-0.3027002131665002,-0.8458367369061083,0.6921241050119332,0.8730403669491174,1.0,7/19,28.53%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,protein localization to condensed chromosome (GO:1903083),-0.33608068798302015,-0.8456066178133976,0.6946386946386947,0.8728397672957283,1.0,6/12,32.58%,MTBP;ZW10;BUB3;IK;TTK;ZWILCH
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.28515161338139305,0.8453790337971994,0.6845238095238095,0.980956388356503,1.0,7/38,12.73%,IL34;UNC119;DLG3;RELN;GRM5;DLG4;CASS4
prerank,toll-like receptor signaling pathway (GO:0002224),0.2527515140623716,0.8451408878349029,0.717948717948718,0.980770757865888,1.0,17/84,17.67%,COLEC12;UNC93B1;NR1H4;TLR6;TLR8;LGMN;TLR4;BIRC2;IRAK1;MAPKAPK3;S100A1;HSP90B1;UBE2D1;RIPK1;TIRAP;LGALS9;MYD88
prerank,response to molecule of bacterial origin (GO:0002237),-0.21987002997762195,-0.8450808237798341,0.7859778597785978,0.873243156760388,1.0,8/69,8.26%,SMAD6;FOXP1;FER;NOS3;LBP;PELI1;IFNAR1;GCH1
prerank,positive regulation of cell cycle (GO:0045787),-0.22251542121882623,-0.8446755600973462,0.7715231788079471,0.8733688800884511,1.0,17/62,22.16%,EGFR;CCNYL1;APP;CCND2;TGFB2;LRP6;RPS15A;CITED2;CCND1;TAL1;ANKRD17;EIF4EBP1;PKN2;AKT1;RGCC;ASNS;NUPR1
prerank,protein glycosylation (GO:0006486),0.23862847294940856,0.8444928259416059,0.7658779576587795,0.981558403973117,1.0,22/125,14.57%,PLOD1;ST8SIA1;OGT;GALNT18;RPN2;GCNT2;ENTPD5;DAD1;POMT1;ALG6;GFPT2;B3GNT8;MAN1C1;GOLGA2;GALNT10;ALG5;FKTN;TUSC3;TMEM258;B4GALT7;B3GALT5;PMM2
prerank,protein lipidation (GO:0006497),0.26782566824970966,0.8443501234203427,0.6995884773662552,0.9811927880075904,1.0,21/59,27.31%,PIGV;GPLD1;PIGQ;WDR45B;PIGP;PIGA;PIGL;ZDHHC2;HHAT;ZDHHC6;WIPI2;ZDHHC9;ZDHHC8;ATG10;ZDHHC17;PIGN;SELENOK;MPPE1;PIGB;WIPI1;PIK3C3
prerank,defense response to symbiont (GO:0140546),0.25111083540532547,0.8442896024357874,0.7536041939711664,0.9806514677976055,1.0,14/92,15.88%,MAP3K14;RTP4;CD40;IFIT2;TLR8;PDE12;TRIM56;IFNLR1;EIF2AK2;PYCARD;AGBL4;SERINC5;CNOT7;EXOSC5
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3105871477832701,-0.8440675388921706,0.6962962962962963,0.873928681779545,1.0,4/16,10.62%,FOXD1;SIX1;FGF1;NPNT
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.31469531797962524,0.8439792159454446,0.6602870813397129,0.9806625094852117,1.0,7/24,18.49%,NR1H2;LRRK2;HERPUD1;OPA1;CREB3L1;CLU;ALOX5
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.36938035336689834,0.8439500073242541,0.657243816254417,0.9800579697553502,1.0,2/12,9.69%,GCNT2;BMP7
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.31393263286643114,0.8433890519594012,0.6604651162790698,0.9805408374084228,1.0,3/26,8.55%,ATP1A2;FMR1;GNB5
prerank,organelle assembly (GO:0070925),0.21913093046018317,0.8433326100894338,0.8414766558089034,0.9799850628715456,1.0,78/384,18.18%,DYNLL1;CDC14B;ATG9B;TRAF3IP1;CCDC61;DZIP1;NPHP3;WDPCP;WDR35;HAUS3;WDR45B;HAUS1;GBF1;LSM14A;CCDC57;RAB8A;CENPE;STARD9;DISC1;ATP2A2;LSM4;E2F4;CAPN3;IFT81;HAUS8;FAM161A;BSCL2;GOLGA2;HPS1;ABCB6;SNAP29;RB1CC1;CCDC65;AHI1;TCTN2;IFT74;RCC1;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;EDC3;IQCB1;SSX2IP;RFX2;TUBGCP4;IFT88;CENPC;HGS;RAB11FIP3;CEP126;CENPW;SCLT1;TXNDC15;EIF2S1;ACTR2;ATG9A;TSG101;EIF4ENIF1;DYNLL2;CEP250;ATG14;SNF8;TUBGCP6;PTPDC1;CENPF;ULK2;IFT43;UBXN2B;CLUAP1;VPS4B;GOLGA8B;BBS1;WIPI2;PCM1;ATP6V0D1;WDR90
prerank,dendritic cell differentiation (GO:0097028),0.32177848831069034,0.8433067793756481,0.6727574750830565,0.9793886124707467,1.0,6/22,19.87%,AXL;CAMK4;TRPM2;LYN;LGALS9;PRTN3
prerank,regulation of axon extension (GO:0030516),-0.25132963143600506,-0.8432448756338558,0.7452229299363057,0.8748864305309649,1.0,8/37,13.68%,NTN1;SEMA7A;RUFY3;APOE;GSK3B;MAPT;GOLGA4;MACF1
prerank,regulation of Golgi organization (GO:1903358),-0.2944753351738259,-0.8429662450776142,0.6997518610421837,0.8747702616811239,1.0,4/17,18.35%,ARMH3;STX18;MAP2K2;CAMSAP2
prerank,gluconeogenesis (GO:0006094),0.28563115759122004,0.8428272621588048,0.706766917293233,0.979738613009991,1.0,6/39,11.23%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3
prerank,regulation of TOR signaling (GO:0032006),-0.21727583797781508,-0.8426337381776643,0.7910447761194029,0.8747891510823345,1.0,15/67,16.15%,FNIP1;DEPTOR;RICTOR;PRKAA2;SH3BP4;UBR1;LAMTOR5;RRAGC;HDAC3;UBR2;TBC1D7;LAMTOR3;TBCK;SIRT1;PRKAA1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.31417673985421424,-0.8424144181942488,0.6835748792270532,0.8746030657738779,1.0,11/14,50.62%,TYROBP;CSF1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;TRAF6;IL12B
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.3229398203823769,-0.8423463446899521,0.6821705426356589,0.8741008412848555,1.0,8/13,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;GAL3ST3;B4GAT1;B3GNT6
prerank,positive regulation of organelle assembly (GO:1902117),0.2841202698454259,0.8422995234062867,0.7147058823529412,0.9802052519188807,1.0,9/44,13.02%,PIP4K2A;FSCN1;GPSM2;IL5;TAPT1;ASAP1;ARHGAP35;ENTR1;CNOT1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24816256465463551,0.8420640244183872,0.7421465968586387,0.9800209099721175,1.0,28/88,23.38%,FBXO9;PSMD1;FBXO31;DMAC2;PSMD10;PSMA5;PSMB5;AMN1;FBXO17;PSMC4;PSMA4;PSMC5;FBXW5;FBXL13;CUL5;PSMB9;PSMA7;PSMD14;PSMA2;CUL4A;PSMD11;FBXO4;FBXW4;FBXL22;BTRC;FBXL5;FBXL12;KIF14
prerank,connective tissue development (GO:0061448),0.2962745825143265,0.8418278496090403,0.6573116691285081,0.9798106317937818,1.0,5/35,5.84%,SULF1;PGRMC2;SOX6;ZBTB16;CREB3L2
prerank,cellular copper ion homeostasis (GO:0006878),0.35295850058051204,0.8417301604765414,0.6529516994633273,0.979362819654331,1.0,3/14,14.03%,CCDC22;ABCB6;ATP7A
prerank,ERAD pathway (GO:0036503),0.25213110413708173,0.8413734037899584,0.7284768211920529,0.9794443769401342,1.0,22/83,16.82%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;SEC61B;RCN3;TMEM67;DNAJC10;USP19;HSP90B1;ATXN3;HSPA5;BAG6;YOD1;BRSK2;UBXN6;USP13;DNAJB14
prerank,phospholipid metabolic process (GO:0006644),-0.2166059934539591,-0.8411713177958354,0.8148148148148148,0.8757600863038335,1.0,19/71,23.41%,PLPP3;MBOAT1;PLA2G4A;SMPD3;AGPAT4;TNFAIP8L3;ENPP2;PIP4P1;PGP;PLAAT3;SMPD1;CLN8;PLA2G4E;PNPLA3;PIP5K1A;AGPAT2;PLA2G4C;PLPPR1;FITM2
prerank,striated muscle cell differentiation (GO:0051146),0.344308294076083,0.8411331714732164,0.6660869565217391,0.9792738107527336,1.0,2/16,3.70%,NRG1;MYEF2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.26586363095946197,-0.8411091186831531,0.7013698630136986,0.8752255090818071,1.0,9/28,25.49%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;NUDT16L1;DTX3L;KMT5C
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.3531897931565747,-0.8407361450038638,0.6556603773584906,0.875303819082347,1.0,5/10,25.65%,CX3CR1;FZD3;CX3CL1;SMARCD3;KDM1A
prerank,response to leucine (GO:0043201),-0.35646038031528904,-0.8405835175327478,0.6866666666666666,0.8743011350440985,1.0,3/10,11.79%,SESN1;UBR1;UBR2
prerank,cellular response to leucine (GO:0071233),-0.35646038031528904,-0.8405835175327478,0.6866666666666666,0.8743011350440985,1.0,3/10,11.79%,SESN1;UBR1;UBR2
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.30451958261475515,-0.8401660904894582,0.6893203883495146,0.8744580193968567,1.0,3/16,10.02%,IGF1R;INSR;CLEC16A
prerank,sphingoid metabolic process (GO:0046519),-0.3371281260858875,-0.8398552930183818,0.696551724137931,0.8743990082105133,1.0,5/12,26.54%,PLPP3;DEGS2;KDSR;SPHK2;ASAH2
prerank,vesicle transport along microtubule (GO:0047496),-0.2787624409536422,-0.839733025783695,0.7296587926509186,0.8739815227177076,1.0,8/23,23.87%,NDEL1;DYNC1H1;TRAK2;RAB1A;DYNC1I1;KIF1C;BICDL1;KIF5B
prerank,endomembrane system organization (GO:0010256),0.2310263259280824,0.8392332077147479,0.7856301531213192,0.9825573641065105,1.0,50/178,22.55%,SEC16B;PHETA2;SEC16A;SPTBN1;ANK3;GBF1;DNAJC28;LRRK2;SMPD4;SUN2;SYP;GOLGA2;PRKD1;RAB30;RAB29;RAB2A;DNM1;WASHC5;LNPK;SYNE1;AP3D1;COG1;TRIP11;CLASP2;PHETA1;HACE1;VPS33B;CLASP1;USP6NL;UBXN2B;TMED3;TMED9;GOLGA8B;GOLGA5;CTDNEP1;CUL7;NUP155;EIF2AK3;MIA3;TRAPPC12;TBC1D20;PLEKHM2;ARFGEF2;PI4K2A;ATL1;TLCD1;SERP1;BAG5;BNIP1;RAB22A
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3263640210650389,0.8382444105656711,0.6704,0.9839419906069333,1.0,2/21,4.06%,LRP1;NR1H2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.26001959030199157,-0.8382199458980986,0.7479224376731302,0.8762679150592285,1.0,10/30,21.86%,CAVIN1;GTF2H5;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,negative regulation of protein catabolic process (GO:0042177),-0.24412726047674685,-0.8380791694156893,0.7669902912621359,0.8759018598691839,1.0,8/40,20.12%,EGFR;PTPN3;CST3;AZIN1;FLNA;CYP51A1;SNX3;TIMP3
prerank,lysine catabolic process (GO:0006554),0.35658224042361575,0.8378373128764229,0.6566901408450704,0.9835285952754268,1.0,3/12,16.27%,SLC25A21;DLST;AASS
prerank,lysine metabolic process (GO:0006553),0.35658224042361575,0.8378373128764229,0.6566901408450704,0.9835285952754268,1.0,3/12,16.27%,SLC25A21;DLST;AASS
prerank,tRNA aminoacylation (GO:0043039),0.28953909335775985,0.8376856316547542,0.6932153392330384,0.9831828327693691,1.0,13/37,26.61%,EPRS1;CARS1;TARS1;YARS1;HARS1;SARS2;SARS1;AIMP1;PPA2;MARS2;AARS1;FARSA;YARS2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.27946135710367404,0.83725051931439,0.7271407837445574,0.9834106856364763,1.0,8/42,14.95%,CECR2;HDAC1;CHD4;MBD3;SPTY2D1;SMARCA1;CHD8;DMAP1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3340810324132087,-0.837204503761636,0.6650485436893204,0.8769244106040801,1.0,6/12,28.65%,SERINC3;PSAT1;CBS;SEPHS2;CTH;GGT1
prerank,mitochondrial fission (GO:0000266),0.3440540383978084,0.8371998823622021,0.6764705882352942,0.982848720328418,1.0,4/16,14.74%,MTFR2;OPA1;DNM1;MTFP1
prerank,positive regulation of lyase activity (GO:0051349),0.35759132891898604,0.8360269857653175,0.6825396825396826,0.9846094214006902,1.0,3/14,6.98%,AKAP5;NF1;FXN
prerank,synaptic vesicle cycle (GO:0099504),0.30251321534752296,0.8360033348901459,0.6916802610114192,0.9840052702073776,1.0,7/30,17.24%,VAMP2;SYNDIG1;SYT7;RIMS1;DNAJC5;PCLO;CDK5
prerank,rRNA catabolic process (GO:0016075),0.3467171239591002,0.8358634439721284,0.6751700680272109,0.9836378423920413,1.0,6/16,19.04%,EXOSC9;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.30044138858587693,-0.8355696833163394,0.7052896725440806,0.8794166136909805,1.0,4/18,9.80%,PSMD9;CCN3;KCNB1;SFRP1
prerank,reverse cholesterol transport (GO:0043691),0.36226655340651415,0.8353874447081474,0.6730769230769231,0.9839470693801965,1.0,3/13,15.09%,LIPC;ABCA5;CLU
prerank,regulation of blood circulation (GO:1903522),0.29305212470082453,0.8353562839576358,0.7177177177177178,0.9833578076172775,1.0,3/34,7.97%,ECE1;KCNIP2;PER2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.36601254242673786,0.8352941905677684,0.6768707482993197,0.9828395592178606,1.0,4/12,15.21%,SEC63;SEC61B;HSPA5;GET3
prerank,epithelial cell-cell adhesion (GO:0090136),0.36873851375044037,0.8352539291979728,0.6456140350877193,0.9822621657535741,1.0,2/11,3.95%,ITGB5;JUP
prerank,regulation of RNA metabolic process (GO:0051252),-0.22195689165578963,-0.8352336092630918,0.8044280442804428,0.8793980649425412,1.0,17/59,18.41%,MBNL1;AHNAK;AHNAK2;NOVA2;CELF1;HNRNPF;PCBP2;PTBP3;RC3H1;MBNL2;FASTK;FUS;HNRNPH1;SRRM4;FAM50A;RASA1;PQBP1
prerank,neuron projection extension (GO:1990138),0.2904464355941817,0.8351771090521197,0.7057926829268293,0.9817740733937363,1.0,10/32,19.08%,AUTS2;SEMA5A;TMEM108;CDKL3;PPP3CB;IMPACT;ULK2;CYFIP1;CDK5;LLPH
prerank,regulation of cell-cell adhesion (GO:0022407),0.28321167731425867,0.8348003187432048,0.6983655274888558,0.9818559933046023,1.0,5/39,7.70%,EPHA7;TENM3;PTPRR;FLOT2;PTK2
prerank,positive regulation of actin nucleation (GO:0051127),-0.34270996203140813,-0.8348002202818333,0.6623093681917211,0.8795877042358571,1.0,2/11,3.69%,WASF2;GSN
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3045580229268023,0.8347360530030788,0.7009345794392523,0.9813469959740586,1.0,6/29,17.28%,CXCL10;PLA2G7;LGMN;IL12A;CALR;LGALS9
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.29841197623413473,0.8344859383032514,0.6776611694152923,0.9811921187271158,1.0,7/30,15.90%,MICALL2;PINK1;SAE1;HTRA2;GSK3A;RNF31;CSNK2A2
prerank,positive regulation of developmental growth (GO:0048639),0.2716796164981954,0.8343101215433134,0.726507713884993,0.9809026965768364,1.0,12/49,20.02%,GHR;CDKL5;LIMK1;RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1;ZFYVE27;MAP3K13
prerank,dendritic cell chemotaxis (GO:0002407),0.3528321775723948,0.8342649640303634,0.6441281138790036,0.9803351668290471,1.0,5/14,25.54%,GPR183;TRPM2;PIK3CG;HMGB1;CCR5
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3705121767511924,0.8340182134777671,0.6819787985865724,0.9802030227465995,1.0,10/10,62.97%,SAG;PDE6A;GRK1;CNGA1;GNB1;CNGB1;GNAT1;RHO;PDE6B;PDE6G
prerank,regulation of cell death (GO:0010941),0.2481932055738977,0.8340159528269101,0.7392438070404173,0.979562305948813,1.0,13/94,9.69%,LRP1;ACOX2;EPHB1;HTR2B;DHCR24;LRRK2;PDE12;DUS2;NPAS2;PRKD1;DCC;RAB29;BMP7
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.29316740774263633,0.8335642471819064,0.6970149253731344,0.9798345999642378,1.0,5/31,14.06%,GLMN;PDCD1LG2;TNFRSF21;CD86;LYN
prerank,positive regulation of nuclear division (GO:0051785),0.3122679435187128,0.8334534644211171,0.6799336650082919,0.9794212882278414,1.0,4/25,12.42%,EDN3;PHIP;NUSAP1;IGF2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3309884552327226,-0.8330379424978472,0.647191011235955,0.8822603826734445,1.0,8/12,37.58%,SMO;SIX1;AGT;SIX4;SOX8;LHX1;PAX8;NOG
prerank,global genome nucleotide-excision repair (GO:0070911),0.309728487036343,0.832738131522455,0.6838709677419355,0.9802022032841217,1.0,9/26,20.54%,ERCC1;ERCC4;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;USP45;DDB1
prerank,artery morphogenesis (GO:0048844),-0.2554158509062431,-0.8325673830321657,0.7416879795396419,0.8824868390893014,1.0,8/30,14.79%,NRP1;BMPR2;NOTCH1;TGFB2;TBX1;TBX2;HEY2;STRA6
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21198189687806684,0.8325186409351604,0.8739754098360656,0.98000323000407,1.0,104/572,17.44%,IL33;ZEB1;ZFHX3;TRPS1;PPARA;MIER2;ETV5;HDAC1;PPID;TAF9B;NR2F2;TCF7L2;SALL1;THRA;NR1H4;PEX2;PER3;MEIS2;NFATC3;PPARD;NR1H2;LOXL2;REST;TBX3;ZBTB16;NEDD4;ZFP37;RTF1;SIRT6;PSMD10;BCOR;GLIS1;DUSP22;TENM2;SRF;BRMS1L;BRMS1;ZBTB2;TRIM37;LYAR;BCL6;NR2C1;TAF3;ZKSCAN3;MDM4;PER2;TWIST1;SOX2;MXI1;NOC2L;PHF6;SP100;NSD1;GLI3;SOX10;TP53;N4BP2L2;ZFPM2;ZNF25;SNW1;EPC1;ESR2;SOX9;MYT1L;IGF2;SAP30;DPF2;KDM1B;CNOT1;PRDM5;ATN1;NRIP1;NFIX;HDAC10;PEG3;MED1;CUX2;UBE2D1;MED25;BPTF;ZBTB32;CHD8;FOXM1;DMAP1;AR;MYC;CRY2;ORC2;DCAF1;FGFR2;KLF11;IMPACT;EFNA1;ZBTB7A;AASS;ZNF3;MAZ;NR1D2;CALR;DNMT3A;SARS1;MBD2;LDB2;LDB1
prerank,secondary alcohol metabolic process (GO:1902652),-0.23757673434802506,-0.8323554276263129,0.7987220447284346,0.8822410786223619,1.0,12/42,23.37%,FDX1;RXRA;APOE;PIP4P1;SOAT1;IDH3B;CLN8;OSBPL1A;IDH3A;EBP;TSKU;CLN6
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3080333840572169,-0.8316830586994576,0.6795454545454546,0.8828895978822238,1.0,5/15,17.19%,NUDT7;ACAT1;PMVK;ACACB;HMGCS2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3435823081154937,-0.8306072887220483,0.6997690531177829,0.8842958023396368,1.0,3/11,11.48%,NSUN2;NRDE2;NUP153
prerank,negative regulation of autophagy (GO:0010507),0.26319388717331454,0.8297818420244198,0.7440559440559441,0.9848941166175262,1.0,13/54,18.12%,EIF4G3;HTR2B;PTPN22;LRRK2;ZKSCAN3;GOLGA2;PINK1;MTOR;DAP;SNRNP70;TSC1;RRAGA;KLHL22
prerank,mucosal immune response (GO:0002385),0.34664406353990096,0.8295409984529445,0.6902800658978583,0.9847441991648954,1.0,15/15,65.37%,IFNLR1;OTUD7B;PLA2G1B;DEFA6;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;RNASE3;RPL39
prerank,long-chain fatty acid import into cell (GO:0044539),0.37440716683371544,0.8294154206459258,0.6672443674176777,0.9843426958034719,1.0,2/10,7.87%,SPX;RPS6KB1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.33978480565908087,-0.8286057144484908,0.6834862385321101,0.8868831289553484,1.0,4/11,19.81%,CCT3;CCT4;CCT7;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.33978480565908087,-0.8286057144484908,0.6834862385321101,0.8868831289553484,1.0,4/11,19.81%,CCT3;CCT4;CCT7;MEPCE
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.3432351950714188,-0.8284759036760139,0.6713615023474179,0.8864880122112885,1.0,6/11,47.99%,SIRT1;TAF7;CIITA;PF4;IL4;TMEM106A
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3029610811021127,0.8283100649743115,0.6909667194928685,0.9852826618808416,1.0,5/29,15.23%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3029610811021127,0.8283100649743115,0.6909667194928685,0.9852826618808416,1.0,5/29,15.23%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3152285170271252,-0.8278043443601211,0.6977777777777778,0.8870584946833608,1.0,6/13,25.75%,RPS15;NOP9;RAN;NPM1;LTV1;LSG1
prerank,cellular response to nitrogen compound (GO:1901699),0.3233242763189479,0.827661506202008,0.6871961102106969,0.9859441687460286,1.0,5/20,11.64%,NR1H4;FMR1;PDE12;DAXX;SPIDR
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2787171439511082,0.8275742908437619,0.7220630372492837,0.9854503216447966,1.0,9/39,16.69%,UTRN;ANK3;SCN2B;NEDD4;FXYD4;FGF12;WNK2;FGF14;HECW1
prerank,positive regulation of cartilage development (GO:0061036),0.3380571663668407,0.8274245763525785,0.6939443535188216,0.9851268868083767,1.0,5/17,12.02%,LOXL2;SOX6;ZBTB16;TAPT1;SOX9
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2902912333076909,0.8261355924782812,0.7008,0.9870508274873852,1.0,6/30,10.60%,NAT10;ERCC4;TERF1;PIF1;TENT4B;TP53
prerank,somite development (GO:0061053),0.36936760695335374,0.8258767128889115,0.6819787985865724,0.9869280705997049,1.0,2/11,10.12%,LOXL3;PPP2R3A
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.36149423979716766,0.8257231734863185,0.6817325800376648,0.9865969382204732,1.0,1/12,1.00%,PPARA
prerank,autophagosome maturation (GO:0097352),-0.25501551356964614,-0.8255653363054615,0.7822085889570553,0.8906053772484961,1.0,6/32,7.76%,UVRAG;GABARAP;EPG5;GABARAPL1;CALM1;VCP
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.27297696389704973,0.8248928641130424,0.7474892395982783,0.9876417884715408,1.0,9/51,15.62%,EPB41L3;CNTNAP2;MAP4K4;LRRK2;BMP7;ATP7A;CTTN;SGK1;TNIK
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3467651797826753,-0.8243511220951251,0.6889400921658986,0.8922171385144915,1.0,3/11,12.73%,TGFB2;SOX4;HEY2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.2565677392128247,-0.8243185762624775,0.7574123989218329,0.8916265193700861,1.0,6/29,12.98%,KANK2;RUNX1;VPS18;WBP2;KCTD6;VPS11
prerank,autophagosome assembly (GO:0000045),-0.22539560116702984,-0.8242677887425532,0.8163265306122449,0.8910711263006794,1.0,22/52,29.09%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;RAB1A;ATG12;ATG2A;MAP1LC3A;AMBRA1;RAB1B;ATG101;MAP1LC3B;WDR45;SMURF1;EMC6;ATG16L1;UBXN2A;RAB19;IRGM
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3586051997473691,0.823794323364717,0.6857142857142857,0.9892591361348582,1.0,4/13,14.78%,GRIN2A;LGMN;ASPH;BAK1
prerank,cellular calcium ion homeostasis (GO:0006874),0.23401776118837178,0.8236392655936564,0.8072855464159812,0.9889124287127825,1.0,16/133,9.08%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ADCY8;CALCA;HERPUD1;CALB1;ATP13A3;TRPC3;PRKACA;MICU3;HTR2C
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3353125810556112,0.8235549299015293,0.6860068259385665,0.9884384372007615,1.0,3/16,12.02%,ACADL;APPL2;SOX9
prerank,icosanoid metabolic process (GO:0006690),-0.23789824255384814,-0.8233725994457681,0.7899408284023669,0.89202567082652,1.0,5/40,5.00%,PTGS1;PLA2G4A;CYP1B1;MGLL;PON3
prerank,regulation of chromatin organization (GO:1902275),-0.30662621362607595,-0.8233156969427224,0.7061503416856492,0.8914789231650317,1.0,3/14,8.36%,MLLT3;TLK1;TLK2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.2974995443054066,0.8230826838257344,0.6957878315132605,0.988753566604041,1.0,5/27,10.83%,UTRN;SCN2B;COMMD1;FXYD4;FGF12
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.36016613400057695,0.8230280118002926,0.6594202898550725,0.9882103001816586,1.0,2/11,7.80%,CCT5;TERF1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.272378610394459,0.8227528921937323,0.7190684133915575,0.9881398893275436,1.0,8/43,15.27%,ZFYVE28;SPRY1;CBLB;EPS15;HGS;SH3KBP1;TSG101;AREG
prerank,regulation of protein catabolic process (GO:0042176),-0.1970063822962234,-0.8223736810181707,0.8930232558139535,0.892536454528327,1.0,24/99,20.49%,FOXO1;WWP1;EGFR;WWP2;GPC3;APC;GSK3B;VCP;AZIN1;SMURF2;EEF1A1;ASB5;RNF41;APC2;FLNA;FURIN;OAZ1;CYP51A1;OAZ2;TMEM9;SNX3;WDR91;FZR1;TNFAIP3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.21619597873593183,0.8222035104685822,0.867237687366167,0.9885690369928076,1.0,82/327,22.96%,RORA;CHD7;ZFHX3;MSC;ATF5;NCOA2;MYT1;TEAD2;REST;SOX6;ZNF423;FOXN2;CXXC1;ZFP37;HP1BP3;SPIN1;SPTY2D1;SOX2;EDF1;DAXX;SRRT;BRCA2;NSD1;TP53;NFXL1;TGFBR1;ESR2;SRSF10;IGF2;TFEB;SAP30;NUP107;ZNF628;CARM1;HDAC10;ARNT2;SSBP2;TGFBRAP1;UBE2V1;HNRNPD;MLF1;ATF2;WTIP;MAFB;ZKSCAN5;TRIP4;NONO;USP13;NR1D2;CALR;ZBTB11;LDB1;MLF2;BMP2;KAT7;SKOR2;REXO4;HIF1A;WWC1;THAP7;TERF2IP;NR2C2;SP1;TRAPPC2;CNBP;DVL2;HCFC2;GON4L;UTP4;APBB3;ASCC1;DDIT3;CREBBP;LIN54;SERTAD3;ATRX;MLLT6;NLK;RREB1;ABL1;HOXB7;ZMIZ1
prerank,mesenchymal cell development (GO:0014031),-0.2934627897501445,-0.8221569064823322,0.7182741116751269,0.8923075282859725,1.0,6/18,12.82%,FOXC1;NOTCH1;TCOF1;HEYL;HEY2;NOLC1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.36683883702584863,0.8221213329960905,0.6666666666666666,0.9880979307050298,1.0,2/11,12.14%,TIMM10;AGK
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.2573897732879758,0.8220380291253967,0.7517433751743375,0.9876229306385388,1.0,17/67,18.81%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;PSMA7;CALR;PSMD14;PSMA2;PSMD11
prerank,regulation of vesicle-mediated transport (GO:0060627),0.24463133762956965,0.8219700844279705,0.7776349614395887,0.9871237893824899,1.0,18/91,15.24%,PLD1;ITGAV;VAMP2;LRRK2;RAB8A;RUFY1;RAB3C;RIMS2;MAP2K1;FGR;OPHN1;SYT7;RAB15;SCFD1;ATP9A;RINT1;SNX12;PACSIN3
prerank,response to nitric oxide (GO:0071731),-0.32909322250077455,-0.8218979444216007,0.6962305986696231,0.8921717421633293,1.0,1/13,0.46%,FOXO1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.25457184056618753,0.8217390120404284,0.7592847317744154,0.9869497260409463,1.0,17/70,18.81%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;PSMA7;CALR;PSMD14;PSMA2;PSMD11
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.28373649883755564,0.8214748554732768,0.7109375,0.9868517456782474,1.0,10/36,17.81%,WNT5A;TCF7L2;AGO4;PPP3CB;AGO3;GNAO1;GNG2;TNRC6B;AGO1;CAMK2A
prerank,negative regulation of ATPase activity (GO:0032780),0.33910918138866236,0.8214359084056482,0.666098807495741,0.986286122658135,1.0,5/16,20.41%,VCPKMT;TP53;PAM16;TSC1;PXK
prerank,oligodendrocyte development (GO:0014003),0.34520755410848863,0.8214135564794647,0.6840277777777778,0.985693731870897,1.0,4/15,13.88%,EIF2B1;SOX10;PLP1;MYRF
prerank,tRNA processing (GO:0008033),0.25563088732247163,0.8210755006826029,0.7403846153846154,0.9857279840806802,1.0,19/61,23.77%,RPP40;CTU1;POP5;QTRT2;POP7;TSEN15;FAM98B;TRMT61A;WDR4;METTL1;PTCD1;SARS1;RPP21;DDX1;TRMT10A;LCMT2;AARS1;TRMT10C;SSB
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.23526876076415845,0.8210631055483887,0.7891491985203453,0.9851148590326237,1.0,17/121,12.93%,GHR;IL34;UNC119;CD40;ERBB4;TSLP;DLG3;DGKQ;IL5;RELN;TP53;GRM5;DLG4;IL12A;IGF2;CASS4;CD81
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.31546300622953716,0.8206313689711069,0.6921850079744817,0.9853337131287159,1.0,4/22,8.98%,PDE4B;FMR1;GNB5;CACNB4
prerank,positive regulation of mitochondrial fission (GO:0090141),0.324469013297613,0.8204752229213929,0.6625,0.9850054196221322,1.0,2/18,8.27%,DCN;PINK1
prerank,negative regulation of cell cycle process (GO:0010948),-0.2136560749285709,-0.8200962371389678,0.8103448275862069,0.89482465537315,1.0,24/61,29.55%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;GPER1;RBBP7;PPP1R10;E2F1;PCGF2;TOM1L2;APAF1;CHMP4C;RNF2;RAD51;BRCA1;CHMP2A;CHEK1;YAF2;BMI1;E2F7
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3222243582118087,0.820028115342302,0.7191558441558441,0.9852721691207278,1.0,2/21,1.52%,SPRY4;SPRY1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2662427300105463,-0.8200002765380282,0.7308707124010554,0.8943363431220135,1.0,7/25,16.04%,SLIT2;KANK1;CAPZB;TBC1D7;EVI5L;PRKCD;ARHGAP44
prerank,regulation of neurogenesis (GO:0050767),0.2676458168543369,0.8199982600715403,0.7434119278779473,0.984700045761164,1.0,9/55,11.46%,REST;SORL1;SERPINF1;DOCK7;PER2;APPL2;WNT3;NAP1L1;SNW1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.316682633397527,-0.8199786217229581,0.713302752293578,0.8937309593020643,1.0,3/13,10.38%,ALG9;ALG12;MPDU1
prerank,cellular response to zinc ion (GO:0071294),-0.30481486803180713,-0.8198186720970814,0.7191283292978208,0.8933681307320022,1.0,11/15,30.92%,MT2A;MT3;HVCN1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,cellular response to reactive oxygen species (GO:0034614),0.26205168329814627,0.8197202310465244,0.7323162274618585,0.9846163684656527,1.0,9/59,11.67%,PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5;FXN;PLEKHA1;TRPM2;PDK2
prerank,centromere complex assembly (GO:0034508),0.28535314396568306,0.819403974810109,0.7246153846153847,0.9846059361879488,1.0,7/36,15.58%,MIS18A;CENPU;CENPE;CENPC;CENPW;MIS18BP1;CENPF
prerank,Rac protein signal transduction (GO:0016601),0.3271048653052637,0.8193580769988921,0.6750841750841751,0.9840554280620833,1.0,5/18,17.40%,ELMO1;HACE1;CYFIP1;HACD3;RHOG
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.31291678408687845,0.8189288015612471,0.7152209492635024,0.9842829004173905,1.0,6/22,17.33%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,stress granule assembly (GO:0034063),-0.2852836851479728,-0.8184624238349297,0.7420212765957447,0.895086882176235,1.0,5/20,15.88%,CSDE1;MAPT;UBAP2L;DYNC1H1;RPS23
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3495197889254336,0.8173912773333164,0.6958855098389982,0.9866587527633616,1.0,3/13,10.80%,GRIK2;SYP;SHISA6
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3312857639811265,-0.8172303259061848,0.7004608294930875,0.8967143303518893,1.0,7/11,46.13%,ADRB2;ARRB2;ADM;DRD3;ADRB3;ARR3;ARRB1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.333240918211319,0.8170914574408764,0.6947194719471947,0.9865868967518597,1.0,4/16,10.89%,HNRNPA2B1;ERCC4;TERF1;DHX36
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3756511662885087,0.8169863381952877,0.6892138939670932,0.9861673110971159,1.0,2/10,14.03%,KYNU;ATP7A
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.342808544413654,-0.8167413131237302,0.7,0.8969839443685942,1.0,2/10,9.33%,NFKBIZ;RC3H1
prerank,maintenance of protein location in nucleus (GO:0051457),0.3159530794242457,0.8163766476905916,0.7015625,0.9867387807747008,1.0,7/20,20.70%,SUN2;TAF3;SP100;SYNE1;TAF8;SUPT7L;BBS4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.27337066349931943,-0.8162709891444057,0.729064039408867,0.8971689603579276,1.0,9/22,24.09%,GTF2H5;UBB;UBC;RAD23B;GTF2H4;CHD1L;UBA52;CETN2;PARP1
prerank,iron-sulfur cluster assembly (GO:0016226),0.3056059726465592,0.8158798070698955,0.7281553398058253,0.9870621873457195,1.0,6/24,16.72%,NUBP2;FXN;CIAO1;ABCB7;MMS19;ISCA1
prerank,rRNA 3'-end processing (GO:0031125),-0.3417036053610866,-0.8158474891678237,0.6869369369369369,0.8972579241290894,1.0,4/10,15.85%,ERI1;RPS21;EXOSC2;EXOSC3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.22513969167948328,0.8158072249003334,0.8323281061519904,0.9865686722984159,1.0,21/163,11.54%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;ICOSLG;PDPK1;PIK3R2;PTPN22;EIF2B1;CD276;PSMD10;PSMA5;PSMB5;PLEKHA1;PRKCB;PSMC4;TNFRSF21;PSMA4;FYN;PSMC5
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.33177338487083885,-0.8157661092368524,0.7126948775055679,0.8967420494866436,1.0,2/10,7.95%,LBP;IFI35
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.24539525294110065,0.815663499770716,0.7676902536715621,0.9862156710108372,1.0,20/84,18.81%,BUB1B;PSMD1;FBXO5;FBXO31;CDC16;PSMD10;CDC20B;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;ANAPC5;PSMB9;UBE2D1;PSMA7;PSMD14;CDC26;PSMA2;PSMD11
prerank,regulation of T cell mediated immunity (GO:0002709),-0.3377194619547866,-0.8153781665117426,0.70509977827051,0.8967999063913726,1.0,6/10,41.56%,TNFRSF1B;AGER;CCR2;TRPM4;ZBTB1;WAS
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2880271133959173,0.8153585668998116,0.732824427480916,0.986173774053958,1.0,6/34,12.59%,EDN3;PHIP;CDC16;NUSAP1;IGF2;ANAPC5
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.2532470741265947,-0.815183463532508,0.7741046831955923,0.8965450415493283,1.0,6/31,10.44%,KMT5B;RBP4;TFRC;DNAJB9;SHLD2;EPHB2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.31969097532665725,-0.8149039373163525,0.7377450980392157,0.896404797689369,1.0,5/12,36.86%,FDX1;FDXR;STAR;TSPO;FDX2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.21679765215250785,-0.8146914645442362,0.8466666666666667,0.8961416641376186,1.0,22/54,29.73%,OTULIN;HIPK1;CASP8;MADD;PTPN2;CYLD;TNFRSF1A;LAPTM5;CCDC3;TRADD;TNFAIP3;CFLAR;TRAF1;RFFL;BIRC3;IKBKB;IKBKG;HSPA1A;PELI3;CASP1;HSPA1B;TRAF2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.2665752283991455,0.8144062384155561,0.7461212976022567,0.9873759707398679,1.0,5/50,7.11%,SH3RF1;NGFR;DHCR24;NOL3;CDKN2D
prerank,regulation of protein localization to nucleus (GO:1900180),-0.23019239496846305,-0.8143119424651831,0.825,0.8961284802074883,1.0,14/43,26.33%,TFRC;GSK3B;LAMTOR5;PARP9;SUMO3;CTNNA1;AKT1;MFHAS1;ILRUN;WWTR1;GLUL;DTX3L;CARD10;PARK7
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3778235779981106,0.8142868759676074,0.68,0.9869716049208065,1.0,3/10,10.42%,TSPAN6;DHX58;SEC14L1
prerank,regulation of DNA recombination (GO:0000018),0.28681836942588806,0.8140699625692743,0.7089783281733746,0.9867687396559712,1.0,10/32,22.34%,MSH3;SIRT6;ZCWPW1;SPIDR;KPNA1;FIGNL1;MSH6;TERF2IP;PPP4R2;KPNA2
prerank,regulation of mast cell degranulation (GO:0043304),0.33869164922019523,0.8140539192012434,0.7076923076923077,0.9861655242990056,1.0,4/14,17.28%,GAB2;FGR;LYN;LGALS9
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.1945481084238454,-0.8135597149929438,0.8497409326424871,0.896790454976764,1.0,24/104,21.77%,SLC8A3;ACTB;TRIB2;UVRAG;CCND2;CALM1;LRP6;CCNG1;CAB39;PPEF2;MAP2K2;RALB;ETAA1;CCND1;EZH2;CDKN1A;SERTAD1;SIRT1;CCNE2;AKT1;ADRB2;CIB1;DUSP19;CSF1R
prerank,photoperiodism (GO:0009648),0.2918871912703207,0.8134527161152528,0.7306501547987616,0.9866961210764462,1.0,12/28,25.72%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3164527884803719,0.8129119693323703,0.7327731092436974,0.9864624236672762,1.0,7/20,22.28%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;BCKDK;HIBADH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3164527884803719,0.8129119693323703,0.7327731092436974,0.9864624236672762,1.0,7/20,22.28%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;BCKDK;HIBADH
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3430409071401194,-0.8124317282677417,0.7074340527577938,0.8981359249158462,1.0,5/10,30.13%,NUFIP1;RUVBL2;TAF9;PIH1D2;RUVBL1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3162678901921073,0.8124069474642207,0.7040133779264214,0.9867876104388484,1.0,7/20,17.42%,AGO4;AGO3;CNOT1;CNOT7;WTIP;TNRC6B;AGO1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3158266307204214,0.8122613090310167,0.6923076923076923,0.9864659433489268,1.0,2/18,4.94%,FBXO5;CDC7
prerank,keratan sulfate catabolic process (GO:0042340),0.36246531047387565,0.8120996363903046,0.7073608617594255,0.9861413768798029,1.0,3/11,15.26%,LUM;GNS;HEXA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2941953419310708,0.8119676689614762,0.7222222222222222,0.9857913307955634,1.0,5/29,11.37%,NCDN;GRIK2;SYP;SHISA6;DLG4
prerank,negative regulation of histone modification (GO:0031057),0.338206113246481,0.8114056567386582,0.7052631578947368,0.9862592547871027,1.0,4/14,18.84%,TWIST1;NOC2L;AASS;THAP7
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.26932092869594754,-0.811008633980794,0.7534626038781164,0.8999481823980885,1.0,2/23,7.09%,NMT2;CALM1
prerank,regulation of primary metabolic process (GO:0080090),0.22880870528596506,0.8107940376903437,0.812577065351418,0.9867452924060981,1.0,27/126,17.14%,PPARA;ODC1;NCOA2;PSMD1;PPARD;C1QTNF2;PSMD10;SC5D;IRS2;CHD9;PSMA5;PSMB5;EDF1;NCOA1;PSMC4;PSMA4;PSMC5;HMGCS1;PSMB9;CARM1;MED1;SREBF1;ELOVL6;IDI1;PSMA7;NR1D2;PSMD14
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.24099847045985032,-0.8106411694680169,0.8245614035087719,0.899926974962964,1.0,12/37,25.89%,NFKB1;RIN3;APOE;OPTN;ITGB3;EDN1;SDCBP;SIRT5;MTMR2;ANKRD13D;MT3;BRCA1
prerank,copper ion homeostasis (GO:0055070),0.3242482466394977,0.8105777242242799,0.6891891891891891,0.9865626758508083,1.0,4/17,14.03%,CCDC22;ABCB6;COMMD1;ATP7A
prerank,regulation of viral life cycle (GO:1903900),-0.2752415885127218,-0.8095087783500742,0.7578947368421053,0.9012255644215823,1.0,5/21,15.94%,TRIM25;TRIM5;TRIM14;PPIA;TRIM27
prerank,regulation of monocyte chemotaxis (GO:0090025),0.30225134341561194,0.809494243875661,0.7328990228013029,0.9880061986846355,1.0,4/24,9.06%,CXCL10;DUSP1;PLA2G7;LGMN
prerank,maturation of 5.8S rRNA (GO:0000460),0.3254495756933507,0.8092578077649685,0.7071547420965059,0.9878383920162775,1.0,4/17,15.30%,C1D;NOL9;MTREX;EXOSC10
prerank,negative regulation of telomere maintenance (GO:0032205),0.3349683926937519,0.8091164314467091,0.7097844112769486,0.9874644539644682,1.0,3/15,7.80%,ERCC1;ERCC4;TERF1
prerank,skeletal muscle contraction (GO:0003009),-0.2832288506276113,-0.8090519834437646,0.7438423645320197,0.9013410351385323,1.0,14/19,54.12%,STAC;TNNT3;TNNI1;STAC2;TNNC1;TNNI3;CCDC78;TCAP;TNNI2;MYH14;TNNC2;JSRP1;TNNT1;CHRNA1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.22918603111184624,-0.8089766949491431,0.7953020134228188,0.9008559344036654,1.0,11/46,20.68%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;DGKZ;DDHD1;DDHD2;PNPLA3;AGPAT2
prerank,skin development (GO:0043588),0.2517918934675794,0.808690822272145,0.776685393258427,0.9876657518629335,1.0,11/65,14.03%,KDF1;WNT5A;ITGA3;DHCR24;COL1A2;ABCB6;EVPL;FA2H;MED1;STMN1;ATP7A
prerank,cardiocyte differentiation (GO:0035051),0.36412872906197513,0.8086704729527625,0.6793478260869565,0.9870813783185393,1.0,1/10,0.83%,NRG1
prerank,negative regulation of macroautophagy (GO:0016242),-0.2580451239602555,-0.8077990006130965,0.7722222222222223,0.9022467879057863,1.0,15/26,33.92%,MTM1;FEZ2;NRBP2;CLEC16A;TMEM39A;CHMP4B;CHMP4A;AKT1;NUPR1;SMG1;QSOX1;PHF23;FEZ1;LZTS1;PIK3CA
prerank,androgen receptor signaling pathway (GO:0030521),-0.3322520947824265,-0.8074714228483386,0.7384259259259259,0.9021726497787894,1.0,2/11,7.65%,DDX5;TMF1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.28362264178269364,0.8074342367125678,0.7453416149068323,0.98881142821148,1.0,4/33,9.09%,PTEN;SUSD2;GLI1;APPL2
prerank,ncRNA 3'-end processing (GO:0043628),0.34152157215642287,0.8073458665082469,0.6866666666666666,0.9883606355118374,1.0,3/14,15.79%,INTS8;INTS14;PTCD1
prerank,regulation of sensory perception of pain (GO:0051930),-0.32871902792820884,-0.8073098567824167,0.6901408450704225,0.9017906500347457,1.0,2/11,4.87%,MGLL;CCN3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3364113238880791,0.8070546549432559,0.7033898305084746,0.9882906158207662,1.0,6/15,21.14%,UNC119;SMAP1;NEU3;SCYL2;DGKD;SNAP91
prerank,action potential (GO:0001508),0.2652740711387302,0.8070221117856731,0.7631578947368421,0.9877346551212786,1.0,8/44,13.61%,ANK3;CACNA1G;GNA11;KCND2;KCNE4;AKAP6;SCN1A;SCN2A
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3439509608500355,0.8068915877958092,0.676818950930626,0.9873700766957095,1.0,7/13,28.50%,RPP40;NOL9;RRS1;UTP20;ABT1;RCL1;TBL3
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.24576476579281492,0.8068538371066736,0.7855227882037533,0.9868104784194325,1.0,21/78,19.81%,PRICKLE1;RNF180;LRRK2;SIRT6;PSMD10;HERPUD1;CBFA2T3;CDC20B;NKD2;ZYG11B;HECTD1;GSK3A;DDA1;CLU;CSNK1E;DET1;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.23755745238284448,-0.8064044733800432,0.7832369942196532,0.9026711380321466,1.0,6/38,10.98%,CACNA1C;CAV1;CAMK2D;ANK2;KCNJ2;KCNQ1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.3304106516870385,0.8061439828108531,0.7166666666666667,0.9875628632547994,1.0,1/17,0.79%,XCL1
prerank,positive regulation of JNK cascade (GO:0046330),0.24884933364938894,0.8058256596845489,0.7918918918918919,0.9875524606678588,1.0,4/70,2.24%,SH3RF1;EDA2R;TRAF4;SH3RF3
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.23061059267198722,-0.8056073211054118,0.8427672955974843,0.9034346058628407,1.0,27/43,38.41%,FOXN3;INTS3;BRCC3;ATM;NBN;CDKN1A;PABIR1;DONSON;HUS1;CHFR;ORC1;FZR1;TAOK2;TRIM39;BRSK1;BRCA1;CHEK1;UIMC1;NOP53;DTL;BABAM2;HUS1B;MRE11;PLK1;CDK1;CDC6;TICRR
prerank,metal ion transport (GO:0030001),0.24115635192112927,0.8055499923987078,0.7750325097529259,0.9874374310209543,1.0,19/86,20.11%,CACNA1E;CALCRL;ITPR1;CACNG3;RYR2;SLC30A5;TRPC3;NDFIP2;FYN;TRPM2;TUSC3;RYR3;CACNA2D1;NDFIP1;GRIN3A;CAMK2A;ATP2C1;TRPC1;NIPA2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.27244699032550596,0.8055269012099704,0.7639097744360902,0.9868688445224787,1.0,10/39,18.87%,ZFYVE28;SPRY1;EPS15;LGMN;HGS;SH3KBP1;TSG101;AREG;PTPN18;SPRY2
prerank,regulation of endocytic recycling (GO:2001135),-0.3272328704812527,-0.8053982756204954,0.7272727272727273,0.9031620245800711,1.0,2/11,5.18%,ACTN2;INPP5F
prerank,membrane fusion (GO:0061025),0.28219816257898783,0.8048437892928432,0.7514970059880239,0.9875458253834971,1.0,10/33,16.86%,VAMP2;SNAP23;OPA1;SNAP29;RIMS1;DNM1;RABIF;HACE1;VPS33B;UBXN2B
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.25861783431445495,0.8048140863654232,0.7675378266850069,0.9869784266537938,1.0,10/63,11.50%,SH3RF1;TCF7L2;PHIP;ITGAV;FGFR1;NOL3;G0S2;SP100;PYCARD;TGFBR1
prerank,ventricular septum development (GO:0003281),0.2820438388514051,0.8046371538988152,0.7271317829457364,0.9867009526000807,1.0,8/37,15.14%,ROBO2;SALL1;MDM4;ZFPM2;TGFBR1;HECTD1;DAND5;GJA5
prerank,negative regulation of organelle assembly (GO:1902116),0.2795541029846355,0.8044878379552355,0.734472049689441,0.9863732987293619,1.0,6/35,11.18%,MDM1;LRRK2;TRIM37;PINK1;KAT2A;SCFD1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.32381503213014495,0.8041585034775405,0.7215815485996705,0.9863843170452646,1.0,1/19,0.79%,XCL1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2831756632825151,-0.8040658418264592,0.7408312958435208,0.904795911379937,1.0,1/18,0.46%,PLCB1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2447043990167209,-0.803878464492249,0.7827298050139275,0.9044574951789277,1.0,10/33,25.15%,AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;EGF;AGT;DOK1;CNOT9
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.23073756501901949,-0.8028614530827279,0.8244514106583072,0.9055162463521074,1.0,11/42,20.69%,LBP;RPS19;DROSHA;SERPINE1;OPTN;RPL30;RNASE7;MPEG1;HMGB2;CHGA;ROMO1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.27869066126873515,0.8026431598992557,0.7534456355283308,0.9885522326903096,1.0,5/39,7.53%,PIK3R1;PIP4K2A;PIK3R2;EFR3A;PI4KA
prerank,intracellular sterol transport (GO:0032366),0.3472353576581123,0.8022345632088814,0.6993006993006993,0.9886866025208982,1.0,5/13,19.35%,RELCH;SERAC1;ARV1;OSBP;NPC2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3337695214392904,0.8016529530255196,0.6970198675496688,0.9891676480454146,1.0,4/15,12.46%,SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,aminoglycan biosynthetic process (GO:0006023),0.2625296660758163,0.801276184450971,0.7668097281831188,0.9892445984861606,1.0,12/49,15.44%,HSPG2;GPC4;GCNT2;GPC5;B3GNT8;HS6ST2;B4GALT7;B3GALT5;HS3ST6;HS3ST5;HEXA;SDC2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.21495251015531108,0.801046416011016,0.8690344062153164,0.9890686811005084,1.0,63/241,22.68%,TRA2B;EIF4A3;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNRPB2;SMU1;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;SRSF10;SYF2;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;CTNNBL1;ZCRB1;RBM6;POLR2L;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.24691101226739137,-0.8010375274712904,0.8045977011494253,0.9079762324944894,1.0,4/31,4.36%,RBPJ;TPM1;NOTCH1;TGFB2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3346984870178379,-0.8008468446780462,0.7105263157894737,0.9076573982347111,1.0,2/10,3.59%,OSR1;CAMK2D
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3107612112327684,0.8007059033810116,0.7365853658536585,0.98909691358129,1.0,4/19,14.93%,TLR8;TLR4;DHX36;DHX9
prerank,ketone body metabolic process (GO:1902224),0.3728602034003223,0.800495875027219,0.7113970588235294,0.9888818434478962,1.0,1/10,1.09%,ACSS3
prerank,regulation of chromatin binding (GO:0035561),0.36134783623263234,0.8002278345945277,0.7006802721088435,0.9887475391590937,1.0,4/10,14.16%,GMNN;CDT1;BTAF1;MED25
prerank,cellular protein-containing complex assembly (GO:0034622),0.22252641073299395,0.80018248712471,0.8441247002398081,0.9882181781475596,1.0,28/159,15.58%,NRG1;STXBP6;TCF4;VAMP2;DNAJC28;CENPE;EPS15;OMA1;DNAAF3;IMMP2L;TTC12;DNAI4;CCDC65;CYBA;DNAJB12;VAMP4;TBCE;CENPC;CENPW;NUP107;AXIN1;LONP1;HSPA4;DHX9;CLU;COX7A2L;CCDC39;CENPF
prerank,rRNA transcription (GO:0009303),-0.28981523802816983,-0.799911432864212,0.7530562347188264,0.9085489539917144,1.0,6/17,22.51%,CAVIN1;TCOF1;NIFK;GTF3C6;POLR1G;GTF3A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.3576792257371479,0.7996455527375754,0.696969696969697,0.9886019172027029,1.0,6/11,28.95%,JAK1;IL12A;CANX;STAT1;JAK2;STAT3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3236508388901609,-0.7996279435903314,0.6992665036674817,0.9083716351816526,1.0,7/11,27.19%,SERTAD1;ARID1B;SMARCD1;ELOF1;PADI2;CDCA4;CHEK1
prerank,tRNA export from nucleus (GO:0006409),0.2806448613810777,0.7995883413373502,0.7449768160741885,0.9874731297390001,1.0,10/32,23.77%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2806448613810777,0.7995883413373502,0.7449768160741885,0.9874731297390001,1.0,10/32,23.77%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,regulation of protein localization to cell periphery (GO:1904375),0.32294940884586143,0.7994582636275873,0.7372881355932204,0.9870864408798039,1.0,6/18,19.41%,SPTBN1;AR;LDLRAP1;ZDHHC2;CDK5;ABCA2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24506320748516836,0.7989043387099987,0.7776280323450134,0.9874688537611512,1.0,6/66,5.48%,PIK3R1;NGFR;JUP;PIK3R2;ZIC1;CCT5
prerank,anterior/posterior pattern specification (GO:0009952),-0.2166040440772491,-0.7988997621117898,0.8701754385964913,0.9089681469815954,1.0,14/53,19.43%,BMPR2;SKI;WLS;TBX1;HOXC6;HEYL;HEY2;PCSK5;ATP6AP2;ACVR2B;HHEX;BHLHE40;HOXD3;HOXB6
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3535653470489631,0.7987554123760386,0.7073170731707317,0.98712191415427,1.0,4/11,20.44%,NR1H4;DGKQ;BMP2;BMP5
prerank,regulation of DNA replication (GO:0006275),-0.22051658787025766,-0.7987401355107777,0.85,0.9085775625410364,1.0,10/49,12.73%,EGFR;S100A11;GLI2;PPP2R1A;ACVRL1;ESCO1;ATR;CCDC88A;PCNA;STN1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.29372102681884665,-0.7985172931387698,0.7493670886075949,0.9082997645101752,1.0,8/15,26.33%,RPL5;RPS7;RPL11;RPL23;SMAD7;BAG2;DTX3L;PARK7
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.33750591551559445,0.7984985694194681,0.7155025553662692,0.9869726975660434,1.0,5/13,21.91%,CISD3;CIAO1;MMS19;ISCA1;YAE1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.30636323583267416,0.7982051967024992,0.7078464106844741,0.9869166102470284,1.0,1/22,0.79%,XCL1
prerank,regulation of ion transport (GO:0043269),0.24508106698129103,0.7980661016692437,0.7877947295423023,0.9865819299702713,1.0,19/76,20.41%,NKAIN1;ANK3;NKAIN2;VAMP2;NEDD4;SYT3;HTR1A;SYT7;P2RX4;SYT5;KCNJ8;GDNF;STC1;KCNJ10;KCNJ3;SYT6;SYT1;KCNJ16;PXK
prerank,long-chain fatty acid transport (GO:0015909),0.2843316387484973,0.7978508647898142,0.7533432392273403,0.9863635663275245,1.0,7/30,12.16%,ABCD2;FABP5;FABP4;SPX;RPS6KB1;SLC25A20;FABP3
prerank,myofibril assembly (GO:0030239),0.27069620382845266,0.7973930212982511,0.7533432392273403,0.986584668236657,1.0,1/42,0.14%,PDGFRA
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.24734746204912966,0.797379524451269,0.8065843621399177,0.9859994612045357,1.0,9/65,8.14%,PPARA;SPRY1;PDPK1;SPRED1;HTRA3;MTMR4;IL17RD;CIDEA;SPRED2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.23941305397274368,0.797333551976867,0.8069241011984021,0.985471748723005,1.0,23/88,19.79%,EIF4A3;NANOS3;EPRS1;DNAJC1;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;CNOT1;MALSU1;EIF4ENIF1;PUS7;BAG6;CNOT7;TSC1;IGF2BP3;CALR;CDK5;ILF3;EIF2AK3;FXR1;PLAT
prerank,vesicle transport along actin filament (GO:0030050),0.31526846830186334,0.7969164371163867,0.7320872274143302,0.9856351823554169,1.0,4/19,11.63%,MYO7A;MYO1B;MYO6;MYO1G
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2631864839198487,-0.7966961808286199,0.7526315789473684,0.910663250396018,1.0,9/22,30.22%,ROCK2;GSK3B;PPP4R4;PPP1R11;MGAT5;IKBKB;NCKAP1L;FKBP1A;PPP1R15A
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2594117900013116,-0.796492922634628,0.8031088082901554,0.9103528505760664,1.0,12/25,29.64%,PRKDC;MAPK14;ETS1;TAL1;HMGB2;ABCB10;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,axonal transport of mitochondrion (GO:0019896),0.35150704905692803,0.7963628268696947,0.6750448833034112,0.9860364626906282,1.0,4/11,20.27%,OPA1;SYBU;HIF1A;ACTR10
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.312134460807473,-0.796207382347932,0.751219512195122,0.9095427550832651,1.0,3/12,11.96%,IGF1;LMCD1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.312134460807473,-0.796207382347932,0.751219512195122,0.9095427550832651,1.0,3/12,11.96%,IGF1;LMCD1;CAMTA1
prerank,mitochondrial genome maintenance (GO:0000002),0.35650677568662403,0.7960736710747209,0.7061946902654868,0.985934181433992,1.0,4/11,13.98%,OPA1;SLC25A33;TOP3A;LONP1
prerank,regulation of pH (GO:0006885),0.3519288119770676,0.7959539890346979,0.6953405017921147,0.9855616795108029,1.0,4/11,18.98%,SLC9A1;CLCN3;PDK2;ATP6AP1
prerank,histone H2A monoubiquitination (GO:0035518),0.3246109135263417,0.7955554848128185,0.7262103505843072,0.9856696591633183,1.0,3/17,9.24%,BCOR;TRIM37;RNF168
prerank,regulation of heart contraction (GO:0008016),0.23660982397833735,0.7948896883619562,0.8270481144343304,0.9862791141703485,1.0,16/90,15.14%,ATP1A2;ITPR1;RYR2;TMEM65;ATP1A3;KCNIP2;ATP2A2;PRKACA;FXYD4;P2RX4;S100A1;GSK3A;RYR3;ASPH;STIM1;GJA5
prerank,actin filament-based transport (GO:0099515),0.3053136475278066,0.7948670161519059,0.729483282674772,0.9857102992283584,1.0,5/21,11.63%,MYO7A;MYO1B;SUN2;MYO6;MYO1G
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3665177022516656,0.7946254370579655,0.7334494773519163,0.9855685586706638,1.0,2/10,8.20%,HRG;JAM3
prerank,mitochondrial gene expression (GO:0140053),-0.22367816194315726,-0.7945631271988918,0.8258064516129032,0.9115928942426608,1.0,18/42,29.56%,IARS2;MRPS7;NOA1;MRPS17;MRPL16;MRPS18A;MRPL2;MRPS18B;POLRMT;GATC;TWNK;MRPL57;PTCD3;LARS2;MRPS34;MRPS12;FASTKD2;MRPS2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.30867976814418796,0.79397274841778,0.7172859450726979,0.9861556495238499,1.0,8/22,20.42%,RPP40;NOL9;EXOSC9;RRS1;EXOSC10;EXOSC8;URB1;UTP20
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.27640951576635764,-0.7938454541776507,0.7524752475247525,0.9121296433019692,1.0,11/19,30.47%,AMPD3;TERT;DCK;GMPR2;APRT;TYMS;CDA;POLD2;PNP;POLD1;ADA
prerank,macrophage chemotaxis (GO:0048246),0.3708260105448155,0.7931219186071594,0.7210144927536232,0.9870901575436656,1.0,10/10,62.94%,CCL2;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3109172390948693,0.7927947865617784,0.747870528109029,0.9870728510075806,1.0,5/17,16.92%,NTRK2;SORL1;RTN2;CLU;RTN3
prerank,ureteric bud morphogenesis (GO:0060675),0.3247120776753544,0.7926835971955195,0.7096219931271478,0.9866738285956472,1.0,6/16,24.18%,SALL1;GDNF;MYC;BMP2;PAX2;BMP4
prerank,regulation of interleukin-12 production (GO:0032655),-0.21982653956764958,-0.7925396680548918,0.8445945945945946,0.9135294202604701,1.0,3/47,2.21%,PLCB1;FOXP1;THBS1
prerank,double-strand break repair (GO:0006302),0.2223025000827004,0.7925137246359254,0.8554216867469879,0.9863757176647954,1.0,37/158,20.19%,MORF4L1;ERCC1;LIG3;FAN1;FEN1;POLQ;ERCC5;POLA1;RPA1;ERCC4;POLL;MMS22L;RNF168;BRCA2;UBE2V2;ZFYVE26;REV3L;RECQL;SPIDR;POLN;XRCC1;POLB;CYREN;RAD52;EME2;PAXIP1;KDM2A;NHEJ1;PSMD14;SMARCAL1;HELQ;WRN;FBH1;RIF1;TRIP13;MTA1;DDX1
prerank,cellular response to acid chemical (GO:0071229),0.2909530829053132,0.7919932873098365,0.7516025641025641,0.9867093509145877,1.0,7/27,18.69%,CPEB1;MTOR;GLRA1;GLRA2;RRAGA;RRAGD;CAPN2
prerank,cardiac muscle cell contraction (GO:0086003),-0.27875297845437697,-0.7919776817124006,0.770573566084788,0.9138155625313504,1.0,3/19,3.69%,CACNA1C;CAMK2D;GSN
prerank,acylglycerol biosynthetic process (GO:0046463),0.30192000451258977,0.7917477194672421,0.7438825448613376,0.9865745051788984,1.0,5/23,15.43%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,regulation of leukocyte migration (GO:0002685),-0.295839712261226,-0.7916716237748626,0.754950495049505,0.9136743743851271,1.0,2/16,5.15%,ANXA1;RAC1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2588859679807979,-0.7911752828422436,0.7921348314606742,0.9138407311479401,1.0,2/27,3.33%,CD200;SIRPA
prerank,BMP signaling pathway (GO:0030509),0.2482173287547464,0.7909483720723444,0.7871148459383753,0.9873743353206847,1.0,4/62,2.78%,RUNX2;RGMB;RGMA;SMAD5
prerank,phosphatidylcholine catabolic process (GO:0034638),0.35468175029763893,0.7908612293628363,0.7045871559633028,0.9869418926018068,1.0,2/10,8.18%,LIPC;PLA2G7
prerank,apoptotic mitochondrial changes (GO:0008637),-0.24233910567415995,-0.7900716979049952,0.782608695652174,0.9149586992904521,1.0,8/32,13.64%,BCL2L1;VPS35;SOD2;HK2;BAD;BAX;BID;BOK
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.30298956496133644,0.7891704338117285,0.7368421052631579,0.9893201588055247,1.0,5/23,12.46%,SEC16A;SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.28232516989171574,-0.7886361719831301,0.770573566084788,0.9166037245383402,1.0,4/18,12.91%,ANXA1;KLF9;FAM107A;NR3C1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2772197254807163,-0.7882927197882121,0.7680798004987531,0.9165217970821801,1.0,7/18,23.27%,PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2308051060738202,-0.7881929092178753,0.8382352941176471,0.9160432026050194,1.0,18/40,28.73%,THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;DONSON;ALYREF;CDK9;SETMAR;MCM9;RFWD3;ZRANB3;RAD51;CENPX;GEN1;POLD1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.26677998083171617,-0.7881498966247511,0.8123249299719888,0.9154793831976048,1.0,14/23,34.97%,PRCC;INTS3;ZW10;WEE1;PLK5;PABIR1;SETMAR;CHFR;CHMP4C;CHEK1;PLK3;ZWILCH;VPS4A;PLK2
prerank,mRNA catabolic process (GO:0006402),0.2595783902008777,0.787956325330057,0.7901785714285714,0.9909390146916236,1.0,11/44,17.91%,AGO4;ZC3H12D;PDE12;ZFP36L2;AGO3;EXOSC9;DIS3L2;MRTO4;EXOSC10;AGO1;DXO
prerank,nuclear envelope organization (GO:0006998),-0.27590782276224307,-0.7874213952949671,0.7592137592137592,0.9160105279596684,1.0,7/20,26.13%,LEMD3;REEP3;TOR1A;TMEM170A;TOR1AIP1;EMD;REEP4
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.30876450659300675,-0.787160773935331,0.7581863979848866,0.9158044808250788,1.0,7/12,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B4GAT1;B3GNT6
prerank,mismatch repair (GO:0006298),0.287681223246065,0.7870701840166581,0.7736757624398074,0.9919389945163947,1.0,9/27,23.02%,ERCC1;MSH3;RPA1;XPC;MUTYH;MSH6;MLH1;ABL1;TDG
prerank,mRNA metabolic process (GO:0016071),0.23647394954811296,0.7870582821724832,0.8435462842242504,0.9913557180494248,1.0,19/90,16.75%,AGO4;GEMIN2;ZC3H12D;LSM11;ZFP36L2;PCBP3;HNRNPA2B1;SRSF11;PRKACA;NUDT21;TP53;AGO3;PRPF18;DIS3L2;SLBP;SNRPF;SRSF9;NONO;SF3A3
prerank,regulation of sequestering of triglyceride (GO:0010889),0.32572991810709856,0.7869129253838427,0.7222222222222222,0.9909940366365155,1.0,3/15,14.09%,PPARA;CIDEA;PLIN2
prerank,negative regulation of cell cycle (GO:0045786),0.23785137019401584,0.7866976949116574,0.8366013071895425,0.9907532047131162,1.0,14/73,16.22%,PTEN;NR2F2;CDKN2A;SIPA1;SCRIB;DUSP1;GMNN;BMP7;HTRA2;PDCD4;TSPYL2;TFAP4;RNF167;BRINP1
prerank,negative regulation of secretion by cell (GO:1903531),0.26531308723346136,0.7860430309611686,0.7683109118086696,0.9913365508631646,1.0,6/38,16.32%,STXBP6;PNKD;TRH;IL12A;GRM7;IL1RAPL1
prerank,calcium ion import (GO:0070509),0.27931016422389154,0.7857094845436793,0.7847113884555382,0.9913110124482484,1.0,4/28,8.94%,CACNA1E;ATP2A2;CACNA1G;MICU3
prerank,establishment of spindle orientation (GO:0051294),0.281368406741298,0.7856467733954898,0.7377049180327869,0.9908221372187179,1.0,7/28,16.86%,GJA1;LLGL1;GPSM2;SPDL1;INSC;CLASP1;UBXN2B
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.24522501643700154,-0.7854971441427747,0.8016759776536313,0.9178437569593451,1.0,11/30,21.55%,BCL2L1;ACKR3;THOC1;CD44;RTEL1;TPT1;SIRT1;SNAI1;CD74;MIF;CCAR2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.31166592081891364,0.7852599434916305,0.7413793103448276,0.9909102108045009,1.0,2/18,5.80%,TMEM102;NAIF1
prerank,pre-replicative complex assembly (GO:0036388),0.24496230959186677,0.7851122432412938,0.8076923076923077,0.9905885492182226,1.0,17/64,18.81%,PSMD1;MCM7;PSMD10;GMNN;PSMA5;PSMB5;PSMC4;MCM4;PSMA4;PSMC5;CDT1;PSMB9;ORC2;PSMA7;PSMD14;PSMA2;PSMD11
prerank,microtubule nucleation (GO:0007020),0.31423890796605136,0.7848439429355962,0.7361344537815127,0.9904472360995791,1.0,6/19,15.81%,CCDC57;GOLGA2;TUBGCP4;CLASP2;TUBGCP6;CLASP1
prerank,axonal fasciculation (GO:0007413),0.34034808641434766,0.7847211078690403,0.7313974591651543,0.9900568279215758,1.0,5/12,15.96%,SEMA5A;CNTN4;EPHA3;ARHGAP35;NRCAM
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.23302516730258943,0.7843281727145305,0.8386683738796414,0.9901409467359228,1.0,25/96,21.20%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,regulation of autophagosome assembly (GO:2000785),0.2754369941070663,0.7840905924906676,0.7576219512195121,0.9899581408515684,1.0,6/33,12.23%,PIP4K2A;NPRL2;LRRK2;PINK1;SCFD1;IFT88
prerank,regulation of DNA metabolic process (GO:0051052),0.2635943628540436,0.7838643940750143,0.7851002865329513,0.989764007396422,1.0,15/44,22.34%,USP1;PIF1;UBE2V2;POLH;MPHOSPH8;KPNA1;CDT1;KDM1B;UBE2V1;HNRNPD;MYC;KAT7;TERF2IP;WDR18;KPNA2
prerank,organelle disassembly (GO:1903008),0.2798636804314562,0.7837613989318728,0.7677725118483413,0.9893450513229379,1.0,10/33,19.53%,GBF1;GOLGA2;RB1CC1;TEX264;KIF9;GFM2;VRK1;ULK2;MTIF2;DDRGK1
prerank,mitotic nuclear division (GO:0140014),0.24412569121480712,0.7837157306408544,0.8189081225033289,0.9888201693820415,1.0,19/71,21.10%,CCDC61;LSM14A;AAAS;SGO1;GOLGA2;CEP192;NSL1;NUSAP1;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;KLHL22;RHOA;KPNB1;SMC3;KIF11
prerank,NIK/NF-kappaB signaling (GO:0038061),0.23937378492536077,0.783531735004199,0.796373779637378,0.9885526683555873,1.0,17/72,18.81%,MAP3K14;PSMD1;TLR6;PSMD10;PSMA5;PSMB5;BIRC2;IRAK1;PSMC4;PSMA4;PSMC5;PSMB9;TIRAP;PSMA7;PSMD14;PSMA2;PSMD11
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.28059205662219405,0.7833314852705,0.7412698412698413,0.9883148145884196,1.0,1/29,0.79%,XCL1
prerank,membrane lipid metabolic process (GO:0006643),0.2961293334286535,0.7831329084980855,0.7525252525252525,0.9880688737012739,1.0,5/22,12.14%,SERINC1;SPTLC1;AGMO;B4GALT4;AGK
prerank,respiratory tube development (GO:0030323),0.28175997235820005,0.7831096947011593,0.7751572327044025,0.9875083647105607,1.0,6/28,15.69%,ITGA3;NPHP3;LOXL3;BAG6;CCDC39;FGFR2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3204427789897857,0.7827710251991551,0.7352445193929174,0.9875141079762672,1.0,2/16,12.10%,PTPN22;IL12A
prerank,regulation of presynapse assembly (GO:1905606),0.31155111396616664,0.7827607316108384,0.7470489038785835,0.9863493104354,1.0,5/18,18.74%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of presynapse organization (GO:0099174),0.31155111396616664,0.7827607316108384,0.7470489038785835,0.9863493104354,1.0,5/18,18.74%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3154447199421058,-0.7826990886074654,0.7626262626262627,0.9215751176778618,1.0,8/12,30.17%,CD44;RPL26;SIRT1;CD74;MIF;KDM1A;TAF9;TRIAP1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3305188843400446,0.7825573240423457,0.718801996672213,0.9860958955044627,1.0,2/13,8.27%,PPARA;PINK1
prerank,lipid modification (GO:0030258),0.26457244487255394,0.7822825535032958,0.7754491017964071,0.9859773216069254,1.0,8/37,14.60%,PLPPR3;DGKQ;PLA2G7;PLPPR2;PLPP6;DGKI;MBOAT7;PLPP5
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2831384189652897,0.7819932263290859,0.7531645569620253,0.9859156950816488,1.0,7/27,18.13%,MORF4L1;BRD8;KAT2A;NAA50;BAG6;PHF20L1;KAT7
prerank,positive regulation of intracellular transport (GO:0032388),-0.2304689328505986,-0.7810330557531348,0.8449367088607594,0.9235288470007565,1.0,11/38,19.79%,ACTN2;STX18;RUFY3;PRR5L;CEP290;DYNC1H1;OAZ1;BCAS3;OAZ2;NUMA1;PLA2G4E
prerank,lipid phosphorylation (GO:0046834),-0.33065413436437086,-0.7808523250125171,0.7459954233409611,0.9231539756967072,1.0,3/10,12.53%,DGKH;DGKG;DGKZ
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.26119454755200594,-0.7808444525606048,0.7481108312342569,0.9225206081505153,1.0,3/21,10.66%,CCN3;DAB2;SH2B1
prerank,prostanoid metabolic process (GO:0006692),0.3332131512808272,0.7808334728197495,0.7120141342756183,0.9873077966501012,1.0,3/13,12.62%,PTGES;PLAA;PTGR2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.25549007402829943,-0.7798121190909415,0.8226600985221675,0.9234722112755823,1.0,7/24,24.21%,LEPR;COQ10A;COX15;SDHAF4;PID1;MRAP2;MT3
prerank,protein K48-linked deubiquitination (GO:0071108),-0.25955957118256157,-0.7796001226637895,0.8402061855670103,0.9231740344670538,1.0,11/23,32.74%,VCPIP1;MINDY1;OTUB1;USP25;TNFAIP3;BAP1;USP37;USP20;OTUB2;OTUD4;OTUD5
prerank,negative regulation of protein depolymerization (GO:1901880),0.2890909427419821,0.7794939084868399,0.7636080870917574,0.9890563518658821,1.0,6/24,18.52%,PLEKHH2;STMN2;NAV3;CLASP2;CLASP1;SPEF1
prerank,sister chromatid segregation (GO:0000819),0.2778094545996961,0.7792783404266163,0.7737003058103975,0.9888499347881334,1.0,7/31,18.12%,TOP2B;SGO1;NSL1;NUSAP1;TOP2A;SMC1A;KLHL22
prerank,thyroid hormone generation (GO:0006590),0.3549330769185403,0.7791627667527344,0.6969147005444646,0.9884576397647968,1.0,1/10,4.90%,CPQ
prerank,macromolecule catabolic process (GO:0009057),0.28709793847463566,0.7790254341011488,0.765,0.988123488322398,1.0,5/26,9.11%,NEDD4;CAPN3;UCHL3;LGMN;MTOR
prerank,protein alkylation (GO:0008213),0.301690573023256,0.7789249546995151,0.7760252365930599,0.9877045740730999,1.0,9/22,28.62%,PRMT3;VCPKMT;FAM98B;PRMT2;CAMKMT;ETF1;PCMT1;FAM98A;METTL22
prerank,regulation of glycogen metabolic process (GO:0070873),-0.31126891128879797,-0.7788659161484953,0.7695652173913043,0.9237025412077736,1.0,7/12,40.72%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3D;GCGR
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3214845882134132,0.7784590146066701,0.7398945518453427,0.9879047730524237,1.0,4/15,18.74%,TLR6;TLR4;MYD88;HIF1A
prerank,DNA duplex unwinding (GO:0032508),0.25593674245500553,0.7784132748462674,0.8014184397163121,0.987394686199251,1.0,16/50,20.54%,MCM7;RPA1;PIF1;XPC;MCM4;RECQL;GTF2H3;ERCC2;DHX9;GTF2H1;MCMDC2;WRN;SSBP1;CUL4A;DDX1;DDB1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.35256124783104864,0.7778756925951235,0.7559726962457338,0.9877415247488324,1.0,2/11,7.25%,NOVA1;PCBP3
prerank,histone exchange (GO:0043486),0.26941206066374607,0.7777341585369985,0.7839416058394161,0.9873891101296817,1.0,7/37,14.95%,MIS18A;CENPU;SPTY2D1;CENPC;CENPW;MIS18BP1;DMAP1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.31607424889415264,0.7774856422735852,0.7565217391304347,0.9872478331553997,1.0,4/17,12.81%,PSMD10;TWIST1;ARMC10;PTTG1IP
prerank,protein neddylation (GO:0045116),-0.3059131205146438,-0.7773777441753269,0.750561797752809,0.9253401379771227,1.0,3/13,17.01%,UBE2F;NEDD8;DCUN1D3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.21907909111672957,0.7772041387912935,0.8779904306220095,0.9871362176562221,1.0,20/148,11.13%,HDAC1;L3MBTL1;TAF9B;PIP4K2A;TAF12;PDPK1;PRR5;CHD4;MBD3;TAF15;RPA1;TAF3;MDM4;NOC2L;MTOR;DAXX;RFC3;TP53;TOP3A;RPL37
prerank,ceramide biosynthetic process (GO:0046513),0.26526687903587487,0.7771204934069703,0.7987421383647799,0.9866922278861855,1.0,9/40,12.53%,CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;ST6GALNAC6
prerank,positive regulation of neutrophil migration (GO:1902624),0.311732098320521,0.7770936652447479,0.7570247933884298,0.9861521224164116,1.0,1/18,0.79%,XCL1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2329161153100116,0.7768147441999756,0.8488830486202366,0.9860237957929757,1.0,23/85,19.81%,PRICKLE1;FMR1;RNF180;LRRK2;PSMD10;CBFA2T3;NKD2;PSMC5;ZYG11B;HECTD1;GSK3A;DDA1;ATXN3;BAG6;CLU;CSNK1E;DET1;USP13;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2985259548038294,-0.7766418373831806,0.7793764988009593,0.9258371544405523,1.0,5/13,19.19%,RNF8;RECQL5;EAPP;NELFCD;HEXIM1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2636155476584223,-0.7764407210859954,0.803763440860215,0.9255029128262482,1.0,9/21,26.33%,BCL2L1;TMBIM6;NCK1;BOK;CREB3;SELENOS;BCL2L11;HSPA1A;PARK7
prerank,negative regulation of cellular catabolic process (GO:0031330),0.243593817287991,0.7758822523029325,0.8324175824175825,0.9869853135884018,1.0,10/63,12.54%,EIF4G3;GPLD1;HTR2B;PTPN22;SORL1;ZKSCAN3;GOLGA2;MTOR;DAP;GSK3A
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2893856021864344,0.7758298262895953,0.7648902821316614,0.986500680208985,1.0,6/26,15.31%,POR;HTR2B;CDH3;S100A1;ATP7A;GDNF
prerank,histone ubiquitination (GO:0016574),-0.2676171671841615,-0.7757576630201237,0.7944162436548223,0.9258762611403195,1.0,7/21,24.94%,RNF8;UBE2A;UBR2;UBE2N;LEO1;RNF20;DTX3L
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2467942879291241,0.7757299371662497,0.8109919571045576,0.9860924126769655,1.0,14/62,15.09%,LRRK2;NOL3;HERPUD1;CDKN2D;PINK1;NOC2L;ARMC10;OPA1;RTKN2;BCL2L2;HTRA2;PTTG1IP;CREB3L1;CLU
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2707383436125175,-0.7756614363769434,0.8197530864197531,0.925393915654927,1.0,5/19,16.40%,CAT;MAOB;GPX1;PRDX1;PRDX3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3042439025696748,-0.7756101560446969,0.7574370709382151,0.9248418803861265,1.0,5/12,19.19%,RNF8;RECQL5;EAPP;NELFCD;HEXIM1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3360402213681682,0.7755823514366703,0.7641996557659209,0.9857511001665655,1.0,3/14,10.21%,SCRIB;FSCN1;OPHN1
prerank,organonitrogen compound catabolic process (GO:1901565),0.24797658593713598,0.7755161728059128,0.8311688311688312,0.9852747539315724,1.0,9/57,12.19%,CPQ;LIPC;CAPN3;UCHL3;PLA2G7;MTOR;ADO;TXN2;SGPL1
prerank,Golgi to endosome transport (GO:0006895),-0.28110624138651674,-0.7752188562879556,0.7608695652173914,0.9247836272065327,1.0,5/16,14.68%,DOP1B;AP2A1;KLHL20;MON2;VPS13A
prerank,lymphocyte proliferation (GO:0046651),-0.2542934231775862,-0.7747364392538312,0.8292682926829268,0.9248265606032441,1.0,3/22,6.09%,MEF2C;CTPS1;ELF4
prerank,negative regulation of translational initiation (GO:0045947),-0.30630217000386856,-0.7744060147778076,0.7848699763593381,0.9246639372707751,1.0,5/13,17.68%,PAIP2;RBM4;EIF4EBP1;EIF3E;AGO2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.29431398274184584,-0.7740747073698713,0.7941888619854721,0.9245460321163792,1.0,5/15,23.21%,SMO;SIX1;AGT;SIX4;SOX8
prerank,regulation of cell cycle process (GO:0010564),0.2263734149279749,0.7739631404313185,0.8743718592964824,0.9872987188641975,1.0,17/104,14.50%,ATF5;L3MBTL1;TIPIN;PKMYT1;FBXO5;CDK13;ZFYVE26;RCC1;MKI67;SOX9;USP19;RAB11FIP3;ENTR1;BUB1;MAP9;DBF4;CEP250
prerank,mitochondrial transcription (GO:0006390),0.3547903410093838,0.7738035760548027,0.7523277467411545,0.9869933039524944,1.0,5/10,27.93%,SLC25A33;TEFM;TFAM;FOXO3;MRPL12
prerank,regulation of lipid storage (GO:0010883),-0.257457658080248,-0.7737085906666956,0.821522309711286,0.9244342749976545,1.0,5/22,16.00%,NFKB1;NFKBIA;PTPN2;ITGB3;SIRT1
prerank,positive regulation of dephosphorylation (GO:0035306),0.2799885465026351,0.7734934656417293,0.7738853503184714,0.986912380528884,1.0,1/27,0.26%,DLC1
prerank,response to alcohol (GO:0097305),0.27966235719027027,0.7725732841246539,0.7632398753894081,0.9878426253951469,1.0,6/27,19.41%,GRIN2B;GRIN2A;GLRA1;TGFBR1;GRIN3A;ABCA2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.30968300767670864,-0.7725031790060057,0.757847533632287,0.925670169499479,1.0,3/12,16.99%,ELAVL1;TERT;ESR1
prerank,mRNA processing (GO:0006397),0.2044294990926255,0.7719655419018887,0.9299568965517241,0.9882855313762429,1.0,74/287,22.68%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;THOC7;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNRPB2;PRKACA;SMU1;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;GTF2H3;SRSF10;PRPF18;SYF2;ERCC2;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;GTF2H1;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;THOC5;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;CTNNBL1;ZCRB1;RBM6;CHTOP;POLR2L;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CDK7;RNGTT;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3245711262739357,0.7717935720299521,0.7564766839378239,0.9879843602980959,1.0,4/15,18.55%,KCNIP2;KCNN2;KCNJ8;KCNJ3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.2818136943784039,-0.7717706884845041,0.801007556675063,0.9260957368326385,1.0,5/16,21.55%,BCL2L1;ACKR3;TPT1;SNAI1;CCAR2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.25447880295637887,0.7716300892528706,0.8161244695898161,0.9876738004888262,1.0,6/45,10.90%,WNT5A;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3537104197426064,0.7715486739042505,0.7517482517482518,0.987239058536135,1.0,2/10,4.84%,PRKD3;HTR2B
prerank,histone H2A acetylation (GO:0043968),0.3201429849717603,0.77140676382895,0.7504187604690117,0.9868898612371076,1.0,8/16,26.16%,MORF4L1;BRD8;EPC1;DMAP1;ING3;ACTL6A;MORF4L2;YEATS4
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.26839485516449946,-0.7711923758533744,0.7799511002444988,0.9262561976097976,1.0,6/18,23.90%,ASH1L;SMYD2;EEF1AKMT2;SETMAR;SETD1A;KMT2B
prerank,actin filament polymerization (GO:0030041),-0.23832812613469423,-0.7703585384272373,0.8370786516853933,0.9268692245433806,1.0,6/29,10.35%,DIAPH1;GSN;RAC1;COBL;GAS7;FAM107A
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2737689045522138,0.7691087250702899,0.7788309636650869,0.9900826832662142,1.0,6/31,17.28%,CD40;IL16;TLR4;TIRAP;MAPK11;LGALS9
prerank,hexose biosynthetic process (GO:0019319),0.2558361729254133,0.7686636428782091,0.8075801749271136,0.9902095831717967,1.0,6/42,11.23%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3279030190538047,-0.7685499768037775,0.786697247706422,0.9287996383489086,1.0,5/10,35.38%,CX3CR1;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,TOR signaling (GO:0031929),-0.2475249748386491,-0.7684788279653942,0.8297297297297297,0.9282792382946233,1.0,15/26,35.05%,FNIP1;RICTOR;PRR5L;CCDC88A;MAPKAP1;EIF4EBP1;AKT1;NPRL3;RHEBL1;MLST8;EIF4EBP2;SMG1;SYAP1;RPS6KB2;CARD11
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2514986304478557,0.7684689653957922,0.8225108225108225,0.9899308421599278,1.0,6/50,7.97%,OGT;PRMT3;FBXO5;ADGRB1;LIMK1;PER2
prerank,cellular component maintenance (GO:0043954),0.33775300760387733,0.7680539286700792,0.7605118829981719,0.9900464392861426,1.0,3/12,12.48%,ITGA3;FYN;LNPK
prerank,negative regulation of cell communication (GO:0010648),-0.26210402006097877,-0.7679770824239411,0.7865168539325843,0.9283739386523233,1.0,7/21,28.49%,IGFBP3;ACVR1;PTPN1;ERBB3;SOCS5;BRAP;KIF26A
prerank,regulation of interleukin-8 production (GO:0032677),-0.19311703429538973,-0.76780501180658,0.9340659340659341,0.9279957052816946,1.0,12/69,17.22%,AFAP1L2;KLF4;LBP;ANXA1;MAVS;LAMTOR5;SERPINE1;TMSB4X;MAP2K5;ANXA4;RAB1A;CD74
prerank,myoblast fusion (GO:0007520),0.3399079031979668,0.7676757131698729,0.7672849915682968,0.9900873328457637,1.0,4/12,18.99%,ADGRB3;ADAM12;CD81;KCNH1
prerank,mitochondrial translational termination (GO:0070126),0.22825287187046062,0.7673509061745046,0.8621586475942783,0.9900648840717332,1.0,24/88,23.64%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.30079553284855265,-0.7669596368894711,0.7928571428571428,0.9285943919200887,1.0,6/13,22.16%,MTM1;FEZ2;TMEM39A;CHMP4B;CHMP4A;NUPR1
prerank,epidermal cell differentiation (GO:0009913),-0.22196515132138653,-0.7668962780535831,0.897196261682243,0.9280449869377807,1.0,11/41,20.57%,CLIC4;ANXA1;TXNIP;CASP3;UGCG;GATA6;BCR;WNT16;EPHA2;ADAM9;PIP5K1A
prerank,glial cell development (GO:0021782),0.2855985568440134,0.7667479755184116,0.768503937007874,0.9904184336598161,1.0,5/25,13.88%,MXRA8;EIF2B1;NF1;SOX10;MYRF
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3437531527606806,0.7660542697347743,0.7520661157024794,0.9909489925742135,1.0,1/11,1.73%,TAF9B
prerank,spinal cord development (GO:0021510),0.3335681771650624,0.7659641022894741,0.7642980935875217,0.9905260890133403,1.0,3/12,8.43%,LOXL3;NF1;RELN
prerank,cell junction maintenance (GO:0034331),0.32869276936446323,0.7656775071832784,0.7562604340567612,0.9904051521299064,1.0,5/14,27.42%,CBLN1;F2R;PRTN3;MYADM;DCTN1
prerank,alcohol catabolic process (GO:0046164),-0.32341679355163633,-0.7655814400805591,0.7699115044247787,0.9293268083757591,1.0,3/10,13.08%,SCARF1;APOE;SNX17
prerank,negative regulation of DNA replication (GO:0008156),0.32990111380127124,0.765419076183862,0.7775919732441472,0.9902604365041869,1.0,5/13,24.44%,GMNN;TERF1;TSPYL2;GMNC;GTPBP4
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2684436165094846,0.7654163090172733,0.7887537993920972,0.9896855757939872,1.0,8/32,19.31%,CDK14;FBXO5;POLA1;CDT1;KLF11;CDK5;CCNE1;TFDP1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.32127339207235694,0.7651787889313256,0.7788944723618091,0.9894941738245661,1.0,6/15,24.26%,GRM5;GRM7;GRM1;HOMER3;HOMER2;GRM8
prerank,retrograde axonal transport (GO:0008090),0.3164103748398114,0.7649296828615025,0.7791304347826087,0.9893243337430533,1.0,2/16,6.29%,DLG2;TMEM108
prerank,regulation of protein modification process (GO:0031399),0.2503377899531135,0.764839598686561,0.7980225988700564,0.9888957372302983,1.0,12/50,16.18%,PHIP;RABL3;SPRED1;PTK2;SPRED2;GRM5;FKTN;PLXNB2;IGF2;LYN;ATG14;NDUFS4
prerank,cardiac muscle contraction (GO:0060048),0.26935326818130967,0.7647459128041912,0.7833333333333333,0.9884635814566656,1.0,3/34,4.25%,ATP1A2;RYR2;SCN2B
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.282155699608208,-0.764550108388255,0.7808857808857809,0.930122645453012,1.0,4/16,13.27%,BMPR2;ACE;KLK2;DDAH1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.2662644018792323,-0.764473630318844,0.817258883248731,0.9296012886590224,1.0,6/20,16.11%,ERLIN1;WNT4;SIK1;CEACAM1;ASXL3;GPER1
prerank,protein localization to mitochondrion (GO:0070585),-0.3100903435795672,-0.7643697448778747,0.8084112149532711,0.9291060505455111,1.0,5/11,22.03%,HK1;HK2;ISG15;AKT1;COX18
prerank,synaptic vesicle localization (GO:0097479),0.32232604543107485,0.763703309888464,0.7455516014234875,0.9895681239925277,1.0,4/13,17.24%,SYNDIG1;KIF5C;TMEM230;CDK5
prerank,regulation of activated T cell proliferation (GO:0046006),0.2713122348176785,0.7636273133988306,0.8097412480974124,0.9891132711407151,1.0,7/30,17.28%,SCRIB;ICOSLG;PDCD1LG2;PYCARD;IGF2;PRKAR1A;LGALS9
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.2321271183650115,0.7634866994864212,0.8421052631578947,0.9887739400410863,1.0,7/73,9.15%,NTRK3;SH2D3C;MTCP1;DOCK7;PINK1;PRKD1;TENM1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.32616917757082675,0.7630949488013422,0.7670753064798599,0.9882831700305806,1.0,1/12,1.17%,SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.32616917757082675,0.7630949488013422,0.7670753064798599,0.9882831700305806,1.0,1/12,1.17%,SPRY4
prerank,neural crest cell development (GO:0014032),0.25249099253525864,0.7629332181687006,0.8219971056439942,0.9879757609333312,1.0,6/44,10.26%,NRG1;SEMA5A;ERBB4;HTR2B;TAPT1;SOX10
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.30887870371740217,0.7628872531888017,0.8043117744610282,0.9874887894004674,1.0,2/16,9.92%,NAA10;NAA50
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.29089729504099965,0.7627507295571126,0.7843803056027164,0.9871281535056678,1.0,6/22,18.28%,PSMA5;PSMB5;PSMA4;PSMB9;PSMA7;PSMA2
prerank,actin polymerization or depolymerization (GO:0008154),0.25032715678187956,0.7623704346385713,0.8373408769448374,0.9871702668182439,1.0,4/50,6.98%,SVIL;MICALL2;ARHGAP6;WASF3
prerank,regulation of centrosome duplication (GO:0010824),0.2719266121216014,0.7622871257688697,0.7968992248062016,0.9867355664815148,1.0,7/29,19.18%,NAT10;CEP295;TMEM67;FBXW5;VPS4B;ALMS1;CENATAC
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.258710716962878,-0.7620260573847765,0.7946859903381642,0.9318105153944005,1.0,4/20,19.11%,PLCB1;RGS10;LYPD1;AGRN
prerank,DNA modification (GO:0006304),0.29189110979585736,0.761765777775993,0.7797427652733119,0.9870032451487546,1.0,6/22,19.03%,NEIL3;TERF1;MUTYH;MBD4;EXOSC5;TERF2IP
prerank,positive regulation of DNA recombination (GO:0045911),0.28238835250738203,0.7615202108321891,0.7941653160453809,0.9868211096550148,1.0,8/27,18.77%,ZCWPW1;MRNIP;HMCES;ACTR2;ERCC2;PAXIP1;MMS19;RIF1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.30122258489774456,-0.7611710513449004,0.7764976958525346,0.9318357677726756,1.0,2/12,9.10%,GSK3B;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.30122258489774456,-0.7611710513449004,0.7764976958525346,0.9318357677726756,1.0,2/12,9.10%,GSK3B;DYRK2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3404882203331587,0.7606691255681373,0.7486818980667839,0.9875452265075395,1.0,1/11,1.25%,PTPRT
prerank,positive regulation of viral transcription (GO:0050434),-0.2510414645954857,-0.7603235084782003,0.7804878048780488,0.9323665142476896,1.0,10/25,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;CDK9;NELFCD;GTF2F2;CTDP1;POLR2I;POLR2K
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.2775634068277062,0.7602671027298026,0.781055900621118,0.9876277472928365,1.0,3/26,9.80%,TREML4;PTPN22;CYBA
prerank,cellular response to misfolded protein (GO:0071218),-0.25788665244674397,-0.7601215493414348,0.8201058201058201,0.9320145592028619,1.0,6/20,21.67%,RNF185;VCP;TOR1A;CUL3;RNF5;UGGT1
prerank,negative regulation of signaling (GO:0023057),-0.24602141947717387,-0.7599752520251731,0.817910447761194,0.9315719931277028,1.0,4/25,10.53%,IGFBP3;ACVR1;PTPN1;OPTN
prerank,necroptotic process (GO:0070266),-0.27487929721159843,-0.7599261091252557,0.8034825870646766,0.9309909582841357,1.0,6/16,19.96%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96
prerank,negative regulation of phosphatase activity (GO:0010923),0.28116235572467035,0.7594683516650464,0.7993630573248408,0.9883279218506817,1.0,6/25,15.54%,BOD1;GPATCH2;PTPA;PPP1R26;ZCCHC9;CRY2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3192068487426551,0.758968793401342,0.7542662116040956,0.9885144690343135,1.0,3/15,10.89%,GSTO2;DAXX;DHX36
prerank,postreplication repair (GO:0006301),0.25108532633727865,0.7589600128153856,0.8135838150289018,0.9879586500069945,1.0,11/45,14.55%,POLK;RPA1;RFC3;UBE2V2;POLH;FAAP20;POLN;SPRTN;REV1;POLI;UBE2V1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.307065819321424,-0.7586233687518029,0.7884615384615384,0.932168548879168,1.0,6/12,24.44%,CLN5;ATP6AP2;TMEM9;CLN6;CCDC115;TMEM199
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22123579979729519,0.7581273098570473,0.8814814814814815,0.9886654548290977,1.0,20/110,16.01%,NRG1;HRG;TRAF3IP1;SORL1;NAPB;MPP7;PINK1;SLF1;SAR1A;EIF2AK2;IAPP;SPIDR;CDT1;KIF9;HSPA5;BAK1;CLU;SLF2;TIRAP;IMPACT
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3428408037361639,0.7576558832495438,0.7567084078711985,0.9888424499688062,1.0,5/10,24.42%,DSE;CSGALNACT2;B3GAT3;DSEL;B3GAT2
prerank,heart contraction (GO:0060047),0.2605440324864359,0.7568681755365958,0.825,0.989497267328802,1.0,3/41,4.25%,ATP1A2;RYR2;SCN2B
prerank,embryonic hemopoiesis (GO:0035162),0.3310449450512526,0.7567057555321696,0.746551724137931,0.9891883081208922,1.0,2/12,4.58%,FLT3LG;KMT2A
prerank,telomere maintenance via telomerase (GO:0007004),0.2713708946802357,0.7566427165507421,0.8241758241758241,0.9887178744544606,1.0,7/28,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19820792840050744,0.7565236043787041,0.9428263214670982,0.988335611377584,1.0,92/314,24.56%,BUB1B;FBXO9;FBXO45;PSMD1;BFAR;FBXO5;FBXO31;SEL1L;ZSWIM8;NEDD4;DMAC2;CDC16;PSMD10;CRBN;HERPUD1;CDC20B;PSMA5;ECPAS;PSMB5;AMN1;UBE2G2;UBXN4;BIRC2;PLAA;DNAJB12;FBXO17;PSMC4;MAN1B1;SEC61B;PSMA4;TMEM67;PSMC5;DNAJC10;FBXW5;USP19;FBXL13;HSP90B1;CUL5;GSK3A;ANAPC5;PSMB9;AREL1;TRIM2;ATXN3;UBE2D1;HSPA5;RNF122;BAG6;TRIM3;HACE1;YOD1;PSMA7;HECW1;DNAJB14;UBXN2B;PSMD14;FEM1B;CDC26;KLHL22;RNF187;PSMA2;DCAF11;ZFAND2A;CUL4A;PSMD11;FBXO4;FBXW4;SPSB2;UBE2J1;MTA1;DDB1;UBE2K;FBXL22;DDIT3;BTRC;RNF216;RMND5B;UBR3;SPSB3;ANAPC4;FAF1;FBXL5;FBXL12;NHLRC3;KIF14;UBE2J2;UFD1;UBE4A;FBXO44;SPSB1;OS9;MAD2L1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.2800960601647844,-0.7564569956977146,0.7696078431372549,0.9344800033864766,1.0,9/14,31.99%,WNT9A;PTHLH;RFLNA;EFEMP1;CHADL;RFLNB;GREM1;ADAMTS7;SNAI2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.29558708312002513,0.7563824342654242,0.7921440261865794,0.9879948250692572,1.0,6/19,20.25%,NR1H4;TLR4;IRAK1;TIRAP;LGALS9;RAB11FIP2
prerank,neuron projection fasciculation (GO:0106030),0.3434756461781805,0.7561933909708947,0.7431192660550459,0.9877329558398753,1.0,4/10,15.96%,SEMA5A;CNTN4;ARHGAP35;NRCAM
prerank,regulation of neuron apoptotic process (GO:0043523),0.22192945902791794,0.7561900042240285,0.8774703557312253,0.987168965759984,1.0,9/96,9.06%,EPHA7;SLC30A10;NTRK2;GRID2;PRKCI;NF1;EGLN2;PINK1;LGMN
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.25820273527682513,0.7554913614935552,0.8222222222222222,0.9877007116991908,1.0,7/38,14.73%,MIS18A;CENPU;ASF1A;UBN1;CENPC;CENPW;MIS18BP1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3204603550604175,-0.7551164223617395,0.7949308755760369,0.9357049384031237,1.0,6/10,28.15%,RAPGEF3;SPHK2;BRCA1;SMAD4;CHEK1;HDAC5
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.267217330952755,-0.754624306371509,0.8157894736842105,0.9357304062909065,1.0,4/18,12.13%,PARN;CCT3;CCT4;CCT7
prerank,NAD biosynthetic process (GO:0009435),0.2944546839562531,0.7544955114009367,0.7996742671009772,0.9886173039766181,1.0,3/20,11.85%,NMNAT3;KYNU;PTGIS
prerank,protein monoubiquitination (GO:0006513),-0.22383316514405355,-0.7544676065334037,0.853448275862069,0.9352938417233795,1.0,8/36,24.94%,MGRN1;UBE2D3;TRIM25;UBE3D;CUL3;LEO1;RNF20;DTX3L
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.29466575051039223,-0.7543690928585488,0.7909090909090909,0.9348075026533947,1.0,5/13,21.97%,PRPF3;LSM2;CD2BP2;PRPF19;DDX20
prerank,neuron apoptotic process (GO:0051402),0.29452477741153005,0.7541493239994287,0.782392026578073,0.9886016907740895,1.0,6/19,17.24%,NGFR;TNFRSF21;FAM162A;ATN1;SCN2A;CDK5
prerank,pseudouridine synthesis (GO:0001522),-0.2902762635115673,-0.7529890140018252,0.812933025404157,0.9360205123762592,1.0,6/13,33.68%,PUS10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,protein polyglutamylation (GO:0018095),0.33308297557555533,0.7529283534736968,0.764406779661017,0.9899331489049298,1.0,2/11,13.44%,TTLL6;TPGS1
prerank,positive regulation of protein processing (GO:0010954),0.29153824343455137,0.7529155888985712,0.7876823338735819,0.9893859626443242,1.0,5/19,19.56%,KLKB1;CLEC3B;NKD2;ADAM8;RHBDD1
prerank,negative regulation of cilium assembly (GO:1902018),-0.3042384550098083,-0.75278358900139,0.7697368421052632,0.93563577302264,1.0,7/12,42.80%,TBC1D7;EVI5L;ODF2L;MAP4;TBC1D30;TCHP;CCP110
prerank,body fluid secretion (GO:0007589),0.31371911464277713,0.7523967594575569,0.7833622183708839,0.9896234953418104,1.0,1/15,2.16%,ERBB4
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2554828184613124,0.751943131130893,0.8126888217522659,0.9897532166693436,1.0,11/42,20.56%,POLQ;SIRT6;MRNIP;SPIDR;FIGNL1;ACTR2;MMS19;FBH1;RIF1;TERF2IP;PPP4R2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.2750849529930497,0.7518904985800808,0.7993680884676145,0.9892613094929698,1.0,7/27,16.43%,PDE4B;RYR2;JUP;ATP2A2;CTNNA3;GJA5;STC1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.297686975050464,-0.7518730633502025,0.7995169082125604,0.9361780785488569,1.0,4/13,17.56%,EPN2;NIBAN2;PTPN1;HHEX
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2832582778805495,0.7517517683343279,0.7954911433172303,0.9883472734343185,1.0,7/22,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2832582778805495,0.7517517683343279,0.7954911433172303,0.9883472734343185,1.0,7/22,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,histone deubiquitination (GO:0016578),0.30064690446998094,0.7517135981324182,0.8023850085178875,0.9878381372190567,1.0,6/18,18.17%,KAT2A;ENY2;USP21;USP16;USP49;TAF10
prerank,positive regulation of cholesterol transport (GO:0032376),0.27861890291376235,0.7513677067412456,0.7993630573248408,0.9878081558895557,1.0,2/27,4.06%,LRP1;NR1H2
prerank,heterocycle biosynthetic process (GO:0018130),-0.2843969050925544,-0.7512342862436486,0.7990654205607477,0.9363646957335087,1.0,7/14,27.94%,NFS1;GCH1;MOCS1;NOXRED1;PYCR2;MOCS3;PYCR3
prerank,positive regulation of protein kinase activity (GO:0045860),0.21115462389040662,0.7511695361009244,0.9001189060642093,0.9875365778803017,1.0,26/148,17.33%,IL34;UNC119;TRAF4;MAP4K4;DLG3;CENPE;MTCP1;CALCA;MRNIP;PTK2;RELN;JTB;DAXX;CACUL1;MAP2K1;GRM5;DLG4;INCENP;CASS4;AXIN1;STRADB;CLU;TNIK;EFNA1;PAK5;ADRA2A
prerank,L-serine metabolic process (GO:0006563),-0.3163970982974743,-0.7507037086500196,0.7798594847775175,0.9363971275064769,1.0,3/10,17.47%,SERINC3;PSAT1;CBS
prerank,mitochondrial membrane organization (GO:0007006),-0.2280658389822425,-0.7504657652187876,0.8801261829652997,0.9360716941248246,1.0,10/32,25.67%,BCL2L1;APOOL;MICOS10;BAD;SLC25A5;GHITM;CHCHD3;PPIF;APOO;SLC25A4
prerank,mitotic cytokinesis (GO:0000281),0.24305372407389625,0.7503783525546389,0.8471428571428572,0.9881945869357687,1.0,12/47,17.84%,UNC119;SPTBN1;ANK3;EFHC1;JTB;NUSAP1;INCENP;RTKN;STMN1;CEP55;STAMBP;CUL7
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3290341298463598,0.7499334251484194,0.7763636363636364,0.9877296832913646,1.0,3/11,17.42%,AGO4;AGO3;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3290341298463598,0.7499334251484194,0.7763636363636364,0.9877296832913646,1.0,3/11,17.42%,AGO4;AGO3;AGO1
prerank,lung development (GO:0030324),0.26534686795146994,0.7499022101856355,0.825,0.98721273778804,1.0,7/33,15.69%,ITGA3;NPHP3;LOXL3;RCN3;BAG6;CCDC39;FGFR2
prerank,actin filament network formation (GO:0051639),0.33480349443986146,0.7494182990018693,0.7408056042031523,0.987378146314929,1.0,7/11,29.22%,ACTN1;CARMIL2;SPIRE1;PLS3;CARMIL1;LCP1;FHOD3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.30529972888392015,0.7492791128888863,0.8177257525083612,0.9870306026873042,1.0,8/17,25.81%,SEL1L;HERPUD1;SEC61B;HSP90B1;RHBDD1;UFD1;OS9;AUP1
prerank,regulation of viral genome replication (GO:0045069),0.24145531469452786,0.7491213612342724,0.8445078459343794,0.9867027275337766,1.0,5/56,7.13%,PPARA;PPID;PPIH;PDE12;STAU1
prerank,regulation of cellular catabolic process (GO:0031329),0.23603071852287927,0.7488125996559886,0.8623978201634878,0.9865693303147447,1.0,13/62,18.15%,PIP4K2A;ITPR1;PIK3R2;MTMR4;LRRK2;RAB8A;WDR24;USP33;CISD2;USP13;RRAGA;GPR137B;RRAGD
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.24609404857302017,0.7484468801538497,0.8581560283687943,0.9865703509431543,1.0,13/50,22.24%,CCNJ;PKMYT1;CDKN2D;CCNB2;CDKN2C;CCNA2;GTF2H1;CCNK;CCNE1;CDK5R1;CCND3;CDK7;CCNT2
prerank,glycerol metabolic process (GO:0006071),0.33535930631939104,0.7478616814468922,0.7453874538745388,0.9869028990057869,1.0,2/10,10.39%,COQ3;GK
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.299163313686165,0.7476299509816675,0.7704081632653061,0.9866685366524051,1.0,5/18,17.82%,TLR4;LRRC17;FBN1;MAFB;GPR137B
prerank,protein localization to vacuole (GO:0072665),0.3204248777236977,0.7475123266279552,0.7614035087719299,0.986283154477353,1.0,3/13,12.93%,SZT2;RNF128;CD81
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3290135912986317,0.7471674562263576,0.7652329749103942,0.9862449343262916,1.0,3/11,14.59%,SIRT6;MPHOSPH8;RESF1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2691946196234277,-0.746926230138766,0.8388625592417062,0.9400836136358045,1.0,3/16,11.42%,ST3GAL4;ETS1;MDK
prerank,calcium ion homeostasis (GO:0055074),0.22198250612186782,0.7468609973641007,0.8987804878048781,0.9861535967613176,1.0,9/95,9.08%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ATP13A3;HTR2C
prerank,'de novo' posttranslational protein folding (GO:0051084),0.26353378032484787,0.7468425816738191,0.8301886792452831,0.9856260028206179,1.0,10/30,22.09%,ENTPD5;SELENOF;DNAJB12;HSPA13;HSPA5;DNAJB14;HSPE1;ST13;HSPA9;CHCHD4
prerank,negative regulation of cellular component organization (GO:0051129),0.23014966639284362,0.7467174861048267,0.8788282290279628,0.9852494572974245,1.0,13/74,16.01%,TRAF3IP1;FAP;NR1H4;SORL1;CARMIL2;PRKD1;EPHA3;IAPP;HSPA5;CLU;PACSIN3;AR;IMPACT
prerank,protein depolymerization (GO:0051261),-0.2378541121464908,-0.7465529630853659,0.8516483516483516,0.9399039143181019,1.0,8/27,21.46%,MICAL2;GSN;KIF24;CFL1;DSTN;MICAL3;KATNB1;TWF2
prerank,negative regulation of ion transport (GO:0043271),0.2790345526691403,0.7463588062589507,0.8112633181126332,0.985205028393222,1.0,6/24,17.33%,GPM6B;NEDD4;WNK2;PACSIN3;STC1;ADRA2A
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2569191174201939,-0.7457289935283805,0.8375634517766497,0.9403443741006905,1.0,4/18,13.03%,ADAM10;APOE;APH1A;APH1B
prerank,ncRNA export from nucleus (GO:0097064),0.25572490504205425,0.7456328631700794,0.8221225710014948,0.9857200311649968,1.0,11/36,23.77%,NUP214;AAAS;POM121;NUP42;NUP107;TSC1;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.22981411972212457,0.7455112467473994,0.8703208556149733,0.9853489787907935,1.0,17/69,16.82%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;SEC61B;TMEM67;DNAJC10;USP19;HSP90B1;HSPA5;BAG6;YOD1;DNAJB14
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.28626431741085556,0.7452488742246818,0.8080645161290323,0.9851912491195037,1.0,2/20,4.94%,PPID;PPIH
prerank,histone acetylation (GO:0016573),0.23052190468563083,0.7451818334138837,0.875,0.9847311913328641,1.0,19/69,21.85%,TAF12;MORF4L1;BRD8;WDR5;BRCA2;KAT2A;NAA50;JADE1;EPC1;POLE3;DMAP1;ATF2;PHF20L1;KAT7;TAF10;MBIP;SUPT7L;ING3;CREBBP
prerank,fatty acid oxidation (GO:0019395),0.23844659249098968,0.7447778178534097,0.8559322033898306,0.9847621511646371,1.0,5/57,6.33%,ABCD2;PEX2;PPARD;ACADL;ACADS
prerank,snRNA metabolic process (GO:0016073),-0.2736058872095869,-0.7444593956039834,0.8160377358490566,0.9413778945663401,1.0,6/17,19.81%,INTS3;RBM7;INTS9;INTS10;INTS1;MEPCE
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24609581731488234,0.7443343535954188,0.8521870286576169,0.9848430288659462,1.0,11/48,18.74%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,DNA recombination (GO:0006310),0.2509409148465746,0.744002356672697,0.8397626112759644,0.984795088263462,1.0,10/37,22.27%,ERCC1;MSH3;RPA1;RECQL;RAD52;HDAC10;WRN;FBH1;RAD54L;HMGB1
prerank,respiratory electron transport chain (GO:0022904),0.314678758391604,0.7439834772114012,0.7930434782608695,0.9842697602880487,1.0,2/14,8.61%,SDHB;SLC25A22
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.3478652807587606,0.7439444342659467,0.7721518987341772,0.9837831579444204,1.0,2/10,8.31%,GFPT2;PFKM
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3141815949619946,-0.7437723385135706,0.8129175946547884,0.9416026336747588,1.0,4/10,24.67%,DCLRE1A;RTEL1;DCLRE1B;ACD
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2892458532904659,0.7436641225949544,0.806873977086743,0.983616667809617,1.0,2/18,8.85%,XCL1;NAV3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.26971476982061837,0.7433850183723573,0.8213166144200627,0.9834747826037185,1.0,9/29,21.60%,ERCC5;RPA1;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1;CDK7
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.2807166910143765,0.7428279541879527,0.8023064250411862,0.9837498796313684,1.0,4/23,11.67%,SLC12A6;SLC9A1;CLCN3;PDK2
prerank,lipid oxidation (GO:0034440),-0.29517952145265586,-0.7425477703152138,0.7945823927765236,0.9424907029433648,1.0,1/12,2.57%,ADIPOR2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.25594901424433536,-0.7425261374628602,0.8341836734693877,0.9418764651284568,1.0,7/19,29.92%,PRKDC;MDK;PPP2R3C;RHOH;CD27;NCKAP1L;IL7
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.30020018767637446,0.7424257022114046,0.7843803056027164,0.983758324125014,1.0,2/15,7.16%,REST;ZFP36L2
prerank,regulation of RNA splicing (GO:0043484),0.2314343368949741,0.742382951918635,0.8649386084583902,0.9832626474005003,1.0,15/69,18.67%,PIK3R1;TRA2B;AFF2;PRX;KHDRBS3;CWC22;SRSF10;RBM20;ZNF326;SNRNP70;HNRNPLL;HNRNPL;HABP4;RRP1B;KHDRBS1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.2987701890447619,-0.7423828092658834,0.7980295566502463,0.9414193818134325,1.0,2/13,4.78%,PLA2G4A;MGLL
prerank,positive regulation of secretion by cell (GO:1903532),0.22944064861939883,0.7420876116725499,0.8622994652406417,0.983150027237868,1.0,14/70,18.98%,CADPS2;EDN3;PPID;CADPS;IER3IP1;P2RX4;EXOC1;CLASP2;CLASP1;ADAM8;STXBP5;RAB2B;BMP2;ATP6AP1
prerank,serine family amino acid metabolic process (GO:0009069),0.30297051170972855,0.7418889714354856,0.7764705882352941,0.9828797487337847,1.0,1/16,1.42%,THNSL2
prerank,regulation of chromosome segregation (GO:0051983),0.301946699920422,0.74150288916279,0.7811447811447811,0.9829076434578919,1.0,3/16,15.90%,MKI67;BUB1;CSNK2A2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.31115371050248397,-0.7414942280827826,0.7829977628635347,0.9412785231130615,1.0,6/10,31.65%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2;ALKBH1
prerank,DNA dealkylation (GO:0035510),-0.31115371050248397,-0.7414942280827826,0.7829977628635347,0.9412785231130615,1.0,6/10,31.65%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2;ALKBH1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.31239060096219934,0.7414135962620481,0.7946428571428571,0.9824894375908437,1.0,5/15,21.31%,REEP2;LNPK;RTN3;ZFYVE27;ATL1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.199448863859214,-0.7413564014931556,0.9292929292929293,0.9408161188583173,1.0,13/49,26.33%,AFAP1L2;LBP;MAVS;LAMTOR5;SERPINE1;RAB1A;CD74;TLR7;BCL10;HYAL2;NOD2;HSPA1A;PARK7
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.20637402688265016,-0.7406935203678674,0.9267515923566879,0.9410012033721038,1.0,12/52,15.85%,TUT7;SAMD4A;CNOT10;PARN;PAN3;LSM6;CNOT8;RC3H1;EXOSC2;LSM2;NT5C3B;EXOSC3
prerank,post-translational protein modification (GO:0043687),0.19458549432913788,0.740001647752304,0.9743315508021391,0.9839624231362009,1.0,86/332,23.17%,LAMC1;LAMB1;CCDC22;FBXO9;MXRA8;PRKCSH;COPS3;PSMD1;VCAN;FBXO31;ZBTB16;SPP1;RAB8A;EPAS1;PSMD10;UCHL3;AMELX;PSMA5;WDR5;PSMB5;APLP2;COMMD1;FBXO17;PSMC4;KCTD7;PSMA4;ASB1;PSMC5;RAB2A;FBXW5;FBXL13;HSP90B1;CUL5;COPS4;CAND1;PSMB9;LGALS1;SPARCL1;DDA1;ASB10;CHML;FBN1;SDC2;SERPINC1;PSMA7;DCAF4;IGFBP7;PSMD14;SOCS6;FEM1B;CUL7;WSB2;KLHL22;CALU;PSMA2;DCAF11;RCN1;HIF1A;CUL4A;PSMD11;ANO8;FBXO4;MIA3;DCAF10;RHBDD1;FBXW4;WSB1;SPSB2;MEN1;SCG2;DDB1;MBTPS1;FBXL22;CHGB;SENP8;WDTC1;RBBP5;BTRC;UBXN7;ASB13;KTN1;SPSB3;FBXO21;KLHL5;FBXL5;FBXL12
prerank,macroautophagy (GO:0016236),0.21403798545083821,0.7399798771483349,0.9113924050632911,0.9834493446244621,1.0,25/118,17.76%,DYNLL1;PIP4K2A;VPS39;VIPAS39;PINK1;SNAP29;RB1CC1;PLAA;ARL8B;TMEM74;LIX1L;VAMP7;HGS;MFN1;HDAC10;TSG101;DYNLL2;ATG14;SNF8;YOD1;VPS33B;CSNK2A2;UBXN6;VPS4B;WIPI2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2717207729104775,0.7396899590497997,0.8291873963515755,0.9833345695145862,1.0,5/24,15.36%,NCKAP5L;STMN2;STMN4;STMN1;KIF2A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2700065291710958,-0.7395137514698961,0.8350515463917526,0.9418714302337116,1.0,5/17,17.86%,SOD2;HSPB1;PPIA;SIRT1;AKT1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.2453541237342258,-0.7392947405947897,0.8778409090909091,0.9415561502341276,1.0,8/23,23.87%,HOOK1;CCDC88A;CCDC186;CCDC88C;DYNC1I1;KIF1C;TUBA1C;KIF5B
prerank,acyl-CoA metabolic process (GO:0006637),0.258352456289955,0.7390454483168938,0.8170542635658915,0.9837140168387649,1.0,7/35,17.51%,ACSF2;DLST;ACOT7;HMGCS1;ACSL6;ACOT2;MCEE
prerank,RNA biosynthetic process (GO:0032774),0.2607457033089392,0.7387547729886458,0.8144171779141104,0.9835812739113952,1.0,3/31,10.16%,TAF12;POLA1;TBPL1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.22006808381782778,-0.7383841068944963,0.8810198300283286,0.9420755723197574,1.0,10/35,20.30%,EZR;MINK1;XDH;GADD45B;CYLD;MAP3K4;PER1;DLG1;MFHAS1;GADD45G
prerank,snRNA transcription (GO:0009301),0.2276570593203969,0.7380572452668726,0.8666666666666667,0.9839853708428596,1.0,23/70,26.43%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;USPL1;SP1;TAF11;POLR2L;GTF2B;CDK7;GTF2A2;CCNT2;POLR2D;TAF5;GTF2E1;POU2F1;ELL;RPRD2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.31126105174625457,0.7380525412712712,0.7828282828282829,0.9834431831145344,1.0,3/14,12.41%,CD40;PRKCI;PDCD4
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2728436006454886,0.7379839728546617,0.8291139240506329,0.9830071717169764,1.0,8/26,20.52%,C1QC;TLR4;LRRC17;FBN1;MYC;MAFB;GPR137B;INHBA
prerank,RNA export from nucleus (GO:0006405),0.21805005341134825,0.7379175379093988,0.9060913705583756,0.9825600296969618,1.0,25/100,21.20%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,pentose-phosphate shunt (GO:0006098),-0.30143886238570633,-0.7374882053772975,0.8044554455445545,0.9425612170713769,1.0,5/11,24.52%,DERA;TALDO1;PGM2;SHPK;PGLS
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.24949953799729926,-0.736944528806494,0.8496042216358839,0.9425767303039667,1.0,11/21,36.06%,NES;CX3CR1;MDK;FZD3;CX3CL1;SMARCD3;KDM1A;DLL4;DISP3;LRP2;FZD9
prerank,positive regulation of DNA replication (GO:0045740),-0.27069260906655895,-0.7366119379773036,0.8324873096446701,0.9423667233222857,1.0,5/16,18.27%,EGFR;GLI2;PCNA;STN1;EGF
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.201755384630877,-0.735972629563777,0.9335548172757475,0.9425111164798906,1.0,19/48,32.93%,SLIT2;ROBO1;SAMHD1;PTPN2;NLRC5;ISG15;CCDC3;USP18;RFFL;SIGIRR;YTHDF2;PADI2;PELI3;TTLL12;PPARG;OTUD4;PYDC1;GPS2;TREM2
prerank,piRNA metabolic process (GO:0034587),0.28613931695697103,0.7356075575767136,0.8186440677966101,0.9853558762122469,1.0,1/19,2.39%,TDRKH
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2840657870720476,-0.7351357680663059,0.8194774346793349,0.9429250619270357,1.0,5/14,24.67%,TNKS2;ATR;TERT;TPP1;ACD
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3177716137137778,-0.7347750446103015,0.7972972972972973,0.9427267832513058,1.0,4/10,12.00%,NCK1;CITED2;VHL;BAG3
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2229279564971169,-0.7347048518281826,0.8917378917378918,0.9421802963157977,1.0,8/31,15.33%,TMBIM6;HSPA8;HSPB8;BAX;PTPN1;OPTN;BAG3;ERN1
prerank,programmed necrotic cell death (GO:0097300),-0.2592313886850405,-0.734619912112667,0.8457583547557841,0.9416633493410745,1.0,7/18,22.66%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96;PPIF
prerank,regulation of microtubule depolymerization (GO:0031114),-0.24381524519818096,-0.7345395217819453,0.8342696629213483,0.9411298113708019,1.0,7/25,21.22%,ATXN7;APC;APC2;TRPV4;CAMSAP2;CIB1;KATNB1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2742929493602494,-0.7344897984952322,0.8511111111111112,0.9405624498113083,1.0,5/15,19.75%,SMPD3;SDC4;SDC1;SDCBP;PDCD6IP
prerank,positive regulation of cellular senescence (GO:2000774),0.32942454442421204,0.7343606126157222,0.7777777777777778,0.9865294776995462,1.0,1/10,2.62%,CDKN2A
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.28721436023236824,0.7341495729284101,0.8010033444816054,0.9862893823817556,1.0,7/20,18.37%,SPRY1;TBX3;TGFBR1;PDCD4;OLFM1;BMP2;HEY1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.22822871383622298,0.7339879285488333,0.8956276445698167,0.9859727678019198,1.0,17/62,23.31%,NUP214;AAAS;FMR1;DND1;POM121;NUP42;NUP107;DHX9;WTIP;NUP54;AGO1;NUP155;FXR1;POLR2L;RANBP2;IPO8;NUP35
prerank,transition metal ion transport (GO:0000041),0.2549030385951317,0.7339149997807932,0.8543543543543544,0.9855266685035077,1.0,8/35,19.43%,SLC30A10;SLC30A5;TRPC3;TRPC7;HEPH;ATP7A;ATP2C1;TRPC1
prerank,transferrin transport (GO:0033572),0.25753311774178683,0.7334528442219972,0.8296943231441049,0.9856319594575146,1.0,7/33,18.98%,STEAP3;ARHGAP1;ATP6V0E1;MCOLN1;ATP6V0D1;ATP6V1G2;ATP6AP1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2822802459832282,0.73268770143561,0.815267175572519,0.9861421207074388,1.0,7/22,22.24%,CDK13;CCNK;THOC5;KAT7;CDC73;DDX39B;CCNT2
prerank,regulation of cell division (GO:0051302),0.22287831700648125,0.7320460822639147,0.9021739130434783,0.9865023396955979,1.0,12/72,15.69%,KDF1;SUSD2;EFHC1;NCOA3;HTR2B;ZFYVE26;INSC;RAB11FIP3;ENTR1;SMYD5;MYC;FGFR2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.2282957661163014,-0.7314404269632087,0.8985507246376812,0.9435937429535844,1.0,9/32,21.86%,CAVIN1;GTF2H5;UBTF;POLR2H;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,proton transmembrane transport (GO:1902600),0.25503928054481106,0.7314072464121129,0.8426626323751891,0.9868409694449891,1.0,3/36,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,rRNA methylation (GO:0031167),0.28460248039919267,0.7313738408459775,0.8115942028985508,0.9863378652690652,1.0,12/22,31.71%,MRM3;DIMT1;NSUN3;MTERF4;NSUN5;METTL15;METTL5;ZCCHC4;NSUN4;FTSJ3;EMG1;METTL16
prerank,cellular response to BMP stimulus (GO:0071773),0.22753753057388695,0.7310533340705594,0.8816155988857939,0.986264423671286,1.0,8/66,12.41%,RUNX2;RGMB;RGMA;SMAD5;ADAMTS12;BMP7;SOX9;PDCD4
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2754093098538768,-0.7308442959655085,0.8208955223880597,0.9436643032636305,1.0,3/14,13.03%,ADAM10;APH1A;APH1B
prerank,mesonephros development (GO:0001823),-0.30049626330074597,-0.7306036040168018,0.8186046511627907,0.9433154747292956,1.0,2/11,7.93%,OSR1;FGF1
prerank,regulation of defense response to virus (GO:0050688),0.3030962216251699,0.7302143828804972,0.7916666666666666,0.9868877340699621,1.0,3/14,14.93%,TRAF3IP1;IFNLR1;DHX9
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.282790336660231,0.7300968067374393,0.8306709265175719,0.986505089948182,1.0,2/20,3.83%,MBTPS2;NGFR
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.2698070233371426,0.729879860117153,0.8309859154929577,0.9862741514536318,1.0,6/26,13.74%,PDPK1;DUSP22;ZFP36L2;SOX9;GAREM1;MED1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3067030628139087,-0.7289591850022091,0.8381374722838137,0.9446694200399572,1.0,5/10,24.32%,THOC1;ETAA1;CCAR2;RFWD3;RPA2
prerank,regulation of chromosome organization (GO:0033044),-0.24333529668507906,-0.7283561068944726,0.8722826086956522,0.9447530602100661,1.0,9/22,26.33%,SMG6;MAPT;HDAC8;SMG5;SETMAR;SHCBP1L;RMI2;LIG4;RB1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.20394340978991393,0.7281015310619363,0.9338942307692307,0.988171297873741,1.0,20/136,15.41%,XCL1;TCF7L2;CDKN2A;FOXS1;PSMD10;BRMS1;TRIM37;TAF3;LRRC14;SP100;COMMD1;BMP7;IRAK1;PYCARD;DAP;PTGIS;PIM1;CTNNBIP1;PRMT2;PAXIP1
prerank,mitochondrial translation (GO:0032543),0.21189498803079904,0.7280515125498531,0.9218158890290038,0.9877017472603743,1.0,27/104,23.64%,MRPL44;EARS2;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;HARS1;MRPS23;MRPL3;MTIF2;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21
prerank,nucleotide biosynthetic process (GO:0009165),0.29449805534729845,0.7280261972154173,0.8140703517587939,0.9871914803629229,1.0,3/18,10.63%,NMNAT3;PRPS1L1;PRPS1
prerank,positive regulation of type I interferon production (GO:0032481),-0.18243462116336315,-0.7279527614883732,0.9583333333333334,0.9446294048677969,1.0,23/73,27.47%,NFKB1;PRKDC;POLR3E;MAVS;CRCP;IRF1;GAPDH;RIOK3;POLR2H;POLR3G;POLR3D;TBK1;NFKB2;ISG15;PQBP1;POLR1C;POLR3K;TLR7;HSPD1;IRF5;FLOT1;ZBP1;POLR2K
prerank,zymogen activation (GO:0031638),0.2498252008092292,0.7279263685483727,0.8501529051987767,0.9867852840941036,1.0,7/39,14.78%,KLKB1;GRIN2A;OMA1;PLAU;LGMN;ASPH;BAK1
prerank,error-free translesion synthesis (GO:0070987),-0.2392492913755117,-0.7273743806420138,0.8785529715762274,0.9446949568373127,1.0,5/22,12.61%,NPLOC4;UBB;VCP;RCHY1;PCNA
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.30766109949899095,0.7268708814895545,0.8014059753954306,0.9876721941329798,1.0,5/14,21.79%,TLR6;IRAK1;TIRAP;TNFRSF10B;MALT1
prerank,translational termination (GO:0006415),0.2136579528724823,0.7267217488856249,0.9191270860077022,0.987325536347562,1.0,28/95,25.44%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;N6AMT1;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;ETF1;MRPL14;MRPL32
prerank,epithelial cell development (GO:0002064),-0.2550843588184247,-0.726712024313317,0.8461538461538461,0.9448765545807873,1.0,13/20,44.96%,WNT5B;ACTA2;DACT2;SLC4A7;EXPH5;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1
prerank,spliceosomal snRNP assembly (GO:0000387),0.2481305670778558,0.726496564579297,0.8621190130624092,0.9870849893389371,1.0,13/38,25.56%,GEMIN2;LSM4;SNUPN;SRSF10;CLNS1A;SNRPF;USP4;GEMIN8;PRPF8;SRSF12;GEMIN5;GEMIN7;SNRPG
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.28003764689220617,0.7259077304563307,0.8209876543209876,0.9873290724424527,1.0,3/21,8.79%,PTEN;CNKSR3;INPP5J
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.25679368776236255,0.7258589679717177,0.8467374810318664,0.9868527119546032,1.0,1/32,0.36%,CDC14B
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.32756380847287314,0.7256374079069956,0.7807486631016043,0.9866027911395402,1.0,5/10,24.06%,EMC2;EMC9;EMC8;EMC10;EMC4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.25693711765750954,-0.725553003406448,0.8525798525798526,0.9455687214471068,1.0,9/17,32.58%,MTBP;ZW10;BUB3;CTCF;RB1;IK;TTK;CENPA;ZWILCH
prerank,tRNA modification (GO:0006400),0.229002572577204,0.7240077258842178,0.8881019830028328,0.9882993489283423,1.0,19/62,24.77%,CTU1;DUS2;QTRT2;TRMT13;OSGEP;TYW3;TRMT44;TRMT61A;PUS7;WDR4;METTL1;THUMPD3;TRMT10A;METTL2A;METTL2B;LCMT2;AARS1;SSB;NSUN6
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.23583309612765915,0.7238679031288551,0.879136690647482,0.987936312910667,1.0,14/49,23.38%,TRAF3IP1;THRA;SORL1;JAM3;IAPP;HSPA5;CLU;IMPACT;PTGER4;TFIP11;HMGB1;ANKRD27;NLRP2B;KIF14
prerank,cellular response to inorganic substance (GO:0071241),0.2723754803632654,0.7236422632696291,0.836038961038961,0.9876990835985151,1.0,4/21,11.64%,ADCY10;FMR1;KCNC2;SPIDR
prerank,protein methylation (GO:0006479),0.24775481295126014,0.7228464627145609,0.8556998556998557,0.9882279731303726,1.0,17/40,28.62%,PRMT3;VCPKMT;NSD1;FAM98B;CARM1;PRMT2;N6AMT1;EHMT2;ATPSCKMT;CAMKMT;EHMT1;PRMT6;ETF1;PCMT1;FAM98A;NSD3;METTL22
prerank,cellular response to radiation (GO:0071478),0.24530332228568283,0.7225868622662234,0.8662613981762918,0.9880556228954032,1.0,5/40,12.57%,GPR88;GPR52;TP53;SPIDR;FIGNL1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.30037808250412956,0.7224868423728373,0.8006700167504187,0.9876397214327736,1.0,4/15,19.65%,RYR2;SRPRA;ZFAND2A;RAB3GAP2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.25703778510037933,0.722456252053957,0.8746177370030581,0.9871343501642874,1.0,10/31,20.38%,PTEN;CDKN2A;SUSD2;CDKN2D;JADE1;CDKN2C;PRMT2;BRD7;CDC73;CCL2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.30870633373897716,0.722401786317797,0.7862068965517242,0.9866628191873716,1.0,2/13,10.06%,L2HGDH;DLST
prerank,negative regulation of phagocytosis (GO:0050765),-0.2620668140730761,-0.7223836454562034,0.8674418604651163,0.9485142208908003,1.0,5/17,31.67%,SIRPA;DYSF;SNX3;FCGR2B;CD300LF
prerank,tRNA transport (GO:0051031),0.2512281592252309,0.7220967923108008,0.852359208523592,0.9865401795554491,1.0,10/35,23.77%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2186779559074718,0.7218599837190909,0.9127604166666666,0.9863112707900901,1.0,15/76,17.95%,C5AR1;P2RY1;HTR2B;CALCA;TRHR;CCKBR;HTR2C;GNA11;LPAR1;GRM5;F2R;LHCGR;ADRA2A;GPR35;GRM1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.25094967387266165,0.7214802201447245,0.8516228748068007,0.9862796352639097,1.0,5/32,15.72%,DLC1;MTOR;PTPA;ANKLE2;SYMPK
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.23226495266479644,0.7214729191308867,0.8809523809523809,0.9857502884332029,1.0,8/57,15.32%,CDC14B;TIPIN;FBXO31;MRNIP;TP53;RINT1;EME2;ATF2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.2554134423074972,-0.7204006375412756,0.8425,0.9501270399230769,1.0,5/17,23.43%,CD55;TRIM5;CX3CL1;LY96;SIGIRR
prerank,RNA methylation (GO:0001510),-0.1890317444847599,-0.7203825481892558,0.9722222222222222,0.9495166385946929,1.0,17/60,26.01%,VIRMA;NSUN2;TRMT61B;CMTR1;FTSJ1;TRDMT1;TRMT5;THUMPD2;METTL6;GTPBP3;RBM15B;MEPCE;TRMT6;MRM2;TRMT12;TRMT112;NOP2
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.2067241758289966,-0.7203142451853847,0.9216300940438872,0.9489730665866012,1.0,6/40,10.69%,SLC13A3;SLC38A11;SLC16A1;SLC38A5;SLC38A10;SLC7A5
prerank,negative regulation of histone methylation (GO:0031061),0.3314994266175561,0.719216997361889,0.8097826086956522,0.9881072494714721,1.0,3/10,16.27%,BCOR;WDR5;AASS
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3078547678946066,0.7178924592847374,0.7962003454231433,0.9892610536478851,1.0,2/13,10.04%,UNC93B1;IRAK1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.2929165734839714,-0.7163968471976805,0.8103837471783296,0.9526164831307802,1.0,6/11,34.90%,ZC3H3;LEO1;NCBP2;AHCYL1;BARD1;PAPOLA
prerank,translesion synthesis (GO:0019985),0.23914145013155527,0.7163561899575462,0.8824383164005806,0.9906760410505085,1.0,10/42,14.01%,POLK;RPA1;RFC3;REV3L;POLH;FAAP20;POLN;SPRTN;REV1;POLI
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.28057717939347687,-0.7160945272966812,0.8256880733944955,0.9523125554482655,1.0,3/12,13.82%,DIAPH1;ANK2;PTK2B
prerank,regulation of cellular amide metabolic process (GO:0034248),0.25332761946090043,0.7160149012806011,0.8482871125611745,0.9905890866303437,1.0,7/32,16.56%,NANOS3;NR1H4;MTPN;GRM5;RBM4B;TSC1;CYFIP1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.24073698034281948,0.7157379641298116,0.8797101449275362,0.990394336353855,1.0,12/42,23.52%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS2;SARS1;AIMP1;PPA2;MARS2;AARS1
prerank,microtubule anchoring at centrosome (GO:0034454),0.32648461061357326,0.7154652774107858,0.8136200716845878,0.9901960144199364,1.0,5/10,20.71%,PCM1;CEP19;KIF3A;BBS4;NIN
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2794601604077883,-0.7152800783637641,0.84,0.9525817585628242,1.0,3/13,15.02%,TRIM5;TRIM11;TRIM35
prerank,synaptic vesicle membrane organization (GO:0048499),0.27908737076544154,0.7151696772382063,0.8254799301919721,0.9900130342323495,1.0,4/17,13.39%,SNAP23;SYP;SNAP29;AP3D1
prerank,regulation of striated muscle contraction (GO:0006942),0.2623321735576649,0.7148025508625995,0.8408037094281299,0.9899535578277963,1.0,5/27,15.14%,ATP1A2;RYR2;PRKACA;P2RX4;GJA5
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.28611573271652146,-0.7138958936131359,0.8433734939759037,0.9533684935871972,1.0,5/12,25.16%,CRYAB;APOE;PFDN4;PFDN6;PFDN2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.26525848948642394,-0.7138584549944478,0.8627906976744186,0.9527778674763835,1.0,3/14,18.37%,MOXD1;NOS1;SLC22A2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.27867302590370135,0.7135809318810631,0.8330605564648118,0.991001398562306,1.0,4/20,14.79%,OGT;FLOT2;BIRC2;RIPK1
prerank,positive regulation of viral life cycle (GO:1903902),0.2677990776694651,0.7134080623662661,0.8438003220611916,0.9906818943963436,1.0,7/22,22.34%,FMR1;AXL;LGALS1;TSG101;LGALS9;DDB1;KPNA2
prerank,protein sumoylation (GO:0016925),0.2301906085614115,0.712761371357006,0.8838896952104499,0.9909848611324191,1.0,18/49,26.97%,NUP214;AAAS;POM121;PIAS2;SAE1;NUP42;NUP107;NUP54;NUP155;SUMO2;RANBP2;NUP35;TRIM28;UBA2;NSMCE2;IFIH1;NUP210;NUP88
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2876932927475015,0.7125861925666059,0.81438127090301,0.9906708979535833,1.0,7/18,22.36%,NOL3;PINK1;HTRA2;NONO;HIF1A;BAG5;MAPK7
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.21793143145089894,0.7121178097640397,0.9061224489795918,0.9906894374361106,1.0,3/72,4.21%,FLRT2;FGFR1;SPRED1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.20685694065015417,-0.7099938388727848,0.9079754601226994,0.9563565219892259,1.0,15/45,24.00%,THAP4;GOT2;GPT2;RIMKLB;OAT;MTHFR;NOX4;ASS1;DDAH1;CBS;KYAT3;ASNS;DDAH2;GLUL;PYCR2
prerank,negative regulation of calcium ion transport (GO:0051926),0.302622936808264,0.7099013824781735,0.8311036789297659,0.9929164637666589,1.0,4/15,17.33%,ATP1A2;PACSIN3;STC1;ADRA2A
prerank,potassium ion import across plasma membrane (GO:1990573),0.2373965124203686,0.7098900469170857,0.8839941262848752,0.9923958235215717,1.0,10/41,21.25%,ATP1A2;SLC12A6;ATP1A3;HCN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;ABCC9;SLC12A9
prerank,CENP-A containing chromatin organization (GO:0061641),0.25753722278011865,0.7092977210627813,0.8761609907120743,0.9920976322030635,1.0,5/29,14.73%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.25753722278011865,0.7092977210627813,0.8761609907120743,0.9920976322030635,1.0,5/29,14.73%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,histone mRNA metabolic process (GO:0008334),0.2635938422178815,0.709233534207472,0.8505564387917329,0.9916327847971543,1.0,6/27,15.30%,LSM11;TENT4B;TENT2;SLBP;SNRPF;EXOSC10
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.29267439527987693,0.7087894706263714,0.8261617900172117,0.9916390039013298,1.0,3/17,8.14%,SPRED1;DGKQ;SPRED2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23675957545110862,0.7084047600457296,0.8928046989720999,0.9915874836051626,1.0,6/45,9.77%,BUB1B;SCRIB;ZFP36L2;BCL6;BMP7;NME6
prerank,positive regulation of ruffle assembly (GO:1900029),0.2997738112186714,0.7080794997535079,0.8059964726631393,0.9914755026798451,1.0,2/13,8.92%,CARMIL2;EPS8L1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.25570751864983676,0.7077801884791276,0.8473767885532592,0.9913134739899333,1.0,11/29,23.83%,ELOVL2;HSD17B8;ACSL6;ACLY;ELOVL6;ELOVL1;ACSBG1;SCD5;ACACA;ELOVL5;TECR
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.29988748902660317,0.7076754265910183,0.8206429780033841,0.9908920087657523,1.0,4/14,14.64%,LRRK2;HERPUD1;OPA1;CREB3L1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.181703917192866,-0.7075101768463911,0.967479674796748,0.9583060495691507,1.0,22/68,28.51%,CAVIN1;GTF2H5;WDR33;UBTF;SNRPE;POLR2H;TTF1;POLR1H;CLP1;TAF1C;GTF2H4;POLR1G;POLR1C;NCBP2;POLR3K;LSM10;SMN1;SSU72;CPSF7;POLR2K;MED18;MTERF2
prerank,establishment of vesicle localization (GO:0051650),-0.246997247325601,-0.7074860113608583,0.8746803069053708,0.9577011898448865,1.0,9/18,34.42%,CCDC186;TOR1A;SYNJ1;SPG11;KIF5B;IKBKG;RAB11A;F8A1;DNM2
prerank,positive regulation of T cell activation (GO:0050870),-0.18790656970171937,-0.70746925975193,0.9678571428571429,0.9570946897389133,1.0,6/62,6.18%,SIRPA;ANXA1;IL6ST;SLC7A1;TFRC;NCK1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2644209282706249,0.7074128675815871,0.8499184339314845,0.9906447592074409,1.0,5/23,20.54%,COPS3;XPC;COPS4;CUL4A;DDB1
prerank,negative regulation by host of viral process (GO:0044793),-0.29471342297310876,-0.7073096753873725,0.8235294117647058,0.9566420379140613,1.0,7/10,46.02%,VAPA;PSMC3;CRP;ZC3H12A;CCL8;PRKN;PTX3
prerank,positive regulation of protein maturation (GO:1903319),-0.2865570908326658,-0.7070814170627671,0.851063829787234,0.9562628132481826,1.0,2/11,7.88%,SOX4;CCBE1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.2169617697743652,-0.7067073396766163,0.9118457300275482,0.9560126767316083,1.0,14/33,29.64%,PRKDC;MAPK14;ETS1;TAL1;HMGB2;ABCB10;PITHD1;FES;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,response to histamine (GO:0034776),-0.2904109528990729,-0.7066842489526237,0.8568181818181818,0.9554201741460822,1.0,1/10,2.26%,DIAPH1
prerank,sulfur amino acid metabolic process (GO:0000096),0.26515597374562844,0.7066634323696842,0.8673139158576052,0.9910456368943513,1.0,7/24,22.78%,MTRR;ADO;TXN2;DPEP1;MMUT;MSRA;MTHFD1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.25447947954414746,-0.7061961277767219,0.875,0.9553090308604787,1.0,2/18,2.06%,NPLOC4;DDX60
prerank,phagosome maturation (GO:0090382),0.24861743881047826,0.7059840934222618,0.8742603550295858,0.9913085334944586,1.0,2/35,2.26%,RAB34;RAB20
prerank,regulation of biosynthetic process (GO:0009889),0.317063784213265,0.7055615868949379,0.8362989323843416,0.9912999369293671,1.0,2/11,18.49%,SLC25A33;ALOX5
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.21888231802872327,0.7053909322832689,0.9139784946236559,0.9909814948242465,1.0,22/69,26.43%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;SP1;TAF11;POLR2L;GTF2B;CDK7;GTF2A2;CCNT2;POLR2D;TAF5;GTF2E1;POU2F1;ELL;RPRD2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.23561946349011648,0.704737745550296,0.8874074074074074,0.9912533441215823,1.0,5/39,10.83%,UTRN;SCN2B;NEDD4;FXYD4;FGF12
prerank,cellular macromolecule catabolic process (GO:0044265),0.2291993482247759,0.704238036779067,0.8888888888888888,0.9913474981843461,1.0,10/49,16.58%,RNASEH2C;UBE2G2;FBXO17;MTREX;RNASEH2B;HTRA2;RIPK1;HNRNPD;RNASEH1;PPP1R8
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2752286995585897,0.7040503640604071,0.8429054054054054,0.9910276769389171,1.0,3/19,10.06%,SLC25A21;ASPA;DLST
prerank,protein complex oligomerization (GO:0051259),0.20886950829102727,0.7036691924374875,0.9440104166666666,0.9909586286448073,1.0,13/85,11.72%,POLQ;MPP2;NOL3;SLC9A1;ADCY8;KCNC2;OPA1;GLRA3;NUDT21;GSDMD;VSTM5;PYCARD;WDCP
prerank,negative regulation of bone remodeling (GO:0046851),-0.29120587084643046,-0.703558130964156,0.850356294536817,0.957331419370247,1.0,6/11,25.13%,SFRP1;TMEM119;P2RX7;GPR137;TNFAIP3;GREM1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.252826087791098,0.7031399508485334,0.840983606557377,0.9910691027657563,1.0,6/29,14.79%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,pigment granule transport (GO:0051904),-0.2546341793499699,-0.7030158349267286,0.8746928746928747,0.9565693894739017,1.0,6/18,28.53%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,melanosome transport (GO:0032402),-0.2546341793499699,-0.7030158349267286,0.8746928746928747,0.9565693894739017,1.0,6/18,28.53%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,regulation of programmed cell death (GO:0043067),0.1943691545165101,0.7027232241123464,0.9660421545667447,0.9910462254155159,1.0,32/161,17.24%,CXCL10;STEAP3;HS1BP3;CASP6;LRRK2;TM7SF3;ACTN1;OMA1;BRMS1;BCL6;USP42;CIDEA;PINK1;BIRC2;DAXX;TMEM219;TP53;SLK;PSMC5;SOX9;RTKN;LGALS1;NME1;RIPK1;CLU;AIFM2;SGK1;ZBTB7A;SRA1;HAX1;CALR;CDK5
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.24919964173331882,0.7024617790494969,0.8779342723004695,0.9908147836131038,1.0,7/29,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,snRNA processing (GO:0016180),0.28739211065766046,0.701040973045476,0.8356643356643356,0.9920052372319906,1.0,2/16,11.40%,INTS8;INTS14
prerank,regulation of interferon-alpha production (GO:0032647),0.2619305011174731,0.7005981741029117,0.8679245283018868,0.9920018951196959,1.0,4/23,14.93%,TLR8;TLR4;DHX36;DHX9
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.24882363786421213,0.7001682383763173,0.8405797101449275,0.9919557900687761,1.0,6/30,14.79%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.266506186203216,0.6997667020837256,0.84399375975039,0.9918902208937673,1.0,2/21,4.94%,FBXO5;CDC7
prerank,cellular response to chemical stress (GO:0062197),0.20634952668529372,0.6993243170462995,0.9551020408163265,0.991878122799243,1.0,19/96,17.24%,ETV5;PRDX6;ALDH3B1;LRRK2;PRDX5;CCS;PYCR1;PINK1;PRKD1;CYBA;ERMP1;HTRA2;EIF2S1;RAD52;LONP1;VKORC1L1;TXNRD2;NOX1;NUDT2
prerank,positive regulation of transporter activity (GO:0032411),0.3011788267685896,0.6987722373202405,0.8477508650519031,0.9919862418135648,1.0,3/13,15.57%,KMT2A;KCTD7;SGK1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.23281588786710655,0.6980925070401931,0.8938307030129125,0.9922032528182406,1.0,7/45,15.27%,PIK3R1;SLC30A10;PDPK1;PTK2;SOX9;GAREM1;AREG
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.18613941237583279,-0.6978146237196087,0.974910394265233,0.9610062649508996,1.0,14/63,15.10%,PRKDC;CNOT10;CRADD;SOX4;CASP2;PLAGL1;CNOT8;BTG2;BAX;RPL26;PCNA;ATM;CCND1;CDKN1A
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2665271724042627,-0.6973052668984954,0.8906976744186047,0.9608829992278013,1.0,1/14,2.21%,THBS1
prerank,membrane repolarization during action potential (GO:0086011),0.3014078007997014,0.6970100188002823,0.8584070796460177,0.9929045087591731,1.0,2/13,10.96%,KCNIP2;KCNE4
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3207281112248872,0.6963689541105565,0.8354661791590493,0.9931272860608297,1.0,3/10,19.29%,PDE4B;CACNA2D1;NIPSNAP2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3021119485239928,0.696138895539053,0.8461538461538461,0.9928607714783128,1.0,5/14,22.88%,NOL9;DDX18;URB1;RPL35;ZNHIT6
prerank,protein targeting to membrane (GO:0006612),0.21114575168430344,0.695555019691329,0.9434724091520862,0.9929870571947952,1.0,21/83,20.14%,RTP4;ABCD2;PEX2;PRKCI;SEC63;ZDHHC24;SRPRA;SLC25A17;GET3;PEX19;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;PEX3;ZDHHC9;ALDH3A2;PEX14;SSR1;RABGEF1;MICALL1
prerank,macrophage migration (GO:1905517),0.3016510766526459,0.6954897298009852,0.8209459459459459,0.9925210461167724,1.0,13/13,69.86%,P2RX4;CCL2;P2RY12;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF;CCR2
prerank,chromatin remodeling at centromere (GO:0031055),0.24983011495708946,0.6954492364513958,0.8835403726708074,0.9920462831796448,1.0,5/31,14.73%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.20627293429586338,-0.6946466433197723,0.9437869822485208,0.9627713056986147,1.0,9/36,20.76%,ITGB1;SHANK3;NRP1;EPHB2;EDN1;HFE;EGF;ADRB2;HDAC6
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.2578561655384051,0.6942010861865886,0.8676236044657097,0.9929330125042168,1.0,4/26,9.55%,FLOT2;LRRC14;APPL2;BIRC2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2561051714059656,-0.6937201420489075,0.8624078624078624,0.9629935977932326,1.0,10/15,43.15%,MAPK14;RAPGEF3;ADAM9;TYROBP;FLOT1;TREM2;EHD2;SCGB3A1;EHD1;IL4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2518871033320693,-0.6936226293583414,0.8866498740554156,0.9624538628764603,1.0,4/16,16.16%,AMPD3;ADSS2;LHPP;PFAS
prerank,regulation of protein acetylation (GO:1901983),0.3021733278064678,0.6934552878884171,0.8413547237076648,0.9932174194945208,1.0,2/12,7.99%,CEP295;FAM161A
prerank,peptidyl-methionine modification (GO:0018206),0.3059076631783211,0.6930107971892047,0.8421052631578947,0.9931520598131593,1.0,1/12,6.10%,METAP1D
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.24804535573217007,0.692421873246653,0.8790697674418605,0.9933008586881067,1.0,11/33,21.21%,NCOA2;DNAAF4;AXIN1;CARM1;SAFB2;PRMT2;AR;CALR;CBFB;DDRGK1;TRIM68
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.23676977384666614,0.6920792372461098,0.8951965065502183,0.9931626617089818,1.0,6/39,11.63%,MYO7A;MYO1B;MYO6;PPFIA2;TANC2;MYO1G
prerank,cellular response to leucine starvation (GO:1990253),0.3118541082727134,0.6916838359918274,0.8351449275362319,0.9930651713417115,1.0,3/10,18.15%,MTOR;IMPACT;RRAGD
prerank,response to interferon-alpha (GO:0035455),0.2732152637591012,0.6912732093051973,0.8624161073825504,0.9929788402756925,1.0,5/16,19.64%,PDE12;AXL;EIF2AK2;ADAR;RO60
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.2797603042220286,-0.6912019644885944,0.8400900900900901,0.9641158545145795,1.0,3/11,17.57%,RENBP;UAP1;UAP1L1
prerank,glycine transport (GO:0015816),0.30943610376541214,0.6911844019106194,0.8218923933209648,0.9925449824009307,1.0,4/10,25.71%,SLC7A8;SLC25A38;SLC6A5;SLC36A1
prerank,regulation of JUN kinase activity (GO:0043506),-0.20456513698355205,-0.6909059423862487,0.9313432835820895,0.9637518354333602,1.0,7/33,17.50%,MAP3K5;HIPK3;PPEF2;MAP3K4;MAPK8IP1;EDN1;MAP3K10
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.25513098559778874,0.690869481081939,0.8973561430793157,0.9923761861129,1.0,10/25,27.62%,CDK13;RNF168;NELFA;EAF2;LDB1;CDC73;NELFB;EAF1;ELL;WDR43
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2614933444011931,-0.6905475684427799,0.9093078758949881,0.9635093836521487,1.0,6/14,32.76%,PTPN2;CCDC3;RFFL;PELI3;PYDC1;GPS2
prerank,protein acylation (GO:0043543),-0.19988333269482605,-0.6905215240067977,0.9391025641025641,0.9629025881163392,1.0,17/38,30.47%,FOXO1;ZDHHC21;ZDHHC16;ZDHHC14;ING4;ZDHHC18;ING5;CLOCK;NAA80;ZDHHC3;NAT9;GLUL;ZDHHC5;PORCN;KAT6A;ZDHHC23;ZDHHC12
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.23112482694952755,-0.6902901451352593,0.8847117794486216,0.9624944054419933,1.0,3/22,9.87%,PPM1E;PPM1F;PPM1D
prerank,positive regulation of rRNA processing (GO:2000234),0.30736449790144105,0.690123560845685,0.816793893129771,0.9926633633557852,1.0,5/10,27.62%,UTP15;DIMT1;HEATR1;RIOK2;WDR43
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2382314684552004,-0.6900063427087237,0.9093264248704663,0.9621443792869934,1.0,6/21,21.22%,ATXN7;APC;APC2;CAMSAP2;CIB1;KATNB1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2770131960370549,0.6898074756855593,0.8466898954703833,0.9925006589756595,1.0,8/18,23.89%,LYAR;UTP15;EIF2AK3;POLR2L;HEATR1;DHX33;MAF1;ATF4
prerank,melanosome localization (GO:0032400),-0.2388925699305637,-0.689287351751784,0.9097560975609756,0.9621891521350706,1.0,8/21,31.77%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A;VPS33A
prerank,protein insertion into membrane (GO:0051205),0.24209548758249336,0.6891862788063955,0.8873456790123457,0.9926771993080694,1.0,4/32,11.32%,RTP4;VAMP2;SEC61B;TRAM2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21433439501360602,0.6887356631749656,0.9308437067773168,0.9926459922706828,1.0,14/72,15.41%,ARID3A;CNOT11;E2F4;RPS6KA6;MYO6;MDM4;SP100;TP53;CNOT1;CARM1;FOXM1;TFAP4;CNOT7;PAXIP1
prerank,positive regulation of interferon-beta production (GO:0032728),0.24056102576821378,0.687867713345032,0.9006024096385542,0.993066896711516,1.0,6/33,16.13%,DHX58;TLR8;TRIM56;TLR4;DHX9;POLR3A
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.30156767261105466,0.686975248059676,0.8535353535353535,0.9935382749317586,1.0,5/13,24.18%,CAMK4;ZC3H8;ADAM8;TOX;BMP4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.20020482615900762,0.686586621510846,0.9437908496732026,0.9929192429774243,1.0,14/104,14.06%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,cellular response to lectin (GO:1990858),0.20020482615900762,0.686586621510846,0.9437908496732026,0.9929192429774243,1.0,14/104,14.06%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,proteasomal protein catabolic process (GO:0010498),0.185108513226008,0.6864916637840071,0.982837528604119,0.9924909083413828,1.0,68/201,26.63%,FBXO45;PSMD1;BFAR;SEL1L;ZSWIM8;NEDD4;PSMD10;CRBN;PSMA5;PSMB5;BIRC2;PLAA;DNAJB12;PSMC4;PSMA4;RCN3;PSMC5;FBXW5;GSK3A;PSMB9;AREL1;TRIM2;ATXN3;RNF122;BAG6;TRIM3;HACE1;BRSK2;UBXN6;PSMA7;HECW1;UBXN2B;PSMD14;SOCS6;FEM1B;KLHL22;RNF187;PSMA2;DCAF11;ZFAND2A;CUL4A;PSMD11;RHBDD1;SPSB2;MTA1;DDB1;UBE2K;FBXL22;DDIT3;BTRC;RNF216;RMND5B;SPSB3;FAF1;NHLRC3;KIF14;CCDC47;FBXO44;SPSB1;CTNNB1;AGAP3;PSMB2;RMND5A;COP1;NR1D1;UBE4B;SKP2;KLHL42
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.2496120836062969,-0.6859876438265141,0.9217171717171717,0.96447452235482,1.0,3/17,16.77%,SLC7A5;PRKCZ;HAVCR2
prerank,maintenance of protein localization in organelle (GO:0072595),0.2749050992288123,0.6859188226843164,0.8719135802469136,0.9925963088556299,1.0,7/19,20.70%,TAF3;PINK1;TAPT1;HSPA5;TAF8;SUPT7L;BBS4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2262199019779835,0.6859147677783489,0.9117647058823529,0.9920780073682178,1.0,8/52,11.95%,MDH1;L2HGDH;MTRR;MTHFD1L;DLST;HOGA1;ALDH5A1;ACLY
prerank,regulation of tumor necrosis factor production (GO:0032680),0.19592248596887446,0.6855029122354299,0.9761006289308176,0.9919868868296426,1.0,9/112,10.90%,IL33;WNT5A;NR1H4;PTPN22;CIDEA;TWIST1;TLR4;CYBA;PYCARD
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.1994645763280062,0.6849810491976139,0.9478487614080835,0.9920156046282638,1.0,14/105,14.06%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,iron ion transport (GO:0006826),0.22925908231937608,0.6844872957893902,0.9185393258426966,0.9920205390424889,1.0,10/47,18.98%,STEAP3;ARHGAP1;HEPH;ATP6V0E1;ABCB7;MCOLN1;SLC39A14;ATP6V0D1;ATP6V1G2;ATP6AP1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.29804698639498106,0.6840048412551786,0.833634719710669,0.992010402042676,1.0,2/11,13.23%,KCNIP2;AKAP6
prerank,myeloid dendritic cell activation (GO:0001773),0.2910963702899121,0.6839315012646866,0.8531468531468531,0.9915517202134954,1.0,2/12,10.90%,CAMK4;PYCARD
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.23171361916860495,0.6828043040898484,0.9109792284866469,0.9922359835060587,1.0,14/38,26.69%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,tRNA methylation (GO:0030488),0.24030724132180933,0.6818956242012991,0.8955453149001537,0.992700728738252,1.0,13/34,24.77%,PRORP;TRMT13;TYW3;TRMT44;TRMT61A;METTL1;THUMPD3;TRMT10A;METTL2A;METTL2B;LCMT2;TRMT10C;NSUN6
prerank,response to UV-A (GO:0070141),0.2816494385787827,0.6810936318022214,0.8709122203098106,0.9929854822614653,1.0,1/14,1.67%,PPID
prerank,B cell activation involved in immune response (GO:0002312),0.2882027260158696,0.6806819062853676,0.8469945355191257,0.9928951789262126,1.0,4/13,19.61%,GPR183;RNF168;MSH6;CD180
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.20931541613349638,0.6803967146665404,0.9448924731182796,0.9926575118353869,1.0,15/76,18.44%,NTRK3;SEMA5A;FCHSD2;LIMK1;GPSM2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;HAX1;CDK5;VASP;CDC42EP3
prerank,secretory granule organization (GO:0033363),-0.2855814647238094,-0.6801038070894373,0.8602620087336245,0.969039297465715,1.0,1/10,3.41%,SRGN
prerank,positive regulation of myelination (GO:0031643),-0.27643061207955394,-0.6799093326655665,0.8806306306306306,0.9685773831730862,1.0,2/11,6.78%,PARD3;DICER1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.23419873493080734,0.6788221694104319,0.901743264659271,0.9937860984089535,1.0,9/38,19.61%,DHX58;TLR8;AKIRIN2;PRKCA;CYBA;DHX9;ZCCHC3;ADAM8;CD180
prerank,mitochondrial translational elongation (GO:0070125),0.2020281917346947,0.6781409215497335,0.9557867360208062,0.9939651208482767,1.0,30/88,28.50%,MRPL44;MRPS31;MRPS24;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;MRPL14;MRPL32;GFM1;CHCHD1;MRPL12;MRPL1;MRPL47;MRPS11
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.22455890266466721,-0.6775149524289589,0.9285714285714286,0.9698808728157758,1.0,3/23,5.15%,SLIT2;DPP4;RAC1
prerank,polarized epithelial cell differentiation (GO:0030859),-0.26098489585551743,-0.6768696585407211,0.8762135922330098,0.969824847917037,1.0,2/13,5.90%,EZR;CDC42
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.25009743304604803,-0.6765362121776085,0.892271662763466,0.9694780598189213,1.0,6/15,30.13%,CCT3;CCT4;CCT7;RUVBL2;NHP2;RUVBL1
prerank,negative regulation of dephosphorylation (GO:0035305),0.27246113995502347,0.6749232481518981,0.8722689075630252,0.9966218240191632,1.0,5/18,16.58%,GPATCH2;PTPA;PPP1R26;ZCCHC9;PPP1R8
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.24327516369231622,-0.6746734591874417,0.9044117647058824,0.9704663110128177,1.0,5/17,21.03%,ALG9;ALG12;MPDU1;NUS1;DOLPP1
prerank,non-motile cilium assembly (GO:1905515),0.24407030965416093,0.6746697076322001,0.8945736434108527,0.9963386523643346,1.0,11/30,25.19%,DISC1;RPGRIP1;IFT88;CEP250;BBS1;PCM1;BBS4;RPGRIP1L;IFT122;TOGARAM1;TMEM216
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.24982572747715376,0.6742192594894253,0.9006309148264984,0.9962541438404274,1.0,6/27,17.95%,CALCA;HTR2C;LPAR1;F2R;GPR35;GRM1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.2459228340043565,-0.6723946188139398,0.9007444168734491,0.971688050442592,1.0,9/16,35.47%,TRIB2;TYROBP;JAK3;VSIR;FCGR2B;DLL1;AGER;LILRB1;CD274
prerank,smoothened signaling pathway (GO:0007224),0.23923993232043658,0.6714792047212529,0.9176829268292683,0.9985216682466306,1.0,5/32,10.58%,PTCH2;PTCHD1;GLI1;GLI3;TCTN2
prerank,protein targeting (GO:0006605),0.19278062763614323,0.6712494121884517,0.9701492537313433,0.9982161827833943,1.0,28/118,21.72%,RTP4;TIMM10;DNAJC19;CACNG3;SORL1;PRKCI;SEC63;ZDHHC24;SRPRA;PITRM1;TIMM44;AKAP6;PEX19;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;LTBP2;ZFAND2A;ZDHHC9;PEX6;KIF13B;HOMER3;RABGEF1;MICALL1;MFN2;FUT10;GDAP1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.19979027968247487,-0.6709824764386403,0.9431818181818182,0.9722099706554947,1.0,14/35,29.64%,PRKDC;CDK6;MAPK14;ETS1;TAL1;HMGB2;ABCB10;ACVR2A;HSPA1A;SPI1;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,positive regulation of isotype switching (GO:0045830),0.273812189180664,0.670253884209548,0.8912655971479501,0.9986778640209839,1.0,4/15,18.77%,CD40;HMCES;PAXIP1;RIF1
prerank,cholesterol efflux (GO:0033344),-0.22932494040465357,-0.6698555226687318,0.9057591623036649,0.9724395427290196,1.0,3/20,12.84%,SCARB1;APOE;SOAT1
prerank,methylguanosine-cap decapping (GO:0110156),0.30053179526277624,0.6697284834562738,0.8323699421965318,0.9986457647593732,1.0,2/10,13.47%,EDC3;EDC4
prerank,early endosome to Golgi transport (GO:0034498),-0.26957876200056347,-0.6688271295190323,0.8870967741935484,0.9726537297933104,1.0,5/11,28.35%,SURF4;LMAN1;RAB6A;SNX2;STX5
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.281160663564927,-0.6685351528332663,0.867579908675799,0.9722548690991695,1.0,2/10,7.13%,PDGFA;TBX1
prerank,response to iron ion (GO:0010039),-0.2650322862571647,-0.6675610293445061,0.874384236453202,0.9724546219207999,1.0,4/12,24.08%,B2M;ACO1;HFE;SLC11A2
prerank,regulation of gene silencing by RNA (GO:0060966),0.21562215294316836,0.6675564136560381,0.9322533136966127,0.999663623073998,1.0,13/50,23.31%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;NUP54;AGO1;NUP155;POLR2L;RANBP2;IPO8;NUP35
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21562215294316836,0.6675564136560381,0.9322533136966127,0.999663623073998,1.0,13/50,23.31%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;NUP54;AGO1;NUP155;POLR2L;RANBP2;IPO8;NUP35
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.28728949875268806,0.6669097329208481,0.8609154929577465,0.9997500098117973,1.0,3/13,12.81%,PSMD10;TWIST1;PTTG1IP
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.29690418591202783,0.6668075831651961,0.8801431127012522,0.9993273079401739,1.0,2/11,9.11%,PWP1;MTOR
prerank,intracellular cholesterol transport (GO:0032367),0.2789387172006986,0.6666050728009796,0.8686006825938567,0.9990094127880103,1.0,5/15,19.35%,RELCH;SERAC1;LDLRAP1;OSBP;NPC2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.24208218603380474,0.6665636860125831,0.8995568685376661,0.9985265726094661,1.0,6/30,19.53%,OGT;EIF3H;FHIT;BAG6;USP14;DDRGK1
prerank,mitotic metaphase plate congression (GO:0007080),0.21602935138960241,0.6656621288432232,0.9345661450924608,0.9988634112330196,1.0,11/51,18.72%,BOD1;DCTN2;CENPE;SPDL1;RMDN1;CENPC;CDT1;RRS1;CEP55;VPS4B;KPNB1
prerank,response to acidic pH (GO:0010447),0.28435707333083615,0.6654064086921404,0.8615107913669064,0.9985769267403737,1.0,3/13,16.01%,SLC9A1;LGMN;IMPACT
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.23059024417698448,0.6650273506391262,0.911144578313253,0.9984111215135855,1.0,13/35,25.52%,BOD1;PPP6R2;MTOR;PTPA;HSP90B1;CRY2;TSC1;PPP6R3;PDGFRB;BOD1L1;NUAK1;STYXL1;CALM2
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.21915924918259191,-0.664655968174136,0.9328165374677002,0.9740556713336685,1.0,4/22,11.42%,SLC16A2;NES;GATA2;MDK
prerank,insulin secretion (GO:0030073),0.26146281589137144,0.6646031116555625,0.8711864406779661,0.9982959593698352,1.0,2/19,6.62%,PTPRN2;RIMS2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.20806181998795742,-0.6641316297946619,0.9371428571428572,0.9738293847985506,1.0,14/29,40.06%,PLA2G4A;PLA2G6;PLAAT3;PLA2G4E;DBI;PLA2G4C;LPCAT2;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4;PLBD1;PLB1
prerank,histone H2A ubiquitination (GO:0033522),0.27012801557752597,0.6638860430283688,0.8953687821612349,0.9984498065602159,1.0,3/17,9.24%,BCOR;TRIM37;RNF168
prerank,regulation of trophoblast cell migration (GO:1901163),0.27830097608060916,0.6635027694293756,0.8821548821548821,0.9983117850535426,1.0,3/14,18.21%,GJA1;CALR;SYDE1
prerank,histone H3 acetylation (GO:0043966),0.22743290495783894,0.6633645157140963,0.92992700729927,0.9979070945281749,1.0,11/40,20.15%,TAF12;WDR5;BRCA2;KAT2A;JADE1;POLE3;LDB1;KAT7;TAF10;MBIP;SUPT7L
prerank,ubiquinone metabolic process (GO:0006743),0.27672835160075077,0.6632061209538679,0.8920863309352518,0.9975482427215228,1.0,5/15,19.09%,COQ3;AIFM2;PDSS2;COQ8B;COQ7
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.23656522681278447,0.6627212060024524,0.9177215189873418,0.9974828167508055,1.0,7/32,18.52%,CLIP3;STMN2;NAV3;STMN1;CLASP2;CLASP1;SPEF1
prerank,regulation of protein neddylation (GO:2000434),-0.2713316437362497,-0.6626224671352094,0.9110070257611241,0.9744093588519376,1.0,4/10,20.00%,RPL5;RPL11;DCUN1D3;COPS9
prerank,RNA 3'-end processing (GO:0031123),0.2082647610665507,0.6625109914543882,0.9515477792732167,0.9971672327417943,1.0,13/69,17.43%,EIF4A3;LIN28B;THOC7;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SYMPK;SRSF9;THOC5;SRSF6
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2740265015555235,0.6620018285766801,0.8909710391822828,0.9971222764383212,1.0,2/15,10.60%,TCF7L2;TP53
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.2693325957357492,-0.6614531971179776,0.9092920353982301,0.9746641943679385,1.0,2/11,6.65%,ITPKB;IP6K2
prerank,lysosome localization (GO:0032418),0.23090653799856511,0.6597579365829478,0.9355783308931186,0.9986090333176907,1.0,7/37,19.53%,RAB34;KXD1;ARL8B;TFEB;VPS33B;PIK3CG;PLEKHM2
prerank,regulation of vasculature development (GO:1901342),0.24449880053542097,0.6594521243136346,0.9158576051779935,0.9983619837475831,1.0,3/26,9.31%,ADGRA2;NF1;SP100
prerank,Golgi ribbon formation (GO:0090161),-0.25508230144033506,-0.6591436428423996,0.900709219858156,0.9757236484027507,1.0,4/13,22.19%,VTI1A;OPTN;FHDC1;MYO18A
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.20974345254130927,-0.6590806592431293,0.9421487603305785,0.9751476042675608,1.0,9/27,30.15%,SIRPA;CD44;ETS1;MDK;SKAP1;HSPD1;ITGB2;HAS2;CCR2
prerank,peptide hormone secretion (GO:0030072),0.24463288394936428,0.6587902709501599,0.889261744966443,0.998446491146202,1.0,2/26,6.62%,EDN3;RIMS2
prerank,mRNA 3'-end processing (GO:0031124),0.2031835566278904,0.6586263126702997,0.9424083769633508,0.9980716290731636,1.0,18/78,20.64%,EIF4A3;THOC7;LSM11;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SLBP;SYMPK;SRSF9;THOC5;SRSF6;PAPOLB;CHTOP;CDC73;DDX39B
prerank,negative regulation of locomotion (GO:0040013),0.2828796178291435,0.6583471657378563,0.873015873015873,0.9978028457368393,1.0,3/12,18.39%,SPOCK3;CRK;FBLN1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23717393593779992,0.6582499721302492,0.9185667752442996,0.9973857297434339,1.0,8/31,15.88%,LSM4;EDC3;EXOSC9;DIS3L2;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,intracellular pH reduction (GO:0051452),0.2308607427783357,0.657658188947869,0.9219440353460973,0.9974159842182478,1.0,9/33,23.56%,RAB20;CLCN3;ATP6V0E1;ATP6V0D1;ATP6V1G2;GPR89A;GPR89B;ATP6V0B;DMXL1
prerank,RNA modification (GO:0009451),0.2086822048359846,0.6573697602610727,0.9344729344729344,0.9971573432625821,1.0,15/54,24.77%,NAT10;CTU1;QTRT2;TRMT61A;PUS7;WDR4;METTL1;ADAR;NSUN3;RBM15;LCMT2;NSUN5;AARS1;SSB;NSUN6
prerank,calcium ion import across plasma membrane (GO:0098703),0.27965588846518286,0.6573604042101798,0.8894830659536542,0.9966549453199604,1.0,3/14,15.77%,TRPV3;TRPM2;CACNA2D1
prerank,cellular response to hydroxyurea (GO:0072711),-0.269544858591224,-0.657050769428803,0.9135514018691588,0.9759669103193988,1.0,3/10,16.20%,DDI2;DDX11;NSMCE3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2291518883099669,0.6569581605006793,0.922316384180791,0.9965233770211374,1.0,6/37,15.90%,OGT;EIF3H;PDCL3;FHIT;BAG6;CSNK2A2
prerank,positive regulation of calcium ion import (GO:0090280),0.2914987280891381,0.656896969355311,0.8877005347593583,0.9960642353544126,1.0,3/12,20.38%,STC1;PDGFRB;CCL2
prerank,negative regulation of innate immune response (GO:0045824),0.22881075558315359,0.6565003988168697,0.9195046439628483,0.9958982986414214,1.0,6/34,17.51%,SUSD4;DHX58;LYAR;FAM3A;CNOT7;A2M
prerank,phosphatidylserine metabolic process (GO:0006658),0.23052122153373814,0.6564246468991793,0.918960244648318,0.9954470850278169,1.0,6/32,14.68%,SERINC1;ABHD16A;ABHD12;PTDSS2;SERINC5;PLA2G12A
prerank,DNA replication checkpoint signaling (GO:0000076),0.27203244058143106,0.6557307305638983,0.893687707641196,0.9955575743575628,1.0,2/16,12.29%,TIPIN;CDT1
prerank,modulation by host of symbiont process (GO:0051851),0.2383592181534834,0.6556107297153028,0.9357366771159875,0.9951457611292205,1.0,8/31,20.00%,HDAC1;REST;SNW1;SAP30;TFAP4;RRP1B;SP1;TAF11
prerank,protein tetramerization (GO:0051262),0.20259894857713123,0.6545493262977473,0.9570200573065902,0.9955315029328193,1.0,13/67,18.60%,TRPA1;GRIN2B;GOLGA2;APPL2;HSD17B8;HCN1;NUDT21;TRPM2;RYR3;USP16;MCOLN1;ALDH9A1;SSBP1
prerank,positive regulation of cell aging (GO:0090343),0.2871302422174599,0.6539794477594092,0.8785211267605634,0.9955002382377177,1.0,1/11,2.62%,CDKN2A
prerank,monosaccharide transmembrane transport (GO:0015749),0.2690568881074972,0.6538324947473956,0.8859060402684564,0.9951086608915679,1.0,16/16,73.12%,SLC2A9;SLC45A3;SLC2A7;SLC2A8;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC2A6;SLC5A3;SLC50A1;SLC23A1;SLC23A2;SLC2A2;SLC2A12
prerank,B cell mediated immunity (GO:0019724),0.2946933942381789,0.6538013369175268,0.8731884057971014,0.9946258878046434,1.0,1/10,6.37%,TLR8
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.27139799247191543,-0.6535174038622991,0.8843537414965986,0.9777953503828313,1.0,2/10,17.54%,SMYD2;EEF1AKMT2
prerank,relaxation of muscle (GO:0090075),0.2808865064491381,0.6532780345711391,0.8607809847198642,0.9945822460181144,1.0,2/13,11.17%,ATP1A2;P2RX4
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.2468748667704585,-0.6532626312628941,0.8878718535469108,0.9773649969668898,1.0,2/14,15.22%,IL6ST;PTGS2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.23264272899430782,0.6531535752455001,0.9165424739195231,0.9941726379423389,1.0,6/33,17.00%,LSM11;NUDT21;SLBP;SNRPF;SYMPK;MAZ
prerank,regulation of oxidoreductase activity (GO:0051341),-0.25670417807011703,-0.65259974750512,0.9074074074074074,0.9772142126008497,1.0,5/13,24.35%,ECSIT;HDAC6;OXA1L;MT3;NOD2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3005196445967456,0.6525326076821367,0.8720292504570384,0.9942047456094628,1.0,2/10,12.41%,PTPN22;PDCD4
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.23947032179189132,-0.6518309335633676,0.9134615384615384,0.9771463279742924,1.0,4/17,15.56%,STX1A;KCNB1;SLC4A8;RAB3D
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2421482755083586,0.6515027760955157,0.9136212624584718,0.9945518719840092,1.0,5/23,20.78%,ACOT7;ELOVL6;ALOX5;ACSBG1;GSTM1
prerank,regulation of T cell proliferation (GO:0042129),-0.17123201025991805,-0.6508292906479601,0.996551724137931,0.9772595847454717,1.0,7/61,11.77%,ANXA1;IL6ST;SLC7A1;TFRC;NCK1;SDC4;DLG5
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.24777706079159023,0.6506174579822978,0.8996598639455783,0.9947682527684253,1.0,8/22,23.89%,PWP1;LYAR;MTOR;UTP15;EIF2AK3;HEATR1;DHX33;ATF4
prerank,cellular response to interferon-beta (GO:0035458),-0.2501910348780569,-0.6497492359078202,0.9200968523002422,0.9774041656701837,1.0,7/14,29.09%,IRF1;CDC34;IFITM2;NDUFA13;PNPT1;TRIM6;IRGM
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.2647321492803616,-0.6495796576808093,0.9178082191780822,0.9768999497564418,1.0,6/12,32.75%,ERLIN1;CEACAM1;SIRT1;BRCA1;TRIB3;APOC1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2759841481725045,0.6486875099674362,0.8761384335154827,0.9958465962214728,1.0,2/12,12.02%,TLR4;SOX9
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.2884933155575717,0.6486561335105574,0.8726333907056799,0.9953656125087288,1.0,3/12,21.94%,ELOVL2;ELOVL1;ELOVL5
prerank,RNA destabilization (GO:0050779),0.26064887724037855,0.6485360348606974,0.8907014681892332,0.9949564145226629,1.0,5/18,18.68%,RBM24;LIN28B;FTO;DXO;YTHDF1
prerank,positive regulation of protein acetylation (GO:1901985),0.28540314233366526,0.6484454649824984,0.8710280373831776,0.9945250603894115,1.0,2/12,7.99%,CEP295;FAM161A
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.22129572630680136,-0.6480060314609974,0.9407008086253369,0.9773698551114881,1.0,5/23,15.12%,HACD1;FAR2;ACSL4;ELOVL7;ACSL5
prerank,protein destabilization (GO:0031648),-0.19654374861102744,-0.6476365709205216,0.9730458221024259,0.9769848651319046,1.0,6/32,16.68%,GSN;SOX17;CTSH;CCDC88C;SIRT1;CUL3
prerank,striated muscle contraction (GO:0006941),0.20960168405137286,0.6473611082979756,0.9501424501424501,0.9949231646158055,1.0,3/53,4.25%,ATP1A2;RYR2;SCN2B
prerank,protein localization to centrosome (GO:0071539),0.2605778123356858,0.6472648232316154,0.9025641025641026,0.9944958034454647,1.0,7/17,25.79%,DCTN2;CEP192;PCM1;NUDCD3;BBS4;GOLGB1;CCDC14
prerank,negative regulation of cartilage development (GO:0061037),-0.253708829972154,-0.6472290805680123,0.8926829268292683,0.9766356742231488,1.0,8/13,31.99%,WNT9A;PTHLH;EFEMP1;WNT11;CHADL;GREM1;ADAMTS7;SNAI2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2574464793753083,0.6470740371043164,0.8938356164383562,0.9941541692522569,1.0,8/18,25.73%,ASPA;NAT8L;FOLH1;MSRA;ASPG;MTHFD1;NAALAD2;SMS
prerank,peptidyl-lysine acetylation (GO:0018394),0.28942388275195585,0.6461888083848679,0.8817391304347826,0.9943734061664319,1.0,4/10,21.85%,KAT2A;BAG6;KAT7;CREBBP
prerank,cellular respiration (GO:0045333),0.2190062915130051,0.6461716164001817,0.9428571428571428,0.9938842850516144,1.0,7/41,16.18%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14;NDUFS4
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.22448646943657466,0.6460333355271225,0.9298245614035088,0.9934971495666769,1.0,4/36,10.27%,OGT;EIF3H;OPHN1;FHIT
prerank,amino sugar biosynthetic process (GO:0046349),-0.255023984955512,-0.6455207317403618,0.8931818181818182,0.9771017182382313,1.0,3/12,17.57%,RENBP;UAP1;UAP1L1
prerank,regulation of defense response to virus by host (GO:0050691),0.22812828778056343,0.6454837291190355,0.9465408805031447,0.9934195709824866,1.0,8/30,25.31%,PTPN22;IFNLR1;TRIM44;DHX9;RNF216;STAT1;TRAF3IP2;AIM2
prerank,nuclear transport (GO:0051169),0.2621035914055242,0.6448802512229148,0.8955954323001631,0.9934051068027927,1.0,2/16,5.60%,AAAS;NUTF2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.24316368068707037,-0.6442826952563162,0.916083916083916,0.9772834688445939,1.0,9/15,47.10%,SYN3;ZDHHC3;ZDHHC12;ADRA1A;HAP1;STXBP1;NPAS4;NPS;DRD2
prerank,positive regulation of cellular protein localization (GO:1903829),0.20043232311295217,0.6437090513987719,0.9681440443213296,0.9938559159329569,1.0,16/69,19.53%,GNL3;NGFR;NECAB2;FYN;GAS8;CDT1;ENTR1;MEAK7;CEP250;FERMT2;GPR137B;KAT7;ORMDL3;EIF2AK3;TRAPPC12;DDRGK1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.2970429552128879,0.6433555927333652,0.8909710391822828,0.9936386785446207,1.0,3/10,17.14%,IGF2;KDM1B;DNMT3A
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.26657424153855547,0.6428432230128613,0.903169014084507,0.9935603051420161,1.0,3/15,15.04%,ADGRV1;SCN1A;PDZD7
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.25127400350752255,-0.6420837761119512,0.9052132701421801,0.9780837322394014,1.0,3/13,17.57%,RENBP;UAP1;UAP1L1
prerank,peptidyl-lysine methylation (GO:0018022),-0.20655767270656974,-0.641878015549671,0.9390581717451524,0.977595404561522,1.0,3/26,11.45%,SMYD3;SMYD2;EEF2KMT
prerank,regulation of actin filament-based movement (GO:1903115),0.2918595885281176,0.6418476494955001,0.891500904159132,0.9938440627022506,1.0,1/10,2.74%,PDE4B
prerank,glycoprotein catabolic process (GO:0006516),-0.23157396265371946,-0.6414666124190821,0.9451073985680191,0.9772727435916999,1.0,5/17,19.06%,OGA;MANBA;NGLY1;EDEM1;STT3B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.22327756205585503,-0.6413934855688981,0.928921568627451,0.9767011154846443,1.0,5/19,16.30%,HIPK1;DYRK2;HIPK2;SIRT1;TMEM109
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2530359397745714,0.6413140639176591,0.9136,0.993238205451881,1.0,2/20,7.44%,GSTO2;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.2530359397745714,0.6413140639176591,0.9136,0.993238205451881,1.0,2/20,7.44%,GSTO2;GSTA3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.25933822344900925,0.6411303466185271,0.883248730964467,0.9928724840331203,1.0,3/17,12.64%,RYR2;KCNE4;KCNJ8
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2468344219027875,-0.6407944046467478,0.9203747072599532,0.9764520803613107,1.0,3/13,10.44%,NCK1;DNAJB9;PTPN1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2845948171925081,0.6405574565798452,0.9066901408450704,0.9928280616543338,1.0,4/11,22.51%,ASF1A;UBN1;ATRX;IPO4
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2890558912605631,0.6404926045431512,0.88,0.9923751551845431,1.0,4/10,24.38%,UBE2G2;YOD1;UBE2J1;OS9
prerank,negative regulation of protein metabolic process (GO:0051248),0.21065445951564943,0.6402068943039537,0.95900439238653,0.9920985783990381,1.0,8/48,15.09%,ITGAV;ADGRB1;FLOT2;MDM4;EIF2AK1;IAPP;SNX12;CLU
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.20209240129294687,-0.6392538675862635,0.9723756906077348,0.9767756502441272,1.0,8/28,30.15%,SIRPA;PRKDC;TICAM1;TYROBP;HSPD1;NOD2;NCKAP1L;CCR2
prerank,axonal transport (GO:0098930),0.22233328250039544,0.6385344520285411,0.933641975308642,0.9929208208106186,1.0,10/36,22.83%,TMEM108;AP3M1;OPA1;SYBU;AP3D1;HIF1A;KIF3A;KIF1B;AP3B2;BLOC1S6
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2081851317945989,-0.6381025953858089,0.9544159544159544,0.9768499096540945,1.0,13/23,43.85%,MAP3K5;MAP3K4;EDN1;MAP3K10;DUSP19;TRAF2;FZD10;SASH1;RPS3;MAP3K7;DAB2IP;ARHGEF5;TAOK3
prerank,lung epithelium development (GO:0060428),-0.26469839684549135,-0.6375673738781107,0.9134199134199135,0.976578637493689,1.0,2/10,14.79%,ERRFI1;STRA6
prerank,melanosome organization (GO:0032438),0.23935215270901022,0.637442235349848,0.9184339314845025,0.9932471326724402,1.0,4/26,13.39%,HPS1;RAB29;ABCB6;AP3D1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.23791834604889117,0.6373311229505123,0.9184952978056427,0.9928374062095174,1.0,5/22,17.34%,NEDD4;PLAA;TSG101;SNF8;VPS4B
prerank,regulation of microglial cell activation (GO:1903978),-0.23632824762981103,-0.6369887004299415,0.9269521410579346,0.9763256297817681,1.0,15/15,76.40%,CX3CL1;TTBK1;TREM2;STAP1;CST7;TAFA3;IL6;CCL3;GRN;SYT11;LDLR;MMP8;SPHK1;NR1D1;PTPRC
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2430992831299225,0.6357238603820725,0.9244094488188976,0.9935516729967745,1.0,8/20,27.04%,ATP2A2;HERPUD1;BAK1;PACS2;FIS1;CCDC47;SELENOK;BCAP31
prerank,histone mRNA catabolic process (GO:0071044),-0.2328364137277159,-0.6349310104651581,0.9204819277108434,0.9769747793262774,1.0,3/15,13.13%,TUT7;ERI1;ATM
prerank,transcription by RNA polymerase III (GO:0006383),-0.19847786791835784,-0.6349204219851137,0.9556786703601108,0.9763677133479821,1.0,10/27,32.22%,SNAPC3;CRCP;POLR3G;GTF3C6;POLR3K;GTF3A;ICE1;POLR2K;SNAPC2;GTF3C5
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.26574519755778864,0.6348316116041545,0.9003496503496503,0.993715306520743,1.0,3/14,9.23%,ERH;DHODH;DPYS
prerank,erythrocyte development (GO:0048821),0.2880188693345863,0.6340489050164533,0.8848263254113345,0.9937930721692999,1.0,3/10,16.24%,LYAR;MED1;ZBTB7A
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.20376278535754608,-0.6337861492966281,0.9388888888888889,0.976443551370761,1.0,12/25,35.61%,TNFSF10;BAD;BAX;BID;GPER1;PPIF;BCL2L11;BIK;DNM1L;BMF;HRK;PMAIP1
prerank,negative regulation of cation channel activity (GO:2001258),0.23812035441440366,0.6336550753880629,0.9282296650717703,0.9935814380425835,1.0,3/26,8.55%,FMR1;KCNAB1;GNB5
prerank,establishment of mitotic spindle orientation (GO:0000132),0.23674925311868145,0.633235773565729,0.9183333333333333,0.9933844317408685,1.0,4/23,11.84%,GJA1;GPSM2;SPDL1;INSC
prerank,positive regulation of immune response (GO:0050778),0.19770608797911743,0.6331725219083089,0.9780521262002744,0.9929365768158578,1.0,9/64,17.31%,HRG;TLR8;AKIRIN2;CYBA;PYCARD;CD81;DHX9;LGALS9;ADAM8
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.266973996379287,0.6326070983845482,0.8890845070422535,0.9928474423697065,1.0,2/14,9.66%,DUSP1;PPP2R2A
prerank,negative regulation of DNA recombination (GO:0045910),0.2077252525393651,0.6315732636860562,0.9539170506912442,0.9930959886999423,1.0,10/43,22.12%,POLQ;MSH3;TERF1;DAXX;MSH6;FBH1;RIF1;TERF2IP;POLR2L;ATRX
prerank,nucleocytoplasmic transport (GO:0006913),0.21349685025977866,0.6314342128867103,0.9353383458646617,0.9927025735638192,1.0,12/40,25.56%,GEMIN2;AAAS;NUTF2;SNUPN;NXT2;SNRPF;GEMIN8;XPO1;MALT1;GEMIN5;GEMIN7;SNRPG
prerank,calcium ion import into cytosol (GO:1902656),0.2640413375440923,0.630662177036152,0.9213286713286714,0.9927592233507717,1.0,3/15,15.77%,TRPV3;TRPM2;CACNA2D1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.23086730324460278,0.6291098241970352,0.9272997032640949,0.9933706547763448,1.0,5/28,15.81%,STMN2;STMN4;STMN1;CLASP2;CLASP1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.2629771547178694,0.628757969183193,0.8772563176895307,0.9926347231214108,1.0,8/15,30.60%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1;SNAPIN;BLOC1S5;AP3M2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.2629771547178694,0.628757969183193,0.8772563176895307,0.9926347231214108,1.0,8/15,30.60%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1;SNAPIN;BLOC1S5;AP3M2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.24811562091405037,-0.6281896848017277,0.9137168141592921,0.9790603720044518,1.0,8/14,39.86%,DDX60;ANKRD17;ZDHHC5;PUM1;OASL;TLR5;TLR3;TLR2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.22943801355972204,0.6275050344019713,0.9205607476635514,0.9930235229889565,1.0,5/28,16.74%,ABITRAM;FCHSD2;ARHGAP35;CTTN;HAX1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.22974367752602037,0.6265423231236116,0.9244992295839753,0.9931750563837959,1.0,6/25,18.37%,PER2;TWIST1;NSD1;DOT1L;ZBTB7A;HEY1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.21091132889331438,0.6260262655363523,0.9521044992743106,0.9930497123214042,1.0,11/44,18.44%,FCHSD2;CARMIL2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;SPIRE1;VASP;CDC42EP3
prerank,nucleosome organization (GO:0034728),0.20232096116788095,0.6252563440263048,0.9713506139154161,0.993072991152861,1.0,15/55,22.19%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;NAP1L1;SOX9;POLE3;BPTF;DMAP1;SMARCD2;MCM3AP;LIN54;ATRX;ZNHIT1
prerank,acute-phase response (GO:0006953),-0.252183370106949,-0.6242000549684996,0.926829268292683,0.9806477095556972,1.0,3/12,23.43%,LBP;IL22;SIGIRR
prerank,DNA geometric change (GO:0032392),0.2344531237875186,0.6241518542193238,0.9184339314845025,0.993331467668004,1.0,8/24,22.27%,HNRNPA2B1;PIF1;DHX36;RECQL;DHX9;WRN;DDX1;HMGB1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.27754933242943586,0.623440152020333,0.9016100178890877,0.9933164108762029,1.0,1/12,6.05%,LIN28B
prerank,anterograde axonal transport (GO:0008089),-0.18077918330714854,-0.6230879010133875,0.9767441860465116,0.9806741439594774,1.0,6/37,13.35%,MAPK8IP3;RAB21;AP3B1;HSPB1;AP3S2;TRAK2
prerank,response to UV-B (GO:0010224),-0.25128372974138896,-0.6230290390733233,0.8984198645598194,0.9800837315005744,1.0,8/12,36.07%,CRIP1;HYAL1;CDKN1A;MME;HYAL2;MSH2;HYAL3;RELA
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2109700633178389,-0.6218232853991256,0.9484536082474226,0.9801608853233359,1.0,2/20,4.60%,GCLC;GATM
prerank,mitochondrial fusion (GO:0008053),-0.21616268830444288,-0.6214173182120168,0.9638888888888889,0.9797691302881391,1.0,6/18,25.59%,MIEF1;USP30;BAX;CHCHD3;MIGA1;MIEF2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.22357350947567622,0.6198302280744,0.9449838187702265,0.9951738890313295,1.0,7/29,15.88%,LSM4;EDC3;EXOSC9;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.23346723065380082,0.6192506757706152,0.9387755102040817,0.9950409275580934,1.0,4/22,15.73%,PTPN22;APPL2;LYN;TIRAP
prerank,lipoprotein biosynthetic process (GO:0042158),0.27515891800734565,0.6191548124769989,0.895017793594306,0.9946031806912113,1.0,6/11,29.02%,WDR45B;WIPI2;ATG10;WIPI1;PIK3C3;ATG7
prerank,negative regulation of T cell differentiation (GO:0045581),0.2847344205728839,0.6181850747349547,0.9109947643979057,0.9947351416203473,1.0,2/10,10.74%,GLI3;ZC3H8
prerank,steroid hormone biosynthetic process (GO:0120178),0.2225775330313165,0.6177411092961342,0.9540059347181009,0.9945173569946452,1.0,5/29,17.79%,HSD17B8;MED1;AKR1B1;HSD17B11;HSD17B2
prerank,peptidyl-proline modification (GO:0018208),0.22748524843225612,0.6169335085673497,0.9404388714733543,0.9945173242737472,1.0,2/25,4.94%,PPID;PPIH
prerank,histone H2B ubiquitination (GO:0033523),0.2779964962455743,0.6168745345380258,0.9098939929328622,0.9940556373723856,1.0,1/10,4.62%,RNF40
prerank,response to hydroxyurea (GO:0072710),0.2734281589686279,0.6166687335688891,0.9186851211072664,0.9937032849101078,1.0,4/11,22.12%,FMR1;SPIDR;KAT7;ATRX
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.2421447707264261,0.6161391898191394,0.9294117647058824,0.9935555386020379,1.0,4/20,14.06%,PTPN22;TLR4;IRAK1;LYN
prerank,regulation of rRNA processing (GO:2000232),0.2521658522943973,0.6152221085568291,0.9107468123861566,0.9936021664902186,1.0,7/16,27.62%,UTP15;DIMT1;SHQ1;HEATR1;RIOK2;USP36;WDR43
prerank,detection of mechanical stimulus (GO:0050982),0.24684160699825575,0.6145225453695969,0.9173693086003373,0.993573684077631,1.0,2/19,7.70%,JUP;PTK2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2329003383941905,0.6144278161267921,0.9299363057324841,0.9931295642802662,1.0,1/22,1.70%,WNT5A
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.21212329106262745,-0.6137241126747472,0.967391304347826,0.9832638668017197,1.0,9/21,30.22%,YWHAB;GSK3B;PPP1R16B;PPP4R4;PPP1R11;MFHAS1;ENSA;FKBP1A;PPP1R15A
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2787348462067503,0.613327026579522,0.8994800693240901,0.9933095051741571,1.0,3/10,23.58%,AREG;ADRA2A;ADAM17
prerank,negative regulation of transmembrane transport (GO:0034763),0.2836422750936358,0.6132200411954024,0.9057971014492754,0.9928823253675336,1.0,2/10,9.16%,IRS2;PRKCB
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26345771060273154,0.6129857090905219,0.9095744680851063,0.9925343589549948,1.0,1/13,3.37%,JAK1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.25284827211080707,0.6126760395001539,0.9398625429553265,0.9922095447967118,1.0,7/16,28.18%,HSD17B8;ACLY;SCD5;ACACA;DIP2A;PPT1;SLC25A1
prerank,negative regulation of cell division (GO:0051782),0.2681843443274641,0.6120837057147237,0.9045996592844975,0.9920872092550651,1.0,1/11,3.05%,SUSD2
prerank,natural killer cell mediated immunity (GO:0002228),0.2537997925729142,0.6119089918555566,0.9059674502712477,0.9916872735468406,1.0,3/15,22.59%,ARL8B;PLEKHM2;ULBP1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.20256987555383468,-0.6116981750377907,0.9584415584415584,0.9837258556101898,1.0,15/23,48.45%,PVR;PIK3R6;RAET1E;ARRB2;LAMP1;AP1G1;RASGRP1;LILRB1;SLAMF6;CD226;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,regulation of interferon-beta production (GO:0032648),0.204190829009883,0.6116077059802918,0.9632352941176471,0.9913792585654423,1.0,18/46,28.85%,DHX58;TLR8;TRIM56;TLR4;PYCARD;DHX9;TIRAP;POLR3A;PTPN11;RNF216;CACTIN;PPM1B;POLR3F;IFIH1;POLR3B;RELB;PTPRS;POLR3C
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.21674120931074037,-0.6114311267901035,0.96,0.9832722809896994,1.0,7/18,38.72%,PRKDC;PRELID1;PRDM1;NCKAP1L;CCR2;IL4I1;IKZF3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2154596229237407,-0.6112160815194094,0.9598997493734336,0.9827736670390741,1.0,2/18,5.51%,FER;IL6ST
prerank,purine-containing compound salvage (GO:0043101),0.264869330431175,0.610183911646727,0.9050179211469535,0.9917557161535699,1.0,3/12,12.95%,ADK;AMPD2;DGUOK
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.2601015861878978,0.6098298873354622,0.9112627986348123,0.9914947622371058,1.0,3/14,16.00%,MRNIP;ACTR2;MMS19
prerank,regulation of catecholamine secretion (GO:0050433),-0.19276627422123976,-0.6090537187740616,0.967479674796748,0.9832258279469112,1.0,3/29,7.77%,SYT9;STX1A;KCNB1
prerank,protein localization to chromosome (GO:0034502),0.21231049694048368,0.6090514737011409,0.9516380655226209,0.9914511703615241,1.0,4/34,10.29%,BOD1;RPA1;MRNIP;SLF1
prerank,regulation of histone methylation (GO:0031060),0.2632348031975882,0.608620411957659,0.9267015706806283,0.9912017742280294,1.0,3/13,19.18%,NSD1;AASS;CHTOP
prerank,spliceosomal complex assembly (GO:0000245),0.19904376831292123,0.6085389409594419,0.979381443298969,0.9907614519392531,1.0,12/46,20.64%,ZRSR2;NOL3;CELF4;LUC7L2;SRSF10;SRSF9;RBM5;SF3A3;SRSF6;DDX1;LUC7L3;DDX39B
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.23633284648055436,-0.6084606906851215,0.9389671361502347,0.9828845801743413,1.0,2/13,10.66%,DAB2;SH2B1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.254148537958537,0.6083292278000954,0.913477537437604,0.9904072488310106,1.0,4/14,19.53%,BFAR;HSPA5;BAK1;DDRGK1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2606523443706212,0.6079182719032852,0.9173989455184535,0.990156166222023,1.0,1/13,3.91%,DUSP1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2549480665967202,0.6072458810535886,0.9165217391304348,0.9900688283422935,1.0,2/14,6.12%,ADK;GMPS
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.19828381182605076,-0.6070003251978711,0.9667519181585678,0.9830082128356046,1.0,11/25,32.54%,PTGES3;HSPA8;GAK;DNAJB5;DNAJB1;HSPA14;HSPA1A;HSPA1B;DNAJB4;HSPA2;SDF2L1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.2390622790431593,0.6065404392338344,0.915282392026578,0.9899867099439237,1.0,7/18,23.83%,ELOVL2;ACSL6;ELOVL6;ELOVL1;ACSBG1;ELOVL5;TECR
prerank,relaxation of cardiac muscle (GO:0055119),0.26832282086957937,0.6056140697060011,0.9330985915492958,0.9900615952242297,1.0,2/13,11.17%,ATP1A2;P2RX4
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.2416022017117953,-0.6052101500461626,0.9399538106235565,0.9832380954309392,1.0,2/13,7.77%,STX1A;KCNB1
prerank,folic acid metabolic process (GO:0046655),0.24137309711506022,0.6048329816512393,0.922077922077922,0.9900423848995414,1.0,6/18,24.36%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,regulation of calcium ion transport (GO:0051924),0.19268585402388388,0.60405777451922,0.9807956104252401,0.9900108057397691,1.0,12/54,19.25%,IL16;GRAMD2A;P2RX4;STIM1;F2R;PACSIN3;CACNA2D1;STC1;ADRA2A;CAMK2A;CRACR2A;HOMER3
prerank,vitamin D metabolic process (GO:0042359),0.2656111060488249,0.6030213877811795,0.9033391915641477,0.9900864227489998,1.0,2/13,16.48%,LGMN;CYP2R1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.24209550189509838,-0.6029470895275136,0.958139534883721,0.9836903847396169,1.0,5/12,26.57%,NINL;BICD2;CCDC68;CCDC120;BICD1
prerank,regulation of histone acetylation (GO:0035065),0.21287106073192805,0.6025422747640319,0.9521674140508222,0.9898709266639681,1.0,7/33,18.84%,KMT2A;SETD5;NOC2L;PAXIP1;IWS1;BRD7;THAP7
prerank,folic acid-containing compound metabolic process (GO:0006760),0.23642486341283042,0.6006105823318673,0.9174917491749175,0.9904677623927326,1.0,6/19,24.36%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,purine nucleotide metabolic process (GO:0006163),0.2211773964562888,0.599487387697842,0.944620253164557,0.9905950556391785,1.0,4/24,10.63%,ITPA;FHIT;PRPS1L1;PRPS1
prerank,regulation of interleukin-17 production (GO:0032660),0.21065415553839054,0.5986852490208266,0.9476923076923077,0.9905500733780762,1.0,3/31,12.10%,NR1H4;TLR4;IL12A
prerank,microglial cell activation (GO:0001774),0.23146830814299307,0.5985154639279813,0.9392446633825944,0.9901546138650176,1.0,2/21,7.19%,C5AR1;C1QA
prerank,regulation of B cell proliferation (GO:0030888),0.19973511184728684,0.5960432688575622,0.9660766961651918,0.9909600107939056,1.0,7/44,15.73%,CD40;IRS2;GPR183;TNFRSF21;CD81;LYN;TIRAP
prerank,mitochondrial transport (GO:0006839),0.1919686764236521,0.5960071556341157,0.972972972972973,0.9904936809491702,1.0,13/53,24.01%,TIMM10;DNAJC19;BCS1L;PITRM1;TIMM44;BAK1;MFN2;SLC25A16;GDAP1;SLC25A24;FIS1;BNIP3;TOMM34
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.2550831670058013,0.5959939885407295,0.9180887372013652,0.9900163247890588,1.0,4/13,24.06%,SAE1;SENP6;ATG10;UBA2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2157331914807073,0.5950117113707757,0.944620253164557,0.9900291204662184,1.0,5/29,13.42%,FBXO5;LIMK1;PINK1;DCUN1D5;AXIN1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2707605799074011,0.5943670640536096,0.9200710479573713,0.9898825788803208,1.0,4/10,21.50%,MAP2K1;LYN;RNF13;MAPK1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21673063499687673,-0.5940170198743158,0.9647887323943662,0.9869713990975932,1.0,6/15,27.04%,ERN1;CLP1;TSEN34;TRPT1;ZBTB8OS;TSEN54
prerank,mesenchyme development (GO:0060485),0.24573103437333493,0.593920096229177,0.934010152284264,0.9896436049274967,1.0,4/15,18.02%,BMP7;TGFBR1;FGFR2;BMP2
prerank,mitotic sister chromatid segregation (GO:0000070),0.17420397389500494,0.5927581596004763,0.9962073324905183,0.9897465474874292,1.0,18/98,18.72%,BOD1;DCTN2;SGO1;CENPE;TEX14;NAA50;NSL1;SPDL1;NUSAP1;DIS3L2;NCAPH;RRS1;CEP55;CSNK2A2;VPS4B;SMC1A;KLHL22;KPNB1
prerank,tRNA wobble base modification (GO:0002097),-0.22996734055747056,-0.5925922929574018,0.9296116504854369,0.9869551981844384,1.0,9/14,34.98%,TRMT9B;GTPBP3;ELP3;MOCS3;KTI12;URM1;ALKBH1;ADAT2;CTU2
prerank,glucose transmembrane transport (GO:1904659),0.23520181949045543,0.5924828507595323,0.9505766062602965,0.9893916303392243,1.0,1/18,4.00%,PPARD
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24767994142004934,0.5923656633580479,0.9155405405405406,0.9889662452715415,1.0,3/15,15.32%,TIPIN;EME2;ATF2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.25300081609698577,0.5904597125747251,0.9288256227758007,0.9894486955983791,1.0,2/12,9.43%,SNAP23;SNAP29
prerank,protein palmitoylation (GO:0018345),0.2090553822555752,0.5893369367667505,0.9574468085106383,0.9895316221609913,1.0,8/30,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;HHAT;ZDHHC6;ZDHHC9;ZDHHC8
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.20451259277308462,0.5890707611936551,0.9612403100775194,0.9891787714626209,1.0,7/33,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,translational elongation (GO:0006414),-0.14326627480589205,-0.5888451155395045,1.0,0.9878742771341424,1.0,37/101,33.21%,EEF1G;MRPL39;EEF1A1;EEF2K;EEFSEC;EEF1D;MRPS7;GTPBP1;MRPS17;MRPL15;MRPL20;MRPL16;MRPS18A;MRPL2;GADD45GIP1;MRPS18B;MRPL58;MRPL24;OXA1L;MRPL57;MRPL55;PTCD3;MRPS34;MRPL36;MRPL35;MRPS12;MRPL34;MRPL38;MRPS9;MRPS2;MRPL18;GTPBP2;TUFM;MRPL11;MRPS14;MRPL9;MRPS33
prerank,reticulophagy (GO:0061709),-0.23771879377828115,-0.5870945875773971,0.9631336405529954,0.987974371550143,1.0,4/12,22.49%,RETREG1;ATG2B;ATG2A;UFM1
prerank,regulation of actin nucleation (GO:0051125),-0.23759264205037994,-0.5867030048814849,0.9502369668246445,0.9875427648172254,1.0,5/12,29.88%,GSN;ARPIN;CORO1B;ARF1;WHAMM
prerank,negative regulation of interferon-beta production (GO:0032688),-0.242026769788598,-0.5846369596510511,0.9377777777777778,0.9877220135835186,1.0,1/10,3.33%,SIRPA
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2643440138100701,0.5844093998200586,0.927536231884058,0.99093512589076,1.0,1/10,3.59%,TSLP
prerank,positive regulation of chromatin organization (GO:1905269),0.2553876217256032,0.5843826270199205,0.9258589511754068,0.9904656091754405,1.0,4/12,22.12%,TERF1;DAXX;TERF2IP;ATRX
prerank,Golgi to lysosome transport (GO:0090160),-0.23773117982363068,-0.5837874851970403,0.9397849462365592,0.9874130858450221,1.0,5/11,33.56%,GAK;LAPTM5;AP4M1;LAMP1;AP1G1
prerank,regulation of spindle organization (GO:0090224),0.23129099883211907,0.582683178246626,0.9425675675675675,0.9907994455235735,1.0,3/18,14.36%,GPSM2;MAP9;SENP6
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.23289649751310137,-0.5821268923822935,0.9496402877697842,0.9874327091369729,1.0,6/12,30.20%,ADSS2;LHPP;PFAS;ATIC;PPAT;PAICS
prerank,nuclear body organization (GO:0030575),0.24959054754355242,0.580521517583292,0.9442446043165468,0.9913713003035924,1.0,3/12,19.34%,AFF2;HABP4;USPL1
prerank,positive regulation of B cell proliferation (GO:0030890),0.20889527928255325,0.579145758350462,0.9720062208398134,0.9915168315753042,1.0,5/29,15.73%,CD40;IRS2;GPR183;CD81;TIRAP
prerank,C4-dicarboxylate transport (GO:0015740),0.24280701616529338,0.579047641303442,0.9320882852292021,0.9910791860474955,1.0,3/14,15.03%,SLC25A22;SLC25A30;SLC25A14
prerank,microtubule anchoring (GO:0034453),0.25430762352419045,0.5781089099997094,0.9426086956521739,0.9910474868284254,1.0,4/12,18.82%,CLASP2;CLASP1;PCM1;PEX14
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.22436003105540797,-0.5776542775318022,0.9626168224299065,0.9884499994601132,1.0,1/13,1.78%,IL18
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2255436930619103,0.5765570231237778,0.9551282051282052,0.9912722568590027,1.0,6/20,19.38%,GMPS;AMPD2;AK4;AK3;ADSS1;IMPDH2
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.1989408014279451,-0.5761417512627374,0.961352657004831,0.9877700137498849,1.0,7/19,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;ACD;POLR2I;POLR2K
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.1989408014279451,-0.5761417512627374,0.961352657004831,0.9877700137498849,1.0,7/19,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;ACD;POLR2I;POLR2K
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.19781667042962411,-0.5756476315523724,0.9809782608695652,0.9873358077560197,1.0,8/20,32.83%,MGRN1;YWHAB;MET;MRAP2;BICD1;ADA;PLEK;RGS2
prerank,V(D)J recombination (GO:0033151),0.2527307377090573,0.5751462041548057,0.9500891265597148,0.9914415833017061,1.0,1/11,3.43%,LIG3
prerank,regulation of exosomal secretion (GO:1903541),0.22367516137379798,0.5698878986539913,0.9458041958041958,0.9932199382806705,1.0,5/19,17.34%,HGS;ATP9A;TSG101;SNF8;VPS4B
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.2288839023170131,-0.5692364167087749,0.9489559164733179,0.9890087856463858,1.0,4/11,26.35%,EGLN3;CRTAP;P4HA3;P4HB
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.1839041399316241,0.5691984457938729,0.9915492957746479,0.9930061641697803,1.0,8/54,15.37%,ARID3A;CNOT11;E2F4;MDM4;TP53;CNOT1;CARM1;CNOT7
prerank,regulation of mitochondrial fusion (GO:0010635),-0.2319244939954295,-0.5689446792288523,0.9463087248322147,0.9884987238458688,1.0,3/11,18.66%,TFRC;ADCK1;PID1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.2518551306878526,0.5687739722005615,0.951048951048951,0.9927020913845762,1.0,2/11,11.19%,GCK;ERFE
prerank,regulation of response to interferon-gamma (GO:0060330),0.23492355857755243,0.5679254040589062,0.95929203539823,0.9925704009681012,1.0,1/14,3.37%,JAK1
prerank,positive regulation of B cell activation (GO:0050871),0.18445846390660722,0.5678730830570252,0.9856938483547926,0.9921095476970604,1.0,8/50,15.73%,CD40;IRS2;HMCES;GPR183;SH3KBP1;CD81;PAXIP1;TIRAP
prerank,regulation of sister chromatid cohesion (GO:0007063),0.24519358047086848,0.5659206730194132,0.9433962264150944,0.9924137497947237,1.0,2/12,13.61%,FEN1;BUB1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.2070225051985513,-0.5653779580061818,0.9733009708737864,0.9890657474833607,1.0,5/16,21.44%,SIX1;PTGS2;SIRT1;ZBTB7B;SOX13
prerank,phagosome acidification (GO:0090383),-0.17954441011163103,-0.5645419231686234,0.9942528735632183,0.9887287107634563,1.0,7/26,23.55%,ATP6V0A4;RAB38;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1;ATP6V1G1
prerank,positive regulation of catalytic activity (GO:0043085),0.19228819816090967,0.5634760736555625,0.9817073170731707,0.9929092430425168,1.0,11/37,22.80%,MSH3;FXN;IGF2;ATP7A;NHEJ1;MSH6;WRN;SSBP1;CHTOP;B3GAT3;ABL1
prerank,eosinophil chemotaxis (GO:0048245),-0.20310145655449524,-0.5630134446476602,0.98,0.9879949172629832,1.0,14/14,79.71%,CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL13;CCL1;CCL3;LGALS3;CCL24;CCL26;CCL2;SCG2
prerank,eosinophil migration (GO:0072677),-0.20310145655449524,-0.5630134446476602,0.98,0.9879949172629832,1.0,14/14,79.71%,CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL13;CCL1;CCL3;LGALS3;CCL24;CCL26;CCL2;SCG2
prerank,membrane raft organization (GO:0031579),0.23270564531400426,0.5611589306784474,0.9483870967741935,0.9933156502063868,1.0,2/15,9.79%,FLOT2;FA2H
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.2143282361963072,0.5611464430740045,0.9598715890850722,0.9928418956008265,1.0,2/22,6.00%,RYR2;SLC9A1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.2048917696752457,-0.5599772961235153,0.9737470167064439,0.9883537103914858,1.0,11/16,48.45%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.2266919777865854,-0.5599315342120349,0.9718004338394793,0.9877584027223175,1.0,4/11,28.64%,RC3H1;ATM;TYROBP;FCGR2B
prerank,positive regulation of fat cell differentiation (GO:0045600),0.18169842360111532,0.5586758164062164,0.9926793557833089,0.9932911550557522,1.0,10/47,20.76%,PPARD;ZBTB16;BMP7;WDFY2;CARM1;PIM1;FRZB;BMP2;CMKLR1;RARRES2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.24288718252055763,0.5582955129618057,0.9395017793594306,0.9929541523363667,1.0,2/12,10.60%,FBXO31;TP53
prerank,negative regulation of histone acetylation (GO:0035067),-0.22766087418434777,-0.5577991520378572,0.9555555555555556,0.9877913490824318,1.0,5/11,31.56%,SIRT1;BRCA1;SPI1;TAF7;SET
prerank,response to peptide (GO:1901652),0.19428041497081658,0.557734658801721,0.9836309523809523,0.9926862119347601,1.0,7/33,23.87%,EIF2B1;IRS1;FYN;KAT7;CACNA1A;EIF2B5;STAT1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2501205111197738,0.5569678507665871,0.9486301369863014,0.9924880718580527,1.0,2/10,18.84%,NOC2L;THAP7
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.23392767453540914,0.5562593912947504,0.9471830985915493,0.9922742110671522,1.0,14/14,76.63%,RAB29;CD81;NECTIN2;PRKD2;LCK;TESPA1;CD226;TRAT1;RELA;RPS3;CARD11;KCNN4;IKBKG;BCL10
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.2192885149830185,-0.5536919043594972,0.9682539682539683,0.9884027431141935,1.0,5/12,32.75%,SOAT1;MFSD2A;P4HB;LPCAT3;APOC1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.20930035294845206,0.5530061041040369,0.965,0.9930047479988926,1.0,1/22,2.85%,NR1H4
prerank,regulation of myoblast fusion (GO:1901739),0.2438366059079586,0.5511150067998942,0.9325044404973357,0.9931982913160835,1.0,1/11,5.41%,ADGRB1
prerank,protein localization to microtubule organizing center (GO:1905508),0.22784946271101,0.5489243829114285,0.9689119170984456,0.9934539486385876,1.0,4/15,20.70%,DCTN2;CEP192;PCM1;BBS4
prerank,regulation of integrin activation (GO:0033623),-0.2003363025438969,-0.545287526969805,0.9759036144578314,0.9900777310977149,1.0,7/15,33.06%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC;PLEK;SELP
prerank,lipid biosynthetic process (GO:0008610),0.16829751530801615,0.544254621783727,0.9946018893387314,0.9945088431786272,1.0,8/77,14.56%,PAM;LIPH;LIPC;HSD17B8;ACSL6;ACLY;SREBF1;NDUFAB1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.24631166795144016,0.5432689136423281,0.9506172839506173,0.9943500819660528,1.0,3/11,15.88%,TENT4B;EXOSC10;EXOSC5
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.23368008362671655,0.5425717522397827,0.9566724436741768,0.9940812480802927,1.0,3/13,21.56%,PER2;HEY1;DDIT3
prerank,negative regulation of inclusion body assembly (GO:0090084),0.24797062662479605,0.5398186706895921,0.9429097605893186,0.9944394857331498,1.0,1/10,5.25%,SORL1
prerank,quinone biosynthetic process (GO:1901663),0.2277272002841157,0.5384594007796991,0.9584837545126353,0.9943894372679969,1.0,4/14,19.09%,COQ3;PDSS2;COQ8B;COQ7
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.2064557573117045,-0.5365743424054249,0.9728506787330317,0.9916618368944431,1.0,6/13,31.80%,SIX1;PTGS2;ZBTB7B;SOX13;FNDC5;VSTM2A
prerank,hexose transmembrane transport (GO:0008645),0.20949934008211146,0.5363304342107175,0.9851973684210527,0.9945153765780864,1.0,1/21,4.00%,PPARD
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.20683755398464176,0.535412372498403,0.9807383627608347,0.994304486177519,1.0,6/20,24.68%,GCK;ERFE;GSK3A;BCKDK;CRY1;CLK2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.19122882562007282,-0.5338118447732303,0.990632318501171,0.9916961075830925,1.0,12/17,50.62%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.21569309572946357,-0.5332872438610055,0.9690949227373068,0.9912108949900996,1.0,7/11,42.14%,PLCG2;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,regulation of mitochondrial translation (GO:0070129),0.2061455378074177,0.5313594601406225,0.9804560260586319,0.9949322513084715,1.0,7/21,23.65%,MALSU1;UQCC2;NSUN3;MRPS27;MTG1;RCC1L;TRMT10C
prerank,negative regulation of receptor internalization (GO:0002091),0.22644335383549322,0.5305178106361197,0.9620253164556962,0.994674319113594,1.0,2/12,11.37%,NECAB2;DLG4
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2172726667493748,0.5277231874766527,0.9754385964912281,0.9949488520666193,1.0,3/16,18.77%,POLQ;FBH1;RIF1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.1633605266026117,-0.524533493611182,0.9972451790633609,0.9925155477093077,1.0,12/30,33.25%,TRIP12;SHLD2;OTUB1;RNF169;SMCHD1;OGG1;NUDT16L1;RMI2;PARPBP;OTUB2;SHLD3;HSF1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.18248528272706827,-0.5241377349551929,0.9894179894179894,0.991993315626492,1.0,3/20,12.18%,FAR2;CBR4;ACSL4
prerank,ubiquinone biosynthetic process (GO:0006744),0.21701476270059133,0.5235119699851158,0.9660714285714286,0.9955575231672286,1.0,4/15,19.09%,COQ3;PDSS2;COQ8B;COQ7
prerank,tetrahydrofolate metabolic process (GO:0046653),0.23422521781463657,0.5228684588321351,0.9533582089552238,0.995256011134496,1.0,4/10,24.36%,MTHFD1L;MTHFD2L;MTHFD1;MTHFS
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.19914615770969363,-0.5212117277687452,0.980440097799511,0.9919667466811326,1.0,14/14,80.11%,NGRN;MPV17L2;FASTKD2;RPUSD3;COA3;C1QBP;RMND1;FASTKD3;TRUB2;RPUSD4;TRMT10C;RCC1L;MRPS27;UQCC2
prerank,T cell proliferation (GO:0042098),0.22166860795254223,0.5141245889516866,0.9646017699115044,0.9968919594747536,1.0,3/13,16.96%,PPP3CB;LMBR1L;PIK3CG
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.21401875175262758,0.5137774718871998,0.9739130434782609,0.9964933271895285,1.0,5/15,23.47%,GLI1;ATAD5;DDRGK1;CDC73;STXBP4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.17842581770756627,0.5132154894881668,0.993920972644377,0.9961448908776583,1.0,10/34,26.10%,TLR6;LRRC14;TLR4;LYN;NFKBIL1;CACTIN;NLRP2B;RAB7B;GRAMD4;NR1D1
prerank,aminoglycan metabolic process (GO:0006022),0.23368064273160927,0.5129763885018502,0.9625468164794008,0.9957266642324569,1.0,10/10,76.65%,B4GALT7;B3GAT3;B3GAT2;CHST9;B3GAT1;XYLT1;GAL3ST3;B3GALT6;XYLT2;CLN6
prerank,synaptic vesicle transport (GO:0048489),0.22365585024145698,0.5116047860765821,0.9628318584070796,0.9955468921669368,1.0,3/11,17.24%,KIF5C;TMEM230;CDK5
prerank,regulation of calcium ion import (GO:0090279),-0.1734467568201431,-0.5090662900888722,0.9840425531914894,0.993681576227956,1.0,6/21,25.69%,TRIM27;EGF;SPHK2;PLN;PLPP4;PSEN2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.21966225123987684,0.5021655426160297,0.9803921568627451,0.9970254238680548,1.0,13/13,78.05%,NUDT21;TUT1;CPSF2;CSTF2T;NCBP1;CPSF1;CSTF2;CPSF4;FIP1L1;CPSF4L;CPSF7;CPSF6;NCBP2
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.22903590258599044,0.49736510270073786,0.9758364312267658,0.9970171734946163,1.0,10/10,77.11%,CEP250;RPE65;GRM6;CACNA1F;GNAT2;CNGB1;REEP6;GNAT1;CACNA2D4;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.22903590258599044,0.49736510270073786,0.9758364312267658,0.9970171734946163,1.0,10/10,77.11%,CEP250;RPE65;GRM6;CACNA1F;GNAT2;CNGB1;REEP6;GNAT1;CACNA2D4;TULP1
prerank,estrogen metabolic process (GO:0008210),0.20733525785088955,0.49187309401215795,0.9776247848537005,0.9975193039063617,1.0,3/15,17.79%,HSD17B8;HSD17B11;HSD17B2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.184025511728473,-0.48951317452336773,0.9953596287703016,0.9960868074404408,1.0,8/14,46.29%,ERN1;NCBP2;CPSF6;CPSF7;CPSF4L;FIP1L1;CPSF4;CSTF2
prerank,superoxide anion generation (GO:0042554),-0.19235837748663043,-0.48845772630244233,0.9901719901719902,0.995597671165394,1.0,4/13,26.71%,NOX4;ALOX12;CYBB;NCF2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.21808426344386558,0.48668216011137533,0.9804964539007093,0.9979129691771124,1.0,1/11,5.86%,KCNIP2
prerank,ether lipid biosynthetic process (GO:0008611),0.22156956965636598,0.48638584204923646,0.9695885509838998,0.9974878503067309,1.0,1/10,5.67%,PEX7
prerank,sulfation (GO:0051923),0.21182546770421815,0.48400427889255343,0.9823321554770318,0.9973884424883777,1.0,2/11,15.14%,HS3ST5;SULT6B1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.20615865429619679,0.48080848517003544,0.9858657243816255,0.9974188594974083,1.0,3/14,20.19%,TSEN15;FAM98B;DDX1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.21271260539658873,0.4793351297566681,0.9786856127886323,0.9962078800405345,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.21271260539658873,0.4793351297566681,0.9786856127886323,0.9962078800405345,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.21271260539658873,0.4793351297566681,0.9786856127886323,0.9962078800405345,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,regulation of cilium movement (GO:0003352),0.21200315427251476,0.4727560141276857,0.983271375464684,0.9966602414646689,1.0,2/10,15.25%,CCDC65;CCDC39
prerank,regulation of B cell activation (GO:0050864),0.17396494314255187,0.47128366681906597,0.9920127795527156,0.9963925173597652,1.0,25/25,82.63%,ZFP36L2;SH3KBP1;TNIP2;ZFP36L1;AHR;TLR9;MZB1;IGLL1;TNFSF4;IL10;CD19;SLAMF8;IL6;CD22;IL4;THEMIS2;IKZF3;IL4I1;FOXJ1;SAMSN1;BANK1;FCGR2B;NOD2;TNFAIP3;LAPTM5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.20399353360658162,0.4480580765165686,0.992831541218638,0.9985277090296878,1.0,2/10,19.84%,DLGAP3;NPTX2
prerank,DNA catabolic process (GO:0006308),-0.18209779674847779,-0.4470111379431797,0.9955456570155902,0.9991163180200868,1.0,11/11,81.81%,SETMAR;MUS81;DFFB;DNASE1L1;DNASE1;XRN2;DNASE1L3;ISG20;DNASE1L2;REXO4;FBH1
prerank,negative regulation of mRNA processing (GO:0050686),-0.16619054842380532,-0.44683719530834415,0.9950617283950617,0.99852028699987,1.0,3/15,16.15%,RBMX;SRSF4;SRSF7
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.18772281307446242,0.44503687060935526,0.9844290657439446,0.9983277100664264,1.0,5/14,25.34%,SRSF10;SRSF9;SRSF6;SRSF12;RNPS1
prerank,ovarian follicle development (GO:0001541),-0.17148044200447432,-0.44271340313218294,0.9925925925925926,0.9982191023983044,1.0,5/13,37.96%,EIF2B4;INHBB;FOXL2;CEBPB;EIF2B2
prerank,organophosphate catabolic process (GO:0046434),-0.1757777328847149,-0.43605201307151187,0.990909090909091,0.9980011908440672,1.0,1/11,9.77%,ENPP2
prerank,regulation of neutrophil migration (GO:1902622),0.19720501613232308,0.4360203625101322,0.9911347517730497,0.9986045205008955,1.0,2/10,17.40%,JAM3;RHOG
prerank,exit from mitosis (GO:0010458),0.1702448210922787,0.3882598852985951,1.0,1.0,1.0,12/12,82.99%,CLASP2;CLASP1;PPP2R2D;SIRT7;SPAST;EPS8;UBE2C;UBE2S;CHMP2A;CTDP1;CHMP7;CHMP4B
prerank,regulation of B cell differentiation (GO:0045577),0.15354324151452098,0.3739090594023277,1.0,1.0,1.0,1/17,7.16%,ZFP36L2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.13566002672699462,0.3651570974944324,1.0,1.0,1.0,2/24,13.25%,PTPN22;TRIM44
prerank,megakaryocyte differentiation (GO:0030219),0.14719728830581907,0.3345679079689115,1.0,0.9999059243039836,1.0,11/11,85.29%,MED1;UBA5;SH2B3;KIT;MPIG6B;GATA1;ZFPM1;THPO;IL11;CDKN2B;TAL1
